PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Geeson, MB; Cummins, CC				Geeson, Michael B.; Cummins, Christopher C.			Phosphoric acid as a precursor to chemicals traditionally synthesized from white phosphorus	SCIENCE			English	Article							CHEMISTRY; FUNCTIONALIZATION; METAL	White phosphorus, generated in the legacy thermal process for phosphate rock upgrading, has long been the key industrial intermediate for the synthesis of phosphorus-containing chemicals, including herbicides, flame-retardants, catalyst ligands, battery electrolytes, pharmaceuticals, and detergents. In contrast, phosphate fertilizers are made on a much larger scale from phosphoric acid, obtained by treating phosphate rock with sulfuric acid. Dehydration of phosphoric acid using sodium chloride gives trimetaphosphate, and here we report that trichlorosilane, primarily used for the production of high-purity silicon, reduces trimetaphosphate to the previously unknown bis(trichlorosilyl) phosphide anion. This anion offers an entry point to value-added organophosphorus chemicals such as primary and secondary alkyl phosphines, and thus to organophosphinates, and can also be used to prepare phosphine gas and the hexafluorophosphate anion, all previously available only downstream from white phosphorus.	[Geeson, Michael B.; Cummins, Christopher C.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Cummins, CC (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ccummins@mit.edu	Cummins, Christopher/J-2961-2014	Cummins, Christopher/0000-0003-2568-3269; Geeson, Michael/0000-0002-9228-7947	Universite Mohammed VI Polytechnique-MIT Research Program; UM6P; OCP Group in Morocco; Massachusetts Institute of Technology	Universite Mohammed VI Polytechnique-MIT Research Program; UM6P; OCP Group in Morocco; Massachusetts Institute of Technology	The authors gratefully acknowledge financial and logistical support received through the Universite Mohammed VI Polytechnique-MIT Research Program, a partnership between UM6P and OCP Group in Morocco and the Massachusetts Institute of Technology dedicated to promoting sustainable development in Africa. The authors acknowledge the Commonwealth Computational Cloud for Data Driven Biology for computing resources.	Anderson NG, 1997, ORG PROCESS RES DEV, V1, P315, DOI 10.1021/op9702105; BARTLETT N, 1968, CHEM COMMUN, P1046, DOI 10.1039/c19680001046; BECKE AD, 1990, J CHEM PHYS, V92, P5397, DOI 10.1063/1.458517; BENKESER RA, 1971, ACCOUNTS CHEM RES, V4, P94, DOI 10.1021/ar50039a003; BESECKER CJ, 1985, ORGANOMETALLICS, V4, P564, DOI 10.1021/om00122a024; Bettermann G., 2000, ULLMANNS ENCY IND CH; Bohme U, 2016, EUR J INORG CHEM, P5028, DOI 10.1002/ejic.201600763; Borger JE, 2017, CHEM-EUR J, V23, P11738, DOI 10.1002/chem.201702067; BUCKLER SA, 1962, TETRAHEDRON, V18, P1221, DOI 10.1016/0040-4020(62)80003-9; Chan VS, 2006, J AM CHEM SOC, V128, P2786, DOI 10.1021/ja058100y; Deloitte Sustainability British Geological Survey, 2017, TECH REP; Diskowski H., 2000, ULLMANNS ENCY IND CH; Emsley J., 2000, 13 ELEMENT SORDID TA; Franz J. E., 1997, GLYPHOSATE UNIQUE GL; Gary DC, 2013, CHEM MATER, V25, P2463, DOI 10.1021/cm401289j; Gilmour R, 2014, PHOSPHORIC ACID: PURIFICATION, USES, TECHNOLOGY, AND ECONOMICS, P1; HEALY MD, 1989, J CHEM SOC CHEM COMM, P359, DOI 10.1039/c39890000359; Herault D, 2015, CHEM SOC REV, V44, P2508, DOI 10.1039/c4cs00311j; Kaz?n M, 2017, UNPUBLISHED RAW DATA; Minh DP, 2012, IND ENG CHEM RES, V51, P3851, DOI 10.1021/ie201085b; Olaru M, 2017, ANGEW CHEM INT EDIT, V56, P16490, DOI 10.1002/anie.201710416; Peruzzini M, 2005, CHEM SOC REV, V34, P1038, DOI 10.1039/b510917e; Pyykko P, 2009, CHEM-EUR J, V15, P12770, DOI 10.1002/chem.200901472; Quin L. D., 2000, GUIDE ORGANOPHOSPHOR, P82; REBEK J, 1979, TETRAHEDRON, V35, P723, DOI 10.1016/0040-4020(79)80087-3; Schipper W, 2014, EUR J INORG CHEM, V2014, P1567, DOI 10.1002/ejic.201400115; Schrodter K., 2008, ULLMANNS ENCY IND CH; Simmler W., 2000, ULLMANNS ENCY IND CH; Tamang S, 2016, CHEM MATER, V28, P2491, DOI 10.1021/acs.chemmater.5b05044; Weinhold F., 2005, VALENCY BONDING NATU; Werner H, 2000, ORGANOMETALLICS, V19, P4756, DOI 10.1021/om0004646; Wicht D. K., 2001, CATALYTIC HETEROFUNC, P143, DOI DOI 10.1002/3527600159.CH5; Younesi R, 2015, ENERG ENVIRON SCI, V8, P1905, DOI 10.1039/c5ee01215e	33	64	64	8	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2018	359	6382			SI		1383	1385		10.1126/science.aar6620	http://dx.doi.org/10.1126/science.aar6620			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA0ZG	29439027				2022-12-28	WOS:000428043600041
J	Vainchtein, ID; Chin, G; Cho, FS; Kelley, KW; Miller, JG; Chien, EC; Liddelow, SA; Nguyen, PT; Nakao-Inoue, H; Dorman, LC; Akil, O; Joshita, S; Barres, B; Paz, JT; Molofsky, AB; Molofsky, AV				Vainchtein, Ilia D.; Chin, Gregory; Cho, Frances S.; Kelley, Kevin W.; Miller, John G.; Chien, Elliott C.; Liddelow, Shane A.; Nguyen, Phi T.; Nakao-Inoue, Hiromi; Dorman, Leah C.; Akil, Omar; Joshita, Satoru; Barres, Ben A.; Paz, Jeanne T.; Molofsky, Ari B.; Molofsky, Anna V.			Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development	SCIENCE			English	Article							INJURY; BRAIN; HOMEOSTASIS; ROLES; CNS; INFLAMMATION; RECOVERY; IL-33; GLIA	Neuronal synapse formation and remodeling are essential to central nervous system (CNS) development and are dysfunctional in neurodevelopmental diseases. Innate immune signals regulate tissue remodeling in the periphery, but how this affects CNS synapses is largely unknown. Here, we show that the interleukin-1 family cytokine interleukin-33 (IL-33) is produced by developing astrocytes and is developmentally required for normal synapse numbers and neural circuit function in the spinal cord and thalamus. We find that IL-33 signals primarily to microglia under physiologic conditions, that it promotes microglial synapse engulfment, and that it can drive microglial-dependent synapse depletion in vivo. These data reveal a cytokine-mediated mechanism required to maintain synapse homeostasis during CNS development.	[Vainchtein, Ilia D.; Chin, Gregory; Kelley, Kevin W.; Miller, John G.; Chien, Elliott C.; Nguyen, Phi T.; Nakao-Inoue, Hiromi; Dorman, Leah C.; Molofsky, Anna V.] Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Akil, Omar] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; [Paz, Jeanne T.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Cho, Frances S.; Dorman, Leah C.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Nguyen, Phi T.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Cho, Frances S.; Paz, Jeanne T.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Liddelow, Shane A.; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Palo Alto, CA 94304 USA; [Joshita, Satoru] Shinshu Univ, Div Gastroenterol & Hepatol, Dept Med, Sch Med, Matsumoto, Nagano, Japan; [Joshita, Satoru] Shinshu Univ, Res Ctr Next Generat Med, Matsumoto, Nagano, Japan; [Liddelow, Shane A.] NYU, Neurosci Inst, Langone Med Sch, New York, NY USA; [Liddelow, Shane A.] NYU, Dept Neurosci & Physiol, Langone Med Sch, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Stanford University; Shinshu University; Shinshu University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Molofsky, AV (corresponding author), Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Molofsky, AB (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	ari.molofsky@ucsf.edu; anna.molofsky@ucsf.edu	Molofsky, Anna Victoria/P-2506-2018; Liddelow, Shane/ABE-6456-2020; Joshita, Satoru/K-5679-2019	Molofsky, Anna Victoria/0000-0002-4709-2411; Liddelow, Shane/0000-0002-0840-1437; Joshita, Satoru/0000-0002-6364-9654; Vainchtein, Ilia Davidovich/0000-0003-3190-8524; Molofsky, Ari/0000-0003-0764-3175; Chin, Gregory/0000-0001-7805-7240; Cho, Frances/0000-0002-2576-7801; Dorman, Leah/0000-0002-5511-887X; Nakao-Inoue, Hiromi/0000-0001-5418-0973; Chien, Elliott/0000-0002-5517-1654	Pew Scholars Award; NIMH [K08MH104417]; Brain and Behavior Research Foundation; Burroughs Wellcome Fund; National Institute of Diabetes and Digestive and Kidney Diseases [K08DK101604]; Larry L. Hillblom Foundation; National Institute of Neurological Disorders and Stroke [R01NS096369]; Australian National Health and Medical Research Council [GNT1052961]; Glenn Foundation Glenn Award; Graduate Student Fellowships from the National Science Foundation [NSF 1144247, NSF 1650113]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH116507, K08MH104417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096369, P30NS065780] Funding Source: NIH RePORTER	Pew Scholars Award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Larry L. Hillblom Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Glenn Foundation Glenn Award; Graduate Student Fellowships from the National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	A.V.M. is supported by a Pew Scholars Award, NIMH (K08MH104417), the Brain and Behavior Research Foundation, and the Burroughs Wellcome Fund. A.B.M. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K08DK101604) and the Larry L. Hillblom Foundation. J.T.P. is supported by the National Institute of Neurological Disorders and Stroke (R01NS096369). S.A.L. is supported by the Australian National Health and Medical Research Council (GNT1052961) and the Glenn Foundation Glenn Award. F.S.C. (NSF 1144247) and P.T.N. (NSF 1650113) were supported by Graduate Student Fellowships from the National Science Foundation.	Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Fu AKY, 2016, P NATL ACAD SCI USA, V113, pE2705, DOI 10.1073/pnas.1604032113; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Luo Y, 2015, BRAIN RES, V1597, P86, DOI 10.1016/j.brainres.2014.12.005; Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Pannasch U, 2014, NAT NEUROSCI, V17, P549, DOI 10.1038/nn.3662; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Wicher G, 2013, NEUROSCI LETT, V555, P171, DOI 10.1016/j.neulet.2013.09.046	27	250	255	8	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2018	359	6381					1269	1273	aal3589	10.1126/science.aal3589	http://dx.doi.org/10.1126/science.aal3589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3QN	29420261	Green Accepted			2022-12-28	WOS:000427504900044
J	Mills, LS; Bragina, EV; Kumar, AV; Zimova, M; Lafferty, DJR; Feltner, J; Davis, BM; Hacklander, K; Alves, PC; Good, JM; Melo-Ferreira, J; Dietz, A; Abramov, AV; Lopatina, N; Fay, K				Mills, L. Scott; Bragina, Eugenia V.; Kumar, Alexander V.; Zimova, Marketa; Lafferty, Diana J. R.; Feltner, Jennifer; Davis, Brandon M.; Hacklaender, Klaus; Alves, Paulo C.; Good, Jeffrey M.; Melo-Ferreira, Jose; Dietz, Andreas; Abramov, Alexei V.; Lopatina, Natalia; Fay, Kairsten			Winter color polymorphisms identify global hot spots for evolutionary rescue from climate change	SCIENCE			English	Article							SEASONAL COAT COLOR; CONSERVATION	Maintenance of biodiversity in a rapidly changing climate will depend on the efficacy of evolutionary rescue, whereby population declines due to abrupt environmental change are reversed by shifts in genetically driven adaptive traits. However, a lack of traits known to be under direct selection by anthropogenic climate change has limited the incorporation of evolutionary processes into global conservation efforts. In 21 vertebrate species, some individuals undergo a seasonal color molt from summer brown to winter white as camouflage against snow, whereas other individuals remain brown. Seasonal snow duration is decreasing globally, and fitness is lower for winter white animals on snowless backgrounds. Based on 2713 georeferenced samples of known winter coat color-from eight species across trophic levels-we identify environmentally driven clinal gradients in winter coat color, including polymorphic zones where winter brown and white morphs co-occur. These polymorphic zones, underrepresented by existing global protected area networks, indicate hot spots for evolutionary rescue in a changing climate.	[Mills, L. Scott] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Mills, L. Scott] Univ Montana, Off Vice President Res & Creat Scholarship, Missoula, MT 59812 USA; [Mills, L. Scott; Bragina, Eugenia V.; Kumar, Alexander V.; Zimova, Marketa; Lafferty, Diana J. R.; Feltner, Jennifer; Davis, Brandon M.; Hacklaender, Klaus; Fay, Kairsten] North Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Kumar, Alexander V.; Zimova, Marketa; Lafferty, Diana J. R.; Feltner, Jennifer; Davis, Brandon M.; Alves, Paulo C.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Hacklaender, Klaus] Univ Nat Resources & Life Sci, BOKU, Inst Wildlife Biol & Game Management, Vienna, Austria; [Alves, Paulo C.; Melo-Ferreira, Jose] Univ Porto, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, InBIO Lab Assoc, Campus Agr Vairao, P-4485661 Vairao, Portugal; [Alves, Paulo C.; Melo-Ferreira, Jose] Univ Porto, Dept Biol, Fac Ciencias, Rua Campo Alegre, P-4169007 Porto, Portugal; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Dietz, Andreas] German Remote Sensing Data Ctr, Earth Observat Ctr, German Aerosp Ctr, D-82234 Wessling, Germany; [Abramov, Alexei V.] Russian Acad Sci, Zool Inst, St Petersburg 199034, Russia; [Lopatina, Natalia] RAS, SB, Inst Systemat & Ecol Anim, Novosibirsk 630091, Russia	University of Montana System; University of Montana; University of Montana System; University of Montana; University of North Carolina; North Carolina State University; University of Montana System; University of Montana; University of Natural Resources & Life Sciences, Vienna; Universidade do Porto; Universidade do Porto; University of Montana System; University of Montana; Helmholtz Association; German Aerospace Centre (DLR); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Russian Academy of Sciences	Mills, LS (corresponding author), Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA.; Mills, LS (corresponding author), Univ Montana, Off Vice President Res & Creat Scholarship, Missoula, MT 59812 USA.; Mills, LS (corresponding author), North Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	scott.mills@umontana.edu	ALVES, Paulo Célio/B-5448-2009; Abramov, Alexei/AAO-9176-2021; Lopatina, Natalia/AGJ-3574-2022; Hackländer, Klaus/ABC-4327-2020; Abramov, Alexei V./A-9334-2011; Melo-Ferreira, José/E-9784-2010; Mills, Luther Scott/K-2458-2012	ALVES, Paulo Célio/0000-0003-4797-0939; Abramov, Alexei/0000-0001-9709-4469; Abramov, Alexei V./0000-0001-9709-4469; Melo-Ferreira, José/0000-0003-4473-1908; Mills, Luther Scott/0000-0001-8771-509X; Kumar, Alexander/0000-0003-3831-5924; Bragina, Eugenia/0000-0001-8791-3619; Dietz, Andreas/0000-0002-5733-7136; Davis, Brandon/0000-0003-2013-7875; Hacklander, Klaus/0000-0002-6774-435X; Good, Jeffrey/0000-0003-0707-5374; Lafferty, Diana J. R./0000-0001-8938-7130; Zimova, Marketa/0000-0002-8264-9879	National Science Foundation Division of Environmental Biology [0841884]; National Science Foundation Graduate Research Fellowship [DGE-1252376]; FLAD, Luso-American Development Foundation; Department of the Interior Southeast Climate Science Center Global Change Fellowship [G10AC00624]; Fundacao para a Ciencia e a Tecnologia Grants "CHANGE" [PTDC/BIA-EVF/1624/2014]; Investigador Fundacao para a Ciencia e a Tecnologia (Programa Operacional Potencial Humano-Quadro de Referencia Estrategica Nacional funds from European Social Fund and Ministerio da Ciencia, Tecnologia e Ensino Superior) [IF/00033/2014/CP1256/CT0005]; SYNTHESYS [SE-TAF-4695]; European Union [226506]; National Science Foundation EPSCoR grant [1736249]; Russian Foundation for Basic Research [17-04-00269 A]	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); FLAD, Luso-American Development Foundation; Department of the Interior Southeast Climate Science Center Global Change Fellowship; Fundacao para a Ciencia e a Tecnologia Grants "CHANGE"; Investigador Fundacao para a Ciencia e a Tecnologia (Programa Operacional Potencial Humano-Quadro de Referencia Estrategica Nacional funds from European Social Fund and Ministerio da Ciencia, Tecnologia e Ensino Superior); SYNTHESYS; European Union(European Commission); National Science Foundation EPSCoR grant; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	L.S.M.: National Science Foundation Division of Environmental Biology Grant 0841884; A.V.K.: National Science Foundation Graduate Research Fellowship under grant no. DGE-1252376; P.C.A.: FLAD, Luso-American Development Foundation; M.Z.: The Department of the Interior Southeast Climate Science Center Global Change Fellowship (Cooperative Agreement No. G10AC00624); J.M.-F.: Fundacao para a Ciencia e a Tecnologia Grants "CHANGE" PTDC/BIA-EVF/1624/2014 (Portuguese national funds) and IF/00033/2014/CP1256/CT0005 Investigador Fundacao para a Ciencia e a Tecnologia (Programa Operacional Potencial Humano-Quadro de Referencia Estrategica Nacional funds from European Social Fund and Ministerio da Ciencia, Tecnologia e Ensino Superior), and SYNTHESYS grant SE-TAF-4695 (European Union Seventh Framework Programme; agreement 226506) to access the Swedish Museum of Natural History; J.M.G.: National Science Foundation EPSCoR grant 1736249; N.L.: Russian Foundation for Basic Research (17-04-00269 A).	Bergengren A., 1969, VILTREVY, V6, P380; Bertzky B., 2012, PROTECTED PLANT REPO; Carlson SM, 2014, TRENDS ECOL EVOL, V29, P521, DOI 10.1016/j.tree.2014.06.005; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Diefenbach DR, 2016, NORTHEAST NAT, V23, P229; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Ferreira MS, 2017, MOL ECOL, V26, P4173, DOI 10.1111/mec.14177; FORD EB, 1945, BIOL REV, V20, P73, DOI 10.1111/j.1469-185X.1945.tb00315.x; Forsman A, 2016, MOL ECOL, V25, P2693, DOI 10.1111/mec.13629; Gonzalez A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0404; Hall E. R., 1951, University of Kansas Publications of the Museum of Natural History, V4, P1; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hannah L, 2014, TRENDS ECOL EVOL, V29, P390, DOI 10.1016/j.tree.2014.04.006; Hansen R. M., 1963, Journal of Mammalogy, V44, P420, DOI 10.2307/1377217; HUXLEY JULIAN, 1955, HEREDITY, V9, P1, DOI 10.1038/hdy.1955.1; Imperio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081598; IUCN, 2015, STAND ID KEY BIOD AR; Kunkel KE, 2016, CURR CLIM CHANGE REP, V2, P65, DOI 10.1007/s40641-016-0036-8; Lavergne S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0091; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mills LS, 2013, P NATL ACAD SCI USA, V110, P7360, DOI 10.1073/pnas.1222724110; Pedersen S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1722; Pfaff A, 2017, FORESTS, V8, DOI 10.3390/f8010017; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Soule M. E., 1981, CONSERVATION EVOLUTI; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Sultaire SM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3104; Vage DI, 2005, PEPTIDES, V26, P1814, DOI 10.1016/j.peptides.2004.11.040; Wal EV, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0090; Wennersten L, 2012, BIOL REV, V87, P756, DOI 10.1111/j.1469-185X.2012.00231.x; Zimova M, 2016, ECOL LETT, V19, P299, DOI 10.1111/ele.12568	33	64	66	8	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2018	359	6379					1033	1036		10.1126/science.aan8097	http://dx.doi.org/10.1126/science.aan8097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8SV	29449510	Green Submitted			2022-12-28	WOS:000426366200042
J	Feller-Kopman, D; Light, R				Feller-Kopman, David; Light, Richard			Pleural Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SPONTANEOUS PNEUMOTHORAX; PARAPNEUMONIC EMPYEMA; SURGICAL-MANAGEMENT; THORACIC ULTRASOUND; RANDOMIZED-TRIAL; TALC POUDRAGE; LUNG-CANCER; CHEST TUBE; EFFUSIONS; FLUID		[Feller-Kopman, David] Johns Hopkins Univ, Div Pulm Crit Care & Sleep Med, Baltimore, MD USA; [Light, Richard] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, 221 Kirkland Hall, Nashville, TN 37235 USA	Johns Hopkins University; Vanderbilt University	Feller-Kopman, D (corresponding author), Johns Hopkins Univ Hosp, Sect Intervent Pulmonol, 1800 Orleans St,Suite 7-125, Baltimore, MD 21287 USA.	dfk@jhmi.edu		Feller-Kopman, David/0000-0002-9008-3617; Perricone, Giovanni/0000-0003-3890-5393	CareFusion/BD	CareFusion/BD	Dr. Feller-Kopman reports receiving grant support and consulting fees from CareFusion/BD; and Dr. Light, serving on an advisory committee for CareFusion and holding a patent (US 6103695 A) on transforming growth factor beta for pleurodesis. No other potential conflict of interest relevant to this article was reported.	Adams F., 1848, GENUINE WORKS HIPPOC; AGOSTONI E, 1969, RESP PHYSIOL, V6, P330, DOI 10.1016/0034-5687(69)90032-2; AGOSTONI E, 1972, PHYSIOL REV, V52, P57, DOI 10.1152/physrev.1972.52.1.57; Agusti AGN, 1997, AM J RESP CRIT CARE, V156, P1205, DOI 10.1164/ajrccm.156.4.9612113; ASHBAUGH DG, 1991, CHEST, V99, P1162, DOI 10.1378/chest.99.5.1162; Baumann MH, 2001, CHEST, V119, P590, DOI 10.1378/chest.119.2.590; Bender JM, 2009, EMERG INFECT DIS, V15, P44, DOI 10.3201/eid1501.080618; Bhatnagar R, 2018, AM J RESP CRIT CARE, V197, P136, DOI 10.1164/rccm.201701-0097LE; Bielsa S, 2012, RESPIROLOGY, V17, P721, DOI 10.1111/j.1440-1843.2012.02155.x; Bintcliffe OJ, 2016, EUR RESPIR REV, V25, P303, DOI 10.1183/16000617.0026-2016; Bintcliffe OJ, 2015, LANCET RESP MED, V3, P578, DOI 10.1016/S2213-2600(15)00220-9; Cao GQ, 2012, ANN THORAC SURG, V93, P1652, DOI 10.1016/j.athoracsur.2012.01.093; CARR DT, 1958, NEW ENGL J MED, V259, P926, DOI 10.1056/NEJM195811062591909; Chen A, 2016, ANN AM THORAC SOC, V13, P862, DOI 10.1513/AnnalsATS.201510-688BC; Clive AO, 2014, THORAX, V69, P1098, DOI 10.1136/thoraxjnl-2014-205285; COSTA M, 1995, CHEST, V108, P1260, DOI 10.1378/chest.108.5.1260; Davies HE, 2010, THORAX S2, V65; Davies HE, 2012, JAMA-J AM MED ASSOC, V307, P2383, DOI 10.1001/jama.2012.5535; Diacon AH, 2003, CHEST, V123, P436, DOI 10.1378/chest.123.2.436; Dresler CM, 2005, CHEST, V127, P909, DOI 10.1378/chest.127.3.909; EIBENBERGER KL, 1994, RADIOLOGY, V191, P681, DOI 10.1148/radiology.191.3.8184046; El Solh AA, 2007, J AM GERIATR SOC, V55, P1847, DOI 10.1111/j.1532-5415.2007.01392.x; ESTENNE M, 1983, AM J MED, V74, P813, DOI 10.1016/0002-9343(83)91072-0; Fysh ETH, 2013, CHEST, V144, P1597, DOI 10.1378/chest.12-3103; Gonzalez AV, 2010, CHEST, V137, P1375, DOI 10.1378/chest.09-2020; Gordon CE, 2010, ARCH INTERN MED, V170, P332, DOI 10.1001/archinternmed.2009.548; Grathwohl KW, 2003, NEW ENGL J MED, V349, P1829, DOI 10.1056/NEJMicm010281; Grijalva CG, 2011, THORAX, V66, P663, DOI 10.1136/thx.2010.156406; GROGAN DR, 1990, ARCH INTERN MED, V150, P873, DOI 10.1001/archinte.150.4.873; Hallifax RJ, 2016, RESPIROLOGY, V21, P958, DOI 10.1111/resp.12725; Hasley PB, 1996, ARCH INTERN MED, V156, P2206, DOI 10.1001/archinte.156.19.2206; Havelock T, 2010, THORAX, V65, P61, DOI 10.1136/thx.2010.137026; Heffner JE, 2000, CHEST, V117, P87, DOI 10.1378/chest.117.1.87; Heffner JE, 1997, CHEST, V111, P970, DOI 10.1378/chest.111.4.970; Hippocrates, APH HIPP; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Hooper CE, 2015, EUR RESPIR J, V46, P456, DOI 10.1183/09031936.00147214; Hooper CE, 2010, RESPIROLOGY, V15, P1028, DOI 10.1111/j.1440-1843.2010.01832.x; Keeling AN, 2008, CARDIOVASC INTER RAD, V31, P135, DOI 10.1007/s00270-007-9197-0; Kelly AM, 2008, RESP MED, V102, P1830, DOI 10.1016/j.rmed.2008.07.026; Kheir F, 2016, AM J THER, V23, pE1300, DOI 10.1097/MJT.0000000000000197; Kim BY, 2004, AM J SURG, V188, P321, DOI 10.1016/j.amjsurg.2004.06.009; KOHAN JM, 1986, AM REV RESPIR DIS, V133, P1124; Kolditz M, 2006, EUR RESPIR J, V28, P144, DOI 10.1183/09031936.06.00113205; KRELL WS, 1985, J APPL PHYSIOL, V59, P1458, DOI 10.1152/jappl.1985.59.5.1458; Lai-Fook SJ, 2004, PHYSIOL REV, V84, P385, DOI 10.1152/physrev.00026.2003; Light R., PLEURAL DIS; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Majid A, 2016, ANN AM THORAC SOC, V13, P212, DOI 10.1513/AnnalsATS.201507-471BC; Marks DJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030074; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; Miserocchi G, 1997, EUR RESPIR J, V10, P219, DOI 10.1183/09031936.97.10010219; Noppen M, 2004, AM J RESP CRIT CARE, V170, P680, DOI 10.1164/rccm.200404-438CR; Noppen M, 2000, AM J RESP CRIT CARE, V162, P1023, DOI 10.1164/ajrccm.162.3.9910050; Ost DE, 2017, CHEST; Paddock FK, 1940, NEW ENGL J MED, V223, P1010, DOI 10.1056/NEJM194012192232503; Patil M, 2017, CHEST, V151, P626, DOI 10.1016/j.chest.2016.10.052; Pompili C, 2014, ANN THORAC SURG, V98, P490, DOI 10.1016/j.athoracsur.2014.03.043; Porcel JM, 2016, REV CLIN ESP, V216, P361, DOI 10.1016/j.rce.2016.04.004; Porcel JM, 2004, AM J MED, V116, P417, DOI 10.1016/j.amjmed.2003.11.008; Porcel JM, 2001, ANN CLIN BIOCHEM, V38, P671, DOI 10.1258/0004563011901082; Porcel JM, 2015, RESPIROLOGY, V20, P654, DOI 10.1111/resp.12496; Postmus PE, 2007, J THORAC ONCOL, V2, P686, DOI 10.1097/JTO.0b013e31811f4703; Psallidas I, 2016, EUR RESPIR REV, V25, P189, DOI 10.1183/16000617.0019-2016; Qureshi NR, 2009, THORAX, V64, P139, DOI 10.1136/thx.2008.100545; Rahman NM, 2014, CHEST, V145, P848, DOI 10.1378/chest.13-1558; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Rahman NM, 2010, CHEST, V137, P536, DOI 10.1378/chest.09-1044; Reddy C, 2011, CHEST, V139, P1419, DOI 10.1378/chest.10-1868; Reed MF, 2015, ANN THORAC SURG, V100, P1181, DOI 10.1016/j.athoracsur.2015.04.104; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Romero-Candeira S, 2002, CHEST, V122, P1524, DOI 10.1378/chest.122.5.1524; Romero-Candeira S, 2001, AM J MED, V110, P681, DOI 10.1016/S0002-9343(01)00726-4; Sadikot RT, 1997, THORAX, V52, P805, DOI 10.1136/thx.52.9.805; Scarci M, 2015, EUR J CARDIO-THORAC, V48, P642, DOI 10.1093/ejcts/ezv272; Shahin Y, 2010, INTERACT CARDIOV TH, V10, P565, DOI 10.1510/icvts.2009.215004; Shaikhrezai K, 2011, EUR J CARDIO-THORAC, V40, P120, DOI 10.1016/j.ejcts.2010.10.012; Stathopoulos GT, 2008, AM J RESP CRIT CARE, V178, P50, DOI 10.1164/rccm.200710-1513OC; Taghizadeh N, 2017, CHEST, V151, P845, DOI 10.1016/j.chest.2016.11.010; Tremblay A, 2006, CHEST, V129, P362, DOI 10.1378/chest.129.2.362; Wahidi MM, 2017, AM J RESP CRIT CARE, V195, P1050, DOI 10.1164/rccm.201607-1404OC; Wait MA, 1997, CHEST, V111, P1548, DOI 10.1378/chest.111.6.1548; Walker SP, 2017, CHEST, V151, P1099, DOI 10.1016/j.chest.2016.12.014; Wang NS, 1998, CLIN CHEST MED, V19, P229, DOI 10.1016/S0272-5231(05)70074-5; West JB, 2002, NEWS PHYSIOL SCI, V17, P47, DOI 10.1152/nips.01374.2001; West JB, 2001, RESP PHYSIOL, V126, P1, DOI 10.1016/S0034-5687(01)00203-1; YANG PC, 1992, AM J ROENTGENOL, V159, P29, DOI 10.2214/ajr.159.1.1609716	89	106	108	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2018	378	8					740	751		10.1056/NEJMra1403503	http://dx.doi.org/10.1056/NEJMra1403503			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8VA	29466146				2022-12-28	WOS:000425613900011
J	Amstad, E				Amstad, Esther			Capsules made from prefabricated thin films	SCIENCE			English	Editorial Material							MICROCAPSULES; RELEASE		[Amstad, Esther] Ecole Polytech Fed Lausanne, Inst Mat, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Amstad, E (corresponding author), Ecole Polytech Fed Lausanne, Inst Mat, Lausanne, Switzerland.							Abbaspourrad A, 2013, LANGMUIR, V29, P12697, DOI 10.1021/la403064f; Amstad E, 2017, ACS MACRO LETT, V6, P841, DOI 10.1021/acsmacrolett.7b00472; Datta SS, 2014, ADV MATER, V26, P2205, DOI 10.1002/adma.201305119; De Cock LJ, 2010, ANGEW CHEM INT EDIT, V49, P6954, DOI 10.1002/anie.200906266; Gaitzsch J, 2016, CHEM REV, V116, P1053, DOI 10.1021/acs.chemrev.5b00241; Hitchcock JP, 2015, ACS APPL MATER INTER, V7, P14808, DOI 10.1021/acsami.5b03116; Kumar D, 2018, SCIENCE, V359, P775, DOI 10.1126/science.aao1290; Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018; Shchukin DG, 2004, ADV MATER, V16, P671, DOI 10.1002/adma.200306466; Skorb EV, 2013, ADV MATER, V25, P5029, DOI 10.1002/adma.201302142; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; Zhang J, 2012, SCIENCE, V335, P690, DOI 10.1126/science.1215416; Zoldesi CI, 2005, ADV MATER, V17, P924, DOI 10.1002/adma.200401183	13	5	5	4	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					743	743	aar4027	10.1126/science.aar4027	http://dx.doi.org/10.1126/science.aar4027			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449478				2022-12-28	WOS:000425116200027
J	Kumar, D; Paulsen, JD; Russell, TP; Menon, N				Kumar, Deepak; Paulsen, Joseph D.; Russell, Thomas P.; Menon, Narayanan			Wrapping with a splash: High-speed encapsulation with ultrathin sheets	SCIENCE			English	Article							LIQUID; FABRICATION; POLYHEDRA; SCALE; DROPS	Many complex fluids rely on surfactants to contain, protect, or isolate liquid drops in an immiscible continuous phase. Thin elastic sheets can wrap liquid drops in a spontaneous process driven by capillary forces. For encapsulation by sheets to be practically viable, a rapid, continuous, and scalable process is essential. We exploit the fast dynamics of droplet impact to achieve wrapping of oil droplets by ultrathin polymer films in a water phase. Despite the violence of splashing events, the process robustly yields wrappings that are optimally shaped to maximize the enclosed fluid volume and have near-perfect seams. We achieve wrappings of targeted three-dimensional (3D) shapes by tailoring the 2D boundary of the films and show the generality of the technique by producing both oil-in-water and water-in-oil wrappings.	[Kumar, Deepak; Menon, Narayanan] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Kumar, Deepak; Russell, Thomas P.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; [Paulsen, Joseph D.] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA; [Russell, Thomas P.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Russell, Thomas P.] Beijing Univ Chem Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing 100029, Peoples R China; [Russell, Thomas P.] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, 2-1-1 Katehira, Sendai, Miyagi 9808577, Japan	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Syracuse University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Beijing University of Chemical Technology; Tohoku University	Menon, N (corresponding author), Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA.	menon@physics.umass.edu	Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826; Paulsen, Joseph/0000-0001-6048-456X; Kumar, Deepak/0000-0001-9528-3258; Menon, Narayanan/0000-0003-0901-8488	W. M. Keck Foundation; NSF-DMR [1506750]; NSF-DMR-CAREER [1654102]	W. M. Keck Foundation(W.M. Keck Foundation); NSF-DMR(National Science Foundation (NSF)); NSF-DMR-CAREER	We acknowledge financial support from the W. M. Keck Foundation, NSF-DMR 1506750 (N.M.), and NSF-DMR-CAREER-1654102 (J.D.P.). We also acknowledge valuable guidance from J. Chang in making thin films. Raw data supporting the results presented in the paper and the supplementary materials can be obtained by requesting them from the corresponding author.	Abkarian M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2869; Akiyama J, 2006, COMP GEOM-THEOR APPL, V34, P2, DOI 10.1016/j.comgeo.2005.07.003; Akiyama J, 2005, LECT NOTES COMPUT SC, V3330, P34; Antkowiak A, 2011, P NATL ACAD SCI USA, V108, P10400, DOI 10.1073/pnas.1101738108; Binks BP, 2006, COLLOIDAL PARTICLES; CAI YK, 1989, EXP FLUIDS, V7, P388; Cui MM, 2013, SCIENCE, V342, P460, DOI 10.1126/science.1242852; Davidovitch B, 2011, P NATL ACAD SCI USA, V108, P18227, DOI 10.1073/pnas.1108553108; Demaine Erik., 2007, GEOMETRIC FOLDING AL; Fedorchenko AI, 2004, PHYS FLUIDS, V16, P1349, DOI 10.1063/1.1652061; Gracias DH, 2002, ADV MATER, V14, P235, DOI 10.1002/1521-4095(20020205)14:3<235::AID-ADMA235>3.0.CO;2-B; King H, 2012, P NATL ACAD SCI USA, V109, P9716, DOI 10.1073/pnas.1201201109; Leng LJ, 2001, J FLUID MECH, V427, P73, DOI 10.1017/S0022112000002500; Lhuissier H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.264503; MACKLIN WC, 1976, J APPL PHYS, V47, P3963, DOI 10.1063/1.323218; Paulsen JD, 2015, NAT MATER, V14, P1206, DOI 10.1038/nmat4397; Pepper RE, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2969755; Py C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156103; Schroll RD, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.014301; Terfort A, 1997, NATURE, V386, P162, DOI 10.1038/386162a0	20	38	38	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					775	778	aao1290	10.1126/science.aao1290	http://dx.doi.org/10.1126/science.aao1290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449487				2022-12-28	WOS:000425116200040
J	Resnic, FS; Matheny, ME				Resnic, Frederic S.; Matheny, Michael E.			Medical Devices in the Real World	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Resnic, Frederic S.] Lahey Clin Fdn, Burlington, MA 01805 USA; [Resnic, Frederic S.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Matheny, Michael E.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Matheny, Michael E.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Lahey Hospital & Medical Center; Tufts University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Resnic, FS (corresponding author), Lahey Clin Fdn, Burlington, MA 01805 USA.; Resnic, FS (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.		Matheny, Michael E/B-3541-2008	Matheny, Michael E/0000-0003-3217-4147				[Anonymous], 2017, GUID IND US REAL WOR; [Anonymous], 2017, FDA FACTS POSTM PAT; Schillaci G, 2014, NEW ENGL J MED, V371, P182, DOI 10.1056/NEJMc1405677	3	23	25	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					595	597		10.1056/NEJMp1712001	http://dx.doi.org/10.1056/NEJMp1712001			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW0QK	29443668				2022-12-28	WOS:000425000000003
J	Wu, GA; Terol, J; Ibanez, V; Lopez-Garcia, A; Perez-Roman, E; Borreda, C; Domingo, C; Tadeo, FR; Carbonell-Caballero, J; Alonso, R; Curk, F; Du, DL; Ollitrault, P; Roose, ML; Dopazo, J; Gmitter, FG; Rokhsar, DS; Talon, M				Wu, Guohong Albert; Terol, Javier; Ibanez, Victoria; Lopez-Garcia, Antonio; Perez-Roman, Estela; Borreda, Carles; Domingo, Concha; Tadeo, Francisco R. .; Carbonell-Caballero, Jose; Alonso, Roberto; Curk, Franck; Du, Dongliang; Ollitrault, Patrick; Roose, Mikeal L.; Dopazo, Joaquin; Gmitter, Frederick G., Jr.; Rokhsar, Daniel S.; Talon, Manuel			Genomics of the origin and evolution of Citrus	NATURE			English	Article							SUBFAMILY RUTACEAE AURANTIOIDEAE; LATE MIOCENE; SOUTHEAST-ASIA; HISTORY; YUNNAN; PLANTS; CHINA; PHYLOGENY; MANDARIN; INSIGHTS	The genus Citrus, comprising some of the most widely cultivated fruit crops worldwide, includes an uncertain number of species. Here we describe ten natural citrus species, using genomic, phylogenetic and biogeographic analyses of 60 accessions representing diverse citrus germ plasms, and propose that citrus diversified during the late Miocene epoch through a rapid southeast Asian radiation that correlates with a marked weakening of the monsoons. A second radiation enabled by migration across the Wallace line gave rise to the Australian limes in the early Pliocene epoch. Further identification and analyses of hybrids and admixed genomes provides insights into the genealogy of major commercial cultivars of citrus. Among mandarins and sweet orange, we find an extensive network of relatedness that illuminates the domestication of these groups. Widespread pummelo admixture among these mandarins and its correlation with fruit size and acidity suggests a plausible role of pummelo introgression in the selection of palatable mandarins. This work provides a new evolutionary framework for the genus Citrus.	[Wu, Guohong Albert; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Terol, Javier; Ibanez, Victoria; Lopez-Garcia, Antonio; Perez-Roman, Estela; Borreda, Carles; Domingo, Concha; Tadeo, Francisco R. .; Talon, Manuel] IVIA, Ctr Genom, Valencia, Spain; [Carbonell-Caballero, Jose; Alonso, Roberto; Dopazo, Joaquin] CIPF, Computat Genom Dept, Valencia, Spain; [Curk, Franck] INRA, AGAP Res Unit, San Giuliano, France; [Du, Dongliang; Gmitter, Frederick G., Jr.] Univ Florida, CREC, IFAS, Lake Alfred, FL USA; [Ollitrault, Patrick] Ctr Cooperat Int Rech Agron Dev CIRAD, AGAP Res Unit, Petit Bourg, Guadeloupe, France; [Roose, Mikeal L.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Dopazo, Joaquin] Spanish Natl Inst Bioinformat ELIXIR Es CIPF, Funct Genom Node, Valencia, Spain; [Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Rokhsar, Daniel S.] Grad Univ, Okinawa Inst Sci & Technol, Mol Genet Unit, Okinawa 9040495, Japan	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Prince Felipe Research Center; INRAE; State University System of Florida; University of Florida; CIRAD; University of California System; University of California Riverside; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Okinawa Institute of Science & Technology Graduate University	Wu, GA; Rokhsar, DS (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.; Talon, M (corresponding author), IVIA, Ctr Genom, Valencia, Spain.; Rokhsar, DS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Rokhsar, DS (corresponding author), Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA.; Rokhsar, DS (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Mol Genet Unit, Okinawa 9040495, Japan.	gwu@lbl.gov; dsrokhsar@gmail.com; talon_man@gva.es	Borredá, Carles/R-6914-2018; Tadeo, Francisco R/C-8977-2014; Terol, Javier/H-6401-2013; Domingo, Concha/D-3372-2012; Wu, Guohong/W-3217-2019; Talon, Manuel/C-8540-2014	Borredá, Carles/0000-0001-9624-7152; Tadeo, Francisco R/0000-0002-5839-4255; Terol, Javier/0000-0003-3345-0078; Domingo, Concha/0000-0002-7204-7591; Talon, Manuel/0000-0003-4291-9333; Rokhsar, Daniel/0000-0002-8704-2224; Alonso Valero, Roberto/0000-0002-2737-7559; Ollitrault, Patrick/0000-0002-9456-5517; Carbonell Caballero, Jose/0000-0002-9170-0533				[Anonymous], 1954, SPECIES PROBLEM CITR; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Beattie G. A. C., 2009, ORIGINS CITRUS HUANG, P25; Brophy JJ, 2001, J ESSENT OIL RES, V13, P264, DOI 10.1080/10412905.2001.9699690; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Clift PD, 2014, EARTH-SCI REV, V130, P86, DOI 10.1016/j.earscirev.2014.01.002; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Curk F, 2016, ANN BOT-LONDON, V117, P565, DOI 10.1093/aob/mcw005; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Frost H.B., 1968, CITRUS IND, V2, P290; Gaut BS, 2015, TRENDS GENET, V31, P709, DOI 10.1016/j.tig.2015.10.002; Gibbard P, 2008, EPISODES, V31, P243, DOI 10.18814/epiiugs/2008/v31i2/011; GMITTER FG, 1990, ECON BOT, V44, P267, DOI 10.1007/BF02860491; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagerty MJ, 1923, TOUNG PAO, V22, P63; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; HIRAI M, 1990, J JPN SOC HORTIC SCI, V59, P1, DOI 10.2503/jjshs.59.1; Huang Shing-Fan, 2014, Taiwania, V59, P139, DOI 10.6165/tai.2014.59.139; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Jacques FMB, 2014, PALAEOGEOGR PALAEOCL, V411, P208, DOI 10.1016/j.palaeo.2014.06.041; Jacques FMB, 2011, PALAEOGEOGR PALAEOCL, V304, P318, DOI 10.1016/j.palaeo.2010.04.014; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MelendezHevia E, 1996, J MOL EVOL, V43, P293, DOI 10.1007/PL00006089; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Mudge K., 2009, Horticultural Reviews, V35, P437; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nesom G. L., 2014, PHYTONEURON, V46, P1; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pfeil BE, 2008, AM J BOT, V95, P1621, DOI 10.3732/ajb.0800214; Richardson J.E., 2012, BIOTIC EVOLUTION ENV, P138, DOI DOI 10.1017/CBO9780511735882.008; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Shimizu T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166969; Swingle W.T., 1943, CITRUS IND, V1, p128?474; Swingle W T, 1967, CITRUS IND, P190; TANAKA T., 1931, Studia Citrologica, V5, P1; Thomas DC, 2012, J BIOGEOGR, V39, P98, DOI 10.1111/j.1365-2699.2011.02596.x; Trabut JL, 1902, REV HORTICOLE, V10, P232; Valdiya KS, 2002, PROG PHYS GEOG, V26, P360, DOI 10.1191/0309133302pp342ra; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang X, 2017, NAT GENET, V49, P765, DOI 10.1038/ng.3839; Welzen P. C. van, 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P199; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xie SP, 2013, INT J PLANT SCI, V174, P1201, DOI 10.1086/671796; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Zhang W. C., 1982, Proceedings of the International Society of Citriculture, 1981. Volume I., P51; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	55	307	337	42	317	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					311	+		10.1038/nature25447	http://dx.doi.org/10.1038/nature25447			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29414943	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000424996300028
J	Su, SC; Chen, JN; Yao, HR; Liu, J; Yu, SB; Lao, LY; Wang, MH; Luo, ML; Xing, Y; Chen, F; Huang, D; Zhao, JH; Yang, LB; Liao, D; Su, FX; Li, MF; Liu, Q; Song, EW				Su, Shicheng; Chen, Jianing; Yao, Herui; Liu, Jiang; Yu, Shubin; Lao, Liyan; Wang, Minghui; Luo, Manli; Xing, Yue; Chen, Fei; Huang, Di; Zhao, Jinghua; Yang, Linbin; Liao, Dan; Su, Fengxi; Li, Mengfeng; Liu, Qiang; Song, Erwei			CD10(+) GPR77(+) Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness	CELL			English	Article							STROMAL FIBROBLASTS; CELLS; RESISTANCE; DIVERSE; PATHWAY; ROLES; LOOP	Carcinoma-associated fibroblasts (CAFs) are abundant and heterogeneous stromal cells in tumor microenvironment that are critically involved in cancer progression. Here, we demonstrate that two cell-surface molecules, CD10 and GPR77, specifically define a CAF subset correlated with chemoresistance and poor survival in multiple cohorts of breast and lung cancer patients. CD10(+) GPR77(+) CAFs promote tumor formation and chemoresistance by providing a survival niche for cancer stem cells (CSCs). Mechanistically, CD10(+) GPR77(+) CAFs are driven by persistent NF-kappa B activation via p65 phosphorylation and acetylation, which is maintained by complement signaling via GPR77, a C5a receptor. Furthermore, CD10(+) GPR77(+) CAFs promote successful engraftment of patient-derived xenografts (PDXs), and targeting these CAFs with a neutralizing anti-GPR77 antibody abolishes tumor formation and restores tumor chemosensitivity. Our study reveals a functional CAF subset that can be defined and isolated by specific cell-surface markers and suggests that targeting the CD10(+) GPR77(+) CAF subset could be an effective therapeutic strategy against CSC-driven solid tumors.	[Su, Shicheng; Chen, Jianing; Liu, Jiang; Yu, Shubin; Lao, Liyan; Luo, Manli; Xing, Yue; Chen, Fei; Huang, Di; Zhao, Jinghua; Yang, Linbin; Liao, Dan; Su, Fengxi; Liu, Qiang; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Su, Shicheng; Chen, Jianing; Liu, Jiang; Yu, Shubin; Lao, Liyan; Luo, Manli; Xing, Yue; Chen, Fei; Huang, Di; Zhao, Jinghua; Yang, Linbin; Liao, Dan; Su, Fengxi; Liu, Qiang; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China; [Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou 510120, Guangdong, Peoples R China; [Wang, Minghui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Thorac Surg, Guangzhou 510120, Guangdong, Peoples R China; [Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510080, Guangdong, Peoples R China; [Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Song, Erwei] Sun Yat Sen Univ, Zhongshan Sch Med, Program Mol Med, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Song, EW (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China.; Song, EW (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China.; Song, EW (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Program Mol Med, Guangzhou 510080, Guangdong, Peoples R China.	songew@mail.sysu.edu.cn	meng, li/GVT-2063-2022; Liu, Qiang/HHZ-3181-2022; luo, man/HGC-7868-2022; Luo, Man/GWQ-4789-2022	Yao, Herui/0000-0001-5520-6469; Liu, Qiang/0000-0002-5451-4862	National Key Research and Development Program of China [2017YFA0106300, 2016YFC1302300]; National Natural Science Foundation of China [81622036, 81472468, 81672614, 81720108029, 81621004, 81490750, 81230060, 81442009, 81372819, 81572596, U1601223, 81672620]; Science Foundation of Guangdong Province [2016A030306023, 2014A030313094, S2012030006287, 2016B030229004, 2015B050501004, 2017A030313878, 2017A030313828]; Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program [2016TQ03R553]; Guangzhou science and technology project [201710010083, 2014J4100170, 201704020131]; Guangzhou Science Technology and Innovation Commission [201508020008, 201508020249]; Guangdong Science and Technology Department [2015B050501004]; Translational medicine public platform of Guangdong Province [4202037]; Guangdong Department of Science & Technology Translational Medicine Center [2011A080300002]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program; Guangzhou science and technology project; Guangzhou Science Technology and Innovation Commission; Guangdong Science and Technology Department; Translational medicine public platform of Guangdong Province; Guangdong Department of Science & Technology Translational Medicine Center	This work was supported by grants from the National Key Research and Development Program of China (2017YFA0106300 and 2016YFC1302300), the National Natural Science Foundation of China (81622036,81472468, 81672614, 81720108029, 81621004, 81490750, 81230060, 81442009, 81372819, 81572596, U1601223, and 81672620), Science Foundation of Guangdong Province (2016A030306023, 2014A030313094, S2012030006287, 2016B030229004, 2015B050501004, 2017A030313878, and 2017A030313828), Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program (No. 2016TQ03R553), Guangzhou science and technology project (201710010083 and 2014J4100170, 201704020131), Guangzhou Science Technology and Innovation Commission (201508020008 and 201508020249), Guangdong Science and Technology Department (2015B050501004), Translational medicine public platform of Guangdong Province (4202037), and Guangdong Department of Science & Technology Translational Medicine Center grant (2011A080300002).	Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Huang Y, 2002, J IMMUNOL, V169, P2627, DOI 10.4049/jimmunol.169.5.2627; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Prowell TM, 2012, NEW ENGL J MED, V366, P2438, DOI 10.1056/NEJMp1205737; Reis ES, 2018, NAT REV IMMUNOL, V18, P5, DOI 10.1038/nri.2017.97; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Su XM, 2015, SCI REP-UK, V5, DOI 10.1038/srep18588; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Takahashi RU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8318; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	35	552	568	16	193	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					841	+	856.e16	10.1016/j.cell.2018.01.009	http://dx.doi.org/10.1016/j.cell.2018.01.009			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29395328	Bronze			2022-12-28	WOS:000424648800022
J	Steinhubl, SR; Kim, KI; Ajayi, T; Topol, EJ				Steinhubl, Steven R.; Kim, Kwang-Il; Ajayi, Toluwalase; Topol, Eric J.			Virtual care for improved global health	LANCET			English	Editorial Material							COUNTRIES		[Steinhubl, Steven R.; Kim, Kwang-Il; Ajayi, Toluwalase; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Kim, Kwang-Il] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea; [Steinhubl, Steven R.; Topol, Eric J.] Wave Res Ctr, La Jolla, CA USA	Scripps Research Institute; Seoul National University (SNU)	Steinhubl, SR (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Steinhubl, SR (corresponding author), Wave Res Ctr, La Jolla, CA USA.	steinhub@scripps.edu	Kim, Kwang-il/AAP-7315-2021; Kim, Kwang-il/D-8024-2012	Kim, Kwang-il/0000-0002-6658-047X; Kim, Kwang-il/0000-0002-6658-047X; Ajayi, Toluwalase/0000-0001-5739-4918	US National Institutes of Health/National Center for Advancing Translational Sciences [UL1TR001114]; Qualcomm Foundation	US National Institutes of Health/National Center for Advancing Translational Sciences; Qualcomm Foundation	SRS and EJT are supported by the US National Institutes of Health/National Center for Advancing Translational Sciences grant UL1TR001114 and a grant from the Qualcomm Foundation	Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Bhatti Y, 2017, HEALTH AFFAIR, V36, P1912, DOI 10.1377/hlthaff.2017.0480; Naslund JA, 2017, LANCET PSYCHIAT, V4, P486, DOI 10.1016/S2215-0366(17)30096-2	3	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					419	419		10.1016/S0140-6736(18)30109-0	http://dx.doi.org/10.1016/S0140-6736(18)30109-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407024				2022-12-28	WOS:000424333600016
J	Watts, G				Watts, Geoff			Fotis Kafatos Obituary	LANCET			English	Biographical-Item																		KAFATOS F, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					424	424		10.1016/S0140-6736(18)30112-0	http://dx.doi.org/10.1016/S0140-6736(18)30112-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV1OL	29407027	Bronze			2022-12-28	WOS:000424333600019
J	Boylan-Kolchin, M				Boylan-Kolchin, Michael			Galaxy motions cause trouble for cosmology	SCIENCE			English	Editorial Material							ANDROMEDA GALAXY; DWARF GALAXIES; THIN PLANE; SATELLITES; UNIVERSE		[Boylan-Kolchin, Michael] Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Boylan-Kolchin, M (corresponding author), Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA.	mbk@astro.as.utexas.edu	Boylan-Kolchin, Michael/A-7200-2011	Boylan-Kolchin, Michael/0000-0002-9604-343X				Buck T, 2016, MON NOT R ASTRON SOC, V460, P4348, DOI 10.1093/mnras/stw1232; Bullock JS, 2017, ANNU REV ASTRON ASTR, V55, P343, DOI 10.1146/annurev-astro-091916-055313; Ibata RA, 2013, NATURE, V493, P62, DOI 10.1038/nature11717; Kroupa P, 2005, ASTRON ASTROPHYS, V431, P517, DOI 10.1051/0004-6361:20041122; LYNDENBELL D, 1976, MON NOT R ASTRON SOC, V174, P695, DOI 10.1093/mnras/174.3.695; Muller O, 2018, SCIENCE, V359, P534, DOI 10.1126/science.aao1858; Schaye J, 2015, MON NOT R ASTRON SOC, V446, P521, DOI 10.1093/mnras/stu2058; Springel V, 2006, NATURE, V440, P1137, DOI 10.1038/nature04805; Vogelsberger M, 2014, MON NOT R ASTRON SOC, V444, P1518, DOI 10.1093/mnras/stu1536; WEINBERG S, 1989, REV MOD PHYS, V61, P1, DOI 10.1103/RevModPhys.61.1	11	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					520	521		10.1126/science.aar7375	http://dx.doi.org/10.1126/science.aar7375			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420279				2022-12-28	WOS:000423795800024
J	Hernan, MA				Hernan, Miguel A.			How to estimate the effect of treatment duration on survival outcomes using observational data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIRETROVIRAL THERAPY; TARGET TRIAL; MORTALITY; AIDS	When using observational data, quantifying the effect of treatment duration on survival outcomes is not straightforward because only people who live for a long time can receive treatment for a long time. This problem doesn't apply to randomised trials because people are classified based on the treatment duration they are assigned, rather than the treatment duration that they achieve. This approach accepts that dead people do not deviate from their assigned treatment strategy. By transferring this insight to the analysis of observational data, we can follow three steps to estimate the effect of treatment duration from observational data without the bias of naive comparisons between long term and short term users. The first step is cloning people to assign them to multiple treatment strategies. The second step is censoring clones when they deviate from their assigned treatment strategy. The third step is performing inverse probability weighting to adjust for the potential selection bias introduced by censoring. The procedure can be used to compare any treatment strategies that are sustained over time. Cloning, censoring, and weighting eliminates immortal time bias in the estimates of absolute and relative risk, which helps researchers focus their attention on other biases that may be present in observational analyses and are not so easily eliminated.	[Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Harvard MIT Div Hlth Sci Technol, Dept Epidemiol, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Harvard MIT Div Hlth Sci Technol, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Hernan, MA (corresponding author), Harvard TH Chan Sch Publ Hlth, Harvard MIT Div Hlth Sci Technol, Dept Epidemiol, Boston, MA 02115 USA.; Hernan, MA (corresponding author), Harvard TH Chan Sch Publ Hlth, Harvard MIT Div Hlth Sci Technol, Dept Biostat, Boston, MA 02115 USA.	miguel_hernan@post.harvard.edu			NIH [R01 AI102634]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH grant R01 AI102634.	Cain LE, 2016, INT J EPIDEMIOL, V45, P2038, DOI 10.1093/ije/dyv295; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Cole SR, 2007, AM J EPIDEMIOL, V166, P219, DOI 10.1093/aje/kwm047; Emilsson L, 2017, JAMA ONCOL IN PRESS; Garcia-Albeniz X, 2015, EUR J CANCER, V51, P817, DOI 10.1016/j.ejca.2015.03.003; Garcia-Albeniz X, 2017, EUR J EPIDEMIOL, V32, P495, DOI 10.1007/s10654-017-0287-2; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2018, CAUSAL INFERENCE; Hernan MA, 2017, NEW ENGL J MED, V377, P1391, DOI 10.1056/NEJMsm1605385; Hernan MA, 2016, J CLIN EPIDEMIOL, V79, P70, DOI 10.1016/j.jclinepi.2016.04.014; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Hernan MA, 2015, AM J EPIDEMIOL, V182, P834, DOI 10.1093/aje/kwv215; Levesque LE, 2010, BMJ, V340, pb5087, DOI DOI 10.1136/BMJ.B5087; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; ORELLANA L, 2010, INT J BIOSTAT, V6, P1; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Zhang Yi, 2014, Med Care, V52 Suppl 3, pS132, DOI 10.1097/MLR.0b013e3182a53ca8	19	43	43	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2018	360								k182	10.1136/bmj.k182	http://dx.doi.org/10.1136/bmj.k182			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TT	29419381	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000423846200004
J	So, C; Siddiqui, MM				So, Conan; Siddiqui, M. Minhaj			Urothelial Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[So, Conan; Siddiqui, M. Minhaj] Univ Maryland, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Siddiqui, MM (corresponding author), Univ Maryland, Baltimore, MD 21201 USA.	msiddiqui@som.umaryland.edu	Siddiqui, Mohummad/V-1196-2019						0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					E8	E8		10.1056/NEJMicm1709216	http://dx.doi.org/10.1056/NEJMicm1709216			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29385365				2022-12-28	WOS:000423783200001
J	Gaeta, JM; Racine, M				Gaeta, Jessie M.; Racine, Melanie			New Strategies Are Needed to Stop Overdose Fatalities: The Case for Supervised Injection Facilities	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gaeta, Jessie M.; Racine, Melanie] Boston Hlth Care Homeless Program, Inst Res Qual & Policy Homeless Hlth Care, 780 Albany St, Boston, MA 02118 USA; [Gaeta, Jessie M.] Boston Med Ctr, Sect Gen Internal Med, Boston, MA 02118 USA	Boston Medical Center	Gaeta, JM (corresponding author), Boston Hlth Care Homeless Program, Inst Res Qual & Policy Homeless Hlth Care, 780 Albany St, Boston, MA 02118 USA.	jgaeta@bhchp.org	Racine, Melanie/GNH-3956-2022					*AMER MED ASS, 2017, AMA WANTS NEW APPR C; DeBeck K, 2011, DRUG ALCOHOL DEPEN, V113, P172, DOI 10.1016/j.drugalcdep.2010.07.023; Kerr T, 2006, BRIT MED J, V332, P220, DOI 10.1136/bmj.332.7535.220; Kral AH, 2017, AM J PREV MED, V53, P919, DOI 10.1016/j.amepre.2017.06.010; LEON C, 2017, SUBSTANCE ABUSEL, P1; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; *MASS MED SOC, 2017, EST PIL MED SUP INJ; Potier C, 2014, DRUG ALCOHOL DEPEN, V145, P48, DOI 10.1016/j.drugalcdep.2014.10.012; Takach, 2016, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20160831.056280/full/, DOI 10.1377/HBLOG20160831.056280/FULL]; WOOD, 2006, N ENGL 4 7ED, V354, P2512	10	2	2	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					664	666		10.7326/M18-0258	http://dx.doi.org/10.7326/M18-0258			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3BZ	29404601				2022-12-28	WOS:000434247300024
J	Mahon, FX; Boquimpani, C; Kim, DW; Benyamini, N; Clementino, NCD; Shuvaev, V; Ailawadhi, S; Lipton, JH; Turkina, AG; De Paz, R; Moiraghi, B; Nicolini, FE; Dengler, J; Sacha, T; Takahashi, N; Fellague-Chebra, R; Acharya, S; Wong, S; Jin, Y; Hughes, TP				Mahon, Francois-Xavier; Boquimpani, Carla; Kim, Dong-Wook; Benyamini, Noam; Clementino, Nelma Cristina D.; Shuvaev, Vasily; Ailawadhi, Sikander; Lipton, Jeffrey Howard; Turkina, Anna G.; De Paz, Raquel; Moiraghi, Beatriz; Nicolini, Franck E.; Dengler, Jolanta; Sacha, Tomasz; Takahashi, Naoto; Fellague-Chebra, Rafik; Acharya, Sandip; Wong, Stephane; Jin, Yu; Hughes, Timothy P.			Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; MUSCULOSKELETAL PAIN; WITHDRAWAL SYNDROME; MOLECULAR RESPONSE; IMATINIB TREATMENT; DISCONTINUATION; CML; CHROMOSOME; LONGER; TRIAL	Background: Treatment-free remission (TFR)-that is, stopping tyrosine kinase inhibitor (TKI)therapy without loss of response-is an emerging treatment goal in chronic myeloid leukemia (CML). Objective: To evaluate TFR after discontinuation of second-line nilotinib therapy. Design: Single-group, phase 2, open-label study. Setting: 63 centers in 18 countries. Patients: Adults with CML in chronic phase who received TKI therapy for at least 3 years (>4 weeks with imatinib, then >= 2 years with nilotinib) and achieved MR4.5 (BCR-ABL1 <= 0.0032% on the International Scale [BCR-ABL1(IS)]) while receiving nilotinib entered a 1-year consolidation phase. Those with sustained MR4.5 during consolidation were eligible to enter TFR. Interventions: Patients received nilotinib during consolidation; those who entered TFR stopped treatment. Patients with loss of major molecular response (MMR) (BCR-ABL1(IS) <= 0.1%) or confirmed loss of MR4 (BCR-ABL1(IS) <= 0.01%) during TFR reinitiated nilotinib treatment. Measurements: Proportion of patients without loss of MMR, confirmed loss of MR4, or treatment reinitiation within 48 weeks of stopping treatment (primary end point). Results: 163 patients who had switched from imatinib to nilotinib (for reasons including resistance, intolerance, and physician preference) enrolled in the study and entered the consolidation phase. Of these patients, 126 met the criteria for entering the TFR phase, and 73 (58% [95% CI, 49% to 67%]) and 67 (53% [CI, 44% to 62%]) maintained TFR at 48 weeks (primary end point) and 96 weeks, respectively. Of the 56 patients who reinitiated nilotinib therapy, 55 regained MMR or better and 52 regained MR4.5. None had CML progression to accelerated phase or blast crisis. Musculoskeletal pain was more frequent during the first 48 weeks after nilotinib discontinuation. Limitation: The study included a heterogeneous patient population and was not designed to compare outcomes between patients continuing and those stopping treatment. Conclusion: TFR seems achievable in patients with sustained MR4.5 after switching to nilotinib.	[Mahon, Francois-Xavier] CRLCC Inst Bergonie, 229 Cours Argonne, F-33076 Bordeaux, France; [Boquimpani, Carla] Ctr Rio Janeiro, HEMORIO, Rua Frei Caneca 8, BR-20211030 Rio De Janeiro, Brazil; [Kim, Dong-Wook] Catholic Univ Korea, Seoul St Marys Hosp, 62 Youidodong Youngdeungpogu, Seoul 150713, South Korea; [Benyamini, Noam] Rambam Med Ctr, Dept Hematol & Bone Marrow Transplantat, Rambam Hlth Care Campus, IL-31096 Haifa, Israel; [Clementino, Nelma Cristina D.] Univ Fed Minas Gerais, Hosp Clin UFMG, BR-31270901 Belo Horizonte, MG, Brazil; [Shuvaev, Vasily] Russian Res Inst Hematol & Transfusiol, St Petersburg 191024, Russia; [Ailawadhi, Sikander] Mayo Clin Florida, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Lipton, Jeffrey Howard] Univ Toronto, Princess Margaret Canc Ctr, 610 Univ Ave,5th Floor,Room 106, Toronto, ON M5G 2M9, Canada; [Turkina, Anna G.] FGBS Hematol Res Ctr Hlth Minist, 125 127,Novy Zykovsky Pr 4a, Moscow 125167, Russia; [De Paz, Raquel] Hosp Univ La Paz, Paseo Castellana 261, Madrid 28046, Spain; [Moiraghi, Beatriz] Hosp Jose Maria Ramos Mejia, Gen Urquiza 609,C1221ADC, Buenos Aires, DF, Argentina; [Nicolini, Franck E.] Ctr Hosp Lyon Sud D, Hematol Clin 1G, 165 Chemin Grand Revoyet, F-69495 Pierre Benite 03, Laennec, France; [Dengler, Jolanta] Onkol Schwerpunktpraxis Heilbronn, Allee 40, D-74072 Heilbronn, Germany; [Sacha, Tomasz] Jagiellonian Univ, Med Coll, Dept Haematol, Swietej Anny 12, PL-31008 Krakow, Poland; [Takahashi, Naoto] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Hondo 1-1-1, Akita 0108543, Japan; [Fellague-Chebra, Rafik] Novartis Pharma SAS, 2&4 Rue Lionel Terray, F-92500 Rueil Malmaison, France; [Acharya, Sandip] Salarpuria Sattva Knowledge City, Rangareddy 500081, Andhra Pradesh, India; [Wong, Stephane] 45 Sidney St,2nd Floor 609-2116P, Cambridge, MA 02139 USA; [Jin, Yu] USEH, Novartis Pharmaceut Corp, 337-A7-3A,One Hlth Plaza, E Hanover, NJ 07936 USA; [Hughes, Timothy P.] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia	UNICANCER; Institut Bergonie; Catholic University of Korea; Seoul St. Mary's Hospital; Rambam Health Care Campus; Technion Israel Institute of Technology; Universidade Federal de Minas Gerais; Russian Research Institute of Hematology & Transfusiology; Mayo Clinic; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Hospital Universitario La Paz; Hospital Ramos Mejia; Jagiellonian University; Collegium Medicum Jagiellonian University; Akita University; Novartis; Novartis; South Australian Health & Medical Research Institute (SAHMRI)	Hughes, TP (corresponding author), South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia.	tim.hughes@sahmri.com	Hughes, Tim/AAO-9975-2021; Shuvaev, V./P-8279-2019; Turkina, Anna/GQP-6907-2022	Shuvaev, V./0000-0003-3536-0770; Hughes, Timothy/0000-0002-0910-3730	Novartis Pharmaceuticals Corporation	Novartis Pharmaceuticals Corporation(Novartis)	By Novartis Pharmaceuticals Corporation, which also provided financial support for medical editorial assistance.	Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; Berger MG, 2015, BLOOD, V126; Boquimpani CM, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4547.4547; Bower H, 2016, J CLIN ONCOL, V34, P2851, DOI 10.1200/JCO.2015.66.2866; Cross NCP, 2015, LEUKEMIA, V29, P999, DOI 10.1038/leu.2015.29; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Etienne G, 2017, J CLIN ONCOL, V35, P298, DOI 10.1200/JCO.2016.68.2914; Hochhaus A, 2017, ANN ONCOL, V28, P41, DOI 10.1093/annonc/mdx219; Hochhaus A, 2016, LEUKEMIA, V30, P1044, DOI 10.1038/leu.2016.5; Hochhaus A, 2016, LEUKEMIA, V30, P57, DOI 10.1038/leu.2015.270; Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Hughes TP, 2016, BLOOD, V128, P17, DOI 10.1182/blood-2016-01-694265; Hughes TP, 2014, BLOOD, V124, P729, DOI 10.1182/blood-2013-12-544015; HUGHES TP, 2015, HAEMATOLOGICA S1, V100, P61; Imagawa J, 2015, LANCET HAEMATOL, V2, pE528, DOI 10.1016/S2352-3026(15)00196-9; Lee SE, 2016, HAEMATOLOGICA, V101, P717, DOI 10.3324/haematol.2015.139899; Mahon FX, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.151.151; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; MAHON FX, 2016, BLOOD, V128; Mahon KL, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.4_suppl.11; Mori S, 2016, HAEMATOLOGICA, V101, P62; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; NOWELL PC, 1960, SCIENCE, V132, P1497; Park JS, 2015, LEUKEMIA LYMPHOMA, V12, P1; Rea D, 2014, BLOOD, V124; Rea D, 2015, BLOOD, V126; Richter J, 2016, HAEMATOLOGICA, V101, P22; Richter J, 2014, J CLIN ONCOL, V32, P2821, DOI 10.1200/JCO.2014.55.6910; Ritchie EK, 2015, BLOOD, V126; Ross D, 2016, HAEMATOLOGICA, V101, P238; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Rousselot P, 2014, J CLIN ONCOL, V32, P2823, DOI 10.1200/JCO.2014.56.3858; Rousselot P, 2014, J CLIN ONCOL, V32, P424, DOI 10.1200/JCO.2012.48.5797; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Saussele S, 2016, LEUKEMIA, V30, P1638, DOI 10.1038/leu.2016.115; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Takahashi N, 2016, HAEMATOLOGICA, V101, P61; Takahashi N, 2012, HAEMATOL-HEMATOL J, V97, P903, DOI 10.3324/haematol.2011.056853; US Department of Health and Human Services, 2010, NIH PUBLICATION, V10-7606	41	83	87	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2018	168	7					461	+		10.7326/M17-1094	http://dx.doi.org/10.7326/M17-1094			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4AB	29459949				2022-12-28	WOS:000429000900004
J	Huberfeld, N				Huberfeld, Nicole			Can Work Be Required in the Medicaid Program?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huberfeld, Nicole] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Huberfeld, Nicole] Boston Univ, Sch Law, Boston, MA 02215 USA	Boston University; Boston University	Huberfeld, N (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA.; Huberfeld, N (corresponding author), Boston Univ, Sch Law, Boston, MA 02215 USA.			Huberfeld, Nicole/0000-0001-9206-2257				[Anonymous], 2018, COMMUNICATION; [Anonymous], 2017, COMMUNICATION; [Anonymous], 2017, NY TIMES; Garfield R., 2018, UNDERSTANDING INTERS; Stevens R., 2004, WELFARE MED AM CASE	5	14	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2018	378	9					788	791		10.1056/NEJMp1800549	http://dx.doi.org/10.1056/NEJMp1800549			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX7GP	29412779				2022-12-28	WOS:000426256300002
J	Murphy, PJ; Wu, SF; James, CR; Wike, CL; Cairns, BR				Murphy, Patrick J.; Wu, Shan Fu; James, Cody R.; Wike, Candice L.; Cairns, Bradley R.			Placeholder Nucleosomes Underlie Germline-to-Embryo DNA Methylation Reprogramming	CELL			English	Article							HISTONE CHAPERONE; CHROMATIN; H2A.Z; ZEBRAFISH; GENOME; DYNAMICS; H3K4ME3; DEMETHYLATION; COMPLEX; GENES	The fate and function of epigenetic marks during the germline-to-embryo transition is a key issue in developmental biology, with relevance to stem cell programming and transgenerational inheritance. In zebrafish, DNA methylation patterns are programmed in transcriptionally quiescent cleavage embryos; paternally inherited patterns are maintained, whereas maternal patterns are reprogrammed to match the paternal. Here, we provide the mechanism by demonstrating that "Placeholder" nucleosomes, containing histone H2A variant H2A.Z(FV) and H3K4me1, virtually occupy all regions lacking DNA methylation in both sperm and cleavage embryos and reside at promoters encoding housekeeping and early embryonic transcription factors. Upon genome-wide transcriptional onset, genes with Placeholder become either active (H3K4me3) or silent (H3K4me3/K27me3). Notably, perturbations causing Placeholder loss confer DNA methylation accumulation, whereas acquisition/expansion of Placeholder confers DNA hypomethylation and improper gene activation. Thus, during transcriptionally quiescent gametic and embryonic stages, an H2A.Z(FV)/H3K4me1-containing Placeholder nucleosome deters DNA methylation, poising parental genes for either gene-specific activation or facultative repression.	[Cairns, Bradley R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Ontol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Ontol Sci, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu			Howard Hughes Medical Institute; Huntsman Cancer Institute core facilities [CA24014]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH [T32HD007491]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Huntsman Cancer Institute core facilities; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Brian Dailey for sequencing expertise and Tim Parnell, Tim Mosbruger, and Jingtao Guo for discussing bioinformatics. We thank Jason Gertz, Margaret Kasten, Cedric Clapier, Simon Curie, and Edward Grow for advice on techniques. We extend a special thanks to K.T. Varley for helping us adapt RRBS, David Grunwald and his laboratory for help with parthenogenesis, and Marnie Halpern for sharing the H2AFV:GFP fish. B.R.C. is an investigator with the HHMI. Financial support was received from the Howard Hughes Medical Institute and the Huntsman Cancer Institute core facilities (CA24014). P.J.M. was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH (T32HD007491). Imaging was performed at the University of Utah Microscopy Core (1S10RR024761-01).	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Amouroux R, 2016, NAT CELL BIOL, V18, P225, DOI 10.1038/ncb3296; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bogdanovic O, 2016, NAT GENET, V48, P417, DOI 10.1038/ng.3522; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Boskovic A, 2012, EPIGENETICS-US, V7, P747, DOI 10.4161/epi.20584; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chen P, 2014, NUCLEUS-PHILA, V5, P21, DOI 10.4161/nucl.28067; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Heier J, 2015, DEV DYNAM, V244, P1300, DOI 10.1002/dvdy.24315; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindeman LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015651; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mao Z, 2014, CELL RES, V24, P389, DOI 10.1038/cr.2014.30; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Nix DA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-455; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Westerfield M., 2007, THE ZEBRAFISH BOOK A; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2014, GENOME RES, V24, P260, DOI 10.1101/gr.157750.113; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	55	77	79	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2018	172	5					993	+		10.1016/j.cell.2018.01.022	http://dx.doi.org/10.1016/j.cell.2018.01.022			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FX2ZG	29456083	Bronze, Green Submitted			2022-12-28	WOS:000425937100011
J	Freund, Y; Cachanado, M; Aubry, A; Orsini, C; Raynal, PA; Feral-Pierssens, AL; Charpentier, S; Dumas, F; Baarir, N; Truchot, J; Desmettre, T; Tazarourte, K; Beaune, S; Leleu, A; Khellaf, M; Wargon, M; Bloom, B; Rousseau, A; Simon, T; Riou, B				Freund, Yonathan; Cachanado, Marine; Aubry, Adeline; Orsini, Charlotte; Raynal, Pierre-Alexis; Feral-Pierssens, Anne-Laure; Charpentier, Sandrine; Dumas, Florence; Baarir, Nacera; Truchot, Jennifer; Desmettre, Thibaut; Tazarourte, Karim; Beaune, Sebastien; Leleu, Agathe; Khellaf, Mehdi; Wargon, Mathias; Bloom, Ben; Rousseau, Alexandra; Simon, Tabassome; Riou, Bruno		PROPER Investigator Grp	Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients The PROPER Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERC RULE; D-DIMER; PRETEST PROBABILITY; COMPUTED-TOMOGRAPHY; DIAGNOSIS; OVERDIAGNOSIS; MULTICENTER; MANAGEMENT; CT; ANGIOGRAPHY	IMPORTANCE The safety of the pulmonary embolism rule-out criteria (PERC), an 8-item block of clinical criteria aimed at ruling out pulmonary embolism (PE), has not been assessed in a randomized clinical trial. OBJECTIVE To prospectively validate the safety of a PERC-based strategy to rule out PE. DESIGN, SETTING, AND PATIENTS A crossover cluster-randomized clinical noninferiority trial in 14 emergency departments in France. Patients with a low gestalt clinical probability of PE were included from August 2015 to September 2016, and followed up until December 2016. INTERVENTIONS Each center was randomized for the sequence of intervention periods. In the PERC period, the diagnosis of PE was excluded with no further testing if all 8 items of the PERC rule were negative. MAIN OUTCOMES AND MEASURES The primary end point was the occurrence of a thromboembolic event during the 3-month follow-up period that was not initially diagnosed. The noninferiority margin was set at 1.5%. Secondary end points included the rate of computed tomographic pulmonary angiography (CTPA), median length of stay in the emergency department, and rate of hospital admission. RESULTS Among 1916 patients who were cluster-randomized (mean age 44 years, 980 [51%] women), 962 were assigned to the PERC group and 954 were assigned to the control group. A total of 1749 patients completed the trial. A PE was diagnosed at initial presentation in 26 patients in the control group (2.7%) vs 14 (1.5%) in the PERC group (difference, 1.3%[95% CI, -0.1% to 2.7%]; P =.052). One PE (0.1%) was diagnosed during follow-up in the PERC group vs none in the control group (difference, 0.1%[95% CI, -infinity to 0.8%]). The proportion of patients undergoing CTPA in the PERC group vs control group was 13% vs 23%(difference, -10% [95% CI, -13% to -6%]; P <.001). In the PERC group, rates were significantly reduced for the median length of emergency department stay (mean reduction, 36 minutes [95% CI, 4 to 68]) and hospital admission (difference, 3.3%[95% CI, 0.1% to 6.6%]). CONCLUSIONS AND RELEVANCE Among very low-risk patients with suspected PE, randomization to a PERC strategy vs conventional strategy did not result in an inferior rate of thromboembolic events over 3 months. These findings support the safety of PERC for very low-risk patients presenting to the emergency department.	[Freund, Yonathan; Simon, Tabassome; Riou, Bruno] Sorbonne Univ, INSERM, IHU ICAN, UMRS 1166, Paris, France; [Freund, Yonathan; Aubry, Adeline; Riou, Bruno] Hop Univ Pitie Salpetriere, AP HP, Emergency Dept, Paris, France; [Cachanado, Marine; Rousseau, Alexandra; Simon, Tabassome] Hop St Antoine, AP HP, Clin Res Platform, URC,CRC,CRB, Paris, France; [Orsini, Charlotte] Hop Avicenne, AP HP, Emergency Dept, Bobigny, France; [Raynal, Pierre-Alexis] Hop St Antoine, AP HP, Emergency Dept, Paris, France; [Feral-Pierssens, Anne-Laure] Hop Europeen Georges Pompidou, AP HP, Emergency Dept, Paris, France; [Charpentier, Sandrine] Univ Toulouse III Paul Sabatier, INSERM, CHU Toulouse, Emergency Dept,UMR 1027, Toulouse, France; [Dumas, Florence] Univ Paris 05, Hop Cochin, AP HP, INSERM,Emergency Dept,UMR970, Paris, France; [Baarir, Nacera] Hop Tenon, AP HP, Emergency Dept, Paris, France; [Truchot, Jennifer] Hop Lariboisiere, AP HP, Emergency Dept, Paris, France; [Desmettre, Thibaut] Univ Bourgogne Franche Comte, CHRU Minjoz, Emergency Dept, Besancon, France; [Tazarourte, Karim] Univ Claude Bernard Lyon1, Hop Edouard Herriot, Hosp Civils Lyon, Emergency Dept,HESPER EA 7425, Lyon, France; [Beaune, Sebastien] Hop Ambroise Pare, AP HP, Emergency Dept, Boulogne, France; [Leleu, Agathe] Hop Bichat Claude Bernard, AP HP, Emergency Dept, Paris, France; [Khellaf, Mehdi] Univ Paris Est, Hop Henri Mondor, AP HP, INSERM,Emergency Dept,U955, Creteil, France; [Wargon, Mathias] Hop St Camille, Emergency Dept, Bry Sur Marne, France; [Bloom, Ben] Barts Hlth NHS Trust, Emergency Dept, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Barts Health NHS Trust	Freund, Y (corresponding author), Serv Accueil Urgences, 47-83 Bd Hop, F-75013 Paris, France.	yonathan.freund@aphp.fr	DESMETTRE, Thibaut/GLT-4326-2022; beaune, sebastien/L-6527-2017; Bouzid, Donia/AAC-9054-2022; Tazarourte, karim/GQZ-6054-2022	DESMETTRE, Thibaut/0000-0003-4585-5494; Bouzid, Donia/0000-0002-7538-3320; tazarourte, karim/0000-0002-3376-1258; Bloom, Ben/0000-0002-3016-4925	Programme Hospitalier de Recherche Clinique-PHRC (Ministere de la Sante, Paris, France); Assistance Publique-Hopitaux de Paris	Programme Hospitalier de Recherche Clinique-PHRC (Ministere de la Sante, Paris, France); Assistance Publique-Hopitaux de Paris	The research was funded by a grant from Programme Hospitalier de Recherche Clinique-PHRC 2014 (Ministere de la Sante, Paris, France). The sponsor was Assistance Publique-Hopitaux de Paris.	Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Dronkers CEA, 2017, J THROMB HAEMOST, V15, P1040, DOI 10.1111/jth.13654; Freund Y, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1049-7; Hugli O, 2011, J THROMB HAEMOST, V9, P300, DOI 10.1111/j.1538-7836.2010.04147.x; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Kline JA, 2014, ANN EMERG MED, V63, P275, DOI 10.1016/j.annemergmed.2013.08.023; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Lapner ST, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f757; Mongan J, 2015, EMERG MED J, V32, P840, DOI 10.1136/emermed-2014-204531; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Penaloza A, 2012, J THROMB HAEMOST, V10, P375, DOI 10.1111/j.1538-7836.2012.04631.x; Penaloza A, 2017, LANCET HAEMATOL, V4, pE615, DOI 10.1016/S2352-3026(17)30210-7; Penaloza A, 2013, ANN EMERG MED, V62, P117, DOI 10.1016/j.annemergmed.2012.11.002; Penaloza A, 2012, THROMB RES, V129, pE189, DOI 10.1016/j.thromres.2012.02.016; Pernod G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169268; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Righini M, 2005, J THROMB HAEMOST, V3, P188, DOI 10.1111/j.1538-7836.2004.01097.x; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Sheh SH, 2012, AM J ROENTGENOL, V198, P1340, DOI 10.2214/AJR.11.6426; Singh B, 2013, EMERG MED J, V30, P701, DOI 10.1136/emermed-2012-201730; Stein PD, 2012, CLIN APPL THROMB-HEM, V18, P20, DOI 10.1177/1076029611422363; Tan S, 2016, AM J ROENTGENOL, V206, pW59, DOI 10.2214/AJR.15.15769; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178	30	68	73	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					559	566		10.1001/jama.2017.21904	http://dx.doi.org/10.1001/jama.2017.21904			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450523	Green Published, Bronze			2022-12-28	WOS:000424908400016
J	Chen, S; Weitemier, AZ; Zeng, X; He, LM; Wang, XY; Tao, YQ; Huang, AJY; Hashimotodani, Y; Kano, M; Iwasaki, H; Parajuli, LK; Okabe, S; Teh, DBL; All, AH; Tsutsui-Kimura, I; Tanaka, KF; Liu, XG; McHugh, TJ				Chen, Shuo; Weitemier, Adam Z.; Zeng, Xiao; He, Linmeng; Wang, Xiyu; Tao, Yanqiu; Huang, Arthur J. Y.; Hashimotodani, Yuki; Kano, Masanobu; Iwasaki, Hirohide; Parajuli, Laxmi Kumar; Okabe, Shigeo; Teh, Daniel B. Loong; All, Angelo H.; Tsutsui-Kimura, Iku; Tanaka, Kenji F.; Liu, Xiaogang; McHugh, Thomas J.			Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics	SCIENCE			English	Article							EXCITATION; NANOCRYSTALS; THERANOSTICS; INHIBITION; DYNAMICS	Optogenetics has revolutionized the experimental interrogation of neural circuits and holds promise for the treatment of neurological disorders. It is limited, however, because visible light cannot penetrate deep inside brain tissue. Upconversion nanoparticles (UCNPs) absorb tissue-penetrating near-infrared (NIR) light and emit wavelength-specific visible light. Here, we demonstrate that molecularly tailored UCNPs can serve as optogenetic actuators of transcranial NIR light to stimulate deep brain neurons. Transcranial NIR UCNP-mediated optogenetics evoked dopamine release from genetically tagged neurons in the ventral tegmental area, induced brain oscillations through activation of inhibitory neurons in the medial septum, silenced seizure by inhibition of hippocampal excitatory cells, and triggered memory recall. UCNP technology will enable less-invasive optical neuronal activity manipulation with the potential for remote therapy.	[Chen, Shuo; Weitemier, Adam Z.; He, Linmeng; Wang, Xiyu; Tao, Yanqiu; Huang, Arthur J. Y.; McHugh, Thomas J.] RIKEN Brain Sci Inst, Lab Circuit & Behav Physiol, Wako, Saitama 3510198, Japan; [Zeng, Xiao; Liu, Xiaogang] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Hashimotodani, Yuki; Kano, Masanobu] Univ Tokyo, Dept Neurophysiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Kano, Masanobu] Univ Tokyo, Int Res Ctr Neurointellegence WPI, Inst Adv Studies, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Iwasaki, Hirohide; Parajuli, Laxmi Kumar; Okabe, Shigeo] Univ Tokyo, Dept Cellular Neurobiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Teh, Daniel B. Loong] Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Singapore 117456, Singapore; [All, Angelo H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Tsutsui-Kimura, Iku; Tanaka, Kenji F.] Keio Univ, Dept Neuropsychiatry, Sch Med, Tokyo 1608582, Japan; [Liu, Xiaogang] Agcy Sci Technol & Res, Inst Mat Res & Engn, Singapore 117602, Singapore; [McHugh, Thomas J.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	RIKEN; National University of Singapore; University of Tokyo; University of Tokyo; University of Tokyo; National University of Singapore; Johns Hopkins University; Keio University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE); University of Tokyo	Chen, S; McHugh, TJ (corresponding author), RIKEN Brain Sci Inst, Lab Circuit & Behav Physiol, Wako, Saitama 3510198, Japan.; Liu, XG (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.; Liu, XG (corresponding author), Agcy Sci Technol & Res, Inst Mat Res & Engn, Singapore 117602, Singapore.; McHugh, TJ (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	shuoshu@gmail.com; chmlx@nus.edu.sg; tjmchugh@brain.riken.jp	LIU, XIAOGANG/A-8038-2011; McHugh, Thomas/M-6159-2019; Hashimotodani, Yuki/W-4690-2018; McHugh, Thomas J/A-6693-2010; wang, xiyu/GYA-4086-2022; Loong, Daniel Teh Boon/AAF-6660-2019	LIU, XIAOGANG/0000-0003-2517-5790; McHugh, Thomas/0000-0002-1243-5189; Hashimotodani, Yuki/0000-0001-6723-2736; McHugh, Thomas J/0000-0002-1243-5189; Loong, Daniel Teh Boon/0000-0002-4560-8568; Weitemier, Adam/0000-0002-4806-9299; Iwasaki, Hirohide/0000-0002-7432-5938; HE, LINMENG/0000-0001-5212-4847; Wang, Xiyu/0000-0003-0705-7336; Tsutsui-Kimura, Iku/0000-0001-7554-4764; Parajuli, Laxmi Kumar/0000-0003-1112-4415; Chen, Shuo/0000-0003-3581-0997; TAO, YANQIU/0000-0001-6397-8362; Okabe, Shigeo/0000-0003-1216-8890; Tanaka, Kenji/0000-0003-2511-0057; Kano, Masanobu/0000-0002-0725-3292	JSPS (Japan Society for the Promotion of Science) Postdoctoral Fellowship [16F16386]; RIKEN Special Postdoctoral Researchers Program; RIKEN BSI; MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan) [17H05591]; Singapore Ministry of Education [R143000627112, R143000642112]; National Research Foundation of Singapore under its Competitive Research Programme (CRP Award) [NRF-CRP15-2015-03]; Japanese Science and Technology Agency [JPMJCR14W2];  [16K18373];  [25000015];  [17H01387];  [25117006]; Grants-in-Aid for Scientific Research [17H01387, 25117006, 17H05591] Funding Source: KAKEN	JSPS (Japan Society for the Promotion of Science) Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Special Postdoctoral Researchers Program; RIKEN BSI; MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Singapore Ministry of Education(Ministry of Education, Singapore); National Research Foundation of Singapore under its Competitive Research Programme (CRP Award)(National Research Foundation, Singapore); Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Wada and T. Tsukihana (RIKEN Center for Advanced Photonics) for technical advice and assistance with laser optics; H. Hirase [RIKEN Brain Science Institute (BSI)] for helpful discussion on in vivo toxicity assay and gifts of antibodies against GFAP (glial fibrillary acidic protein) and Iba1; S. Itohara (RIKEN BSI) for the gift of antibody against Caspase-3; T. Launey (RIKEN BSI) for helpful discussion on electron microscopy; and C. Yokoyama (RIKEN BSI) and F. Xu (University of Science and Technology of China) for comments on the manuscript. This work was supported by JSPS (Japan Society for the Promotion of Science) Postdoctoral Fellowship (16F16386) (S.C.); RIKEN Special Postdoctoral Researchers Program (S.C.); RIKEN BSI (T.J.M.); Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan) (17H05591) (T.J.M.); Grant-in-Aid for Young Scientists B (16K18373) (S.C.); the Singapore Ministry of Education (grant R143000627112, R143000642112) (X.L.); the National Research Foundation of Singapore under its Competitive Research Programme (CRP Award no. NRF-CRP15-2015-03) (X.L.); Grants-in-Aid for Scientific Research (25000015) (M.K.); Grants-in-Aid for Scientific Research (17H01387 and 25117006) (S.O.); and Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency (JPMJCR14W2) (S.O.). All data necessary to assess the conclusions of this research are available in the text and supplementary materials. Data related to the synthesis and characterization of UCNPs are available via the X.L. laboratory website (http://liuxg.science.nus.edu.sg). Data related to the application of UCNP-mediated optogenetics in the mouse brain are archived on the servers of Laboratory for Circuit and Behavioral Physiology at the RIKEN Brain Science Institute and accessible at http://cbp.brain.riken.jp/chen_et_al. All materials are available upon request.	Ai Xiangzhao, 2017, Angew Chem Int Ed Engl, V56, P3031, DOI 10.1002/anie.201612142; Airan R, 2017, SCIENCE, V357, DOI 10.1126/science.aao1200; Anikeeva P., 2011, Google Patents, Patent No. [PCT/US2011/059287, 2011059287]; Bansal A, 2016, SMALL, V12, P1732, DOI 10.1002/smll.201503792; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bozkurt A, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-9; Chen GY, 2014, CHEM REV, V114, P5161, DOI 10.1021/cr400425h; Chen R, 2015, SCIENCE, V347, P1477, DOI 10.1126/science.1261821; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Grossman N, 2017, CELL, V169, P1029, DOI 10.1016/j.cell.2017.05.024; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Hososhima S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16533; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liu JN, 2015, ACCOUNTS CHEM RES, V48, P1797, DOI 10.1021/acs.accounts.5b00078; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Ni DL, 2014, ACS NANO, V8, P1231, DOI 10.1021/nn406197c; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Shah S, 2015, NANOSCALE, V7, P16571, DOI 10.1039/c5nr03411f; Stanley SA, 2016, NATURE, V531, P647, DOI 10.1038/nature17183; Vo-Dinh T, 2014, BIOMED PHOTONICS, DOI 10.1201/9780203008997-38; Wanat Matthew J, 2009, Curr Drug Abuse Rev, V2, P195; Wu X, 2016, ACS NANO, V10, P1060, DOI 10.1021/acsnano.5b06383; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhou B, 2015, NAT NANOTECHNOL, V10, P924, DOI [10.1038/nnano.2015.251, 10.1038/NNANO.2015.251]	35	604	616	98	1003	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					679	683		10.1126/science.aaq1144	http://dx.doi.org/10.1126/science.aaq1144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439241				2022-12-28	WOS:000425117700039
J	Gligorovski, S; Abbatt, JPD				Gligorovski, Sasho; Abbatt, Jonathan P. D.			An indoor chemical cocktail	SCIENCE			English	Editorial Material							OZONE; OXIDATION		[Gligorovski, Sasho] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochem, Guangzhou 510640, Guangdong, Peoples R China; [Abbatt, Jonathan P. D.] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada	Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS; University of Toronto	Gligorovski, S (corresponding author), Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Organ Geochem, Guangzhou 510640, Guangdong, Peoples R China.	gligorovski@gig.ac.cn; jabbatt@chem.utoronto.ca	Gligorovski, Sasho/HHZ-1976-2022; Gligorovski, Sasho/D-2253-2010; Gligorovski, Sasho/ABH-8175-2020	Abbatt, Jonathan/0000-0002-3372-334X	Alfred P. Sloan Foundation; Chinese Academy of Sciences; Alfred P. Sloan Foundation; Chinese Academy of Sciences	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences)	J.P.D.A. is supported by the Alfred P. Sloan Foundation. S.G. is supported by the Chinese Academy of Sciences.	Berndt T, 2017, J AM CHEM SOC, V139, P13387, DOI 10.1021/jacs.7b05849; Crounse JD, 2013, J PHYS CHEM LETT, V4, P3513, DOI 10.1021/jz4019207; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Gandolfo A, 2017, APPL CATAL B-ENVIRON, V209, P429, DOI 10.1016/j.apcatb.2017.03.021; Gomez Alvarez E, 2013, P NATL ACAD SCI USA, V110, P13294, DOI 10.1073/pnas.1308310110; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu S, 2017, ENVIRON SCI TECHNOL, V51, P5454, DOI 10.1021/acs.est.7b01358; Nazaroff WW, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015022; Sleiman M, 2010, P NATL ACAD SCI USA, V107, P6576, DOI 10.1073/pnas.0912820107; Tang XC, 2016, ENVIRON SCI TECHNOL, V50, P12686, DOI 10.1021/acs.est.6b04415; Weschler CJ, 2012, INDOOR AIR, V22, P356, DOI 10.1111/j.1600-0668.2012.00772.x; Wisthaler A, 2010, P NATL ACAD SCI USA, V107, P6568, DOI 10.1073/pnas.0904498106; Wong JPS, 2017, INDOOR AIR, V27, P1082, DOI 10.1111/ina.12402; Zhou SM, 2016, ENVIRON SCI TECHNOL, V50, P11688, DOI 10.1021/acs.est.6b03270; Zhou SM, 2016, ENVIRON SCI TECH LET, V3, P170, DOI 10.1021/acs.estlett.6b00086	15	63	63	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					631	+	aar6837	10.1126/science.aar6837	http://dx.doi.org/10.1126/science.aar6837			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439226				2022-12-28	WOS:000425117700019
J	Blencowe, NS; Waldon, R; Vipond, MN				Blencowe, Natalie S.; Waldon, Richard; Vipond, Mark N.			PRACTICE POINTER Management of patients after laparoscopic procedures	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGERY		[Blencowe, Natalie S.] Univ Bristol, Bristol, Avon, England; [Blencowe, Natalie S.] Severn Deanery, Bristol, Avon, England; [Waldon, Richard] Rowcroft Med Ctr, Stroud, Glos, England; [Vipond, Mark N.] Gloucestershire Hosp NHS Fdn Trust, Cheltenham, Glos, England	University of Bristol; Gloucestershire Hospitals NHS Foundation Trust	Vipond, MN (corresponding author), Gloucestershire Hosp NHS Fdn Trust, Cheltenham, Glos, England.	mark.vipond@nhs.net		Blencowe, Natalie/0000-0002-6111-2175	National Institute for Health Research [CL-2014-25-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abbott TEF, 2017, BRIT J ANAESTH, V119, P249, DOI 10.1093/bja/aex137; Agha R, 2003, J ROY SOC MED, V96, P544, DOI 10.1258/jrsm.96.11.544; Association of Laparoscopic Surgeons, REC MAN PREV ABD COM; Bartlett MA, 2015, VASC HEALTH RISK MAN, V11, P461, DOI 10.2147/VHRM.S73799; Blazeby J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2270; Blencowe NS, 2016, BRIT J SURG, V103, P1738, DOI 10.1002/bjs.10274; Cuesta MA, 2012, J THORAC DIS, V4, P462, DOI 10.3978/j.issn.2072-1439.2012.08.12; Driver and Vehicle Licensing Agency, 2017, ASS FITN DRIV GUID M; Green CJ, 2009, J PUBLIC HEALTH-UK, V31, P541, DOI 10.1093/pubmed/fdp027; Inderbitzin DT, 2007, BRIT J SURG, V94, P599, DOI 10.1002/bjs.5666; Ismail W, 2000, BRIT MED J, V321, P1056, DOI 10.1136/bmj.321.7268.1056; Janda M, 2017, JAMA-J AM MED ASSOC, V317, P1224, DOI 10.1001/jama.2017.2068; Mechanick JI, 2013, SURG OBES RELAT DIS, V9, P159, DOI 10.1016/j.soard.2012.12.010; NICE, 2015, VEN THROMB RED RISK; Pavlin DJ, 1999, ANESTHESIOLOGY, V91, P42, DOI 10.1097/00000542-199907000-00010; Rawal N, 2001, BRIT J ANAESTH, V87, P73, DOI 10.1093/bja/87.1.73; The Association of Anaesthetists of Great Britain and Ireland and the Association of Day Surgery, 2011, DAY CAS SHORT STA SU; van Vliet DCR, 2016, SURG ENDOSC, V30, P5583, DOI 10.1007/s00464-016-4931-9; Varadhan KK, 2010, CLIN NUTR, V29, P434, DOI 10.1016/j.clnu.2010.01.004; Vohra RS, 2016, BRIT J SURG, V103, P1704, DOI 10.1002/bjs.10287	20	6	6	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2018	360								k120	10.1136/bmj.k120	http://dx.doi.org/10.1136/bmj.k120			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0IA	29437677	Green Submitted			2022-12-28	WOS:000424976200001
J	Pagano, AM; Durner, GM; Rode, KD; Atwood, TC; Atkinson, SN; Peacock, E; Costa, DP; Owen, MA; Williams, TM				Pagano, A. M.; Durner, G. M.; Rode, K. D.; Atwood, T. C.; Atkinson, S. N.; Peacock, E.; Costa, D. P.; Owen, M. A.; Williams, T. M.			High-energy, high-fat lifestyle challenges an Arctic apex predator, the polar bear	SCIENCE			English	Article							SOUTHERN BEAUFORT SEA; URSUS-MARITIMUS; BODY-COMPOSITION; ACTIVITY PATTERNS; MARINE MAMMALS; METABOLIC-RATE; TEMPERATURE; POPULATION; BEHAVIOR; WATER	Regional declines in polar bear (Ursus maritimus) populations have been attributed to changing sea ice conditions, but with limited information on the causative mechanisms. By simultaneously measuring field metabolic rates, daily activity patterns, body condition, and foraging success of polar bears moving on the spring sea ice, we found that high metabolic rates (1.6 times greater than previously assumed) coupled with low intake of fat-rich marine mammal prey resulted in an energy deficit for more than half of the bears examined. Activity and movement on the sea ice strongly influenced metabolic demands. Consequently, increases in mobility resulting from ongoing and forecasted declines in and fragmentation of sea ice are likely to increase energy demands and may be an important factor explaining observed declines in body condition and survival.	[Pagano, A. M.; Durner, G. M.; Rode, K. D.; Atwood, T. C.; Peacock, E.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Pagano, A. M.; Costa, D. P.; Williams, T. M.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; [Atkinson, S. N.] Grp 7, POB 19,RR2, Dugald, MB R0E 0K0, Canada; [Owen, M. A.] San Diego Zoo Global, Inst Conservat Res, San Diego, CA 92027 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Cruz	Pagano, AM (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.; Pagano, AM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA.	apagano@usgs.gov	; Costa, Daniel/E-2616-2013	Durner, George/0000-0002-3370-1191; Rode, Karyn/0000-0002-3328-8202; Williams, Terrie/0000-0001-8170-009X; Atwood, Todd/0000-0002-1971-3110; Costa, Daniel/0000-0002-0233-5782; Owen, Megan/0000-0003-1655-3972; Pagano, Anthony/0000-0003-2176-0909	U.S. Geological Survey's Changing Arctic Ecosystems Initiative; Polar Bears International; North Pacific Research Board; Washington State University; World Wildlife Fund (Canada); San Diego Zoo Global; SeaWorld and Busch Gardens Conservation Fund; University of California, Santa Cruz; International Association for Bear Research and Management; NSF Instrument Development for Biological Research grant [1255913-015]	U.S. Geological Survey's Changing Arctic Ecosystems Initiative; Polar Bears International; North Pacific Research Board; Washington State University; World Wildlife Fund (Canada); San Diego Zoo Global; SeaWorld and Busch Gardens Conservation Fund; University of California, Santa Cruz(University of California System); International Association for Bear Research and Management; NSF Instrument Development for Biological Research grant	This work was supported by the U.S. Geological Survey's Changing Arctic Ecosystems Initiative. Additional support was provided by Polar Bears International; the North Pacific Research Board; Washington State University; World Wildlife Fund (Canada); San Diego Zoo Global; SeaWorld and Busch Gardens Conservation Fund; University of California, Santa Cruz; and the International Association for Bear Research and Management. Funding for the resting metabolic study was also provided by a NSF Instrument Development for Biological Research grant 1255913-015 (to T.M.W.). We thank M. Bakhtiari (Exeye) for developing the video collars used in this study. We thank T. Donnelly, K. Simac, and M. Spriggs for assistance in the field. We thank helicopter pilot F. Ross (Soloy Helicopters) for field support. We thank San Diego Zoo polar bear trainers T. Batson, N. Wagner, B. Wolf, and P. O'Neill. We thank members of the T.M.W. laboratory, D. Rizzolo, and B. Lyon for comments on previous drafts of the manuscript. This research used resources of the Core Science Analytics and Synthesis Applied Research Computing program at the U.S. Geological Survey. Data reported in this paper are archived at https://doi.org/10.5066/F7XW4H0P. The authors declare no competing financial interests. Any use of trade, firm, or product names is for descriptive purposes only and does not reflect endorsement by the U.S. government.	Atkinson SN, 1996, PHYSIOL ZOOL, V69, P304, DOI 10.1086/physzool.69.2.30164186; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Berta A, 2012, RETURN TO THE SEA: THE LIFE AND EVOLUTIONARY TIMES OF MARINE MAMMALS, P1, DOI 10.1525/california/9780520270572.001.0001; Bromaghin JF, 2015, ECOL APPL, V25, P634, DOI 10.1890/14-1129.1; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Costa Daniel P., 1999, P176; DEROCHER AE, 1990, MAR MAMMAL SCI, V6, P196, DOI 10.1111/j.1748-7692.1990.tb00243.x; Durner GM, 2017, GLOBAL CHANGE BIOL, V23, P3460, DOI 10.1111/gcb.13746; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Ferguson SH, 1999, ECOL LETT, V2, P311, DOI 10.1046/j.1461-0248.1999.00090.x; GEFFEN E, 1992, J ANIM ECOL, V61, P611, DOI 10.2307/5616; Griffen BD, 2018, POLAR BIOL, V41, P491, DOI 10.1007/s00300-017-2209-x; Hurst R. J., 1981, THESIS; HURST RJ, 1982, CAN J ZOOL, V60, P40, DOI 10.1139/z82-005; HURST RJ, 1982, ACTA PHYSIOL SCAND, V115, P391, DOI 10.1111/j.1748-1716.1982.tb07096.x; Kingsley M. C. S., 1998, RINGED SEALS N ATLAN, V1, P181; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; MCNAB BK, 1988, Q REV BIOL, V63, P25, DOI 10.1086/415715; MESSIER F, 1992, J ZOOL, V226, P219, DOI 10.1111/j.1469-7998.1992.tb03835.x; Molnar PK, 2009, J EXP BIOL, V212, P2313, DOI 10.1242/jeb.026146; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Paisley S, 2006, J ZOOL, V268, P25, DOI 10.1111/j.1469-7998.2005.00019.x; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Rode KD, 2018, GLOBAL CHANGE BIOL, V24, P410, DOI 10.1111/gcb.13933; Rode KD, 2014, WILDLIFE RES, V41, P311, DOI 10.1071/WR13225; Sahanatien V, 2012, ANIM CONSERV, V15, P397, DOI 10.1111/j.1469-1795.2012.00529.x; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; Stirling I, 1999, ARCTIC, V52, P294; STIRLING I, 1974, CAN J ZOOL, V52, P1191, DOI 10.1139/z74-157; STIRLING I, 1990, INT C BEAR, V8, P189; Stirling I, 2016, MAR MAMMAL SCI, V32, P13, DOI 10.1111/mms.12291; Stroeve JC, 2014, GEOPHYS RES LETT, V41, P1216, DOI 10.1002/2013GL058951; Ware JV, 2017, OECOLOGIA, V184, P87, DOI 10.1007/s00442-017-3839-y; WATTS PD, 1991, COMP BIOCHEM PHYS A, V98, P191, DOI 10.1016/0300-9629(91)90518-H; WATTS PD, 1987, PHYSIOL ZOOL, V60, P687, DOI 10.1086/physzool.60.6.30159983; Whiteman JP, 2015, SCIENCE, V349, P295, DOI 10.1126/science.aaa8623; Williams JB, 1997, ECOLOGY, V78, P2588; Williams TM, 2001, COMP BIOCHEM PHYS A, V129, P785, DOI 10.1016/S1095-6433(01)00347-6	43	89	90	3	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					568	+		10.1126/science.aan8677	http://dx.doi.org/10.1126/science.aan8677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420288				2022-12-28	WOS:000423795800040
J	Iglehart, JK				Iglehart, John K.			The Challenging Quest to Improve Rural Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; PHYSICIAN ASSISTANTS; NURSE-PRACTITIONERS; LIFE EXPECTANCY; LEADING CAUSES; WORKFORCE; HOSPITALS; MORTALITY; COUNTIES; ACCESS											Abutaleb Y, 2018, KENTUCKY BECOMES 1 U; Alfero C, 2013, FUTURE RURAL HLTH WH; Allen SM, 2013, ACAD MED, V88, P1862, DOI 10.1097/ACM.0000000000000008; American Hospital Association, 2016, ENS ACC CAR VULN COM, DOI 10.1056/NEJMhpr1707176; [Anonymous], 2015, GAO1617; [Anonymous], 2015, MORTALITY LIFE EXPEC; [Anonymous], 2012, MEDICARE HLTH CARE D, P115; Association of American Medical Colleges, 2017, RES 2016 MED SCH ENR; Case A, 2017, BROOKINGS PAP ECO AC, P397; Center for Health Reform and Modernization, 2011, 6 CTR HLTH REF MOD; Chen F, 2010, ACAD MED, V85, P594, DOI 10.1097/ACM.0b013e3181d280e9; Dark C, 2017, HEALTH AFFAIR, V36, P1712, DOI 10.1377/hlthaff.2017.0235; Dawsey J, 2018, WASHINGTON POST; Department of Veterans Affairs, 2016, FED REGISTER, V81, P90198; Dill MJ, 2013, HEALTH AFFAIR, V32, P1135, DOI 10.1377/hlthaff.2012.1150; Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918; Fahrenthold DA, 2012, WASH POST, pA1; Foutz J, 2017, ROLE MED RURAL AM; Fraher EP., 2015, STATE PHYS WORKFORCE; Garcia MC, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6602a1; Hawkins Merritt, 2017, WHITE PAPER SERIES; Hinton E., 2017, SECTION 1115 MED DEM; Hoadley J, 2017, MED SMALL TOWNS RURA; Holmes GM, 2017, J RURAL HEALTH, V33, P239, DOI 10.1111/jrh.12187; Hooker RS, 2016, J AM ASSOC NURSE PRA, V28, P39, DOI 10.1002/2327-6924.12293; Hung P., 2015, WHICH RURAL URBAN HO; Hung PY, 2017, HEALTH AFFAIR, V36, P1663, DOI 10.1377/hlthaff.2017.0338; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P1379, DOI 10.1001/jama.2013.2366; Kangovi S, 2017, AM J PUBLIC HEALTH, V107, P1660, DOI [10.2105/AJPH.2017.303985, 10.2105/ajph.2017.303985]; Lindrooth RC, 2018, HEALTH AFFAIR, V37, P111, DOI 10.1377/hlthaff.2017.0976; Lynge DC, 2008, ARCH SURG-CHICAGO, V143, P345, DOI 10.1001/archsurg.143.4.345; Malcarney MB, 2017, HEALTH SERV RES, V52, P360, DOI 10.1111/1475-6773.12657; Medicare Payment Advisory Commission, 2017, REP C MED HLTH CAR D; Medicare Payment Advisory Commission, 2016, REP C MED HLTH CAR D; Meit M, 2014, 2014 UPDATE RURAL UR; Meit M, 2017, APPALACHIAN DIS DESP; Moy E, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6601a1; Musumeci MB., 2012, GUIDE SUPREME COURTS; Newmyer Tory, 2017, WASHINGTON POST; Rabinowitz HK, 2012, ACAD MED, V87, P493, DOI 10.1097/ACM.0b013e3182488c06; Rabinowitz HK, 2011, ACAD MED, V86, P264, DOI 10.1097/ACM.0b013e31820add6c; Ricketts III TC, 1999, RURAL HLTH US; Robinson L, 2017, MMWR SURVEILL SUMM, V66, P1; ROSENBLATT RA, 1992, JAMA-J AM MED ASSOC, V268, P1559, DOI 10.1001/jama.268.12.1559; Salsberg E, 2017, DOCTOR OSTEOPATHIC M; Shipman SA, 2013, ACAD MED, V88, P1904, DOI 10.1097/ACM.0000000000000040; Singh GK, 2014, AM J PREV MED, V46, pE19, DOI 10.1016/j.amepre.2013.10.017; Smith B., 2017, RURAL BROADBAND STRA	48	34	34	2	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					473	479		10.1056/NEJMhpr1707176	http://dx.doi.org/10.1056/NEJMhpr1707176			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29385378				2022-12-28	WOS:000423783200014
J	Dyson, JK; Beuers, U; Jones, DEJ; Lohse, AW; Hudson, M				Dyson, Jessica K.; Beuers, Ulrich; Jones, David E. J.; Lohse, Ansgar W.; Hudson, Mark			Primary sclerosing cholangitis	LANCET			English	Review							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS; MAGNETIC-RESONANCE CHOLANGIOGRAPHY; DOSE URSODEOXYCHOLIC ACID; CHILD-PUGH CLASSIFICATION; BILIARY-TRACT DISEASE; NATURAL-HISTORY MODEL; BINARY HCO3-UMBRELLA; BILE-DUCT STENOSES	Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and fibrosis of bile ducts and the liver are followed by impaired bile formation or flow and progressive liver dysfunction. Patients might be asymptomatic at presentation or might have pruritus, fatigue, right upper quadrant pain, recurrent cholangitis, or sequelae of portal hypertension. The key diagnostic elements are cholestatic liver biochemistry and bile duct stricturing on cholangiography. Genetic and environmental factors are important in the cause of the disease, with the intestinal microbiome increasingly thought to play a pathogenetic role. Approximately 70% of patients have concurrent inflammatory bowel disease and patients require colonoscopic screening and surveillance. Primary sclerosing cholangitis is associated with increased malignancy risk and surveillance strategies for early cholangiocarcinoma detection are limited. No single drug has been proven to improve transplant-free survival. Liver transplantation is effective for advanced disease but at least 25% of patients develop recurrent disease in the graft.	[Dyson, Jessica K.; Jones, David E. J.; Hudson, Mark] Newcastle Univ, Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Hepatol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Dyson, Jessica K.; Jones, David E. J.; Hudson, Mark] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Lohse, Ansgar W.] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of Amsterdam; Academic Medical Center Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dyson, JK (corresponding author), Newcastle Univ, Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Hepatol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Dyson, JK (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jessica.dyson@nuth.nhs.uk						Aabakken L, 2017, J HEPATOL, V66, P1265, DOI 10.1016/j.jhep.2017.02.013; Abraham SC, 2006, AM J SURG PATHOL, V30, P1454, DOI 10.1097/01.pas.0000213286.65907.ea; Al Mamari S, 2013, J HEPATOL, V58, P329, DOI 10.1016/j.jhep.2012.10.013; Al-Chalabi T, 2008, ALIMENT PHARM THER, V28, P209, DOI 10.1111/j.1365-2036.2008.03722.x; Alabraba E, 2009, LIVER TRANSPLANT, V15, P330, DOI 10.1002/lt.21679; Alderlieste YA, 2009, DIGESTION, V79, P220, DOI 10.1159/000213364; Allison MC, 2009, GUT, V58, P869, DOI 10.1136/gut.2007.136580; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Angulo P, 2000, AM J GASTROENTEROL, V95, P2333; Angulo P, 2000, J HEPATOL, V33, P520, DOI 10.1034/j.1600-0641.2000.033004520.x; Angulo P, 2011, GASTROENTEROLOGY, V140, P180, DOI 10.1053/j.gastro.2010.10.014; Azeem N, 2014, GASTROINTEST ENDOSC, V79, P773, DOI 10.1016/j.gie.2013.09.017; Baluyut AR, 2001, GASTROINTEST ENDOSC, V53, P308, DOI 10.1067/mge.2001.112739; Bergquist A, 2002, J HEPATOL, V36, P321, DOI 10.1016/S0168-8278(01)00288-4; Bergquist A, 2008, CLIN GASTROENTEROL H, V6, P939, DOI 10.1016/j.cgh.2008.03.016; BEUERS U, 1992, HEPATOLOGY, V16, P707, DOI 10.1002/hep.1840160315; Beuers U, 2015, DIGEST DIS, V33, P176, DOI 10.1159/000440830; Beuers U, 2010, HEPATOLOGY, V52, P1489, DOI 10.1002/hep.23810; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Bjornsson E, 2004, AM J GASTROENTEROL, V99, P502, DOI 10.1111/j.1572-0241.2004.04106.x; Bjornsson E, 2002, GUT, V51, P731, DOI 10.1136/gut.51.5.731; Bjornsson E, 2008, GASTROENTEROLOGY, V134, P975, DOI 10.1053/j.gastro.2008.01.042; Bjoro K, 2006, SEMIN LIVER DIS, V26, P69, DOI 10.1055/s-2006-933565; Boberg KM, 2006, J HEPATOL, V45, P568, DOI 10.1016/j.jhep.2006.05.010; Boberg KM, 2011, J HEPATOL, V54, P374, DOI 10.1016/j.jhep.2010.09.002; Boberg KM, 2003, SCAND J GASTROENTERO, V38, P991, DOI 10.1080/00365520310005172; Boberg KM, 2002, HEPATOLOGY, V35, P652, DOI 10.1053/jhep.2002.31872; Boberg KM, 2002, SCAND J GASTROENTERO, V37, P1205, DOI 10.1080/003655202760373434; Boonstra K, 2014, HEPATOLOGY, V59, P1954, DOI 10.1002/hep.26977; Boonstra K, 2013, HEPATOLOGY, V58, P2045, DOI 10.1002/hep.26565; Boonstra K, 2012, INFLAMM BOWEL DIS, V18, P2270, DOI 10.1002/ibd.22938; Boonstra K, 2012, J HEPATOL, V56, P1181, DOI 10.1016/j.jhep.2011.10.025; Broome U, 1996, GUT, V38, P610, DOI 10.1136/gut.38.4.610; BROOME U, 1995, HEPATOLOGY, V22, P1404, DOI 10.1016/0270-9139(95)90144-2; Buckles DC, 2002, AM J GASTROENTEROL, V97, P1138; Burak KW, 2003, AM J GASTROENTEROL, V98, P1155, DOI 10.1111/j.1572-0241.2003.07401.x; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Chang JC, 2016, HEPATOLOGY, V64, P522, DOI 10.1002/hep.28550; Chapman MH, 2012, EUR J GASTROEN HEPAT, V24, P1051, DOI 10.1097/MEG.0b013e3283554bbf; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Charatcharoenwitthaya P, 2008, HEPATOLOGY, V48, P1106, DOI 10.1002/hep.22441; Charatcharoenwitthaya P, 2008, HEPATOLOGY, V47, P133, DOI 10.1002/hep.21960; Chazouilleres O, 2012, CLIN RES HEPATOL GAS, V36, pS21, DOI 10.1016/S2210-7401(12)70017-7; Chen YK, 2009, GASTROINTEST ENDOSC, V69, pAB264, DOI 10.1016/j.gie.2009.03.695; Cholongitas E, 2008, LIVER TRANSPLANT, V14, P138, DOI 10.1002/lt.21260; Claessen MMH, 2009, INFLAMM BOWEL DIS, V15, P1331, DOI 10.1002/ibd.20886; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; Corpechot C, 2014, GASTROENTEROLOGY, V146, P970, DOI 10.1053/j.gastro.2013.12.030; Dave M, 2010, RADIOLOGY, V256, P387, DOI 10.1148/radiol.10091953; Davies YK, 2008, J PEDIATR GASTR NUTR, V47, P61, DOI 10.1097/MPG.0b013e31816fee95; de Vries AB, 2015, WORLD J GASTROENTERO, V21, P1956, DOI 10.3748/wjg.v21.i6.1956; Doorenspleet ME, 2016, HEPATOLOGY, V64, P501, DOI 10.1002/hep.28568; Dyson JK, 2015, LIVER INT, V35, P1633, DOI 10.1111/liv.12709; Ehlken H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164224; Ehlken H, 2016, GUT, V65, P1230, DOI 10.1136/gutjnl-2016-311452; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Farkkila M, 2004, HEPATOLOGY, V40, P1379, DOI 10.1002/hep.20457; Fevery J, 2012, LIVER INT, V32, P214, DOI 10.1111/j.1478-3231.2011.02575.x; Floreani A, 2005, AM J GASTROENTEROL, V100, P1516, DOI 10.1111/j.1572-0241.2005.41841.x; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Fosby B, 2012, WORLD J GASTROENTERO, V18, P1, DOI 10.3748/wjg.v18.i1.1; Gossard AA, 2005, AM J GASTROENTEROL, V100, P1330, DOI 10.1111/j.1572-0241.2005.41526.x; Gotthardt DN, 2010, GASTROINTEST ENDOSC, V71, P527, DOI 10.1016/j.gie.2009.10.041; Gregorio GV, 2001, HEPATOLOGY, V33, P544, DOI 10.1053/jhep.2001.22131; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hansen JD, 2013, DIGEST DIS SCI, V58, P3079, DOI 10.1007/s10620-013-2772-0; Harnois DM, 1997, J HEPATOL, V27, P512, DOI 10.1016/S0168-8278(97)80356-X; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Hegade VS, 2016, DIGEST DIS SCI, V61, P3037, DOI 10.1007/s10620-016-4250-y; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hilscher M, 2016, ANN HEPATOL, V15, P246, DOI 10.5604/16652681.1193721; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Hohenester S, 2012, HEPATOLOGY, V55, P173, DOI 10.1002/hep.24691; Hommes DW, 2008, J CLIN GASTROENTEROL, V42, P522, DOI 10.1097/MCG.0b013e3181662426; Itoi T, 2010, CLIN GASTROENTEROL H, V8, P934, DOI 10.1016/j.cgh.2010.06.029; Ji SG, 2017, NAT GENET, V49, P269, DOI 10.1038/ng.3745; Kahaleh M, 2008, GASTROINTEST ENDOSC, V67, P446, DOI 10.1016/j.gie.2007.06.057; Kalaitzakis E, 2012, EUR J GASTROEN HEPAT, V24, P656, DOI 10.1097/MEG.0b013e3283526fa1; Kalaitzakis E, 2011, CLIN GASTROENTEROL H, V9, P800, DOI 10.1016/j.cgh.2011.05.019; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Karaahmet F, 2012, ALIMENT PHARM THER, V35, P490, DOI 10.1111/j.1365-2036.2011.04974.x; Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Katt J, 2013, HEPATOLOGY, V58, P1084, DOI 10.1002/hep.26447; Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; Khungar V, 2016, CLIN LIVER DIS, V20, P191, DOI 10.1016/j.cld.2015.08.011; Kim WR, 2000, MAYO CLIN PROC, V75, P688; Kim WR, 1999, HEPATOLOGY, V29, P1643, DOI 10.1002/hep.510290607; KNOX TA, 1994, GASTROENTEROLOGY, V106, P494, DOI 10.1016/0016-5085(94)90610-6; Kurland J, 2009, GASTROINTEST ENDOSC, V69, pAB273, DOI 10.1016/j.gie.2009.03.727; LARUSSO NF, 1988, GASTROENTEROLOGY, V95, P1036, DOI 10.1016/0016-5085(88)90180-1; Lemoinne SCC, 2015, HEPATOLOGY S1, V62; Leung UC, 2007, ANZ J SURG, V77, P355, DOI 10.1111/j.1445-2197.2007.04059.x; Linder S, 2001, HEPATO-GASTROENTEROL, V48, P387; Lindor KD, 1997, NEW ENGL J MED, V336, P691, DOI 10.1056/NEJM199703063361003; Lindor KD, 2015, AM J GASTROENTEROL, V110, P646, DOI 10.1038/ajg.2015.112; Lindor KD, 2009, HEPATOLOGY, V50, P808, DOI 10.1002/hep.23082; Lindstrom L, 2013, CLIN GASTROENTEROL H, V11, P841, DOI 10.1016/j.cgh.2012.12.032; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; LO SK, 1994, J HEPATOL, V21, P974, DOI 10.1016/S0168-8278(05)80604-X; Luth S, 2009, J CLIN GASTROENTEROL, V43, P75, DOI 10.1097/MCG.0b013e318157c614; Lunder AK, 2016, GASTROENTEROLOGY, V151, P660, DOI 10.1053/j.gastro.2016.06.021; Mahajan A, 2009, GASTROINTEST ENDOSC, V70, P303, DOI 10.1016/j.gie.2008.11.029; Mieli-Vergani G, 2009, J PEDIATR GASTR NUTR, V49, P158, DOI 10.1097/MPG.0b013e3181a1c265; Molodecky NA, 2011, HEPATOLOGY, V53, P1590, DOI 10.1002/hep.24247; Murad SD, 2012, GASTROENTEROLOGY, V143, P88, DOI 10.1053/j.gastro.2012.04.008; Naitoh I, 2015, J GASTROEN HEPATOL, V30, P1104, DOI 10.1111/jgh.12894; Navaneethan U, 2015, GASTROINTEST ENDOSC, V81, P943, DOI 10.1016/j.gie.2014.09.041; Navaneethan U, 2014, GASTROINTEST ENDOSC, V79, P943, DOI 10.1016/j.gie.2013.11.001; Negm AA, 2010, GASTROINTEST ENDOSC, V72, P284, DOI 10.1016/j.gie.2010.02.043; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Olsson R, 2005, GASTROENTEROLOGY, V129, P1464, DOI 10.1053/j.gastro.2005.08.017; OLSSON R, 1995, GASTROENTEROLOGY, V108, P1199, DOI 10.1016/0016-5085(95)90220-1; Pohl J, 2006, EUR J GASTROEN HEPAT, V18, P69, DOI 10.1097/00042737-200601000-00012; Ponsioen C, 2017, J HEPATOL, V66, pS1, DOI 10.1016/S0168-8278(17)30265-9; Ponsioen CY, 1999, ENDOSCOPY, V31, P305; Ponsioen CY, 2002, GUT, V51, P562, DOI 10.1136/gut.51.4.562; Ponsioen CY, 2016, HEPATOLOGY, V63, P1357, DOI 10.1002/hep.28256; Ravi K, 2009, INFLAMM BOWEL DIS, V15, P1326, DOI 10.1002/ibd.20898; Rea DJ, 2005, ANN SURG, V242, P451, DOI 10.1097/01.sla.0000179678.13285.fa; Rizvi S, 2015, CLIN GASTROENTEROL H, V13, P2152, DOI 10.1016/j.cgh.2015.05.035; Rudolph G, 2009, J HEPATOL, V51, P149, DOI 10.1016/j.jhep.2009.01.023; Rupp C, 2014, ALIMENT PHARM THER, V40, P1292, DOI 10.1111/apt.12979; Rupp C, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0562-8; Sabino J, 2016, GUT, V65, P1681, DOI 10.1136/gutjnl-2015-311004; Sandanayake NS, 2009, CLIN GASTROENTEROL H, V7, P1089, DOI 10.1016/j.cgh.2009.03.021; Schramm C, 1999, ANN INTERN MED, V131, P943, DOI 10.7326/0003-4819-131-12-199912210-00006; Schramm C, 2017, HEPATOLOGY, V66, P1675, DOI 10.1002/hep.29293; SCHRUMPF E, 1994, J HEPATOL, V21, P1061, DOI 10.1016/S0168-8278(05)80618-X; Shetty K, 1997, HEPATOLOGY, V25, P1049, DOI 10.1002/hep.510250501; Stanich PP, 2011, DIGEST LIVER DIS, V43, P309, DOI 10.1016/j.dld.2010.12.008; Stiehl A, 2002, J HEPATOL, V36, P151, DOI 10.1016/S0168-8278(01)00251-3; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Tabibian JH, 2013, ALIMENT PHARM THER, V37, P604, DOI 10.1111/apt.12232; Tabibian JH, 2016, HEPATOLOGY, V64, P340, DOI 10.1002/hep.28624; Talwalkar JA, 2005, AM J GASTROENTEROL, V100, P308, DOI 10.1111/j.1572-0241.2005.40484.x; Talwalkar JA, 2007, LIVER INT, V27, P451, DOI 10.1111/j.1478-3231.2007.01441.x; Tanaka A, 2008, LIVER INT, V28, P983, DOI 10.1111/j.1478-3231.2008.01726.x; Tanaka A, 2014, J HEPATO-BIL-PAN SCI, V21, P43, DOI 10.1002/jhbp.50; Terjung B, 2005, CLIN REV ALLERG IMMU, V28, P115, DOI 10.1385/CRIAI:28:2:115; Tischendorf JJW, 2006, ENDOSCOPY, V38, P665, DOI 10.1055/s-2006-925257; Tischendorf JJW, 2007, AM J GASTROENTEROL, V102, P107, DOI 10.1111/j.1572-0241.2006.00872.x; Trikudanathan G, 2014, GASTROINTEST ENDOSC, V79, P783, DOI 10.1016/j.gie.2013.09.015; vandeMeeberg PC, 1996, GUT, V39, P594, DOI 10.1136/gut.39.4.594; Vesterhus M, 2015, HEPATOLOGY, V62, P188, DOI 10.1002/hep.27825; Weismuller TJ, 2017, GASTROENTEROLOGY, V152, P1975, DOI 10.1053/j.gastro.2017.02.038; Wenniger LJMD, 2015, DIGEST DIS, V33, P397, DOI 10.1159/000371864; Wenniger LJMD, 2013, HEPATOLOGY, V57, P2390, DOI 10.1002/hep.26232; WIESNER RH, 1989, HEPATOLOGY, V10, P430, DOI 10.1002/hep.1840100406; Wu YM, 2008, LIVER TRANSPLANT, V14, P279, DOI 10.1002/lt.21287; Zein CO, 2004, HEPATOLOGY, V39, P204, DOI 10.1002/hep.20029; Zenouzi R, 2014, J HEPATOL, V61, P1189, DOI 10.1016/j.jhep.2014.08.002; Zenouzi R, 2014, CLIN GASTROENTEROL H, V12, P1733, DOI 10.1016/j.cgh.2014.02.008	154	145	156	3	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2018	391	10139					2547	2559		10.1016/S0140-6736(18)30300-3	http://dx.doi.org/10.1016/S0140-6736(18)30300-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK7QP	29452711				2022-12-28	WOS:000436403700029
J	Kaufmann, R; Halm, JA; Eker, HH; Klitsie, PJ; Nieuwenhuizen, J; van Geldere, D; Simons, MP; van der Harst, E; van't Riet, M; van der Holt, B; Kleinrensink, GJ; Jeekel, J; Lange, JF				Kaufmann, Ruth; Halm, Jens A.; Eker, Hasan H.; Klitsie, Pieter J.; Nieuwenhuizen, Jeroen; van Geldere, Dick; Simons, Maarten P.; van der Harst, Erwin; van't Riet, Martijne; van der Holt, Bronno; Kleinrensink, Gert Jan; Jeekel, Johannes; Lange, Johan F.			Mesh versus suture repair of umbilical hernia in adults: a randomised, double-blind, controlled, multicentre trial	LANCET			English	Article							TERM-FOLLOW-UP; PRIMARY INGUINAL-HERNIA; ABDOMINAL-WALL HERNIAS; INCISIONAL HERNIA; CLINICAL-TRIAL; EPIGASTRIC HERNIAS.; ELECTIVE REPAIR; RECURRENCE; EXPERIENCE	Background Both mesh and suture repair are used for the treatment of umbilical hernias, but for smaller umbilical hernias (diameter 1-4 cm) there is little evidence whether mesh repair would be beneficial. In this study we aimed to investigate whether use of a mesh was better in reducing recurrence compared with suture repair for smaller umbilical hernias. Methods We did a randomised, double-blind, controlled multicentre trial in 12 hospitals (nine in the Netherlands, two in Germany, and one in Italy). Eligible participants were adults aged at least 18 years with a primary umbilical hernia of diameter 1-4 cm, and were randomly assigned (1: 1) intraoperatively to either suture repair or mesh repair. In the first 3 years of the inclusion period, blocked randomisation (of non-specified size) was achieved by an envelope randomisation system; after this time computer-generated randomisation was introduced. Patients, investigators, and analysts were masked to the allocated treatment, and participants were stratified by hernia size (1-2 cm and > 2-4 cm). At study initiation, all surgeons were invited to training sessions to ensure they used the same standardised techniques for suture repair or mesh repair. Patients underwent physical examinations at 2 weeks, and 3, 12, and 24-30 months after the operation. The primary outcome was the rate of recurrences of the umbilical hernia after 24 months assessed in the modified intention-to-treat population by physical examination and, in case of any doubt, abdominal ultrasound. This trial is registered with ClinicalTrials.gov, number NCT00789230. Findings Between June 21, 2006, and April 16, 2014, we randomly assigned 300 patients, 150 to mesh repair and 150 to suture repair. The median follow-up was 25.1 months (IQR 15.5-33.4). After a maximum follow-up of 30 months, there were fewer recurrences in the mesh group than in the suture group (six [4%] in 146 patients vs 17 [12%] in 138 patients; 2-year actuarial estimates of recurrence 3.6% [95% CI 1.4-9.4] vs 11.4% (6.8-18.9); p=0.01, hazard ratio 0.31, 95% CI 0.12-0.80, corresponding to a number needed to treat of 12.8). The most common postoperative complications were seroma (one [< 1%] in the suture group vs five [3%] in the mesh group), haematoma (two [1%] vs three [2%]), and wound infection (one [< 1%] vs three [2%]). There were no anaesthetic complications or postoperative deaths. Interpretation This is the first study showing high level evidence for mesh repair in patients with small hernias of diameter 1-4 cm. Hence we suggest mesh repair should be used for operations on all patients with an umbilical hernia of this size.	[Kaufmann, Ruth; Eker, Hasan H.; Klitsie, Pieter J.; Nieuwenhuizen, Jeroen; Lange, Johan F.] Erasmus Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands; [Kaufmann, Ruth] Albert Schweitzer Hosp, Dept Surg, Dordrecht, Netherlands; [Halm, Jens A.] Acad Med Ctr, Dept Surg, Trauma Unit, Amsterdam, Netherlands; [Eker, Hasan H.] Vrije Univ Amsterdam Med Ctr, Dept Surg, Amsterdam, Netherlands; [Klitsie, Pieter J.] HagaZiekenhuis, Dept Orthopaed Surg, The Hague, Netherlands; [Nieuwenhuizen, Jeroen] LUMC, Dept Surg, Leiden, Netherlands; [van Geldere, Dick] Isala, Dept Surg, Zwolle, Netherlands; [Simons, Maarten P.] Onze Lieve Vrouw Hosp, Dept Surg, Amsterdam, Netherlands; [van der Harst, Erwin] Maasstad Hosp, Dept Surg, Rotterdam, Netherlands; [van't Riet, Martijne] Reinier de Graaf Gasthuis, Dept Surg, Delft, Netherlands; [van der Holt, Bronno] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands; [Kleinrensink, Gert Jan; Jeekel, Johannes] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Albert Schweitzer Ziekenhuis; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Haga Hospital; Leiden University; Leiden University Medical Center (LUMC); Onze Lieve Vrouwe Gasthuis Hospital; Maasstad Hospital; Reinier de Graaf Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Kaufmann, R (corresponding author), Erasmus Univ, Med Ctr, NL-3015 CN Rotterdam, Netherlands.	ruth.kaufmann@gmail.com	Kaufmann, Ruth/N-8235-2019	Kaufmann, Ruth/0000-0003-1039-0607; van der Holt, Bronno/0000-0001-6414-2671; Halm, Jens/0000-0002-3649-0609	Department of Surgery, Erasmus University Medical Center, Rotterdam, Netherlands	Department of Surgery, Erasmus University Medical Center, Rotterdam, Netherlands	Department of Surgery, Erasmus University Medical Center, Rotterdam, Netherlands.	Abdel-Baki N A, 2007, Hernia, V11, P163, DOI 10.1007/s10029-007-0189-4; Arroyo A, 2001, BRIT J SURG, V88, P1321, DOI 10.1046/j.0007-1323.2001.01893.x; Asolati M, 2006, AM J SURG, V192, P627, DOI 10.1016/j.amjsurg.2006.08.022; Berger RL, 2014, J SURG RES, V192, P426, DOI 10.1016/j.jss.2014.05.080; Burger JWA, 2004, ANN SURG, V240, P578; Christoffersen MW, 2013, WORLD J SURG, V37, P2548, DOI 10.1007/s00268-013-2160-0; Christoffersen MW, 2015, AM J SURG, V209, P725, DOI 10.1016/j.amjsurg.2014.05.021; Dalenback J, 2013, HERNIA, V17, P493, DOI 10.1007/s10029-012-0988-0; Erritzoe-Jervild L, 2013, HERNIA, V17, P211, DOI 10.1007/s10029-012-0960-z; Eryilmaz R, 2006, INT SURG, V91, P258; Farrow B, 2008, AM J SURG, V196, P647, DOI 10.1016/j.amjsurg.2008.07.018; Fayers P., 2007, QUALITY LIFE ASSESSM; Halm J A, 2005, Hernia, V9, P334, DOI 10.1007/s10029-005-0010-1; Knook MTT, 2001, SURG ENDOSC-ULTRAS, V15, P1471, DOI 10.1007/s00464-001-0048-9; Kohler G, 2015, WORLD J SURG, V39, P121, DOI 10.1007/s00268-014-2765-y; Kulah B, 2001, AM J SURG, V181, P101, DOI 10.1016/S0002-9610(00)00563-8; Lal K, 2012, MED CHANNEL, V19, P110; Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603; Malik A M, 2008, J Ayub Med Coll Abbottabad, V20, P54; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mayo WJ, 1904, ANN SURG, V34, P276, DOI 10.1097/00000658-190107000-00021; Murtaza B, 2009, JCPSP-J COLL PHYSICI, V19, P763, DOI 12.2009/JCPSP.763767; Muysoms FE, 2009, HERNIA, V13, P407, DOI 10.1007/s10029-009-0518-x; Polat C, 2005, AM J SURG, V190, P61, DOI 10.1016/j.amjsurg.2004.09.021; Sadiq F, 2013, PAK J MED HEALTH SCI, V7, P926; Schumacher OP, 2003, CHIRURG, V74, P50, DOI 10.1007/s00104-002-0536-z; Stabilini C, 2009, ANN ITAL CHIR, V80, P183; Tollens T, 2011, HERNIA, V15, P531, DOI 10.1007/s10029-011-0816-y; van Veen RN, 2007, BRIT J SURG, V94, P506, DOI 10.1002/bjs.5627; van Veen RN, 2008, ANN SURG, V247, P428, DOI 10.1097/SLA.0b013e318165b0ff; Venclauskas L, 2008, MEDICINA-LITHUANIA, V44, P855, DOI 10.3390/medicina44110108; Vrijland WW, 2002, BRIT J SURG, V89, P293, DOI 10.1046/j.0007-1323.2001.02030.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Witherspoon P, 2005, Hernia, V9, P259, DOI 10.1007/s10029-005-0331-0	35	81	80	2	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2018	391	10123					860	869		10.1016/S0140-6736(18)30298-8	http://dx.doi.org/10.1016/S0140-6736(18)30298-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX9XF	29459021				2022-12-28	WOS:000426463500023
J	Mai, LM; Oczkowski, W				Mai, Lauren M.; Oczkowski, Wes			Late thrombectomy reduced disability in acute stroke with mismatched clinical deficit and infarction volume	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mai, Lauren M.; Oczkowski, Wes] McMaster Univ, Hamilton, ON, Canada	McMaster University	Mai, LM (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC17	JC17		10.7326/ACPJC-2018-168-4-017	http://dx.doi.org/10.7326/ACPJC-2018-168-4-017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459954				2022-12-28	WOS:000425434000005
J	Bao, YM; Zheng, YJ				Bao, Yanmin; Zheng, YueJie			Drug-Resistant Miliary Tuberculosis in a Child	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bao, Yanmin; Zheng, YueJie] Shenzhen Childrens Hosp, Shenzhen, Peoples R China		Zheng, YJ (corresponding author), Shenzhen Childrens Hosp, Shenzhen, Peoples R China.	yuejiez@sina.com							0	0	0	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					E10	E10		10.1056/NEJMicm1706353	http://dx.doi.org/10.1056/NEJMicm1706353			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW0QK	29443677				2022-12-28	WOS:000425000000001
J	Amo, A				Amo, Alberto			When quantum optics meets topology	SCIENCE			English	Editorial Material							INSULATOR		[Amo, Alberto] Univ Lille, CNRS, UMR 8523, Lab Phys Lasers Atomes & Mol PhLAM, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lille - ISITE; Universite de Lille	Amo, A (corresponding author), Univ Lille, CNRS, UMR 8523, Lab Phys Lasers Atomes & Mol PhLAM, F-59000 Lille, France.	alberto.amo@univ-lille1.fr						Barik S, 2018, SCIENCE, V359, P666, DOI 10.1126/science.aaq0327; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; He C, 2016, NAT PHYS, V12, P1124, DOI [10.1038/nphys3867, 10.1038/NPHYS3867]; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Khanikaev AB, 2013, NAT MATER, V12, P233, DOI [10.1038/nmat3520, 10.1038/NMAT3520]; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lodahl P, 2017, NATURE, V541, P473, DOI 10.1038/nature21037; Lu L., 2014, NAT PHOTONICS; Piggott AY, 2015, NAT PHOTONICS, V9, P374, DOI [10.1038/nphoton.2015.69, 10.1038/NPHOTON.2015.69]; Sollner I, 2015, NAT NANOTECHNOL, V10, P775, DOI [10.1038/NNANO.2015.159, 10.1038/nnano.2015.159]; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Wu LH, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.223901; Yves S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16023	13	5	5	4	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					638	639	aar7396	10.1126/science.aar7396	http://dx.doi.org/10.1126/science.aar7396			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439230				2022-12-28	WOS:000425117700023
J	Vampa, G; Hammond, TJ; Nesrallah, M; Naumov, AY; Corkum, PB; Brabec, T				Vampa, G.; Hammond, T. J.; Nesrallah, M.; Naumov, A. Yu.; Corkum, P. B.; Brabec, T.			Light amplification by seeded Kerr instability	SCIENCE			English	Article							MODULATIONAL INSTABILITY; PARAMETRIC AMPLIFICATION; OPTICAL PULSES; Z-SCAN; GENERATION	Amplification of femtosecond laser pulses typically requires a lasing medium or a nonlinear crystal. In either case, the chemical properties of the lasing medium or the momentum conservation in the nonlinear crystal constrain the frequency and the bandwidth of the amplified pulses. We demonstrate high gain amplification (greater than 1000) of widely tunable (0.5 to 2.2 micrometers) and short (less than 60 femtosecond) laser pulses, up to intensities of 1 terawatt per square centimeter, by seeding the modulation instability in an Y3Al5O12 crystal pumped by femtosecond near-infrared pulses. Ourmethod avoids constraints related to doping and phase matching and therefore can occur in a wider pool of glasses and crystals even at far-infrared frequencies and for single-cycle pulses. Such amplified pulses are ideal to study strong-field processes in solids and highly excited states in gases.	[Vampa, G.; Hammond, T. J.; Nesrallah, M.; Corkum, P. B.; Brabec, T.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Vampa, G.] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA; [Naumov, A. Yu.; Corkum, P. B.] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada	University of Ottawa; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National Research Council Canada	Vampa, G; Brabec, T (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.; Vampa, G (corresponding author), SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA.	gvampa@stanford.edu; thomas.brabec@uottawa.ca		Corkum, Paul/0000-0003-3394-5572	Air Force Office of Scientific Research (AFOSR) [FA9550-16-1-0109]; AFOSR Multidisciplinary University Research Initiative grant [FA9550-15-1-0037]; Canada's National Research Council; Natural Sciences and Engineering Research Council	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); AFOSR Multidisciplinary University Research Initiative grant; Canada's National Research Council; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	We acknowledge valuable financial support from the Air Force Office of Scientific Research (AFOSR) under award FA9550-16-1-0109, the AFOSR Multidisciplinary University Research Initiative grant FA9550-15-1-0037, and from Canada's National Research Council and Natural Sciences and Engineering Research Council. The authors declare no competing financial interests. G.V. thanks B. Schmidt for insightful discussions. All data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials.	Alam MZ, 2016, SCIENCE, V352, P795, DOI 10.1126/science.aae0330; BAUMGARTNER RA, 1979, IEEE J QUANTUM ELECT, V15, P432, DOI 10.1109/JQE.1979.1070043; Boyd R. W., 2003, NONLINEAR OPTICS; DUBIETIS A, 1992, OPT COMMUN, V88, P437, DOI 10.1016/0030-4018(92)90070-8; Dudley JM, 2014, NAT PHOTONICS, V8, DOI [10.1038/nphoton.2014.220, 10.1038/NPHOTON.2014.220]; Eichmann U, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203002; Gattass RR, 2008, NAT PHOTONICS, V2, P219, DOI 10.1038/nphoton.2008.47; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Kip D, 2000, SCIENCE, V290, P495, DOI 10.1126/science.290.5491.495; Krauss G, 2010, NAT PHOTONICS, V4, P33, DOI 10.1038/NPHOTON.2009.258; Krogen P, 2017, NAT PHOTONICS, V11, P222, DOI [10.1038/nphoton.2017.34, 10.1038/NPHOTON.2017.34]; Kruger M, 2011, NATURE, V475, P78, DOI 10.1038/nature10196; Liang HK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00193-4; LIOU LW, 1992, PHYS REV A, V46, P4202, DOI 10.1103/PhysRevA.46.4202; Manzoni C, 2016, J OPTICS-UK, V18, DOI 10.1088/2040-8978/18/10/103501; Nesrallah M., 2017, ARXIV171104417PHYSIC; Nikogosyan D. N., 2006, NONLINEAR OPTICAL CR; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schmidt BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4643; Smektala F, 2000, J NON-CRYST SOLIDS, V274, P232, DOI 10.1016/S0022-3093(00)00215-5; STRICKLAND D, 1985, OPT COMMUN, V55, P447, DOI 10.1016/0030-4018(85)90151-8; TAI K, 1986, PHYS REV LETT, V56, P135, DOI 10.1103/PhysRevLett.56.135; TAI K, 1986, APPL PHYS LETT, V49, P236, DOI 10.1063/1.97181; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Wirth A, 2011, SCIENCE, V334, P195, DOI 10.1126/science.1210268; Zhang H, 2012, OPT LETT, V37, P1856, DOI 10.1364/OL.37.001856	28	11	11	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					673	+		10.1126/science.aaq0053	http://dx.doi.org/10.1126/science.aaq0053			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439240	Green Submitted			2022-12-28	WOS:000425117700037
J	Kampouri, E; Vaucher, J				Kampouri, Eleftheria; Vaucher, Julien			Electrocardiographic Changes in Hypothermia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kampouri, Eleftheria; Vaucher, Julien] Lausanne Univ Hosp, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kampouri, E (corresponding author), Lausanne Univ Hosp, Lausanne, Switzerland.	eleftheria-evdokia.kampouri@chuv.ch		Vaucher, Julien/0000-0002-3230-3693; Kampouri, Eleftheria/0000-0001-8019-3073					0	0	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					460	460		10.1056/NEJMicm1704534	http://dx.doi.org/10.1056/NEJMicm1704534			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29385369	Green Published			2022-12-28	WOS:000423783200010
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Doctors and families must be able to work together for safer care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Clinical Human Factors Group, MANIFESTO; Clinical Human Factors Group, MART BROM; Cohen D, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5534; Dyer C, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k417	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2018	360								k443	10.1136/bmj.k443	http://dx.doi.org/10.1136/bmj.k443			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TQ	29386319	Green Published, Bronze			2022-12-28	WOS:000423845900006
J	Tu, HK; Wen, CP; Tsai, SP; Chow, WH; Wen, C; Ye, YQ; Zhao, H; Tsai, MK; Huang, MS; Dinney, CP; Tsao, CK; Wu, XF				Tu, Huakang; Wen, Chi Pang; Tsai, Shan Pou; Chow, Wong-Ho; Wen, Christopher; Ye, Yuanqing; Zhao, Hua; Tsai, Min Kuang; Huang, Maosheng; Dinney, Colin P.; Tsao, Chwen Keng; Wu, Xifeng			Cancer risk associated with chronic diseases and disease markers: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC KIDNEY-DISEASE; SERUM URIC-ACID; FOLLOW-UP; DIABETES-MELLITUS; PHYSICAL-ACTIVITY; CHOLESTEROL LEVELS; BLOOD-PRESSURE; ALL-CAUSE; MORTALITY; POPULATION	OBJECTIVES To assess the independent and joint associations of major chronic diseases and disease markers with cancer risk and to explore the benefit of physical activity in reducing the cancer risk associated with chronic diseases and disease markers. DESIGN Prospective cohort study. SETTING Standard medical screening program in Taiwan. PARTICIPANTS 405 878 participants, for whom cardiovascular disease markers (blood pressure, total cholesterol, and heart rate), diabetes, chronic kidney disease markers (proteinuria and glomerular filtration rate), pulmonary disease, and gouty arthritis marker (uric acid) were measured or diagnosed according to standard methods, were followed for an average of 8.7 years. MAIN OUTCOME MEASURES Cancer incidence and cancer mortality. RESULTS A statistically significantly increased risk of incident cancer was observed for the eight diseases and markers individually (except blood pressure and pulmonary disease), with adjusted hazard ratios ranging from 1.07 to 1.44. All eight diseases and markers were statistically significantly associated with risk of cancer death, with adjusted hazard ratios ranging from 1.12 to 1.70. Chronic disease risk scores summarizing the eight diseases and markers were positively associated with cancer risk in a dose-response manner, with the highest scores associated with a 2.21-fold (95% confidence interval 1.77-fold to 2.75-fold) and 4.00-fold (2.84-fold to 5.63-fold) higher cancer incidence and cancer mortality, respectively. High chronic disease risk scores were associated with substantial years of life lost, and the highest scores were associated with 13.3 years of life lost in men and 15.9 years of life lost in women. The population attributable fractions of cancer incidence or cancer mortality from the eight chronic diseases and markers together were comparable to those from five major lifestyle factors combined (cancer incidence: 20.5% v 24.8%; cancer mortality: 38.9% v 39.7%). Among physically active (versus inactive) participants, the increased cancer risk associated with chronic diseases and markers was attenuated by 48% for cancer incidence and 27% for cancer mortality. CONCLUSIONS Chronic disease is an overlooked risk factor for cancer, as important as five major lifestyle factors combined. In this study, chronic diseases contributed to more than one fifth of the risk for incident cancer and more than one third of the risk for cancer death. Physical activity is associated with a nearly 40% reduction in the cancer risk associated with chronic diseases.	[Tu, Huakang; Chow, Wong-Ho; Ye, Yuanqing; Zhao, Hua; Huang, Maosheng; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wen, Chi Pang; Tsai, Min Kuang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Wen, Chi Pang] China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung, Taiwan; [Wen, Chi Pang] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Tsai, Shan Pou] MJ Hlth Res Fdn, Taipei, Taiwan; [Wen, Christopher] Univ Calif Irvine, Radiol, Long Beach Vet Adm Hosp, Irvine, CA USA; [Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Tsao, Chwen Keng] MJ Hlth Management Inst, Taipei, Taiwan	University of Texas System; UTMD Anderson Cancer Center; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of Texas System; UTMD Anderson Cancer Center	Wu, XF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org		Dinney, Colin/0000-0002-8969-711X	NCI [R01 CA170298, R01 CA180083]; Center for Transnational and Public Health Genomics at MD Anderson Cancer Center; Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW107-TDU-B-212-123004]; NATIONAL CANCER INSTITUTE [R01CA170298, R01CA180083] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Transnational and Public Health Genomics at MD Anderson Cancer Center; Taiwan Ministry of Health and Welfare Clinical Trial Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI R01 CA170298 to XW, NCI R01 CA180083 to XW, Center for Transnational and Public Health Genomics at MD Anderson Cancer Center, and in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW107-TDU-B-212-123004). The funding source had no role in study design, data collection, data analysis, data interpretation, writing of the report, or the decision to submit the paper for publication. XW had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Batty GD, 2003, BRIT J CANCER, V89, P1243, DOI 10.1038/sj.bjc.6601255; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Blendon RJ, 2011, KEY FINDINGS 5 COUNT; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Chiang CL, 1984, LIFE TABLE ITS APPL; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CP Wild, 2014, WORLD CANC REPORT 20; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Fini MA, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-16; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOB STRAT DIAGN MAN; Goon PKY, 2007, CURR PHARM DESIGN, V13, P2539, DOI 10.2174/138161207781663073; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; Iff S, 2014, AM J KIDNEY DIS, V63, P23, DOI 10.1053/j.ajkd.2013.07.008; Iso H, 2009, INT J CANCER, V125, P2679, DOI 10.1002/ijc.24668; Jacobs EJ, 2009, CANCER EPIDEM BIOMAR, V18, P2805, DOI 10.1158/1055-9965.EPI-09-1027; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jouven X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021310; Kitahara CM, 2011, J CLIN ONCOL, V29, P1592, DOI 10.1200/JCO.2010.31.5200; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Lam EKK, 2011, ANN ONCOL, V22, P730, DOI 10.1093/annonc/mdq405; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lin CC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-381; Lowrance WT, 2014, J AM SOC NEPHROL, V25, P2327, DOI 10.1681/ASN.2013060604; Mok Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153429; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; SabatU E., 2003, ADHERENCE LONG TERM; Saito E, 2016, CANCER SCI, V107, P521, DOI 10.1111/cas.12902; SCHATZKIN A, 1987, LANCET, V2, P298; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; SHERWIN RW, 1987, JAMA-J AM MED ASSOC, V257, P943; Song YM, 2000, AM J EPIDEMIOL, V151, P739, DOI 10.1093/oxfordjournals.aje.a010272; Stengel B, 2010, J NEPHROL, V23, P253; Stocks T, 2015, INT J EPIDEMIOL, V44, P1353, DOI 10.1093/ije/dyv001; Stocks T, 2012, HYPERTENSION, V59, P802, DOI 10.1161/HYPERTENSIONAHA.111.189258; Strasak AM, 2007, ANN ONCOL, V18, P1893, DOI 10.1093/annonc/mdm338; Strasak AM, 2007, CANCER CAUSE CONTROL, V18, P1021, DOI 10.1007/s10552-007-9043-3; Strasak AM, 2009, ANN EPIDEMIOL, V19, P15, DOI 10.1016/j.annepidem.2008.08.009; Strohmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054242; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Taghizadeh N, 2014, CANCER CAUSE CONTROL, V25, P1075, DOI 10.1007/s10552-014-0408-0; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WANNAMETHEE G, 1993, AM J EPIDEMIOL, V137, P735, DOI 10.1093/oxfordjournals.aje.a116734; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; WHO, 2003, WHO TECH REP SER, V916, P1; who.int, 2009, WHO GLOB HLTH RISKS; Wong G, 2009, J AM SOC NEPHROL, V20, P1341, DOI 10.1681/ASN.2008090998; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2007, CANCER CONTROL KNOWL; World Health Organization, DEF DIAGN DIAB MELL; Wu XF, 2017, INT J EPIDEMIOL, V46, P1744, DOI 10.1093/ije/dyw282	57	65	73	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2018	360								k134	10.1136/bmj.k134	http://dx.doi.org/10.1136/bmj.k134			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TQ	29386192	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000423845900001
J	Watts, G				Watts, Geoff			Viroj Tangcharoensathien: master carpenter of Thai health care	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2022	399	10327					E9	E9		10.1016/S0140-6736(18)30055-2	http://dx.doi.org/10.1016/S0140-6736(18)30055-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZJ4WT	29397199				2022-12-28	WOS:000762307100002
J	Heinemann, L; Freckmann, G; Ehrmann, D; Faber-Heinemann, G; Guerra, S; Waldenmaier, D; Hermanns, N				Heinemann, Lutz; Freckmann, Guido; Ehrmann, Dominic; Faber-Heinemann, Gabriele; Guerra, Stefania; Waldenmaier, Delia; Hermanns, Norbert			Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial	LANCET			English	Article							PUMP THERAPY; GLYCEMIC CONTROL; CLINICAL-TRIAL; MELLITUS; METAANALYSIS; UNAWARENESS; DIAMOND; RISK; IDDM	Background The effectiveness of real-time continuous glucose monitoring (rtCGM) in avoidance of hypoglycaemia among high-risk individuals with type 1 diabetes treated with multiple daily insulin injections (MDI) is unknown. We aimed to ascertain whether the incidence and severity of hypoglycaemia can be reduced through use of rtCGM in these individuals. Methods The HypoDE study was a 6-month, multicentre, open-label, parallel, randomised controlled trial done at 12 diabetes practices in Germany. Eligible participants had type 1 diabetes and a history of impaired hypoglycaemia awareness or severe hypoglycaemia during the previous year. All participants wore a masked rtCGM system for 28 days and were then randomly assigned to 26 weeks of unmasked rtCGM (Dexcom G5 Mobile system) or to the control group (continuing with self-monitoring of blood glucose). Block randomisation with 1:1 allocation was done centrally, with the study site as the stratifying variable. Masking of participants and study sites was not possible. Control participants wore a masked rtCGM system during the follow-up phase (weeks 22-26). The primary outcome was the baseline-adjusted number of hypoglycaemic events (defined as glucose <= 3.0 mmol/L for >= 20 min) during the follow-up phase. The full dataset analysis comprised participants who wore the rtCGM system during the baseline and follow-up phases. The intention-to-treat analysis comprised all randomised participants. This trial is registered with ClinicalTrials.gov, number NCT02671968. Findings Between March 4, 2016, and Jan 12, 2017, 149 participants were randomly assigned (n=74 to the control group; n=75 to the rtCGM group) and 141 completed the follow-up phase (n=66 in the control group, n=75 in the rtCGM group). The mean number of hypoglycaemic events per 28 days among participants in the rtCGM group was reduced from 10.8 (SD 10.0) to 3.5 (4.7); reductions among control participants were negligible (from 14.4 [12.4] to 13.7 [11.6]). Incidence of hypoglycaemic events decreased by 72% for participants in the rtCGM group (incidence rate ratio 0. 28 [95% CI 0.20-0.39], p<0.0001). 18 serious adverse events were reported: seven in the control group, ten in the rtCGM group, and one before randomisation. No event was considered to be related to the investigational device. Interpretation Usage of rtCGM reduced the number of hypoglycaemic events in individuals with type 1 diabetes treated by MDI and with impaired hypoglycaemia awareness or severe hypoglycaemia.	[Heinemann, Lutz; Faber-Heinemann, Gabriele] Sci Consulting Diabet GmbH, Dusseldorf, Germany; [Freckmann, Guido; Waldenmaier, Delia] Univ Ulm, IDT, Forschungs & Entwicklungsgesell mbH, Ulm, Germany; [Ehrmann, Dominic; Hermanns, Norbert] Diabet Acad Mergentheim FIDAM, Diabet Res Inst, D-97980 Bad Mergentheim, Germany; [Ehrmann, Dominic; Hermanns, Norbert] Univ Bamberg, Dept Clin Psychol & Psychotherapy, Bamberg, Germany; [Guerra, Stefania] Dexcom Inc, San Diego, CA USA	Ulm University; Otto Friedrich University Bamberg	Hermanns, N (corresponding author), Diabet Acad Mergentheim FIDAM, Diabet Res Inst, D-97980 Bad Mergentheim, Germany.	hermanns@fidam.de	Freckmann, Guido/AAQ-7377-2020; Hermanns, Norbert/AAG-7060-2020	Freckmann, Guido/0000-0002-0406-9529; Hermanns, Norbert/0000-0002-2903-2677; Ehrmann, Dominic/0000-0002-5794-5596	Dexcom Inc	Dexcom Inc	Dexcom Inc.	[Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Battelino T, 2012, DIABETOLOGIA, V55, P3155, DOI 10.1007/s00125-012-2708-9; Battelino T, 2011, DIABETES CARE, V34, P795, DOI 10.2337/dc10-1989; Beck RW, 2017, LANCET DIABETES ENDO, V5, P700, DOI 10.1016/S2213-8587(17)30217-6; Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975; Beck Roy W, 2011, J Diabetes Sci Technol, V5, P999; Boehm BO, THERAPIE DIABETES ME; CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; El Youssef J, 2016, LANCET DIABETES ENDO, V4, P874, DOI 10.1016/S2213-8587(16)30261-3; Fanelli CG, 1998, DIABETOLOGIA, V41, P720, DOI 10.1007/s001250050974; Fisher L, 2015, J DIABETES COMPLICAT, V29, P572, DOI 10.1016/j.jdiacomp.2015.01.012; Frier BM, 2014, NAT REV ENDOCRINOL, V10, P711, DOI 10.1038/nrendo.2014.170; Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x; Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Gubitosi-Klug RA, 2017, DIABETES CARE, V40, P1010, DOI 10.2337/dc16-2723; Heinemann Lutz, 2015, J Diabetes Sci Technol, V9, P651, DOI 10.1177/1932296815575999; Joshi M, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0644-z; Kovatchev BP, 1998, DIABETES CARE, V21, P1870, DOI 10.2337/diacare.21.11.1870; Laffel L, 2016, DIABETES TECHNOL THE, V18, P23, DOI 10.1089/dia.2015.0380; Lind M, 2017, JAMA-J AM MED ASSOC, V317, P379, DOI 10.1001/jama.2016.19976; Little SA, 2014, DIABETES CARE, V37, P2114, DOI 10.2337/dc14-0030; Ly TT, 2013, JAMA-J AM MED ASSOC, V310, P1240, DOI 10.1001/jama.2013.277818; Malkani S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/7425925; Pickup JC, 2012, NEW ENGL J MED, V366, P1616, DOI 10.1056/NEJMct1113948; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; Polonsky WH, 2015, DIABETES TECHNOL THE, V17, P657, DOI 10.1089/dia.2014.0417; van Beers CAJ, 2016, LANCET DIABETES ENDO, V4, P893, DOI 10.1016/S2213-8587(16)30193-0; Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508	30	233	236	4	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2018	391	10128					1367	1377		10.1016/S0140-6736(18)30297-6	http://dx.doi.org/10.1016/S0140-6736(18)30297-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB8RK	29459019				2022-12-28	WOS:000429342800025
J	Thiele, EA; Marsh, ED; French, JA; Mazurkiewicz-Beldzinska, M; Benbadis, SR; Joshi, C; Lyons, PD; Taylor, A; Roberts, C; Sommerville, K				Thiele, Elizabeth A.; Marsh, Eric D.; French, Jacqueline A.; Mazurkiewicz-Beldzinska, Maria; Benbadis, Selim R.; Joshi, Charuta; Lyons, Paul D.; Taylor, Adam; Roberts, Claire; Sommerville, Kenneth		GWPCARE4 Study Grp	Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial	LANCET			English	Article							VAGUS NERVE-STIMULATION; CONSENSUS APPROACH; EPILEPSY; CHILDREN; CLOBAZAM; TOLERABILITY; EXPERIENCE; RUFINAMIDE; DIAGNOSIS; EFFICACY	Background Patients with Lennox-Gastaut syndrome, a rare, severe form of epileptic encephalopathy, are frequently treatment resistant to available medications. No controlled studies have investigated the use of cannabidiol for patients with seizures associated with Lennox-Gastaut syndrome. We therefore assessed the efficacy and safety of cannabidiol as an add-on anticonvulsant therapy in this population of patients. Methods In this randomised, double-blind, placebo-controlled trial done at 24 clinical sites in the USA, the Netherlands, and Poland, we investigated the efficacy of cannabidiol as add-on therapy for drop seizures in patients with treatment-resistant Lennox-Gastaut syndrome. Eligible patients (aged 2-55 years) had Lennox-Gastaut syndrome, including a history of slow (<3 Hz) spike-and-wave patterns on electroencephalogram, evidence of more than one type of generalised seizure for at least 6 months, at least two drop seizures per week during the 4-week baseline period, and had not responded to treatment with at least two antiepileptic drugs. Patients were randomly assigned (1: 1) using an interactive voice response system, stratified by age group, to receive 20 mg/kg oral cannabidiol daily or matched placebo for 14 weeks. All patients, caregivers, investigators, and individuals assessing data were masked to group assignment. The primary endpoint was percentage change from baseline in monthly frequency of drop seizures during the treatment period, analysed in all patients who received at least one dose of study drug and had post-baseline efficacy data. All randomly assigned patients were included in the safety analyses. This study is registered with ClinicalTrials.gov, number NCT02224690. Findings Between April 28, 2015, and Oct 15, 2015, we randomly assigned 171 patients to receive cannabidiol (n=86) or placebo (n=85). 14 patients in the cannabidiol group and one in the placebo group discontinued study treatment; all randomly assigned patients received at least one dose of study treatment and had post-baseline efficacy data. The median percentage reduction in monthly drop seizure frequency from baseline was 43.9% (IQR -69.6 to -1.9) in the cannibidiol group and 21.8% (IQR -45.7 to 1.7) in the placebo group. The estimated median difference between the treatment groups was -17.21 (95% CI -30.32 to -4.09; p=0.0135) during the 14-week treatment period. Adverse events occurred in 74 (86%) of 86 patients in the cannabidiol group and 59 (69%) of 85 patients in the placebo group; most were mild or moderate. The most common adverse events were diarrhoea, somnolence, pyrexia, decreased appetite, and vomiting. 12 (14%) patients in the cannabidiol group and one (1%) patient in the placebo group withdrew from the study because of adverse events. One patient (1%) died in the cannabidiol group, but this was considered unrelated to treatment. Interpretation Add-on cannabidiol is efficacious for the treatment of patients with drop seizures associated with Lennox-Gastaut syndrome and is generally well tolerated. The long-term efficacy and safety of cannabidiol is currently being assessed in the open-label extension of this trial.	[Thiele, Elizabeth A.] Massachusetts Gen Hosp, Pediat Epilepsy Program, Boston, MA 02114 USA; [Marsh, Eric D.] Childrens Hosp Philadelphia, Div Child Neurol, Philadelphia, PA 19104 USA; [French, Jacqueline A.] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Mazurkiewicz-Beldzinska, Maria] Med Univ Gdansk, Dept Dev Neurol, Gdansk, Poland; [Benbadis, Selim R.] Univ S Florida, Tampa, FL USA; [Joshi, Charuta] Childrens Hosp Colorado, Aurora, CO USA; [Lyons, Paul D.] Winchester Neurol Consultants, Winchester, VA USA; [Taylor, Adam; Roberts, Claire] GW Res, Cambridge, England; [Sommerville, Kenneth] Greenwich Biosci, Res Triangle Pk, NC USA; [Sommerville, Kenneth] Duke Univ, Durham, NC USA	Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; New York University; Fahrenheit Universities; Medical University Gdansk; State University System of Florida; University of South Florida; Children's Hospital Colorado; Duke University	Thiele, EA (corresponding author), Massachusetts Gen Hosp, Pediat Epilepsy Program, Boston, MA 02114 USA.	ethiele@mgh.harvard.edu	French, Jacqueline A/G-6795-2013; Thio, Liu Lin/A-4318-2008	French, Jacqueline A/0000-0003-2242-8027; Thio, Liu Lin/0000-0002-9779-7903; Mazurkiewicz-Beldzinska, Maria/0000-0002-9405-5066; Kessler, Sudha/0000-0002-9325-9972	GW Pharmaceuticals	GW Pharmaceuticals	GW Pharmaceuticals.	Arzimanoglou A, 2009, LANCET NEUROL, V8, P82, DOI 10.1016/S1474-4422(08)70292-8; Autry AR, 2010, J CHILD NEUROL, V25, P441, DOI 10.1177/0883073809348355; Babalonis S, 2017, DRUG ALCOHOL DEPEN, V172, P9, DOI 10.1016/j.drugalcdep.2016.11.030; Bih CI, 2015, NEUROTHERAPEUTICS, V12, P699, DOI 10.1007/s13311-015-0377-3; Bourgeois BFD, 2014, EPILEPSIA, V55, P4, DOI 10.1111/epi.12567; Cersosimo RO, 2011, EPILEPTIC DISORD, V13, P382, DOI 10.1684/epd.2011.0479; Devinsky O, NEUROLOGY IN PRESS; Devinsky O, 2017, NEW ENGL J MED, V376, P2011, DOI 10.1056/NEJMoa1611618; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Doring JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161660; Douglass LM, 2014, EPILEPSIA, V55, P21, DOI 10.1111/epi.12742; Dura-Trave T, 2007, J CHILD NEUROL, V22, P823, DOI 10.1177/0883073807304207; Geffrey AL, 2015, EPILEPSIA, V56, P1246, DOI 10.1111/epi.13060; Glauser T, 2008, NEUROLOGY, V70, P1950, DOI 10.1212/01.wnl.0000303813.95800.0d; Hancock EC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003277.pub3; Jones NA, 2010, J PHARMACOL EXP THER, V332, P569, DOI 10.1124/jpet.109.159145; Kang HC, 2005, EPILEPSIA, V46, P272, DOI 10.1111/j.0013-9580.2005.48504.x; Kossoff EHW, 2014, EPILEPSIA, V55, P29, DOI 10.1111/epi.12546; Kothare S, 2017, SEIZURE-EUR J EPILEP, V47, P25, DOI 10.1016/j.seizure.2017.02.008; Lancman G, 2013, SEIZURE-EUR J EPILEP, V22, P3, DOI 10.1016/j.seizure.2012.09.014; Lundbeck, 2016, ONFI CLOBAZAM FULL P; Montouris GD, 2014, EPILEPSIA, V55, P10, DOI 10.1111/epi.12732; Ng YT, 2011, NEUROLOGY, V77, P1473, DOI 10.1212/WNL.0b013e318232de76; Purcarin G, 2014, THER ADV NEUROL DISO, V7, P169, DOI 10.1177/1756285614521314; Trevathan E, 1997, EPILEPSIA, V38, P1283, DOI 10.1111/j.1528-1157.1997.tb00065.x; Turner SE, 2017, PROG CHEM ORG NAT PR, V103, P61, DOI 10.1007/978-3-319-45541-9_3; U. S. Department of Health and Human Services, 2009, GUID IND DRUG IND IN; van Rijckevorsel Kenou, 2008, Neuropsychiatr Dis Treat, V4, P1001	28	429	446	2	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1085	1096		10.1016/S0140-6736(18)30136-3	http://dx.doi.org/10.1016/S0140-6736(18)30136-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ4TP	29395273				2022-12-28	WOS:000427585100027
J	Shen, EZ; Chen, H; Ozturk, AR; Tu, SK; Shirayama, M; Tang, W; Ding, YH; Dai, SY; Weng, ZP; Mello, CC				Shen, En-Zhi; Chen, Hao; Ozturk, Ahmet R.; Tu, Shikui; Shirayama, Masaki; Tang, Wen; Ding, Yue-He; Dai, Si-Yuan; Weng, Zhiping; Mello, Craig C.			Identification of piRNA Binding Sites Reveals the Argonaute Regulatory Landscape of the C-elegans Germline	CELL			English	Article							EPIGENETIC MEMORY; MESSENGER-RNAS; PROTEINS; BIOGENESIS; MICRORNAS; ALIGNMENT; 21U-RNAS; TARGETS; CELLS; CSR-1	piRNAs (Piwi-interacting small RNAs) engage Piwi Argonautes to silence transposons and promote fertility in animal germlines. Genetic and computational studies have suggested that C. elegans piRNAs tolerate mismatched pairing and in principle could target every transcript. Here we employ in vivo cross-linking to identify transcriptome-wide interactions between piRNAs and target RNAs. We show that piRNAs engage all germline mRNAs and that piRNA binding follows microRNA-like pairing rules. Targeting correlates better with binding energy than with piRNA abundance, suggesting that piRNA concentration does not limit targeting. In mRNAs silenced by piRNAs, secondary small RNAs accumulate at the center and ends of piRNA binding sites. In germline-expressed mRNAs, however, targeting by the CSR-1 Argonaute correlates with reduced piRNA binding density and suppression of piRNA-associated secondary small RNAs. Our findings reveal physiologically important and nuanced regulation of individual piRNA targets and provide evidence for a comprehensive post-transcriptional regulatory step in germline gene expression.	[Shen, En-Zhi; Ozturk, Ahmet R.; Shirayama, Masaki; Tang, Wen; Ding, Yue-He; Dai, Si-Yuan; Mello, Craig C.] Univ Massachusetts, RNA Therapeut Inst, Med Sch, Worcester, MA 01605 USA; [Chen, Hao; Tu, Shikui; Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Med Sch, Worcester, MA 01605 USA; [Chen, Hao] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Tu, Shikui] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai, Peoples R China; [Tu, Shikui] Shanghai Jiao Tong Univ, CMaCH Ctr, Shanghai, Peoples R China; [Shirayama, Masaki; Mello, Craig C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Howard Hughes Medical Institute	Mello, CC (corresponding author), Univ Massachusetts, RNA Therapeut Inst, Med Sch, Worcester, MA 01605 USA.; Mello, CC (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	Craig.mello@umassmed.edu	Chen, Hao/AAN-4948-2021; ding, yuehe/AAZ-6994-2021	, Enzhi/0000-0002-6095-7803	NIH [HD078253, GM058800]; NIH Pathway to Independence Award [GM124460]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM124460, R37GM058800, K99GM124460, R01GM058800] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Zamore and V. Ambros for suggestions; members of Mello and Ambros labs for discussions, D. Conte for comments and edits on the text; W. Gu for providing the reagents for preparing RNA seq libraries; M. Carmell for proofreading; E. Kittler, D. Wilmot and the Umass Deep Sequencing Core for offering high-throughput sequencing; Caenorhabditis Genetics Center (CGC) for providing strain. This work was supported by an NIH grant (HD078253) to Z. W.; NIH Pathway to Independence Award (GM124460) to W.T.; and NIH grants (GM058800 and HD078253) to C.C.M. C.C.M. is a Howard Hughes Medical Institute Investigator.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRENNER S, 1974, GENETICS, V77, P71; Broughton JP, 2016, MOL CELL, V64, P320, DOI 10.1016/j.molcel.2016.09.004; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Carmi I, 1998, NATURE, V396, P168, DOI 10.1038/24164; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Fagegaltier D, 2016, GENE DEV, V30, P1623, DOI 10.1101/gad.284927.116; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JJ, 2014, GENOME RES, V24, P1086, DOI 10.1101/gr.170100.113; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matsumoto N, 2016, CELL, V167, P484, DOI 10.1016/j.cell.2016.09.002; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Molla-Herman A, 2015, EMBO J, V34, P3009, DOI 10.15252/embj.201591006; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seth M, 2018, CELL REP, V22, P2254, DOI 10.1016/j.celrep.2018.02.009; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Simon M, 2014, CELL REP, V7, P762, DOI 10.1016/j.celrep.2014.03.056; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tang W, 2018, DEV CELL, V44, P762, DOI 10.1016/j.devcel.2018.01.025; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vourekas A, 2016, NATURE, V531, P390, DOI 10.1038/nature17150; Vourekas A, 2014, METHODS MOL BIOL, V1093, P73, DOI 10.1007/978-1-62703-694-8_7; Wang W, 2014, MOL CELL, V56, P708, DOI 10.1016/j.molcel.2014.10.016; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamanaka S, 2015, EMBO J, V34, P2988, DOI 10.15252/embj.201593322; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635; Zhang P, 2015, CELL RES, V25, P193, DOI [10.1038/cr.2015.14, 10.1038/cr.2015.4]; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9; Zhou XF, 2017, RNA BIOL, V14, P1492, DOI 10.1080/15476286.2017.1341034	64	110	115	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2018	172	5					937	+		10.1016/j.cell.2018.02.002	http://dx.doi.org/10.1016/j.cell.2018.02.002			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FX2ZG	29456082	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000425937100007
J	Marcus, A; Oransky, I				Marcus, Adam; Oransky, Ivan			THE DATA THUGS	SCIENCE			English	Editorial Material																			0	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					730	732						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449473				2022-12-28	WOS:000425116200022
J	Knott, SRV; Wagenblast, E; Khan, S; Kim, SY; Soto, M; Wagner, M; Turgeon, MO; Fish, L; Erard, N; Gable, AL; Maceli, AR; Dickopf, S; Papachristou, EK; D'Santos, CS; Carey, LA; Wilkinson, JE; Harrell, JC; Perou, CM; Goodarzi, H; Poulogiannis, G; Hannon, GJ				Knott, Simon R. V.; Wagenblast, Elvin; Khan, Showkhin; Kim, Sun Y.; Soto, Mar; Wagner, Michel; Turgeon, Marc-Olivier; Fish, Lisa; Erard, Nicolas; Gable, Annika L.; Maceli, Ashley R.; Dickopf, Steffen; Papachristou, Evangelia K.; D'Santos, Clive S.; Carey, Lisa A.; Wilkinson, John E.; Harrell, J. Chuck; Perou, Charles M.; Goodarzi, Hani; Poulogiannis, George; Hannon, Gregory J.			Asparagine bioavailability governs metastasis in a model of breast cancer	NATURE			English	Article							MAMMARY-TUMOR; HETEROGENEITY; EXPRESSION	Using a functional model of breast cancer heterogeneity, we previously showed that clonal sub-populations proficient at generating circulating tumour cells were not all equally capable of forming metastases at secondary sites(1). A combination of differential expression and focused in vitro and in vivo RNA interference screens revealed candidate drivers of metastasis that discriminated metastatic clones. Among these, asparagine synthetase expression in a patient's primary tumour was most strongly correlated with later metastatic relapse. Here we show that asparagine bioavailability strongly influences metastatic potential. Limiting asparagine by knockdown of asparagine synthetase, treatment with l-asparaginase, or dietary asparagine restriction reduces metastasis without affecting growth of the primary tumour, whereas increased dietary asparagine or enforced asparagine synthetase expression promotes metastatic progression. Altering asparagine availability in vitro strongly influences invasive potential, which is correlated with an effect on proteins that promote the epithelial-to-mesenchymal transition. This provides at least one potential mechanism for how the bioavailability of a single amino acid could regulate metastatic progression.	[Knott, Simon R. V.; Erard, Nicolas; Papachristou, Evangelia K.; D'Santos, Clive S.; Hannon, Gregory J.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England; [Knott, Simon R. V.; Wagenblast, Elvin; Khan, Showkhin; Kim, Sun Y.; Soto, Mar; Gable, Annika L.; Maceli, Ashley R.; Dickopf, Steffen; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Knott, Simon R. V.] Cedars Sinai Med Ctr, Ctr Bioinformat & Funct Genom, Dept Biomed Sci, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Wagenblast, Elvin] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Wagenblast, Elvin] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Khan, Showkhin; Hannon, Gregory J.] New York Genome Ctr, 101 6th Ave, New York, NY 10013 USA; [Wagner, Michel; Turgeon, Marc-Olivier; Poulogiannis, George] Inst Canc Res, Div Canc Biol, 237 Fulham Rd, London SW3 6JB, England; [Fish, Lisa; Goodarzi, Hani] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Fish, Lisa; Goodarzi, Hani] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA; [Fish, Lisa; Goodarzi, Hani] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Carey, Lisa A.] Univ North Carolina Chapel Hill, Div Hematol & Oncol, 170 Manning Dr,CB7305, Chapel Hill, NC 27599 USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Harrell, J. Chuck] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA; [Perou, Charles M.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Dept Genet & Pathol, Chapel Hill, NC 27599 USA; [Poulogiannis, George] Imperial Coll London, Dept Surg & Canc, Div Computat & Syst Med, London SW7 2AZ, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cedars Sinai Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Michigan System; University of Michigan; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Imperial College London	Hannon, GJ (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.; Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.; Hannon, GJ (corresponding author), New York Genome Ctr, 101 6th Ave, New York, NY 10013 USA.	Greg.Hannon@cruk.cam.ac.uk	Perou, Charles M/H-9934-2014; Poulogiannis, George/AAE-1966-2019; Hannon, Gregory/AAB-3568-2019; Poulogiannis, George/AAY-2210-2021	Perou, Charles M/0000-0001-9827-2247; Poulogiannis, George/0000-0002-0529-8614; Goodarzi, Hani/0000-0002-9648-8949; Gable, Annika Lisa/0000-0002-8965-0848; Turgeon, Marc-Olivier/0000-0002-3034-2154; Kim, Sun/0000-0001-8133-865X; Wagenblast, Elvin/0000-0002-0709-2759; Fish, Lisa/0000-0001-9184-0512	Cancer Center Support Grant [5P30CA045508]; The Hope Funds for Cancer Research; Human Frontier Science Program; Susan G. Komen Foundation [SAC110006]; NCI Breast SPORE program [P50-CA58223-09A1]; Breast Cancer Research Foundation; Triple Negative Breast Cancer Foundation; National Institutes of Health (NIH) [NCI R00 CA194077]; Institute of Cancer Research, London; Cancer Research UK [C59824/A25044]; NIH [5 P01 CA013106-44]; Department of Defense Breast Cancer Research Program [W81XWH-12-1-0300]; NATIONAL CANCER INSTITUTE [P50CA058223, P01CA013106, P30CA016086, R00CA194077, P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; Cancer Research UK [22310, 21143] Funding Source: researchfish	Cancer Center Support Grant; The Hope Funds for Cancer Research; Human Frontier Science Program(Human Frontier Science Program); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NCI Breast SPORE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Triple Negative Breast Cancer Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Cancer Research, London; Cancer Research UK(Cancer Research UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Research UK(Cancer Research UK)	This work was performed with assistance from CSHL Shared Resources, which are funded, in part, by the Cancer Center Support Grant 5P30CA045508. We thank M. Mosquera, M. Cahn, J. Coblentz, and L. Bianco for support with mouse work; K. Cheng, J. Bourbonniere, D. Hoppe, A. Nourjanova, and R. Puzis for support with histology; E. Hodges and E. Lee for support with next-generation sequencing; and J. Johnson for assistance with HPLC. This work was also performed with the assistance of the Cancer Research UK, Cambridge Institute Proteomics Core Facility. S.R.V.K. is supported by a fellowship from The Hope Funds for Cancer Research. E.W. is supported by a long-term fellowship from the Human Frontier Science Program. L.A.C. is supported by the Susan G. Komen Foundation (SAC110006) and the NCI Breast SPORE program (P50-CA58223-09A1). J.C.H. and C.M.P. are supported by funds from the NCI Breast SPORE program (P50-CA58223-09A1), the Breast Cancer Research Foundation, and the Triple Negative Breast Cancer Foundation. H.G. is supported by a grant from the National Institutes of Health (NIH) (NCI R00 CA194077). Work in the G.P. laboratory is supported by the Institute of Cancer Research, London and a Cancer Research UK grand challenge award (C59824/A25044). G.J.H. is the Royal Society Wolfson Research Professor and is supported by core funding from Cancer Research UK, by a Program Project grant from the NIH (5 P01 CA013106-44), and by a grant from the Department of Defense Breast Cancer Research Program (W81XWH-12-1-0300).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Al-Baghdadi RJT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01041-7; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Gowen BG, 2015, ELIFE, V4, DOI 10.7554/eLife.08474; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Knott SRV, 2014, MOL CELL, V56, P796, DOI 10.1016/j.molcel.2014.10.025; Krall AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11457; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; MILLER FR, 1983, INVAS METAST, V3, P22; Richards NGJ, 1998, ADV ENZYMOL RAMB, V72, P145; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Stams WAG, 2005, BLOOD, V105, P4223, DOI 10.1182/blood-2004-10-3892; TALLAL L, 1970, Cancer, V25, P306, DOI 10.1002/1097-0142(197002)25:2<306::AID-CNCR2820250206>3.0.CO;2-H; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018	24	240	245	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					378	+		10.1038/nature25465	http://dx.doi.org/10.1038/nature25465			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29414946	Green Submitted, Green Accepted			2022-12-28	WOS:000424996300042
J	Xu, M; Pokrovskii, M; Ding, Y; Yi, R; Au, C; Harrison, OJ; Galan, C; Elkaid, YB; Onneau, RB; Littman, DR				Xu, Mo; Pokrovskii, Maria; Ding, Yi; Yi, Ren; Au, Christy; Harrison, Oliver J.; Galan, Carolina; Elkaid, Yasmine B.; Onneau, Richard B.; Littman, Dan R.			c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont	NATURE			English	Article							MICROBIOTA; ANTIGEN; IMMUNITY; DIFFERENTIATION; EXPRESSION; INDUCTION; COMMENSAL; RESPONSES; COLITIS; PLAYS	Both microbial and host genetic factors contribute to the pathogenesis of autoimmune diseases(1-4). There is accumulating evidence that microbial species that potentiate chronic inflammation, as in inflammatory bowel disease, often also colonize healthy individuals. These microorganisms, including the Helicobacter species, can induce pathogenic T cells and are collectively referred to as pathobionts(4-6). However, how such T cells are constrained in healthy individuals is not yet understood. Here we report that host tolerance to a potentially pathogenic bacterium, Helicobacter hepaticus, is mediated by the induction of ROR gamma t(+)FOXP3(+) regulatory T (iT(reg)) cells that selectively restrain pro-inflammatory T helper 17 (T(H)17) cells and whose function is dependent on the transcription factor c-MAF. Whereas colonization of wild-type mice by H. hepaticus promoted differentiation of ROR gamma t-expressing microorganism-specific iT(reg) cells in the large intestine, in disease-susceptible IL-10-deficient mice, there was instead expansion of colitogenic T(H)17 cells. Inactivation of c-MAF in the T-reg cell compartment impaired differentiation and function, including IL-10 production, of bacteria-specific iT(reg) cells, and resulted in the accumulation of H. hepaticus-specific inflammatory T(H)17 cells and spontaneous colitis. By contrast, ROR gamma t inactivation in T-reg cells had only a minor effect on the bacteria-specific T-reg and T(H)17 cell balance, and did not result in inflammation. Our results suggest that pathobiont-dependent inflammatory bowel disease is driven by microbiota-reactive T cells that have escaped this c-MAF-dependent mechanism of iT(reg)-T(H)17 homeostasis.	[Xu, Mo; Pokrovskii, Maria; Au, Christy; Galan, Carolina; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Ding, Yi] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Yi, Ren; Onneau, Richard B.] NYU, Courant Inst Math Sci, Comp Sci Dept, New York, NY 10003 USA; [Au, Christy; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Harrison, Oliver J.; Elkaid, Yasmine B.] NIAID, Mucosal Immun Sect, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA; [Elkaid, Yasmine B.] NIAID, Microbiome Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Onneau, Richard B.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Onneau, Richard B.] Simons Fdn, Flatiron Inst, Ctr Computat Biol, New York, NY 10010 USA	New York University; University of Rochester; New York University; Howard Hughes Medical Institute; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University	Littman, DR (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA.; Littman, DR (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	dan.littman@med.nyu.edu		Harrison, Oliver/0000-0003-1515-9586	National Institutes of Health [S10OD010584-01A1, S10OD018338-01, R01DK103358]; Cancer Center Support grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; Irvington Institute fellowship program of the Cancer Research Institute; training program in Immunology and Inflammation [5T32AI100853]; Helen and Martin Kimmel Center for Biology and Medicine; Colton Center for Autoimmunity; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100853, ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103358] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010584, S10OD018338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support grant at the Laura and Isaac Perlmutter Cancer Center; Irvington Institute fellowship program of the Cancer Research Institute; training program in Immunology and Inflammation; Helen and Martin Kimmel Center for Biology and Medicine; Colton Center for Autoimmunity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Y. Kim and the NYU Rodent Genetic Engineering Laboratory (RGEL) for generating TCR transgenic mice, A. Heguy and colleagues at the NYU School of Medicine's Genome Technology Center (GTC) for preparation of RNA-seq libraries and RNA sequencing, the NIH Tetramer Core Facility for generating MHC class II tetramers, K. Murphy for providing the 58 alpha<SUP>-</SUP>beta<SUP>-</SUP> hybridoma line, D. E. Levy for providing the Stat3<SUP>fl/fl</SUP>; Cd4<SUP>cre</SUP> mice, J. Fox for providing the H. hepaticus strain, P. Dash and P.G. Thomas for advice on single-cell TCR cloning, and J. A. Hall, J. Muller and J. Lafaille for suggestions on the manuscript. The Experimental Pathology Research Laboratory of NYU Medical Center is supported by National Institutes of Health Shared Instrumentation grants S10OD010584-01A1 and S10OD018338-01. The GTC is partially supported by the Cancer Center Support grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. This work was supported by the Irvington Institute fellowship program of the Cancer Research Institute (M.X.); the training program in Immunology and Inflammation 5T32AI100853 (M.P.); the Helen and Martin Kimmel Center for Biology and Medicine (D.R.L.); the Colton Center for Autoimmunity (D.R.L.); and National Institutes of Health grant R01DK103358 (R.B. and D.R.L.). D.R.L. is an Investigator of the Howard Hughes Medical Institute.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mach N, 2000, CANCER RES, V60, P3239; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; R Development Core Team, 2016, R LANG ENV STAT COMP; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; SANDERSON S, 1995, J EXP MED, V182, P1751, DOI 10.1084/jem.182.6.1751; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	44	238	245	2	79	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					373	+		10.1038/nature25500	http://dx.doi.org/10.1038/nature25500			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29414937	Green Accepted, Green Submitted			2022-12-28	WOS:000424996300041
J	Grossman, DC; Curry, SJ; Owens, DK; Barry, MJ; Davidson, KW; Doubeni, CA; Epling, JW; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, S; Mangione, CM; Phipps, MG; Silverstein, M; Simon, MA; Tseng, CW				Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael J.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Serv Task Force	Screening for Ovarian Cancer US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TRIAL; MORTALITY; WOMEN; PROSTATE; LUNG	IMPORTANCE With approximately 14 000 deaths per year, ovarian cancer is the fifth most common cause of cancer death among US women and the leading cause of death from gynecologic cancer. More than 95% of ovarian cancer deaths occur among women 45 years and older. OBJECTIVE To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on screening for ovarian cancer. EVIDENCE REVIEW The USPSTF reviewed the evidence on the benefits and harms of screening for ovarian cancer in asymptomatic women not known to be at high risk for ovarian cancer (ie, high risk includes women with certain hereditary cancer syndromes that increase their risk for ovarian cancer). Outcomes of interest included ovarian cancer mortality, quality of life, false-positive rate, surgery and surgical complication rates, and psychological effects of screening. FINDINGS The USPSTF found adequate evidence that screening for ovarian cancer does not reduce ovarian cancer mortality. The USPSTF found adequate evidence that the harms from screening for ovarian cancer are at least moderate and may be substantial in some cases, and include unnecessary surgery for women who do not have cancer. Given the lack of mortality benefit of screening, and the moderate to substantial harms that could result from false-positive screening test results and subsequent surgery, the USPSTF concludes with moderate certainty that the harms of screening for ovarian cancer outweigh the benefit, and the net balance of the benefit and harms of screening is negative. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends against screening for ovarian cancer in asymptomatic women. (D recommendation) This recommendation applies to asymptomatic women who are not known to have a high-risk hereditary cancer syndrome.	[Grossman, David C.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA 98101 USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W., Jr.] Virginia Tech, Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA	Kaiser Permanente; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; Columbia University; University of Pennsylvania; Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Brown University; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute	Grossman, DC (corresponding author), Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA 98101 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Epling, John W/J-1097-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ); NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians, 2017, CLIN PREV SERV REC O; American Cancer Society, 2017, CANC FACTS FIG 2015; Andersen MR, 2007, PSYCHO-ONCOLOGY, V16, P814, DOI 10.1002/pon.1151; Barrett J, 2014, BJOG-INT J OBSTET GY, V121, P1071, DOI 10.1111/1471-0528.12870; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P947, DOI [10.1001/jama.2016.12819, 10.1001/jama.2017.0807]; Brown DL, 2010, ULTRASOUND Q, V26, P219, DOI 10.1097/RUQ.0b013e3181fdd604; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Doroudi M, 2017, J MED SCREEN, V24, P220, DOI 10.1177/0969141316680381; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Henderson JT, 2018, JAMA-J AM MED ASSOC, V319, P595, DOI 10.1001/jama.2017.21421; Henderson JT, 2018, SCREENING OVARIAN CA, V157; Howlader N, 2017, SEER CANC STAT REV C; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Matteson KA, 2017, OBSTET GYNECOL, V130, pE146, DOI 10.1097/AOG.0000000000002299; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747; Moyer VA, 2012, ANN INTERN MED, V157, P900, DOI 10.7326/0003-4819-157-11-201212040-00539; National Academies of Sciences Engineering and Medicine, 2016, OV CANC EV PAR RES C; National Cancer Institute, 2017, CANC STAT FACTS OV C; National Cancer Institute, 2017, GEN BREAST GYN CANC; NCCN, 2017, CLIN PRACT GUID ONC; Pinsky PF, 2016, GYNECOL ONCOL, V143, P270, DOI 10.1016/j.ygyno.2016.08.334; Smith RA, 2017, CA-CANCER J CLIN, V67, P100, DOI 10.3322/caac.21392; Stormo AR, 2012, PREV MED, V54, P415, DOI 10.1016/j.ypmed.2012.03.012; US Cancer StatisticsWorking Group, 2017, US CANC STAT USCS 19	25	126	130	10	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					588	594		10.1001/jama.2017.21926	http://dx.doi.org/10.1001/jama.2017.21926			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450531	Bronze			2022-12-28	WOS:000424908400019
J	Wainwright, PC				Wainwright, Peter C.			How hummingbirds stay nimble on the wing	SCIENCE			English	Editorial Material							INSECT FLIGHT; DIVERSIFICATION; ECOLOGY		[Wainwright, Peter C.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA	University of California System; University of California Davis	Wainwright, PC (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA.	pcwainwright@ucdavis.edu						Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Dakin R, 2018, SCIENCE, V359, P653, DOI 10.1126/science.aao7104; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Heers AM, 2015, EVOLUTION, V69, P305, DOI 10.1111/evo.12576; Irschick DJ, 2001, ANNU REV ECOL SYST, V32, P367, DOI 10.1146/annurev.ecolsys.32.081501.114048; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Sholtis KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125659; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295	11	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					636	637	aar7615	10.1126/science.aar7615	http://dx.doi.org/10.1126/science.aar7615			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439229				2022-12-28	WOS:000425117700022
J	Cibelli, JB; Gurdon, JB				Cibelli, Jose B.; Gurdon, John B.			Custom-Made Oocytes to Clone Non-human Primates	CELL			English	Editorial Material							NUCLEAR TRANSFER; CELLS; EMBRYOS	In this issue of Cell, Liu et al. (2018) report the birth of two healthy cloned macaque monkeys using fetal fibroblasts. Byartificially enhancingthe arsenal of epigeneticmodifiers in the oocyte, the authors overcome the earliest roadblocks that take place during somatic cell nuclear transfer (SCNT).	[Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Cibelli, Jose B.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Gurdon, John B.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England	Michigan State University; Michigan State University; University of Cambridge	Cibelli, JB (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.; Cibelli, JB (corresponding author), Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA.	cibelli@msu.edu		Cibelli, Jose/0000-0002-2176-3854; GURDON, JOHN/0000-0002-5621-3799				[Anonymous], TITLE ERROR; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chung YG, 2002, BIOL REPROD, V66, P1178, DOI 10.1095/biolreprod66.4.1178; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015	10	5	5	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					647	649		10.1016/j.cell.2018.01.030	http://dx.doi.org/10.1016/j.cell.2018.01.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425487	Bronze			2022-12-28	WOS:000424648800007
J	Ferraro, JV; Binetti, KM; Wiest, LA; Esker, D; Baker, LE; Forman, SL				Ferraro, Joseph V.; Binetti, Katie M.; Wiest, Logan A.; Esker, Donald; Baker, Lori E.; Forman, Steven L.			Contesting early archaeology in California	NATURE			English	Letter							PERCUSSION; TAPHONOMY; AMERICA; ORIGINS; BONES; SITES; USA		[Ferraro, Joseph V.; Binetti, Katie M.; Baker, Lori E.] Baylor Univ, Dept Anthropol, Waco, TX 76798 USA; [Ferraro, Joseph V.; Binetti, Katie M.; Wiest, Logan A.; Esker, Donald; Baker, Lori E.; Forman, Steven L.] Baylor Univ, Inst Archaeol, Waco, TX 76798 USA; [Wiest, Logan A.; Esker, Donald; Forman, Steven L.] Baylor Univ, Terr Paleoclimatol Res Grp, Dept Geosci, Waco, TX 76798 USA	Baylor University; Baylor University; Baylor University	Ferraro, JV (corresponding author), Baylor Univ, Dept Anthropol, Waco, TX 76798 USA.; Ferraro, JV (corresponding author), Baylor Univ, Inst Archaeol, Waco, TX 76798 USA.	joseph_ferraro@baylor.edu	Forman, Steven/ABD-7720-2021	Forman, Steven/0000-0002-2080-7915				BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grayson DK, 2015, J ARCHAEOL SCI, V56, P177, DOI 10.1016/j.jas.2015.02.009; Haynes G., 1991, MAMMOTHS MASTODONTS; Haynes G, 2017, QUATERN INT, V445, P171, DOI 10.1016/j.quaint.2016.02.034; Holen S., 2012, 4 S INT HOMBR TEMPR, P85; Holen SR, 2006, QUATERN INT, V142, P30, DOI 10.1016/j.quaint.2005.03.003; Holen SR, 2017, NATURE, V544, P479, DOI 10.1038/nature22065; Hunt A. P., 2015, NEW MEXICO MUSEUM NA, V68, P9; Krasinski K.E., 2010, THESIS; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; Wiest LA, 2016, PALAIOS, V31, P592, DOI 10.2110/palo.2016.053	15	12	12	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					E1	E2		10.1038/nature25165	http://dx.doi.org/10.1038/nature25165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420468				2022-12-28	WOS:000424332600001
J	May, PA; Chambers, CD; Kalberg, WO; Zellner, J; Feldman, H; Buckley, D; Kopald, D; Hasken, JM; Xu, R; Honerkamp-Smith, G; Taras, H; Manning, MA; Robinson, LK; Adam, MP; Abdul-Rahman, O; Vaux, K; Jewett, T; Elliott, AJ; Kable, JA; Akshoomoff, N; Falk, D; Arroyo, JA; Hereld, D; Riley, EP; Charness, ME; Coles, CD; Warren, KR; Jones, KL; Hoyme, HE				May, Philip A.; Chambers, Christina D.; Kalberg, Wendy O.; Zellner, Jennifer; Feldman, Haruna; Buckley, David; Kopald, David; Hasken, Julie M.; Xu, Ronghui; Honerkamp-Smith, Gordon; Taras, Howard; Manning, Melanie A.; Robinson, Luther K.; Adam, Margaret P.; Abdul-Rahman, Omar; Vaux, Keith; Jewett, Tamison; Elliott, Amy J.; Kable, Julie A.; Akshoomoff, Natacha; Falk, Daniel; Arroyo, Judith A.; Hereld, Dale; Riley, Edward P.; Charness, Michael E.; Coles, Claire D.; Warren, Kenneth R.; Jones, Kenneth Lyons; Hoyme, H. Eugene			Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; CHILDREN; PHOSPHATIDYLETHANOL; EPIDEMIOLOGY; DRINKING; PROVINCE; SAMPLE; FASD	IMPORTANCE Fetal alcohol spectrum disorders are costly, life-long disabilities. Older data suggested the prevalence of the disorder in the United States was 10 per 1000 children; however, there are few current estimates based on larger, diverse US population samples. OBJECTIVE To estimate the prevalence of fetal alcohol spectrum disorders, including fetal alcohol syndrome, partial fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder, in 4 regions of the United States. DESIGN, SETTING, AND PARTICIPANTS Active case ascertainment methods using a cross-sectional design were used to assess children for fetal alcohol spectrum disorders between 2010 and 2016. Children were systematically assessed in the 4 domains that contribute to the fetal alcohol spectrum disorder continuum: dysmorphic features, physical growth, neurobehavioral development, and prenatal alcohol exposure. The settings were 4 communities in the Rocky Mountain, Midwestern, Southeastern, and Pacific Southwestern regions of the United States. First-grade children and their parents or guardians were enrolled. EXPOSURES Alcohol consumption during pregnancy. MAIN OUTCOMES AND MEASURES Prevalence of fetal alcohol spectrum disorders in the 4 communities was the main outcome. Conservative estimates for the prevalence of the disorder and 95% CIs were calculated using the eligible first-grade population as the denominator. Weighted prevalences and 95% CIs were also estimated, accounting for the sampling schemes and using data restricted to children who received a full evaluation. RESULTS A total of 6639 children were selected for participation from a population of 13 146 first-graders (boys, 51.9%; mean age, 6.7 years [SD, 0.41] and white maternal race, 79.3%). A total of 222 cases of fetal alcohol spectrum disorders were identified. The conservative prevalence estimates for fetal alcohol spectrum disorders ranged from 11.3 (95% CI, 7.8-15.8) to 50.0 (95% CI, 39.9-61.7) per 1000 children. The weighted prevalence estimates for fetal alcohol spectrum disorders ranged from 31.1 (95% CI, 16.1-54.0) to 98.5 (95% CI, 57.5-139.5) per 1000 children. CONCLUSIONS AND RELEVANCE Estimated prevalence of fetal alcohol spectrum disorders among first-graders in 4 US communities ranged from 1.1% to 5.0% using a conservative approach. These findings may represent more accurate US prevalence estimates than previous studies but may not be generalizable to all communities.	[May, Philip A.; Hasken, Julie M.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [May, Philip A.; Kalberg, Wendy O.; Buckley, David] Univ New Mexico, Ctr Alcoholism Subst Abuse & Addict, Albuquerque, NM 87131 USA; [Chambers, Christina D.; Zellner, Jennifer; Feldman, Haruna; Kopald, David; Xu, Ronghui; Honerkamp-Smith, Gordon; Taras, Howard; Vaux, Keith; Akshoomoff, Natacha; Jones, Kenneth Lyons] Univ Calif San Diego, Sch Med, 9500 Gilman Dr,MC 0828, La Jolla, CA 92093 USA; [Manning, Melanie A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Robinson, Luther K.] SUNY Buffalo, Sch Med, Buffalo, NY USA; [Adam, Margaret P.] Univ Washington, Sch Med, Seattle, WA USA; [Abdul-Rahman, Omar] Univ Nebraska, Med Ctr, Omaha, NE USA; [Jewett, Tamison] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Elliott, Amy J.] Avera McKennan Hosp, Sioux Falls, SD USA; [Elliott, Amy J.] Univ Hlth Ctr, Sioux Falls, SD USA; [Kable, Julie A.; Coles, Claire D.] Emory Univ, Sch Med, Atlanta, GA USA; [Falk, Daniel; Arroyo, Judith A.; Hereld, Dale; Warren, Kenneth R.] NIAAA, Bethesda, MD USA; [Riley, Edward P.] San Diego State Univ, Ctr Behav Teratol, San Diego, CA 92182 USA; [Charness, Michael E.] VA Boston Healthcare Syst, Boston, MA USA; [Charness, Michael E.] Harvard Med Sch, Boston, MA USA; [Charness, Michael E.] Boston Univ, Sch Med, Boston, MA USA; [Hoyme, H. Eugene] Univ Arizona, Coll Med, Tucson, AZ USA; [Hoyme, H. Eugene] Univ South Dakota, Sanford Sch Med, Sanford Res, Vermillion, SD USA; [Chambers, Christina D.; Jones, Kenneth Lyons] Rady Childrens Hosp San Diego, San Diego, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of New Mexico; University of California System; University of California San Diego; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Washington; University of Washington Seattle; University of Nebraska System; University of Nebraska Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); California State University System; San Diego State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Boston University; University of Arizona; Sanford Health; University of South Dakota; Rady Childrens Hospital San Diego	Chambers, CD (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr,MC 0828, La Jolla, CA 92093 USA.	chchambers@ucsd.edu	Vaux, Keith/R-2716-2019; Riley, Edward Patrick/AAA-4503-2022	Vaux, Keith/0000-0001-8738-5940; Chambers, Christina D/0000-0003-4675-7722; Elliott, Amy/0000-0003-0608-8931; Charness, Michael/0000-0002-3301-8966; May, Philip/0000-0003-1939-8701; Zellner, Jennifer/0000-0003-3484-786X	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U01 AA019894, U01 AA019879]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019894] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded grant U01 AA019894 (Dr May) and U01 AA019879 (Dr Chambers) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA).	Bakhireva LN, 2017, ALCOHOL CLIN EXP RES, V41, P1004, DOI 10.1111/acer.13375; Bakhireva LN, 2014, ALCOHOL CLIN EXP RES, V38, P1078, DOI 10.1111/acer.12349; Blankenship J, 2016, PEDIATRICS, V138; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1118; Chasnoff IJ, 2015, PEDIATRICS, V135, P264, DOI 10.1542/peds.2014-2171; Christensen DL, 2016, J DEV BEHAV PEDIATR, V37, P1, DOI 10.1097/DBP.0000000000000235; Clarren SH, 2001, TERATOLOGY, V63, P3, DOI 10.1002/1096-9926(200101)63:1<3::AID-TERA1001>3.0.CO;2-P; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; Green PP, 2016, MMWR-MORBID MORTAL W, V65, P91, DOI 10.15585/mmwr.mm6504a6; Landgren M, 2017, ACTA PAEDIATR, V106, P353, DOI 10.1111/apa.13696; May PA, 2006, ALCOHOL CLIN EXP RES, V30, P1562, DOI 10.1111/j.1530-0277.2006.00188.x; May PA, 2015, DRUG ALCOHOL DEPEN, V155, P118, DOI 10.1016/j.drugalcdep.2015.08.006; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; McCormack C, 2017, ALCOHOL CLIN EXP RES, V41, P369, DOI 10.1111/acer.13305; Petkovic G, 2013, INT J ENV RES PUB HE, V10, P1547, DOI 10.3390/ijerph10041547; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; Stratton K., 1996, FETAL ALCOHOL SYNDRO; Tan CH, 2015, MMWR-MORBID MORTAL W, V64, P1042, DOI 10.15585/mmwr.mm6437a3; Viljoen DL, 2005, J STUD ALCOHOL, V66, P593, DOI 10.15288/jsa.2005.66.593; Woolfenden S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-231	25	353	355	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					474	482		10.1001/jama.2017.21896	http://dx.doi.org/10.1001/jama.2017.21896			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411031	Green Published, Bronze			2022-12-28	WOS:000424224500017
J	Dejea, CM; Fathi, P; Craig, JM; Boleij, A; Taddese, R; Geis, AL; Wu, XQ; Shields, CED; Hechenbleikner, EM; Huso, DL; Anders, RA; Giardiello, FM; Wick, EC; Wang, H; Wu, SG; Pardoll, DM; Housseau, F; Sears, CL				Dejea, Christine M.; Fathi, Payam; Craig, John M.; Boleij, Annemarie; Taddese, Rahwa; Geis, Abby L.; Wu, Xinqun; Shields, Christina E. DeStefano; Hechenbleikner, Elizabeth M.; Huso, David L.; Anders, Robert A.; Giardiello, Francis M.; Wick, Elizabeth C.; Wang, Hao; Wu, Shaoguang; Pardoll, Drew M.; Housseau, Franck; Sears, Cynthia L.			Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CANCER; GENE; MICROBIOTA; MUCOSA	Individuals with sporadic colorectal cancer (CRC) frequently harbor abnormalities in the composition of the gut microbiome; however, the microbiota associated with precancerous lesions in hereditary CRC remains largely unknown. We studied colonic mucosa of patients with familial adenomatous polyposis (FAP), who develop benign precursor lesions (polyps) early in life. We identified patchy bacterial biofilms composed predominately of Escherichia coli and Bacteroides fragilis. Genes for colibactin (clbB) and Bacteroides fragilis toxin (bft), encoding secreted oncotoxins, were highly enriched in FAP patients' colonic mucosa compared to healthy individuals. Tumor-prone mice cocolonized with E. coli (expressing colibactin), and enterotoxigenic B. fragilis showed increased interleukin-17 in the colon and DNA damage in colonic epithelium with faster tumor onset and greater mortality, compared to mice with either bacterial strain alone. These data suggest an unexpected link between early neoplasia of the colon and tumorigenic bacteria.	[Dejea, Christine M.; Fathi, Payam; Boleij, Annemarie; Geis, Abby L.; Wu, Xinqun; Shields, Christina E. DeStefano; Wang, Hao; Wu, Shaoguang; Pardoll, Drew M.; Housseau, Franck; Sears, Cynthia L.] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21218 USA; [Dejea, Christine M.; Fathi, Payam; Geis, Abby L.; Shields, Christina E. DeStefano; Giardiello, Francis M.; Wang, Hao; Pardoll, Drew M.; Housseau, Franck; Sears, Cynthia L.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA; [Fathi, Payam; Wu, Xinqun; Giardiello, Francis M.; Wu, Shaoguang; Sears, Cynthia L.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Craig, John M.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Boleij, Annemarie; Taddese, Rahwa] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, Postbus 9101, NL-6500 HB Nijmegen, Netherlands; [Hechenbleikner, Elizabeth M.; Wick, Elizabeth C.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Huso, David L.] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Anders, Robert A.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Dejea, Christine M.] 10903 New Hampshire Ave,WO22 RM 5171, Silver Spring, MD 20993 USA; [Fathi, Payam] Vanderbilt Univ, Sch Med, 340 Light Hall, Nashville, TN 37232 USA; [Geis, Abby L.] Arkansas Coll Osteopath Med, 7000 Chad Colley Blvd, Ft Smith, AR 72916 USA; [Hechenbleikner, Elizabeth M.] Mt Sinai Hosp, Dept Surg, 5 East 98th St, New York, NY 10029 USA; [Wick, Elizabeth C.] Univ Calif San Francisco, Dept Surg, 513 Parnassus Ave,S 549, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Vanderbilt University; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco	Sears, CL (corresponding author), Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21218 USA.; Sears, CL (corresponding author), Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA.; Sears, CL (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	csears@jhmi.edu	Sears, Cynthia L/AAJ-6704-2020; Taddese, Rahwa/O-4602-2016; Geis, Abby/AAZ-3059-2020; Boleij, Annemarie/L-3975-2013	Sears, Cynthia L/0000-0003-4059-1661; Taddese, Rahwa/0000-0002-4516-6050; Geis, Abby/0000-0002-3659-5734; Boleij, Annemarie/0000-0003-4495-5880; Hechenbleikner, Elizabeth/0000-0002-0706-7860; FATHI, PAYAM/0000-0003-0545-5023; DeStefano Shields, Christina/0000-0003-4714-3423	Bloomberg Philanthropies; NIH [R01 CA151393, K08 DK087856, 5T32CA126607-05, P30 DK089502, P30 CA006973, P50 CA62924]; Alexander and Margaret Stewart Trust (Johns Hopkins University School of Medicine); American Society of Colon and Rectal Surgeons [GSRRIG-015]; Netherlands Organization for Scientific Research [NWO 825.11.03, 016.166.089]; Institute Merieux; Bristol-Myers Squibb; Compugen; Ervaxx; Potenza; Bristol-Myers Squibb Co-International Immuno-Oncology Network-IION Resource Model [300-2344]; NATIONAL CANCER INSTITUTE [P50CA062924, P30CA006973, T32CA126607, R01CA151393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK087856, P30DK089502] Funding Source: NIH RePORTER	Bloomberg Philanthropies; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Trust (Johns Hopkins University School of Medicine); American Society of Colon and Rectal Surgeons; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Institute Merieux; Bristol-Myers Squibb(Bristol-Myers Squibb); Compugen; Ervaxx; Potenza; Bristol-Myers Squibb Co-International Immuno-Oncology Network-IION Resource Model; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Kinzler and B. Vogelstein for valuable discussions; K. Romans and L. Hylind for assistance with patient enrollment; and S. Besharati for assistance with histopathologic analyses. The data presented in this manuscript are tabulated in the main text and supplementary materials and methods. This work was supported by the Bloomberg Philanthropies and by NIH grants R01 CA151393 (to C.L.S., D.M.P.), K08 DK087856 (to E.C.W.), 5T32CA126607-05 (to E.M.H.), P30 DK089502 (Johns Hopkins University School of Medicine), P30 CA006973 (Johns Hopkins University School of Medicine), and P50 CA62924 (Johns Hopkins University School of Medicine). Funding was also provided through a research agreement with Bristol-Myers Squibb Co-International Immuno-Oncology Network-IION Resource Model, 300-2344 (to D.M.P.); Alexander and Margaret Stewart Trust (Johns Hopkins University School of Medicine); GSRRIG-015 (American Society of Colon and Rectal Surgeons to E.M.H.); The Netherlands Organization for Scientific Research (NWO 825.11.03 and 016.166.089 to A.B.); and a grant from the Institute Merieux (to C.L.S. and D.M.P.). D.M.P. discloses consultant relationships with Aduro Biotech, Amgen, Astra Zeneca, Bayer, Compugen, DNAtrix, Five Prime, GlaxoSmithKline, ImmuneXcite, Jounce Therapeutics, Neximmune, Pfizer, Rock Springs Capital, Sanofi, Tizona, Janssen, Merck, Astellas, Flx Bio, Ervaxx, and DNAX. D.M.P. receives research support from Bristol-Myers Squibb, Compugen, Ervaxx, and Potenza. D.M.P. is a scientific advisory board member for Immunomic Therapeutics. D.M.P. shares intellectual property with Aduro Biotech, BristolMyers Squibb, Compugen, and Immunomic Therapeutics. All other authors declare no competing interests. C.L.S., D.M.P., C.M.D., and E.C.W. are inventors on patent application PCT/US2014/055123 submitted by Johns Hopkins University that covers use of biofilm formation to define risk for colon cancer.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Dejea C, 2013, FUTURE MICROBIOL, V8, P445, DOI [10.2217/fmb.13.17, 10.2217/FMB.13.17]; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GIARDIELLO FM, 1994, GASTROENTEROLOGY, V106, P1542, DOI 10.1016/0016-5085(94)90408-1; Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011; Martinez-Medina M, 2009, J CLIN MICROBIOL, V47, P3968, DOI 10.1128/JCM.01484-09; Prindiville TP, 2000, EMERG INFECT DIS, V6, P171, DOI 10.3201/eid0602.000210; Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739; Son JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127985; Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	14	463	494	24	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					592	+		10.1126/science.aah3648	http://dx.doi.org/10.1126/science.aah3648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420293	Green Accepted			2022-12-28	WOS:000423795800046
J	Chappell, LC; Chambers, J; Thornton, JG; Williamson, C				Chappell, Lucy C.; Chambers, Jenny; Thornton, Jim G.; Williamson, Catherine			UNCERTAINTIES Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Chappell, Lucy C.; Williamson, Catherine] Kings Coll London, Womens Hlth Acad Ctr, London, England; [Chambers, Jenny] ICP Support, Sutton Coldfield, England; [Thornton, Jim G.] Univ Nottingham, Div Child Hlth Obstet & Gynaecol, Nottingham, England	University of London; King's College London; University of Nottingham	Chappell, LC (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, London, England.	lucy.chappell@kcl.ac.uk	Thornton, Jim/B-8336-2008	Thornton, Jim/0000-0001-9764-6876	National Institute of Health Research Efficacy and Mechanism Evaluation panel; National Institute for Health Research [12/164/16, RP-2014-05-019] Funding Source: researchfish	National Institute of Health Research Efficacy and Mechanism Evaluation panel; National Institute for Health Research(National Institute for Health Research (NIHR))	We have read and understood the BMJ policy on declaration of interests and declare the following interests: all four authors are co-investigators on the PITCHES trial identified in the article funded by the National Institute of Health Research Efficacy and Mechanism Evaluation panel.	Abedin P, 1999, Ethn Health, V4, P35; ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin, 2002, OBSTET GYNECOL, V99; Allen AM, 2016, CLIN GASTROENTEROL H, V14, P287, DOI 10.1016/j.cgh.2015.08.022; [Anonymous], 2013, Obstet Gynecol, V121, P911, DOI 10.1097/01.AOG.0000428649.57622.a7; Arthur C, 2014, AUST NZ J OBSTET GYN, V54, P263, DOI 10.1111/ajo.12178; Beuers U, 2015, J HEPATOL, V62, pS25, DOI 10.1016/j.jhep.2015.02.023; Carey EJ, 2012, EXPERT OPIN PHARMACO, V13, P2473, DOI 10.1517/14656566.2012.736491; Chappell LC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002161; Chappell LC, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3799; Dixon PH, 2016, CLIN RES HEPATOL GAS, V40, P141, DOI 10.1016/j.clinre.2015.12.008; FISK NM, 1988, BRIT J OBSTET GYNAEC, V95, P1137, DOI 10.1111/j.1471-0528.1988.tb06791.x; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Gurung V, 2013, COCHRANE DB SYST REV, V6; Kenyon AP, 2010, OBSTET MED, V3, P25, DOI 10.1258/om.2010.090055; Marschall HU, 2013, HEPATOLOGY, V58, P1385, DOI 10.1002/hep.26444; Royal College of Obstetricians and Gynaecologists, 2011, OBST CHOL GREEN TOP, P43; Saleh MM, 2007, BJOG-INT J OBSTET GY, V114, P99, DOI 10.1111/j.1471-0528.2006.01102.x; Williamson C, 2014, OBSTET GYNECOL, V124, P120, DOI 10.1097/AOG.0000000000000346; Zhang Yu, 2016, 2016 IEEE International Conference on Electronic Information and Communication Technology (ICEICT). Proceedings, P16, DOI 10.1109/ICEICT.2016.7879644	20	10	10	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2018	360								k104	10.1136/bmj.k104	http://dx.doi.org/10.1136/bmj.k104			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TT	29419378	Green Accepted			2022-12-28	WOS:000423846200003
J	Monteiro, JM; Pereira, AR; Reichmann, NT; Saraival, BM; Fernandes, PB; Veiga, H; Tavares, AC; Santos, M; Ferreira, MT; Macario, V; VanNieuwenhze, MS; Filipe, SR; Pinho, MG				Monteiro, Jodo M.; Pereira, Ana R.; Reichmann, Nathalie T.; Saraival, Bruno M.; Fernandes, Pedro B.; Veiga, Helena; Tavares, Andreia C.; Santos, Margarida; Ferreira, Maria T.; Macario, Vdnia; VanNieuwenhze, Michael S.; Filipe, Sergio R.; Pinho, Mariana G.			Peptidoglycan synthesis drives an FtsZ-treadmilling-independent step of cytokinesis	NATURE			English	Article							CELL-WALL SYNTHESIS; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; DIVISION; BACTERIA; IDENTIFICATION; FILAMENTS; PROTEINS; GLYCOSYLTRANSFERASE; PRECURSORS	Peptidoglycan is the main component of the bacterial wall and protects cells from the mechanical stress that results from high intracellular turgor. Peptidoglycan biosynthesis is very similar in all bacteria; bacterial shapes are therefore mainly determined by the spatial and temporal regulation of peptidoglycan synthesis rather than by the chemical composition of peptidoglycan. The form of rod-shaped bacteria, such as Bacillus subtilis or Escherichia coli, is generated by the action of two peptidoglycan synthesis machineries that act at the septum and at the lateral wall in processes coordinated by the cytoskeletal proteins FtsZ and MreB, respectively(1,2). The tubulin homologue FtsZ is the first protein recruited to the division site, where it assembles in filaments-forming the Z ring-that undergo treadmilling and recruit later divisome proteins(3,4). The rate of treadmilling in B. subtilis controls the rates of both peptidoglycan synthesis and cell division(3). The actin homologue MreB forms discrete patches that move circumferentially around the cell in tracks perpendicular to the long axis of the cell, and organize the insertion of new cell wall during elongation(5,6). Cocci such as Staphylococcus aureus possess only one type of peptidoglycan synthesis machinery(7,8), which is diverted from the cell periphery to the septum in preparation for division(9). The molecular cue that coordinates this transition has remained elusive. Here we investigate the localization of S. aureus peptidoglycan biosynthesis proteins and show that the recruitment of the putative lipid II flippase Murj to the septum, by the DivIB-DivIC-FtsL complex, drives peptidoglycan incorporation to the midcell. Murj recruitment corresponds to a turning point in cytokinesis, which is slow and dependent on FtsZ treadmilling before MurJ arrival but becomes faster and independent of FtsZ treadmilling after peptidoglycan synthesis activity is directed to the septum, where it provides additional force for cell envelope constriction.	[Monteiro, Jodo M.; Pereira, Ana R.; Reichmann, Nathalie T.; Saraival, Bruno M.; Fernandes, Pedro B.; Veiga, Helena; Tavares, Andreia C.; Santos, Margarida; Ferreira, Maria T.; Macario, Vdnia; Pinho, Mariana G.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Bacterial Cell Biol, Oeiras, Portugal; [VanNieuwenhze, Michael S.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Filipe, Sergio R.] Univ Nova Lisboa, Ituto Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Filipe, Sergio R.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Oeiras, Portugal	Universidade Nova de Lisboa; Indiana University System; Indiana University Bloomington; Universidade Nova de Lisboa; Universidade Nova de Lisboa	Pinho, MG (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Bacterial Cell Biol, Oeiras, Portugal.	mgpinho@itqb.unl.pt	Filipe, Sergio Raposo/B-9167-2008; Pinho, Mariana/B-9192-2008	Filipe, Sergio Raposo/0000-0002-4485-832X; Pinho, Mariana/0000-0002-7132-8842; Reichmann, Nathalie/0000-0003-1003-6376; Monteiro, Joao Miguel/0000-0001-5181-1397; Saraiva, Bruno/0000-0002-9151-5477; Veiga, Helena/0000-0001-5345-475X; Fernandes, Pedro/0000-0002-4513-0736; Pereira, Ana Raquel/0000-0001-9957-815X; Tavares, Andreia/0000-0002-8260-0776	European Research Council [ERC-2012-StG-310987]; Microbiologia Molecular, Estrutural e Celular [LISBOA-01-0145-FEDER-007660]; National Institutes of Health [NIHGM113172]; FCT fellowships [SFRH/BD/71993/2010, SFRH/BD/86416/2012, SFRH/BPD/95031/2013, SFRH/BPD/87374/2012, SFRH/BD/52204/2013, SFRH/BD/77849/2011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113172] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Microbiologia Molecular, Estrutural e Celular; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT fellowships(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Sobral for the construction of pSG-murF plasmid; A. Jorge for the construction of the pSG-EzrA plasmid; T. Roemer for providing DMPI and strains AS-022 and AS-185; M. DeLisa for pTRC99a-P7; Richard Novick for pCN51; S. Foster for antibodies against DivIB and DivIC; A. Henriques for critical reading of the manuscript and L Krippahl for help with image analysis tools. This study was funded by the European Research Council through grant ERC-2012-StG-310987 (to M.G.P), by Project LISBOA-01-0145-FEDER-007660 Microbiologia Molecular, Estrutural e Celular (to ITQB-NOVA), by the National Institutes of Health through grant NIHGM113172 (to M.V.N.) and FCT fellowships SFRH/BD/71993/2010 (J.M.M.), SFRH/BD/86416/2012 (A.R.P), SFRH/BPD/95031/2013 (N.T.R.), SFRH/BPD/87374/2012 (H.V.), SFRH/BD/52204/2013 (A.C.T.) and SFRH/BD/77849/2011 (M.T.F).	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Benson TE, 2002, STRUCTURE, V10, P1107, DOI 10.1016/S0969-2126(02)00807-9; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; Coltharp C, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600179; Coltharp C, 2016, P NATL ACAD SCI USA, V113, pE1044, DOI 10.1073/pnas.1514296113; DIASVELASCO FR, 1980, IEEE T SYST MAN CYB, V10, P771; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Donald RGK, 2009, CHEM BIOL, V16, P826, DOI 10.1016/j.chembiol.2009.07.004; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Emami K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.253; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Falcao AX, 2004, IEEE T PATTERN ANAL, V26, P19, DOI 10.1109/TPAMI.2004.1261076; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Jorge AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027542; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Mann PA, 2013, ACS CHEM BIOL, V8, P2442, DOI 10.1021/cb400487f; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Monteiro JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9055; Moore DA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00553-16; Nair DR, 2015, ANTIMICROB AGENTS CH, V59, P1876, DOI 10.1128/AAC.04164-14; OSHIDA T, 1992, J BACTERIOL, V174, P4952, DOI 10.1128/JB.174.15.4952-4959.1992; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Pinho MG, 2004, FEMS MICROBIOL LETT, V240, P145, DOI 10.1016/j.femsle.2004.09.038; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Son SH, 2013, BIOCHEM BIOPH RES CO, V433, P108, DOI 10.1016/j.bbrc.2013.02.055; Wada A, 1998, J BACTERIOL, V180, P2759, DOI 10.1128/JB.180.10.2759-2765.1998; Yang XX, 2017, SCIENCE, V355, P744, DOI 10.1126/science.aak9995; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102	43	93	95	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					528	+		10.1038/nature25506	http://dx.doi.org/10.1038/nature25506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29443967	Green Accepted			2022-12-28	WOS:000425597400047
J	Reznick, D; Travis, J				Reznick, David; Travis, Joseph			Is evolution predictable?	SCIENCE			English	Editorial Material							DIFFERENCE EQUATION PREDICTORS; ECOLOGICAL TIME-SERIES; BOX-JENKINS ANALYSIS; POPULATION FLUCTUATIONS; SELECTION; MORPHS; POOLE		[Reznick, David] Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA; [Travis, Joseph] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA	University of California System; University of California Riverside; State University System of Florida; Florida State University	Reznick, D (corresponding author), Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA.	david.reznick@ucr.edu		reznick, david/0000-0002-1144-0568				ALLEN JA, 1988, PHILOS T R SOC B, V319, P485, DOI 10.1098/rstb.1988.0061; ANDERSON OD, 1978, THEOR POPUL BIOL, V13, P179, DOI 10.1016/0040-5809(78)90040-0; ANDERSON OD, 1978, THEOR POPUL BIOL, V14, P68, DOI 10.1016/0040-5809(78)90005-9; Fraser BA, 2013, J EVOLUTION BIOL, V26, P2597, DOI 10.1111/jeb.12251; JONES JS, 1977, ANNU REV ECOL SYST, V8, P109, DOI 10.1146/annurev.es.08.110177.000545; Lassig M, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0077; Langley SA, 2006, OECOLOGIA, V150, P172, DOI 10.1007/s00442-006-0486-0; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2018, SCIENCE, V359, P765, DOI 10.1126/science.aap9125; POOLE RW, 1976, THEOR POPUL BIOL, V9, P25, DOI 10.1016/0040-5809(76)90033-2; POOLE RW, 1978, THEOR POPUL BIOL, V13, P190, DOI 10.1016/0040-5809(78)90041-2; SANDOVAL CP, 1994, BIOL J LINN SOC, V52, P341; SANDOVAL CP, 1994, EVOLUTION, V48, P1866, DOI 10.1111/j.1558-5646.1994.tb02220.x	13	3	3	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					738	739		10.1126/science.aas9043	http://dx.doi.org/10.1126/science.aas9043			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449475				2022-12-28	WOS:000425116200024
J	Feliu, N; Neher, E; Parak, WJ				Feliu, Neus; Neher, Erwin; Parak, Wolfgang J.			Toward an optically controlled brain	SCIENCE			English	Editorial Material							NANOSTRUCTURES; NANOPARTICLES; OPTOGENETICS		[Feliu, Neus; Parak, Wolfgang J.] Univ Hamburg, Fachbereich Phys & Chem, Hamburg, Germany; [Feliu, Neus; Parak, Wolfgang J.] Univ Hamburg, Ctr Hybrid Nanostruct, Hamburg, Germany; [Feliu, Neus] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Neher, Erwin] Max Planck Inst Biophys Chem, Gottingen, Germany; [Parak, Wolfgang J.] CIC BiomaGUNE, San Sebastian, Spain; [Parak, Wolfgang J.] Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn, Shanghai, Peoples R China	University of Hamburg; University of Hamburg; Karolinska Institutet; Max Planck Society; CIC biomaGUNE; Shanghai Jiao Tong University	Parak, WJ (corresponding author), Univ Hamburg, Fachbereich Phys & Chem, Hamburg, Germany.; Parak, WJ (corresponding author), Univ Hamburg, Ctr Hybrid Nanostruct, Hamburg, Germany.; Parak, WJ (corresponding author), CIC BiomaGUNE, San Sebastian, Spain.; Parak, WJ (corresponding author), Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn, Shanghai, Peoples R China.	wolfgang.parak@uni-hamburg.de	Feliu Torres, Neus/C-4873-2019	Feliu Torres, Neus/0000-0002-7886-1711	Deutsche Forschungsgemeinschaft (DFG) [PA 794/21-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	W.J.P. acknowledges the Deutsche Forschungsgemeinschaft (DFG grant PA 794/21-1) and N.F. acknowledges the Swedish Governmental Agency for Innovation Systems (Vinnova).	Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Chen S, 2018, SCIENCE, V359, P679, DOI 10.1126/science.aaq1144; Feliu N, 2016, CHEM SOC REV, V45, P2440, DOI 10.1039/c5cs00699f; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Hegemann P, 2013, EMBO MOL MED, V5, P173, DOI 10.1002/emmm.201202387; Kolinko I, 2014, NAT NANOTECHNOL, V9, P193, DOI [10.1038/nnano.2014.13, 10.1038/NNANO.2014.13]; Marchesan S, 2015, ACS NANO, V9, P9441, DOI 10.1021/acsnano.5b04956; Nazarenus M, 2014, BEILSTEIN J NANOTECH, V5, P1477, DOI 10.3762/bjnano.5.161; Parak WJ, 2011, SCIENCE, V334, P1359, DOI 10.1126/science.1215080; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Plaza DO, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0477-8; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Wadman M., 2017, SCIENCE, DOI [10.1126/science.aan6920, DOI 10.1126/SCIENCE.AAN6920]; Wilhelm S, 2017, ACS NANO, V11, P10644, DOI 10.1021/acsnano.7b07120	14	9	9	5	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					632	634	aar7379	10.1126/science.aar7379	http://dx.doi.org/10.1126/science.aar7379			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439227				2022-12-28	WOS:000425117700020
J	English, T; Ribeiro, B				English, Terence; Ribeiro, Bernard			Should doctor assisted dying be legal?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[English, Terence; Ribeiro, Bernard] Royal Coll Surg, Oxford, England			tenglish@doctors.org.uk; ribeirob@parliament.uk						[Anonymous], 2000, NON TRADITIONAL REF; [Anonymous], 2014, ASSISTED DYING BILL; Morrison RS, 2015, AM CARE SERIOUS ILLN; Ribeiro B., 2015, TELEGRAPH; Royal College of Physicians, 2009, COMMUNICATION	5	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2018	360								k562	10.1136/bmj.k562	http://dx.doi.org/10.1136/bmj.k562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HY	29437655				2022-12-28	WOS:000424975900014
J	Roehr, B				Roehr, Bob			Assisted dying in US and Canada: controversy subsides after legalisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bobroehr@aol.com						[Anonymous], 2016, OREGON DEATH DIGNITY; Compassion and Choices, 2017, POLL VOT SUPP MED AI; Frye J, 2016, ANN INTERN MED, V165, P733, DOI 10.7326/M16-1319; Hedberg K, 2017, ANN INTERN MED, V167, P579, DOI 10.7326/M17-2300; Kussmaul WG, 2017, ANN INTERN MED, V167, P595, DOI 10.7326/M17-2072; Medscape, 2016, ETH REP; Quinn KL, 2017, JAMA INTERN MED, V177, P1251, DOI 10.1001/jamainternmed.2017.2862; Stahl RY, 2017, NEW ENGL J MED, V376, P1380, DOI 10.1056/NEJMsb1612472; Sulmasy LS, 2017, ANN INTERN MED, V167, P576, DOI 10.7326/M17-0938	9	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2018	360								k503	10.1136/bmj.k503	http://dx.doi.org/10.1136/bmj.k503			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HY	29437666				2022-12-28	WOS:000424975900009
J	Blackley, DJ; Reynolds, LE; Short, C; Carson, R; Storey, E; Halldin, CN; Laney, AS				Blackley, David J.; Reynolds, Laura E.; Short, Connie; Carson, Ron; Storey, Eileen; Halldin, Cara N.; Laney, A. Scott			Progressive Massive Fibrosis in Coal Miners From 3 Clinics in Virginia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Blackley, David J.; Reynolds, Laura E.; Storey, Eileen; Halldin, Cara N.; Laney, A. Scott] NIOSH, Resp Hlth Div, 1095 Willowdale Rd,Mail Stop HG900-2, Morgantown, WV 26505 USA; [Short, Connie; Carson, Ron] Stone Mt Hlth Serv, St Charles Resp Care Ctr, St Charles, VA USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Blackley, DJ (corresponding author), NIOSH, Resp Hlth Div, 1095 Willowdale Rd,Mail Stop HG900-2, Morgantown, WV 26505 USA.	dblackley@cdc.gov						Blackley DJ, 2014, AM J RESP CRIT CARE, V190, P708, DOI 10.1164/rccm.201407-1286LE; Laney AS, 2010, OCCUP ENVIRON MED, V67, P652, DOI 10.1136/oem.2009.047126; U.S. Department of Labor, 2014, FED REG, V79	3	56	59	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					500	501		10.1001/jama.2017.18444	http://dx.doi.org/10.1001/jama.2017.18444			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411024	Green Published, Bronze			2022-12-28	WOS:000424224500021
J	Calderon-Margalit, R; Golan, E; Twig, G; Leiba, A; Tzur, D; Afek, A; Skorecki, K; Vivante, A				Calderon-Margalit, Ronit; Golan, Eliezer; Twig, Gilad; Leiba, Adi; Tzur, Dorit; Afek, Arnon; Skorecki, Karl; Vivante, Asaf			History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							URINARY-TRACT-INFECTION; OF-THE-LITERATURE; CONGENITAL-ANOMALIES; FUNCTIONING KIDNEY; CHILDREN; BIRTH; METAANALYSIS; HYPERTENSION; ADOLESCENTS	BACKGROUND The long-term risk associated with childhood kidney disease that had not progressed to chronic kidney disease in childhood is unclear. We aimed to estimate the risk of future end-stage renal disease (ESRD) among adolescents who had normal renal function and a history of childhood kidney disease. METHODS We conducted a nationwide, population-based, historical cohort study of 1,521,501 Israeli adolescents who were examined before compulsory military service in 1967 through 1997; data were linked to the Israeli ESRD registry. Kidney diseases in childhood included congenital anomalies of the kidney and urinary tract, pyelonephritis, and glomerular disease; all participants included in the primary analysis had normal renal function and no hypertension in adolescence. Cox proportional-hazards models were used to estimate the hazard ratio for ESRD associated with a history of childhood kidney disease. RESULTS During 30 years of follow-up, ESRD developed in 2490 persons. A history of any childhood kidney disease was associated with a hazard ratio for ESRD of 4.19 (95% confidence interval [CI], 3.52 to 4.99). The associations between each diagnosis of kidney disease in childhood (congenital anomalies of the kidney and urinary tract, pyelonephritis, and glomerular disease) and the risk of ESRD in adulthood were similar in magnitude (multivariable-adjusted hazard ratios of 5.19 [95% CI, 3.41 to 7.90], 4.03 [95% CI, 3.16 to 5.14], and 3.85 [95% CI, 2.77 to 5.36], respectively). A history of kidney disease in childhood was associated with younger age at the onset of ESRD (hazard ratio for ESRD among adults <40 years of age, 10.40 [95% CI, 7.96 to 13.59]). CONCLUSIONS A history of clinically evident kidney disease in childhood, even if renal function was apparently normal in adolescence, was associated with a significantly increased risk of ESRD, which suggests that kidney injury or structural abnormality in childhood has long-term consequences.	[Calderon-Margalit, Ronit] Hadassah Hebrew Univ, Braun Sch Publ Hlth, Jerusalem, Israel; [Afek, Arnon] Israel Minist Hlth, Jerusalem, Israel; [Golan, Eliezer] Meir Med Ctr, Dept Hypertens & Nephrol, Kefar Sava, Israel; [Golan, Eliezer] Israel Renal Registry, Tel Aviv, Israel; [Golan, Eliezer; Leiba, Adi; Afek, Arnon; Vivante, Asaf] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Twig, Gilad; Leiba, Adi; Tzur, Dorit; Vivante, Asaf] Israel Def Forces Med Corps, Tel Hashomer, Israel; [Twig, Gilad; Vivante, Asaf] Talpiot Med Leadership Program, Tel Hashomer, Israel; [Afek, Arnon] Chaim Sheba Med Ctr Management, Tel Hashomer, Israel; [Vivante, Asaf] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Dept B, Tel Hashomer, Israel; [Vivante, Asaf] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Nephrol Unit, Tel Hashomer, Israel; [Leiba, Adi] Assuta Ashdod Acad Med Ctr, Inst Nephrol & Hypertens, Ashdod, Israel; [Leiba, Adi] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Dept Nephrol, Rappaport Fac Med, Rambam Hlth Care Campus, Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Res Inst, Rambam Hlth Care Campus, Haifa, Israel; [Leiba, Adi] Harvard Med Sch, Mt Auburn Hosp, Dept Med, Cambridge, MA USA; [Vivante, Asaf] Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA USA; [Vivante, Asaf] Harvard Med Sch, Boston, MA USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ben Gurion University; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Harvard University; Mount Auburn Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Calderon-Margalit, R (corresponding author), Hadassah Hebrew Univ, Braun Sch Publ Hlth, Hadassah Kerem, POB 12272, IL-9112102 Jerusalem, Israel.; Vivante, A (corresponding author), Edmond & Lily Safra Childrens Hosp, Sackler Fac Med, Sheba Med Ctr, Pediat Dept B, IL-5265601 Ramat Gan, Israel.; Vivante, A (corresponding author), Edmond & Lily Safra Childrens Hosp, Sackler Fac Med, Sheba Med Ctr, Pediat Nephrol Unit, IL-5265601 Ramat Gan, Israel.	ronitcm@gmail.com; asafvivante@gmail.com	Twig, Gilad/C-4373-2018	Twig, Gilad/0000-0003-2829-3645				Abou Jaoude P, 2011, NEPHROL DIAL TRANSPL, V26, P2188, DOI 10.1093/ndt/gfq659; Andres-Jensen L, 2016, ARCH DIS CHILD, V101, P819, DOI 10.1136/archdischild-2015-309784; Calderon-Margalit R, 2008, NEPHROL DIAL TRANSPL, V23, P659, DOI 10.1093/ndt/gfm597; European Surveillance of Congenital Anomalies, 2016, EUROCAT PREV DAT UR; Gordon I, 2003, J AM SOC NEPHROL, V14, P739, DOI 10.1097/01.ASN.0000053416.93518.63; Grams ME, 2016, NEW ENGL J MED, V374, P411, DOI 10.1056/NEJMoa1510491; Harambat J, 2012, PEDIATR NEPHROL, V27, P363, DOI 10.1007/s00467-011-1939-1; Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5; Ingelfinger JR, 2003, NEW ENGL J MED, V348, P99, DOI 10.1056/NEJMp020168; Ingelfinger JR, 2016, NEPHROL DIAL TRANSPL, V31, P327, DOI 10.1093/ndt/gfw003; Ishikura K, 2013, NEPHROL DIAL TRANSPL, V28, P2345, DOI 10.1093/ndt/gfs611; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Luyckx VA, 2010, J AM SOC NEPHROL, V21, P898, DOI 10.1681/ASN.2009121248; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Montini G, 2011, NEW ENGL J MED, V365, P239, DOI 10.1056/NEJMra1007755; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Postoev VA, 2016, BIRTH DEFECTS RES A, V106, P185, DOI 10.1002/bdra.23475; Shaikh N, 2014, JAMA PEDIATR, V168, P893, DOI 10.1001/jamapediatrics.2014.637; Skrzypczyk P, 2014, CLIN NEPHROL, V81, P166, DOI 10.5414/CN108044; Tain YL, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002659; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; United States Renal Data System, 2016, 2016 USRDS ANN DAT R; Vivante A, 2014, JAMA-J AM MED ASSOC, V311, P1155, DOI 10.1001/jama.2013.284310; Vivante A, 2011, JAMA-J AM MED ASSOC, V306, P729, DOI 10.1001/jama.2011.1141; Vu KH, 2008, EUR J PEDIATR, V167, P885, DOI 10.1007/s00431-007-0612-y; Westland R, 2011, NEPHROL DIAL TRANSPL, V26, P1533, DOI 10.1093/ndt/gfq844; Wuhl E, 2013, CLIN J AM SOC NEPHRO, V8, P67, DOI 10.2215/CJN.03310412	27	88	93	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					428	438		10.1056/NEJMoa1700993	http://dx.doi.org/10.1056/NEJMoa1700993			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU3WP	29385364				2022-12-28	WOS:000423783200007
J	Mosler, G; Euba, T				Mosler, Gioia; Euba, Tunde			The art of medicine Taking control through drama	LANCET			English	Editorial Material									[Mosler, Gioia] Queen Mary Univ London, Blizard Inst, Ctr Genom & Child Hlth, Barts & London Sch Med & Dent, London E1 2AT, England; [Euba, Tunde] Greenwich & Lewisham Young Peoples Theatre, London, England	University of London; Queen Mary University London	Mosler, G (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Genom & Child Hlth, Barts & London Sch Med & Dent, London E1 2AT, England.	g.mosler@qmul.ac.uk		Mosler, Gioia/0000-0002-6900-4080	Health Foundation; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust	Health Foundation; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust	Gioia Mosler is the Outreach and Learning Manager for the School-based Asthma Project at the Blizard Institute, Queen Mary University of London, UK. Tunde Euba is a London-based freelance arts practitioner and photographer who works in collaboration with Greenwich & Lewisham Young People's Theatre (GLYPT). For making this project possible, we thank all members of GLYPT, especially Jeremy James, Artistic Director of GLYPT, Tony Casement, Associate Artistic Director, and the actors who brought the In Control theatre to life. We also thank Professor Jonathan Grigg and Katherine Harris from the School-based Asthma Project. In Control is supported by the Health Foundation, an independent charity committed to bringing about better health and health care for people in the UK. The project was in addition supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.		0	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2018	391	10118					303	304		10.1016/S0140-6736(17)32283-3	http://dx.doi.org/10.1016/S0140-6736(17)32283-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU5CE	29413036				2022-12-28	WOS:000423869500018
J	Seita, A; Goldsmith, A; Hababeh, M; Shahin, Y				Seita, Akihiro; Goldsmith, Amelia; Hababeh, Majed; Shahin, Yousef			Amid US funding cuts, UNRWA appeals for health and dignity of Palestinian refugees	LANCET			English	Editorial Material									[Seita, Akihiro; Goldsmith, Amelia; Hababeh, Majed; Shahin, Yousef] UNRWA Hlth Dept, UNRWA Headquarters, Amman 11814, Jordan		Seita, A (corresponding author), UNRWA Hlth Dept, UNRWA Headquarters, Amman 11814, Jordan.	a.seita@unrwa.org						UNRWA, 2017, COMMUNICATION   0117; *UNRWA, 2017, HLTH DEP ANN REP 201; US State Department. Department Press Briefing-January 16 2018, 2018, COMMUNICATION   0116	3	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2018	391	10118					294	295		10.1016/S0140-6736(18)30113-2	http://dx.doi.org/10.1016/S0140-6736(18)30113-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU5CE	29395267				2022-12-28	WOS:000423869500012
J	Khullar, D; Burke, GC; Casalino, LP				Khullar, Dhruv; Burke, Gregory C.; Casalino, Lawrence P.			Can Small Physician Practices Survive? Sharing Services as a Path to Viability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Khullar, Dhruv; Casalino, Lawrence P.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, 402 E 67th St, New York, NY 10065 USA; [Khullar, Dhruv] Weill Cornell Med Coll, Dept Med, 402 E 67th St, New York, NY 10065 USA; [Burke, Gregory C.] United Hosp Fund, New York, NY USA	Cornell University; Cornell University	Khullar, D (corresponding author), Weill Cornell Med Coll, Dept Healthcare Policy & Res, 402 E 67th St, New York, NY 10065 USA.; Khullar, D (corresponding author), Weill Cornell Med Coll, Dept Med, 402 E 67th St, New York, NY 10065 USA.	Khd9010@med.cornell.edu	Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859	New York City Population Health Improvement Program; American Medical Association Professional Satisfaction and Practice Sustainability Advisory Committee	New York City Population Health Improvement Program; American Medical Association Professional Satisfaction and Practice Sustainability Advisory Committee	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Mr Burke reported that he received a grant from the New York City Population Health Improvement Program. Dr Casalino reported that he received personal fees for serving on the American Medical Association Professional Satisfaction and Practice Sustainability Advisory Committee. No other disclosures were reported.	[Anonymous], 2017, FED REGISTER, V82, P53568; Baker LC, 2014, JAMA-J AM MED ASSOC, V312, P1653, DOI 10.1001/jama.2014.10921; Casalino LP, 2014, HEALTH AFFAIR, V33, P1680, DOI 10.1377/hlthaff.2014.0434; Kane CK, 2015, JAMA; Kralewski JE, 2012, HEALTH AFFAIR, V31, P1830, DOI 10.1377/hlthaff.2011.0887; Muhlestein DB, 2016, HEALTH AFFAIR, V35, P1638, DOI 10.1377/hlthaff.2016.0130; Post B, 2018, MED CARE RES REV, V75, P399, DOI 10.1177/1077558717727834	7	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2018	319	13					1321	1322		10.1001/jama.2017.21704	http://dx.doi.org/10.1001/jama.2017.21704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GB4NC	29459948				2022-12-28	WOS:000429035900012
J	Opel, DJ; Sonne, JA; Mello, MM				Opel, Douglas J.; Sonne, James A.; Mello, Michelle M.			Vaccination without Litigation - Addressing Religious Objections to Hospital Influenza-Vaccination Mandates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Opel, Douglas J.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Sonne, James A.; Mello, Michelle M.] Stanford Univ, Sch Med, Stanford Law Sch, Stanford, CA USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA	University of Washington; University of Washington Seattle; Stanford University; Stanford University	Opel, DJ (corresponding author), Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA.			Mello, Michelle/0000-0003-2877-4270				Black CL, 2017, MMWR-MORBID MORTAL W, V66, P1009, DOI 10.15585/mmwr.mm6638a1	1	12	12	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2018	378	9					785	788		10.1056/NEJMp1716147	http://dx.doi.org/10.1056/NEJMp1716147			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX7GP	29384718	Bronze			2022-12-28	WOS:000426256300001
J	Emanuel, EJ; Gudbranson, E				Emanuel, Ezekiel J.; Gudbranson, Emily			Does Medicine Overemphasize IQ?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.; Gudbranson, Emily] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA.	MEHPchair@upenn.edu						[Anonymous], 2010, CONCENTRATION HLTH C; [Anonymous], 2016, MCAT SCOR GPAS APPL; Diamond S., 2009, GETTING MORE NEGOTIA; Gardner H, 1983, FRAMES MIND THEORY M; Goleman D, 1998, HARVARD BUS REV, V76, P92; Jewell RT, 2013, APPL ECON, V45, P1185, DOI 10.1080/00036846.2011.621884; McKee A., 2016, HARV BUS REV; Rojstaczer S., 2010, TEACH COLL REC	8	29	30	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2018	319	7					651	652		10.1001/jama.2017.20141	http://dx.doi.org/10.1001/jama.2017.20141			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW7MQ	29379958				2022-12-28	WOS:000425508400010
J	Siegel, D				Siegel, David			Review: In hypertension, BP self-monitoring interventions improve BP levels and BP control at 12 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Siegel, David] VA Northern Calif Hlth Care Syst, Mather, CA 95655 USA		Siegel, D (corresponding author), VA Northern Calif Hlth Care Syst, Mather, CA 95655 USA.							Muntner P, 2018, CIRCULATION, V137, P109, DOI 10.1161/CIRCULATIONAHA.117.032582; Nwankwo Tatiana, 2013, NCHS Data Brief, P1	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC16	JC16		10.7326/ACPJC-2018-168-4-016	http://dx.doi.org/10.7326/ACPJC-2018-168-4-016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459953				2022-12-28	WOS:000425434000004
J	Varner, C; Carpenter, CR				Varner, Catherine; Carpenter, Christopher R.			Ibuprofen plus acetaminophen did not differ from opioids plus acetaminophen for reducing acute extremity pain at 2 h	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Varner, Catherine] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada; [Carpenter, Christopher R.] Washington Univ, St Louis, MO USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Washington University (WUSTL)	Varner, C (corresponding author), Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada.		Carpenter, Christopher R./E-3720-2013	Carpenter, Christopher R./0000-0002-2603-7157; Varner, Catherine/0000-0002-9696-1329				Holland WC, 2016, ACAD EMERG MED, V23, P306, DOI 10.1111/acem.12888; Lipp C, 2013, CRIT CARE, V17, DOI 10.1186/cc12521; Todd KH, 2017, PAIN THER, V6, P193, DOI 10.1007/s40122-017-0090-5	3	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC21	JC21		10.7326/ACPJC-2018-168-4-021	http://dx.doi.org/10.7326/ACPJC-2018-168-4-021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459958				2022-12-28	WOS:000425434000009
J	Maskell, G				Maskell, Giles			The new chest x ray	BMJ-BRITISH MEDICAL JOURNAL			English	Letter							PULMONARY-EMBOLISM					gilesmaskell@nhs.net						Gans SL, 2012, INT J GEN MED, V5, P525, DOI 10.2147/IJGM.S17410; Hall WB, 2009, ARCH INTERN MED, V169, P1961, DOI 10.1001/archinternmed.2009.360; Kim Y, 2015, AM J ROENTGENOL, V204, P1197, DOI 10.2214/AJR.14.13629; Nadalo LA, 2016, MEDSCAPE; RadiologyInfo.org, 2017, RAD DOS XRAY CT EX; Stapley S, 2006, BRIT J GEN PRACT, V56, P570; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; Yazdani M, 2015, RADIOGRAPHICS, V35, P1245, DOI 10.1148/rg.2015140280	8	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2018	360								k769	10.1136/bmj.k769	http://dx.doi.org/10.1136/bmj.k769			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX1ED	29459479				2022-12-28	WOS:000425790700005
J	Sartor, O; de Bono, JS				Sartor, Oliver; de Bono, Johann S.			Metastatic Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							POST HOC ANALYSIS; ABIRATERONE ACETATE; PHASE-III; RADIOGRAPHIC PROGRESSION; 1ST-LINE CHEMOTHERAPY; INCREASED SURVIVAL; PROGNOSTIC MODEL; PLUS PREDNISONE; CLINICAL-TRIAL; CASTRATION		[Sartor, Oliver] Tulane Med Sch, New Orleans, LA USA; [de Bono, Johann S.] Inst Canc Res, London, England; [de Bono, Johann S.] Royal Marsden NHS Fdn Trust, London, England	Tulane University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Sartor, O (corresponding author), Tulane Canc Ctr, Box SL-42,1430 Tulane Ave, New Orleans, LA 70112 USA.	osartor@tulane.edu		de Bono, Johann S/0000-0002-2034-595X	Bavarian Nordic; Oncogenex; Medivation; Pfizer; Myovant Sciences; Tokai; Astellas; Janssen; Endocyte and Advanced Accelerator Applications; EMD-Serono; Bayer; Sanofi; Cougar; Endocyte; Dendreon; PSMA Development; Eli Lilly; Merck; Innocrin; Genentech; AstraZeneca; GlaxoSmithKline; Sanofi-Aventis	Bavarian Nordic; Oncogenex; Medivation; Pfizer(Pfizer); Myovant Sciences; Tokai; Astellas(Astellas Pharmaceuticals); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Endocyte and Advanced Accelerator Applications; EMD-Serono; Bayer(Bayer AG); Sanofi; Cougar; Endocyte(Novartis); Dendreon; PSMA Development; Eli Lilly(Eli Lilly); Merck(Merck & Company); Innocrin; Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis)	Dr. Sartor reports receiving fees for serving as chair of the data management center and consulting fees from Bavarian Nordic, Oncogenex, Medivation, Pfizer, Myovant Sciences, Tokai, and Astellas, fees for serving as chair of the data management center, consulting fees, and travel support from Janssen, consulting fees from Endocyte and Advanced Accelerator Applications, consulting fees and travel support from Sanofi, Bayer, and EMD-Serono, and grant support from Bayer, Cougar, Endocyte, Dendreon, Tokai, Sanofi, PSMA Development, Eli Lilly, Merck, Innocrin, and Genentech; and Dr. de Bono, receiving grant support and advisory board fees from AstraZeneca, Genentech, GlaxoSmithKline, Janssen, Merck, and Pfizer, advisory board fees from Astellas and Bayer, grant support, advisory board fees, and provision of free drugs from Sanofi-Aventis, and being named as an inventor, with no financial interest, for patent 8,822,438. No other potential conflict of interest relevant to this article was reported.	Antonarakis ES, 2015, JAMA ONCOL, V1, P582, DOI 10.1001/jamaoncol.2015.1341; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.5004; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beer TM, 2017, EUR UROL, V71, P151, DOI 10.1016/j.eururo.2016.07.032; Blattner M, 2017, CANCER CELL, V31, P436, DOI 10.1016/j.ccell.2017.02.004; Bouchelouche K, 2016, SEMIN NUCL MED, V46, P522, DOI 10.1053/j.semnuclmed.2016.07.006; Carles J, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw372.24; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Cheng HH, 2016, EUR UROL, V69, P992, DOI 10.1016/j.eururo.2015.11.022; Conteduca V, 2017, ANN ONCOL, V28, P1508, DOI 10.1093/annonc/mdx155; de Bono JS, 2017, EUR UROL, V71, P656, DOI 10.1016/j.eururo.2016.06.033; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Eisenberger M, 2017, J CLIN ONCOL, V35, P3198, DOI 10.1200/JCO.2016.72.1076; FDA, 2017, FDA GRANTS ACC APPR; Fischer S, 2018, ANN ONCOL, V29; Fitzpatrick JM, 2014, EUR UROL, V65, P1198, DOI 10.1016/j.eururo.2013.07.022; Fizazi K, 2017, NEW ENGL J MED, V377, P352, DOI 10.1056/NEJMoa1704174; Gill D, 2017, CLIN GENITOURIN CANC, V15, pE599, DOI 10.1016/j.clgc.2016.12.008; Graff JN, 2016, ONCOTARGET, V7, P52810, DOI 10.18632/oncotarget.10547; Guinney J, 2017, LANCET ONCOL, V18, P132, DOI 10.1016/S1470-2045(16)30560-5; Halabi S, 2014, J CLIN ONCOL, V32, P671, DOI 10.1200/JCO.2013.52.3696; Hansen A, 2016, ANN ONCOL, V27, DOI [10.1093/annonc/mdw372.09, DOI 10.1093/ANNONC/MDW372.09]; Henriksen G, 2002, CANCER RES, V62, P3120; Ho Y, 2017, ENDOCRINOLOGY, V158, P1533, DOI 10.1210/en.2017-00109; Huggins C, 1941, CANCER RES, V1, P293; James ND, 2017, NEW ENGL J MED, V377, P338, DOI 10.1056/NEJMoa1702900; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kratochwil C, 2017, J NUCL MED, V58, P1624, DOI 10.2967/jnumed.117.191395; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Lallous N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0864-1; Lecarpentier J, 2017, J CLIN ONCOL, V35, P2240, DOI 10.1200/JCO.2016.69.4935; Lecouvet FE, 2012, EUR UROL, V62, P68, DOI 10.1016/j.eururo.2012.02.020; Li ZF, 2015, NATURE, V523, P347, DOI 10.1038/nature14406; Mannweiler S, 2009, PATHOL ONCOL RES, V15, P167, DOI 10.1007/s12253-008-9104-2; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; Morris MJ, 2015, J CLIN ONCOL, V33, P1356, DOI 10.1200/JCO.2014.55.3875; Na R, 2017, EUR UROL, V71, P740, DOI 10.1016/j.eururo.2016.11.033; Noonan KL, 2013, ANN ONCOL, V24, P1802, DOI 10.1093/annonc/mdt138; Oudard S, 2017, J CLIN ONCOL, V35, P3189, DOI 10.1200/JCO.2016.72.1068; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Pomerantz MM, 2017, CANCER-AM CANCER SOC, V123, P3532, DOI 10.1002/cncr.30808; POTTER GA, 1995, J MED CHEM, V38, P2463, DOI 10.1021/jm00013a022; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Rahbar K, 2017, J NUCL MED, V58, P85, DOI 10.2967/jnumed.116.183194; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Romanel A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9511; Ryan CJ, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.6_suppl.193; Ryan CJ, 2015, LANCET ONCOL, V16, P152, DOI 10.1016/S1470-2045(14)71205-7; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2016, JAMA ONCOL, V2, P1441, DOI 10.1001/jamaoncol.2016.1828; Scher HI, 2015, J CLIN ONCOL, V33, P1348, DOI 10.1200/JCO.2014.55.3487; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schrader AJ, 2014, EUR UROL, V65, P30, DOI 10.1016/j.eururo.2013.06.042; Smith MR, 2017, EUR UROL, V72, P10, DOI 10.1016/j.eururo.2017.03.007; Sun MX, 2016, JAMA ONCOL, V2, P500, DOI 10.1001/jamaoncol.2015.4917; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Tagawa ST, 2013, CLIN CANCER RES, V19, P5182, DOI 10.1158/1078-0432.CCR-13-0231; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Vale CL, 2016, LANCET ONCOL, V17, P243, DOI 10.1016/S1470-2045(15)00489-1; van Soest RJ, 2015, ANN ONCOL, V26, P743, DOI 10.1093/annonc/mdu569; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wil L, 2017, Q J NUCL MED MOL IM, V61, P168, DOI 10.23736/S1824-4785.17.02977-6; Wyatt AW, 2016, JAMA ONCOL, V2, P1598, DOI 10.1001/jamaoncol.2016.0494; Xu D, 2015, CANCER RES, V75, P3663, DOI 10.1158/0008-5472.CAN-15-0381	76	241	243	3	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					645	657		10.1056/NEJMra1701695	http://dx.doi.org/10.1056/NEJMra1701695			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0QK	29412780				2022-12-28	WOS:000425000000010
J	Aakhus, E; Mitra, N; Lautenbach, E; Joffe, S				Aakhus, Erin; Mitra, Nandita; Lautenbach, Ebbing; Joffe, Steven			Gender and Byline Placement of Co-first Authors in Clinical and Basic Science Journals With High Impact Factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Aakhus, Erin] Univ Penn, Div Hematol Oncol, Perelman Sch Med, 3400 Civ Ctr Blvd,PCAM 10 SPE, Philadelphia, PA 19104 USA; [Mitra, Nandita] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lautenbach, Ebbing] Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Joffe, Steven] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Aakhus, E (corresponding author), Univ Penn, Div Hematol Oncol, Perelman Sch Med, 3400 Civ Ctr Blvd,PCAM 10 SPE, Philadelphia, PA 19104 USA.	erin.aakhus@uphs.upenn.edu	Aakhus, Erin/AAF-2925-2019; Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384; Aakhus, Erin/0000-0001-8204-0062				Akhabue E, 2010, ANN EPIDEMIOL, V20, P868, DOI 10.1016/j.annepidem.2010.08.004; NamepediA, NAM DAT INCL GIV FAM; Social Security Administration, POP BAB NAM; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	5	29	29	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					610	611		10.1001/jama.2017.18672	http://dx.doi.org/10.1001/jama.2017.18672			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450515	Green Published, Bronze			2022-12-28	WOS:000424908400022
J	Larson, C				Larson, Christina			CHINA'S AI IMPERATIVE	SCIENCE			English	Editorial Material																			0	11	12	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					628	630		10.1126/science.359.6376.628	http://dx.doi.org/10.1126/science.359.6376.628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439225				2022-12-28	WOS:000425117700018
J	Lambert, SA; Jolma, A; Campitelli, LF; Das, PK; Yin, YM; Albu, M; Chen, XT; Taipale, J; Hughes, TR; Weirauch, MT				Lambert, Samuel A.; Jolma, Arttu; Campitelli, Laura F.; Das, Pratyush K.; Yin, Yimeng; Albu, Mihai; Chen, Xiaoting; Taipale, Jussi; Hughes, Timothy R.; Weirauch, Matthew T.			The Human Transcription Factors	CELL			English	Review							PROTEIN-DNA INTERACTIONS; FACTOR SEQUENCE SPECIFICITY; ZINC-FINGER PROTEINS; EMBRYONIC STEM-CELLS; FACTOR-BINDING; HUMAN GENOME; FUNCTIONAL DIVERSITY; REGULATORY PROTEINS; GENE-EXPRESSION; IMMUNE-SYSTEM	Transcription factors (TFs) recognize specific DNA sequences to control chromatin and transcription, forming a complex system that guides expression of the genome. Despite keen interest in understanding how TFs control gene expression, it remains challenging to determine how the precise genomic binding sites of TFs are specified and how TF binding ultimately relates to regulation of transcription. This review considers how TFs are identified and functionally characterized, principally through the lens of a catalog of over 1,600 likely human TFs and binding motifs for two-thirds of them. Major classes of human TFs differ markedly in their evolutionary trajectories and expression patterns, underscoring distinct functions. TFs likewise underlie many different aspects of human physiology, disease, and variation, highlighting the importance of continued effort to understand TF-mediated gene regulation.	[Lambert, Samuel A.; Campitelli, Laura F.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Jolma, Arttu; Albu, Mihai; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Das, Pratyush K.; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland; [Yin, Yimeng; Taipale, Jussi] Karolinska Inst, Dept Med Biochem & Biophys, Div Funct Genom & Syst Biol, Solna, Sweden; [Chen, Xiaoting; Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol CAGE, Cincinnati, OH 45229 USA; [Taipale, Jussi] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45220 USA	University of Toronto; University of Toronto; University of Helsinki; Karolinska Institutet; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Cambridge; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hughes, TR (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Hughes, TR (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.; Taipale, J (corresponding author), Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland.; Taipale, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Funct Genom & Syst Biol, Solna, Sweden.; Weirauch, MT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol CAGE, Cincinnati, OH 45229 USA.; Taipale, J (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.; Weirauch, MT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA.; Weirauch, MT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.; Weirauch, MT (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45220 USA.	ajt208@cam.ac.uk; t.hughes@utoronto.ca; Matthew.Weirauch@cchmc.org	Jolma, Arttu/AAK-9649-2021; Weirauch, Matthew/M-5459-2019; Lambert, Samuel/ABA-7732-2021	Lambert, Samuel/0000-0001-8222-008X; Das, Pratyush Kumar/0000-0003-2822-9619; Jolma, Arttu/0000-0002-2543-7490	NIH [R01 NS099068-01A1]; Lupus Research Alliance "Novel Approaches''; Cincinnati Children's Hospital "Center for Pediatric Genomics pilot study''; Trustee Award; Endowed Scholar award; CIHR Foundation Award; Swedish Research Council "Vetenskapsradet'' postdoctoral grant [2016-00158]; NSERC PGS-D scholarships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Alliance "Novel Approaches''; Cincinnati Children's Hospital "Center for Pediatric Genomics pilot study''; Trustee Award; Endowed Scholar award; CIHR Foundation Award(Canadian Institutes of Health Research (CIHR)); Swedish Research Council "Vetenskapsradet'' postdoctoral grant; NSERC PGS-D scholarships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We apologize to colleagues whose important primary studies could not be cited due to space constraints. This work was supported by NIH R01 NS099068-01A1, Lupus Research Alliance "Novel Approaches,'' Cincinnati Children's Hospital "Center for Pediatric Genomics pilot study,'' "Trustee Award,'' and "Endowed Scholar award'' (M.T.W.), and a CIHR Foundation Award (T.R.H.). A.J. was supported by Swedish Research Council "Vetenskapsradet'' postdoctoral grant (2016-00158). S.A.L. and L.F.C. are supported by NSERC PGS-D scholarships. T.R.H. is a Senior Fellow of CIFAR and the Billes Chair of Medical Research at the University of Toronto.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Barrera LA, 2016, SCIENCE, V351, P1450, DOI 10.1126/science.aad2257; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Burglin TR, 2011, SUBCELL BIOCHEM, V52, P95, DOI 10.1007/978-90-481-9069-0_5; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Campagne S, 2010, NUCLEIC ACIDS RES, V38, P3466, DOI 10.1093/nar/gkq053; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cusanovich DA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004226; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Deplancke B, 2016, CELL, V166, P538, DOI 10.1016/j.cell.2016.07.012; Dunwell TL, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0140-y; Ecco G, 2017, DEVELOPMENT, V144, P2719, DOI 10.1242/dev.132605; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Ernst J, 2016, NAT BIOTECHNOL, V34, P1180, DOI 10.1038/nbt.3678; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fong AP, 2013, CURR OPIN GENET DEV, V23, P568, DOI 10.1016/j.gde.2013.05.002; Font J, 2010, METHODS MOL BIOL, V649, P479, DOI 10.1007/978-1-60761-753-2_29; Frietze S, 2011, SUBCELL BIOCHEM, V52, P261, DOI 10.1007/978-90-481-9069-0_12; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/nmeth.2411, 10.1038/NMETH.2411]; Geertz M, 2012, P NATL ACAD SCI USA, V109, P16540, DOI 10.1073/pnas.1206011109; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Hayward A, 2015, P NATL ACAD SCI USA, V112, P464, DOI 10.1073/pnas.1414980112; Herrero J., 2016, ENSEMBL COMPARATIVE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Hunt RW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0412-4; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2011, SUBCELL BIOCHEM, V52, P155, DOI 10.1007/978-90-481-9069-0_7; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lambert SA, 2016, BIOINFORMATICS, V32, P3504, DOI 10.1093/bioinformatics/btw489; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li HJ, 2017, NATURE, V549, P287, DOI 10.1038/nature23881; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marcon E, 2014, CELL REP, V8, P297, DOI 10.1016/j.celrep.2014.05.050; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Morgunova E, 2017, CURR OPIN STRUC BIOL, V47, P1, DOI 10.1016/j.sbi.2017.03.006; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Nitta KR, 2015, ELIFE, V4, DOI 10.7554/eLife.04837; Ou JH, 2018, NAT METHODS, V15, P8, DOI 10.1038/nmeth.4555; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Ptashne M, 2011, NAT CHEM BIOL, V7, P484, DOI 10.1038/nchembio.611; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reece-Hoyes JS, 2012, METHODS, V57, P441, DOI 10.1016/j.ymeth.2012.07.027; Reiter F, 2017, CURR OPIN GENET DEV, V43, P73, DOI 10.1016/j.gde.2016.12.007; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rippe K, 2007, P NATL ACAD SCI USA, V104, P15635, DOI 10.1073/pnas.0702430104; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schmitges FW, 2016, GENOME RES, V26, P1742, DOI 10.1101/gr.209643.116; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Singh H, 2014, TRENDS IMMUNOL, V35, P211, DOI 10.1016/j.it.2014.03.006; Sizemore GM, 2017, NAT REV CANCER, V17, P337, DOI 10.1038/nrc.2017.20; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Smale ST, 2014, TRENDS IMMUNOL, V35, P190, DOI 10.1016/j.it.2014.03.003; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stubbs L, 2011, SUBCELL BIOCHEM, V52, P75, DOI 10.1007/978-90-481-9069-0_4; Sur I, 2016, NAT REV CANCER, V16, P483, DOI 10.1038/nrc.2016.62; Swinstead EE, 2016, BIOESSAYS, V38, P1150, DOI 10.1002/bies.201600137; Swinstead EE, 2016, CELL, V165, P593, DOI 10.1016/j.cell.2016.02.067; Tacheny A, 2013, J PROTEOMICS, V94, P89, DOI 10.1016/j.jprot.2013.09.011; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wingender E, 2015, NUCLEIC ACIDS RES, V43, pD97, DOI 10.1093/nar/gku1064; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Zabidi MA, 2016, TRENDS GENET, V32, P801, DOI 10.1016/j.tig.2016.10.003	117	950	969	24	243	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					650	665		10.1016/j.cell.2018.01.029	http://dx.doi.org/10.1016/j.cell.2018.01.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425488	Bronze			2022-12-28	WOS:000424648800008
J	Mohidin, B				Mohidin, Barian			SPOT DIAGNOSIS Skin changes after a magnetic resonance imaging scan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mohidin, Barian] Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Mohidin, B (corresponding author), Royal Free Hosp, London, England.	barian.mohidin@nhs.net						Chopra T, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/912189; Cowper SE, 2001, NEPHROGENIC SYSTEMIC; Ramalho J, 2016, AM J NEURORADIOL, V37, P1192, DOI 10.3174/ajnr.A4615; Wagner B, 2016, AM J PHYSIOL-RENAL, V311, pF1, DOI 10.1152/ajprenal.00166.2016	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2018	360								k77	10.1136/bmj.k77	http://dx.doi.org/10.1136/bmj.k77			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0IA	29437683				2022-12-28	WOS:000424976200009
J	Garg, R				Garg, Rajesh			Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A(1c) Levels	ANNALS OF INTERNAL MEDICINE			English	Letter									[Garg, Rajesh] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Garg, R (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.							Bergenstal RM, 2017, ANN INTERN MED, V167, P95, DOI 10.7326/M16-2596	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					232	232		10.7326/L17-0588	http://dx.doi.org/10.7326/L17-0588			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29404585				2022-12-28	WOS:000424224300016
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Do bed and chair sensors really stop falls in hospital?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Barker AL, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6781; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Cracknell Alison, 2016, Future Hosp J, V3, ps31, DOI 10.7861/futurehosp.3-2s-s31; Donnelly L, 2017, TELEGRAPH; Healey F, 2014, AGE AGEING, V43, P484, DOI 10.1093/ageing/aft190; National Institute for Health and Care Excellence, 2013, FALLS OLD PEOPL ASS; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Royal College of Physicians, 2015, NAIF AUD REP 2015; Sahota O, 2014, AGE AGEING, V43, P247, DOI 10.1093/ageing/aft155; Shorr RI, 2012, ANN INTERN MED, V157, P692, DOI 10.7326/0003-4819-157-10-201211200-00005	10	2	2	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2018	360								k433	10.1136/bmj.k433	http://dx.doi.org/10.1136/bmj.k433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HT	29437682	Bronze, Green Published			2022-12-28	WOS:000424975300005
J	Voelker, R				Voelker, Rebecca			Gene Therapy for Vision Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					434	434		10.1001/jama.2017.21710	http://dx.doi.org/10.1001/jama.2017.21710			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411019				2022-12-28	WOS:000424224500005
J	Devi, S				Devi, Sharmila			FGM in Sierra Leone	LANCET			English	Editorial Material																			0	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					415	415		10.1016/S0140-6736(18)30189-2	http://dx.doi.org/10.1016/S0140-6736(18)30189-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407020				2022-12-28	WOS:000424333600012
J	Summerfield, D				Summerfield, D			Palestine: the assault on health and other war crimes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Psychiat, London, England	University of London; King's College London	Summerfield, D (corresponding author), Inst Psychiat, London, England.	derek.summerfield@slam.nhs.uk							0	19	19	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 16	2004	329	7471					924	924		10.1136/bmj.329.7471.924	http://dx.doi.org/10.1136/bmj.329.7471.924			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863MU	29465916	Green Published			2022-12-28	WOS:000224566800052
J	Merchant, RR; Edwards, JT; Qin, T; Kruszyk, MM; Bi, C; Che, GD; Bao, DH; Qiao, WH; Sun, LJ; Collins, MR; Fadeyi, OO; Gallego, GM; Mousseau, JJ; Nuhant, P; Baran, PS				Merchant, Rohan R.; Edwards, Jacob T.; Qin, Tian; Kruszyk, Monika M.; Bi, Cheng; Che, Guanda; Bao, Deng-Hui; Qiao, Wenhua; Sun, Lijie; Collins, Michael R.; Fadeyi, Olugbeminiyi O.; Gallego, Gary M.; Mousseau, James J.; Nuhant, Philippe; Baran, Phil S.			Modular radical cross-coupling with sulfones enables access to sp(3)-rich (fluoro)alkylated scaffolds	SCIENCE			English	Article							REDOX-ACTIVE ESTERS; FLUORINATED SULFONES; GRIGNARD-REAGENTS; NICKEL CATALYSIS; BORONIC ACIDS; ARYL HALIDES; PHOTOREDOX; CONSTRUCTION; ALKYLATION; IODIDES	Cross-coupling chemistry is widely applied to carbon-carbon bond formation in the synthesis of medicines, agrochemicals, and other functional materials. Recently, single-electron-induced variants of this reaction class have proven particularly useful in the formation of C(sp(2))-C(sp(3)) linkages, although certain compound classes have remained a challenge. Here, we report the use of sulfones to activate the alkyl coupling partner in nickel-catalyzed radical cross-coupling with aryl zinc reagents. This method's tolerance of fluoroalkyl substituents proved particularly advantageous for the streamlined preparation of pharmaceutically oriented fluorinated scaffolds that previously required multiple steps, toxic reagents, and nonmodular retrosynthetic blueprints. Five specific sulfone reagents facilitate the rapid assembly of a vast set of compounds, many of which contain challenging fluorination patterns.	[Merchant, Rohan R.; Edwards, Jacob T.; Qin, Tian; Kruszyk, Monika M.; Bi, Cheng; Baran, Phil S.] Scripps Res Inst TSRI, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Che, Guanda; Bao, Deng-Hui; Qiao, Wenhua; Sun, Lijie] Asymchem Life Sci Tianjin, Tianjin Econ Technol Dev Zone, Tianjin 300457, Peoples R China; [Collins, Michael R.; Gallego, Gary M.] La Jolla Labs, Dept Chem, 10770 Sci Ctr Dr, San Diego, CA 92121 USA; [Fadeyi, Olugbeminiyi O.; Mousseau, James J.; Nuhant, Philippe] Pfizer Med Sci, Eastern Point Rd, Groton, CT 06340 USA	Scripps Research Institute; Pfizer	Baran, PS (corresponding author), Scripps Res Inst TSRI, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Mousseau, James/R-3935-2019		Pfizer; National Institutes of Health [GM-118176]; Vividion Therapeutics; U.S. Department of Defense; Innovation Fund Denmark [4135-00085B]; Nankai University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118176] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vividion Therapeutics; U.S. Department of Defense(United States Department of Defense); Innovation Fund Denmark; Nankai University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by Pfizer and the National Institutes of Health (grant GM-118176). Vividion Therapeutics supported a predoctoral fellowship to R.R.M., the U.S. Department of Defense supported a predoctoral fellowship to J.T.E. (National Defense Science and Engineering Graduate Fellowship Program), the Innovation Fund Denmark supported a predoctoral fellowship to M.M.K. (grant 4135-00085B), and Nankai University supported C.B.	An L, 2015, ANGEW CHEM INT EDIT, V54, P9079, DOI 10.1002/anie.201502882; [Anonymous], 2015, ENERC24232012SI26737, P1; Ariki ZT, 2018, J AM CHEM SOC, V140, P78, DOI 10.1021/jacs.7b10855; Azimioara M., 2010, U.S. Patent, Patent No. [20100022515 A1, 20100022515]; Baroudy B. M., 2002, US Patent, Patent No. [US6391865B1, 6391865, US6391865 B1]; Basch CH, 2017, J AM CHEM SOC, V139, P5313, DOI 10.1021/jacs.7b02389; Caldwell C., 2001, U.S. Patent, Patent No. [US6265434 B1, 6265434]; Cornella J, 2016, J AM CHEM SOC, V138, P2174, DOI 10.1021/jacs.6b00250; Denmark SE, 2013, J ORG CHEM, V78, P12593, DOI 10.1021/jo402246h; Edwards JT, 2017, NATURE, V545, P213, DOI 10.1038/nature22307; Fu GC, 2017, ACS CENTRAL SCI, V3, P692, DOI 10.1021/acscentsci.7b00212; Green SA, 2016, J AM CHEM SOC, V138, P12779, DOI 10.1021/jacs.6b08507; Hong K, 2014, J AM CHEM SOC, V136, P10581, DOI 10.1021/ja505455z; Jouffroy M, 2016, J AM CHEM SOC, V138, P475, DOI 10.1021/jacs.5b10963; Lo JC, 2017, J AM CHEM SOC, V139, P2484, DOI 10.1021/jacs.6b13155; Lynch CL, 2003, BIOORG MED CHEM LETT, V13, P119, DOI 10.1016/S0960-894X(02)00829-6; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Miao WJ, 2018, J AM CHEM SOC, V140, P880, DOI 10.1021/jacs.7b11976; Nakajima K, 2016, ANGEW CHEM INT EDIT, V55, P14106, DOI 10.1002/anie.201606513; Prakash GKS, 2007, ACCOUNTS CHEM RES, V40, P921, DOI 10.1021/ar700149s; Qin T, 2017, ANGEW CHEM INT EDIT, V56, P260, DOI 10.1002/anie.201609662; Qin T, 2016, SCIENCE, V352, P801, DOI 10.1126/science.aaf6123; Rodrigo E, 2016, J ORG CHEM, V81, P10887, DOI 10.1021/acs.joc.6b01956; Rong J, 2016, ANGEW CHEM INT EDIT, V55, P2743, DOI 10.1002/anie.201510533; Sheng J, 2017, ORG LETT, V19, P4480, DOI 10.1021/acs.orglett.7b02012; Simpkins N.S., 1993, SULPHONES ORGANIC SY; Smith JM, 2017, ANGEW CHEM INT EDIT, V56, P11906, DOI 10.1002/anie.201705107; Sun DQ, 2009, BIOORG MED CHEM LETT, V19, P1522, DOI 10.1016/j.bmcl.2008.12.114; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Toriyama F, 2016, J AM CHEM SOC, V138, P11132, DOI 10.1021/jacs.6b07172; Wang J, 2016, ANGEW CHEM INT EDIT, V55, P9676, DOI 10.1002/anie.201605463; WOOLRIDGE EM, 1989, TETRAHEDRON LETT, V30, P6117, DOI 10.1016/S0040-4039(01)93319-2; Wu JC, 2012, ANGEW CHEM INT EDIT, V51, P9909, DOI 10.1002/anie.201205969; Xiao YL, 2016, ANGEW CHEM INT EDIT, V55, P5837, DOI 10.1002/anie.201601351; Yan M, 2016, J AM CHEM SOC, V138, P12692, DOI 10.1021/jacs.6b08856; Zhang X., 2017, Chinese patent, Patent No. [CN106278847A, 106278847]; Zhao YC, 2013, ACS CATAL, V3, P631, DOI 10.1021/cs4000574; Zhao YC, 2010, ORG LETT, V12, P1444, DOI 10.1021/ol100090r; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	40	125	126	10	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2018	360	6384					75	80	aar7335	10.1126/science.aar7335	http://dx.doi.org/10.1126/science.aar7335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB7OE	29456201	Green Accepted			2022-12-28	WOS:000429263100049
J	Kim, YH; Marhon, SA; Zhang, YX; Steger, DJ; Won, KJ; Lazar, MA				Kim, Yong Hoon; Marhon, Sajid A.; Zhang, Yuxiang; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.			Rev-erb alpha dynamically modulates chromatin looping to control circadian gene transcription	SCIENCE			English	Article							BROMODOMAIN PROTEIN BRD4; HUMAN GENOME; CLOCK; ORGANIZATION; INHIBITION; PRINCIPLES; ARCHITECTURE; METABOLISM; LANDSCAPE; ENHANCERS	Mammalian physiology exhibits 24-hour cyclicity due to circadian rhythms of gene expression controlled by transcription factors that constitute molecular clocks. Core clock transcription factors bind to the genome at enhancer sequences to regulate circadian gene expression, but not all binding sites are equally functional. We found that in mice, circadian gene expression in the liver is controlled by rhythmic chromatin interactions between enhancers and promoters. Rev-erb alpha, a core repressive transcription factor of the clock, opposes functional loop formation between Rev-erb alpha-regulated enhancers and circadian target gene promoters by recruitment of the NCoR-HDAC3 co-repressor complex, histone deacetylation, and eviction of the elongation factor BRD4 and the looping factor MED1. Thus, a repressive arm of the molecular clock operates by rhythmically modulating chromatin loops to control circadian gene transcription.	[Kim, Yong Hoon; Marhon, Sajid A.; Zhang, Yuxiang; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Kim, Yong Hoon; Marhon, Sajid A.; Zhang, Yuxiang; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Kim, Yong Hoon; Marhon, Sajid A.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Won, KJ; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.; Won, KJ; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.; Won, KJ; Lazar, MA (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.	wonk@pennmedicine.upenn.edu; lazar@pennmedicine.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	Lazar, Mitchell/0000-0001-8653-1280; Marhon, Sajid/0000-0002-1046-9852; Kim, Yong Hoon/0000-0002-0872-4244; Won, Kyoung Jae/0000-0002-2924-9630	JPB Foundation; NIH [R01 DK45586, P30 DK19525, R01 DK106027, T32 GM007170, T32 GM008216, F30 DK112507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK112507, P01DK049210, P30DK019525, P30DK050306, R01DK106027, R01DK045586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170, T32GM008216] Funding Source: NIH RePORTER	JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Adlanmerini, P. Dierickx, B. Fang, D. Guan, R. Papazyan, R. Soccio, Y. Aubert, and the Lazar laboratory for helpful discussions; J. Phillips-Cremins (University of Pennsylvania) and P. Huang and C. Edwards (Children's Hospital of Philadelphia) for technical advice; the Functional Genomics Core of the Penn Diabetes Research Center and the Penn Epigenetics Institute for next-generation sequencing; and the Viral Vector Core of the Penn Diabetes Research Center for recombinant virus preparation. ChIP-seq and Hi-C data have been deposited in the Gene Expression Omnibus (GSE104129). Supported by the JPB Foundation (M.A.L.) and by NIH grants R01 DK45586 and P30 DK19525 (M.A.L.), R01 DK106027 (K.-J.W.), and T32 GM007170, T32 GM008216, and F30 DK112507 (Y.H.K.).	Aguilar-Arnal L, 2013, NAT STRUCT MOL BIOL, V20, P1206, DOI 10.1038/nsmb.2667; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Bhagwat AS, 2016, CELL REP, V15, P519, DOI 10.1016/j.celrep.2016.03.054; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Grosso AR, 2012, GENOME RES, V22, P1447, DOI 10.1101/gr.138057.112; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Siersbaek R, 2017, MOL CELL, V66, P420, DOI 10.1016/j.molcel.2017.04.010; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Xu YC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005992; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021; Zhao HL, 2015, MOL CELL, V59, P984, DOI 10.1016/j.molcel.2015.07.019	30	107	108	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2018	359	6381					1274	+	aao6891	10.1126/science.aao6891	http://dx.doi.org/10.1126/science.aao6891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3QN	29439026	Green Accepted			2022-12-28	WOS:000427504900045
J	Pritchard, HD				Pritchard, Hamish D.			RETRACTION: Asia's glaciers are a regionally important buffer against drought (Retraction of Vol 545, Pg 169, 2017)	NATURE			English	Retraction													Pritchard, Hamish Daniel/AAU-4696-2021					Pritchard HD, 2017, NATURE, V545, P169, DOI 10.1038/nature22062	1	2	2	6	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 8	2018	555	7695								10.1038/nature25779	http://dx.doi.org/10.1038/nature25779			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4AQ	29443968	Bronze			2022-12-28	WOS:000426763400059
J	Mariathasan, S; Turley, SJ; Nickles, D; Castiglioni, A; Yuen, K; Wang, YL; Kadel, EE; Koeppen, H; Astarita, JL; Cubas, R; Jhunjhunwala, S; Banchereau, R; Yang, YG; Guan, YH; Chalouni, C; Ziai, J; Senbabaoglu, Y; Santoro, S; Sheinson, D; Hung, J; Giltnane, JM; Pierce, AA; Mesh, K; Lianoglou, S; Riegler, J; Carano, RAD; Eriksson, P; Hoglund, M; Somarriba, L; Halligan, DL; van der Heijden, MS; Loriot, Y; Rosenberg, JE; Fong, L; Mellman, I; Chen, DS; Green, M; Derleth, C; Fine, GD; Hegde, PS; Bourgon, R; Powles, T				Mariathasan, Sanjeev; Turley, Shannon J.; Nickles, Dorothee; Castiglioni, Alessandra; Yuen, Kobe; Wang, Yulei; Kadel, Edward E., III; Koeppen, Hartmut; Astarita, Jillian L.; Cubas, Rafael; Jhunjhunwala, Suchit; Banchereau, Romain; Yang, Yagai; Guan, Yinghui; Chalouni, Cecile; Ziai, James; Senbabaoglu, Yasin; Santoro, Stephen; Sheinson, Daniel; Hung, Jeffrey; Giltnane, Jennifer M.; Pierce, Andrew A.; Mesh, Kathryn; Lianoglou, Steve; Riegler, Johannes; Carano, Richard A. D.; Eriksson, Pontus; Hoglund, Mattias; Somarriba, Loan; Halligan, Daniel L.; van der Heijden, Michiel S.; Loriot, Yohann; Rosenberg, Jonathan E.; Fong, Lawrence; Mellman, Ira; Chen, Daniel S.; Green, Marjorie; Derleth, Christina; Fine, Gregg D.; Hegde, Priti S.; Bourgon, Richard; Powles, Thomas			TGF beta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells	NATURE			English	Article							ADAPTIVE IMMUNE RESISTANCE; UROTHELIAL CARCINOMA; METASTATIC MELANOMA; CTLA-4 BLOCKADE; BLADDER-CANCER; THERAPY; LANDSCAPE; MPDL3280A; SUBTYPES; GENES	Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients with various cancers, including metastatic urothelial cancer(1-5). However, these responses only occur in a subset of patients. Elucidating the determinants of response and resistance is key to improving outcomes and developing new treatment strategies. Here we examined tumours from a large cohort of patients with metastatic urothelial cancer who were treated with an anti-PD-L1 agent (atezolizumab) and identified major determinants of clinical outcome. Response to treatment was associated with CD8(+) T-effector cell phenotype and, to an even greater extent, high neoantigen or tumour mutation burden. Lack of response was associated with a signature of transforming growth factor beta (TGF beta) signalling in fibroblasts. This occurred particularly in patients with tumours, which showed exclusion of CD8(+) T cells from the tumour parenchyma that were instead found in the fibroblast-and collagen-rich peritumoural stroma; a common phenotype among patients with metastatic urothelial cancer. Using a mouse model that recapitulates this immune-excluded phenotype, we found that therapeutic co-administration of TGF beta-blocking and anti-PD-L1 antibodies reduced TGF beta signalling in stromal cells, facilitated T-cell penetration into the centre of tumours, and provoked vigorous anti-tumour immunity and tumour regression. Integration of these three independent biological features provides the best basis for understanding patient outcome in this setting and suggests that TGF beta shapes the tumour microenvironment to restrain anti-tumour immunity by restricting T-cell infiltration.	[Mariathasan, Sanjeev; Turley, Shannon J.; Nickles, Dorothee; Castiglioni, Alessandra; Yuen, Kobe; Wang, Yulei; Kadel, Edward E., III; Koeppen, Hartmut; Astarita, Jillian L.; Cubas, Rafael; Jhunjhunwala, Suchit; Banchereau, Romain; Yang, Yagai; Guan, Yinghui; Chalouni, Cecile; Ziai, James; Senbabaoglu, Yasin; Santoro, Stephen; Sheinson, Daniel; Hung, Jeffrey; Giltnane, Jennifer M.; Pierce, Andrew A.; Mesh, Kathryn; Lianoglou, Steve; Riegler, Johannes; Carano, Richard A. D.; Mellman, Ira; Chen, Daniel S.; Green, Marjorie; Derleth, Christina; Fine, Gregg D.; Hegde, Priti S.; Bourgon, Richard] Genentech Inc, San Francisco, CA 94080 USA; [Eriksson, Pontus; Hoglund, Mattias] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, S-22381 Lund, Skane, Sweden; [Somarriba, Loan; Halligan, Daniel L.] Fios Genom, Edinburgh EH16 4UX, Midlothian, Scotland; [van der Heijden, Michiel S.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Loriot, Yohann] Univ Paris Sud, Inst Gustave Roussy, Dept Canc Med, F-94800 Villejuif, France; [Rosenberg, Jonathan E.] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, New York, NY 10065 USA; [Fong, Lawrence] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Powles, Thomas] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London EC1M 6BQ, England	Roche Holding; Genentech; Lund University; Netherlands Cancer Institute; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of London; Queen Mary University London	Mariathasan, S; Turley, SJ; Bourgon, R (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	mariathasan.sanjeev@gene.com; turley.shannon@gene.com; bourgon.richard@gene.com	Jhunjhunwala, Suchit/GNH-2256-2022; Loriot, Yohann/W-5572-2019; Mellman, Ira/ABG-5896-2020; Chen, Daniel Shin-Yu/AGD-8923-2022	Jhunjhunwala, Suchit/0000-0003-3484-0588; Chen, Daniel Shin-Yu/0000-0001-5085-3579; Halligan, Daniel/0000-0003-4726-6343; Cubas, Rafael/0000-0002-3450-9054; Bourgon, Richard/0000-0002-5890-4374; Pierce, Andrew/0000-0002-2692-4514; Eriksson, Pontus/0000-0003-3317-865X; Wang, Yulei/0000-0002-9057-9786; Castiglioni, Alessandra/0000-0002-1761-9761; Lianoglou, Steve/0000-0002-0924-1754	NCI [1R01CA194511]; NCI [1R01CA194511];  [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA194511] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the patients and their families; all of the investigators and their staff involved in IMvigor210 study; C. Ahearn, S. Lau, C. Havnar, Z. Boyd, S. Sampath, D. Wilson, J. Doss and medical writers at Health Interactions. J.E.R acknowledges support from P30 CA008748. L.E acknowledges support from NCI 1R01CA194511.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2021, LANG ENV STAT COMP; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; Hegde PS, 2016, CLIN CANCER RES, V22, P1865, DOI 10.1158/1078-0432.CCR-15-1507; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Lin RL, 2015, CANCER BIOL MED, V12, P385, DOI 10.7497/j.issn.2095-3941.2015.0015; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sjodahl G, 2013, AM J PATHOL, V183, P681, DOI 10.1016/j.ajpath.2013.05.013; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	34	2059	2103	43	534	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					544	+		10.1038/nature25501	http://dx.doi.org/10.1038/nature25501			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29443960	Green Submitted, Green Accepted			2022-12-28	WOS:000425597400050
J	Carnicelli, AP; Granger, CB				Carnicelli, Anthony P.; Granger, Christopher B.			Sodium bicarb vs sodium chloride, and acetylcysteine vs placebo, did not differ for adverse events after angiography	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONTRAST-INDUCED NEPHROPATHY		[Carnicelli, Anthony P.; Granger, Christopher B.] Duke Univ, Durham, NC 27708 USA	Duke University	Carnicelli, AP (corresponding author), Duke Univ, Durham, NC 27708 USA.							Nijssen EC, 2017, LANCET, V389, P1312, DOI 10.1016/S0140-6736(17)30057-0; Subramaniam RM, 2016, ANN INTERN MED, V164, P406, DOI 10.7326/M15-1456; Zhang B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006989	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC22	JC22		10.7326/ACPJC-2018-168-4-022	http://dx.doi.org/10.7326/ACPJC-2018-168-4-022			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459959				2022-12-28	WOS:000425434000010
J	Bui, AD; Nguyen, TM; Limouse, C; Kim, HK; Szabo, GG; Felong, S; Maroso, M; Soltesz, I				Bui, Anh D.; Nguyen, Theresa M.; Limouse, Charles; Kim, Hannah K.; Szabo, Gergely G.; Felong, Sylwia; Maroso, Mattia; Soltesz, Ivan			Dentate gyrus mossy cells control spontaneous convulsive seizures and spatial memory	SCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; IN-VIVO; GRANULE CELLS; RAT; REPRESENTATIONS; EPILEPTOGENESIS; INHIBITION; MODELS	Temporal lobe epilepsy (TLE) is characterized by debilitating, recurring seizures and an increased risk for cognitive deficits. Mossy cells (MCs) are key neurons in the hippocampal excitatory circuit, and the partial loss of MCs is a major hallmark of TLE. We investigated how MCs contribute to spontaneous ictal activity and to spatial contextual memory in a mouse model of TLE with hippocampal sclerosis, using a combination of optogenetic, electrophysiological, and behavioral approaches. In chronically epileptic mice, real-time optogenetic modulation of MCs during spontaneous hippocampal seizures controlled the progression of activity from an electrographic to convulsive seizure. Decreased MC activity is sufficient to impede encoding of spatial context, recapitulating observed cognitive deficits in chronically epileptic mice.	[Bui, Anh D.; Nguyen, Theresa M.; Kim, Hannah K.; Szabo, Gergely G.; Felong, Sylwia; Maroso, Mattia; Soltesz, Ivan] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Bui, Anh D.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Limouse, Charles] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Irvine; Stanford University	Bui, AD (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.; Bui, AD (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	adbui@stanford.edu		Soltesz, Ivan/0000-0003-1493-3744; Kim, Hannah/0000-0003-3478-2883	NIH National Institute of Neurological Disorders and Stroke [F31NS086429]; University of California Irvine Medical Scientist Training Program; NIH [NS074702, NS094668, NS069375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375, R01NS074702, R01NS094668, F31NS086429] Funding Source: NIH RePORTER	NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of California Irvine Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Nakazawa and S. Jinde for their generous gift of the Crlr-Cre mice. We thank members of the Soltesz laboratory for useful discussions. We thank M. Oijala, J. Liang, A. Wong, J. Nguyen, J. Vargane, R. Zhu, C. Lozoya, L. Saw, and A. Olson for technical support. A. D. B. was supported by NIH National Institute of Neurological Disorders and Stroke F31NS086429 and the University of California Irvine Medical Scientist Training Program. I. S. was supported by NIH grants NS074702 and NS094668. This work was made possible, in part, by the Stanford Neuroscience Microscopy Service, supported by NIH NS069375. We declare no conflicts of interest. All data are available in the supplementary materials. Custom Matlab scripts can be downloaded from the GitHub repository at https://gitlab.com/climouse/mossycells_paper_analysis.	Blumcke I, 2000, EPILEPSIA, V41, pS174, DOI 10.1111/j.1528-1157.2000.tb01577.x; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Buckmaster PS, 1996, J COMP NEUROL, V366, P270, DOI 10.1002/(SICI)1096-9861(19960304)366:2<270::AID-CNE7>3.0.CO;2-2; BUZSAKI G, 1981, BRAIN RES, V230, P346, DOI 10.1016/0006-8993(81)90413-3; Danielson NB, 2017, NEURON, V93, P552, DOI 10.1016/j.neuron.2016.12.019; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; GoodSmith D, 2017, NEURON, V93, P677, DOI 10.1016/j.neuron.2016.12.026; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Hsu TT, 2016, CEREB CORTEX, V26, P2715, DOI 10.1093/cercor/bhv127; Hyde RA, 2012, NAT NEUROSCI, V15, P1430, DOI 10.1038/nn.3208; Jinde S, 2012, NEURON, V76, P1189, DOI 10.1016/j.neuron.2012.10.036; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Krook-Magnuson E, 2015, J PHYSIOL-LONDON, V593, P2379, DOI 10.1113/JP270056; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Lin H, 2009, HIPPOCAMPUS, V19, P817, DOI 10.1002/hipo.20565; Mahn M, 2016, NAT NEUROSCI, V19, P554, DOI 10.1038/nn.4266; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ratzliff ADH, 2004, J NEUROSCI, V24, P2259, DOI 10.1523/JNEUROSCI.5191-03.2004; Scharfman HE, 2016, NAT REV NEUROSCI, V17, P562, DOI 10.1038/nrn.2016.87; Senzai Y, 2017, NEURON, V93, P691, DOI 10.1016/j.neuron.2016.12.011; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; Sugaya Y, 2016, CELL REP, V16, P1405, DOI 10.1016/j.celrep.2016.06.083; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Volz F, 2011, EPILEPSIA, V52, P1579, DOI 10.1111/j.1528-1167.2011.03086.x; Zhuo JM, 2016, ELIFE, V5, DOI 10.7554/eLife.22429	27	109	111	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					787	790	aan4074	10.1126/science.aan4074	http://dx.doi.org/10.1126/science.aan4074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449490	Green Accepted			2022-12-28	WOS:000425116200043
J	Provenzano, AM				Provenzano, Audrey M.			Caring for Ms. L. - Overcoming My Fear of Treating Opioid Use Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Provenzano, Audrey M.] MGH Chelsea Hlth Ctr, Chelsea, MA 02150 USA; [Provenzano, Audrey M.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Provenzano, AM (corresponding author), MGH Chelsea Hlth Ctr, Chelsea, MA 02150 USA.; Provenzano, AM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							[Anonymous], 2011, DEF ADD, DOI [10.1056/NEJMp1715093, DOI 10.1056/NEJMP1715093]	1	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					600	601		10.1056/NEJMp1715093	http://dx.doi.org/10.1056/NEJMp1715093			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW0QK	29443676	Bronze			2022-12-28	WOS:000425000000005
J	Gotz, M				Goetz, Magdalena			Revising concepts about adult stem cells	SCIENCE			English	Editorial Material							NEURAL STEM; NEUROGENESIS; BEHAVIOR; NEURONS		[Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Helmholtz Ctr Munich, Inst Stem Cell Res, Munich, Germany; [Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Biomed Ctr, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich	Gotz, M (corresponding author), Ludwig Maximilians Univ Munchen, Helmholtz Ctr Munich, Inst Stem Cell Res, Munich, Germany.; Gotz, M (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr, Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de						Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Beumer J, 2016, DEVELOPMENT, V143, P3639, DOI 10.1242/dev.133132; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Engerer P, 2017, EMBO J, V36, P1134, DOI 10.15252/embj.201694230; Falk S, 2017, CURR OPIN NEUROBIOL, V47, P188, DOI 10.1016/j.conb.2017.10.025; Falkner S, 2016, NATURE, V539, P248, DOI 10.1038/nature20113; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; McIntosh R, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160312; Pilz GA, 2018, SCIENCE, V359, P658, DOI 10.1126/science.aao5056; Pilz GA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3125; Sierra A, 2015, CELL STEM CELL, V16, P488, DOI 10.1016/j.stem.2015.04.003; Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396	15	4	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					639	640	aar7732	10.1126/science.aar7732	http://dx.doi.org/10.1126/science.aar7732			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439231				2022-12-28	WOS:000425117700024
J	Amari, T; Canou, A; Aly, JJ; Delyon, F; Alauzet, F				Amari, Tahar; Canou, Aurelien; Aly, Jean-Jacques; Delyon, Francois; Alauzet, Frederic			Magnetic cage and rope as the key for solar eruptions	NATURE			English	Article							RECONNECTION; RELAXATION; HELICITY; FLARES; FORCE	Solar flares are spectacular coronal events that release large amounts of energy. They are classified as either eruptive or confined(1,2), depending on whether they are associated with a coronal mass ejection. Two types of model have been developed to identify the mechanism that triggers confined flares, although it has hitherto not been possible to decide between them because the magnetic field at the origin of the flares could not be determined with the required accuracy(3-8). In the first type of model, the triggering is related to the topological complexity of the flaring structure, which implies the presence of magnetically singular surfaces(9-11). This picture is observationally supported by the fact that radiative emission occurs near these features in many flaring regions(12-17). The second type of model attributes a key role to the formation of a twisted flux rope, which becomes unstable. Its plausibility is supported by simulations(18-22), by interpretations of some observations(23,24) and by laboratory experiments(25). Here we report modelling of a confined event that uses the measured photospheric magnetic field as input. We first use a static model to compute the slowly evolving magnetic state of the corona before the eruption, and then use a dynamical model to determine the evolution during the eruption itself. We find that a magnetic flux rope must be present throughout the entire event to match the field measurements. This rope evolves slowly before saturating and suddenly erupting. Its energy is insufficient to break through the overlying field, whose lines form a confining cage, but its twist is large enough to trigger a kink instability, leading to the confined flare, as previously suggested(18,19). Topology is not the main cause of the flare, but it traces out the locations of the X-ray emission. We show that a weaker magnetic cage would have produced a more energetic eruption with a coronal mass ejection, associated with a predicted energy upper bound for a given region.	[Amari, Tahar] Univ Paris Saclay, CPHT, Ecole Polytech, CNRS, Route Saclay, F-91128 Palaiseau, France; [Canou, Aurelien] Ecole Polytech, Ctr Phys Theor, F-91128 Palaiseau, France; [Aly, Jean-Jacques] Univ Paris Diderot, AIM, Sorbonne Paris Cite, CEA,CNRS, F-91191 Gif Sur Yvette, France; [Delyon, Francois] Univ Paris 06, LPTMC, CNRS, UMR 7600, Paris, France; [Alauzet, Frederic] INRIA Saclay Ile De France, Projet Gamma 3, 1 Rue Honore dEstienne dOrves, F-91126 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite	Amari, T (corresponding author), Univ Paris Saclay, CPHT, Ecole Polytech, CNRS, Route Saclay, F-91128 Palaiseau, France.	tahar.amari@polytechnique.edu			Institut du Developpement et de Ressources en Informatique (IDRIS) under Grand Equipement National de Calcul Intensif (GENCI) [2016-16050438]; Centre National d'Etudes Spatiales (CNES); Direction Generale de l'Armement (DGA)	Institut du Developpement et de Ressources en Informatique (IDRIS) under Grand Equipement National de Calcul Intensif (GENCI); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Direction Generale de l'Armement (DGA)	We were granted access to the High Performance Computing resources of the Centre Informatique National de l'Enseignement Superieur (CINES) and of the Institut du Developpement et de Ressources en Informatique (IDRIS) under allocation 2016-16050438 made by Grand Equipement National de Calcul Intensif (GENCI) and also to the mesocentre Phymat of the Centre National de la Recherche Scientifique/Ecole Polytechnique. We acknowledge support of the Centre National d'Etudes Spatiales (CNES) and of the Direction Generale de l'Armement (DGA). T.A. thanks R. Huart for discussions. The Solar Dynamics Observatory (SDO) data are courtesy of the National Aeronautics and Space Administration (NASA), and the SDO/HMI and AIA science teams.	Alauzet F, 2007, J COMPUT PHYS, V222, P592, DOI 10.1016/j.jcp.2006.08.012; Amari T, 2003, ASTROPHYS J, V595, P1231, DOI 10.1086/377444; Amari T, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220787; Amari T, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L27; Amari T, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913058; Amari T, 1999, SIAM J SCI COMPUT, V21, P970, DOI 10.1137/S1064827596304824; Amari T, 2000, PHYS REV LETT, V84, P1196, DOI 10.1103/PhysRevLett.84.1196; Amari T., 2012, ASP C SERIES, V459, P189; Amari T, 2014, NATURE, V514, P465, DOI 10.1038/nature13815; Bagala LG, 2000, ASTRON ASTROPHYS, V363, P779; Chen HD, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/1/L24; Dalmasse K, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201323206; Demoulin P, 1996, ASTRON ASTROPHYS, V308, P643; DeRosa ML, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/2/107; GARY GA, 1990, SOL PHYS, V126, P21, DOI 10.1007/BF00158295; Gorbachev V. S., 1988, Soviet Astronomy, V32, P308; Guo Y, 2016, ASTROPHYS J, V828, DOI 10.3847/0004-637X/828/2/82; Hassanin A, 2016, ASTROPHYS J, V832, DOI 10.3847/0004-637X/832/2/106; Inoue S, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/2/168; Jiang CW, 2016, ASTROPHYS J, V828, DOI 10.3847/0004-637X/828/1/62; Jiang CW, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/85; Kliem B, 2004, ASTRON ASTROPHYS, V413, pL23, DOI 10.1051/0004-6361:20031690; Kumar P, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/83; Lee KS, 2017, ASTROPHYS J, V836, DOI 10.3847/1538-4357/aa5b8b; Li Y, 2016, ASTROPHYS J LETT, V823, DOI 10.3847/2041-8205/823/1/L13; Liu R, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/2/148; Mandrini CH, 2014, SOL PHYS, V289, P2041, DOI 10.1007/s11207-013-0458-6; Mandrini CH, 1997, SOL PHYS, V174, P229, DOI 10.1023/A:1004950009970; Myers CE, 2015, NATURE, V528, P526, DOI 10.1038/nature16188; Pinto RF, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201526633; Priest E, 2014, MAGNETOHYDRODYNAMICS OF THE SUN; Romano P, 2017, ASTROPHYS J, V837, DOI 10.3847/1538-4357/aa63f4; Schmieder B, 2015, SOL PHYS, V290, P3457, DOI 10.1007/s11207-015-0712-1; Schrijver CJ, 2015, ADV SPACE RES, V55, P2745, DOI 10.1016/j.asr.2015.03.023; Sun XD, 2015, ASTROPHYS J LETT, V804, DOI 10.1088/2041-8205/804/2/L28; TAYLOR JB, 1974, PHYS REV LETT, V33, P1139, DOI 10.1103/PhysRevLett.33.1139; Thompson WT, 2006, ASTRON ASTROPHYS, V449, P791, DOI 10.1051/0004-6361:20054262; Titov VS, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/70; Torok T, 2005, ASTROPHYS J, V630, pL97, DOI 10.1086/462412; Wang HM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8008; Wheatland MS, 2009, ASTROPHYS J LETT, V700, pL88, DOI 10.1088/0004-637X/700/2/L88; Yang K, 2016, ASTROPHYS J, V824, DOI 10.3847/0004-637X/824/2/148	42	65	65	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					211	+		10.1038/nature24671	http://dx.doi.org/10.1038/nature24671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420473				2022-12-28	WOS:000424332600033
J	Wang, Z; Wu, JD; Yang, W; Bera, AK; Kamenskyi, D; Islam, ATMN; Xu, SL; Law, JM; Lake, B; Wu, CJ; Loidl, A				Wang, Zhe; Wu, Jianda; Yang, Wang; Bera, Anup Kumar; Kamenskyi, Dmytro; Islam, A. T. M. Nazmul; Xu, Shenglong; Law, Joseph Matthew; Lake, Bella; Wu, Congjun; Loidl, Alois			Experimental observation of Bethe strings	NATURE			English	Article							BOUND-STATES; CHAIN; SPIN; EXCITATIONS; EXCHANGE; ANSATZ; METAL; MODEL	Almost a century ago, string states-complex bound states of magnetic excitations-were predicted to exist in one-dimensional quantum magnets(1). However, despite many theoretical studies(2-11), the experimental realization and identification of string states in a condensed-matter system have yet to be achieved. Here we use high-resolution terahertz spectroscopy to resolve string states in the antiferromagnetic Heisenberg-Ising chain SrCo2V2O8 in strong longitudinal magnetic fields. In the field-induced quantum-critical regime, we identify strings and fractional magnetic excitations that are accurately described by the Bethe ansatz(1,3,4). Close to quantum criticality, the string excitations govern the quantum spin dynamics, whereas the fractional excitations, which are dominant at low energies, reflect the antiferromagnetic quantum fluctuations. Today, Bethe's result(1) is important not only in the field of quantum magnetism but also more broadly, including in the study of cold atoms and in string theory; hence, we anticipate that our work will shed light on the study of complex many-body systems in general.	[Wang, Zhe; Loidl, Alois] Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, Expt Phys 5, D-86135 Augsburg, Germany; [Wang, Zhe] Helmholtz Zentrum Dresden Rossendorf, Inst Radiat Phys, D-01328 Dresden, Germany; [Wu, Jianda; Yang, Wang; Xu, Shenglong; Wu, Congjun] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Bera, Anup Kumar; Islam, A. T. M. Nazmul; Lake, Bella] Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany; [Bera, Anup Kumar] Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India; [Kamenskyi, Dmytro] Radboud Univ Nijmegen, High Field Magnet Lab, NL-6525 ED Nijmegen, Netherlands; [Law, Joseph Matthew] Helmholtz Zentrum Dresden Rossendorf, Hochfeld Magnetlab Dresden, D-01314 Dresden, Germany; [Lake, Bella] Tech Univ Berlin, Inst Festkorperphys, D-10623 Berlin, Germany; [Wu, Jianda] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	University of Augsburg; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of California System; University of California San Diego; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Bhabha Atomic Research Center (BARC); Radboud University Nijmegen; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technical University of Berlin; Max Planck Society	Wang, Z (corresponding author), Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, Expt Phys 5, D-86135 Augsburg, Germany.; Wang, Z (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiat Phys, D-01328 Dresden, Germany.	wangzhe.nju@gmail.com	Kamenskyi, Dmytro/J-8530-2014; Lake, Bella/A-6264-2011; Wu, Jianda/H-8765-2018; Bera, Anup Kumar/K-6477-2015; Wang, Zhe/Y-5566-2019; Xu, Shenglong/AAW-3618-2021; Wu, Congjun/L-1750-2015; Loidl, Alois/L-8199-2015; ISLAM, A.T.M. NAZMUL/J-3575-2013	Kamenskyi, Dmytro/0000-0002-6538-141X; Lake, Bella/0000-0003-0034-0964; Wu, Jianda/0000-0002-3571-3348; Bera, Anup Kumar/0000-0003-0222-0990; Xu, Shenglong/0000-0002-8591-5562; Loidl, Alois/0000-0002-5579-0746; Wang, Zhe/0000-0001-7464-5408; ISLAM, A.T.M. NAZMUL/0000-0002-2139-7508	DFG via the Transregional Collaborative Research Center [TRR 80]; HFML-RU/FOM; HLD-HZDR, members of the European Magnetic Field Laboratory (EMFL); NSF [DMR-1410375]; AFOSR [FA9550-14-1-0168]; National Natural Science Foundation of China [11729402]	DFG via the Transregional Collaborative Research Center; HFML-RU/FOM; HLD-HZDR, members of the European Magnetic Field Laboratory (EMFL); NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank I. Bloch, M. Karbach, T. Lorenz and X. Zotos for discussions. We acknowledge partial support by the DFG via the Transregional Collaborative Research Center TRR 80, and by the HFML-RU/FOM and the HLD-HZDR, members of the European Magnetic Field Laboratory (EMFL). J.W., W.Y., S.X. and C.W. are supported by NSF grant number DMR-1410375 and AFOSR grant number FA9550-14-1-0168. C.W. also acknowledges partial support from the National Natural Science Foundation of China (grant number 11729402).	Batchelor MT, 2007, PHYS TODAY, V60, P36, DOI 10.1063/1.2709557; Bera AK, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.054423; Bera AK, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.094402; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Essler F, 2005, FIELDS STRINGS CIRCU, P684; FADDEEV LD, 1981, PHYS LETT A, V85, P375, DOI 10.1016/0375-9601(81)90335-2; FOGEDBY HC, 1980, J PHYS C SOLID STATE, V13, pL195, DOI 10.1088/0022-3719/13/9/005; Fukuhara T, 2013, NATURE, V502, P76, DOI 10.1038/nature12541; Ganahl M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.077206; GAUDIN M, 1971, PHYS REV LETT, V26, P1301, DOI 10.1103/PhysRevLett.26.1301; Grenier B, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.017201; He F, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.220401; Karbach M, 2000, PHYS REV B, V62, P14871, DOI 10.1103/PhysRevB.62.14871; Kitanine N, 1999, NUCL PHYS B, V554, P647, DOI 10.1016/S0550-3213(99)00295-3; Kohno M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.037203; Lake B, 2010, NAT PHYS, V6, P50, DOI 10.1038/NPHYS1462; LIEB EH, 1968, PHYS REV LETT, V20, P1445, DOI 10.1103/PhysRevLett.20.1445; LINES ME, 1963, PHYS REV, V131, P546, DOI 10.1103/PhysRev.131.546; MINAHAN JA, 2003, J HIGH ENERGY PHYS; Mourigal M, 2013, NAT PHYS, V9, P435, DOI [10.1038/nphys2652, 10.1038/NPHYS2652]; Nishida Y, 2013, NAT PHYS, V9, P93, DOI 10.1038/nphys2523; Pereira RG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.027206; Sato J, 2004, J PHYS SOC JPN, V73, P3008, DOI 10.1143/JPSJ.73.3008; Shiba H, 2003, J PHYS SOC JPN, V72, P2326, DOI 10.1143/JPSJ.72.2326; Stone MB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.037205; Subrahmanyam V, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.034304; TAKAHASHI M, 1972, PROG THEOR PHYS, V48, P2187, DOI 10.1143/PTP.48.2187; Takahashi M., 2005, THERMODYNAMICS ONE D; TENNANT DA, 1993, PHYS REV LETT, V70, P4003, DOI 10.1103/PhysRevLett.70.4003; Wang Z, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.125130; Wang Z, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.140404; WORTIS M, 1963, PHYS REV, V132, P85, DOI 10.1103/PhysRev.132.85; Wu LS, 2016, SCIENCE, V352, P1206, DOI 10.1126/science.aaf0981; YANG CN, 1966, PHYS REV, V150, P327, DOI 10.1103/PhysRev.150.327; Yang W., 2017, PREPRINT	38	62	62	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					219	+		10.1038/nature25466	http://dx.doi.org/10.1038/nature25466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420471	Green Submitted			2022-12-28	WOS:000424332600035
J	Voelker, R				Voelker, Rebecca			New Human Insulin Analog Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					434	434		10.1001/jama.2017.21720	http://dx.doi.org/10.1001/jama.2017.21720			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411020				2022-12-28	WOS:000424224500006
J	Zhang, LX; Wang, HB; Li, QZ; Zhao, MH; Zhan, QM				Zhang, Luxia; Wang, Haibo; Li, Quanzheng; Zhao, Ming-Hui; Zhan, Qi-Min			Big data and medical research in China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; DISEASE; FUTURE		[Zhang, Luxia; Zhao, Ming-Hui] Peking Univ, Inst Nephrol, Dept Med, Renal Div,Hosp 1, Beijing, Peoples R China; [Zhang, Luxia] Peking Univ, Ctr Data Sci Hlth & Med, Beijing, Peoples R China; [Wang, Haibo] Sun Yat Sen Univ, Clin Trial Unit, Affiliated Hosp 1, Guangzhou, Peoples R China; [Wang, Haibo] China Stand Med Informat Res Ctr, Shenzhen, Peoples R China; [Li, Quanzheng] Harvard Med Sch, Massachusetts Gen Hosp, MGH & BWH Ctr Clin Data Sci, Boston, MA USA; [Zhao, Ming-Hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Zhan, Qi-Min] Peking Univ, Hlth Sci Ctr, Beijing, Peoples R China	Peking University; Peking University; Sun Yat Sen University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Peking University	Zhang, LX (corresponding author), Peking Univ, Inst Nephrol, Dept Med, Renal Div,Hosp 1, Beijing, Peoples R China.; Zhang, LX (corresponding author), Peking Univ, Ctr Data Sci Hlth & Med, Beijing, Peoples R China.	zhanglx@bjmu.edu.cn		Luxia, Zhang/0000-0003-2349-2936	World Health Organization (WHO) [2014/435380-0]; Ministry of Science and Technology [2016YFC1305400]; University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research [BMU20140479]	World Health Organization (WHO)(World Health Organization); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research	We have read and understood BMJ policy on declaration of interests and declare that the article was funded by the World Health Organization (WHO Reference 2014/435380-0), the National Key Technology R&D Program of the Ministry of Science and Technology (2016YFC1305400), and the University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research (BMU20140479).	Altman RB, 2015, CIRCULATION, V131, P232, DOI 10.1161/CIRCULATIONAHA.114.014106; [Anonymous], 2017, BMJ OPEN, V7, DOI [10.1136, DOI 10.1136]; Auffray C, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0265-4; Austin C, 2016, J INTERV CARD ELECTR, V47, P51, DOI 10.1007/s10840-016-0104-y; Baro E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/639021; Fernandez-Luque L, 2015, HEALTHC INFORM RES, V21, P67, DOI 10.4258/hir.2015.21.2.67; Kruse CS, 2016, JMIR MED INF, V4, DOI 10.2196/medinform.5359; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; National Health and Family Planning Commission of the PRC, 2016, CHIN BUILD HLTH CAR; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Rumsfeld JS, 2016, NAT REV CARDIOL, V13, P350, DOI 10.1038/nrcardio.2016.42; Shan LS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014425; The State Council, 2017, CHIN ISS GUID ART IN; The State Council, 2016, CHIN BOOST BIG DAT A; Ward JC, 2014, J ONCOL PRACT, V10, P83, DOI 10.1200/JOP.2014.001308; Zhang LX, 2017, AM J KIDNEY DIS, V69, pS5, DOI 10.1053/j.ajkd.2016.06.011; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	18	59	70	2	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2018	360								j5910	10.1136/bmj.j5910	http://dx.doi.org/10.1136/bmj.j5910			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HP	29437562	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000424974800003
J	Howard, S				Howard, Sally			REPRODUCTIVE MEDICINE Fear and infertility research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sal@sallyhoward.net						McDermott N., 2016, SUN; Palacios-Gonzalez C, 2017, REPROD BIOMED ONLINE, V35, P387, DOI 10.1016/j.rbmo.2017.06.007; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2018	360								k434	10.1136/bmj.k434	http://dx.doi.org/10.1136/bmj.k434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TT	29419382				2022-12-28	WOS:000423846200007
J	Morris, CA; Miller, JB				Morris, Charles A.; Miller, Jonathan B.			Broken Hearts and Opened Eyes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morris, Charles A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Miller, Jonathan B.] Off Attorney Gen Massachusetts, Boston, MA USA	Harvard University; Brigham & Women's Hospital	Morris, CA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2018	378	12					1078	1080		10.1056/NEJMp1802509	http://dx.doi.org/10.1056/NEJMp1802509			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ9OV	29466100				2022-12-28	WOS:000427942300003
J	Agusti, A				Agusti, Alvar			Filling the gaps in COPD: the TRIBUTE study	LANCET			English	Editorial Material									[Agusti, Alvar] Univ Barcelona, Hosp Clin, Resp Inst, IDIBAPS, E-08036 Barcelona, Spain; [Agusti, Alvar] CIBERES, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Agusti, A (corresponding author), Univ Barcelona, Hosp Clin, Resp Inst, IDIBAPS, E-08036 Barcelona, Spain.; Agusti, A (corresponding author), CIBERES, Barcelona, Spain.	aagusti@clinic.cat						Agusti A, 2017, EUR RESPIR J, V50, P1; Global Initiative for Chronic Obstructive Lung Disease, 2018, GLOB STRAT PREV DIAG; Papi Alberto, 2018, LANCET; Pascoe SJ, 2016, EUR RESPIR J, V48, P320, DOI 10.1183/13993003.02165-2015	4	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1004	1006		10.1016/S0140-6736(18)30252-6	http://dx.doi.org/10.1016/S0140-6736(18)30252-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29429594				2022-12-28	WOS:000427585100008
J	Newton, JN; Dockrell, M; Marczylo, T				Newton, John N.; Dockrell, Martin; Marczylo, Tim			Making sense of the latest evidence on electronic cigarettes	LANCET			English	Editorial Material							TOBACCO		[Newton, John N.; Dockrell, Martin] Publ Hlth England, Hlth Improvement Directorate, London SE1 8UG, England; [Marczylo, Tim] Publ Hlth England, Ctr Radiat Chem & Environm Hazards, London SE1 8UG, England	Public Health England; Public Health England	Newton, JN (corresponding author), Publ Hlth England, Hlth Improvement Directorate, London SE1 8UG, England.	john.newton@phe.gov.uk	Newton, John/HCH-8693-2022; Marczylo, Tim/I-2470-2019	Marczylo, Tim/0000-0001-9744-473X; Newton, John/0000-0002-5641-6457				[Anonymous], 2017, LANCET, V390, P1715, DOI 10.1016/S0140-6736(17)32636-3; Associated Press, 2018, STAT NEWS       0125; Bauld L, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14090973; Beard E, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4645; Best C, 2018, TOB CONTROL, V27, P373, DOI 10.1136/tobaccocontrol-2017-053691; British American Tobacco, GLOB MARK TRENDS AFF; British Medical Association, 2017, E CIG BAL RISKS OPP; Caputi TL, 2017, TOB CONTROL, V26, P609, DOI 10.1136/tobaccocontrol-2016-053264; Coleman BN, 2017, TOB CONTROL, V26, pe117, DOI 10.1136/tobaccocontrol-2016-053462; Department of Health (DoH), 2017, SMOK GEN TOB CONTR P; Fairchild AL, 2018, NEW ENGL J MED, V378, P216, DOI 10.1056/NEJMp1711991; Farsalinos KE, 2015, ADDICTION, V110, P1352, DOI 10.1111/add.12942; HARTMANNBOYCE J, 2018, BMJ-BRIT MED J, V360, P12538, DOI DOI 10.1136/BMJ.J5543; Institute for Global Tobacco Control, 2017, GLOB TOB CONTR COUNT; Kennedy RD, 2017, TOB CONTROL, V26, P440, DOI 10.1136/tobaccocontrol-2016-053179; McNeill A., 2015, REPORT COMMISSIONED; McNeill A, 2018, EVIDENCE REV E CIGAR; National Academies of Sciences, 2018, COMM REV HLTH EFF EL; Polosa R, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0187-5; Public Health England, 2016, US E CIG PUBL PLAC W; Public Health England, 2016, E CIG DEV PUBL HLTH; Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; Stephens WE, 2018, TOB CONTROL, V27, P10, DOI 10.1136/tobaccocontrol-2017-053808; US Centers for Disease Control and Prevention, 2017, EL CIG; US Food and Drug Administration, 2017, FDA ANN COMPR REG PL; Vanyukov MM, 2012, DRUG ALCOHOL DEPEN, V123, pS3, DOI 10.1016/j.drugalcdep.2011.12.018; Weinmeyer Richard, 2016, AMA J Ethics, V18, P252, DOI 10.1001/journalofethics.2016.18.3.hlaw1-1603; West R, 2016, ADDICTION, V111, P1118, DOI 10.1111/add.13343; WHO, 2016, C PART WHO FRAMCONV; Wilson N, 2017, B WORLD HEALTH ORGAN, V95, P540, DOI 10.2471/BLT.16.186536	30	22	22	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2018	391	10121					639	642		10.1016/S0140-6736(18)30202-2	http://dx.doi.org/10.1016/S0140-6736(18)30202-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW4MN	29426674				2022-12-28	WOS:000425287800008
J	Labinger, JA				Labinger, Jay A.			Comment on "Selective anaerobic oxidation of methane enables direct synthesis of methanol"	SCIENCE			English	Editorial Material									[Labinger, Jay A.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology	Labinger, JA (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	jal@its.caltech.edu						Periana RA, 2017, SCIENCE, V358, DOI 10.1126/science.aan5970; Ravi M, 2017, ANGEW CHEM INT EDIT, V56, P16464, DOI 10.1002/anie.201702550; Sushkevich VL, 2017, SCIENCE, V358, DOI 10.1126/science.aan6083; Sushkevich VL, 2017, SCIENCE, V356, P523, DOI 10.1126/science.aam9035	4	7	7	9	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377								10.1126/science.aar4968	http://dx.doi.org/10.1126/science.aar4968			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449463				2022-12-28	WOS:000425116200001
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: The Bawa-Garba case, doctors, and the GMC-what next?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						BMA, 2018, GMC COMM FOLL BAW CA; Dyer C, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k572; General Medical Council, RAIS ACT PAT SAF; General Medical Council, FREQ ASK QUEST LIC; General Medical Council, 2018, GMC LOOK WID ISS MAN; Matthews-King Alex, 2018, INDEPENDENT	6	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2018	360						20	21	k646	10.1136/bmj.k646	http://dx.doi.org/10.1136/bmj.k646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KW	29440063	Bronze, Green Published			2022-12-28	WOS:000425582200005
J	Rubin, R				Rubin, Rita			Obesity Tied to Income, Education, But Not in All Populations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					540	540		10.1001/jama.2018.0381	http://dx.doi.org/10.1001/jama.2018.0381			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450533				2022-12-28	WOS:000424908400007
J	Chen, YN; Popko, B				Chen, Yanan; Popko, Brian			Cholesterol crystals impede nerve repair	SCIENCE			English	Editorial Material							LIVER X RECEPTORS; MULTIPLE-SCLEROSIS; CNS REMYELINATION; MACROPHAGES; MYELIN		[Chen, Yanan; Popko, Brian] Univ Chicago, Dept Neurol, Ctr Peripheral Neuropathy, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Popko, B (corresponding author), Univ Chicago, Dept Neurol, Ctr Peripheral Neuropathy, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bpopko@neurology.bsd.uchicago.edu		Popko, Brian/0000-0001-9948-2553	National Institutes of Health [NS034939, NS099334]; National Multiple Sclerosis Society [RG-1501-02797]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034939, R01NS099334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	B.P. is supported by grants from the National Institutes of Health (NS034939, NS099334), the National Multiple Sclerosis Society (RG-1501-02797), and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.	Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453; Cantuti-Castelvetri L, 2018, SCIENCE, V359, P684, DOI 10.1126/science.aan4183; Dendrou CA, 2017, CURR OPIN IMMUNOL, V49, P37, DOI 10.1016/j.coi.2017.08.013; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Meffre D, 2015, P NATL ACAD SCI USA, V112, P7587, DOI 10.1073/pnas.1424951112; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Natrajan MS, 2015, BRAIN, V138, P3581, DOI 10.1093/brain/awv289; Roszer T, 2013, TRENDS ENDOCRIN MET, V24, P460, DOI 10.1016/j.tem.2013.04.004; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479; Way SW, 2016, LANCET NEUROL, V15, P434, DOI 10.1016/S1474-4422(15)00381-6	15	4	4	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					635	636	aar7369	10.1126/science.aar7369	http://dx.doi.org/10.1126/science.aar7369			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439228				2022-12-28	WOS:000425117700021
J	Pilz, GA; Bottes, S; Betizeau, M; Jorg, DJ; Carta, S; Simons, BD; Helmchen, F; Jessberger, S				Pilz, Gregor-Alexander; Bottes, Sara; Betizeau, Marion; Jorg, David J.; Carta, Stefano; Simons, Benjamin D.; Helmchen, Fritjof; Jessberger, Sebastian			Live imaging of neurogenesis in the adult mouse hippocampus	SCIENCE			English	Article							NEURAL STEM-CELLS; ANALYSIS REVEALS; DENTATE GYRUS; NEURONS; BEHAVIOR; NICHE; MULTIPOTENT; HOMEOSTASIS; MECHANISM; NEOCORTEX	Neural stem and progenitor cells (NSPCs) generate neurons throughout life in the mammalian hippocampus. We used chronic in vivo imaging and followed genetically labeled individual NSPCs and their progeny in the mouse hippocampus for up to 2 months. We show that NSPCs targeted by the endogenous Achaete-scute homolog 1 (Ascl1) promoter undergo limited rounds of symmetric and asymmetric divisions, eliciting a burst of neurogenic activity, after which they are lost. Further, our data reveal unexpected asymmetric divisions of nonradial glia-like NSPCs. Cell fates of Ascl1-labeled lineages suggest a developmental-like program involving a sequential transition from a proliferative to a neurogenic phase. By providing a comprehensive description of lineage relationships, from dividing NSPCs to newborn neurons integrating into the hippocampal circuitry, our data offer insight into how NSPCs support life-long hippocampal neurogenesis.	[Pilz, Gregor-Alexander; Bottes, Sara; Betizeau, Marion; Carta, Stefano; Jessberger, Sebastian] Univ Zurich, Brain Res Inst, Fac Med, Lab Neural Plast, CH-8057 Zurich, Switzerland; [Pilz, Gregor-Alexander; Bottes, Sara; Betizeau, Marion; Carta, Stefano; Jessberger, Sebastian] Univ Zurich, Brain Res Inst, Fac Sci, Lab Neural Plast, CH-8057 Zurich, Switzerland; [Betizeau, Marion] Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; [Betizeau, Marion] Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; [Jorg, David J.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Jorg, David J.; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Carta, Stefano; Helmchen, Fritjof] Univ Zurich, Lab Neural Circuit Dynam, Brain Res Inst, Fac Med, CH-8057 Zurich, Switzerland; [Carta, Stefano; Helmchen, Fritjof] Univ Zurich, Lab Neural Circuit Dynam, Brain Res Inst, Fac Sci, CH-8057 Zurich, Switzerland	University of Geneva; University of Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge; University of Cambridge; University of Cambridge; University of Geneva; University of Zurich; University of Zurich	Jessberger, S (corresponding author), Univ Zurich, Brain Res Inst, Fac Med, Lab Neural Plast, CH-8057 Zurich, Switzerland.; Jessberger, S (corresponding author), Univ Zurich, Brain Res Inst, Fac Sci, Lab Neural Plast, CH-8057 Zurich, Switzerland.	jessberger@hifo.uzh.ch	Simons, Benjamin/AAY-8920-2020; Jessberger, Sebastian/AAJ-4032-2020; Jorg, David/I-3905-2012; Helmchen, Fritjof/A-6255-2008	Simons, Benjamin/0000-0002-3875-7071; Jorg, David/0000-0001-5960-0260; Bottes, Sara/0000-0003-1801-9247; Carta, Stefano/0000-0001-7691-7550; Betizeau, Marion/0000-0002-0851-292X; Jessberger, Sebastian/0000-0002-0056-8275; Helmchen, Fritjof/0000-0002-8867-9569	European Research Council; Swiss National Science Foundation [BSCGI0_157859]; Zurich Neuroscience Center; Wellcome Trust [098357/Z/12/Z]; European Molecular Biology Organization Long-Term Fellowship; SystemsX transition postdoctoral fellowship	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Zurich Neuroscience Center; Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO)); SystemsX transition postdoctoral fellowship	This work was supported by the European Research Council (to S.J. and F.H.), the Swiss National Science Foundation (BSCGI0_157859 to S.J.), the Zurich Neuroscience Center, and the Wellcome Trust (098357/Z/12/Z to B.D.S.). G.A.P. was supported by a European Molecular Biology Organization Long-Term Fellowship. M.B. was supported by a SystemsX transition postdoctoral fellowship.	Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Bonaguidi MA, 2012, CURR OPIN NEUROBIOL, V22, P754, DOI 10.1016/j.conb.2012.03.013; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Chaker Z, 2016, WIRES DEV BIOL, V5, P640, DOI 10.1002/wdev.248; DeCarolis NA, 2013, HIPPOCAMPUS, V23, P708, DOI 10.1002/hipo.22130; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gurevich DB, 2016, SCIENCE, V353, DOI 10.1126/science.aad9969; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 2011, CELL, V145, P1009, DOI 10.1016/j.cell.2011.06.011; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Moore DL, 2015, SCIENCE, V349, P1334, DOI 10.1126/science.aac9868; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Pilz GA, 2016, J NEUROSCI, V36, P7407, DOI 10.1523/JNEUROSCI.3065-15.2016; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rompolas P, 2016, SCIENCE, V352, P1471, DOI 10.1126/science.aaf7012; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun GJ, 2015, P NATL ACAD SCI USA, V112, P9484, DOI 10.1073/pnas.1508545112; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Urban N, 2016, SCIENCE, V353, P292, DOI 10.1126/science.aaf4802; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yun S, 2016, NAT MED, V22, P1239, DOI 10.1038/nm.4218	38	160	162	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					658	+		10.1126/science.aao5056	http://dx.doi.org/10.1126/science.aao5056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439238	Green Accepted, Green Submitted			2022-12-28	WOS:000425117700033
J	Jung, H; Baek, M; D'Elia, KP; Boisvert, C; Currie, PD; Tay, BH; Venkatesh, B; Brown, SM; Heguy, A; Schoppik, D; Dasen, JS				Jung, Heekyung; Baek, Myungin; D'Elia, Kristen P.; Boisvert, Catherine; Currie, Peter D.; Tay, Boon-Hui; Venkatesh, Byrappa; Brown, Stuart M.; Heguy, Adriana; Schoppik, David; Dasen, Jeremy S.			The Ancient Origins of Neural Substrates for Land Walking	CELL			English	Article							SPINAL MOTOR-NEURONS; LOCOMOTOR CIRCUITS; GENE-EXPRESSION; HOX GENES; EVOLUTION; ORGANIZATION; IDENTITY; CONNECTIVITY; FISHES; FINS	Walking is the predominant locomotor behavior expressed by land-dwelling vertebrates, but it is unknown when the neural circuits that are essential for limb control first appeared. Certain fish species display walking-like behaviors, raising the possibility that the underlying circuitry originated in primitive marine vertebrates. We show that the neural substrates of bipedalism are present in the little skate Leucoraja erinacea, whose common ancestor with tetrapods existed similar to 420 million years ago. Leucoraja exhibits core features of tetrapod locomotor gaits, including left-right alternation and reciprocal extension-flexion of the pelvic fins. Leucoraja also deploys a remarkably conserved Hox transcription factor-dependent program that is essential for selective innervation of fin/limb muscle. This network encodes peripheral connectivity modules that are distinct from those used in axial muscle-based swimming and has apparently been diminished in most modern fish. These findings indicate that the circuits that are essential for walking evolved through adaptation of a genetic regulatory network shared by all vertebrates with paired appendages.	[Jung, Heekyung; Baek, Myungin; D'Elia, Kristen P.; Schoppik, David; Dasen, Jeremy S.] NYU, Sch Med, Dept Neurosci & Physiol, Neurosci Inst, New York, NY 10016 USA; [Boisvert, Catherine] Curtin Univ, Dept Environm & Agr, Bentley, WA 6102, Australia; [Boisvert, Catherine; Currie, Peter D.] Monash Univ, ARMI, Clayton, Vic 3800, Australia; [Currie, Peter D.] Monash Univ, Melbourne Node, EMBL Australia, Clayton, Vic 3800, Australia; [Tay, Boon-Hui; Venkatesh, Byrappa] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 119228, Singapore; [Brown, Stuart M.] NYU, Sch Med, Appl Bioinformat Lab, New York, NY 10016 USA; [Heguy, Adriana] NYU, Sch Med, Div Adv Res Technol, Genome Technol Ctr, New York, NY 10016 USA; [Heguy, Adriana] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Schoppik, David] NYU, Sch Med, Dept Otolaryngol, New York, NY 10016 USA	New York University; Curtin University; Australian Regenerative Medicine Institute; Monash University; European Molecular Biology Laboratory (EMBL); Monash University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; New York University; New York University; New York University; New York University	Dasen, JS (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, Neurosci Inst, New York, NY 10016 USA.	jeremy.dasen@nyumc.org	Boisvert, Catherine A/A-9782-2019; Heguy, Adriana/GPP-3907-2022; Brown, Stuart/A-9880-2016	Boisvert, Catherine A/0000-0002-0618-7270; Venkatesh, Byrappa/0000-0003-3620-0277; Schoppik, David/0000-0001-7969-9632; Currie, Peter/0000-0001-8874-8862; Brown, Stuart/0000-0002-0906-9907; D'Elia, Kristen/0000-0003-1532-7797	Biomedical Research Council of A*STAR; Cancer Center Support Grant [P30CA016087]; Australian Research Council [DP1096002, DP160104427]; Human Frontiers Science Program [LT000130/2009L]; National Institute on Deafness and Communication Disorders [R00 DC012775]; National Institute of Neurological Disorders and Stroke (NINDS) [R21 NS099933, R01 NS062822]; HHMI; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062822, R21NS099933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC012775] Funding Source: NIH RePORTER	Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR)); Cancer Center Support Grant; Australian Research Council(Australian Research Council); Human Frontiers Science Program(Human Frontier Science Program); National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Claude Desplan, Gord Fishell, Michael Halassa, Tom Jessell, and the Dasen lab members for feedback, Sylvie Mazan for providing Scyliorhinus embryos, and David Lee and Helen Kim for technical assistance. We are indebted to Andrew Gillis and Martin Cohn for advice regarding Leucoraja manipulations. We thank the NYU Genome Technology Center and Applied Bioinformatics Laboratories for their expert assistance with the analysis and interpretation of data. This work was supported by the Biomedical Research Council of A*STAR (to B.V.), Cancer Center Support Grant P30CA016087 (to A.H.), Australian Research Council Discovery Grants DP1096002 and DP160104427 (to P.D.C.), Human Frontiers Science Program LT000130/2009L (to C.B.), National Institute on Deafness and Communication Disorders R00 DC012775 (to D.S.), and National Institute of Neurological Disorders and Stroke (NINDS) R21 NS099933 and R01 NS062822 and the HHMI (to J.S.D.).	Appel B, 1995, DEVELOPMENT, V121, P4117; Baek M, 2017, CELL REP, V21, P867, DOI 10.1016/j.celrep.2017.10.004; Bagnall MW, 2014, SCIENCE, V343, P197, DOI 10.1126/science.1245629; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chevallier S, 2008, BRAIN RES REV, V57, P147, DOI 10.1016/j.brainresrev.2007.07.006; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dixit R, 2008, DEV NEUROBIOL, V68, P309, DOI 10.1002/dneu.20589; FETCHO JR, 1992, BRAIN BEHAV EVOLUT, V40, P82, DOI 10.1159/000113905; Flammang BE, 2016, SCI REP-UK, V6, DOI 10.1038/srep23711; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gillis JA, 2009, GENESIS, V47, P825, DOI 10.1002/dvg.20567; Goetz C, 2015, NEURON, V85, P131, DOI 10.1016/j.neuron.2014.11.024; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Hinckley CA, 2015, NEURON, V87, P1008, DOI 10.1016/j.neuron.2015.08.005; HOLST RJ, 1993, PHILOS T R SOC B, V339, P105, DOI 10.1098/rstb.1993.0007; Jung H, 2015, DEV CELL, V32, P408, DOI 10.1016/j.devcel.2015.01.008; Jung H, 2014, DEV CELL, V29, P171, DOI 10.1016/j.devcel.2014.03.008; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; Kao TJ, 2012, SEMIN CELL DEV BIOL, V23, P83, DOI 10.1016/j.semcdb.2011.10.016; King BL, 2011, SCIENCE, V334, P1517, DOI 10.1126/science.1210912; King HM, 2011, P NATL ACAD SCI USA, V108, P21146, DOI 10.1073/pnas.1118669109; Koester DM, 2003, COPEIA, P553; Lacombe J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003184; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lucifora LO, 2002, BIOL J LINN SOC, V77, P35, DOI 10.1046/j.1095-8312.2002.00085.x; Ma LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1045; Macesic LJ, 2010, J MORPHOL, V271, P1219, DOI 10.1002/jmor.10865; Machado TA, 2015, CELL, V162, P338, DOI 10.1016/j.cell.2015.06.036; Maxwell EE, 2008, ANAT REC, V291, P1079, DOI 10.1002/ar.20719; Mulley JF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-218; Murakami Y, 2011, DEV BIOL, V355, P164, DOI 10.1016/j.ydbio.2011.04.009; Nakamura T, 2015, P NATL ACAD SCI USA, V112, P15940, DOI 10.1073/pnas.1521818112; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Nishimoto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004245; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenberger LJ, 2001, J EXP BIOL, V204, P379; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Song JR, 2016, NATURE, V529, P399, DOI 10.1038/nature16497; Standen EM, 2014, NATURE, V513, P54, DOI 10.1038/nature13708; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanaka M, 2012, EVOL DEV, V14, P412, DOI 10.1111/j.1525-142X.2012.00561.x; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773; Wyffels Jennifer, 2014, F1000Res, V3, P191, DOI 10.12688/f1000research.4996.1; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013	53	45	45	7	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					667	+		10.1016/j.cell.2018.01.013	http://dx.doi.org/10.1016/j.cell.2018.01.013			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425489	Green Accepted, Bronze			2022-12-28	WOS:000424648800009
J	Raskind, MA; Peskind, ER; Chow, B; Harris, C; Davis-Karim, A; Holmes, HA; Hart, KL; McFall, M; Mellman, TA; Reist, C; Romesser, J; Rosenheck, R; Shih, MC; Stein, MB; Swift, R; Gleason, T; Lu, Y; Huang, GD				Raskind, M. A.; Peskind, E. R.; Chow, B.; Harris, C.; Davis-Karim, A.; Holmes, H. A.; Hart, K. L.; McFall, M.; Mellman, T. A.; Reist, C.; Romesser, J.; Rosenheck, R.; Shih, M. -C.; Stein, M. B.; Swift, R.; Gleason, T.; Lu, Y.; Huang, G. D.			Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SLEEP DISTURBANCES; COMBAT VETERANS; PLACEBO; PTSD; NOREPINEPHRINE; NIGHTMARES; SYMPTOMS; RISPERIDONE; VALIDITY; QUALITY	BACKGROUND In randomized trials, prazosin, an alpha(1)-adrenoreceptor antagonist, has been effective in alleviating nightmares associated with post-traumatic stress disorder (PTSD) in military veterans. METHODS We recruited veterans from 13 Department of Veterans Affairs medical centers who had chronic PTSD and reported frequent nightmares. Participants were randomly assigned to receive prazosin or placebo for 26 weeks; the drug or placebo was administered in escalating divided doses over the course of 5 weeks to a daily maximum of 20 mg in men and 12 mg in women. After week 10, participants continued to receive prazosin or placebo in a double-blind fashion for an additional 16 weeks. The three primary outcome measures were the change in score from baseline to 10 weeks on the Clinician-Administered PTSD Scale (CAPS) item B2 ("recurrent distressing dreams"; scores range from 0 to 8, with higher scores indicating more frequent and more distressing dreams); the change in score from baseline to 10 weeks on the Pittsburgh Sleep Quality Index (PSQI; scores range from 0 to 21, with higher scores indicating worse sleep quality); and the Clinical Global Impression of Change (CGIC) score at 10 weeks (scores range from 1 to 7, with lower scores indicating greater improvement and a score of 4 indicating no change). RESULTS A total of 304 participants underwent randomization; 152 were assigned to prazosin, and 152 to placebo. At 10 weeks, there were no significant differences between the prazosin group and the placebo group in the mean change from baseline in the CAPS item B2 score (between-group difference, 0.2; 95% confidence interval [CI], -0.3 to 0.8; P = 0.38), in the mean change in PSQI score (between-group difference, 0.1; 95% CI, -0.9 to 1.1; P = 0.80), or in the CGIC score (between-group difference, 0; 95% CI, -0.3 to 0.3; P = 0.96). There were no significant differences in these measures at 26 weeks (a secondary outcome) or in other secondary outcomes. At 10 weeks, the mean difference between the prazosin group and the placebo group in the change from baseline in supine systolic blood pressure was a decrease of 6.7 mm Hg. The adverse event of new or worsening suicidal ideation occurred in 8% of the participants assigned to prazosin versus 15% of those assigned to placebo. CONCLUSIONS In this trial involving military veterans who had chronic PTSD, prazosin did not alleviate distressing dreams or improve sleep quality.	[Raskind, M. A.; Peskind, E. R.; Holmes, H. A.; Hart, K. L.; McFall, M.] Vet Affairs VA Northwest Network Mental Illness R, Seattle, WA USA; [Raskind, M. A.; Peskind, E. R.; McFall, M.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Chow, B.; Shih, M. -C.; Lu, Y.] VA Cooperat Studies Program Coordinating Ctr, Palo Alto, CA USA; [Reist, C.] Univ Calif Irvine, VA Long Beach Healthcare Syst, Dept Human Behav, Irvine, CA 92697 USA; [Shih, M. -C.; Lu, Y.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [Stein, M. B.] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA; [Stein, M. B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Stein, M. B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Harris, C.; Davis-Karim, A.] Clin Res Pharm Coordinating Ctr, VA Cooperat Studies Program, Albuquerque, NM USA; [Mellman, T. A.] Howard Univ, Dept Psychiat, Washington, DC 20059 USA; [Huang, G. D.] Cent Off, Cooperat Studies Program, Washington, DC USA; [Gleason, T.] Off Res & Dev, Dept Vet Affairs, Washington, DC USA; [Romesser, J.] VA Salt Lake City, Salt Lake City, UT USA; [Rosenheck, R.] VA Northeast Program Evaluat Ctr, West Haven, CT USA; [Rosenheck, R.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Rosenheck, R.] Yale Sch Med, Dept Publ Hlth, New Haven, CT USA; [Swift, R.] Brown Alpert Med Sch, Providence VA Med Ctr, Providence, RI USA; [Swift, R.] Brown Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI USA	University of Washington; University of Washington Seattle; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Stanford University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard University; US Department of Veterans Affairs; Yale University; Yale University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Raskind, MA (corresponding author), VA Puget Sound Hlth Care Syst, 1660 S Columbian Way,S-116 MIRECC, Seattle, WA 98108 USA.; Raskind, MA (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	murray.raskind@va.gov		Lu, Ying/0000-0002-7698-8962	Department of Veterans Affairs Cooperative Studies Program; Merck; Tonix Pharmaceuticals; Jazz Pharmaceuticals; Actelion Pharmaceuticals; Neurocrine Biosciences; Pfizer; Braeburn Pharmaceuticals; Aptinyx; Janssen; Resilience Therapeutics; Laboratorio Farmaceutico CT; PTC Therapeutics; Boehringer Ingelheim; PaxVax; PACT [NCT00532493]	Department of Veterans Affairs Cooperative Studies Program(US Department of Veterans Affairs); Merck(Merck & Company); Tonix Pharmaceuticals; Jazz Pharmaceuticals(Jazz Pharmaceuticals); Actelion Pharmaceuticals; Neurocrine Biosciences; Pfizer(Pfizer); Braeburn Pharmaceuticals; Aptinyx; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Resilience Therapeutics; Laboratorio Farmaceutico CT; PTC Therapeutics; Boehringer Ingelheim(Boehringer Ingelheim); PaxVax; PACT	Supported by the Department of Veterans Affairs Cooperative Studies Program.r Dr. Mellman reports receiving grant support, lecture fees, and consulting fees from Merck and consulting fees from Tonix Pharmaceuticals and Jazz Pharmaceuticals; Dr. Stein, receiving consulting fees from Actelion Pharmaceuticals, Neurocrine Biosciences, Pfizer, Braeburn Pharmaceuticals, and Aptinyx, grant support and consulting fees from Janssen, consulting fees and founder's stocks and options from Resilience Therapeutics, and stock options from Oxeia Biopharmaceuticals; Dr. Swift, receiving grant support from Laboratorio Farmaceutico CT and honoraria and travel support from Lundbeck; and Dr. Lu, receiving fees for serving on a safety monitoring committee for PaxVax, advisory fees from PTC Therapeutics, and lecture fees from Boehringer Ingelheim. No other potential conflict of interest relevant to this article was reported.r Funded by the Department of Veterans Affairs Cooperative Studies Program; PACT ClinicalTrials.gov number, NCT00532493.	Ahmadpanah M, 2014, NEUROPSYCHOBIOLOGY, V69, P235, DOI 10.1159/000362243; Bernardy NC, 2012, J CLIN PSYCHIAT, V73, P297, DOI 10.4088/JCP.11m07311; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Colvonen PJ, 2015, J CLIN SLEEP MED, V11, P513, DOI 10.5664/jcsm.4692; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; Frisch M.B., 1994, MANUAL TREATMENT GUI; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Germain A, 2012, J PSYCHOSOM RES, V72, P89, DOI 10.1016/j.jpsychores.2011.11.010; Guy W., 1976, BEHAV RES THER; HILAKIVI I, 1984, ACTA PHYSIOL SCAND, V120, P363, DOI 10.1111/j.1748-1716.1984.tb07396.x; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; lqbal SU, VETERANS RAND 12 ITE; MELLMAN TA, 1995, BIOL PSYCHIAT, V38, P174, DOI 10.1016/0006-3223(94)00238-X; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Pietrzak RH, 2013, JAMA PSYCHIAT, V70, P1199, DOI 10.1001/jamapsychiatry.2013.399; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Raskind MA, 2013, AM J PSYCHIAT, V170, P1003, DOI 10.1176/appi.ajp.2013.12081133; Rosenheck RA, 2011, NEW ENGL J MED, V364, P842, DOI 10.1056/NEJMoa1005987; ROSS RJ, 1989, AM J PSYCHIAT, V146, P697; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; Taylor FB, 2008, BIOL PSYCHIAT, V63, P629, DOI 10.1016/j.biopsych.2007.07.001; The Management of Posttraumatic Stress Disorder Work Group, 2010, VA DOD CLIN PRACT GU; Westfall TC, 2006, GOOD MAN GILLMANS PH, V11th, P237; Yesavage JA, 2012, AM J GERIAT PSYCHIAT, V20, P199, DOI 10.1097/JGP.0b013e3181e446ea	34	136	138	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					507	517		10.1056/NEJMoa1507598	http://dx.doi.org/10.1056/NEJMoa1507598			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OX	29414272	Bronze			2022-12-28	WOS:000424335200006
J	Chen, YL; Wang, C; Shang, HC; Yang, KH; Norris, SL				Chen, Yaolong; Wang, Chen; Shang, Hongcai; Yang, Kehu; Norris, Susan L.			Clinical practice guidelines in China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMERICAN-COLLEGE; HEALTH-CARE; MANAGEMENT; SOCIETY; DIAGNOSIS; QUALITY; DISEASE		[Chen, Yaolong; Yang, Kehu] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Gansu, Peoples R China; [Chen, Yaolong; Shang, Hongcai] Beijing Univ Chinese Med, Dongzhimen Hosp, Key Lab Chinese Internal Med, Minist Educ, Beijing, Peoples R China; [Wang, Chen] China Japan Friendship Hosp, Ctr Resp Dis, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [Norris, Susan L.] WHO, Guidelines Review Comm, Geneva, Switzerland	Lanzhou University; Beijing University of Chinese Medicine; China-Japan Friendship Hospital; World Health Organization	Chen, YL (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Gansu, Peoples R China.; Chen, YL (corresponding author), Beijing Univ Chinese Med, Dongzhimen Hosp, Key Lab Chinese Internal Med, Minist Educ, Beijing, Peoples R China.	chenyaolong@lzu.edu.cn	wang, chen/GWM-9481-2022; shang, hongcai/H-1257-2014	Chen, Yaolong/0000-0002-9841-5233; Shang, Hongcai/0000-0001-6628-354X	National Natural Science Foundation of China [81503459, 81673825]; open fund of the Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province [EBM 1701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open fund of the Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province	We have read and understood BMJ policy on declaration of interests and declare the following interests: YC and SLN are members of GRADE working group. YC and KY are supported by National Natural Science Foundation of China (grant No 81503459, 81673825) and the open fund of the Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province (grant No EBM 1701) to conduct methodological research on clinical guideline development.	Alderson P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000032; Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen Y, 2016, G I N 2016 C PHIL 27; Chen Y, 2015, BMJ OPEN, V5, DOI [10.1136/bmjopen-2015-008099, DOI 10.1136/BMJOPEN-2015-008099]; Chen YL, 2012, CHINESE MED J-PEKING, V125, P3660, DOI 10.3760/cma.j.issn.0366-6999.2012.20.011; Chen YL, 2017, ANN INTERN MED, V166, P128, DOI 10.7326/M16-1565; China Association of Acupuncture-Moxibustion, 2014, EV BAS GUID CLIN PRA; [中国医师协会生殖医学专业委员会 Chinese Medical Doctor Association Repro], 2017, [中华生殖与避孕杂志, Chinese Journal of Reproduction and Contraception], V37, P87; Chinese Rheumatology Association, 2016, Zhonghua Nei Ke Za Zhi, V55, P892, DOI 10.3760/cma.j.issn.0578-1426.2016.11.019; Deng Wei, 2016, J Evid Based Med, V9, P152, DOI 10.1111/jebm.12197; Feng XT, 2015, J JIANGSU ADM I, V6, P54, DOI [10.3969/j.issn.1009-8860.2015.06.00, DOI 10.3969/J.ISSN.1009-8860.2015.06.00]; Fervers B, 2011, BMJ QUAL SAF, V20, P228, DOI 10.1136/bmjqs.2010.043257; Fu L., 2014, DEV HIV AIDS CLIN NU; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Hesketh T, 1997, BRIT MED J, V315, P115, DOI 10.1136/bmj.315.7100.115; Hui M, 2017, RHEUMATOLOGY, V56, P1056, DOI 10.1093/rheumatology/kex150; Institute of Medicine Committee on Standards for Developing Trusthworthy Clinical Practice Guidelines, 2011, CLIN PRACTICE GUIDEL, DOI [10.17226/13058, DOI 10.17226/13058]; Jiang LX, 2015, LANCET, V386, P1493, DOI 10.1016/S0140-6736(15)00343-8; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Ko TM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4848; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Liu MY, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1946-2; Lund H, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5440; Organization WH, 2015, GUID PREV CAR TREATM; Sheng F, 2014, ARTHRITIS RHEUMATOL, V66, pS76; Tian Y., 2016, GUANGMING DAILY; Wang C, 2010, CHEST, V137, P254, DOI 10.1378/chest.09-0765; Wang T, 2012, 7 AS PAC C EV BAS ME; Zheng ZH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-218; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; 蒋朱明, 2016, [中华医学杂志, National Medical Journal of China], V96, P250; 陈耀龙, 2013, [中国循证儿科杂志, Chinese Journal of Evidence Based Pediatrics], V8, P467	35	40	92	3	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2018	360								j5158	10.1136/bmj.j5158	http://dx.doi.org/10.1136/bmj.j5158			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HP	29437564	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000424974800001
J	Bagla, P				Bagla, Pallava			SPACE EXPLORATION India plans to land near moon's south pole	SCIENCE			English	News Item																			0	5	5	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					503	504		10.1126/science.359.6375.503	http://dx.doi.org/10.1126/science.359.6375.503			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420268				2022-12-28	WOS:000423795800013
J	[Anonymous]				[Anonymous]			The dark side of light (vol 553, pg 268, 2018)	NATURE			English	Correction																		Irwin A, 2018, NATURE, V553, P268, DOI 10.1038/d41586-018-00665-7	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					18	18		10.1038/d41586-018-01422-6	http://dx.doi.org/10.1038/d41586-018-01422-6			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29388985	Bronze			2022-12-28	WOS:000424048900011
J	Balmes, JR				Balmes, John R.			Where There's Wildfire, There's Smoke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH IMPACTS; EXPOSURE		[Balmes, John R.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA; [Balmes, John R.] Univ Calif San Francisco, Ctr Trauma, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA; [Balmes, John R.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Balmes, JR (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA.; Balmes, JR (corresponding author), Univ Calif San Francisco, Ctr Trauma, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA.; Balmes, JR (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA.		Balmes, John/L-6281-2019					[Anonymous], 2017, KQED RADIO      1012; Atkinson RW, 2015, J EXPO SCI ENV EPID, V25, P208, DOI 10.1038/jes.2014.63; Liu JC, 2015, ENVIRON RES, V136, P120, DOI 10.1016/j.envres.2014.10.015; Reid CE, 2016, ENVIRON HEALTH PERSP, V124, P1334, DOI 10.1289/ehp.1409277; Rokos B, 2017, LOS ANGELES DAI 1209	5	26	26	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2018	378	10					881	883		10.1056/NEJMp1716846	http://dx.doi.org/10.1056/NEJMp1716846			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FY4CY	29384719	Bronze			2022-12-28	WOS:000426770200001
J	Rubin, MA; Samore, MH; Harris, AD				Rubin, Michael A.; Samore, Matthew H.; Harris, Anthony D.			The Importance of Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BACTERIA		[Rubin, Michael A.; Samore, Matthew H.] VA Salt Lake City Hlth Care Syst, Salt Lake Informat Decis Enhancement & Analyt Sci, Salt Lake City, UT USA; [Rubin, Michael A.; Samore, Matthew H.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Harris, Anthony D.] VA Maryland Healthcare Syst, Baltimore, MD USA; [Harris, Anthony D.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University System of Maryland; University of Maryland Baltimore	Rubin, MA (corresponding author), VA Salt Lake City Hlth Care Syst, 500 Foothill Dr,MC 182, Salt Lake City, UT 84148 USA.	michael.rubin@hsc.utah.edu			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Service [I50HX001240]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Service(US Department of Veterans Affairs)	This work was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Service (I50HX001240).	Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Marra AR, 2017, AM J INFECT CONTROL; Morgan DJ, 2017, JAMA-J AM MED ASSOC, V318, P329, DOI 10.1001/jama.2017.7419; Morgan DJ, 2015, INFECT CONT HOSP EP, V36, P1163, DOI 10.1017/ice.2015.156; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006	6	31	32	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2018	319	9					863	864		10.1001/jama.2017.21122	http://dx.doi.org/10.1001/jama.2017.21122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY3FW	29435582				2022-12-28	WOS:000426705100010
J	Helgstrand, F; Bisgaard, T				Helgstrand, Frederik; Bisgaard, Thue			Time for use of mesh repair for all umbilical hernias?	LANCET			English	Editorial Material							EPIGASTRIC HERNIA; COMPLICATIONS; RECURRENCE; SUTURE		[Helgstrand, Frederik] Zealand Univ Hosp, Dept Gastrointestinal Surg, Ctr Surg Sci, DK-4600 Koge, Denmark; [Bisgaard, Thue] Univ Copenhagen, Hvidovre Hosp, Surg Div, Ctr Surg Res,Gastrounit, Hvidovre, Denmark	University of Copenhagen	Helgstrand, F (corresponding author), Zealand Univ Hosp, Dept Gastrointestinal Surg, Ctr Surg Sci, DK-4600 Koge, Denmark.	freh@regionsjaelland.dk	Helgstrand, Frederik/AAK-1688-2020	Helgstrand, Frederik/0000-0001-5702-8352				Arroyo A, 2001, BRIT J SURG, V88, P1321, DOI 10.1046/j.0007-1323.2001.01893.x; Aslani N, 2010, HERNIA, V14, P455, DOI 10.1007/s10029-010-0705-9; Christoffersen MW, 2015, AM J SURG, V209, P725, DOI 10.1016/j.amjsurg.2014.05.021; Helgstrand F, 2013, HERNIA, V17, P487, DOI 10.1007/s10029-013-1120-9; Helgstrand F, 2010, HERNIA, V14, P131, DOI [10.1007/s10029-009-0592-0, 10.1007/s10029-010-0757-x]; Holihan JL, 2017, SURG INFECT, V18, P647, DOI 10.1089/sur.2017.029; Kaufmann R, 2017, LANCET; Kokotovic D, 2016, JAMA-J AM MED ASSOC, V316, P1575, DOI 10.1001/jama.2016.15217; Liang MK, 2017, ANN SURG, V265, P80, DOI 10.1097/SLA.0000000000001701; Oma E, 2016, SURGERY, V159, P1677, DOI 10.1016/j.surg.2015.12.025; Ponten JEH, 2018, WORLD J SURG, V42, P1312, DOI 10.1007/s00268-017-4297-8; Poulose BK, 2012, HERNIA, V16, P179, DOI 10.1007/s10029-011-0879-9; Shankar DA, 2017, JAMA SURG, V152, P461, DOI 10.1001/jamasurg.2016.5052; Winsnes A, 2016, HERNIA, V20, P509, DOI 10.1007/s10029-016-1466-x	14	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2018	391	10123					821	822		10.1016/S0140-6736(18)30299-X	http://dx.doi.org/10.1016/S0140-6736(18)30299-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX9XF	29459020				2022-12-28	WOS:000426463500007
J	Aung, K				Aung, Koko			In suspected OSA, home respiratory polygraphy was noninferior to polysomnography for reducing symptoms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Aung, Koko] Paul L Foster Sch Med, El Paso, TX 79905 USA		Aung, K (corresponding author), Paul L Foster Sch Med, El Paso, TX 79905 USA.		Aung, KoKo/I-1236-2019	Aung, KoKo/0000-0002-3152-0610				Berry RB, 2011, SLEEP MED CLIN, V6, P309, DOI 10.1016/j.jsmc.2011.05.002; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002	3	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC20	JC20		10.7326/ACPJC-2018-168-4-020	http://dx.doi.org/10.7326/ACPJC-2018-168-4-020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459957				2022-12-28	WOS:000425434000008
J	Angus-Leppan, H; Saatci, D; Sutcliffe, A; Guiloff, RJ				Angus-Leppan, Heather; Saatci, Defne; Sutcliffe, Alastair; Guiloff, Roberto J.			Abdominal migraine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FUNCTIONAL GASTROINTESTINAL DISORDERS; CYCLICAL VOMITING SYNDROME; BENIGN PAROXYSMAL VERTIGO; PLACEBO-CONTROLLED TRIAL; SUPERIOR SAGITTAL SINUS; PIZOTIFEN SYRUP; TOOTH-PULP; LIMB PAIN; FOLLOW-UP; CHILDREN		[Angus-Leppan, Heather] Royal Free London NHS Fdn Trust, Clin Neurosci, London NW3 2QG, England; [Angus-Leppan, Heather] UCL, Inst Neurol, London, England; [Angus-Leppan, Heather] Univ Hertfordshire, Ctr Res Primary & Community Care, Hatfield, Herts, England; [Saatci, Defne; Sutcliffe, Alastair] UCL, London, England; [Saatci, Defne; Sutcliffe, Alastair] UCL, Great Ormond St Inst Child Hlth, London, England; [Guiloff, Roberto J.] Imperial Coll London, London, England; [Guiloff, Roberto J.] Univ Chile, Fac Med, Santiago, Chile	University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; University of Hertfordshire; University of London; University College London; University of London; University College London; Imperial College London; Universidad de Chile	Angus-Leppan, H (corresponding author), Royal Free London NHS Fdn Trust, Clin Neurosci, London NW3 2QG, England.; Angus-Leppan, H (corresponding author), UCL, Inst Neurol, London, England.; Angus-Leppan, H (corresponding author), Univ Hertfordshire, Ctr Res Primary & Community Care, Hatfield, Herts, England.	heather.angus-leppan@nhs.net	Angus-Leppan, Heather/AAF-5168-2019; Abu-Arafeh, Ishaq/H-7417-2019	Angus-Leppan, Heather/0000-0001-7004-3848; Abu-Arafeh, Ishaq/0000-0003-1252-0153; Saatci, Defne/0000-0002-2414-2906; Sutcliffe, Alastair/0000-0001-8542-6155	Fondecyt (Chile) [1120339]	Fondecyt (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	RJG was part funded by Fondecyt (Chile) Grant 1120339.	Abu-Arafeh I, 1998, BRIT MED J, V317, P682, DOI 10.1136/bmj.317.7159.682a; ABUARAFEH I, 1995, ARCH DIS CHILD, V72, P413, DOI 10.1136/adc.72.5.413; ABUARAFEH I, 1995, J PEDIATR GASTR NUTR, V21, P454, DOI 10.1097/00005176-199511000-00014; Angus-Leppan Heather, 2013, Pract Neurol, V13, P308, DOI 10.1136/practneurol-2012-000502; ANGUSLEPPAN H, 1995, CEPHALALGIA, V15, P191, DOI 10.1046/j.1468-2982.1995.015003191.x; ANGUSLEPPAN H, 1994, NEUROSCI LETT, V182, P275, DOI 10.1016/0304-3940(94)90815-X; APLEY J, 1977, CLIN GASTROENTEROL, V6, P311; Apley J., 1975, CHILD ABDOMINAL PAIN; Berger MY, 2007, BMJ-BRIT MED J, V334, P997, DOI 10.1136/bmj.39189.465718.BE; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Campo JV, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e1; Carson L, 2011, HEADACHE, V51, P707, DOI 10.1111/j.1526-4610.2011.01855.x; CHRISTENSEN MF, 1995, ARCH DIS CHILD, V73, P183, DOI 10.1136/adc.73.2.183-a; Clinch J, 2011, ARTHRITIS RHEUM-US, V63, P2819, DOI 10.1002/art.30435; Costa F, 2007, WORLD J GASTROENTERO, V13, P219, DOI 10.3748/wjg.v13.i2.219; Cranswick N, 2000, Am J Ther, V7, P135, DOI 10.1097/00045391-200007020-00010; Dale RC, 2012, DEV MED CHILD NEUROL, V54, P958, DOI 10.1111/j.1469-8749.2012.04394.x; Di Lorenzo C, 2005, PEDIATRICS, V115, pE370, DOI 10.1542/peds.2004-2523; Dignam F, 2001, ARCH DIS CHILD, V84, P55, DOI 10.1136/adc.84.1.55; Dignan F, 2001, ARCH DIS CHILD, V84, P415, DOI 10.1136/adc.84.5.415; Drossman DA, 2005, GASTROENTEROLOGY, V128, P1771, DOI 10.1053/j.gastro.2005.04.020; Drossman Douglas A, 2006, Chin J Dig Dis, V7, P181, DOI 10.1111/j.1443-9573.2006.00265.x; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1262, DOI 10.1053/j.gastro.2016.02.032; El-Chammas K, 2013, JAMA PEDIATR, V167, P250, DOI 10.1001/jamapediatrics.2013.508; FARQUHAR HG, 1956, BRIT MED J, V1, P1082, DOI 10.1136/bmj.1.4975.1082; Francis MV, 2016, J HEADACHE PAIN MANA, V1, P1010; Franzon RC, 2002, ARQ NEURO-PSIQUIAT, V60, P628, DOI 10.1590/S0004-282X2002000400021; Giffin NJ, 2002, DEV MED CHILD NEUROL, V44, P490; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; GUILOFF RJ, 1988, J NEUROL NEUROSUR PS, V51, P1022, DOI 10.1136/jnnp.51.8.1022; GUILOFF RJ, 1990, HEADACHE, V30, P138, DOI 10.1111/j.1526-4610.1990.hed3003138.x; Henderson FC, 2017, AM J MED GENET C, V175, P195, DOI 10.1002/ajmg.c.31549; Hockaday Judith M., 1992, Cephalalgia, V12, P346; Hotopf M, 1998, BRIT MED J, V316, P1196, DOI 10.1136/bmj.316.7139.1196; Kacperski J, 2016, THER ADV NEUROL DISO, V9, P53, DOI 10.1177/1756285615616586; Kakisaka Yosuke, 2012, World J Exp Med, V2, P75, DOI 10.5493/wjem.v2.i4.75; Kakisaka Y, 2010, J CHILD NEUROL, V25, P234, DOI 10.1177/0883073809336875; Karsan N, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0689-7; Kothare SV, 2005, EUR J PAEDIATR NEURO, V9, P23, DOI 10.1016/j.ejpn.2004.11.002; LeResche L, 2005, PAIN, V118, P201, DOI 10.1016/j.pain.2005.08.011; Lewis ML, 2016, J PEDIATR-US, V177, P39, DOI 10.1016/j.jpeds.2016.04.008; Li BUK, 2009, PEDIATR ANN, V38, P241, DOI 10.9999/00904481-20090415-02; Ligthart L, 2013, J PAIN, V14, P363, DOI 10.1016/j.jpain.2012.12.006; Machnes-Maayan D, 2014, PEDIATR NEUROL, V50, P49, DOI 10.1016/j.pediatrneurol.2013.07.011; Mamouri O, 2017, CEPHALALGIA, DOI 10.1177/0333102417721132.28728427; Marcelli V, 2006, BRAIN DEV-JPN, V28, P80, DOI 10.1016/j.braindev.2005.05.003; MCGRATH P, 1983, CAN FAM PHYSICIAN, V29, P1655; MCGRATH PJ, 1983, ARCH DIS CHILD, V58, P888, DOI 10.1136/adc.58.11.888; Merikangas Kathleen Ries, 2009, Dialogues Clin Neurosci, V11, P7; MIRA E, 1984, ORL J OTO-RHINO-LARY, V46, P97, DOI 10.1159/000275693; MORTIMER MJ, 1993, DEV MED CHILD NEUROL, V35, P243; MORTIMER MJ, 1992, HEADACHE, V32, P353, DOI 10.1111/j.1526-4610.1992.hed3207353.x; Napthali K, 2016, CEPHALALGIA, V36, P980, DOI 10.1177/0333102415617748; National Institute for Health and Care Excellence, 2009, DIARRH VOM CAUS GAST; NICOL AR, 1982, BRIT J HOSP MED, V27, P351; O'Brien HL, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0326-1; Perrott DA, 2004, ARCH PEDIAT ADOL MED, V158, P521, DOI 10.1001/archpedi.158.6.521; Powers SW, 2017, NEW ENGL J MED, V376, P115, DOI 10.1056/NEJMoa1610384; Quak SH, 2015, SINGAP MED J, V56, P125, DOI 10.11622/smedj.2015038; Raina M, 2013, CLIN PEDIATR, V52, P918, DOI 10.1177/0009922813492879; Richer L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005220.pub2; Roberts JE, 2012, AM J MED, V125, P1135, DOI 10.1016/j.amjmed.2012.06.008; Russell George, 2002, Paediatr Drugs, V4, P1; Sakai F, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0478-z; SALMON MA, 1989, INT CONGR SER, V833, P27; SANDERS MR, 1994, J CONSULT CLIN PSYCH, V62, P306, DOI 10.1037/0022-006X.62.2.306; Santoro G, 1990, Funct Neurol, V5, P61; SAWYER MG, 1987, AUST PAEDIATR J, V23, P121; Schulte LH, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0495-7; Sillanpaa M, 2015, CEPHALALGIA, V35, P1246, DOI 10.1177/0333102415576225; Spiri D, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0092-4; Stein R, 2015, GLOB PEDIAT HLTH, V2; Sutherland HG, 2017, HEADACHE, V57, P537, DOI 10.1111/head.13053; Symon DNK, 1999, DIGEST DIS SCI, V44, p23S; SYMON DNK, 1995, ARCH DIS CHILD, V72, P48, DOI 10.1136/adc.72.1.48; SYMON DNK, 1992, CEPHALALGIA, V12, P345, DOI 10.1111/j.1468-2982.1992.00345.x; SYMON DNK, 1986, CEPHALALGIA, V6, P223, DOI 10.1046/j.1468-2982.1986.0604223.x; Tan V, 2006, PSYCHOSOMATICS, V47, P353, DOI 10.1176/appi.psy.47.4.353; Tarantino S, 2014, PEDIATR NEUROL, V51, P645, DOI 10.1016/j.pediatrneurol.2014.07.018; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; van Tilburg MAL, 2010, ANN FAM MED, V8, P134, DOI 10.1370/afm.1053; WALKER LS, 1989, J PEDIATR PSYCHOL, V14, P231, DOI 10.1093/jpepsy/14.2.231; Woodruff AE, 2013, ANN PHARMACOTHER, V47, pE27, DOI 10.1345/aph.1R620; Worawattanakul M, 1999, J PEDIATR GASTR NUTR, V28, P37, DOI 10.1097/00005176-199901000-00010; Yacob D, 2013, J PEDIATR-US, V163, P767, DOI 10.1016/j.jpeds.2013.02.033; ZAHAVI I, 1984, ARCH INTERN MED, V144, P742, DOI 10.1001/archinte.144.4.742	86	13	14	4	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2018	360								k179	10.1136/bmj.k179	http://dx.doi.org/10.1136/bmj.k179			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX1ED	29459383				2022-12-28	WOS:000425790700001
J	Chen, D; Ayala, GE				Chen, Duan; Ayala, Gustavo E.			Innervating Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SWITCH		[Chen, Duan] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Ayala, Gustavo E.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pathol & Lab Med, Houston, TX 77030 USA	Norwegian University of Science & Technology (NTNU); University of Texas System; University of Texas Health Science Center Houston	Chen, D (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway.		Ayala, Gustavo/ABC-6625-2020					Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Hayakawa Y, 2017, SCIENCE, V358, P305, DOI 10.1126/science.aaq0365; Hayakawa Y, 2017, CANCER CELL, V31, P21, DOI 10.1016/j.ccell.2016.11.005; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Renz BW, 2018, CANCER CELL, V33, P75, DOI 10.1016/j.ccell.2017.11.007; Zahalka AH, 2017, SCIENCE, V358, P321, DOI 10.1126/science.aah5072; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	7	14	14	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					675	677		10.1056/NEJMcibr1714003	http://dx.doi.org/10.1056/NEJMcibr1714003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW0QK	29443663				2022-12-28	WOS:000425000000015
J	Grimm, D				Grimm, David			THE HAPPINESS PROJECT	SCIENCE			English	Editorial Material																			0	3	3	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					624	627		10.1126/science.359.6376.624	http://dx.doi.org/10.1126/science.359.6376.624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439224				2022-12-28	WOS:000425117700017
J	[Anonymous]				[Anonymous]			China's planned exascale computer threatens Summit's position at the top	SCIENCE			English	News Item																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					618	618		10.1126/science.359.6376.618	http://dx.doi.org/10.1126/science.359.6376.618			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439218				2022-12-28	WOS:000425117700011
J	Nandagopal, N; Santat, LA; Lebon, L; Sprinzak, D; Bronner, ME; Elowitz, MB				Nandagopal, Nagarajan; Santat, Leah A.; Lebon, Lauren; Sprinzak, David; Bronner, Marianne E.; Elowitz, Michael B.			Dynamic Ligand Discrimination in the Notch Signaling Pathway	CELL			English	Article							MESSENGER-RNA EXPRESSION; CELL-FATE; VERTEBRATE SEGMENTATION; PROGENITOR CELLS; BHLH FACTORS; ACTIVATION; COMMITMENT; TRANSIENT; EMBRYOS; VIVO	The Notch signaling pathway comprises multiple ligands that are used in distinct biological contexts. In principle, different ligands could activate distinct target programs in signal-receiving cells, but it is unclear how such ligand discrimination could occur. Here, we show that cells use dynamics to discriminate signaling by the ligands Dll1 and Dll4 through the Notch1 receptor. Quantitative single-cell imaging revealed that Dll1 activates Notch1 in discrete, frequency-modulated pulses that specifically upregulate the Notch target gene Hes1. By contrast, Dll4 activates Notch1 in a sustained, amplitude-modulated manner that predominantly upregulates Hey1 and HeyL. Ectopic expression of Dll1 or Dll4 in chick neural crest produced opposite effects on myogenic differentiation, showing that ligand discrimination can occur in vivo. Finally, analysis of chimeric ligands suggests that ligand-receptor clustering underlies dynamic encoding of ligand identity. The ability of the pathway to utilize ligands as distinct communication channels has implications for diverse Notch-dependent processes.	[Nandagopal, Nagarajan; Santat, Leah A.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Nandagopal, Nagarajan; Santat, Leah A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Lebon, Lauren] Calico Life Sci, 1170 Vet Blvd, San Francisco, CA 94080 USA; [Sprinzak, David] Tel Aviv Univ, Wise Fac Life Sci, Dept Biochem & Mol Biol, Tel Aviv, Israel; [Bronner, Marianne E.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol & Biol Engn, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Tel Aviv University; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol & Biol Engn, Dept Appl Phys, Pasadena, CA 91125 USA.	melowitz@caltech.edu		LeBon, Lauren/0000-0003-3205-1948	Defense Advanced Research Projects Agency [HR0011-16-0138]; NIH [R01 HD075335]; NSF [EFRI 1137269]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075335] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Mark Budde, Joe Markson, Pulin Li, Yihan Lin, James Linton, Emily Capra, Jordi Garcia-Ojalvo, and Xiaojing Gao for critical feedback on the manuscript, and Young-Wook Jun, Roy Kishony, Irv Bernstein, Stephen Blacklow, and Elizabeth Jensen for helpful discussions. Harry Choi and Colby Calvert, Caltech Flow Cytometry Facility, Caltech Biological Imaging Facility, and the Millard and Muriel Jacobs Genetics and Genomics Laboratory at Caltech provided essential technical assistance. This work was supported by the Defense Advanced Research Projects Agency (HR0011-16-0138), by the NIH (R01 HD075335), and the NSF (EFRI 1137269). N.N. was a Howard Hughes Medical Institute International Student Research fellow.	Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Andrawes MB, 2013, J BIOL CHEM, V288, P25477, DOI 10.1074/jbc.M113.454850; Antebi YE, 2017, CELL, V170, P1184, DOI 10.1016/j.cell.2017.08.015; Barad O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000857; Bardot B, 2005, EXP CELL RES, V304, P202, DOI 10.1016/j.yexcr.2004.10.030; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Cappellari O, 2013, DEV CELL, V24, P586, DOI 10.1016/j.devcel.2013.01.022; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Choi HMT, 2016, DEVELOPMENT, V143, P3632, DOI 10.1242/dev.140137; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Elena de Bellard Maria, 2005, Methods Mol Biol, V294, P247; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Gama-Norton L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9510; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hansen AS, 2016, CURR BIOL, V26, pR269, DOI 10.1016/j.cub.2016.02.058; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Kesarwani M, 2017, NAT MED, V23, P472, DOI 10.1038/nm.4310; Kobayashi T, 2014, CURR TOP DEV BIOL, V110, P263, DOI 10.1016/B978-0-12-405943-6.00007-5; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; LeBon L, 2014, ELIFE, V3, DOI 10.7554/eLife.02950; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Meloty-Kapella L, 2012, DEV CELL, V22, P1299, DOI 10.1016/j.devcel.2012.04.005; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Noren DP, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad3188; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Preusse K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005328; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rios AC, 2011, NATURE, V473, P532, DOI 10.1038/nature09970; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Seo D, 2017, CELL, V169, P1357, DOI 10.1016/j.cell.2017.06.005; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Yissachar N, 2013, MOL CELL, V49, P322, DOI 10.1016/j.molcel.2012.11.003	58	160	163	4	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					869	+	880.e19	10.1016/j.cell.2018.01.002	http://dx.doi.org/10.1016/j.cell.2018.01.002			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29398116	hybrid, Green Accepted			2022-12-28	WOS:000424648800024
J	Netters, S				Netters, Sabine			ESSAY How it feels to help a terminally ill patient to die a dignified death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Netters, Sabine] Isala Oncol Ctr, Zwolle, Netherlands		Netters, S (corresponding author), Isala Oncol Ctr, Zwolle, Netherlands.	f.j.s.netters@isala.nl							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2018	360								k116	10.1136/bmj.k116	http://dx.doi.org/10.1136/bmj.k116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HY	29437687				2022-12-28	WOS:000424975900001
J	Blay, E; Barnard, C; Bilimoria, KY				Blay, Eddie; Barnard, Cynthia; Bilimoria, Karl Y.			Oversedation of a PatientWith Obstructive Sleep Apnea Prior to Imaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SEDATION		[Blay, Eddie; Barnard, Cynthia; Bilimoria, Karl Y.] Northwestern Mem Hosp, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA	Northwestern Memorial Hospital	Bilimoria, KY (corresponding author), Northwestern Mem Hosp, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	kbilimoria@nm.org			American College of Surgeons; American Board of Surgeons; Accreditation Council for Graduate Medical Education	American College of Surgeons; American Board of Surgeons; Accreditation Council for Graduate Medical Education	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bilimoria reports receipt of grants from the American College of Surgeons, the American Board of Surgeons, and the Accreditation Council for Graduate Medical Education and personal fees from the American College of Surgeons. No other disclosures were reported.	Gommers D, 2008, CRIT CARE, V12, DOI 10.1186/cc6150; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Norton JR, 2006, ANESTHESIOLOGY, V104, P1155, DOI 10.1097/00000542-200606000-00009; Panossian Lori, 2013, Continuum (Minneap Minn), V19, P86, DOI 10.1212/01.CON.0000427211.98305.c6; Pfizer, 2014, PRESCR INF AT LOR; Richa F, 2015, J CLIN ANESTH, V27, P698, DOI 10.1016/j.jclinane.2015.05.017	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					495	496		10.1001/jama.2017.22004	http://dx.doi.org/10.1001/jama.2017.22004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411034				2022-12-28	WOS:000424224500019
J	Ng, PY; Ng, AKY; Subramaniam, B; Burns, SM; Herisson, F; Timm, FP; Rudolph, MI; Scheffenbichler, F; Friedrich, S; Houle, TT; Bhatt, DL; Eikermann, M				Ng, Pauline Y.; Ng, Andrew K. -Y.; Subramaniam, Balachundhar; Burns, Sara M.; Herisson, Fanny; Timm, Fanny P.; Rudolph, Maira I.; Scheffenbichler, Flora; Friedrich, Sabine; Houle, Timothy T.; Bhatt, Deepak L.; Eikermann, Matthias			Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL THERAPY; RISK; CLOSURE; PREVALENCE; OUTCOMES; SURGERY	IMPORTANCE Perioperative stroke is a major complication for patients undergoing surgery. Patent foramen ovale (PFO) represents a possible anatomical link between venous thrombosis and stroke. OBJECTIVE To determine whether a preoperatively diagnosed PFO is associated with increased risk of perioperative ischemic stroke. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study from Massachusetts General Hospital and 2 affiliated community hospitals between January 1, 2007, and December 31, 2015. Participants were 182 393 consecutive adults undergoing noncardiac surgery with general anesthesia. EXPOSURES Preoperatively diagnosed PFO. MAIN OUTCOMES AND MEASURES Perioperative ischemic stroke occurring within 30 days of surgery; stroke subtype by Oxfordshire Community Stroke Project classification and stroke severity by National Institute of Health Stroke Scale (NIHSS). RESULTS Among the 150 198 patient cases analyzed (median [SD] age, 55 [16] years), 1540 (1.0%) had a diagnosis of PFO before surgery. A total of 850 (0.6%) ischemic strokes occurred within 30 days of surgery (49 [3.2%] among patients with PFO and 801 [0.5%] among patients without PFO). In adjusted analyses, patients with PFO had an increased risk of ischemic stroke compared with patients without PFO (odds ratio, 2.66 [95% CI, 1.96-3.63]; P < .001). The estimated risks of stroke were 5.9 for every 1000 patients with PFO and 2.2 for every 1000 patients without PFO (adjusted absolute risk difference, 0.4%[95% CI, 0.2%-0.6%). Patients with PFO also had an increased risk of large vessel territory stroke (relative risk ratio, 3.14 [95% CI, 2.21-4.48]; P < .001) and a more severe stroke-related neurologic deficit measured by NIHSS (median, 4 [interquartile range {IQR}, 2-10] vs median, 3 [IQR, 1-6] for those without PFO; P = .02). CONCLUSIONS AND RELEVANCE Among adult patients undergoing noncardiac surgery at 3 hospitals, having a preoperatively diagnosed PFO was significantly associated with increased risk of perioperative ischemic stroke within 30 days after surgery. Further research is needed to confirm these findings and to determine whether interventions would decrease this risk.	[Ng, Pauline Y.; Burns, Sara M.; Timm, Fanny P.; Rudolph, Maira I.; Scheffenbichler, Flora; Friedrich, Sabine; Houle, Timothy T.; Eikermann, Matthias] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 330 Brookline Ave, Boston, MA 02215 USA; [Ng, Pauline Y.] Queen Mary Hosp, Adult Intens Care Unit, Hong Kong, Hong Kong, Peoples R China; [Ng, Andrew K. -Y.; Bhatt, Deepak L.] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, 330 Brookline Ave, Boston, MA 02215 USA; [Ng, Andrew K. -Y.] Grantham Hosp, Cardiac Med Unit, Hong Kong, Hong Kong, Peoples R China; [Subramaniam, Balachundhar; Eikermann, Matthias] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, 330 Brookline Ave, Boston, MA 02215 USA; [Herisson, Fanny] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Neurovasc Res Lab, 330 Brookline Ave, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Hong Kong; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Eikermann, M (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.; Eikermann, M (corresponding author), Harvard Med Sch, 330 Brookline Ave, Boston, MA 02215 USA.	meikerma@bidmc.harvard.edu	Houle, Timothy T/CAF-5465-2022; Houle, Timothy T/I-7649-2019	Burns, Sara/0000-0001-6321-9075; Ng, Pauline Yeung/0000-0001-6671-5963; Ng, Andrew Kei-Yan/0000-0002-5553-016X; Rudolph, Maira I/0000-0003-2307-0864	Jeffrey and Judith Buzen	Jeffrey and Judith Buzen	This work was supported by an unrestricted grant from Jeffrey and Judith Buzen to Dr Eikermann.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Alsheikh-Ali AA, 2009, STROKE, V40, P2349, DOI 10.1161/STROKEAHA.109.547828; American Society of Anesthesiologists, ASA PHYS STAT CLASS; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COLLINS GJ, 1977, AM J SURG, V133, P612, DOI 10.1016/0002-9610(77)90022-8; Cundiff David Keith, 2008, Medscape J Med, V10, P258; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; DITULLIO M, 1992, ANN INTERN MED, V117, P461, DOI 10.7326/0003-4819-117-6-461; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Krasuski RA, 2009, JAMA-J AM MED ASSOC, V302, P290, DOI 10.1001/jama.2009.1012; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Mas JL, 2017, NEW ENGL J MED, V377, P1011, DOI 10.1056/NEJMoa1705915; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; Mashour GA, 2014, J NEUROSURG ANESTH, V26, P273, DOI 10.1097/ANA.0000000000000087; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Meissner I, 2006, J AM COLL CARDIOL, V47, P440, DOI 10.1016/j.jacc.2005.10.044; Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862; Mrkobrada M, 2016, BRIT J ANAESTH, V117, P191, DOI 10.1093/bja/aew179; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Perfetti DC, 2017, J ARTHROPLASTY, V32, P3152, DOI 10.1016/j.arth.2017.05.006; Royal College of Physicians, 2016, NAT CLIN GUID STROK; Saver JL, 2017, NEW ENGL J MED, V377, P1022, DOI 10.1056/NEJMoa1610057; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Sondergaard L, 2017, NEW ENGL J MED, V377, P1033, DOI 10.1056/NEJMoa1707404; Timm FP, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6635; Vaduganathan M, 2017, AM J MED; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6	31	47	49	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					452	462		10.1001/jama.2017.21899	http://dx.doi.org/10.1001/jama.2017.21899			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411032	Green Published, Bronze			2022-12-28	WOS:000424224500015
J	Vermandere, M; Aertgeerts, B; Agoritsas, T; Liu, C; Burgers, J; Merglen, A; Okwen, PM; Lytvyn, L; Chua, S; Vandvik, PO; Guyatt, GH; Beltran-Arroyave, C; Lavergne, V; Speeckaert, R; Steen, FE; Arteaga, V; Sender, R; McLeod, S; Sun, X; Wang, W; Siemieniuk, RAC				Vermandere, Mieke; Aertgeerts, Bert; Agoritsas, Thomas; Liu, Catherine; Burgers, Jako; Merglen, Arnaud; Okwen, Patrick Mbah; Lytvyn, Lyubov; Chua, Shunjie; Vandvik, Per O.; Guyatt, Gordon H.; Beltran-Arroyave, Claudia; Lavergne, Valery; Speeckaert, Reinhart; Steen, Finn E.; Arteaga, Victoria; Sender, Rachelle; McLeod, Shelley; Sun, Xin; Wang, Wen; Siemieniuk, Reed A. C.			Antibiotics after incision and drainage for uncomplicated skin abscesses: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; PLACEBO-CONTROLLED TRIAL; TRIMETHOPRIM-SULFAMETHOXAZOLE; DISEASES SOCIETY; DOUBLE-BLIND; CLINDAMYCIN; CEPHALEXIN; GRADE	What role do antibiotics have in the treatment of uncomplicated skin abscesses after incision and drainage? A recent study suggested that, for small uncomplicated skin abscesses, antibiotics after incision and drainageimprove the chance of short term cure compared with placebo. Triggered by this trial, the Rapid Recommendation team produced a new systematic review. Relying on this review and using the GRADE framework according to the BMJ Rapid Recommendation process, an expert panel makes a weak recommendation in favour of trimethoprimsulfamethoxazole (TMP-SMX, co-trimoxazole) or clindamycin in addition to incision and drainage over incision and drainage alone. For patients who have chosen to initiate antibiotics, the panel issues a strong recommendation for TMP-SMX or clindamycin rather than a cephalosporin and a weak recommendation for TMP-SMX rather than clindamycin. The box overleaf shows the articles and evidence linked to this Rapid Recommendation. The infographic presents the recommendations together with other pertinent information, including an overview of the absolute benefits and harms of candidate antibiotics in the standard GRADE format. The panel emphasises shared decision making in the choice of whether to initiate antibiotics and in which antibiotic to use, because the desirable and undesirable consequences are closely balanced: clinicians using MAGICapp (http://magicapp. org/goto/ guideline/ jlRvQn/ section/ ER5RAn) will find decision aids to support the discussion with patients. Table 2 below shows any evidence that has emerged since the publication of this article.	[Vermandere, Mieke; Aertgeerts, Bert] Katholieke Univ Leuven, Acad Ctr Gen Practice, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Aertgeerts, Bert] Cochrane Belgium, Belgian Ctr Evidence Based Med, CEBAM, Leuven, Belgium; [Agoritsas, Thomas; Guyatt, Gordon H.; Siemieniuk, Reed A. C.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, CH-1211 Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland; [Liu, Catherine] Univ Washington, Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98195 USA; [Liu, Catherine] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Burgers, Jako] Dutch Coll Gen Practitioners, Utrecht, Netherlands; [Burgers, Jako] Care & Publ Hlth Res Inst, Dept Family Med, Maastricht, Netherlands; [Merglen, Arnaud] Univ Geneva, Univ Hosp Geneva, Div Gen Pediat, Geneva, Switzerland; [Merglen, Arnaud] Univ Geneva, Fac Med, Geneva, Switzerland; [Okwen, Patrick Mbah] Bali Dist Hosp, Bali, Cameroon; [Okwen, Patrick Mbah] Ctr Dev Best Practices Hlth, Yaounde, Cameroon; [Lytvyn, Lyubov] Oslo Univ Hosp, N-0317 Oslo, Norway; [Chua, Shunjie] MOH Holdings, Singapore 099253, Singapore; [Vandvik, Per O.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Vandvik, Per O.] Norwegian Inst Publ Hlth, Oslo, Norway; [Beltran-Arroyave, Claudia] Univ Antioquia, Dept Paediat, Medellin, Colombia; [Lavergne, Valery] Univ Montreal, Sacre Coeur Hosp, Dept Med Microbiol & Infect Dis, Montreal, PQ, Canada; [Speeckaert, Reinhart] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium; [Steen, Finn E.] BI Norwegian Business Sch, Oslo, Norway; [Arteaga, Victoria] McMaster Univ, Dept Family Med, Med Sch, Hamilton, ON, Canada; [Sender, Rachelle] Univ Toronto, Sinai Hlth Syst, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [McLeod, Shelley] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [McLeod, Shelley] Sichuan Univ, West China Hosp, Chinese Evidence based Med Ctr, Chengdu 610041, Sichuan, Peoples R China; [Sun, Xin; Wang, Wen] Sichuan Univ, West China Hosp, CREAT Grp, Chengdu 610041, Sichuan, Peoples R China; [Siemieniuk, Reed A. C.] Univ Toronto, Dept Med, Toronto, ON, Canada	KU Leuven; McMaster University; University of Geneva; University of Geneva; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Maastricht University; Maastricht University Medical Centre (MUMC); University of Geneva; University of Geneva; University of Oslo; University of Oxford; Norwegian Institute of Public Health (NIPH); Universidad de Antioquia; Universite de Montreal; Ghent University; Ghent University Hospital; BI Norwegian Business School; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sichuan University; Sichuan University; University of Toronto	Siemieniuk, RAC (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada.; Siemieniuk, RAC (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	reed.siemieniuk@medportal.ca	Agoritsas, Thomas/F-4321-2014; McLeod, Shelley/AAE-9636-2019	Agoritsas, Thomas/0000-0002-6182-9969; McLeod, Shelley/0000-0003-2686-6307; Beltran-Arroyave, Claudia Patricia/0000-0002-5372-8172; Aertgeerts, Bert/0000-0003-1142-5402; Okwen, Patrick/0000-0002-9017-7496	Vanier Canada Graduate Scholarship	Vanier Canada Graduate Scholarship	This guideline was not funded. R Siemieniuk is partially funded through a Vanier Canada Graduate Scholarship.	Aertgeerts B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4090; Agoritsas T, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7624; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2016, NIVEL PRIM CAR DAT; Barbic D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013688; Bons S, 2017, NHG STANDAARD BACTER; Daum RS, 2017, NEW ENGL J MED, V376, P2545, DOI 10.1056/NEJMoa1607033; Duong M, 2010, ANN EMERG MED, V55, P401, DOI 10.1016/j.annemergmed.2009.03.014; Giordano PA, 2006, CURR MED RES OPIN, V22, P2419, DOI 10.1185/030079906X148355; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Karamatsu ML, 2012, PEDIATR EMERG CARE, V28, P131, DOI 10.1097/PEC.0b013e318243fa36; Keiichi F, 1982, CLIN EVAL, V10, P175; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; LLERA JL, 1985, ANN EMERG MED, V14, P15, DOI 10.1016/S0196-0644(85)80727-7; MACFIE J, 1977, BRIT J SURG, V64, P264, DOI 10.1002/bjs.1800640410; Macmorran E, 2017, EPIDEMIOL INFECT, V145, P2817, DOI [10.1017/S0950268817001716, 10.1017/s0950268817001716]; Miller LG, 2015, NEW ENGL J MED, V372, P1093, DOI 10.1056/NEJMoa1403789; Mistry RD, 2013, PEDIATR CLIN N AM, V60, P1063, DOI 10.1016/j.pcl.2013.06.011; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nurjadi D, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.08.021; Nurjadi D, 2014, J ANTIMICROB CHEMOTH, V69, P2361, DOI 10.1093/jac/dku174; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07; Ray GT, 2013, DIAGN MICR INFEC DIS, V76, P24, DOI 10.1016/j.diagmicrobio.2013.02.020; Salava A., 2017, EVIDENCE BASED MED G; Schmitz GR, 2010, ANN EMERG MED, V56, P283, DOI 10.1016/j.annemergmed.2010.03.002; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5191; Stein M, 2016, INT J INFECT DIS, V46, P18, DOI 10.1016/j.ijid.2016.02.016; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Truyers C, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-48; VANDVIK PO, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I5085; Wang W, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020991	33	23	24	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2018	360								k243	10.1136/bmj.k243	http://dx.doi.org/10.1136/bmj.k243			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HT	29437651	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000424975300002
J	Johannsson, H; Rook, W				Johannsson, Helgi; Rook, William			Avoiding blame and liability is vital to learning from errors and engineering a safer NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Johannsson, Helgi] Imperial Coll Healthcare NHS Trust, London, England; [Rook, William] Univ Hosp Leicester NHS Trust, Leicester, Leics, England	Imperial College London; University Hospitals of Leicester NHS Trust; University of Leicester	Johannsson, H (corresponding author), Imperial Coll Healthcare NHS Trust, London, England.	helgijoh@me.com		Rook, William/0000-0001-5834-4576	National Institute for Health Research [ACF-2016-11-009] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2018	360								k447	10.1136/bmj.k447	http://dx.doi.org/10.1136/bmj.k447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TQ	29386316				2022-12-28	WOS:000423845900007
J	Ndeh, D; Rogowski, A; Cartmell, A; Luis, AS; Basle, A; Gray, J; Venditto, I; Briggs, J; Zhang, XY; Labourel, A; Terrapon, N; Buffetto, F; Nepogodiev, S; Xiao, Y; Field, RA; Zhu, YP; O'Neill, MA; Urbanowicz, BR; York, WS; Davies, GJ; Abbott, DW; Ralet, MC; Martens, EC; Henrissat, B; Giilbert, HJ				Ndeh, Didier; Rogowski, Artur; Cartmell, Alan; Luis, Ana S.; Basle, Arnaud; Gray, Joseph; Venditto, Immacolata; Briggs, Jonathon; Zhang, Xiaoyang; Labourel, Aurore; Terrapon, Nicolas; Buffetto, Fanny; Nepogodiev, Sergey; Xiao, Yao; Field, Robert A.; Zhu, Yanping; O'Neill, Malcolm A.; Urbanowicz, Breeanna R.; York, William S.; Davies, Gideon J.; Abbott, D. Wade; Ralet, Marie-Christine; Martens, Eric C.; Henrissat, Bernard; Giilbert, Harry J.			Complex pectin metabolism by gut bacteria reveals novel catalytic functions (vol 544, pg 65, 2017)	NATURE			English	Correction													Terrapon, Nicolas/AAA-9033-2019; Henrissat, Bernard/J-2475-2012; Luis, Ana/ABE-5158-2020	Terrapon, Nicolas/0000-0002-3693-6017; Henrissat, Bernard/0000-0002-3434-8588; Luis, Ana/0000-0002-5086-7353; Abbott, Wade/0000-0003-4893-5799; Basle, Arnaud/0000-0002-4899-3086; , Breeanna/0000-0001-5247-4513				Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091	2	2	2	12	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669								10.1038/nature23659	http://dx.doi.org/10.1038/nature23659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	29411780	Bronze			2022-12-28	WOS:000408703100044
J	Casey, RM; Harris, JB; Ahuka-Mundeke, S; Dixon, MG; Kizito, GM; Nsele, PM; Umutesi, G; Laven, J; Kosoy, O; Paluku, G; Gueye, AS; Hyde, TB; Ewetola, R; Sheria, GKM; Muyembe-Tamfum, JJ; Staples, JE				Casey, Rebecca M.; Harris, Jennifer B.; Ahuka-Mundeke, Steve; Dixon, Meredith G.; Kizito, Gabriel M.; Nsele, Pierre M.; Umutesi, Grace; Laven, Janeen; Kosoy, Olga; Paluku, Gilson; Gueye, Abdou S.; Hyde, Terri B.; Ewetola, Raimi; Sheria, Guylain K. M.; Muyembe-Tamfum, Jean-Jacques; Staples, J. Erin			Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; DOUBLE-BLIND; RECOMMENDATIONS; ANTIBODIES; SAFETY	Background In 2016, the response to a yellow fever outbreak in Angola and the Democratic Republic of Congo led to a global shortage of yellow fever vaccine. As a result, a fractional dose of the 17DD yellow fever vaccine (containing one fifth [0.1 ml] of the standard dose) was offered to 7.6 million children 2 years of age or older and nonpregnant adults in a preemptive campaign in Kinshasa. The goal of this study was to assess the immune response to the fractional dose in a large-scale campaign. Methods We recruited participants in four age strata at six vaccination sites. We assessed neutralizing antibody titers against yellow fever virus in blood samples obtained before vaccination and at 1 month and 1 year after vaccination, using a plaque reduction neutralization test with a 50% cutoff (PRNT50). Participants with a PRNT50 titer of 10 or higher were considered to be seropositive. Those with a baseline titer of less than 10 who became seropositive at follow-up were classified as having undergone seroconversion. Participants who were seropositive at baseline and who had an increase in the titer by a factor of 4 or more at follow-up were classified as having an immune response. Results Among 716 participants who completed the 1-month follow-up, 705 (98%; 95% confidence interval [CI], 97 to 99) were seropositive after vaccination. Among 493 participants who were seronegative at baseline, 482 (98%; 95% CI, 96 to 99) underwent seroconversion. Among 223 participants who were seropositive at baseline, 148 (66%; 95% CI, 60 to 72) had an immune response. Lower baseline titers were associated with a higher probability of having an immune response (P<0.001). Among 684 participants who completed the 1-year follow-up, 666 (97%; 95% CI, 96 to 98) were seropositive for yellow fever antibody. The distribution of titers among the participants who were seronegative for yellow fever antibody at baseline varied significantly among age groups at 1 month and at 1 year (P<0.001 for both comparisons). Conclusions A fractional dose of the 17DD yellow fever vaccine was effective at inducing seroconversion in participants who were seronegative at baseline. Titers remained above the threshold for seropositivity at 1 year after vaccination in nearly all participants who were seropositive at 1 month after vaccination. These findings support the use of fractional-dose vaccination for outbreak control. (Funded by the U.S. Agency for International Development and the Centers for Disease Control and Prevention.) To counter a limited global supply of yellow fever vaccine, the use of a fractional dose of vaccine (one fifth of the standard dose) during an outbreak in the Democratic Republic of Congo resulted in immunogenicity consistent with expected protective titers at 1-month and 1-year follow-up.	[Casey, Rebecca M.; Harris, Jennifer B.; Dixon, Meredith G.; Umutesi, Grace; Paluku, Gilson; Hyde, Terri B.] Ctr Dis Control & Prevent, Global Immunizat Div, CDC, Atlanta, GA USA; [Casey, Rebecca M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, CDC, Atlanta, GA USA; [Ahuka-Mundeke, Steve; Kizito, Gabriel M.; Nsele, Pierre M.; Muyembe-Tamfum, Jean-Jacques] Minist Sante, Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Gueye, Abdou S.] Minist Sante, Div Global Hlth Protect, Kinshasa, DEM REP CONGO; [Ewetola, Raimi] Minist Sante, Div Global HIV & TB, Kinshasa, DEM REP CONGO; [Sheria, Guylain K. M.] Minist Sante, CDC, Kinshasa, DEM REP CONGO; [Sheria, Guylain K. M.] Minist Sante, Programme Elargi Vaccinat, Kinshasa, DEM REP CONGO; [Laven, Janeen; Kosoy, Olga; Staples, J. Erin] CDC, Div Vector Borne Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Institute Nacional de Recherche Biomedical; Centers for Disease Control & Prevention - USA	Casey, RM (corresponding author), Ctr Dis Control & Prevent, Global Immunizat Div, Epidem Intelligence Serv, 1600 Clifton Rd, Atlanta, GA 30329 USA.	rcasey@cdc.gov			U.S. Agency for International Development; Centers for Disease Control and Prevention	U.S. Agency for International Development(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the U.S. Agency for International Development and the Centers for Disease Control and Prevention.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P345; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P450; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269; [Anonymous], 2016, STRAT ADV GROUP EXP; [Anonymous], 2018, EP UPD YELL FEV; [Anonymous], 2017, IMM VACC BIOL DAT ST; Beaty B.J., 1995, DIAGNOSTIC PROCEDURE, P189; Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430; Breugelmans JG, 2013, VACCINE, V31, P1819, DOI 10.1016/j.vaccine.2013.01.054; Camacho LAB, 2004, REV SAUDE PUBL, V38, P671, DOI 10.1590/S0034-89102004000500009; Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391; Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1; Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; LOPES OD, 1988, J BIOL STAND, V16, P77; Martins RD, 2018, VACCINE, V36, P4112, DOI 10.1016/j.vaccine.2018.05.041; Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07; Nzolo D, 2018, VACCINE, V36, P6170, DOI 10.1016/j.vaccine.2018.08.052; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; Roukens AHE, 2012, CURR TOP MICROBIOL, V351, P159, DOI 10.1007/82_2011_124; Roukens AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027753; Roukens AHE, 2018, ANN INTERN MED, V169, P761, DOI 10.7326/M18-1529; Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647; Staples JE, 2018, PLOTKINS VACCINES, P1181; WHO, 2010, REC ASS QUAL SAF EFF; WHO, 2016, SIT REP ZIK VIR MICR; WHO, 2016, YELL FEV MASS VACC C; World Health Organization, 2016, FRACT DOS YELL FEV V	30	50	50	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2019	381	5					444	454		10.1056/NEJMoa1710430	http://dx.doi.org/10.1056/NEJMoa1710430			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IM5WH	29443626	Green Accepted, Bronze			2022-12-28	WOS:000478064200009
J	Yu, CQ; Tang, HJ; Guo, Y; Bian, Z; Yang, L; Chen, YP; Tang, AY; Zhou, X; Yang, X; Chen, JS; Chen, ZM; Lv, J; Li, LM				Yu, Canqing; Tang, Haijing; Guo, Yu; Bian, Zheng; Yang, Ling; Chen, Yiping; Tang, Aiyu; Zhou, Xue; Yang, Xu; Chen, Junshi; Chen, Zhengming; Lv, Jun; Li, Liming		China Kadoorie Biobank Collaborati	Hot Tea Consumption and Its Interactions With Alcohol and Tobacco Use on the Risk for Esophageal Cancer A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							GREEN TEA; COFFEE CONSUMPTION; METAANALYSIS; CHINA; TEMPERATURE; BEVERAGES; FOODS; MEN	Background: Although consumption of tea at high-temperatures has been suggested as a risk factor for esophageal cancer, an association has not been observed consistently, and whether any relationship is independent of alcohol and tobacco exposure has not been evaluated. Objective: To examine whether high-temperature tea drinking, along with the established risk factors of alcohol consumption and smoking, is associated with esophageal cancer risk. Design: China Kadoorie Biobank, a prospective cohort study established during 2004 to 2008. Setting: 10 areas across China. Participants: 456 155 persons aged 30 to 79 years. Those who had cancer at baseline or who reduced consumption of tea, alcohol, or tobacco before baseline were excluded. Measurements: The usual temperature at which tea was consumed, other tea consumption metrics, and lifestyle behaviors were self-reported once, at baseline. Outcome was esophageal cancer incidence up to 2015. Results: During a median follow-up of 9.2 years, 1731 incident esophageal cancer cases were documented. High-temperature tea drinking combined with either alcohol consumption or smoking was associated with a greater risk for esophageal cancer than hot tea drinking alone. Compared with participants who drank tea less than weekly and consumed fewer than 15 g of alcohol daily, those who drank burning-hot tea and 15 g or more of alcohol daily had the greatest risk for esophageal cancer (hazard ratio [HR], 5.00 [95% CI, 3.64 to 6.88]). Likewise, the HR for current smokers who drank burning-hot tea daily was 2.03 (CI, 1.55 to 2.67). Limitation: Tea consumption was self-reported once, at baseline, leading to potential nondifferential misclassification and attenuation of the association. Conclusion: Drinking tea at high temperatures is associated with an increased risk for esophageal cancer when combined with excessive alcohol or tobacco use.	[Yu, Canqing; Lv, Jun; Li, Liming] Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Tang, Haijing; Yang, Xu] Beijing Inst Technol, Sch Software, 5 South Zhongguancun St, Beijing 100081, Peoples R China; [Guo, Yu; Bian, Zheng] Chinese Acad Med Sci, Beijing 102300, Peoples R China; [Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, CTSU, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England; [Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England; [Tang, Aiyu] Suzhou Ctr Dis Control & Prevent, Suzhou 215006, Peoples R China; [Zhou, Xue] Heilongjiang Ctr Dis Control & Prevent, Harbin 150030, Heilongjiang, Peoples R China; [Chen, Junshi] China Natl Ctr Food Safety Risk Assessment, Beijing 100738, Peoples R China	Peking University; Beijing Institute of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; University of Oxford; University of Oxford	Lv, J; Li, LM (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	lvjun@bjmu.edu.cn; lmlee@vip.163.com	Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870	National Natural Science Foundation of China [81530088, 81390540, 81390544, 81390541]; National Key Research and Development Program of China [2016YFC0900500, 2016YFC0900501, 2016YFC0900504]; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust, United Kingdom [202922/Z/16/Z, 088158/Z/09/Z, 104085/Z/14/Z]; Chinese Ministry of Science and Technology [2011BAI09B01]; MRC [MC_UU_12026/2, MC_U137686851] Funding Source: UKRI; Medical Research Council [MC_UU_12026/2, MC_U137686851] Funding Source: researchfish; Wellcome Trust [212946/Z/18/Z] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust, United Kingdom(Wellcome Trust); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	By the National Natural Science Foundation of China (grants 81530088, 81390540, 81390544, and 81390541) and National Key Research and Development Program of China (grants 2016YFC0900500, 2016YFC0900501, and 2016YFC0900504). The CKB baseline survey and first resurvey were supported by a grant from the Kadoorie Charitable Foundation in Hong Kong. The long-term follow-up is supported by Wellcome Trust, United Kingdom (grants 202922/Z/16/Z, 088158/Z/09/Z, and 104085/Z/14/Z), and the Chinese Ministry of Science and Technology (grant 2011BAI09B01).	Andrici J, 2015, AM J PREV MED, V49, P952, DOI 10.1016/j.amepre.2015.07.023; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Boehm K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005004.pub2; Chen YW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1185-1; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Cleves M., 2010, INTRO SURVIVAL ANAL; DEJONG UW, 1972, GUT, V13, P24, DOI 10.1136/gut.13.1.24; Du HD, 2016, NEW ENGL J MED, V374, P1332, DOI 10.1056/NEJMoa1501451; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gupta B, 2017, EUR J CANCER PREV, V26, P107, DOI 10.1097/CEJ.0000000000000249; Ishikawa A, 2006, J EPIDEMIOL, V16, P185, DOI 10.2188/jea.16.185; Islami F, 2009, INT J CANCER, V125, P491, DOI 10.1002/ijc.24445; Kinjo Y, 1998, J Epidemiol, V8, P235; Liu Jianping, 2008, Chin Med, V3, P12, DOI 10.1186/1749-8546-3-12; Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X; Millwood IY, 2013, INT J EPIDEMIOL, V42, P816, DOI 10.1093/ije/dyt078; MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V; Organisation for Economic Co-operation and Development, 2017, TOB CONS GRAMS PER C; Ren JS, 2010, EUR J CANCER, V46, P1873, DOI 10.1016/j.ejca.2010.03.025; Sang LX, 2013, NUTR CANCER, V65, P802, DOI 10.1080/01635581.2013.805423; Sun CL, 2002, CARCINOGENESIS, V23, P1497, DOI 10.1093/carcin/23.9.1497; Wang Li Dong, 2002, Gan To Kagaku Ryoho, V29 Suppl 1, P159; World Cancer Research Fund International/American Institute for Cancer Research, 2016, CONT UPD PROJ REP DI; Yang CS, 2011, PHARMACOL RES, V64, P113, DOI 10.1016/j.phrs.2011.03.001; Yuan JM, 2011, PHARMACOL RES, V64, P123, DOI 10.1016/j.phrs.2011.03.002; Zamora-Ros R, 2014, INT J CANCER, V135, P1470, DOI 10.1002/ijc.28789; Zheng JS, 2013, NUTR CANCER, V65, P1, DOI 10.1080/01635581.2013.741762; Zheng P, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-165	28	59	66	6	49	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2018	168	7					489	+		10.7326/M17-2000	http://dx.doi.org/10.7326/M17-2000			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4AB	29404576	Green Accepted			2022-12-28	WOS:000429000900007
J	Ketteler, M; Block, GA; Evenepoel, P; Fukagawa, M; Herzog, CA; McCann, L; Moe, SM; Shroff, R; Tonelli, MA; Toussaint, ND; Vervloet, MG; Leonard, MB				Ketteler, Markus; Block, Geoffrey A.; Evenepoel, Pieter; Fukagawa, Masafumi; Herzog, Charles A.; McCann, Linda; Moe, Sharon M.; Shroff, Rukshana; Tonelli, Marcello A.; Toussaint, Nigel D.; Vervloet, Marc G.; Leonard, Mary B.			Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update	ANNALS OF INTERNAL MEDICINE			English	Article							HEMODIALYSIS-PATIENTS; PARATHYROID-HORMONE; SERUM PHOSPHATE; CARDIOVASCULAR-DISEASE; RENAL OSTEODYSTROPHY; CALCIUM-CARBONATE; PRACTICE PATTERNS; DIALYSIS PATIENTS; FRACTURE RISK; PHOSPHORUS	Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) is a selective update of the prior CKD-MBD guideline published in 2009. The guideline update and the original publication are intended to assist practitioners caring for adults with CKD and those receiving long-term dialysis. Methods: Development of the guideline update followed an explicit process of evidence review and appraisal. The approach adopted by the Work Group and the evidence review team was based on systematic reviews of relevant trials, appraisal of the quality of the evidence, and rating of the strength of recommendations according to the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Searches of the English-language literature were conducted through September 2015 and were supplemented with targeted searches through February 2017. Final modification of the guidelines was informed by a public review process involving numerous stake-holders, including patients, subject matter experts, and industry and national organizations. Recommendations: The update process resulted in the revision of 15 recommendations. This synopsis focuses primarily on recommendations for diagnosis of and testing for CKD-MBD and treatment of CKD-MBD that emphasizes decreasing phosphate levels, maintaining calcium levels, and addressing elevated parathyroid hormone levels in adults with CKD stage G3a to G5 and those receiving dialysis. Key elements include basing treatment on trends in laboratory values rather than a single abnormal result and being cautious to avoid hypercalcemia when treating secondary hyperparathyroidism.	[Ketteler, Markus] Klinikum Coburg GmbH, Div Nephrol, Ketschendorfer St 33, D-96450 Coburg, Germany; [Leonard, Mary B.] Stanford Univ, Sch Med, 300 Pasteur Dr,Room G-306, Stanford, CA 94305 USA; [Block, Geoffrey A.] Denver Nephrol, 130 Rampart Way,Suite 175, Denver, CO 80230 USA; [Evenepoel, Pieter] Univ Hosp Leuven, Herestr 49, B-3000 Leuven, Belgium; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, 143 Shimo Kasuya, Isehara, Kanagawa 2591193, Japan; [Herzog, Charles A.] Univ Minnesota, Hennepin Cty Med Ctr, 914 South 8th St,Suite S-4-100, Minneapolis, MN 55404 USA; [McCann, Linda] 1406 North Foresto Bello Way, Eagle, ID 83616 USA; [Moe, Sharon M.] Indiana Univ, 950 West Walnut St,R2-202, Indianapolis, IN 46202 USA; [Shroff, Rukshana] Great Ormond St Hosp Children NHS Fdn Trust, Great Ormond St, London WC1 3JH, England; [Tonelli, Marcello A.] Univ Calgary, TRW 7th Floor,3280 Hosp Dr Northwest, Calgary, AB T6G 2G3, Canada; [Toussaint, Nigel D.] Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; [Vervloet, Marc G.] Vrije Univ Amsterdam, Med Ctr, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands	Klinikum Coburg; Stanford University; KU Leuven; University Hospital Leuven; Tokai University; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Indiana University System; Indiana University-Purdue University Indianapolis; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Calgary; Royal Melbourne Hospital; University of Melbourne; Vrije Universiteit Amsterdam	Ketteler, M (corresponding author), Klinikum Coburg GmbH, Div Nephrol, Ketschendorfer St 33, D-96450 Coburg, Germany.; Leonard, MB (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr,Room G-306, Stanford, CA 94305 USA.	markus.ketteler@klinikum-coburg.de; leonard5@stanford.edu	Block, Geoffrey/AAV-8070-2021; Shroff, Rukshana C/C-7347-2008; P, Evenepoel/D-9597-2018; Shroff, Rukshana/AAG-5383-2019; Tonelli, Marcello/B-3028-2009	Block, Geoffrey/0000-0002-4646-7074; Shroff, Rukshana C/0000-0001-8501-1072; P, Evenepoel/0000-0002-2846-2026; Shroff, Rukshana/0000-0001-8501-1072; Tonelli, Marcello/0000-0002-0846-3187; Fukagawa, Masafumi/0000-0002-7832-2339; Vervloet, Marc/0000-0003-4607-9415	KDIGO	KDIGO	This guideline is supported by KDIGO, and no funding is accepted for the development of specific guidelines.	ANDERSON JJB, 2001, PRESENT KNOWLEDGE NU, P281; Benini O, 2011, J RENAL NUTR, V21, P303, DOI 10.1053/j.jrn.2010.06.021; Block GA, 2013, CLIN J AM SOC NEPHRO, V8, P2132, DOI 10.2215/CJN.04260413; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Calvo MS, 2000, NUTRITION, V16, P564, DOI 10.1016/S0899-9007(00)00313-0; Chartsrisak K, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-14; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chonchol M, 2009, AM J KIDNEY DIS, V53, P197, DOI 10.1053/j.ajkd.2008.09.021; Coen G, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-10; Connolly GM, 2009, TRANSPLANTATION, V87, P1040, DOI 10.1097/TP.0b013e31819cd122; Di Iorio B, 2013, AM J KIDNEY DIS, V62, P771, DOI 10.1053/j.ajkd.2013.03.023; Eddington H, 2010, CLIN J AM SOC NEPHRO, V5, P2251, DOI 10.2215/CJN.00810110; Evenepoel P, 2017, NEPHROL DIAL TRANSPL, V32, P1608, DOI 10.1093/ndt/gfw468; Evenepoel P, 2016, KIDNEY INT, V90, P1184, DOI 10.1016/j.kint.2016.06.041; Fein Paul A, 2013, Adv Perit Dial, V29, P61; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Fouque D, 2013, NEPHROL DIAL TRANSPL, V28, P360, DOI 10.1093/ndt/gfs404; Fukagawa M, 2014, AM J KIDNEY DIS, V63, P979, DOI 10.1053/j.ajkd.2013.08.011; Gallieni M, 2012, BONE, V51, P332, DOI 10.1016/j.bone.2012.06.002; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Haghverdi F, 2014, IRAN J KIDNEY DIS, V8, P461; Hill KM, 2013, KIDNEY INT, V83, P959, DOI 10.1038/ki.2012.403; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Jamal SA, 2011, J BONE MINER RES, V26, P1829, DOI 10.1002/jbmr.403; Ketteler M, 2017, KIDNEY INT SUPPL S1, V7, P1, DOI [10.1016/j.kisu.2017.04.001, DOI 10.1016/J.KISU.2017.04.001]; Ketteler M, 2015, KIDNEY INT, V87, P502, DOI 10.1038/ki.2014.425; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lacson E, 2009, AM J KIDNEY DIS, V53, P79, DOI 10.1053/j.ajkd.2008.07.031; Li XH, 2015, NEPHROLOGY, V20, P706, DOI 10.1111/nep.12505; lorio B Di, 2012, CLIN J AM SOC NEPHRO, V7, P487, DOI [DOI 10.2215/CJN.03820411, 10.2215/CJN.03820411]; Markaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052350; McGovern AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074996; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Moe SM, 2015, CIRCULATION, V132, P27, DOI 10.1161/CIRCULATIONAHA.114.013876; Moe SM, 2011, CLIN J AM SOC NEPHRO, V6, P257, DOI 10.2215/CJN.05040610; Moore J, 2011, CLIN TRANSPLANT, V25, P406, DOI 10.1111/j.1399-0012.2010.01292.x; Nakai S, 2008, THER APHER DIAL, V12, P49, DOI 10.1111/j.1744-9987.2007.00540.x; Nakano C, 2012, CLIN J AM SOC NEPHRO, V7, P810, DOI 10.2215/CJN.08680811; Naylor KL, 2015, CLIN J AM SOC NEPHRO, V10, P646, DOI 10.2215/CJN.06040614; Ok E, 2016, J AM SOC NEPHROL, V27, P2475, DOI 10.1681/ASN.2015030268; Peter WLS, 2009, CLIN J AM SOC NEPHRO, V4, P354, DOI 10.2215/CJN.05241008; Raggi P, 2004, J HEART VALVE DIS, V13, P134; Sherman RA, 2015, THER INNOV REGUL SCI, V49, P886, DOI 10.1177/2168479015592194; Sherman RA, 2009, CLIN J AM SOC NEPHRO, V4, P1370, DOI 10.2215/CJN.02830409; Spasovski G, 2007, BONE, V41, P698, DOI 10.1016/j.bone.2007.06.014; Spiegel DM, 2012, KIDNEY INT, V81, P1116, DOI 10.1038/ki.2011.490; Sprague SM, 2016, AM J KIDNEY DIS, V67, P559, DOI 10.1053/j.ajkd.2015.06.023; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Toussaint ND, 2010, AM J KIDNEY DIS, V56, P57, DOI 10.1053/j.ajkd.2009.12.039; Viaene L, 2012, AM J NEPHROL, V35, P242, DOI 10.1159/000336308; Wang AYM, 2014, J AM SOC NEPHROL, V25, P175, DOI 10.1681/ASN.2013010103; West SL, 2015, J BONE MINER RES, V30, P913, DOI 10.1002/jbmr.2406; Xu LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076657; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211	55	157	170	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					422	+		10.7326/M17-2640	http://dx.doi.org/10.7326/M17-2640			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29459980	Green Accepted			2022-12-28	WOS:000427827400017
J	Papi, A; Vestbo, J; Fabbri, L; Corradi, M; Prunier, H; Cohuet, G; Guasconi, A; Montagna, I; Vezzoli, S; Petruzzelli, S; Scuri, M; Roche, N; Singh, D				Papi, Alberto; Vestbo, Jorgen; Fabbri, Leonardo; Corradi, Massimo; Prunier, Helene; Cohuet, Geraldine; Guasconi, Alessandro; Montagna, Isabella; Vezzoli, Stefano; Petruzzelli, Stefano; Scuri, Mario; Roche, Nicolas; Singh, Dave			Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial	LANCET			English	Article							REAL-LIFE; COPD; EXACERBATIONS; GLYCOPYRRONIUM; FLUTICASONE; IMPACT	Background Evidence is scarce on the relative risk-benefit of inhaled triple therapy, consisting of inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta(2)-agonist, versus dual bronchodilation for chronic obstructive pulmonary disease (COPD). We aimed to compare a single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) versus a single-inhaler dual bronchodilator combination of indacaterol plus glycopyrronium (IND/GLY) in terms of the rate of moderate-to-severe COPD exacerbations over 52 weeks of treatment. Methods This randomised, parallel-group, double-blind, double-dummy study was done at 187 sites across 17 countries. Eligible patients had symptomatic COPD, severe or very severe airflow limitation, at least one moderate or severe exacerbation in the previous year, and were receiving inhaled maintenance medication. After a 2 week run-in period with one inhalation per day of IND/GLY (85 mu g/43 mu g), patients were randomly assigned (1:1), via an interactive response technology system, to receive 52 weeks of treatment with two inhalations of extrafine BDP/FF/G (87 mu g/5 mu g/9 mu g) twice per day or one inhalation of IND/GLY (85 mu g/43 mu g) per day. Randomisation was stratified by country and severity of airflow limitation. The primary endpoint was the rate of moderate-to-severe COPD exacerbations across 52 weeks of treatment in all randomised patients who received at least one dose of study drug and had at least one post-baseline efficacy assessment. Safety was assessed in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, number NCT02579850. Findings Between May, 29 2015, and July 10, 2017, 1532 patients received BDP/FF/G (n=764) or IND/GLY (n=768). Moderate-to-severe exacerbation rates were 0.50 per patient per year (95% CI 0.45-0.57) for BDP/FF/G and 0.59 per patient per year (0.53-0.67) for IND/GLY, giving a rate ratio of 0.848 (0.723-0.995, p=0.043) in favour of BDP/FF/G. Adverse events were reported by 490 (64%) of 764 patients receiving BDP/FF/G and 516 (67%) of 768 patients receiving IND/GLY. Pneumonia occurred in 28 (4%) patients receiving BDP/FF/G versus 27 (4%) patients receiving IND/GLY. One treatment-related serious adverse event occurred in each group: dysuria in a patient receiving BDP/FF/G and atrial fibrillation in a patient receiving IND/GLY. Interpretation In patients with symptomatic COPD, severe or very severe airflow limitation, and an exacerbation history despite maintenance therapy, extrafine BDP/FF/G significantly reduced the rate of moderate-to-severe exacerbations compared with IND/GLY, without increasing the risk of pneumonia.	[Papi, Alberto] Univ Ferrara, Res Ctr Asthma & COPD, I-44121 Ferrara, Italy; [Vestbo, Jorgen; Singh, Dave] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Vestbo, Jorgen; Singh, Dave] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester, Lancs, England; [Fabbri, Leonardo] Univ Ferrara, Dept Med, Ferrara, Italy; [Fabbri, Leonardo] Sahlgrens Univ Hosp, COPD Ctr, Gothenburg, Sweden; [Corradi, Massimo] Univ Parma, Dept Med & Surg, Parma, Italy; [Prunier, Helene; Cohuet, Geraldine; Guasconi, Alessandro; Montagna, Isabella; Vezzoli, Stefano; Petruzzelli, Stefano; Scuri, Mario] Chiesi Farmaceut SpA, Global Clin Dev, Parma, Italy; [Roche, Nicolas] Univ Paris 05, Hop Cochin, AP HP, EA2511,Serv Pneumol & Soins Intensifs Resp, Paris, France; [Singh, Dave] Med Evaluat Unit, Manchester, Lancs, England	University of Ferrara; University of Manchester; University of Manchester; University of Ferrara; Sahlgrenska University Hospital; University of Parma; Chiesi Pharmaceuticals Inc; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Papi, A (corresponding author), Univ Ferrara, Res Ctr Asthma & COPD, I-44121 Ferrara, Italy.	ppa@unife.it	Roche, Nicolas/AAE-9206-2021; Roche, Nicolas/AAP-4445-2021; Vestbo, Jorgen/Y-2912-2019; Papi, alberto/AAC-1888-2019; Singh, Dave/AAH-4342-2020; Fabbri, Leonardo/I-4055-2012	Singh, Dave/0000-0001-8918-7075; Vestbo, Jorgen/0000-0001-6355-6362; Fabbri, Leonardo/0000-0001-8894-1689	Chiesi Farmaceutici	Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc)	Chiesi Farmaceutici.	Cazzola M, 2015, DRUGS, V75, P1575, DOI 10.1007/s40265-015-0450-6; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; EMA, 2015, EMACHMPSAWP178465201; European Medicines Agency (EMA), 2012, EMACHMP4835722012; Gershon A, 2013, JAMA INTERN MED, V173, P1175, DOI 10.1001/jamainternmed.2013.1016; Global Initiative for Chronic Obstructive Lung Disease, GLOBAL STRATEGY DIAG; Han MK, 2017, LANCET RESP MED, V5, P619, DOI 10.1016/S2213-2600(17)30207-2; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jones PW, 2014, AM J RESP CRIT CARE, V189, P250, DOI 10.1164/rccm.201310-1863PP; Kardos P, 2017, RESP MED, V124, P57, DOI 10.1016/j.rmed.2017.02.007; Leidy NK, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0124-z; Melani AS, 2011, RESP MED, V105, P930, DOI 10.1016/j.rmed.2011.01.005; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Pascoe SJ, 2016, EUR RESPIR J, V48, P320, DOI 10.1183/13993003.02165-2015; Rabe KF, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02165-2017; Rennard S, 2013, COPD, V10, P393, DOI 10.3109/15412555.2013.795423; Roche N, 2017, AM J RESP CRIT CARE, V195, P1189, DOI 10.1164/rccm.201701-0193OC; Singh D, 2016, LANCET, V388, P963, DOI 10.1016/S0140-6736(16)31354-X; Suissa S, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02245-2016; Vestbo J, 2017, LANCET, V389, P1919, DOI 10.1016/S0140-6736(17)30188-5; Vestbo J, 2014, RESP MED, V108, P729, DOI 10.1016/j.rmed.2014.03.002; Wang MT, 2018, JAMA INTERN MED, V178, P229, DOI 10.1001/jamainternmed.2017.7720; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Wedzicha JA, 2013, LANCET RESP MED, V1, P199, DOI 10.1016/S2213-2600(13)70052-3; Worth H, 2017, RESP MED, V131, P77, DOI 10.1016/j.rmed.2017.08.008	25	62	71	2	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1076	1084		10.1016/S0140-6736(18)30206-X	http://dx.doi.org/10.1016/S0140-6736(18)30206-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ4TP	29429593	Green Submitted			2022-12-28	WOS:000427585100026
J	Barriga, EH; Franze, K; Charras, G; Mayor, R				Barriga, Elias H.; Franze, Kristian; Charras, Guillaume; Mayor, Roberto			Tissue stiffening coordinates morphogenesis by triggering collective cell migration in vivo	NATURE			English	Article							NEURAL CREST; MESENCHYMAL TRANSITION; MECHANICAL-PROPERTIES; ORGANIZATION; CHEMOTAXIS; FIBRONECTIN; ACTOMYOSIN; BEHAVIOR; TENSION; EMBRYO	Collective cell migration is essential for morphogenesis, tissue remodelling and cancer invasion(1,2). In vivo, groups of cells move in an orchestrated way through tissues. This movement involves mechanical as well as molecular interactions between cells and their environment. While the role of molecular signals in collective cell migration is comparatively well understood(1,2), how tissue mechanics influence collective cell migration in vivo remains unknown. Here we investigated the importance of mechanical cues in the collective migration of the Xenopus laevis neural crest cells, an embryonic cell population whose migratory behaviour has been likened to cancer invasion(3). We found that, during morphogenesis, the head mesoderm underlying the cephalic neural crest stiffens. This stiffening initiates an epithelial-to-mesenchymal transition in neural crest cells and triggers their collective migration. To detect changes in their mechanical environment, neural crest cells use mechanosensation mediated by the integrin-vinculin-talin complex. By performing mechanical and molecular manipulations, we show that mesoderm stiffening is necessary and sufficient to trigger neural crest migration. Finally, we demonstrate that convergent extension of the mesoderm, which starts during gastrulation, leads to increased mesoderm stiffness by increasing the cell density underneath the neural crest. These results show that convergent extension of the mesoderm has a role as a mechanical coordinator of morphogenesis, and reveal a link between two apparently unconnected processes-gastrulation and neural crest migration-via changes in tissue mechanics. Overall, we demonstrate that changes in substrate stiffness can trigger collective cell migration by promoting epithelial-to-mesenchymal transition in vivo. More broadly, our results raise the idea that tissue mechanics combines with molecular effectors to coordinate morphogenesis(4).	[Barriga, Elias H.; Charras, Guillaume; Mayor, Roberto] UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England; [Barriga, Elias H.; Charras, Guillaume] UCL, London Ctr Nanotechnol, Gower St, London WC1H 0AH, England; [Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England	University of London; University College London; University of London; University College London; University of Cambridge	Mayor, R (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	r.mayor@ucl.ac.uk		Barriga, Elias H/0000-0003-2912-3613; Franze, Kristian/0000-0002-8425-7297	Medical Research Council [J000655, G1100312/1]; Biotechnology and Biological Sciences Research Council [M008517]; Wellcome Trust; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R21HD080585]; European Research Council [647186]; EMBO [LTF-971]; Marie Sklodowska Curie (IF ST VivoMechCollMigra) [658536]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080585] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/R00627X/1] Funding Source: researchfish; Medical Research Council [G1100312] Funding Source: researchfish; BBSRC [BB/R00627X/1] Funding Source: UKRI; MRC [G1100312] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; European Research Council(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Marie Sklodowska Curie (IF ST VivoMechCollMigra); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A.J. Thompson for assistance with the AFM. This study was supported by grants to R.M. from the Medical Research Council (J000655), Biotechnology and Biological Sciences Research Council (M008517) and Wellcome Trust; to K.F. from the Medical Research Council (Career Development Award G1100312/1) and from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (R21HD080585); to G.C. from the European Research Council (Consolidator grant MolCellTissMech, agreement 647186); and by postdoctoral fellowships to E.H.B. from EMBO (LTF-971) and Marie Sklodowska Curie (IF-2014 ST VivoMechCollMigra, agreement 658536). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfandari D, 2003, DEV BIOL, V260, P449, DOI 10.1016/S0012-1606(03)00277-X; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Barriga EH, 2013, J CELL BIOL, V201, P759, DOI 10.1083/jcb.201212100; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Bjerke MA, 2014, DEV BIOL, V394, P340, DOI 10.1016/j.ydbio.2014.07.023; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Chevalier NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20927; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Gilmour D, 2017, NATURE, V541, P311, DOI 10.1038/nature21348; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Koser DE, 2015, BIOPHYS J, V108, P2137, DOI 10.1016/j.bpj.2015.03.039; Mayor R, 2016, NAT REV MOL CELL BIO, V17, P97, DOI 10.1038/nrm.2015.14; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Nieuwkoop P. D., 1967, NORMAL TABLE OFXENOP; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Poh YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5000; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Roca-Cusachs P, 2013, CURR OPIN CELL BIOL, V25, P543, DOI 10.1016/j.ceb.2013.04.010; SEUFERT DW, 1994, ANAT EMBRYOL, V189, P81; Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126; Shyer AE, 2017, SCIENCE, V357, P811, DOI 10.1126/science.aai7868; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Sunyer R, 2016, SCIENCE, V353, P1157, DOI 10.1126/science.aaf7119; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Wrighton PJ, 2015, CELL STEM CELL, V16, P453, DOI 10.1016/j.stem.2015.04.018; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211	30	224	226	4	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					523	+		10.1038/nature25742	http://dx.doi.org/10.1038/nature25742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29443958	Green Accepted, Green Submitted			2022-12-28	WOS:000425597400046
J	Tauriello, DVF; Palomo-Ponce, S; Stork, D; Berenguer-Llergo, A; Badia-Ramentol, J; Iglesias, M; Sevillano, M; Ibiza, S; Canellas, A; Momblona, XH; Byrom, D; Matarin, JA; Calon, A; Rivas, EI; Nebreda, AR; Riera, A; Attolini, CSO; Batlle, E				Tauriello, Daniele V. F.; Palomo-Ponce, Sergio; Stork, Diana; Berenguer-Llergo, Antonio; Badia-Ramentol, Jordi; Iglesias, Mar; Sevillano, Marta; Ibiza, Sales; Canellas, Adria; Hernando Momblona, Xavier; Byrom, Daniel; Matarin, Joan A.; Calon, Alexandre; Rivas, Elisa I.; Nebreda, Angel R.; Riera, Antoni; Stephan-Otto Attolini, Camille; Batlle, Eduard			TGF beta drives immune evasion in genetically reconstituted colon cancer metastasis	NATURE			English	Article							GROWTH-FACTOR; COLORECTAL-CANCER; STEM-CELLS; MICE; GENE; EXPRESSION; LEADS; TRANSPLANTATION; PROGRESSION; DISRUPTION	Most patients with colorectal cancer die as a result of the disease spreading to other organs. However, no prevalent mutations have been associated with metastatic colorectal cancers(1,2). Instead, particular features of the tumour microenvironment, such as lack of T-cell infiltration(3), low type 1 T-helper cell (T(H)1) activity and reduced immune cytotoxicity(2) or increased TGF beta levels(4) predict adverse outcomes in patients with colorectal cancer. Here we analyse the interplay between genetic alterations and the tumour microenvironment by crossing mice bearing conditional alleles of four main colorectal cancer mutations in intestinal stem cells. Quadruple-mutant mice developed metastatic intestinal tumours that display key hallmarks of human microsatellite-stable colorectal cancers, including low mutational burden(5), T-cell exclusion(3) and TGF beta-activated stroma(4,6,7). Inhibition of the PD-1-PD-L1 immune checkpoint provoked a limited response in this model system. By contrast, inhibition of TGF beta unleashed a potent and enduring cytotoxic T-cell response against tumour cells that prevented metastasis. In mice with progressive liver metastatic disease, blockade of TGF beta signalling rendered tumours susceptible to anti-PD-1-PD-L1 therapy. Our data show that increased TGF beta in the tumour microenvironment represents a primary mechanism of immune evasion that promotes T-cell exclusion and blocks acquisition of the THI-effector phenotype. Immunotherapies directed against TGF beta signalling may therefore have broad applications in treating patients with advanced colorectal cancer.	[Tauriello, Daniele V. F.; Palomo-Ponce, Sergio; Stork, Diana; Berenguer-Llergo, Antonio; Badia-Ramentol, Jordi; Sevillano, Marta; Ibiza, Sales; Canellas, Adria; Hernando Momblona, Xavier; Byrom, Daniel; Matarin, Joan A.; Calon, Alexandre; Rivas, Elisa I.; Nebreda, Angel R.; Riera, Antoni; Stephan-Otto Attolini, Camille; Batlle, Eduard] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri & Reixac 10, Barcelona 08028, Spain; [Tauriello, Daniele V. F.; Palomo-Ponce, Sergio; Iglesias, Mar; Sevillano, Marta; Hernando Momblona, Xavier; Batlle, Eduard] Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain; [Iglesias, Mar] Hosp del Mar, Dept Pathol, Barcelona 08003, Spain; [Iglesias, Mar; Calon, Alexandre; Rivas, Elisa I.] Hosp del Mar, Res Inst IMIM, Canc Res Programme, Barcelona 08003, Spain; [Iglesias, Mar] Autonomous Univ Barcelona UAB, Barcelona, Spain; [Nebreda, Angel R.; Batlle, Eduard] Passeig Lluis Co 23, ICREA, Barcelona 08010, Spain; [Riera, Antoni] Univ Barcelona, Dept Organ Chem, Marti & Franques 1-11, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; ICREA; University of Barcelona	Batlle, E (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri & Reixac 10, Barcelona 08028, Spain.; Batlle, E (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain.; Batlle, E (corresponding author), Passeig Lluis Co 23, ICREA, Barcelona 08010, Spain.	eduard.batlle@irbbarcelona.org	Nebreda, Angel Rodriguez/R-9594-2019; Tauriello, Daniele/H-4644-2018; Calon, Alexandre/GPK-2061-2022; Hernando-Momblona, Xavier/ABH-4881-2020; Batlle, Eduard/K-8080-2014; Palomo-Ponce, Sergio/L-2749-2017; Riera, Antoni/C-4385-2008	Tauriello, Daniele/0000-0003-1522-3496; Batlle, Eduard/0000-0003-2422-0326; Berenguer-LLergo, Antoni/0000-0002-3742-8161; Palomo-Ponce, Sergio/0000-0002-3371-6457; Stephan-Otto Attolini, Camille/0000-0001-8045-320X; SEVILLANO, MARTA/0000-0001-5761-0879; Canellas-Socias, Adria/0000-0002-8373-7803; Riera, Antoni/0000-0001-7142-7675; Hernando-Momblona, Xavier/0000-0003-0755-333X	MINECO; Doctor Josef Steiner Foundation; ERC advanced grant [340176]; Instituto de Salud Carlos III; Olga Torres Foundation; BBVA Foundation [SAF-2014-53784]; Fundacion Botin; Severo Ochoa Award of Excellence from MINECO	MINECO(Spanish Government); Doctor Josef Steiner Foundation; ERC advanced grant(European Research Council (ERC)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Olga Torres Foundation; BBVA Foundation(BBVA Foundation); Fundacion Botin; Severo Ochoa Award of Excellence from MINECO(Spanish Government)	We thank E. Sancho for critical reading of this manuscript, all members of the Batlle laboratory for support and discussions, and members of the Lopez-Bigas laboratory for help with revising the manuscript. We are grateful for the assistance of the IRB Barcelona core facilities for histopathology, functional genomics, mouse mutant and advanced digital microscopy; the flow cytometry and animal facilities of the UB/PCB; and the CRG genomic unit. D.V.FT. held a Juan de la Cierva postdoctoral fellowship from MINECO. This work was supported by grants from the Doctor Josef Steiner Foundation, ERC advanced grant 340176, Instituto de Salud Carlos III, Olga Torres Foundation, BBVA Foundation, grant SAF-2014-53784 (MINECO) and by Fundacion Botin. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cancer Genome Atlas N., 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Melo FDE, 2017, NATURE, V543, P676, DOI 10.1038/nature21713; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Fumagalli A, 2017, P NATL ACAD SCI USA, V114, pE2357, DOI 10.1073/pnas.1701219114; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gelman A., 2009, J STAT SOFTW, V30, P1; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Marino S, 2000, GENE DEV, V14, P994; Mehal WZ, 2005, INT IMMUNOL, V17, P531, DOI 10.1093/intimm/dxh233; Mlecnik B, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6352; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; O'Rourke KP, 2017, NAT BIOTECHNOL, V35, P577, DOI 10.1038/nbt.3837; R Development Core Team, 2009, R LANG ENV STAT COMP; Rodon J, 2015, CLIN CANCER RES, V21, P553, DOI 10.1158/1078-0432.CCR-14-1380; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; WARREN RS, 1995, J CLIN INVEST, V95, P1789, DOI 10.1172/JCI117857; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	43	944	960	13	406	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					538	+		10.1038/nature25492	http://dx.doi.org/10.1038/nature25492			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29443964	Green Accepted			2022-12-28	WOS:000425597400049
J	Poggio, ED; Reese, PP				Poggio, Emilio D.; Reese, Peter P.			The Quest to Define Individual Risk After Living Kidney Donation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DONORS		[Poggio, Emilio D.] Cleveland Clin, 9500 Euclid Ave,Desk Q7, Cleveland, OH 44195 USA; [Reese, Peter P.] Univ Penn, Philadelphia, PA 19104 USA; [Reese, Peter P.] Univ Penn, Ctr Clin Epidemiol & Biostat, 917 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Reese, PP (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, 917 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	peter.reese@uphs.upenn.edu						Grams ME, 2016, NEW ENGL J MED, V374, P411, DOI 10.1056/NEJMoa1510491; Kasiske BL, 2015, AM J KIDNEY DIS, V66, P114, DOI 10.1053/j.ajkd.2015.01.019; Lentine KL, 2017, TRANSPLANTATION, V101, pS7, DOI 10.1097/TP.0000000000001769; Massie AB, 2017, J AM SOC NEPHROL, V28, P2749, DOI 10.1681/ASN.2016101084; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; O'Keeffe LM, 2018, ANN INTERN MED, V168, P276, DOI [10.7326/M17-1235, 10.7326/L18-0341]; Organ Procurement and Transplantation Network, 2017, POL LIV DON; Organ Procurement and Transplantation Network, 2017, NAT DAT; Potluri V, 2015, J AM SOC NEPHROL, V26, P1188, DOI 10.1681/ASN.2014030302; Taler SJ, 2013, AM J TRANSPLANT, V13, P390, DOI 10.1111/j.1600-6143.2012.04321.x	10	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					296	+		10.7326/M17-3249	http://dx.doi.org/10.7326/M17-3249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29379960				2022-12-28	WOS:000425434000022
J	Kasahara, S; Miyoshi, Y; Yokota, S; Mitani, T; Kasahara, Y; Matsuda, S; Kumamoto, A; Matsuoka, A; Kazama, Y; Frey, HU; Ngelopoulos, VA; Kurita, S; Keika, K; Seki, K; Shinohara, I				Kasahara, S.; Miyoshi, Y.; Yokota, S.; Mitani, T.; Kasahara, Y.; Matsuda, S.; Kumamoto, A.; Matsuoka, A.; Kazama, Y.; Frey, H. U. .; Ngelopoulos, V. A.; Kurita, S.; Keika, K.; Seki, K.; Shinohara, I.			Pulsating aurora from electron scattering by chorus waves	NATURE			English	Article							MAGNETOSPHERE; ENERGY; STORMS	Auroral substorms, dynamic phenomena that occur in the upper atmosphere at night, are caused by global reconfiguration of the magnetosphere, which releases stored solar wind energy(1,2). These storms are characterized by auroral brightening from dusk to midnight, followed by violent motions of distinct auroral arcs that suddenly break up, and the subsequent emergence of diffuse, pulsating auroral patches at dawn(1,3). Pulsating aurorae, which are quasiperiodic, blinking patches of light tens to hundreds of kilometres across, appear at altitudes of about 100 kilometres in the high-latitude regions of both hemispheres, and multiple patches often cover the entire sky. This auroral pulsation, with periods of several to tens of seconds, is generated by the intermittent precipitation of energetic electrons (several to tens of kiloelectronvolts) arriving from the magnetosphere and colliding with the atoms and molecules of the upper atmosphere(4-7). A possible cause of this precipitation is the interaction between magnetospheric electrons and electromagnetic waves called whistler-mode chorus waves(8-11). However, no direct observational evidence of this interaction has been obtained so far(12). Here we report that energetic electrons are scattered by chorus waves, resulting in their precipitation. Our observations were made in March 2017 with a magnetospheric spacecraft equipped with a high-angular-resolution electron sensor and electromagnetic field instruments. The measured(13,14) quasiperiodic precipitating electron flux was sufficiently intense to generate a pulsating aurora, which was indeed simultaneously observed by a ground auroral imager.	[Kasahara, S.; Keika, K.; Seki, K.] Univ Tokyo, Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan; [Miyoshi, Y.; Matsuda, S.; Kurita, S.] Nagoya Univ, Inst Space Earth Environm Res, Chikusa Ku, Furo Cho, Nagoya, Aichi 24105, Japan; [Yokota, S.] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka, Japan; [Mitani, T.; Matsuoka, A.; Shinohara, I.] Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa, Japan; [Kasahara, Y.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kakuma Machi, Kanazawa, Ishikawa, Japan; [Kumamoto, A.] Tohoku Univ, Grad Sch Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Kazama, Y.] Acad Sinica, Inst Astron & Astrophys, AS NTU, 11F Astron Math Bldg,1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Frey, H. U. .] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Ngelopoulos, V. A.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90009 USA	University of Tokyo; Nagoya University; Osaka University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Kanazawa University; Tohoku University; Academia Sinica - Taiwan; University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Kasahara, S (corresponding author), Univ Tokyo, Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	s.kasahara@eps.s.u-tokyo.ac.jp	Mitani, Takefumi/GQH-5847-2022; Miyoshi, Yoshizumi/T-5748-2019; Kasahara, Satoshi/T-4592-2019; KASAHARA, Yoshiya/E-7073-2015; Miyoshi, Yoshizumi/B-5834-2015	Miyoshi, Yoshizumi/0000-0001-7998-1240; Kasahara, Satoshi/0000-0002-3479-772X; KASAHARA, Yoshiya/0000-0002-9304-8235; Miyoshi, Yoshizumi/0000-0001-7998-1240; Mitani, Takefumi/0000-0003-0492-3104; Seki, Kanako/0000-0001-5557-9062; yokota, shoichiro/0000-0001-8851-9146; Angelopoulos, Vassilis/0000-0001-7024-1561; Kumamoto, Atsushi/0000-0002-3988-1488; Keika, Kunihiro/0000-0003-0265-4318	JSPS [15H05747, 15H05815, 16H06286, 16H04056, 16H01172]; National Science Foundation (NSF) of the USA [AGS-1004736]; JSPS Kakenhi [17H06140]; NASA [NAS5-02099]; NSF [AGS-1004736]; Grants-in-Aid for Scientific Research [16H01172] Funding Source: KAKEN; Directorate For Geosciences [1004736] Funding Source: National Science Foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation (NSF) of the USA(National Science Foundation (NSF)); JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The observations presented here were obtained with the help of Mitsubishi Heavy Industries, Ltd, Meisei Electric Co., Ltd, Hamamatsu Photonics Co. Ltd, YS DESIGN Co., Ltd, NIPPI Co. Ltd, Sumitomo Heavy Industries, Ltd and TIERRA TECNICA Co. Ltd. We acknowledge the work of the members of the ERG project team over several years. Y.M. is supported by JSPS Kakenhi (15H05747, 15H05815 and 16H06286). Y. Kasahara is supported by JSPS Kakenhi (16H04056 and 16H01172). H.U.F. is supported by grant AGS-1004736 from the National Science Foundation (NSF) of the USA. I.S. is supported by JSPS Kakenhi (17H06140). We thank NASA for contract NAS5-02099, S. Mende and E. Donovan for use of the ASI data, the Canadian Space Agency for logistical support in fielding and data retrieval from the ground-based observatory stations, and the NSF for support of the Ground-based Imager and Magnetometer Network for Auroral Studies programme through grant AGS-1004736. The ERG (Arase) satellite science data is available from the ERG Science Centre operated by the Institute of Space and Astronautical Science of the Japan Aerospace eXploration Agency and the Institute for Space-Earth Environmental Research of Nagoya University (https://ergsc.isee.nagoya-u.ac.jp/index.shtml.en). We are grateful to J. Hohl for assistance in editing the manuscript. We also thank N. Umemura for assistance in source data archiving. S. Kasahara thanks T. Mukai and M. Fujimoto for discussions.	AKASOFU SI, 1968, POLAR MAGNETOSPHERIC, P22; Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; DUTHIE DD, 1977, J ATMOS TERR PHYS, V39, P1429, DOI 10.1016/0021-9169(77)90099-X; Horne RB, 1998, GEOPHYS RES LETT, V25, P3011, DOI 10.1029/98GL01002; Jaynes AN, 2013, J GEOPHYS RES-SPACE, V118, P4884, DOI 10.1002/jgra.50434; JOHNSTONE AD, 1978, NATURE, V274, P119, DOI 10.1038/274119a0; Kasahara S, 2012, NUCL INSTRUM METH A, V664, P282, DOI 10.1016/j.nima.2011.11.033; Kasahara S, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2405358; Katoh Y, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016183; KENNEL CF, 1966, J GEOPHYS RES, V71, P1, DOI 10.1029/JZ071i001p00001; Lessard MR, 2012, GEOPHYS MONOGR SER, V197, P55, DOI 10.1029/2011GM001187; MCEWEN DJ, 1981, CAN J PHYS, V59, P1029, DOI 10.1139/p81-135; Mende SB, 2008, SPACE SCI REV, V141, P357, DOI 10.1007/s11214-008-9380-x; Menietti JD, 2013, J GEOPHYS RES-SPACE, V118, P5592, DOI 10.1002/jgra.50529; Miyoshi Y, 2017, J PHYS CONF SER, V869, DOI 10.1088/1742-6596/869/1/012095; Miyoshi Y, 2015, J GEOPHYS RES-SPACE, V120, P7728, DOI 10.1002/2015JA021562; Miyoshi Y, 2012, GEOPHYS MONOGR SER, V199, P103, DOI 10.1029/2012GM001304; Mozer FS, 2017, J GEOPHYS RES-SPACE, V122, P8604, DOI 10.1002/2017JA024223; Ni BB, 2016, SPACE SCI REV, V200, P205, DOI 10.1007/s11214-016-0234-7; Nishimura Y, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016876; Nishimura Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048281; Nishimura Y, 2010, SCIENCE, V330, P81, DOI 10.1126/science.1193186; Sheeley BW, 2001, J GEOPHYS RES-SPACE, V106, P25631, DOI 10.1029/2000JA000286; Thorne RM, 2010, NATURE, V467, P943, DOI 10.1038/nature09467; Trakhtengerts V. Yu., 1986, Geomagnetism and Aeronomy, V26, P77; Tsyganenko NA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010798; Yahnin AG, 1997, ANN GEOPHYS-ATM HYDR, V15, P943, DOI 10.1007/s00585-997-0943-z	27	114	114	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					337	+		10.1038/nature25505	http://dx.doi.org/10.1038/nature25505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29446380				2022-12-28	WOS:000424996300033
J	Chiara, CJ; Carroll, JJ; Carpenter, MP; Greene, JP; Hartley, DJ; Janssens, RVF; Lane, GJ; Marsh, JC; Matters, DA; Polasik, M; Rzadkiewicz, J; Seweryniak, D; Zhu, S; Bottoni, S; Hayes, AB; Karamian, SA				Chiara, C. J.; Carroll, J. J.; Carpenter, M. P.; Greene, J. P.; Hartley, D. J.; Janssens, R. V. F.; Lane, G. J.; Marsh, J. C.; Matters, D. A.; Polasik, M.; Rzadkiewicz, J.; Seweryniak, D.; Zhu, S.; Bottoni, S.; Hayes, A. B.; Karamian, S. A.			Isomer depletion as experimental evidence of nuclear excitation by electron capture	NATURE			English	Article							COINCIDENCE DATA SETS; DATA SHEETS; GAMMASPHERE; CONVERSION; MO-93; NEEC	The atomic nucleus and its electrons are often thought of as independent systems that are held together in the atom by their mutual attraction. Their interaction, however, leads to other important effects, such as providing an additional decay mode for excited nuclear states, whereby the nucleus releases energy by ejecting an atomic electron instead of by emitting a gamma-ray. This 'internal conversion' has been known for about a hundred years and can be used to study nuclei and their interaction with their electrons(1-3). In the inverse process-nuclear excitation by electron capture ( NEEC)-a free electron is captured into an atomic vacancy and can excite the nucleus to a higher-energy state, provided that the kinetic energy of the free electron plus the magnitude of its binding energy once captured matches the nuclear energy difference between the two states. NEEC was predicted(4) in 1976 and has not hitherto been observed(5,6). Here we report evidence of NEEC in molybdenum-93 and determine the probability and cross-section for the process in a beam-based experimental scenario. Our results provide a standard for the assessment of theoretical models relevant to NEEC, which predict cross-sections that span many orders of magnitude. The greatest practical effect of the NEEC process may be on the survival of nuclei in stellar environments(7), in which it could excite isomers (that is, long-lived nuclear states) to shorter-lived states. Such excitations may reduce the abundance of the isotope after its production. This is an example of 'isomer depletion', which has been investigated previously through other reactions(8-12), but is used here to obtain evidence for NEEC.	[Chiara, C. J.; Marsh, J. C.] US Army, Oak Ridge Associated Univ Fellowship Program, Res Lab, Adelphi, MD 20783 USA; [Carroll, J. J.] US Army, Res Lab, Adelphi, MD 20783 USA; [Carpenter, M. P.; Greene, J. P.; Janssens, R. V. F.; Seweryniak, D.; Zhu, S.; Bottoni, S.] Argonne Natl Lab, Div Phys, 9700 S Cass Ave, Argonne, IL 60439 USA; [Hartley, D. J.] US Naval Acad, Dept Phys, Annapolis, MD 21402 USA; [Lane, G. J.] Australian Natl Univ, Dept Nucl Phys, Res Sch Phys & Engn, Canberra, ACT 0200, Australia; [Matters, D. A.] Def Threat Reduct Agcy, Ft Belvoir, VA 22060 USA; [Polasik, M.] Nicolaus Copernicus Univ Torun, Fac Chem, PL-87100 Torun, Poland; [Rzadkiewicz, J.] Natl Ctr Nucl Res, PL-05400 Otwock, Poland; [Hayes, A. B.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Karamian, S. A.] Joint Inst Nucl Res, Flerov Lab Nucl React, Dubna 141980, Russia; [Janssens, R. V. F.] Univ North Carolina Chapel Hill, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Janssens, R. V. F.] Duke Univ, Triangle Univ Nucl Lab, Durham, NC 27708 USA; [Marsh, J. C.] Frontier Technol Inc, Space & Naval Warfare Syst Command Syst Ctr Pacif, 49599 Lassing Rd, San Diego, CA 92152 USA; [Bottoni, S.] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy; [Bottoni, S.] INFN Sez Milano, I-20133 Milan, Italy	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Defense; United States Navy; United States Naval Academy; Australian National University; United States Department of Defense; Defense Threat Reduction Agency; Nicolaus Copernicus University; National Centre for Nuclear Research; University of Rochester; Joint Institute for Nuclear Research - Russia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill; Duke University; University of Milan; Istituto Nazionale di Fisica Nucleare (INFN)	Chiara, CJ (corresponding author), US Army, Oak Ridge Associated Univ Fellowship Program, Res Lab, Adelphi, MD 20783 USA.	christopher.j.chiara2.ctr@mail.mil	Rzadkiewicz, Jacek/AAF-9022-2019; Lane, Gregory J/A-7570-2011; Greene, John/AFJ-9796-2022; Carpenter, Michael Patten/E-4287-2015; SEWERYNIAK, DARIUSZ/AAO-6611-2021; Polasik, Marek/U-9969-2018	Rzadkiewicz, Jacek/0000-0003-4933-3829; Lane, Gregory J/0000-0003-2244-182X; Greene, John/0000-0002-2095-1394; Carpenter, Michael Patten/0000-0002-3237-5734; Polasik, Marek/0000-0002-8228-6262; Hayes, Adam/0000-0003-3739-5141; Bottoni, Simone/0000-0003-2249-4825	US Army Research Laboratory (ARL) Director's Research Initiative [DRI-FY14-SE-022]; ARL [W911NF-12-2-0019, W911NF-16-2-0034]; US Department of Energy (DOE), Office of Science, Office of Nuclear Physics [DE-AC02-06CH11357]; National Science Foundation [PHY-1203100]; Australian Research Council [FT100100991]; Polish National Science Centre [2011/01/D/ST2/01286, 2017/25/B/ST2/00901]; Ecopulse, Inc. under ARL [W911QX09D0016-0004]	US Army Research Laboratory (ARL) Director's Research Initiative; ARL(United States Department of DefenseUS Army Research Laboratory (ARL)); US Department of Energy (DOE), Office of Science, Office of Nuclear Physics(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Polish National Science Centre; Ecopulse, Inc. under ARL	C.J.C. and J.J.C. thank A.D. Ayangeakaa for input on the potential contributions of Coulomb excitations to the background and M. S. Litz and N. R. Pereira for discussions. We also thank J. Rohrer for assistance in setting up the Gammasphere experiment and the ATLAS operations staff for their efforts. This work was initiated under the US Army Research Laboratory (ARL) Director's Research Initiative, award number DRI-FY14-SE-022. Further support was provided by ARL Cooperative Agreements W911NF-12-2-0019 and W911NF-16-2-0034, the US Department of Energy (DOE), Office of Science, Office of Nuclear Physics under contract number DE-AC02-06CH11357, the National Science Foundation under grant number PHY-1203100, the Australian Research Council under grant number FT100100991, and the Polish National Science Centre under grants 2011/01/D/ST2/01286 and 2017/25/B/ST2/00901. M.P., J.R. and A.B.H. received support through Ecopulse, Inc. under ARL contract number W911QX09D0016-0004. This research used resources of Argonne National Laboratory's ATLAS facility, which is a DOE Office of Science User Facility, and of the HIAF at ANU.	Anderson JT, 2012, IEEE NUCL SCI CONF R, P1536; Baglin CM, 2012, NUCL DATA SHEETS, V113, P2187, DOI 10.1016/j.nds.2012.10.001; Baglin CM, 2011, NUCL DATA SHEETS, V112, P1163, DOI 10.1016/j.nds.2011.04.001; Belic D, 1999, PHYS REV LETT, V83, P5242, DOI 10.1103/PhysRevLett.83.5242; Blatt J. M., 1952, THEORETICAL NUCLEAR, P614; Carroll JJ, 2013, AIP CONF PROC, V1525, P586, DOI 10.1063/1.4802396; Cline D, 2012, GOSIA USER MANUAL SI; FIRESTONE RB, 1996, TABLE ISOTOPES, V2; Fukuchi T, 2005, EUR PHYS J A, V24, P249, DOI 10.1140/epja/i2004-10145-2; GOLDANSKII VI, 1976, PHYS LETT B, V62, P393, DOI 10.1016/0370-2693(76)90665-1; Gosselin G, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.064603; Gunst J, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4935294; Gunst J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.082501; Hamilton J. H., 1966, INTERNAL CONVERSION, P1; Hasegawa M, 2011, PHYS LETT B, V696, P197, DOI 10.1016/j.physletb.2010.10.065; Hayes A. B., 2017, RACHEL GRAPHICAL INT; Karamian SA, 2012, PHYS ATOM NUCL+, V75, P1362, DOI 10.1134/S1063778812110117; Karamian SA, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.024604; Kibedi T, 2008, NUCL INSTRUM METH A, V589, P202, DOI 10.1016/j.nima.2008.02.051; KIMBALL JC, 1991, PHYS LETT A, V152, P367, DOI 10.1016/0375-9601(91)90740-Y; LEE IY, 1990, NUCL PHYS A, V520, pC641, DOI 10.1016/0375-9474(90)91181-P; McCutchan EA, 2009, NUCL INSTRUM METH A, V607, P564, DOI 10.1016/j.nima.2009.06.008; Morel P, 2005, AIP CONF PROC, V769, P1085, DOI 10.1063/1.1945195; Palffy A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.172502; Palffy A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.012709; Polasik M, 2017, PHYS REV C, V95, DOI 10.1103/PhysRevC.95.034312; RADFORD DC, 1995, NUCL INSTRUM METH A, V361, P297, DOI 10.1016/0168-9002(95)00183-2; RADFORD DC, 1995, NUCL INSTRUM METH A, V361, P306, DOI 10.1016/0168-9002(95)00184-0; Roig O, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.064617; Schiwietz G, 2001, NUCL INSTRUM METH B, V175, P125, DOI 10.1016/S0168-583X(00)00583-8; Sethi J, 2016, J PHYS G NUCL PARTIC, V43, DOI 10.1088/0954-3899/43/1/015103; Stefanescu I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.122701; Tarasov OB, 2003, NUCL INSTRUM METH B, V204, P174, DOI 10.1016/S0168-583X(02)01917-1; THOMPSON IJ, 1988, COMPUT PHYS REP, V7, P167, DOI 10.1016/0167-7977(88)90005-6; Wu Y., 2017, TAILORING LASER GENE; YUAN ZS, 1993, PHYS REV C, V47, P323, DOI 10.1103/PhysRevC.47.323	36	34	35	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					216	+		10.1038/nature25483	http://dx.doi.org/10.1038/nature25483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420479	Green Submitted			2022-12-28	WOS:000424332600034
J	Song, JW; Chen, CJ; Zhu, SZ; Zhu, MW; Dai, JQ; Ray, U; Li, YJ; Kuang, YD; Li, YF; Quispe, N; Yao, YG; Gong, A; Leiste, UH; Bruck, HA; Zhu, JY; Vellore, A; Li, H; Minus, ML; Jia, Z; Martini, A; Li, T; Hu, LB				Song, Jianwei; Chen, Chaoji; Zhu, Shuze; Zhu, Mingwei; Dai, Jiaqi; Ray, Upamanyu; Li, Yiju; Kuang, Yudi; Li, Yongfeng; Quispe, Nelson; Yao, Yonggang; Gong, Amy; Leiste, Ulrich H.; Bruck, Hugh A.; Zhu, J. Y.; Vellore, Azhar; Li, Heng; Minus, Marilyn L.; Jia, Zheng; Martini, Ashlie; Li, Teng; Hu, Liangbing			Processing bulk natural wood into a high-performance structural material	NATURE			English	Article							MECHANICAL-PROPERTIES; SET-RECOVERY; DENSIFICATION; TOUGHNESS; DUCTILITY; STRENGTH; NANOCOMPOSITES; ULTRASTRONG; STEEL	Synthetic structural materials with exceptional mechanical performance suffer from either large weight and adverse environmental impact (for example, steels and alloys) or complex manufacturing processes and thus high cost (for example, polymer-based and biomimetic composites)(1-8). Natural wood is a low-cost and abundant material and has been used for millennia as a structural material for building and furniture construction(9). However, the mechanical performance of natural wood (its strength and toughness) is unsatisfactory for many advanced engineering structures and applications. Pre-treatment with steam, heat, ammonia or cold rolling(10-21) followed by densification has led to the enhanced mechanical performance of natural wood. However, the existing methods result in incomplete densification and lack dimensional stability, particularly in response to humid environments(14), and wood treated in these ways can expand and weaken. Here we report a simple and effective strategy to transform bulk natural wood directly into a high-performance structural material with a more than tenfold increase in strength, toughness and ballistic resistance and with greater dimensional stability. Our two-step process involves the partial removal of lignin and hemicellulose from the natural wood via a boiling process in an aqueous mixture of NaOH and Na2SO3 followed by hot-pressing, leading to the total collapse of cell walls and the complete densification of the natural wood with highly aligned cellulose nanofibres. This strategy is shown to be universally effective for various species of wood. Our processed wood has a specific strength higher than that of most structural metals and alloys, making it a low-cost, high-performance, lightweight alternative.	[Song, Jianwei; Chen, Chaoji; Zhu, Mingwei; Dai, Jiaqi; Li, Yiju; Kuang, Yudi; Li, Yongfeng; Yao, Yonggang; Gong, Amy; Hu, Liangbing] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA; [Zhu, Shuze; Ray, Upamanyu; Quispe, Nelson; Bruck, Hugh A.; Jia, Zheng; Li, Teng] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Leiste, Ulrich H.] Univ Maryland, Dept Aerosp Engn, College Pk, MD 20742 USA; [Zhu, J. Y.] US Forest Serv, Forest Prod Lab, USDA, Madison, WI 53726 USA; [Vellore, Azhar; Martini, Ashlie] Univ Calif Merced, Dept Mech Engn, Merced, CA 95343 USA; [Li, Heng; Minus, Marilyn L.] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Merced; Northeastern University	Hu, LB (corresponding author), Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA.; Li, T (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	lit@umd.edu; binghu@umd.edu	Jia, Zheng/H-4894-2013; Li, Heng/A-7023-2017; Ray, Upamanyu/ABH-6032-2020; Bruck, Hugh Alan/I-1154-2018; Chen, Chaoji/G-7577-2017; Jia, Zheng/ADH-7787-2022; Li, Yiju/B-2283-2017; Hu, Liangbing/N-6660-2013; Li, Teng/B-1585-2008; Kuang, Yudi/AAL-3534-2020; Yao, Yonggang/D-2821-2012	Jia, Zheng/0000-0001-8459-515X; Li, Heng/0000-0001-5960-5352; Bruck, Hugh Alan/0000-0002-0845-765X; Chen, Chaoji/0000-0001-9553-554X; Li, Teng/0000-0001-6252-561X; Kuang, Yudi/0000-0002-7072-0797; Yao, Yonggang/0000-0002-9191-2982; Li, Yiju/0000-0001-9240-5686; Ray, Upamanyu/0000-0002-5290-7486; Hu, Liangbing/0000-0002-9456-9315	Maryland NanoCenter; AIMLab; China Scholarship Council	Maryland NanoCenter; AIMLab; China Scholarship Council(China Scholarship Council)	We thank R. Briber for suggestions and R. J. Bonenberger for help with mechanical tests. We acknowledge the support of the Maryland NanoCenter and its AIMLab. J.S. acknowledges financial support from the China Scholarship Council.	Bekhta P, 2009, MATER DESIGN, V30, P947, DOI 10.1016/j.matdes.2008.07.001; Dursun T, 2014, MATER DESIGN, V56, P862, DOI 10.1016/j.matdes.2013.12.002; Erickson E, 1965, MECH PROPERTIES LAMI; Fang CH, 2012, EUR J WOOD WOOD PROD, V70, P155, DOI 10.1007/s00107-011-0524-4; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Frommeyer G, 2006, STEEL RES INT, V77, P627, DOI 10.1002/srin.200606440; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gil FJ, 2003, MAT SCI ENG A-STRUCT, V349, P150, DOI 10.1016/S0921-5093(02)00784-0; Gong M, 2010, J MATER PROCESS TECH, V210, P293, DOI 10.1016/j.jmatprotec.2009.09.013; Hill CAS, 2012, J MATER SCI, V47, P3191, DOI 10.1007/s10853-011-6154-8; Hon D. N. S., 2000, WOOD CELLULOSIC CHEM, P523, DOI DOI 10.1021/JA015237P; Kim KH, 2009, CARBON, V47, P1126, DOI 10.1016/j.carbon.2008.12.043; Kim SH, 2015, NATURE, V518, P77, DOI 10.1038/nature14144; Ku H, 2011, COMPOS PART B-ENG, V42, P856, DOI 10.1016/j.compositesb.2011.01.010; Kultikova EV., 1999, STRUCTURE PROPERTIES; Kutnar A, 2012, WOOD SCI TECHNOL, V46, P73, DOI 10.1007/s00226-010-0380-0; Laine K, 2016, WOOD SCI TECHNOL, V50, P883, DOI 10.1007/s00226-016-0835-z; Laine K, 2013, J MATER SCI, V48, P8530, DOI 10.1007/s10853-013-7671-4; Li YJ, 2009, EUR POLYM J, V45, P738, DOI 10.1016/j.eurpolymj.2008.12.010; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Militzer M, 2002, SCIENCE, V298, P975, DOI 10.1126/science.1078210; Navi P, 2004, MRS BULL, V29, P332, DOI 10.1557/mrs2004.100; O'Connor J.P., 2007, THESIS; Paril P, 2014, EUR J WOOD WOOD PROD, V72, P583, DOI 10.1007/s00107-014-0814-8; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]; Wang JF, 2012, CHEM SOC REV, V41, P1111, DOI 10.1039/c1cs15106a; Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133; Zhu HL, 2015, P NATL ACAD SCI USA, V112, P8971, DOI 10.1073/pnas.1502870112; Zhu YT, 2004, NAT MATER, V3, P351, DOI 10.1038/nmat1141	30	606	634	194	2469	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					224	+		10.1038/nature25476	http://dx.doi.org/10.1038/nature25476			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420466				2022-12-28	WOS:000424332600036
J	Bystritsky, R; Chambers, H				Bystritsky, Rachel; Chambers, Henry			Cellulitis and Soft Tissue Infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; LABORATORY RISK INDICATOR; STAPHYLOCOCCUS-AUREUS; NECROTIZING FASCIITIS; SKIN; ERADICATION; MANAGEMENT; DIAGNOSIS; CHILDREN; WOUNDS		[Bystritsky, Rachel; Chambers, Henry] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bystritsky, R (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.				American College of Physicians	American College of Physicians	American College of Physicians.	Al-Niaimi F, 2009, J LYMPHOEDEMA, V4, P38; Alsaawi A, 2017, EUR J EMERG MED, V24, P162, DOI 10.1097/MEJ.0000000000000340; Anaya DA, 2007, CLIN INFECT DIS, V44, P705, DOI 10.1086/511638; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Bjorndottir S, 2005, CLIN INFECT DIS, V41, P1416, DOI 10.1086/497127; Bruun T, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv181; Burner E, 2016, WEST J EMERG MED, V17, P333, DOI 10.5811/westjem.2016.2.29069; Crisp JG, 2015, CLIN INFECT DIS, V61, P1679, DOI 10.1093/cid/civ655; DIRE DJ, 1995, ACAD EMERG MED, V2, P4, DOI 10.1111/j.1553-2712.1995.tb03070.x; Ellis MW, 2014, CLIN INFECT DIS, V58, P1540, DOI 10.1093/cid/ciu166; Fritz SA, 2012, CLIN INFECT DIS, V54, P743, DOI 10.1093/cid/cir919; Jaindl M, 2016, WIEN KLIN WOCHENSCHR, V128, P367, DOI 10.1007/s00508-015-0900-x; Koning S, 2008, BRIT J DERMATOL, V158, P1077, DOI 10.1111/j.1365-2133.2008.08485.x; Martinez M, 2017, WORLD J SURG; Miller LG, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1071-0; Murphy G, 2013, J PLAST RECONSTR AES, V66, P1712, DOI [10.1016/j.bjps.2013.07.008, 10.1016/j.bjps.013.07.008]; Oh CC, 2014, J INFECTION, V69, P26, DOI 10.1016/j.jinf.2014.02.011; Paschos NK, 2014, INJURY, V45, P237, DOI 10.1016/j.injury.2013.07.010; Quirke M, 2017, BRIT J DERMATOL, V177, P382, DOI 10.1111/bjd.15186; Robicsek A, 2009, INFECT CONT HOSP EP, V30, P623, DOI 10.1086/597550; Schweizer M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2743; Simor AE, 2007, CLIN INFECT DIS, V44, P178, DOI 10.1086/510392; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Thomas KS, 2013, NEW ENGL J MED, V368, P1695, DOI 10.1056/NEJMoa1206300; Torres J, 2017, AM J EMERG MED, V35, P1159, DOI 10.1016/j.ajem.2017.05.039; Weng QY, 2016, JAMA DERMATOL; Wong CH, 2004, CRIT CARE MED, V32, P1535, DOI 10.1097/01.CCM.0000129486.35458.7D	28	18	21	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					ITC17	ITC31		10.7326/AITC201802060	http://dx.doi.org/10.7326/AITC201802060			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29404597				2022-12-28	WOS:000424224300001
J	Normile, D				Normile, Dennis			PHYSICS Accelerator boom hones China's engineering expertise	SCIENCE			English	News Item																			0	0	1	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					507	508		10.1126/science.359.6375.507	http://dx.doi.org/10.1126/science.359.6375.507			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420272				2022-12-28	WOS:000423795800017
J	Smajs, D; Pospisilova, P				Smajs, David; Pospisilova, Petra			Macrolide resistance in yaws	LANCET			English	Editorial Material							TREPONEMA-PALLIDUM STRAINS; RIBOSOMAL-RNA GENE; IDENTIFIED GENOTYPES; PREVALENCE; SYPHILIS		[Smajs, David; Pospisilova, Petra] Masaryk Univ, Fac Med, Dept Biol, CZ-62500 Brno, Czech Republic	Masaryk University Brno	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, CZ-62500 Brno, Czech Republic.	dsmajs@med.muni.cz	Pospisilova, Petra/L-8212-2018					Chen CY, 2013, J CLIN MICROBIOL, V51, P908, DOI 10.1128/JCM.02770-12; Flasarova M, 2012, ACTA DERM-VENEREOL, V92, P669, DOI 10.2340/00015555-1335; Vaulet LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172905; Grillova L, 2014, J CLIN MICROBIOL, V52, P3693, DOI 10.1128/JCM.01292-14; Grimes M, 2012, SEX TRANSM DIS, V39, P954, DOI 10.1097/OLQ.0b013e31826ae7a8; Li Z, 2013, J CLIN MICROBIOL, V51, P4270, DOI 10.1128/JCM.01261-13; Matejkova P, 2009, J MED MICROBIOL, V58, P832, DOI 10.1099/jmm.0.007542-0; Mitja O, 2018, LANCET, V391, P1599, DOI 10.1016/S0140-6736(18)30204-6; Samajs D, 2015, AM J TROP MED HYG, V93, P678, DOI 10.4269/ajtmh.15-0316; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Tipple C, 2011, SEX TRANSM INFECT, V87, P486, DOI 10.1136/sextrans-2011-050082	11	4	4	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1555	1556		10.1016/S0140-6736(18)30205-8	http://dx.doi.org/10.1016/S0140-6736(18)30205-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD5JG	29428184				2022-12-28	WOS:000430542700006
J	Reig, M; Bruix, J				Reig, Maria; Bruix, Jordi			Lenvatinib: can a non-inferiority trial change clinical practice?	LANCET			English	Editorial Material							HEPATOCELLULAR-CARCINOMA; PHASE-III; DOUBLE-BLIND; SORAFENIB; EVENTS		[Reig, Maria; Bruix, Jordi] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer, BCLC Grp,Liver Unit,CIBERehd, E-08036 Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Reig, M (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer, BCLC Grp,Liver Unit,CIBERehd, E-08036 Barcelona, Spain.	mreig1@clinic.ub.es	Reig, Maria/ABB-5414-2021	Reig, Maria/0000-0002-5711-9534; Bruix, Jordi/0000-0002-9826-0753				Branco F, 2017, ANN HEPATOL, V16, P263, DOI 10.5604/16652681.1231585; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kudo M, 2018, LANCET; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030; Rimola J, 2018, HEPATOLOGY, V67, P612, DOI 10.1002/hep.29515; Zhu AX, 2015, J CLIN ONCOL, V33, P559, DOI 10.1200/JCO.2013.53.7746	12	13	13	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1123	1124		10.1016/S0140-6736(18)30208-3	http://dx.doi.org/10.1016/S0140-6736(18)30208-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GA2MF	29433849				2022-12-28	WOS:000428156100006
J	Kingsbury, SR; Tharmanathan, P; Keding, A; Ronaldson, SJ; Grainger, A; Wakefield, RJ; Arundel, C; Birrell, F; Doherty, M; Vincent, T; Watt, FE; Dziedzic, K; O'Neill, TW; Arden, NK; Scott, DL; Dickson, J; Garrood, T; Green, M; Menon, A; Sheeran, T; Torgerson, D; Conaghan, PG				Kingsbury, Sarah R.; Tharmanathan, Puvan; Keding, Ada; Ronaldson, Sarah J.; Grainger, Andrew; Wakefield, Richard J.; Arundel, Catherine; Birrell, Fraser; Doherty, Michael; Vincent, Tonia; Watt, Fiona E.; Dziedzic, Krysia; O'Neill, Terence W.; Arden, Nigel K.; Scott, David L.; Dickson, John; Garrood, Toby; Green, Michael; Menon, Ajit; Sheeran, Tom; Torgerson, David; Conaghan, Philip G.			Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							INFLAMMATORY ULTRASOUND FEATURES; BONE-MARROW LESIONS; TOLL-LIKE RECEPTORS; CLINICAL IMPORTANCE; STRUCTURAL DAMAGE; SYNOVIAL TISSUE; UNITED-STATES; OLDER-ADULTS; FOLLOW-UP; PREVALENCE	Background: Synovitis is believed to play a role in producing symptoms in persons with hand osteoarthritis, but data on slow-acting anti-inflammatory treatments are sparse. Objective: To determine the effectiveness of hydroxychloro-quine versus placebo as an analgesic treatment of hand osteoarthritis. Design: Randomized, double-blind, placebo-controlled clinical trial with 12-month follow-up. (ISRCTN registry number: ISRCTN91859104) Setting: 13 primary and secondary care centers in England. Participants: Of 316 patients screened, 248 participants (82% women; mean age, 62.7 years) with symptomatic (pain >= 4 on a 0- to 10-point visual analogue scale) and radiographic hand osteoarthritis were randomly assigned and 210 (84.7%) completed the 6-month primary end point. Intervention: Hydroxychloroquine (200 to 400 mg) or placebo (1:1) for 12 months with ongoing usual care. Measurements: The primary end point was average hand pain during the previous 2 weeks (on a 0- to 10-point numerical rating scale [NRS]) at 6 months. Secondary end points included self-reported pain and function, grip strength, quality of life, radiographic structural change, and adverse events. Baseline ultrasonography was done. Results: At 6 months, mean hand pain was 5.49 points in the placebo group and 5.66 points in the hydroxychloroquine group, with a treatment difference of -0.16 point (95% Cl, -0.73 to 0.40 point) (P = 0.57). Results were robust to adjustments for adherence, missing data, and use of rescue medication. No significant treatment differences existed at 3, 6, or 12 months for any secondary outcomes. The percentage of participants with at least 1 joint with synovitis was 94% (134 of 143) on grayscale ultrasonography and 59% on power Doppler. Baseline structural damage or synovitis did not affect treatment response. Fifteen serious adverse events were reported (7 in the hydroxychloroquine group [3 defined as possibly related] and 8 in the placebo group). Limitation: Hydroxychloroquine dosage restrictions may have reduced efficacy. Conclusion: Hydroxychloroquine was no more effective than placebo for pain relief in patients with moderate to severe hand pain and radiographic osteoarthritis.	[Kingsbury, Sarah R.; Wakefield, Richard J.; Conaghan, Philip G.] Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, 2nd Floor Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England; [Kingsbury, Sarah R.; Wakefield, Richard J.; Conaghan, Philip G.] Chapel Allerton Hosp, NIHR Leeds Biomed Res Ctr, 2nd Floor Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England; [Tharmanathan, Puvan; Keding, Ada; Ronaldson, Sarah J.; Arundel, Catherine; Torgerson, David] Univ York, Fac Sci, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England; [Birrell, Fraser] Newcastle Univ, Inst Cellular Med, Med Sch, 4th Floor William Leech Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Doherty, Michael] City Hosp, Acad Rheumatol, Clin Sci Bldg, Nottingham NG5 1PB, England; [Vincent, Tonia; Watt, Fiona E.] Univ Oxford, Arthrit Res UK Ctr OA Pathogenesis, Kennedy Inst Rheumatol, NDORMS, Roosevelt Dr, Oxford OX3 7FY, England; [Dziedzic, Krysia] Keele Univ, Arthrit Res UK Primary Care Ctr, Inst Primary Care & Hlth Sci, Primary Care Sci, Keele ST5 5BG, Staffs, England; [O'Neill, Terence W.] Univ Manchester, Fac Biol Med & Hlth, Arthrit Res UK Ctr Epidemiol, Oxford Rd, Manchester M13 9PL, Lancs, England; [Arden, Nigel K.] Univ Oxford, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Nuffield Orthopaed Ctr, NDORMS, Oxford OX3 9DU, England; [Scott, David L.] Kings Coll London, Weston Educ Ctr, Dept Acad Rheumatol, 3rd Floor,Cutcombe Rd, London SE5 9RJ, England; [Dickson, John] Guisborough Primary Care Hosp, South Tees Hosp NHS Fdn Trust, Redcar & Cleveland Specialist Musculoskeletal Ser, 66 Northgate, Middlesbrough TS14 6HZ, Cleveland, England; [Garrood, Toby] Guys Hosp, Guys & St Thomas NHS Fdn Trust, 4th Floor,Tower Wing, London SE1 9RT, England; [Green, Michael] Harrogate Dist Hosp, Harrogate & Dist NHS Fdn Trust, Lancaster Pk Rd, Harrogate HG2 7SX, England; [Menon, Ajit] Haywood Hosp, High Lane, Stoke On Trent ST6 7AG, Staffs, England; [Sheeran, Tom] Cannock Chase Hosp, Brunswick Rd, Cannock WS11 5XY, England	Chapel Allerton Hospital; Chapel Allerton Hospital; Leeds Biomedical Research Centre; University of York - UK; Newcastle University - UK; University of Nottingham; University of Oxford; Keele University; University of Manchester; Nuffield Orthopaedic Centre; University of Oxford; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Kingsbury, SR (corresponding author), Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, 2nd Floor Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England.; Kingsbury, SR (corresponding author), Chapel Allerton Hosp, NIHR Leeds Biomed Res Ctr, 2nd Floor Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England.	s.r.kingsbury@leeds.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Birrell, Fraser/0000-0002-6163-6155; Doherty, Michael/0000-0002-5763-8326; Ronaldson, Sarah Jane/0000-0001-8321-786X; Conaghan, Philip/0000-0002-3478-5665; Vincent, Tonia/0000-0002-3412-5712; Grainger, Andrew/0000-0002-6697-1382; O'Neill, Terence/0000-0002-8896-4677	Arthritis Research UK clinical studies grant [19545]; NIHR through the Leeds Biomedical Research Centre; Knowledge Mobilisation Research Fellowship from the NIHR [KMRF-2014-03-002]; NIHR; MRC [MR/P020941/1] Funding Source: UKRI; Medical Research Council [MR/P020941/1] Funding Source: researchfish; National Institute for Health Research [KMRF-2014-03-002, RP-PG-0407-10386, NF-SI-0611-10031, CAT CDRF 10-018] Funding Source: researchfish; Versus Arthritis [19545] Funding Source: researchfish	Arthritis Research UK clinical studies grant; NIHR through the Leeds Biomedical Research Centre; Knowledge Mobilisation Research Fellowship from the NIHR; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	By an Arthritis Research UK clinical studies grant (reference 19545). Dr. Kingsbury and Prof. Conaghan are partially funded by the NIHR through the Leeds Biomedical Research Centre. Prof. Doherty is partially funded by a Knowledge Mobilisation Research Fellowship (KMRF-2014-03-002) from the NIHR. This article presents independent research funded in part by the NIHR.	ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; Andrianakos AA, 2006, J RHEUMATOL, V33, P2507; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Bellamy N, 2002, OSTEOARTHR CARTILAGE, V10, P855, DOI 10.1053/joca.2002.0837; Bellamy N, 2002, OSTEOARTHR CARTILAGE, V10, P863, DOI 10.1053/joca.2002.0838; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; BRYANT LR, 1995, J RHEUMATOL, V22, P1527; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; Carou AC, 2015, REUMATOL CLIN, V11, P353, DOI 10.1016/j.reuma.2014.12.005; CHANG L, 1994, APPL PSYCH MEAS, V18, P205; CLARK P, 1993, ANN INTERN MED, V119, P1067, DOI 10.7326/0003-4819-119-11-199312010-00002; Dillon CF, 2007, AM J PHYS MED REHAB, V86, P12, DOI 10.1097/PHM.0b013e31802ba28e; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dziedzic K, 2007, RHEUMATOLOGY, V46, P963, DOI 10.1093/rheumatology/kem005; Dziedzic KS, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-156; Ehrlick GE, 2001, EROSIVE INFLAMMATORY; FOX RI, 1993, SEMIN ARTHRITIS RHEU, V23, P82, DOI 10.1016/S0049-0172(10)80012-5; Gilman AL, 1996, BONE MARROW TRANSPL, V17, P1069; Goldman FD, 2000, BLOOD, V95, P3460, DOI 10.1182/blood.V95.11.3460.011k26_3460_3466; Grotle M, 2008, J RHEUMATOL, V35, P677; HAAR D, 1993, SCAND J RHEUMATOL, V22, P113, DOI 10.3109/03009749309099254; Haugen IK, 2016, ANN RHEUM DIS, V75, P702, DOI 10.1136/annrheumdis-2014-206829; Haugen IK, 2012, ANN RHEUM DIS, V71, P899, DOI 10.1136/annrheumdis-2011-200341; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; KALLMAN DA, 1989, ARTHRITIS RHEUM, V32, P1584, DOI 10.1002/anr.1780321213; Keen HI, 2010, RHEUMATOLOGY, V49, P1093, DOI 10.1093/rheumatology/keq010; Keen HI, 2008, ARTHRIT RHEUM-ARTHR, V59, P1756, DOI 10.1002/art.24312; Keenan AM, 2008, ARTHRIT RHEUM-ARTHR, V59, P841, DOI 10.1002/art.23714; Kim HA, 2006, ARTHRITIS RHEUM-US, V54, P2152, DOI 10.1002/art.21951; Kortekaas MC, 2014, OSTEOARTHR CARTILAGE, V22, P40, DOI 10.1016/j.joca.2013.10.015; Kortekaas MC, 2015, ANN RHEUM DIS, V74, P1720, DOI 10.1136/annrheumdis-2013-205003; Krasnokutsky S, 2008, OSTEOARTHR CARTILAGE, V16, pS1, DOI 10.1016/j.joca.2008.06.025; Liu R, 2017, OSTEOARTHR CARTILAGE, V25, P1093, DOI 10.1016/j.joca.2017.02.790; Machado GC, 2017, ANN RHEUM DIS, V76, P1269, DOI 10.1136/annrheumdis-2016-210597; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Mancarella L, 2017, CURR RHEUMATOL REV, V13, P43, DOI 10.2174/1573397112666160909105903; Mannoni A, 2003, ANN RHEUM DIS, V62, P576, DOI 10.1136/ard.62.6.576; Marshall M, 2013, OSTEOARTHR CARTILAGE, V21, P1674, DOI 10.1016/j.joca.2013.08.004; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; MedicinesComplete, 2007, HYDR SULF IND DOS; Myers H, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-85; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Punzi L, 1996, J RHEUMATOL, V23, P1477; Punzi L, 2010, BEST PRACT RES CL RH, V24, P301, DOI 10.1016/j.berh.2009.12.007; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; ROBERTSON CR, 1993, ARTHRITIS RHEUM, V36, pS167; Samuels J, 2008, BULL HOSP JT DIS, V66, P244; Sillat T, 2013, ACTA ORTHOP, V84, P585, DOI 10.3109/17453674.2013.854666; Siviero P, 2016, ARTHRITIS RHEUMATOL, V68, P2662, DOI 10.1002/art.39757; SPERBER K, 1993, J RHEUMATOL, V20, P803; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Vitolins MZ, 2000, CONTROL CLIN TRIALS, V21, p188S, DOI 10.1016/S0197-2456(00)00077-5; Vlychou M, 2009, OSTEOARTHR CARTILAGE, V17, P1283, DOI 10.1016/j.joca.2009.04.020; Vuolteenaho K, 2005, SCAND J RHEUMATOL, V34, P475, DOI 10.1080/03009740510026797; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; White IR, 2001, STAT MED, V20, P2995, DOI 10.1002/sim.927.abs; Zhang YQ, 2003, ARTHRITIS RHEUM-US, V48, P1034, DOI 10.1002/art.10928; Zhang YQ, 2002, AM J EPIDEMIOL, V156, P1021, DOI 10.1093/aje/kwf141	58	40	42	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					385	+		10.7326/M17-1430	http://dx.doi.org/10.7326/M17-1430			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29459986	Green Submitted, Green Accepted			2022-12-28	WOS:000427827400013
J	Hincks, T; Aspinall, W; Cooke, R; Gernon, T				Hincks, Thea; Aspinall, Willy; Cooke, Roger; Gernon, Thomas			Oklahoma's induced seismicity strongly linked to wastewater injection depth	SCIENCE			English	Article							5.8 PAWNEE EARTHQUAKE; FLUID INJECTION; UNITED-STATES; HAZARD; ARKANSAS; DISPOSAL; SEQUENCE; INCREASE; USA	The sharp rise in Oklahoma seismicity since 2009 is due to wastewater injection. The role of injection depth is an open, complex issue, yet critical for hazard assessment and regulation. We developed an advanced Bayesian network to model joint conditional dependencies between spatial, operational, and seismicity parameters. We found that injection depth relative to crystalline basement most strongly correlates with seismic moment release. The joint effects of depth and volume are critical, as injection rate becomesmore influential near the basement interface. Restricting injection depths to 200 to 500 meters above basement could reduce annual seismic moment release by a factor of 1.4 to 2.8. Our approach enables identification of subregions where targeted regulation may mitigate effects of induced earthquakes, aiding operators and regulators in wastewater disposal regions.	[Hincks, Thea; Aspinall, Willy] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Hincks, Thea; Aspinall, Willy] Univ Bristol, Cabot Inst, Royal Ft House, Bristol BS8 1UJ, Avon, England; [Aspinall, Willy] Aspinall & Associates, Cleveland House,High St, Tisbury SP3 6HF, England; [Cooke, Roger] Delft Univ Technol, Mekelweg 4, NL-2628 CD Delft, Netherlands; [Cooke, Roger] Resources Future Inc, 1616 P St NW, Washington, DC 20036 USA; [Gernon, Thomas] Univ Southampton, Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England	University of Bristol; University of Bristol; Delft University of Technology; Resources for the Future; University of Southampton	Gernon, T (corresponding author), Univ Southampton, Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England.	thomas.gernon@noc.soton.ac.uk	Aspinall, Willy/AAW-1022-2020	Aspinall, Willy/0000-0001-6014-6042; Hincks, Thea/0000-0003-4537-6194; cooke, roger/0000-0003-0643-1971; Gernon, Thomas/0000-0002-7717-2092	CREDIBLE consortium (UK Natural Environment Research Council) [NE/J 017299/1]; Risk Management Solutions (RMS)	CREDIBLE consortium (UK Natural Environment Research Council); Risk Management Solutions (RMS)	T.H. and W.A. were supported in part by the CREDIBLE consortium (UK Natural Environment Research Council grant NE/J 017299/1). W.A. received support in part from Risk Management Solutions (RMS) for a conceptual study associated with induced seismicity attribution. D. Ababei at LightTwist Software provided invaluable assistance with UNINET software and scripting (available at www.lighttwist.net/wp/uninet). The study used UIC injection well data obtained from the Oklahoma Corporation Commission (www.occeweb.com/) and earthquake data from the USGS ANSS Comprehensive Catalog (https://earthquake.usgs.gov/data/comcat/). Input data are provided in the supplementary materials. We acknowledge helpful discussions with R. Muir-Wood (RMS, London) and R. J. Briggs (formerly Praedicat Inc., CA). W.A. and T.H. conceived the research. T.H. performed the modeling and analyzed and refined the BN. W.A. provided seismological interpretation. T.G. performed geologic interpretation and coordinated and wrote the paper. R.C. provided support with statistical analysis and performed additional UNINET tests. All authors contributed to the interpretation, discussion, and writing.	Ababei Dan, UNINET SOFTWARE DESI; [Anonymous], 2015, OKLAHOMA CORPORATION; Barbour AJ, 2017, SEISMOL RES LETT, V88, P1040, DOI 10.1785/0220170003; Barrett S., 2016, TECH REP; Campbell J., 2006, 20061 OKL GEOL SURV; Chen XW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04992-z; Currie B. S., 2016, GEOLOGICAL SOC AM AB, V48; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Fielding EJ, 2017, SEISMOL RES LETT, V88, P971, DOI 10.1785/0220170010; Franseen E. K, 2000, COMPASS EARTH SCI J, V75, P68; Goebel THW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700441; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; Kansas Corporation Commission, 2016, 2 ORD RED SALTW INJ; Keranen KM, 2014, SCIENCE, V345, P448, DOI 10.1126/science.1255802; Keranen KM, 2013, GEOLOGY, V41, P699, DOI 10.1130/G34045.1; Kim WY, 2013, J GEOPHYS RES-SOL EA, V118, P3506, DOI 10.1002/jgrb.50247; Langenbruch C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601542; Marsh S., 2016, OF22016 U OKL OKL GE, P73019; McGarr A, 2017, GEOPHYS RES LETT, V44, P9330, DOI 10.1002/2017GL075258; McMahon ND, 2017, GEOPHYS RES LETT, V44, P7149, DOI 10.1002/2017GL072944; McNamara DE, 2015, GEOPHYS RES LETT, V42, P8328, DOI 10.1002/2015GL064669; McNamara DE, 2015, GEOPHYS RES LETT, V42, P2742, DOI 10.1002/2014GL062730; Northcutt R. A., 1998, GEOLOGIC PROVINCES O, P29; NRC, 2013, IND SEISM POT EN TEC; Ogwari PO, 2016, GEOFLUIDS, V16, P954, DOI 10.1111/gfl.12198; Oklahoma Corporation Commission, 2016, CENTR OKL REG VOL RE; Oklahoma Corporation Commission, UIC WELL DAT; Oklahoma Corporation Commission Earthquake, 2016, RESP SUMM; Petersen M. D., 2016, TECH REP; Petersen M. D, 2015, 20151070 US GEOL SUR; Petersen MD, 2017, SEISMOL RES LETT, V88, P772, DOI 10.1785/0220170005; QGIS Development Team, 2016, QGIS GEOGR INF SYST; Schoenball M, 2017, SEISMOL RES LETT, V88, P1252, DOI 10.1785/0220170083; Shah AK, 2017, GEOPHYS RES LETT, V44, P152, DOI 10.1002/2016GL071808; Shirzaei M, 2016, SCIENCE, V353, P1416, DOI 10.1126/science.aag0262; van der Baan M, 2017, GEOCHEM GEOPHY GEOSY, V18, P2467, DOI 10.1002/2017GC006915; Walsh FR, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500195; Weingarten M, 2015, SCIENCE, V348, P1336, DOI 10.1126/science.aab1345; Yeck WL, 2017, GEOPHYS RES LETT, V44, P711, DOI 10.1002/2016GL071685; Yeck WL, 2016, GEOPHYS RES LETT, V43, P10198, DOI 10.1002/2016GL070861; Zhang YP, 2013, GROUND WATER, V51, P525, DOI 10.1111/gwat.12071	41	96	97	7	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2018	359	6381					1251	+		10.1126/science.aap7911	http://dx.doi.org/10.1126/science.aap7911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3QN	29420259	Green Accepted, Green Submitted			2022-12-28	WOS:000427504900039
J	Bottcher, JP; Bonavita, E; Chakravarty, P; Blees, H; Cabeza-Cabrerizo, M; Sammicheli, S; Rogers, NC; Sahai, E; Zelenay, S; Sousa, CRE				Boettcher, Jan P.; Bonavita, Eduardo; Chakravarty, Probir; Blees, Hanna; Cabeza-Cabrerizo, Mar; Sammicheli, Stefano; Rogers, Neil C.; Sahai, Erik; Zelenay, Santiago; Reis e Sousa, Caetano			NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control	CELL			English	Article							DENDRITIC CELLS; INNATE; EXPRESSION; RESPONSES; REVEALS; MACROPHAGES; PROGENITORS; TRAFFICKING; GAMMA	Conventional type 1 dendritic cells (cDC1) are critical for antitumor immunity, and their abundance within tumors is associated with immune-mediated rejection and the success of immunotherapy. Here, we show that cDC1 accumulation in mouse tumors often depends on natural killer (NK) cells that produce the cDC1 chemoattractants CCL5 and XCL1. Similarly, in human cancers, intratumoral CCL5, XCL1, and XCL2 transcripts closely correlate with gene signatures of both NK cells and cDC1 and are associated with increased overall patient survival. Notably, tumor production of prostaglandin E2 (PGE(2)) leads to evasion of the NK cell-cDC1 axis in part by impairing NK cell viability and chemokine production, as well as by causing downregulation of chemokine receptor expression in cDC1. Our findings reveal a cellular and molecular checkpoint for intratumoral cDC1 recruitment that is targeted by tumor-derived PGE(2) for immune evasion and that could be exploited for cancer therapy.	[Boettcher, Jan P.; Blees, Hanna; Cabeza-Cabrerizo, Mar; Sammicheli, Stefano; Rogers, Neil C.; Reis e Sousa, Caetano] Francis Crick Inst, Immunobiol Lab, 1 Midland Rd, London NW1 1AT, England; [Bonavita, Eduardo; Zelenay, Santiago] Univ Manchester, CRUK Manchester Inst, Canc Inflammat & Immun Grp, Manchester M20 4BX, Lancs, England; [Chakravarty, Probir] Francis Crick Inst, Bioinformat, 1 Midland Rd, London NW1 1AT, England; [Sahai, Erik] Francis Crick Inst, Tumour Cell Biol Lab, 1 Midland Rd, London NW1 1AT, England; [Boettcher, Jan P.] Tech Univ Munich, Klinikum Munchen Rechts Isar, Inst Mol Immunol & Expt Oncol, Ismaningerstr 22, D-81675 Munich, Germany	Francis Crick Institute; University of Manchester; Francis Crick Institute; Francis Crick Institute; Technical University of Munich	Bottcher, JP; Sousa, CRE (corresponding author), Francis Crick Inst, Immunobiol Lab, 1 Midland Rd, London NW1 1AT, England.; Bottcher, JP (corresponding author), Tech Univ Munich, Klinikum Munchen Rechts Isar, Inst Mol Immunol & Expt Oncol, Ismaningerstr 22, D-81675 Munich, Germany.	j.boettcher@tum.de; caetano@crick.ac.uk	Bonavita, Eduardo/AAE-3702-2020; Bonavita, Eduardo/P-4370-2014; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021	Bonavita, Eduardo/0000-0003-2335-5827; Bonavita, Eduardo/0000-0003-2335-5827; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Zelenay, Santiago/0000-0002-6865-3978; Rogers, Neil/0000-0001-8977-7585; Cabeza-Cabrerizo, Mar/0000-0001-9061-058X; chakravarty, probir/0000-0003-1146-8824; Bottcher, Jan/0000-0002-8163-8107	Francis Crick Institute from Cancer Research UK [FC001136]; UK Medical Research Council [FC001136]; Wellcome Trust [FC001136]; ERC Advanced Investigator grant [AdG 268670]; Wellcome Investigator Award [WT106973MA]; Marie Sklodowska-Curie Individual Fellowship under Horizon from the European Union; Cancer Research UK [22255, 15689] Funding Source: researchfish; The Francis Crick Institute [10002, 10334, 10144, 10136, 10138] Funding Source: researchfish	Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); ERC Advanced Investigator grant; Wellcome Investigator Award; Marie Sklodowska-Curie Individual Fellowship under Horizon from the European Union; Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank members of the Immunobiology Laboratory for helpful discussions and suggestions. We are grateful to A. Schurich and P. Knolle for the anti- NK1.1 antibody and thank I. Malanchi and V. Bridgeman for MMTV-PyMT mice. This work benefited from data assembled by the ImmGen consortium and The Cancer Genome Atlas. This work was supported by The Francis Crick Institute, which receives core funding from Cancer Research UK (FC001136), the UK Medical Research Council (FC001136), and the Wellcome Trust (FC001136), and by an ERC Advanced Investigator grant (AdG 268670), a Wellcome Investigator Award (WT106973MA), and a prize from The Louis-Jeantet Foundation. J.P.B. was supported by a Marie Sklodowska-Curie Individual Fellowship under Horizon 2020 from the European Union.	Alexandre YO, 2016, J EXP MED, V213, P75, DOI 10.1084/jem.20142350; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Delconte RB, 2016, NAT IMMUNOL, V17, P816, DOI 10.1038/ni.3470; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Fox JC, 2015, CYTOKINE, V71, P302, DOI 10.1016/j.cyto.2014.11.010; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hangai S, 2016, P NATL ACAD SCI USA, V113, P3844, DOI 10.1073/pnas.1602023113; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Heidkamp GF, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7677; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mayer CT, 2014, BLOOD, V124, P3081, DOI 10.1182/blood-2013-12-545772; McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mittal D, 2017, CANCER IMMUNOL RES, V5, P1098, DOI 10.1158/2326-6066.CIR-17-0341; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ohta T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23505; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Pietra G, 2012, CANCER RES, V72, P1407, DOI 10.1158/0008-5472.CAN-11-2544; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Su YY, 2011, CANCER IMMUNOL IMMUN, V60, P111, DOI 10.1007/s00262-010-0924-z; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Velasco-Velazquez M, 2014, EXPERT OPIN THER TAR, V18, P1265, DOI 10.1517/14728222.2014.949238; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	52	737	760	37	174	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2018	172	5					1022	+		10.1016/j.cell.2018.01.004	http://dx.doi.org/10.1016/j.cell.2018.01.004			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FX2ZG	29429633	Green Published, hybrid			2022-12-28	WOS:000425937100013
J	Ashton, BJ; Ridley, AR; Edwards, EK; Thornton, A				Ashton, Benjamin J.; Ridley, Amanda R.; Edwards, Emily K.; Thornton, Alex			Cognitive performance is linked to group size and affects fitness in Australian magpies	NATURE			English	Article							SOCIAL NETWORK SIZE; INTELLIGENCE HYPOTHESIS; CULTURAL INTELLIGENCE; BRAIN STRUCTURE; EVOLUTION; ECOLOGY; SELECTION; PRIMATES; WILD; HERITABILITY	The social intelligence hypothesis states that the demands of social life drive cognitive evolution(1-3). This idea receives support from comparative studies that link variation in group size or mating systems with cognitive and neuroanatomical differences across species(3-7), but findings are contradictory and contentious(8-10). To understand the cognitive consequences of sociality, it is also important to investigate social variation within species. Here we show that in wild, cooperatively breeding Australian magpies, individuals that live in large groups show increased cognitive performance, which is linked to increased reproductive success. Individual performance was highly correlated across four cognitive tasks, indicating a `general intelligence factor' that underlies cognitive performance. Repeated cognitive testing of juveniles at different ages showed that the correlation between group size and cognition emerged in early life, suggesting that living in larger groups promotes cognitive development. Furthermore, we found a positive association between the task performance of females and three indicators of reproductive success, thus identifying a selective benefit of greater cognitive performance. Together, these results provide intraspecific evidence that sociality can shape cognitive development and evolution.	[Ashton, Benjamin J.; Ridley, Amanda R.; Edwards, Emily K.] Univ Western Australia, Sch Biol Sci, Ctr Evolutionary Biol, 35 Stirling Highway, Crawley, WA 6009, Australia; [Thornton, Alex] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus,Treliever Rd, Penryn TR10 9FE, England	University of Western Australia; University of Exeter	Ashton, BJ; Ridley, AR (corresponding author), Univ Western Australia, Sch Biol Sci, Ctr Evolutionary Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.; Thornton, A (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus,Treliever Rd, Penryn TR10 9FE, England.	benjamin.ashton@research.uwa.edu.au; amanda.ridley@uwa.edu.au; alex.thornton@exeter.ac.uk	Ridley, Amanda/D-2636-2011	Ridley, Amanda/0000-0001-5886-0992; Thornton, Alex/0000-0002-1607-2047; Ashton, Benjamin/0000-0003-3357-0395	ARC Discovery grant; University of Western Australia International Postgraduate Research Scholarship; Endeavour Research Fellowship; BBSRC [BB/H021817/1]; BBSRC [BB/H021817/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021817/2, BB/H021817/1] Funding Source: researchfish	ARC Discovery grant(Australian Research Council); University of Western Australia International Postgraduate Research Scholarship; Endeavour Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Russell and the late I. Rowley for access to their life-history records, and for allowing us to continue work on their Guildford magpie population; A. Wolton for help with fieldwork; R. Lymbery for help with statistical analyses; and N. Boogert and A. Young for helpful comments and discussion. This work was funded by an ARC Discovery grant awarded to A.R.R., A.T. and M.B.V. Bell, and a University of Western Australia International Postgraduate Research Scholarship and Endeavour Research Fellowship awarded to B.J.A.A.T. received additional support from a BBSRC David Phillips Fellowship (BB/H021817/1).	Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Arnold KE, 2007, P ROY SOC B-BIOL SCI, V274, P2563, DOI 10.1098/rspb.2007.0687; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; Boogert NJ, 2008, ANIM BEHAV, V76, P1735, DOI 10.1016/j.anbehav.2008.08.009; Boogert NJ, 2011, ANIM BEHAV, V81, P1209, DOI 10.1016/j.anbehav.2011.03.004; Buchanan KL, 2013, TRENDS ECOL EVOL, V28, P290, DOI 10.1016/j.tree.2013.02.004; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Byrne R., 1988, MACHIAVELLIAN INTELL; Chandra SBC, 2000, J COMP PSYCHOL, V114, P86, DOI 10.1037//0735-7036.114.1.86; Croston R, 2015, BEHAV ECOL, V26, P1447, DOI 10.1093/beheco/arv088; DeCasien AR, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0112; Edwards EK, 2015, OSTRICH, V86, P137, DOI 10.2989/00306525.2015.1034219; Fischer S, 2015, AM NAT, V186, P123, DOI 10.1086/681636; Forss SIF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30516; Fox KCR, 2017, NAT ECOL EVOL, V1, P1699, DOI 10.1038/s41559-017-0336-y; Galsworthy MJ, 2005, BEHAV GENET, V35, P675, DOI 10.1007/s10519-005-3423-9; Griffin AS, 2015, BEHAV ECOL, V26, P722, DOI 10.1093/beheco/aru238; Holekamp KE, 2007, TRENDS COGN SCI, V11, P65, DOI 10.1016/j.tics.2006.11.003; Hopkins WD, 2014, CURR BIOL, V24, P1649, DOI 10.1016/j.cub.2014.05.076; Hughes JM, 2003, MOL ECOL, V12, P3441, DOI 10.1046/j.1365-294X.2003.01997.x; Humphrey N., 1976, GROWING POINTS ETHOL, P303; Isden J, 2013, ANIM BEHAV, V86, P829, DOI 10.1016/j.anbehav.2013.07.024; Kanai R, 2012, P ROY SOC B-BIOL SCI, V279, P1327, DOI 10.1098/rspb.2011.1959; Kaplan G., 2004, AUSTR MAGPIE BIOL BE; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kotrschal A, 2013, CURR BIOL, V23, P168, DOI 10.1016/j.cub.2012.11.058; Leadbeater E, 2015, J ZOOL, V295, P4, DOI 10.1111/jzo.12197; Lotem A, 2012, PHILOS T R SOC B, V367, P2686, DOI 10.1098/rstb.2012.0213; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; Morand-Ferron J, 2017, CURR OPIN BEHAV SCI, V16, P73, DOI 10.1016/j.cobeha.2017.03.008; Morand-Ferron J, 2016, BIOL REV, V91, P367, DOI 10.1111/brv.12174; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Pike K. N., 2016, THESIS; Plomin R, 2015, MOL PSYCHIATR, V20, P98, DOI 10.1038/mp.2014.105; Plomin R, 2001, NAT REV NEUROSCI, V2, P136, DOI 10.1038/35053584; Rowe C, 2014, BEHAV ECOL, V25, P1287, DOI 10.1093/beheco/aru090; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Sayol F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13971; Shaw RC, 2015, ANIM BEHAV, V109, P101, DOI 10.1016/j.anbehav.2015.08.001; Sherry David F., 1998, P261; Shultz S, 2007, P ROY SOC B-BIOL SCI, V274, P2429, DOI 10.1098/rspb.2007.0693; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Street SE, 2017, P NATL ACAD SCI USA, V114, P7908, DOI 10.1073/pnas.1620734114; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214	46	133	133	11	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					364	+		10.1038/nature25503	http://dx.doi.org/10.1038/nature25503			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29414945	Green Accepted, Green Submitted			2022-12-28	WOS:000424996300039
J	Huffman, MD; Mohanan, PP; Devarajan, R; Baldridge, AS; Kondal, D; Zhao, LH; Ali, M; Krishnan, MN; Natesan, S; Gopinath, R; Viswanathan, S; Stigi, J; Joseph, J; Chozhakkat, S; Lloyd-Jones, DM; Prabhakaran, D				Huffman, Mark D.; Mohanan, Padinhare P.; Devarajan, Raji; Baldridge, Abigail S.; Kondal, Dimple; Zhao, Lihui; Ali, Mumtaj; Krishnan, Mangalath N.; Natesan, Syam; Gopinath, Rajesh; Viswanathan, Sunitha; Stigi, Joseph; Joseph, Johny; Chozhakkat, Somanathan; Lloyd-Jones, Donald M.; Prabhakaran, Dorairaj		Acute Coronary Syndrome Quality	EffectofaQualityImprovementInterventiononClinicalOutcomes in Patients in India With AcuteMyocardial Infarction The ACS QUIK Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; QUALITY IMPROVEMENT; MULTIFACETED INTERVENTION; MYOCARDIAL-INFARCTION; OUTCOMES; DESIGN; KERALA; RATIONALE; REGISTRY; CARE	IMPORTANCE Wide heterogeneity exists in acute myocardial infarction treatment and outcomes in India. OBJECTIVE To evaluate the effect of a locally adapted quality improvement tool kit on clinical outcomes and process measures in Kerala, a southern Indian state. DESIGN, SETTING, AND PARTICIPANTS Cluster randomized, stepped-wedge clinical trial conducted between November 10, 2014, and November 9, 2016, in 63 hospitals in Kerala, India, with a last date of follow-up of December 31, 2016. During 5 predefined steps over the study period, hospitals were randomly selected to move in a 1-way crossover from the control group to the intervention group. Consecutively presenting patients with acute myocardial infarction were offered participation. INTERVENTIONS Hospitals provided either usual care (control group; n = 10066 participants [step 0: n = 2915; step 1: n = 2649; step 2: n = 2251; step 3: n = 1422; step 4; n = 829; step 5: n = 0]) or care using a quality improvement tool kit (intervention group; n = 11 308 participants [step 0: n = 0; step 1: n = 662; step 2: n = 1265; step 3: n = 2432; step 4: n = 3214; step 5: n = 3735]) that consisted of audit and feedback, checklists, patient education materials, and linkage to emergency cardiovascular care and quality improvement training. MAIN OUTCOMES AND MEASURES The primary outcome was the composite of all-cause death, reinfarction, stroke, or major bleeding using standardized definitions at 30 days. Secondary outcomes included the primary outcome's individual components, 30-day cardiovascular death, medication use, and tobacco cessation counseling. Mixed-effects logistic regression models were used to account for clustering and temporal trends. RESULTS Among 21 374 eligible randomized participants (mean age, 60.6 [SD, 12.0] years; n = 16 183 men [76%]; n = 13 689 [ 64%] with ST-segment elevation myocardial infarction), 21 079 (99%) completed the trial. The primary composite outcome was observed in 5.3% of the intervention participants and 6.4% of the control participants. The observed difference in 30-day major adverse cardiovascular event rates between the groups was not statistically significant after adjustment (adjusted risk difference, -0.09% [95% CI, -1.32% to 1.14%]; adjusted odds ratio, 0.98 [95% CI, 0.80-1.21]). The intervention group had a higher rate of medication use including reperfusion but no effect on tobacco cessation counseling. There were no unexpected adverse events reported. CONCLUSIONS AND RELEVANCE Among patients with acute myocardial infarction in Kerala, India, use of a quality improvement intervention compared with usual care did not decrease a composite of 30-day major adverse cardiovascular events. Further research is needed to understand the lack of efficacy.	[Huffman, Mark D.; Baldridge, Abigail S.; Lloyd-Jones, Donald M.] Northwestern Univ, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA; [Mohanan, Padinhare P.] WestFort Hitech Hosp Ltd, Trichur, India; [Devarajan, Raji; Kondal, Dimple; Zhao, Lihui; Ali, Mumtaj; Prabhakaran, Dorairaj] Ctr Chron Dis Control, Gurgaon, India; [Devarajan, Raji; Kondal, Dimple; Zhao, Lihui; Ali, Mumtaj; Prabhakaran, Dorairaj] Publ Hlth Fdn India, Gurgaon, India; [Krishnan, Mangalath N.] Med Coll Hosp, Kozikhode, India; [Natesan, Syam] Dist Hosp, Kollam, India; [Gopinath, Rajesh] Amala Med Coll, Trichur, India; [Viswanathan, Sunitha] Med Coll Hosp, Alappuzha, India; [Stigi, Joseph] Little Flower Hosp, Angamaly, India; [Joseph, Johny] Caritas Hosp, Kottyam, India; [Chozhakkat, Somanathan] EMS Hosp, Perinthalmana, India; [Prabhakaran, Dorairaj] London Sch Hyg & Trop Med, London, England	Northwestern University; Feinberg School of Medicine; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine	Huffman, MD (corresponding author), Northwestern Univ, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	m-huffman@northwestern.edu	Prabhakaran, Dorairaj/B-4147-2011	Prabhakaran, Dorairaj/0000-0002-3172-834X; Lloyd-Jones, Donald/0000-0003-0847-6110	National Heart, Lung, and Blood Institute [R00 HL107749]; Cardiological Society of India-Kerala Chapter; Centre for Chronic Disease Control; Northwestern University Global Health Initiative; Northwestern University Clinical and Translational Science Institute [UL1TR001422]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL107749] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cardiological Society of India-Kerala Chapter; Centre for Chronic Disease Control; Northwestern University Global Health Initiative; Northwestern University Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was funded by the National Heart, Lung, and Blood Institute (grant R00 HL107749) with support from the Cardiological Society of India-Kerala Chapter, Centre for Chronic Disease Control, Northwestern University Global Health Initiative, and Northwestern University Clinical and Translational Science Institute (grant UL1TR001422).	Alexander T, 2017, JAMA CARDIOL, V2, P498, DOI 10.1001/jamacardio.2016.5977; Berwanger O, 2012, JAMA-J AM MED ASSOC, V307, P2041, DOI 10.1001/jama.2012.413; Berwanger O, 2012, AM HEART J, V163, P323, DOI 10.1016/j.ahj.2012.02.004; BRAUNWALD E, 1993, NEW ENGL J MED, V329, P1650, DOI 10.1056/NEJM199311253292211; Buckley GJ., 2015, IMPROVING QUALITY CA; Cannon CP, 2013, CIRCULATION, V127, P1052, DOI 10.1161/CIR.0b013e3182831a11; Cohen MG, 2010, CIRCULATION, V121, P2294, DOI 10.1161/CIRCULATIONAHA.109.922286; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Hemming K, 2014, STATA J, V14, P363, DOI 10.1177/1536867X1401400208; Huffman MD, 2017, AM HEART J, V185, P154, DOI 10.1016/j.ahj.2016.10.026; Huffman MD, 2013, CIRC-CARDIOVASC QUAL, V6, P436, DOI 10.1161/CIRCOUTCOMES.113.000189; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Kirkwood AA, 2013, CLIN TRIALS, V10, P783, DOI 10.1177/1740774513494504; Ko HCH, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-211; Li SS, 2015, AM HEART J, V169, P349, DOI 10.1016/j.ahj.2014.12.005; Masoudi FA, 2017, J AM COLL CARDIOL, V69, P1427, DOI 10.1016/j.jacc.2016.12.005; Mohanan PP, 2013, EUR HEART J, V34, P121, DOI 10.1093/eurheartj/ehs219; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; WELTY LJ, 2016, STATTAG; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6	26	47	47	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					567	578		10.1001/jama.2017.21906	http://dx.doi.org/10.1001/jama.2017.21906			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450524	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000424908400017
J	Crellin, E; Mansfield, KE; Leyrat, C; Nitsch, D; Douglas, IJ; Root, A; Williamson, E; Smeeth, L; Tomlinson, LA				Crellin, Elizabeth; Mansfield, Kathryn E.; Leyrat, Clemence; Nitsch, Dorothea; Douglas, Ian J.; Root, Adrian; Williamson, Elizabeth; Smeeth, Liam; Tomlinson, Laurie A.			Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE KIDNEY INJURY; PATIENTS RECEIVING INHIBITORS; HIGH-DOSE TRIMETHOPRIM; INDUCED HYPERKALEMIA; SERUM CREATININE; CO-TRIMOXAZOLE; SULFAMETHOXAZOLE; COTRIMOXAZOLE; FAILURE	OBJECTIVE To determine if trimethoprim use for urinary tract infection (UTI) is associated with an increased risk of acute kidney injury, hyperkalaemia, or sudden death in the general population. DESIGN Cohort study. SETTING UK electronic primary care records from practices contributing to the Clinical Practice Research Datalink linked to the Hospital Episode Statistics database. PARTICIPANTS Adults aged 65 and over with a prescription for trimethoprim, amoxicillin, cefalexin, ciprofloxacin, or nitrofurantoin prescribed up to three days after a primary care diagnosis of UTI between April 1997 and September 2015. MAIN OUTCOME MEASURES The outcomes were acute kidney injury, hyperkalaemia, and death within 14 days of a UTI treated with antibiotics. RESULTS Among a cohort of 1 191 905 patients aged 65 and over, 178 238 individuals were identified with at least one UTI treated with antibiotics, comprising a total of 422 514 episodes of UTIs treated with antibiotics. The odds of acute kidney injury in the 14 days following antibiotic initiation were higher following trimethoprim (adjusted odds ratio 1.72, 95% confidence interval 1.31 to 2.24) and ciprofloxacin (1.48, 1.03 to 2.13) compared with amoxicillin. The odds of hyperkalaemia in the 14 days following antibiotic initiation were only higher following trimethoprim (2.27, 1.49 to 3.45) compared with amoxicillin. However, the odds of death within the 14 days following antibiotic initiation were not higher with trimethoprim than with amoxicillin: in the whole population the adjusted odds ratio was 0.90 (95% confidence interval 0.76 to 1.07) while among users of renin-angiotensin system blockers the odds of death within 14 days of antibiotic initiation was 1.12 (0.80 to 1.57). The results suggest that, for 1000 UTIs treated with antibiotics among people 65 and over, treatment with trimethoprim instead of amoxicillin would result in one to two additional cases of hyperkalaemia and two admissions with acute kidney injury, regardless of renin-angiotensin system blockade. However, for people taking renin-angiotensin system blockers and spironolactone treatment with trimethoprim instead of amoxicillin there were 18 additional cases of hyperkalaemia and 11 admissions with acute kidney injury. CONCLUSION Trimethoprim is associated with a greater risk of acute kidney injury and hyperkalaemia compared with other antibiotics used to treat UTIs, but not a greater risk of death. The relative risk increase is similar across population groups, but the higher baseline risk among those taking renin-angiotensin system blockers and potassium-sparing diuretics translates into higher absolute risks of acute kidney injury and hyperkalaemia in these groups.	[Crellin, Elizabeth; Mansfield, Kathryn E.; Nitsch, Dorothea; Douglas, Ian J.; Root, Adrian; Smeeth, Liam; Tomlinson, Laurie A.] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England; [Leyrat, Clemence; Williamson, Elizabeth] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Med Stat, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Mansfield, KE (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	kathryn.mansfield@lshtm.ac.uk	Leyrat, Clémence/I-9413-2019; Smeeth, Liam/X-5862-2018	Leyrat, Clémence/0000-0002-4097-4577; Tomlinson, Laurie/0000-0001-8848-9493; Smeeth, Liam/0000-0002-9168-6022; Nitsch, Dorothea/0000-0001-5767-248X; Crellin, Elizabeth/0000-0001-8774-224X	Wellcome Trust [101143/Z/13/Z, 098504/Z/12/Z]; MRC [MR/M013278/1, G0802403] Funding Source: UKRI; Medical Research Council [G0802403, MR/M013278/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	LAT and KEM were funded by a Wellcome Trust intermediate clinical fellowship (101143/Z/13/Z). LS and EC were supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (098504/Z/12/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alappan R, 1999, AM J NEPHROL, V19, P389, DOI 10.1159/000013483; Antoniou T, 2015, C CAN MED ASS J, V187, P1; Antoniou T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5228; Antoniou T, 2010, ARCH INTERN MED, V170, P1045, DOI 10.1001/archinternmed.2010.142; Bhaskaran K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003389; Bird ST, 2013, CAN MED ASSOC J, V185, pE475, DOI 10.1503/cmaj.121730; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Center for Disease Dynamics Economics and Policy, STAT WORLDS ANT 2015; Chan WY, 2017, BRIT J CLIN PHARMACO, V83, P1808, DOI 10.1111/bcp.13263; Fralick M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6196; Fraser TN, 2012, J ANTIMICROB CHEMOTH, V67, P1271, DOI 10.1093/jac/dks030; Gentry CA, 2013, ANN PHARMACOTHER, V47, P1618, DOI 10.1177/1060028013509973; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Higashioka K, 2016, INTERNAL MED, V55, P467, DOI 10.2169/internalmedicine.55.5697; HSCIC, HOSP EP STAT; Joint Formulary Committee, 2016, BRIT NAT FORM BNF 72; Kolhe NV, 2016, INT J CLIN PRACT, V70, P330, DOI 10.1111/ijcp.12774; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; London School of Hygiene & Tropical Medicine, COD LISTS ADV OUTC F; Mansfield KE, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012690; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Michel A, 2015, EUR J HEART FAIL, V17, P205, DOI 10.1002/ejhf.226; MIHM LB, 1995, PHARMACOTHERAPY, V15, P793; Naderer O, 1997, ANTIMICROB AGENTS CH, V41, P2466, DOI 10.1128/AAC.41.11.2466; NHS England/Commissioning Strategy/Contracts and Incentives, 2017, TECHN GUID ANN B INF; Pannu N, 2008, CRIT CARE MED, V36, pS216, DOI 10.1097/CCM.0b013e318168e375; Perazella MA, 2000, DRUG SAFETY, V22, P227, DOI 10.2165/00002018-200022030-00006; Public Health England, 2017, MAN INF GUID PRIM CA; RUDRA T, 1989, NEPHRON, V53, P85, DOI 10.1159/000185711; SALTISSI D, 1979, BRIT MED J, V1, P1182, DOI 10.1136/bmj.1.6172.1182-a; Sawhney S, 2015, NEPHROL DIAL TRANSPL, V30, P1853, DOI 10.1093/ndt/gfv094; Scottish Intercollegiate Guidelines Network. Scottish Intercollegiate Guidelines Network (SIGN), 2012, MAN SUSP BACT UR TRA; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; SMITH EJ, 1980, JAMA-J AM MED ASSOC, V244, P360, DOI 10.1001/jama.244.4.360; Tomlinson LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-58; TROLLFORS B, 1980, J INFECTION, V2, P221, DOI 10.1016/S0163-4453(80)90626-X	36	28	28	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2018	360								k341	10.1136/bmj.k341	http://dx.doi.org/10.1136/bmj.k341			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0IE	29438980	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000424976600001
J	Ahmad, S; Mu, X; Yang, F; Greenwald, E; Park, JW; Jacob, E; Zhang, CZ; Hur, S				Ahmad, Sadeem; Mu, Xin; Yang, Fei; Greenwald, Emily; Park, Ji Woo; Jacob, Etai; Zhang, Cheng-Zhong; Hur, Sun			Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation	CELL			English	Article							AICARDI-GOUTIERES SYNDROME; INNATE IMMUNE-RESPONSE; DSRNA RECOGNITION; MDA5 FILAMENTS; TRANSCRIPTS; MUTATIONS; INFECTION; CELLS; GAIN; DEAMINASES	Aberrant activation of innate immune receptors can cause a spectrum of immune disorders, such as Aicardi-Goutie` res syndrome (AGS). One such receptor is MDA5, a viral dsRNA sensor that induces antiviral immune response. Using a newly developed RNase-protection/RNA-seq approach, we demonstrate here that constitutive activation of MDA5 in AGS results from the loss of tolerance to cellular dsRNAs formed by Alu retroelements. While wildtype MDA5 cannot efficiently recognize Alu-dsRNAs because of its limited filament formation on imperfect duplexes, AGS variants of MDA5 display reduced sensitivity to duplex structural irregularities, assembling signaling-competent filaments on Alu-dsRNAs. Moreover, we identified an unexpected role of an RNA-rich cellular environment in suppressing aberrant MDA5 oligomerization, highlighting context dependence of self versus non-self discrimination. Overall, our work demonstrates that the increased efficiency of MDA5 in recognizing dsRNA comes at a cost of self-recognition and implicates a unique role of Alu-dsRNAs as virus-like elements that shape the primate immune system.	[Ahmad, Sadeem; Mu, Xin; Yang, Fei; Hur, Sun] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ahmad, Sadeem; Mu, Xin; Yang, Fei; Greenwald, Emily; Park, Ji Woo; Hur, Sun] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Park, Ji Woo] Boston Coll, Biol Dept, Morrissey Coll Arts & Sci, Chestnut Hill, MA USA; [Jacob, Etai; Zhang, Cheng-Zhong] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Jacob, Etai; Zhang, Cheng-Zhong] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhang, Cheng-Zhong] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Yang, Fei] Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Boston College; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hur, S (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Hur, S (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	sun.hur@childrens.harvard.edu	Mu, Xin/W-6780-2018; Mu, Xin/ABG-9796-2021; Park, Ji Woo/T-8021-2019	Mu, Xin/0000-0002-1022-1259; Greenwald, Emily/0000-0001-9991-6489; Park, Ji Woo/0000-0003-0233-0890	Cancer Research Institute; NIH [R01AI106912, R01AI111784, R21AI130791]; March of Dime; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119880, R21AI130791, R01AI106912, R01AI111784] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dime; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Stetson (U of Washington) for sharing the ADAR1-KO 293T cell line and Z.J. Chen (UT Southwestern) for assisting with IRF3 dimerization assays. S.A. is funded by Cancer Research Institute. This work was funded through NIH grants (R01AI106912, R01AI111784, and R21AI130791) and awards from March of Dime and Burroughs Wellcome Fund to S.H.	Aktas T, 2017, NATURE, V544, P115, DOI 10.1038/nature21715; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chiappinelli KB, 2016, CELL, V164, P1073, DOI 10.1016/j.cell.2015.10.020; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Duany YD, 2015, CURR OPIN VIROL, V12, P20, DOI 10.1016/j.coviro.2015.01.011; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jamieson AC, 1996, P NATL ACAD SCI USA, V93, P12834, DOI 10.1073/pnas.93.23.12834; JANG KL, 1989, FEBS LETT, V258, P255, DOI 10.1016/0014-5793(89)81667-9; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Karijolich J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005260; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li Y, 2017, ELIFE, V6, DOI [10.7554/eLife.29914, 10.7554/eLife.25687]; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pham AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005489; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Rutsch F, 2015, AM J HUM GENET, V96, P275, DOI 10.1016/j.ajhg.2014.12.014; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smit AF., 2018, REPEATMASKER; Sugimoto Y, 2015, NATURE, V519, P491, DOI 10.1038/nature14280; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Williams WP, 2004, VIROLOGY, V327, P233, DOI 10.1016/j.virol.2004.06.040; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048	45	192	196	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					797	+		10.1016/j.cell.2017.12.016	http://dx.doi.org/10.1016/j.cell.2017.12.016			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29395326	Green Accepted, Bronze			2022-12-28	WOS:000424648800019
J	Liu, Z; Cai, YJ; Wang, Y; Nie, YH; Zhang, CC; Xu, YT; Zhang, XT; Lu, Y; Wang, ZY; Poo, MM; Sun, Q				Liu, Zhen; Cai, Yijun; Wang, Yan; Nie, Yanhong; Zhang, Chenchen; Xu, Yuting; Zhang, Xiaotong; Lu, Yong; Wang, Zhanyang; Poo, Muming; Sun, Qiang			Cloning of Macaque Monkeys by Somatic Cell Nuclear Transfer	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE DEACETYLASE INHIBITOR; SIGNIFICANT IMPROVEMENT; CLONED EMBRYOS; ADULT; PRIMATES; GENERATION; OOCYTES; EXPRESSION; EFFICIENCY	Generation of genetically uniform non-human primates may help to establish animal models for primate biology and biomedical research. In this study, we have successfully cloned cynomolgus monkeys (Macaca fascicularis) by somatic cell nuclear transfer (SCNT). We found that injection of H3K9me3 demethylase Kdm4d mRNA and treatment with histone deacetylase inhibitor trichostatin A at one-cell stage following SCNT greatly improved blastocyst development and pregnancy rate of transplanted SCNT embryos in surrogate monkeys. For SCNT using fetal monkey fibroblasts, 6 pregnancies were confirmed in 21 surrogates and yielded 2 healthy babies. For SCNT using adult monkey cumulus cells, 22 pregnancies were confirmed in 42 surrogates and yielded 2 babies that were short-lived. In both cases, genetic analyses confirmed that the nuclear DNA and mitochondria DNA of the monkey offspring originated from the nucleus donor cell and the oocyte donor monkey, respectively. Thus, cloning macaque monkeys by SCNT is feasible using fetal fibroblasts.	[Liu, Zhen; Cai, Yijun; Wang, Yan; Nie, Yanhong; Zhang, Chenchen; Xu, Yuting; Zhang, Xiaotong; Lu, Yong; Wang, Zhanyang; Poo, Muming; Sun, Qiang] Chinese Acad Sci, Inst Neurosci, CAS Ctr Excellence Brain Sci & Intelligence Techn, CAS Key Lab Primate Neurobiol,State Key Lab Neuro, Shanghai, Peoples R China	Chinese Academy of Sciences	Sun, Q (corresponding author), Chinese Acad Sci, Inst Neurosci, CAS Ctr Excellence Brain Sci & Intelligence Techn, CAS Key Lab Primate Neurobiol,State Key Lab Neuro, Shanghai, Peoples R China.	qsun@ion.ac.cn	Zhang, Xiaotong/HIR-6204-2022		Chinese Academy of Sciences (Key Research Program of Frontier Sciences) [QYZDY-SSW-SMC001]; CAS Key Technology Talent Program; Shanghai Municipal Government Bureau of Science and Technology Grant [16JC1420200]; National Postdoctoral Program for Innovative Talents [BX201700266]	Chinese Academy of Sciences (Key Research Program of Frontier Sciences); CAS Key Technology Talent Program; Shanghai Municipal Government Bureau of Science and Technology Grant; National Postdoctoral Program for Innovative Talents	We thank Lina Wang, Tikui Zhang, Jia Liu, Qiming Liu, Jiantao Huang, Changshan Gao, and Yuzhuo Li for help in animal breeding and care, Jiahuai Han and Yufeng Yang for providing human Kdm4d plasmid, Qian Hu for the help in fluorescence imaging, and Tiansheng Zhou for the pathology report. This work was supported by grants from Chinese Academy of Sciences (Key Research Program of Frontier Sciences QYZDY-SSW-SMC001) to M.P., CAS Key Technology Talent Program to Q.S., Shanghai Municipal Government Bureau of Science and Technology Grant (16JC1420200) to M.P. and Q.S., and National Postdoctoral Program for Innovative Talents (BX201700266) to Z.L.	Akagi S, 2011, J REPROD DEVELOP, V57, P120, DOI 10.1262/jrd.10-058A; Antony J, 2013, MOL CELL BIOL, V33, P974, DOI 10.1128/MCB.01014-12; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Cui Y., 2018, CELL RES; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jennings C, 2016, NAT NEUROSCI, V19, P1123, DOI 10.1038/nn.4362; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lin JW, 2011, CELL STEM CELL, V8, P371, DOI 10.1016/j.stem.2011.02.007; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Liu Z, 2016, CELL RES, V26, P139, DOI 10.1038/cr.2015.112; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Meng L, 1997, BIOL REPROD, V57, P454, DOI 10.1095/biolreprod57.2.454; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov SM, 2002, BIOL REPROD, V66, P1367, DOI 10.1095/biolreprod66.5.1367; Ng SC, 2004, DEVELOPMENT, V131, P2475, DOI 10.1242/dev.01118; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Rogers CS, 2016, TRANSGENIC RES, V25, P105, DOI 10.1007/s11248-016-9928-6; Schramm R D, 2004, Reprod Biol Endocrinol, V2, P38, DOI 10.1186/1477-7827-2-38; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Smedley JV, 2002, CONTEMP TOP LAB ANIM, V41, P18; Sparman ML, 2010, INT J DEV BIOL, V54, P1671, DOI 10.1387/ijdb.103196ms; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 2007, CLONING STEM CELLS, V9, P3, DOI 10.1089/clo.2006.0002; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287; Yao X., 2018, CELL RES; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	39	150	177	10	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					881	+	887.e7	10.1016/j.cell.2018.01.020	http://dx.doi.org/10.1016/j.cell.2018.01.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29395327	Bronze			2022-12-28	WOS:000424648800025
J	Sexton, PM; Christopoulos, A				Sexton, Patrick M.; Christopoulos, Arthur			To Bind or Not to Bind: Unravelling GPCR Polypharmacology	CELL			English	Editorial Material							DISCOVERY	Interaction of a single drug with multiple targets through "polypharmacology'' is increasingly recognized as necessary for treatment of complex diseases, such as schizophrenia. G protein-coupled receptors (GPCRs) are major medicinal targets, and understanding the structural basis of both GPCR drug selectivity and promiscuity could provide novel avenues for drug development.	[Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Sexton, Patrick M.] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China	Monash University; Fudan University	Sexton, PM; Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.; Sexton, PM (corresponding author), Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China.	patrick.sexton@monash.edu; arthur.christopoulos@monash.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473				Bradley SJ, 2017, J CLIN INVEST, V127, P487, DOI 10.1172/JCI87526; Ngo T, 2017, NAT CHEM BIOL, V13, P235, DOI [10.1038/NCHEMBIO.2266, 10.1038/nchembio.2266]; Peng Y, 2018, CELL, V172, P719, DOI 10.1016/j.cell.2018.01.001; Piscitelli CL, 2015, MOL PHARMACOL, V88, P536, DOI 10.1124/mol.115.099663; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2017, NAT CHEM BIOL, V13, P1143, DOI 10.1038/nchembio.2490; Schmid CL, 2017, CELL, V171, P1165, DOI 10.1016/j.cell.2017.10.035; Schonegge AM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02257-x; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896	9	13	13	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					636	638		10.1016/j.cell.2018.01.018	http://dx.doi.org/10.1016/j.cell.2018.01.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425482	Bronze			2022-12-28	WOS:000424648800002
J	Boerma, T; Requejo, J; Victora, CG; Amouzou, A; George, A; Agyepong, I; Barroso, C; Barros, AJD; Bhutta, ZA; Black, RE; Borghi, J; Buse, K; Aguirre, LC; Chopra, M; Chou, D; Chu, Y; Claeson, M; Daelmans, B; Davis, A; DeJong, J; Diaz, T; El Arifeen, S; Ewerling, F; Fox, M; Gillespie, S; Grove, J; Guenther, T; Haakenstad, A; Hosseinpoor, AR; Hounton, S; Huicho, L; Jacobs, T; Jiwani, S; Keita, Y; Khosla, R; Kruk, ME; Kuo, NT; Kyobutungi, C; Langer, A; Lawn, JE; Leslie, H; Liang, MJ; Maliqi, B; Manu, A; Masanja, H; Marchant, T; Menon, P; Moran, AC; Mujica, OJ; Nambiar, D; Ohiri, K; Park, LA; Patton, GC; Peterson, S; Piwoz, E; Rasanathan, K; Raj, A; Ronsmans, C; Saad-Haddad, G; Sabin, ML; Sanders, D; Sawyer, SM; Silva, ICM; Singh, NS; Somers, K; Spiegel, P; Tappis, H; Temmerman, M; Vaz, LME; Ved, RR; Vidaletti, LP; Waiswa, P; Wehrmeister, FC; Weiss, W; You, DZ; Zaidi, S				Boerma, Ties; Requejo, Jennifer; Victora, Cesar G.; Amouzou, Agbessi; George, Asha; Agyepong, Irene; Barroso, Carmen; Barros, Aluisio J. D.; Bhutta, Zulfiqar A.; Black, Robert E.; Borghi, Josephine; Buse, Kent; Aguirre, Liliana Carvajal; Chopra, Mickey; Chou, Doris; Chu, Yue; Claeson, Mariam; Daelmans, Bernadette; Davis, Austen; DeJong, Jocelyn; Diaz, Theresa; El Arifeen, Shams; Ewerling, Fernanda; Fox, Monica; Gillespie, Stuart; Grove, John; Guenther, Tanya; Haakenstad, Annie; Hosseinpoor, Ahmad Reza; Hounton, Sennen; Huicho, Luis; Jacobs, Troy; Jiwani, Safia; Keita, Youssouf; Khosla, Rajat; Kruk, Margaret E.; Kuo, Nana Taona; Kyobutungi, Catherine; Langer, Ana; Lawn, Joy E.; Leslie, Hannah; Liang, Mengjia; Maliqi, Blerta; Manu, Alexander; Masanja, Honorati; Marchant, Tanya; Menon, Purnima; Moran, Allisyn C.; Mujica, Oscar J.; Nambiar, Devaki; Ohiri, Kelechi; Park, Lois A.; Patton, George C.; Peterson, Stefan; Piwoz, Ellen; Rasanathan, Kumanan; Raj, Anita; Ronsmans, Carine; Saad-Haddad, Ghada; Sabin, Mariam L.; Sanders, David; Sawyer, Susan M.; Silva, Inacio Crochemore M.; Singh, Neha S.; Somers, Kate; Spiegel, Paul; Tappis, Hannah; Temmerman, Marleen; Vaz, Lara M. E.; Ved, Rajani R.; Vidaletti, Luis Paulo; Waiswa, Peter; Wehrmeister, Fernando C.; Weiss, William; You, Danzhen; Zaidi, Shehla		Countdown 2030 Collaboration	Countdown to 2030: tracking progress towards universal coverage for reproductive, maternal, newborn, and child health	LANCET			English	Review							SUSTAINABLE DEVELOPMENT GOALS; MIDDLE-INCOME COUNTRIES; SYSTEMATIC ANALYSIS; GLOBAL HEALTH; POLITICAL PRIORITY; POLICY-ANALYSIS; MORTALITY; POPULATIONS; REFUGEE; AFRICA	Building upon the successes of Countdown to 2015, Countdown to 2030 aims to support the monitoring and measurement of women's, children's, and adolescents' health in the 81 countries that account for 95% of maternal and 90% of all child deaths worldwide. To achieve the Sustainable Development Goals by 2030, the rate of decline in prevalence of maternal and child mortality, stillbirths, and stunting among children younger than 5 years of age needs to accelerate considerably compared with progress since 2000. Such accelerations are only possible with a rapid scale-up of effective interventions to all population groups within countries (particularly in countries with the highest mortality and in those affected by conflict), supported by improvements in underlying socioeconomic conditions, including women's empowerment. Three main conclusions emerge from our analysis of intervention coverage, equity, and drivers of reproductive, maternal, newborn, and child health (RMNCH) in the 81 Countdown countries. First, even though strong progress was made in the coverage of many essential RMNCH interventions during the past decade, many countries are still a long way from universal coverage for most essential interventions. Furthermore, a growing body of evidence suggests that available services in many countries are of poor quality, limiting the potential effect on RMNCH outcomes. Second, within-country inequalities in intervention coverage are reducing in most countries (and are now almost non-existent in a few countries), but the pace is too slow. Third, health-sector (eg, weak country health systems) and non-health-sector drivers (eg, conflict settings) are major impediments to delivering high-quality services to all populations. Although more data for RMNCH interventions are available now, major data gaps still preclude the use of evidence to drive decision making and accountability. Countdown to 2030 is investing in improvements in measurement in several areas, such as quality of care and effective coverage, nutrition programmes, adolescent health, early childhood development, and evidence for conflict settings, and is prioritising its regional networks to enhance local analytic capacity and evidence for RMNCH.	[Boerma, Ties] Univ Manitoba, Rady Fac Hlth Sci, Ctr Global Publ Hlth, 771 McDermot Ave, Winnipeg, MB R3E 0T6, Canada; [Boerma, Ties] Univ Manitoba, Winnipeg, MB, Canada; [Requejo, Jennifer; Amouzou, Agbessi; Black, Robert E.; Chu, Yue; Fox, Monica; Jiwani, Safia; Keita, Youssouf; Park, Lois A.; Spiegel, Paul; Tappis, Hannah; Weiss, William] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Victora, Cesar G.; Barros, Aluisio J. D.; Ewerling, Fernanda; Silva, Inacio Crochemore M.; Vidaletti, Luis Paulo; Wehrmeister, Fernando C.] Univ Fed Pelotas, Pelotas, Brazil; [George, Asha; Sanders, David] Univ Western Cape, Bellville, South Africa; [Agyepong, Irene] Univ Ghana, Accra, Ghana; [Bhutta, Zulfiqar A.; Temmerman, Marleen; Zaidi, Shehla] Aga Khan Univ, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Hosp Sick Children, Toronto, ON, Canada; [Borghi, Josephine; Lawn, Joy E.; Marchant, Tanya; Ronsmans, Carine; Singh, Neha S.] London Sch Hyg & Trop Med, London, England; [Buse, Kent] UNAIDS, Geneva, Switzerland; [Aguirre, Liliana Carvajal; Peterson, Stefan; Rasanathan, Kumanan; You, Danzhen] UNICEF, New York, NY USA; [Chopra, Mickey] World Bank Grp, Washington, DC USA; [Chou, Doris; Daelmans, Bernadette; Diaz, Theresa; Grove, John; Hosseinpoor, Ahmad Reza; Khosla, Rajat; Maliqi, Blerta; Moran, Allisyn C.] WHO, Geneva, Switzerland; [Claeson, Mariam] Global Financing Facil, Oslo, Norway; [Davis, Austen] Norwegian Agcy Dev Cooperat, Oslo, Norway; [DeJong, Jocelyn; Saad-Haddad, Ghada] Amer Univ Beirut, Beirut, Lebanon; [El Arifeen, Shams] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Gillespie, Stuart; Menon, Purnima] Int Food Policy Res Inst, Washington, DC 20036 USA; [Guenther, Tanya; Vaz, Lara M. E.] Save Children USA, Westport, CT USA; [Haakenstad, Annie; Kruk, Margaret E.; Langer, Ana; Leslie, Hannah; Ohiri, Kelechi] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Hounton, Sennen; Liang, Mengjia] UN Populat Fund, New York, NY USA; [Huicho, Luis] Ctr Invest Salud Materna Infantil, New York, NY USA; [Hounton, Sennen] Ctr Invest Desarrollo Integral Sostenible, Guayaquil, Ecuador; [Hounton, Sennen] Univ Peruana Cayetano Heredia, Lima, Peru; [Hounton, Sennen] Univ Nacl Mayor San Marcos, Lima, Peru; [Hounton, Sennen; Weiss, William] US Agcy Int Dev, Washington, DC 20523 USA; [Kuo, Nana Taona] Every Woman Every Child Team, Lima, Peru; [Kyobutungi, Catherine] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Manu, Alexander] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Masanja, Honorati] Ifakara Hlth Inst, Ifakara, Tanzania; [Mujica, Oscar J.] Pan Amer Hlth Org, Washington, DC USA; Publ Hlth Fdn India, New Delhi, India; [Patton, George C.; Sawyer, Susan M.] Univ Melbourne, Melbourne, Vic, Australia; [Piwoz, Ellen; Somers, Kate] Bill & Melinda Gates Fdn, Seattle, WA USA; [Raj, Anita] Univ Calif San Diego, San Diego, CA 92103 USA; [Sabin, Mariam L.] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Ved, Rajani R.] Natl Hlth Syst Resource Ctr, New Delhi, India; [Waiswa, Peter] Makerere Univ, Kampala, Uganda	University of Manitoba; University of Manitoba; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Pelotas; University of the Western Cape; University of Ghana; Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; London School of Hygiene & Tropical Medicine; UNAIDS; UNICEF; The World Bank; World Health Organization; American University of Beirut; International Centre for Diarrhoeal Disease Research (ICDDR); CGIAR; International Food Policy Research Institute (IFPRI); Save the Children; Harvard University; Harvard T.H. Chan School of Public Health; United Nations Population Fund; Universidad Peruana Cayetano Heredia; Universidad Nacional Mayor de San Marcos; United States Agency for International Development (USAID); African Population & Health Research Centre; Liverpool School of Tropical Medicine; Ifakara Health Institute; Pan American Health Organization; Public Health Foundation of India; University of Melbourne; Bill & Melinda Gates Foundation; University of California System; University of California San Diego; Makerere University	Boerma, T (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Ctr Global Publ Hlth, 771 McDermot Ave, Winnipeg, MB R3E 0T6, Canada.	ties.boerma@umanitoba.ca	Buse, Kent/AAK-6688-2020; Silva, Inacio C M/L-9896-2017; Wehrmeister, Fernando/A-3006-2014; Ewerling, Fernanda/Z-2519-2019; Ribeiro, Ana Cristina/HHN-7466-2022; Victora, Cesar Gomes/Y-2455-2019; Barros, Aluisio JD/A-7417-2008; Lawn, Joy/ABE-6382-2020; Saad, Ghada/AAC-9267-2020; Huicho, Luis/AAD-7353-2019; Patton, George C/B-5246-2013; Kruk, Margaret E/E-3058-2010; da Silva, Inacio Crochemore M/S-4743-2019; Hosseinpoor, Ahmad Reza/AFP-8422-2022; Spiegel, Paul/AAL-3238-2021; Tappis, Hannah/F-5005-2011; Bhutta, Zulfiqar/L-7822-2015	Buse, Kent/0000-0002-5485-0110; Silva, Inacio C M/0000-0001-5390-8360; Wehrmeister, Fernando/0000-0001-7137-1747; Ribeiro, Ana Cristina/0000-0002-0493-8376; Victora, Cesar Gomes/0000-0002-2465-2180; Barros, Aluisio JD/0000-0002-2022-8729; Lawn, Joy/0000-0002-4573-1443; Saad, Ghada/0000-0001-6163-4822; Patton, George C/0000-0001-5039-8326; Kruk, Margaret E/0000-0002-9549-8432; da Silva, Inacio Crochemore M/0000-0001-5390-8360; Hosseinpoor, Ahmad Reza/0000-0001-7322-672X; Spiegel, Paul/0000-0002-6158-6661; Zaidi, Shehla/0000-0001-7620-9247; Tappis, Hannah/0000-0002-4289-5418; Borghi, Josephine/0000-0002-0482-5451; George, Asha/0000-0002-5968-1424; Marchant, Tanya/0000-0002-4228-4334; Sabin, Miriam/0000-0002-7758-8338; Mujica, Oscar/0000-0002-2893-4206; Nambiar, Devaki/0000-0001-5682-6109; Barroso, Carmen/0000-0002-9452-7086; Bhutta, Zulfiqar/0000-0003-0637-599X; Diaz, Theresa/0000-0001-5063-8078; Arifeen, Shams/0000-0002-5372-5932; Moran, Allisyn C/0000-0002-4826-1475; Huicho, Luis/0000-0002-5272-5885; Singh, Neha/0000-0003-0057-121X; Agyepong, Irene Akua/0000-0002-0193-5882; Amouzou, Agbessi/0000-0002-6262-3866	Bill & Melinda Gates Foundation; US Government; Norwegian Government; South African Research Chair's Initiative of the Department of Science and Technology; National Research Foundation of South Africa [82769]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Government; Norwegian Government; South African Research Chair's Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa)	Our work was supported by the Bill & Melinda Gates Foundation, and the US and Norwegian Governments. The Wellcome Trust provided support for equity analyses. The funders had no role in the conceptualisation of the paper or in the material presented. AG is supported by the South African Research Chair's Initiative of the Department of Science and Technology and National Research Foundation of South Africa (grant 82769). Any opinion, finding and conclusion, or recommendation expressed in this material is that of the author, and the National Research Foundation does not accept any liability in this regard. We thank Dilip Thandassery Ramachandran (WHO) for compiling the drivers database with the health systems, policies, and domestic financing indicators, Rachel White (Johns Hopkins University) for help with logistics, and Tiziana Leone (London School of Economics) for work on the abortion policy database.	Akseer N, 2016, LANCET GLOB HEALTH, V4, pE395, DOI 10.1016/S2214-109X(16)30002-X; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2017, 2017 REP; [Anonymous], 2015, MILL DEV GOALS SUST; Bahwere P, 2014, FOOD NUTR BULL, V35, pS47; Barros AJD, 2016, PLOS MED, V10, P119; Bhutta ZA, 2016, LANCET, V387, P2060, DOI 10.1016/S0140-6736(15)00527-9; Black RE, 2016, LANCET, V388, P2811, DOI 10.1016/S0140-6736(16)00738-8; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Buse K., 2012, MAKING HLTH POLICY; Checchi F, 2017, LANCET, V390, P2297, DOI 10.1016/S0140-6736(17)30702-X; Claeson M, 2017, LANCET, V389, P1588, DOI 10.1016/S0140-6736(17)31000-0; Columbia University, 2019, AV MAT DEATH DIS AMD; DeJong J, 2017, BMJ GLOB HLTH, V2, P3, DOI [10.1136/bmjgh-2017-000302, DOI 10.1136/BMJGH-2017-000302]; Desai S, 2017, HEALTH POLICY PLANN, V32, P68, DOI 10.1093/heapol/czw099; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Ewerling F, 2017, LANCET GLOB HEALTH, V5, pE916, DOI 10.1016/S2214-109X(17)30292-9; Foster H, 2015, SOC SCI MED, V146, P292, DOI 10.1016/j.socscimed.2015.10.020; Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4; Gao YQ, 2017, LANCET GLOB HEALTH, V5, pE523, DOI 10.1016/s2214-109x(17)30100-6; Gates S, 2016, TRENDS ARMED CONFLIC; GBD 2015 Maternal Mortality Collaborators, 2016, LANCET; George A, 2015, HEALTH POLICY PLANN, V30, P3, DOI 10.1093/heapol/czv096; Grollman C, 2017, LANCET GLOB HEALTH, V5, pE104, DOI 10.1016/S2214-109X(16)30304-7; Grove J, 2015, LANCET, V386, P1511, DOI 10.1016/S0140-6736(15)00517-6; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hug L, 2017, LEVELS TRENDS CHILD; Huicho L, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0790-3; Huicho L, 2016, LANCET GLOB HEALTH, V4, pE414, DOI 10.1016/S2214-109X(16)00085-1; Hynes M, 2002, JAMA-J AM MED ASSOC, V288, P595, DOI 10.1001/jama.288.5.595; Hynes M, 2012, INT PERSPECT SEX R H, V38, P205, DOI 10.1363/3820512; International Labour Organization, 1952, CONV CONC REV MAT PR; Kruk ME, 2016, LANCET GLOB HEALTH, V4, pE594, DOI 10.1016/S2214-109X(16)30131-0; Kuruvilla S, 2014, B WORLD HEALTH ORGAN, V92, P533, DOI 10.2471/BLT.14.138131; Lam E, 2015, HUM VACC IMMUNOTHER, V11, P2627, DOI 10.1080/21645515.2015.1096457; LeFevre AE, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.021001; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lu CL, 2016, LANCET GLOB HEALTH, V4, pE916, DOI [10.1016/S2214-109X(16)30266-2, 10.1016/s2214-109x(16)30266-2]; Maina I, 2017, B WORLD HEALTH ORGAN, V95, P683, DOI 10.2471/BLT.17.194399; Marchant T, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010506; Mason JB, 2012, INT J ENV RES PUB HE, V9, P791, DOI 10.3390/ijerph9030791; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Organisation for Economic Co-operation and Development Eurostat WHO, SYST HLTH ACC 2011 E; Pozo-Martin F, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0190-7; Ramesh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124688; Rutstein S., 2004, DHS WEALTH INDEX COM, V6; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shiffman J, 2014, INT J HEALTH POLICY, V3, P297, DOI 10.15171/ijhpm.2014.120; Singh NS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3402-5; Smith SL, 2014, GLOB PUBLIC HEALTH, V9, P538, DOI 10.1080/17441692.2014.904918; Stark L, 2011, TRAUMA VIOLENCE ABUS, V12, P127, DOI 10.1177/1524838011404252; Temmerman M, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h4414, 10.1136/bmj.h4147]; Tuncalp O, 2015, BJOG-INT J OBSTET GY, V122, P1045, DOI 10.1111/1471-0528.13451; UNICEF, EQ STRAT SAV LIV PUT; UNICEF-WHO-The World Bank Joint Child Malnutrition Estimates, LEV TRENDS CHILD MAL; United Nations, 2015, GLOB STRAT WOM CHILD; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP PROSP 2017; United Nations Department of Economics and Social Affairs, POP POL DAT; United Nations Inter agency Group for Child Mortality Estimation (UN IGME), 2015, LEV TRENDS CHILD MOR; United Nations Refugee Agency, 2017, GLOB TRENDS FORC DIS; USAID, SYST HLTH ACC 2011 W; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; WALT G, 1994, HEALTH POLICY PLANN, V9, P353, DOI 10.1093/heapol/9.4.353; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Wehrmeister FC, 2016, B WORLD HEALTH ORGAN, V94, P903, DOI 10.2471/BLT.16.173138; Whitmill J, RETROSPECTIVE ANAL R; WHO, GLOB HLTH EXP DAT; WHO/UNICEF, 2014, EV NEWB ACT PLAN END; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, IMPR MORT STAT CIV R; Zhao YJ, 2017, PAEDIATR PERINAT EP, V31, P251, DOI 10.1111/ppe.12363	74	196	196	13	86	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1538	1548		10.1016/S0140-6736(18)30104-1	http://dx.doi.org/10.1016/S0140-6736(18)30104-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29395268	Green Submitted			2022-12-28	WOS:000429926000029
J	DeSalvo, KB				DeSalvo, Karen B.			The Health Consequences of Natural Disasters in the United States: Progress, Perils, and Opportunity	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[DeSalvo, Karen B.] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	DeSalvo, KB (corresponding author), 121 Rio Vista Ave, Jefferson, LA 70121 USA.	karen.desalvo@gmail.com						[Anonymous], 2016, NAT RESP FRAM; Berggren R, 2005, NEW ENGL J MED, V353, P1550, DOI 10.1056/NEJMp058239; DeSalvo K, 2014, AM J PUBLIC HEALTH, V104, P1160, DOI 10.2105/AJPH.2014.302009; DeSalvo KB, 2007, J GEN INTERN MED, V22, P1377, DOI 10.1007/s11606-007-0312-3; DeSalvo KB, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.170017; DeSalvo KB, 2016, ANN INTERN MED, V164, P57, DOI 10.7326/M15-2284; Guenther R, 2014, PRIMARY PROTECTION E; Hagland M, 2017, HEALTHCARE INFO 0829; Tuckson RV, 2017, NEW ENGL J MED, V377, P1806, DOI 10.1056/NEJMp1711834; U. S. Department of Health and Human Services, 2012, HEALTHC PREP CAP NAT	10	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					440	+		10.7326/M17-3240	http://dx.doi.org/10.7326/M17-3240			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ8AM	29459975				2022-12-28	WOS:000427827400021
J	Mohanan, V; Nakata, T; Desch, AN; Levesque, C; Boroughs, A; Guzman, G; Cao, ZF; Creasey, E; Yao, JM; Boucher, G; Charron, G; Bhan, AK; Schenone, M; Carr, SA; Reinecker, HC; Daly, MJ; Rioux, JD; Lassen, KG; Xavier, RJ				Mohanan, Vishnu; Nakata, Toru; Desch, A. Nicole; Levesque, Chloe; Boroughs, Angela; Guzman, Gaelen; Cao, Zhifang; Creasey, Elizabeth; Yao, Junmei; Boucher, Gabrielle; Charron, Guy; Bhan, Atul K.; Schenone, Monica; Carr, Steven A.; Reinecker, Hans-Christian; Daly, Mark J.; Rioux, John D.; Lassen, Kara G.; Xavier, Ramnik J.			C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NUCLEOTIDE EXCHANGE FACTORS; F-BOX PROTEINS; PATHOGENESIS; FAMILY; PERMEABILITY; CANCER; ROLES; LOCI	Polymorphisms in C1orf106 are associated with increased risk of inflammatory bowel disease (IBD). However, the function of C1orf106 and the consequences of disease-associated polymorphisms are unknown. Here we demonstrate that C1orf106 regulates adherens junction stability by regulating the degradation of cytohesin-1, a guanine nucleotide exchange factor that controls activation of ARF6. By limiting cytohesin-1-dependent ARF6 activation, C1orf106 stabilizes adherens junctions. Consistent with this model, C1orf106(-/-) mice exhibit defects in the intestinal epithelial cell barrier, a phenotype observed in IBD patients that confers increased susceptibility to intestinal pathogens. Furthermore, the IBD risk variant increases C1orf106 ubiquitination and turnover with consequent functional impairments. These findings delineate a mechanism by which a genetic polymorphism fine-tunes intestinal epithelial barrier integrity and elucidate a fundamental mechanism of cellular junctional control.	[Mohanan, Vishnu; Nakata, Toru; Desch, A. Nicole; Guzman, Gaelen; Schenone, Monica; Carr, Steven A.; Daly, Mark J.; Lassen, Kara G.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mohanan, Vishnu; Nakata, Toru; Desch, A. Nicole; Boroughs, Angela; Cao, Zhifang; Creasey, Elizabeth; Yao, Junmei; Lassen, Kara G.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Levesque, Chloe; Boucher, Gabrielle; Charron, Guy; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Bhan, Atul K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bhan, Atul K.; Daly, Mark J.] Harvard Med Sch, Boston, MA 02114 USA; [Bhan, Atul K.; Reinecker, Hans-Christian; Daly, Mark J.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Reinecker, Hans-Christian; Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Rioux, John D.] Univ Montreal, Dept Med, Montreal, PQ H1T 1C8, Canada; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Universite de Montreal; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Universite de Montreal; Massachusetts Institute of Technology (MIT)	Lassen, KG; Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Lassen, KG; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	klassen@broadinstitute.org; xavier@molbio.mgh.harvard.edu	Carr, Steven A./AAH-8366-2019; Rioux, John D/A-9599-2015; Nakata, Toru/Q-7159-2018; Daly, Mark J/B-2453-2017	Rioux, John D/0000-0001-7560-8326; Daly, Mark J/0000-0002-0949-8752; Nakata, Toru/0000-0003-3678-4807; Mohanan, Vishnu/0000-0002-1314-7090; Creasey, Elizabeth/0000-0002-9724-7979; Yao, Junmei/0000-0002-4074-7761; cao, zhifang/0000-0003-3019-2763; Guzman, Gaelen/0000-0002-7696-6034; Boroughs, Angela/0000-0002-9701-9538	NIAID NIH HHS [R01 AI113333, U19 AI109725] Funding Source: Medline; NIDDK NIH HHS [R01 DK068181, R01 DK064869, P30 DK043351, U01 DK062432, R01 DK091247] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725, R01AI113333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062432, R01DK064869, P30DK043351, R01DK068181, R01DK091247] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swaminathan G, 2012, ONCOGENE, V31, P376, DOI 10.1038/onc.2011.242	19	62	67	6	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1161	+		10.1126/science.aan0814	http://dx.doi.org/10.1126/science.aan0814			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29420262	Green Accepted			2022-12-28	WOS:000426835900047
J	Comerci, G; Katzman, J; Duhigg, D				Comerci, George, Jr.; Katzman, Joanna; Duhigg, Daniel			Controlling the Swing of the Opioid Pendulum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAIN		[Comerci, George, Jr.; Katzman, Joanna] Univ New Mexico, Pain Consultat & Treatment Ctr, Project ECHO Pain & Opioid Management Clin, Albuquerque, NM 87131 USA; [Comerci, George, Jr.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Katzman, Joanna] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Duhigg, Daniel] Presbyterian Healthcare Syst, Dept Addict Serv, Psychiat & Behav Hlth Clin Program, Albuquerque, NM USA	University of New Mexico; University of New Mexico; University of New Mexico	Comerci, G (corresponding author), Univ New Mexico, Pain Consultat & Treatment Ctr, Project ECHO Pain & Opioid Management Clin, Albuquerque, NM 87131 USA.; Comerci, G (corresponding author), Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.							Daitch J, 2012, PAIN PHYSICIAN, V15, pES59; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Katzman JG, 2014, J CONTIN EDUC HEALTH, V34, P68, DOI 10.1002/chp.21210; Leverence RR, 2011, J AM BOARD FAM MED, V24, P551, DOI 10.3122/jabfm.2011.05.110030; Mars SG, 2014, INT J DRUG POLICY, V25, P257, DOI 10.1016/j.drugpo.2013.10.004	5	35	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2018	378	8					691	693		10.1056/NEJMp1713159	http://dx.doi.org/10.1056/NEJMp1713159			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW8VA	29466151	Bronze			2022-12-28	WOS:000425613900004
J	Knuesel, SJ; Guseh, JS; Leaf, RK; Ciaranello, AL; Eng, GM				Knuesel, Steven J.; Guseh, J. Sawalla, II; Leaf, Rebecca Karp; Ciaranello, Andrea L.; Eng, George M.			Case 6-2018: A 35-Year-Old Woman with Headache, Subjective Fever, and Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARVOVIRUS B19 INFECTION; RED-CELL APLASIA; HEMOLYTIC-ANEMIA; ERYTHROCYTES; MARROW		[Knuesel, Steven J.; Guseh, J. Sawalla, II; Leaf, Rebecca Karp; Ciaranello, Andrea L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Eng, George M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Knuesel, Steven J.; Guseh, J. Sawalla, II; Leaf, Rebecca Karp; Ciaranello, Andrea L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Eng, George M.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Knuesel, SJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Knuesel, SJ (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		, Andrea/ABB-3330-2021; Guseh, James/AAB-2712-2022	, Andrea/0000-0002-4268-3263; Guseh, James/0000-0003-0992-5635				ALLISON AC, 1960, NATURE, V188, P37, DOI 10.1038/188037a0; Anderson DR, 2002, COMPLETE SPLEEN STRU, P193; [Anonymous], 2011, 5 DIS PARV B19; Bonsch C, 2008, J VIROL, V82, P11784, DOI 10.1128/JVI.01399-08; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P81; Centers for Disease Control (CDC), 1989, MMWR-MORBID MORTAL W, V38, p[81, 93]; Chen MY, 2001, CLIN INFECT DIS, V32, P1361, DOI 10.1086/319988; Dhaliwal G, 2004, AM FAM PHYSICIAN, V69, P2599; Enders M, 2004, PRENATAL DIAG, V24, P513, DOI 10.1002/pd.940; Gelehrter T, 1998, PRINCIPLES MED GENET, P181; Giovannetti G, 2013, BLOOD TRANSFUS-ITALY, V11, P634, DOI 10.2450/2013.0198-12; Goodnough LT, 2014, WINTROBES CLIN HEMAT, V13, P1419; Laporte JR, 1998, LANCET, V352, P619, DOI 10.1016/S0140-6736(98)24034-7; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Means RT, 2016, BLOOD, V128, P2504, DOI 10.1182/blood-2016-05-717140; Plentz A, 2004, J CLIN VIROL, V31, P16, DOI 10.1016/j.jcv.2004.05.015; PLUMMER FA, 1985, NEW ENGL J MED, V313, P74, DOI 10.1056/NEJM198507113130203; POTTER CG, 1987, J CLIN INVEST, V79, P1486, DOI 10.1172/JCI112978; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zeroncio M, 2017, J CROHNS COLITIS, V11, pS410	21	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2018	378	8					753	760		10.1056/NEJMcpc1712223	http://dx.doi.org/10.1056/NEJMcpc1712223			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8VA	29466149				2022-12-28	WOS:000425613900013
J	Carpenter, CR				Carpenter, Christopher R.			Review: Procalcitonin-guided starting and stopping of antibiotics in acute respiratory infections reduces mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Carpenter, Christopher R.] Washington Univ St Louis, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Carpenter, CR (corresponding author), Washington Univ St Louis, Sch Med, St Louis, MO 63130 USA.		Carpenter, Christopher R./E-3720-2013	Carpenter, Christopher R./0000-0002-2603-7157				El Dib R, 2017, J CLIN EPIDEMIOL, V84, P61, DOI 10.1016/j.jclinepi.2016.12.009; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Huang DT, 2017, BMC EMERG MED, V17, DOI 10.1186/s12873-017-0138-1; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Wirz Y, 2017, ACS INFECT DIS, V3, P875, DOI 10.1021/acsinfecdis.7b00199; Zaas AK, 2014, TRENDS MOL MED, V20, P579, DOI 10.1016/j.molmed.2014.08.001	6	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC19	JC19		10.7326/ACPJC-2018-168-4-019	http://dx.doi.org/10.7326/ACPJC-2018-168-4-019			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459956				2022-12-28	WOS:000425434000007
J	Kaiser, J; Malakoff, D; Mervis, J; Voosen, P				Kaiser, Jocelyn; Malakoff, David; Mervis, Jeffrey; Voosen, Paul			Science gets modest reprieve in Trump budget	SCIENCE			English	News Item																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					723	724						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449467				2022-12-28	WOS:000425116200016
J	Rosen, J				Rosen, Julia			THE CARBON HARVEST	SCIENCE			English	Editorial Material																			0	11	11	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					733	737						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449474				2022-12-28	WOS:000425116200023
J	Akrami, A; Kopec, CD; Diamond, ME; Brody, CD				Akrami, Athena; Kopec, Charles D.; Diamond, Mathew E.; Brody, Carlos D.			Posterior parietal cortex represents sensory history and mediates its effects on behaviour	NATURE			English	Article							WORKING-MEMORY; INFORMATION; PERCEPTION; DISCRIMINATION; FLUTTER; BIASES	Many models of cognition and of neural computations posit the use and estimation of prior stimulus statistics(1-4): it has long been known that working memory and perception are strongly impacted by previous sensory experience, even when that sensory history is not relevant to the current task at hand. Nevertheless, the neural mechanisms and regions of the brain that are necessary for computing and using such prior experience are unknown. Here we report that the posterior parietal cortex (PPC) is a critical locus for the representation and use of prior stimulus information. We trained rats in an auditory parametric working memory task, and found that they displayed substantial and readily quantifiable behavioural effects of sensory-stimulus history, similar to those observed in humans(5,6) and monkeys(7). Earlier proposals that the PPC supports working memory(8,9) predict that optogenetic silencing of this region would impair behaviour in our working memory task. Contrary to this prediction, we found that silencing the PPC significantly improved performance. Quantitative analyses of behaviour revealed that this improvement was due to the selective reduction of the effects of prior sensory stimuli. Electrophysiological recordings showed that PPC neurons carried far more information about the sensory stimuli of previous trials than about the stimuli of the current trial. Furthermore, for a given rat, the more information about previous trial sensory history in the neural firing rates of the PPC, the greater the behavioural effect of sensory history, suggesting a tight link between behaviour and PPC representations of stimulus history. Our results indicate that the PPC is a central component in the processing of sensory-stimulus history, and could enable further neurobiological investigation of long-standing questions regarding how perception and working memory are affected by prior sensory information.	[Akrami, Athena; Kopec, Charles D.; Brody, Carlos D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Akrami, Athena; Kopec, Charles D.; Brody, Carlos D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Akrami, Athena; Brody, Carlos D.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Diamond, Mathew E.] Int Sch Adv Studies SISSA, Tactile Percept & Learning Lab, I-34136 Trieste, Italy	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; International School for Advanced Studies (SISSA)	Akrami, A; Brody, CD (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Akrami, A; Brody, CD (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.; Akrami, A; Brody, CD (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	aakrami@princeton.edu; brody@princeton.edu		Akrami, Athena/0000-0001-5711-0903; DIAMOND, Mathew Ernest/0000-0003-2286-4566				Abrahamyan A, 2016, P NATL ACAD SCI USA, V113, pE3548, DOI 10.1073/pnas.1518786113; Ashourian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019551; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Carandini M, 2013, NAT NEUROSCI, V16, P824, DOI 10.1038/nn.3410; Chater N, 2006, TRENDS COGN SCI, V10, P287, DOI 10.1016/j.tics.2006.05.007; Erlich JC, 2015, ELIFE, V4, DOI 10.7554/eLife.05457; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fassihi A, 2014, P NATL ACAD SCI USA, V111, P2331, DOI 10.1073/pnas.1315171111; Fischer J, 2014, NAT NEUROSCI, V17, P738, DOI 10.1038/nn.3689; Fritsche M, 2017, CURR BIOL, V27, P590, DOI 10.1016/j.cub.2017.01.006; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hollingworth H. L., 1910, J PHILOS PSYCHOL SCI, V7, P461, DOI [10.2307/2012819, DOI 10.2307/2012819]; Hwang EJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01356-z; Ince RAA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.011.2010; Karim M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00255; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LOCKHEAD GR, 1983, J EXP PSYCHOL HUMAN, V9, P461, DOI 10.1037/0096-1523.9.3.461; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Nemenman I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056111; Nogueira R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14823; Olkkonen M, 2014, J VISION, V14, DOI 10.1167/14.11.5; Paninski L, 2004, J NEUROSCI, V24, P8551, DOI 10.1523/JNEUROSCI.0919-04.2004; Papadimitriou C, 2015, J NEUROPHYSIOL, V113, P567, DOI 10.1152/jn.00402.2014; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pouget A, 2013, NAT NEUROSCI, V16, P1170, DOI 10.1038/nn.3495; Preuschhof C, 2010, J COGNITIVE NEUROSCI, V22, P875, DOI 10.1162/jocn.2009.21260; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; Raviv O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002731; RIEKE F, 1993, EUROPHYS LETT, V22, P151, DOI 10.1209/0295-5075/22/2/013; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Schapiro A., 2015, BRAIN MAPPING, V3, P501, DOI DOI 10.1016/B978-0-12-397025-1.00276-1; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sinclair RJ, 1996, PERCEPT PSYCHOPHYS, V58, P680, DOI 10.3758/BF03213100; Steyvers M, 2006, TRENDS COGN SCI, V10, P327, DOI 10.1016/j.tics.2006.05.005; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Visscher KM, 2009, J EXP PSYCHOL LEARN, V35, P46, DOI 10.1037/a0013412	39	135	135	5	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					368	+		10.1038/nature25510	http://dx.doi.org/10.1038/nature25510			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW0PD	29414944	Green Submitted			2022-12-28	WOS:000424996300040
J	Barik, S; Karasahin, A; Flower, C; Cai, T; Miyake, H; DeGottardi, W; Hafezi, M; Waks, E				Barik, Sabyasachi; Karasahin, Aziz; Flower, Christopher; Cai, Tao; Miyake, Hirokazu; DeGottardi, Wade; Hafezi, Mohammad; Waks, Edo			A topological quantum optics interface	SCIENCE			English	Article							EDGE STATES	The application of topology in optics has led to a new paradigm in developing photonic devices with robust properties against disorder. Although considerable progress on topological phenomena has been achieved in the classical domain, the realization of strong light-matter coupling in the quantum domain remains unexplored. We demonstrate a strong interface between single quantum emitters and topological photonic states. Our approach creates robust counter propagating edge states at the boundary of two distinct topological photonic crystals. We demonstrate the chiral emission of a quantum emitter into these modes and establish their robustness against sharp bends. This approach may enable the development of quantum optics devices with built-in protection, with potential applications in quantum simulation and sensing.	[Barik, Sabyasachi; Flower, Christopher; DeGottardi, Wade; Hafezi, Mohammad; Waks, Edo] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Barik, Sabyasachi; Flower, Christopher; Miyake, Hirokazu; DeGottardi, Wade; Hafezi, Mohammad; Waks, Edo] Univ Maryland, Joint Quantum Inst, College Pk, MD 20742 USA; [Karasahin, Aziz; Cai, Tao; Hafezi, Mohammad; Waks, Edo] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA; [Karasahin, Aziz; Cai, Tao; Hafezi, Mohammad; Waks, Edo] Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Hafezi, M; Waks, E (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.; Hafezi, M; Waks, E (corresponding author), Univ Maryland, Joint Quantum Inst, College Pk, MD 20742 USA.; Hafezi, M; Waks, E (corresponding author), Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA.; Hafezi, M; Waks, E (corresponding author), Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA.	hafezi@umd.edu; edowaks@umd.edu	Hafezi, Mohammad/A-1197-2008; Barik, Sabaysachi/E-2219-2012; Waks, Edo/E-3982-2016	Hafezi, Mohammad/0000-0003-1679-4880; Barik, Sabaysachi/0000-0003-3618-5206; Waks, Edo/0000-0003-0299-0784; Karasahin, Aziz/0000-0001-9540-5008; DeGottardi, Wade/0000-0003-3890-4307	Office of Naval Research; Air Force Office of Scientific Research-Multidisciplinary University Research Initiative [FA9550-16-1-0323]; Sloan Foundation; Physics Frontier Center at the Joint Quantum Institute; Division Of Physics [1430094] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research-Multidisciplinary University Research Initiative(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Sloan Foundation(Alfred P. Sloan Foundation); Physics Frontier Center at the Joint Quantum Institute; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors acknowledge fruitful discussions with S. Mittal. All data needed to evaluate the conclusions are present in the paper and/or the supplementary materials. This research was supported by the Office of Naval Research, the Air Force Office of Scientific Research-Multidisciplinary University Research Initiative (grant FA9550-16-1-0323), the Sloan Foundation, and the Physics Frontier Center at the Joint Quantum Institute.	Angelakis DG, 2017, QUANT SCI TECH, P1, DOI 10.1007/978-3-319-52025-4; Barik S, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/11/113013; Bayer M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195315; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; Cheng XJ, 2016, NAT MATER, V15, P542, DOI [10.1038/NMAT4573, 10.1038/nmat4573]; Cirac JI, 2017, NAT PHOTONICS, V11, P18, DOI 10.1038/nphoton.2016.259; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Eckardt A, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.011004; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hafezi M, 2014, PHYS TODAY, V67, P68, DOI 10.1063/PT.3.2394; Hafezi M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063001; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Harari G., 2016, C LAS EL; Kane CL, 2014, NAT PHYS, V10, P39, DOI [10.1038/nphys2835, 10.1038/NPHYS2835]; Kariyado T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16334-0; Lodahl P, 2017, NATURE, V541, P473, DOI 10.1038/nature21037; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Metelmann A, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021025; Paulose J, 2015, NAT PHYS, V11, P153, DOI 10.1038/NPHYS3185; Pilozzi L, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.195317; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Ringel M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/113030; Sollner I, 2015, NAT NANOTECHNOL, V10, P775, DOI [10.1038/NNANO.2015.159, 10.1038/nnano.2015.159]; St-Jean P, 2017, NAT PHOTONICS, V11, P651, DOI 10.1038/s41566-017-0006-2; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Umucalilar RO, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.206809; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Wu LH, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.223901	30	373	377	33	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					666	668		10.1126/science.aaq0327	http://dx.doi.org/10.1126/science.aaq0327			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439239	Green Submitted			2022-12-28	WOS:000425117700035
J	Lin, YJ; Haigis, KM				Lin, Yi-Jang; Haigis, Kevin M.			Brother's Keeper: Wild-Type Mutant K-Ras Dimers Limit Oncogenesis	CELL			English	Editorial Material								K-Ras is the undisputed champion of oncogenes, yet our ability to interfere with its oncogenic function is hampered by insufficient mechanistic understanding. In this issue of Cell, Ambrogio and colleagues connect the ability of K-Ras to dimerize to the ability of wild-type K-Ras to limit the oncogenic properties of the mutant.	[Lin, Yi-Jang; Haigis, Kevin M.] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA; [Lin, Yi-Jang; Haigis, Kevin M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Haigis, KM (corresponding author), Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA.; Haigis, KM (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	khaigis@bidmc.harvard.edu						Ambrogio C, 2018, CELL, V172, P857, DOI 10.1016/j.cell.2017.12.020; Burgess MR, 2017, CELL, V168, P817, DOI 10.1016/j.cell.2017.01.020; Kong G, 2016, LEUKEMIA, V30, P1542, DOI 10.1038/leu.2016.40; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Smith MJ, 2014, NAT CHEM BIOL, V10, P223, DOI [10.1038/NCHEMBIO.1435, 10.1038/nchembio.1435]; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	10	4	4	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					645	647		10.1016/j.cell.2018.01.019	http://dx.doi.org/10.1016/j.cell.2018.01.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425486	Bronze			2022-12-28	WOS:000424648800006
J	Lu, LM; Mao, LF; Yang, T; Ye, JF; Liu, B; Li, HL; Sun, M; Miller, JT; Mathews, S; Hu, HH; Niu, YT; Peng, DX; Chen, YH; Smith, SA; Chen, M; Xiang, KL; Le, CT; Dang, VC; Lu, AM; Soltis, PS; Soltis, DE; Li, JH; Chen, ZD				Lu, Li-Min; Mao, Ling-Feng; Yang, Tuo; Ye, Jian-Fei; Liu, Bing; Li, Hong-Lei; Sun, Miao; Miller, Joseph T.; Mathews, Sarah; Hu, Hai-Hua; Niu, Yan-Ting; Peng, Dan-Xiao; Chen, You-Hua; Smith, Stephen A.; Chen, Min; Xiang, Kun-Li; Le, Chi-Toan; Dang, Viet-Cuong; Lu, An-Ming; Soltis, Pamela S.; Soltis, Douglas E.; Li, Jian-Hua; Chen, Zhi-Duan			Evolutionary history of the angiosperm flora of China	NATURE			English	Article							LIFE-HISTORY; PATTERNS; PLANTS; DIVERSIFICATION; CONSERVATION; DIVERSITY; DETERMINANTS; PHYLOGENIES; RICHNESS; RATES	High species diversity may result from recent rapid speciation in a 'cradle' and/or the gradual accumulation and preservation of species over time in a 'museum'(1,2). China harbours nearly 10% of angiosperm species worldwide and has long been considered as both a museum, owing to the presence of many species with hypothesized ancient origins(3,4), and a cradle, as many lineages have originated as recent topographic changes and climatic shifts-such as the formation of the Qinghai-Tibetan Plateau and the development of the monsoon-provided new habitats that promoted remarkable radiation(5). However, no detailed phylogenetic study has addressed when and how the major components of the Chinese angiosperm flora assembled to form the present-day vegetation. Here we investigate the spatio-temporal divergence patterns of the Chinese flora using a dated phylogeny of 92% of the angiosperm genera for the region, a nearly complete species-level tree comprising 26,978 species and detailed spatial distribution data. We found that 66% of the angiosperm genera in China did not originate until early in the Miocene epoch (23 million years ago (Mya)). The flora of eastern China bears a signature of older divergence (mean divergence times of 22.04-25.39 Mya), phylogenetic overdispersion (spatial co-occurrence of distant relatives) and higher phylogenetic diversity. In western China, the flora shows more recent divergence (mean divergence times of 15.29-18.86 Mya), pronounced phylogenetic clustering (co-occurrence of close relatives) and lower phylogenetic diversity. Analyses of species-level phylogenetic diversity using simulated branch lengths yielded results similar to genus-level patterns. Our analyses indicate that eastern China represents a floristic museum, and western China an evolutionary cradle, for herbaceous genera; eastern China has served as both a museum and a cradle for woody genera. These results identify areas of high species richness and phylogenetic diversity, and provide a foundation on which to build conservation efforts in China.	[Lu, Li-Min; Yang, Tuo; Ye, Jian-Fei; Liu, Bing; Hu, Hai-Hua; Niu, Yan-Ting; Peng, Dan-Xiao; Xiang, Kun-Li; Le, Chi-Toan; Dang, Viet-Cuong; Lu, An-Ming; Chen, Zhi-Duan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Mao, Ling-Feng] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Coll Biol & Environm, Nanjing 210037, Jiangsu, Peoples R China; [Ye, Jian-Fei; Hu, Hai-Hua; Niu, Yan-Ting; Peng, Dan-Xiao; Xiang, Kun-Li; Le, Chi-Toan; Dang, Viet-Cuong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ye, Jian-Fei] Chinese Acad Sci, Beijing Bot Garden, Inst Bot, Beijing 100093, Peoples R China; [Liu, Bing; Chen, Zhi-Duan] Chinese Acad Sci, Sino Africa Joint Res Ctr, Wuhan 430074, Hubei, Peoples R China; [Li, Hong-Lei] Chongqing Univ Arts & Sci, Chongqing Key Lab Econ Plant Biotechnol, Inst Special Plants, Yongchuan 402160, Peoples R China; [Li, Hong-Lei] Fairylake Bot Garden, Shenzhen, Peoples R China; [Li, Hong-Lei] Chinese Acad Sci, Shenzhen 518004, Peoples R China; [Sun, Miao; Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Sun, Miao; Soltis, Pamela S.; Soltis, Douglas E.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Miller, Joseph T.; Mathews, Sarah] Australian Natl Herbarium, CSIRO Natl Res Collect, Canberra, ACT 2601, Australia; [Miller, Joseph T.] Natl Sci Fdn, Off Int Sci & Engn, Alexandria, VA 22314 USA; [Chen, You-Hua] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China; [Smith, Stephen A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Chen, Min] Inst Bot, Nanjing 210014, Jiangsu, Peoples R China; [Chen, Min] Chinese Acad Sci, Nanjing 210014, Jiangsu, Peoples R China; [Li, Jian-Hua] Hope Coll, Dept Biol, Holland, MI 49423 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Nanjing Forestry University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Chongqing University of Arts & Sciences; Chinese Academy of Sciences; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Science Foundation (NSF); Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Hope College	Chen, ZD (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.; Chen, ZD (corresponding author), Chinese Acad Sci, Sino Africa Joint Res Ctr, Wuhan 430074, Hubei, Peoples R China.	zhiduan@ibcas.ac.cn	Sun, Miao/A-6128-2018; Mathews, Sarah/A-6513-2015; Soltis, Douglas/L-5957-2015; Miller, Joseph T./M-2693-2016; Smith, Stephen/AAE-8623-2019; Lu, Limin/V-2804-2019; Le, Chi Toan/AAO-3093-2020; Xiang, Kun-Li/X-1220-2018	Sun, Miao/0000-0001-5701-0478; Mathews, Sarah/0000-0002-5518-7541; Miller, Joseph T./0000-0002-5788-9010; Smith, Stephen/0000-0003-2035-9531; Lu, Limin/0000-0001-6973-7877; Le, Chi Toan/0000-0002-5339-4440; Xiang, Kun-Li/0000-0002-0800-6015; Niu, Yanting/0000-0001-8548-4742; YANG, Tuo/0000-0002-2147-2475	National Key Basic Research Program of China [2014CB954100]; National Natural Science Foundation of China [31590822]; Chinese Academy of Sciences International Institution Development Program [SAJC201613]; National Natural Science Foundation of China; US National Science Foundation Dimensions Collaboration Project [31461123001]; US National Science Foundation [DEB-1207915, DEB-1208428, ABI DBI-1458466, DBI-1458640, EF-1115210, DBI-1547229, DEB-1442280]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Division Of Environmental Biology [1542841] Funding Source: National Science Foundation	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences International Institution Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation Dimensions Collaboration Project; US National Science Foundation(National Science Foundation (NSF)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J.-Y. Fang, D.-Z. Li, K.-P. Ma, S.-Z. Zhang, H. Sun, J.-Q. Liu, Z.-H. Wang, X.-Q. Wang and H.-Z. Kong for help initiating this study. This research was supported by the National Key Basic Research Program of China (2014CB954100), the National Natural Science Foundation of China (31590822), the Chinese Academy of Sciences International Institution Development Program (SAJC201613), the National Natural Science Foundation of China and US National Science Foundation Dimensions Collaboration Project (31461123001), the US National Science Foundation (Open Tree of Life: DEB-1207915, DEB-1208428; ABI DBI-1458466 and DBI-1458640; iDigBio: EF-1115210 and DBI-1547229; US-China Dimensions of Biodiversity: DEB-1442280) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Anderson C. L., 2007, THESIS; Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benton MJ, 1993, THE FOSSIL RECORD; Blackmore S., 2013, PLANTS CHINA COMPANI, P1; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen ZD, 2016, J SYST EVOL, V54, P277, DOI 10.1111/jse.12219; Cleophas TJ, 2015, AM J THER, V22, pE1, DOI 10.1097/MJT.0b013e31824c3ee1; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Klak C, 2004, NATURE, V427, P63, DOI 10.1038/nature02243; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Mishler BD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5473; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Qian H, 1999, AM NAT, V154, P160, DOI 10.1086/303230; Qian H, 2016, J PLANT ECOL, V9, P233, DOI 10.1093/jpe/rtv047; Qian H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075832; R Development Core Team, 2009, R LANG ENV STAT COMP; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Smith SA, 2012, BIOINFORMATICS, V28, P2689, DOI 10.1093/bioinformatics/bts492; Smith SA, 2009, P ROY SOC B-BIOL SCI, V276, P4345, DOI 10.1098/rspb.2009.1176; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Svenning JC, 2015, ANNU REV ECOL EVOL S, V46, P551, DOI 10.1146/annurev-ecolsys-112414-054314; Thornhill AH, 2016, J BIOGEOGR, V43, P2085, DOI 10.1111/jbi.12797; Verboom GA, 2009, MOL PHYLOGENET EVOL, V51, P44, DOI 10.1016/j.ympev.2008.01.037; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Wu Z.Y., 1994, FLORA CHINA, V1; Wu .Z.Y., 2010, FLORISTICS SEED PLAN; Xing YW, 2017, P NATL ACAD SCI USA, V114, pE3444, DOI 10.1073/pnas.1616063114; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhang ZJ, 2015, BIOL CONSERV, V192, P454, DOI 10.1016/j.biocon.2015.10.019	53	207	228	51	511	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					234	+		10.1038/nature25485	http://dx.doi.org/10.1038/nature25485			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420476				2022-12-28	WOS:000424332600038
J	Shen, YM; Wolfe, H; Barman, S				Shen, Yu-Min; Wolfe, Heather; Barman, Stephen			Evaluating Thrombocytopenia During Heparin Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SEROTONIN-RELEASE ASSAY; DIAGNOSIS		[Shen, Yu-Min; Wolfe, Heather] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Shen, Yu-Min] Univ Texas Southwestern Med Ctr Dallas, Div Hematol, Dallas, TX 75390 USA; [Shen, Yu-Min] Univ Texas Southwestern Med Ctr Dallas, Div Oncol, Dallas, TX 75390 USA; [Barman, Stephen] Washington Univ, Sch Med, Div Hematol, St Louis, MO USA; [Barman, Stephen] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); Washington University (WUSTL)	Shen, YM (corresponding author), UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dept Internal Med, Div Hematol & Oncol, 2201 Inwood Rd,Third Floor,Ste 500, Dallas, TX 75390 USA.	yu-min.shen@utsouthwestern.edu			Janssen; Bristol-Myers Squibb; Alexion	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); Alexion	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shen reports receipt of personal fees from Janssen, Bristol-Myers Squibb, and Alexion. No other disclosures were reported.	Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Arepally GM, 2017, BLOOD, V129, P2864, DOI 10.1182/blood-2016-11-709873; Linkins LA, 2012, CHEST, V141, pE495S, DOI 10.1378/chest.11-2303; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Pouplard C, 1999, AM J CLIN PATHOL, V111, P700; Warkentin TE, 2005, J LAB CLIN MED, V146, P341, DOI 10.1016/j.lab.2005.08.003; Warkentin TE, 2015, AM J HEMATOL, V90, P564, DOI 10.1002/ajh.24006; Whitlatch NL, 2010, BLOOD, V116, P1761, DOI 10.1182/blood-2010-01-262659	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					497	498		10.1001/jama.2017.21898	http://dx.doi.org/10.1001/jama.2017.21898			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411014				2022-12-28	WOS:000424224500020
J	Vorosmarty, CJ; Osuna, VR; Koehler, DA; Klop, P; Spengler, JD; Buonocore, JJ; Cak, AD; Tessler, ZD; Corsi, F; Green, PA; Sanchez, R				Vorosmarty, C. J.; Osuna, V. Rodriguez; Koehler, D. A.; Klop, P.; Spengler, J. D.; Buonocore, J. J.; Cak, A. D.; Tessler, Z. D.; Corsi, F.; Green, P. A.; Sanchez, R.			Scientifically assess impacts of sustainable investments	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES		[Vorosmarty, C. J.; Osuna, V. Rodriguez; Cak, A. D.; Tessler, Z. D.; Corsi, F.; Green, P. A.] CUNY, Grad Ctr, Adv Sci Res Ctr, Environm Sci Initiat, New York, NY 10021 USA; [Vorosmarty, C. J.; Corsi, F.] CUNY, Civil Engn Dept, New York, NY 10021 USA; [Koehler, D. A.] UBS Asset Management, New York, NY USA; [Klop, P.] PGGM Investments, Responsible Investment, Zeist, Netherlands; [Spengler, J. D.; Buonocore, J. J.; Sanchez, R.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth & Global Environm, Boston, MA USA	City University of New York (CUNY) System; City University of New York (CUNY) System; PGGM; Harvard University; Harvard T.H. Chan School of Public Health	Vorosmarty, CJ (corresponding author), CUNY, Grad Ctr, Adv Sci Res Ctr, Environm Sci Initiat, New York, NY 10021 USA.; Vorosmarty, CJ (corresponding author), CUNY, Civil Engn Dept, New York, NY 10021 USA.	Charles.Vorosmarty@asrc.cuny.edu	Corsi, Fabio/E-9204-2017; Sanchez, Ramon/AAW-8839-2021	Corsi, Fabio/0000-0002-6469-4086; Sanchez, Ramon/0000-0002-8810-9777	UBS Asset Management; Advanced Science Research Center at the Graduate Center, CUNY; Grove School of Engineering at The City College of New York, CUNY	UBS Asset Management; Advanced Science Research Center at the Graduate Center, CUNY; Grove School of Engineering at The City College of New York, CUNY	Main sponsorship for this work was provided by UBS Asset Management, with additional support from the Advanced Science Research Center at the Graduate Center, CUNY and Grove School of Engineering at The City College of New York, CUNY. We also thank three anonymous reviewers for their helpful inputs. The views expressed herein reflect those of the authors alone, are subject to change, and do not necessarily represent the views, policies, or positions of their employers. Industry and related data contained herein has been compiled in good faith from sources believed to be reliable.	Buonocore JJ, 2016, NAT CLIM CHANGE, V6, P100, DOI [10.1038/nclimate2771, 10.1038/NCLIMATE2771]; Caldecott B. L., 2016, GUEST OPINION ASSET; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Danzon PM, 2011, HEALTH AFFAIR, V30, P1529, DOI 10.1377/hlthaff.2010.0902; GIIN, 2017, ANN IMP INV SURV 201; Green PA, 2015, GLOBAL ENVIRON CHANG, V34, P108, DOI 10.1016/j.gloenvcha.2015.06.007; Hespenheide E. J., 2013, DISCLOSURE LONG TERM; Johnson Ann., 2016, ENV REGULATION TECHN; Lewis, 2016, NAVIGATING SUSTAINAB; PGGM, 2017, PGGM RESP INV REP; The Economist Intelligence Unit, 2015, COST IN REC VAL RISK; The Economist Intelligence Unit, 2016, FUT CLIM REL DISCL; US SIF Foundation, 2016, REP US SUST RESP IMP; WEF, 2013, MARG MAINSTR ASS IMP	14	27	27	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					523	525		10.1126/science.aao3895	http://dx.doi.org/10.1126/science.aao3895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420281				2022-12-28	WOS:000423795800026
J	Schillinger, D; Huey, N				Schillinger, Dean; Huey, Natasha			Messengers of Truth and Health-Young Artists of Color Raise Their Voices to Prevent Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TYPE-1		[Schillinger, Dean] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94143 USA; [Schillinger, Dean] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Huey, Natasha] Youth Speaks, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schillinger, D (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, POB 1364, San Francisco, CA 94110 USA.	dean.schillinger@ucsf.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boal A., 2006, AESTHETICS OPPRESSED; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; Rogers EA, 2014, J HEALTH COMMUN, V19, P144, DOI 10.1080/10810730.2014.940476; Schillinger D, 2017, AM J PREV MED, V53, pS103, DOI 10.1016/j.amepre.2017.05.024	5	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1076	1078		10.1001/jama.2018.0986	http://dx.doi.org/10.1001/jama.2018.0986			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8LL	29450481				2022-12-28	WOS:000427860200001
J	Brennan, N; Ornstein, C; Frakt, AB				Brennan, Niall; Ornstein, Charles; Frakt, Austin B.			Time to Release Medicare Advantage Claims Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Brennan, Niall] Hlth Care Cost Inst, 1100 G St NW,Ste 600, Washington, DC 20005 USA; [Ornstein, Charles] Columbia Univ, ProPubl, New York, NY USA; [Frakt, Austin B.] Boston Univ, Dept Vet Affairs, Boston, MA 02215 USA	Columbia University; Boston University	Brennan, N (corresponding author), Hlth Care Cost Inst, 1100 G St NW,Ste 600, Washington, DC 20005 USA.	nbrennan@healthcostinstitute.org		Frakt, Austin/0000-0002-0795-5462				Brennan N, 2010, AM J MANAG CARE, V16, P841; Martino SC, 2016, HEALTH SERV RES, V51, P1002, DOI 10.1111/1475-6773.12359; Medicare Payment Advisory Commission, REP C MED PAYM POL; Newhouse JP, 2014, MILBANK Q, V92, P351, DOI 10.1111/1468-0009.12061; Office of Inspector General, 2018, MED ADV DAT SHOW PRO; Ornstein A. C., 2014, CONT ISSUES CURRICUL; Ornstein C., 2017, MEDICARE HALTS RELEA; Schulte F., MEDICARE ADVANTAGE A; Teichert E., 2017, UNITEDHEALTH DEFEATS	9	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2018	319	10					975	976		10.1001/jama.2017.21519	http://dx.doi.org/10.1001/jama.2017.21519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ0HS	29459940				2022-12-28	WOS:000427249700008
J	Bagley, N				Bagley, Nicholas			Are Medicaid Work Requirements Legal?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bagley, Nicholas] Univ Michigan, Sch Law, 625 S State St, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Bagley, N (corresponding author), Univ Michigan, Sch Law, 625 S State St, Ann Arbor, MI 48104 USA.	nbagley@umich.edu						Centers for Medicare & Medicaid Services, MEM STAT MED DIR OPP; GOLDSTEIN A, WASHINGTON POST	2	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2018	319	8					763	764		10.1001/jama.2018.0958	http://dx.doi.org/10.1001/jama.2018.0958			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX6GK	29383376	Green Published			2022-12-28	WOS:000426181300013
J	Cartlidge, E				Cartlidge, Edwin			Isotope cloud linked to failed neutrino source	SCIENCE			English	News Item																			0	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					729	729						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449472				2022-12-28	WOS:000425116200021
J	Cheng, CL; Rezac, C				Cheng, Christina L.; Rezac, Craig			The role of robotics in colorectal surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TOTAL MESORECTAL EXCISION; TRANSANAL ENDOSCOPIC MICROSURGERY; MINIMALLY INVASIVE SURGERY; SHORT-TERM-OUTCOMES; LOW-RECTAL-CANCER; LAPAROSCOPIC-ASSISTED RESECTION; RANDOMIZED CLINICAL-TRIAL; LOW ANTERIOR RESECTION; MRC CLASICC TRIAL; INITIAL-EXPERIENCE	Studies of laparoscopic approaches in colorectal surgery support the use of such methods. Compared with the open approach, laparoscopy reduces rates of postoperative complications and decreases length of stay, while providing equivalent oncologic outcomes. Nevertheless, much of colorectal surgery is still being performed by the open approach. This may be partly due to the technical challenges in performing laparoscopy, particularly when working in narrow spaces such as the pelvis. Moreover, some of the current literature has questioned the oncologic outcomes after laparoscopic surgery for rectal cancer. Robotic surgery has been heralded as the minimally invasive tool that can overcome these challenges. It has the advantages that it provides a three dimensional image, uses wristed instruments, and has a computer interface that allows for fluid and accurate movements. Overall, current evidence suggests that robotics is safe and feasible in colorectal surgery, and that short term and long term outcomes are comparable to those seen for laparoscopic approaches. Studies on the costs of robotic surgery show conflicting results, and this is arguably one of the biggest disadvantages of its use. Because robotic surgery is a relatively new technology, few large high quality studies are available. Most of the published studies in this area consist of retrospective reviews, case matched studies, and national database reviews. Large randomized prospective studies are needed to further support its use.	[Cheng, Christina L.] Swedish Med Ctr, Colon & Rectal Clin, 1101 Madison Ave,Ste 510, Seattle, WA 98104 USA; [Rezac, Craig] Virginia Hosp Ctr Phys Grp, 1625 N George Mason Dr,Ste 334, Arlington, VA 22205 USA	Swedish Medical Center	Cheng, CL (corresponding author), Swedish Med Ctr, Colon & Rectal Clin, 1101 Madison Ave,Ste 510, Seattle, WA 98104 USA.	christinal.cheng@gmail.com						Araujo SE, 2015, TECH COLOPROCTOL, V19, P69, DOI 10.1007/s10151-014-1233-x; Atallah S, 2013, TECH COLOPROCTOL, V17, P441, DOI 10.1007/s10151-013-1039-2; Atallah SB, 2011, TECH COLOPROCTOL, V15, P461, DOI 10.1007/s10151-011-0762-9; Baek SJ, 2012, WORLD J SURG, V36, P2722, DOI 10.1007/s00268-012-1728-4; Baik SH, 2008, SURG ENDOSC, V22, P1601, DOI 10.1007/s00464-008-9752-z; Baik SH, 2009, ANN SURG ONCOL, V16, P1480, DOI 10.1245/s10434-009-0435-3; Balachandran B, 2017, WORLD J SURG, V41, P1246, DOI 10.1007/s00268-016-3799-0; Barendse RM, 2013, SURG ENDOSC, V27, P3591, DOI 10.1007/s00464-013-2931-6; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Benoist S, 2000, AM J SURG, V179, P275, DOI 10.1016/S0002-9610(00)00337-8; Bhama AR, 2016, SURG ENDOSC, V30, P1576, DOI 10.1007/s00464-015-4381-9; Blum CA, 2011, J MINIM ACCESS SURG, V7, P165, DOI 10.4103/0972-9941.83506; Bravo R, 2017, TECH COLOPROCTOL, V21, P233, DOI 10.1007/s10151-017-1597-9; Buchs NC, 2016, COLORECTAL DIS, V18, P1154, DOI 10.1111/codi.13394; Buchs NC, 2013, DIS COLON RECTUM, V56, P1194, DOI 10.1097/DCR.0b013e3182a2ac84; Byrn JC, 2014, SURG ENDOSC, V28, P3101, DOI 10.1007/s00464-014-3591-x; Champagne BJ, 2012, ANN SURG, V255, P66, DOI 10.1097/SLA.0b013e3182378442; Cho Jung Hoon, 2012, J Korean Soc Coloproctol, V28, P42, DOI 10.3393/jksc.2012.28.1.42; Cho MS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000522; Clancy C, 2015, DIS COLON RECTUM, V58, P254, DOI 10.1097/DCR.0000000000000309; D'Annibale A, 2013, SURG ENDOSC, V27, P1887, DOI 10.1007/s00464-012-2731-4; Davis BR, 2014, JSLS-J SOC LAPAROEND, V18, P211, DOI 10.4293/108680813X13753907291035; de Jesus JP, 2016, EJSO-EUR J SURG ONC, V42, P808, DOI 10.1016/j.ejso.2016.03.002; Deleon MF, 2016, AM SOC COL RECT SURG; Deleon MF, 2015, AM SOC COL RECT SURG; deSouza AL, 2010, DIS COLON RECTUM, V53, P1000, DOI 10.1007/DCR.0b013e3181d32096; Deutsch GB, 2012, SURG ENDOSC, V26, P956, DOI 10.1007/s00464-011-1977-6; Elhage O, 2015, BJU INT, V115, P274, DOI 10.1111/bju.12680; Erenler I, 2017, COLORECTAL DIS, V19, P401, DOI 10.1111/codi.13638; Fernandez-Hevia M, 2015, ANN SURG, V261, P221, DOI 10.1097/SLA.0000000000000865; Feroci F, 2016, WORLD J GASTROENTERO, V22, P3602, DOI 10.3748/wjg.v22.i13.3602; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Fleshman J, 2015, JAMA-J AM MED ASSOC, V314, P1346, DOI 10.1001/jama.2015.10529; Fowler D L, 1991, Surg Laparosc Endosc, V1, P183; Franklin Morris E Jr, 2004, Rev Gastroenterol Mex, V69 Suppl 1, P65; Gallagher AG, 1998, ENDOSCOPY, V30, P617, DOI 10.1055/s-2007-1001366; Geiger Timothy M, 2011, Clin Colon Rectal Surg, V24, P274, DOI 10.1055/s-0031-1295692; Gendall KA, 2007, DIS COLON RECTUM, V50, P2223, DOI 10.1007/s10350-007-9051-0; Ruiz MG, 2015, DIS COLON RECTUM, V58, P145, DOI 10.1097/DCR.0000000000000265; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Haahr C, 2014, DAN MED J, V61; Halabi WJ, 2013, WORLD J SURG, V37, P2782, DOI 10.1007/s00268-013-2024-7; Harr JN, 2017, SURG ENDOSC, V31, P2813, DOI 10.1007/s00464-016-5291-1; Helvind NM, 2013, SURG ENDOSC, V27, P2575, DOI 10.1007/s00464-013-2792-z; Hompes R, 2014, BRIT J SURG, V101, P578, DOI 10.1002/bjs.9454; Jamali FR, 2008, ARCH SURG-CHICAGO, V143, P762, DOI 10.1001/archsurg.143.8.762; Jayne D, 2017, JAMA-J AM MED ASSOC, V318, P1569, DOI 10.1001/jama.2017.7219; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Jeong SY, 2014, LANCET ONCOL, V15, P767, DOI 10.1016/S1470-2045(14)70205-0; Jeong WK, 2009, SURG ENDOSC, V23, P2575, DOI 10.1007/s00464-009-0466-7; Junginger T, 2016, DIS COLON RECTUM, V59, P8; Juo YY, 2015, SURG ENDOSC, V29, P1976, DOI 10.1007/s00464-014-3896-9; Kamoun S, 2009, AM J SURG, V198, P450, DOI 10.1016/j.amjsurg.2008.09.022; Kang J, 2013, ANN SURG, V257, P95, DOI 10.1097/SLA.0b013e3182686bbd; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Keller DS, 2016, J GASTROINTEST SURG, V20, P463, DOI 10.1007/s11605-015-3036-4; Keller DS, 2016, J GASTROINTEST SURG, V20, P488, DOI 10.1007/s11605-015-3016-8; Kim CW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000823; Kim JY, 2012, ANN SURG ONCOL, V19, P2485, DOI 10.1245/s10434-012-2262-1; Kudsi OY, 2017, SURG ENDOSC, V31, P3242, DOI 10.1007/s00464-016-5353-4; Kuo LJ, 2017, INT J COLORECTAL DIS, V32, P249, DOI 10.1007/s00384-016-2686-3; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Lascano CA, 2006, AM J SURG, V192, P357, DOI 10.1016/j.amjsurg.2006.04.011; Lee KH, 2013, SURG ENDOSC, V27, P1986, DOI 10.1007/s00464-012-2698-1; Lee L, 2018, ANN SURG, V267, P910, DOI 10.1097/SLA.0000000000002190; Liao GX, 2016, SCI REP-UK, V6, DOI 10.1038/srep26981; Lim MS, 2013, SURG ENDOSC, V27, P1021, DOI 10.1007/s00464-012-2549-0; Lue JR, 2016, J MINIM ACCESS SURG, V12, P186, DOI 10.4103/0972-9941.158969; Lujan HJ, 2015, J LAPAROENDOSC ADV S, V25, P117, DOI 10.1089/lap.2014.0199; Lujan HJ, 2017, SURG LAPARO ENDO PER, DOI [10.1097/SLE.0000000000000384.pmid:28319493, DOI 10.1097/SLE.0000000000000384.PMID:28319493]; Ma B, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2428-5; Middleton PF, 2005, DIS COLON RECTUM, V48, P270, DOI 10.1007/s10350-004-0804-8; Midura EF, 2015, SURGERY, V158, P453, DOI 10.1016/j.surg.2015.02.020; Miller AT, 2012, J GASTROINTEST SURG, V16, P587, DOI 10.1007/s11605-011-1692-6; Moghadamyeghaneh Z, 2016, SURG ENDOSC, V30, P2792, DOI 10.1007/s00464-015-4552-8; Morelli L, 2016, INT J COLORECTAL DIS, V31, P1639, DOI 10.1007/s00384-016-2631-5; Nayeemuddin M, 2013, ASSOC OPER ROOM NURS, V98, P343, DOI 10.1016/j.aorn.2013.08.012; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Oh JH, 2016, ANN SURG TREAT RES, V91, P187, DOI 10.4174/astr.2016.91.4.187; Parfitt JR, 2007, J CLIN PATHOL, V60, P849, DOI 10.1136/jcp.2006.043802; Park JS, 2012, BRIT J SURG, V99, P1219, DOI 10.1002/bjs.8841; Park JS, 2011, SURG ENDOSC, V25, P240, DOI 10.1007/s00464-010-1166-z; Park SY, 2013, SURG ENDOSC, V27, P48, DOI 10.1007/s00464-012-2405-2; Patel CB, 2011, DIS COLON RECTUM, V54, P144, DOI 10.1007/DCR.0b013e3181fec377; Perdawood SK, 2016, COLORECTAL DIS, V18, P51, DOI 10.1111/codi.13225; Pietrabissa A, 2012, ARCH SURG-CHICAGO, V147, P709, DOI 10.1001/archsurg.2012.508; Ptok H, 2009, EJSO-EUR J SURG ONC, V35, P1273, DOI 10.1016/j.ejso.2009.06.006; Quirke P, 2009, LANCET, V373, P821, DOI 10.1016/S0140-6736(09)60485-2; Ragupathi M, 2011, SURG ENDOSC, V25, P199, DOI 10.1007/s00464-010-1159-y; REICH H, 1989, J GYNECOL SURG, V5, P213, DOI 10.1089/gyn.1989.5.213; Rezac C., 2015, AM SOC COL RECT SURG; Rimonda R, 2013, SURG ENDOSC, V27, P3762, DOI 10.1007/s00464-013-2962-z; SEMM K, 1983, ENDOSCOPY, V15, P59, DOI 10.1055/s-2007-1021466; Skullman S, 2000, DIGEST SURG, V17, P617; Somashekhar SP, 2015, INDIAN J SURG, V77, pS788, DOI 10.1007/s12262-013-1003-4; Speicher PJ, 2015, ANN SURG, V262, P1040, DOI 10.1097/SLA.0000000000001017; Spinoglio G, 2015, INT J MED ROBOT COMP, V11, P135, DOI 10.1002/rcs.1609; Stefanidis D, 2009, SURG ENDOSC, V23, P16, DOI 10.1007/s00464-008-0103-x; Stein SA, 2013, TECH COLOPROCTOL, V17, pS35, DOI 10.1007/s10151-012-0937-z; Stevenson ARL, 2015, JAMA-J AM MED ASSOC, V314, P1356, DOI 10.1001/jama.2015.12009; Supe Avinash N, 2010, J Minim Access Surg, V6, P31, DOI 10.4103/0972-9941.65161; Tam MS, 2016, SURG ENDOSC, V30, P455, DOI 10.1007/s00464-015-4218-6; Tan WS, 2009, INT J COLORECTAL DIS, V24, P1333, DOI 10.1007/s00384-009-0743-x; Tan WJ, 2016, WORLD J GASTRO SURG, V8, P452, DOI 10.4240/wjgs.v8.i6.452; Tong Daniel K H, 2007, JSLS, V11, P76; Trastulli S, 2015, SURG ENDOSC, V29, P1512, DOI 10.1007/s00464-014-3835-9; Trastulli S, 2013, INT J COLORECTAL DIS, V28, P807, DOI 10.1007/s00384-012-1604-6; Turchetti G, 2012, SURG ENDOSC, V26, P598, DOI 10.1007/s00464-011-1936-2; Tyler JA, 2013, DIS COLON RECTUM, V56, P458, DOI 10.1097/DCR.0b013e31827085ec; Valverde A, 2017, SURG ENDOSC, V31, P4085, DOI 10.1007/s00464-017-5455-7; Vasudevan V, 2016, SURG ENDOSC, V30, P5490, DOI 10.1007/s00464-016-4910-1; Velthuis S, 2013, BRIT J SURG, V100, P828, DOI 10.1002/bjs.9069; Velthuis S, 2014, SURG ENDOSC, V28, P3494, DOI 10.1007/s00464-014-3636-1; Vergis AS, 2015, CAN J SURG, V58, P63, DOI 10.1503/cjs.001914; Verheijen PM, 2014, INT J MED ROBOT COMP, V10, P423, DOI 10.1002/rcs.1594; White I, 2011, JSLS-J SOC LAPAROEND, V15, P182, DOI 10.4293/108680811X13071180406439; Xu HR, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-274; Yamamoto S, 2009, J AM COLL SURGEONS, V208, P383, DOI 10.1016/j.jamcollsurg.2008.12.002; Yeo HL, 2016, DIS COLON RECTUM, V59, P535, DOI 10.1097/DCR.0000000000000580; Zhang X, 2016, SURG ENDOSC, V30, P5601, DOI 10.1007/s00464-016-4892-z	120	29	29	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2018	360								j5304	10.1136/bmj.j5304	http://dx.doi.org/10.1136/bmj.j5304			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KT	29440057				2022-12-28	WOS:000425581700001
J	Murphy, F				Murphy, Flynn			ECONOMIC DEVELOPMENT Rise of a new superpower: health and China's global trade ambitions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												flynnpmurphy@gmail.com						[Anonymous], 2017, LANCET GLOB HEALTH, V5, pE948, DOI 10.1016/S2214-109X(17)30349-2; [Anonymous], 2012, ZAMBIAN MINERS KILL; [Anonymous], 2017, SCHOL FOR STUD; [Anonymous], 2017, CHINA DAILY; [Anonymous], 2018, NDTV            0109; [Anonymous], 2014, CHIN FOR AID; [Anonymous], 2017, HELGA ZEPP LAROUCHE; [Anonymous], 2017, ASIA TIMES; [Anonymous], 2017, 1 ECONOMIST      SEP; Association for Magazine Media, 2018, NEW YORKER; Cai Peter, 2017, UNDERSTANDING CHINAS; Chanda M., 2010, BBC NEWS; Crocker B., 2013, GLOBALJOURNALIS 1122; Embassy of the People's Republic of China in the Republic of Liberia, CHIN ASS AFR FIGHT E; Frankapan P., 2016, CHINA DAILY; Grepin KA, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0084-6; Hawksworth J, 2017, THE WORLD IN 2050; Husain L, 2017, WILL CHINAS BELT ROA; Imaduddin, 2017, BUSINESS RECORD 1002; Kuo L., 2017, QUARTZ AFRICA   0607; Li C., 2012, POLITICAL MAPPING CH; Madan T., 2016, WHAT INDIA THINKS CH; Mardell J., 2017, COMMUNITY COMMON DES; National Development and Reform Commission, 2015, PEOPL REP CHIN VIS A; National Health and Family Planning Commission of the PRC, 2017, BEIJ COMM BELT ROAD; Online T, 2017, TOBACCO ASIA    0714; Perez CJ, 2017, ANOTHER MEASURE SHOW; Perlez J, 2017, CHINAS 1 TRILLION PL; PricewaterhouseCoopers, 2016, LONG WIND ROAD; Prior G., 2017, CONSTRUCTION ENQ JUL; RAVEN R J, 1988, American Museum Novitates, P1; Shepard W, 2017, FORBES; Su X., 2017, DIPLOMAT; Wade G., 2016, CHINAS ONE BELT ONE; WHO Framework Convention on Tobacco Control, WHO FRAM CONV TOB CO; WHO Framework Convention on Tobacco Control, 2016, WHO FRAM CONV TOB CO; World Health Organization, 2017, HLTH SILK ROAD; World Health Organization, TOB IN CHIN; Xi J., 2017, BBC NEWS; Zahra-Malik M., 2017, LAND RUSH PAKISTANS; Zambia, 2017, CHINA SIGN 2 AGREEME; Zambia, 2017, CGTN AFRICA     0605; Zhou L., 2017, S CHINA MORNING POST	43	9	9	3	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2018	360								k595	10.1136/bmj.k595	http://dx.doi.org/10.1136/bmj.k595			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0IE	29439007				2022-12-28	WOS:000424976600002
J	Voelker, R				Voelker, Rebecca			Therapy Approved for Rare Inflammatory Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					434	434		10.1001/jama.2017.21626	http://dx.doi.org/10.1001/jama.2017.21626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411018				2022-12-28	WOS:000424224500004
J	Fu, W; Zhao, SL; Zhang, YH; Chai, PP; Goss, J				Fu, Wei; Zhao, Shuli; Zhang, Yuhui; Chai, Peipei; Goss, John			Research in health policy making in China: out-of-pocket payments in Healthy China 2030	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; EXPENDITURE		[Fu, Wei; Zhang, Yuhui; Chai, Peipei] China Natl Hlth & Dev Res Ctr, Beijing, Peoples R China; [Zhao, Shuli] Natl & Family Planning Commiss, Dept Finance, Beijing, Peoples R China; [Chai, Peipei; Goss, John] Univ Canberra, Canberra, ACT, Australia	University of Canberra	Fu, W (corresponding author), China Natl Hlth & Dev Res Ctr, Beijing, Peoples R China.	fuwei@nhei.cn						[Anonymous], 2011, 12 5 YEAR PLAN HLTH; [Anonymous], 2016, CHIN STAT YB 2016; Astolfi R, 2012, OECD HLTH WORKING PA, V59; China National Health Development Research Center, 2016, HLTH EXP FOR ITS FIN; China National Health Development Research Center, 2017, CHIN NAT HLTH ACC RE; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Healthy China 2030, 2016, XINHUA NEWS AGENCY; Hsiao WC, 2007, HEALTH ECON POLICY L, V2, P241, DOI 10.1017/S1744133107004197; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Langenbrunner JC., 2011, HLTH HARMONIOUS LIFE; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; OECD EaWHO, 2017, SYST HLTH ACC 2022, DOI [10.1787/9789264270985-en, DOI 10.1787/9789264270985-EN]; Ramesh M, 2014, HEALTH POLICY PLANN, V29, P663, DOI 10.1093/heapol/czs109; World Health Organization, 2000, WORLD HLTH REP 2000; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zeng Y, 2012, CHINA ECON J, V5, P131, DOI 10.1080/17538963.2013.764677; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x	19	44	46	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2018	360								k234	10.1136/bmj.k234	http://dx.doi.org/10.1136/bmj.k234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HP	29437565	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000424974800004
J	Filewod, NC; Batt, J; Kapus, A; Szaszi, K; Fairn, GD; Slutsky, AS; Lee, WL				Filewod, Niall C.; Batt, Jane; Kapus, Andras; Szaszi, Katalin; Fairn, Gregory D.; Slutsky, Arthur S.; Lee, Warren L.			Should basic science matter to clinicians?	LANCET			English	Editorial Material							MEDICAL-EDUCATION		[Filewod, Niall C.; Batt, Jane; Kapus, Andras; Szaszi, Katalin; Fairn, Gregory D.; Slutsky, Arthur S.; Lee, Warren L.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Filewod, Niall C.; Slutsky, Arthur S.; Lee, Warren L.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Batt, Jane; Slutsky, Arthur S.; Lee, Warren L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kapus, Andras; Szaszi, Katalin; Fairn, Gregory D.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Lee, WL (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada.; Lee, WL (corresponding author), Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada.; Lee, WL (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	leew@smh.ca	Slutsky, Arthur/M-3325-2019	Kapus, Andras/0000-0002-6610-9530; Lee, Warren/0000-0002-1788-6587				Bardhan K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00550; Brouwer MC, 2015, COCHRANE DB SYST REV, V12; Fox RD, 1998, BRIT MED J, V316, P466, DOI 10.1136/bmj.316.7129.466; Goldenberg Neil M, 2016, CMAJ Open, V4, pE444; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hirsch T, 2017, NATURE, V551, P327, DOI 10.1038/nature24487; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kozminski KG, 2012, MOL BIOL CELL, V23, P751, DOI 10.1091/mbc.E11-11-0922; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Milstein C, 1999, BIOESSAYS, V21, P966, DOI 10.1002/(SICI)1521-1878(199911)21:11<966::AID-BIES9>3.0.CO;2-Z; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; National Institute of General Medical Sciences, 2012, CUR CREAT CUR VAL IM; Pettit RS, 2012, ANN PHARMACOTHER, V46, P1065, DOI 10.1345/aph.1R076; Pincock S, 2005, LANCET, V366, P1429, DOI 10.1016/S0140-6736(05)67587-3; Quintero GA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0213-3; Steinberg BE, 2016, FASEB J, V30, P515, DOI 10.1096/fj.15-281758; Stephenson J, 1997, JAMA-J AM MED ASSOC, V278, P1479; Tajika A, 2015, BRIT J PSYCHIAT, V207, P357, DOI 10.1192/bjp.bp.113.143701; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Wachtler Caroline, 2006, BMC Med Educ, V6, P16, DOI 10.1186/1472-6920-6-16	21	9	10	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					410	412		10.1016/S0140-6736(18)30199-5	http://dx.doi.org/10.1016/S0140-6736(18)30199-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407017				2022-12-28	WOS:000424333600009
J	Voosen, P				Voosen, Paul			SPACE WEATHER NASA seeks to revive lost probe that traced solar storms	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					505	505		10.1126/science.359.6375.505	http://dx.doi.org/10.1126/science.359.6375.505			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420270				2022-12-28	WOS:000423795800015
J	Marrouche, NF; Brachmann, J; Andresen, D; Siebels, J; Boersma, L; Jordaens, L; Merkely, B; Pokushalov, E; Sanders, P; Proff, J; Schunkert, H; Christ, H; Vogt, J; Bansch, D				Marrouche, Nassir F.; Brachmann, Johannes; Andresen, Dietrich; Siebels, Juergen; Boersma, Lucas; Jordaens, Luc; Merkely, Bela; Pokushalov, Evgeny; Sanders, Prashanthan; Proff, Jochen; Schunkert, Heribert; Christ, Hildegard; Vogt, Juergen; Baensch, Dietmar		CASTLE-AF Investigators	Catheter Ablation for Atrial Fibrillation with Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; VENTRICULAR SYSTOLIC DYSFUNCTION; PULMONARY-VEIN ISOLATION; RADIOFREQUENCY ABLATION; ANTIARRHYTHMIC-DRUGS; RHYTHM ASSOCIATION; 1ST-LINE TREATMENT; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; RANDOMIZED-TRIAL	BACKGROUND Mortality and morbidity are higher among patients with atrial fibrillation and heart failure than among those with heart failure alone. Catheter ablation for atrial fibrillation has been proposed as a means of improving outcomes among patients with heart failure who are otherwise receiving appropriate treatment. METHODS We randomly assigned patients with symptomatic paroxysmal or persistent atrial fibrillation who did not have a response to antiarrhythmic drugs, had unacceptable side effects, or were unwilling to take these drugs to undergo either catheter ablation (179 patients) or medical therapy (rate or rhythm control) (184 patients) for atrial fibrillation in addition to guidelines-based therapy for heart failure. All the patients had New York Heart Association class II, III, or IV heart failure, a left ventricular ejection fraction of 35% or less, and an implanted defibrillator. The primary end point was a composite of death from any cause or hospitalization for worsening heart failure. RESULTS After a median follow-up of 37.8 months, the primary composite end point occurred in significantly fewer patients in the ablation group than in the medicaltherapy group (51 patients [28.5%] vs. 82 patients [44.6%]; hazard ratio, 0.62; 95% confidence interval [CI], 0.43 to 0.87; P = 0.007). Significantly fewer patients in the ablation group died from any cause (24 [13.4%] vs. 46 [25.0%]; hazard ratio, 0.53; 95% CI, 0.32 to 0.86; P = 0.01), were hospitalized for worsening heart failure (37 [20.7%] vs. 66 [35.9%]; hazard ratio, 0.56; 95% CI, 0.37 to 0.83; P = 0.004), or died from cardiovascular causes (20 [11.2%] vs. 41 [22.3%]; hazard ratio, 0.49; 95% CI, 0.29 to 0.84; P = 0.009). CONCLUSIONS Catheter ablation for atrial fibrillation in patients with heart failure was associated with a significantly lower rate of a composite end point of death from any cause or hospitalization for worsening heart failure than was medical therapy. (Funded by Biotronik; CASTLE-AF ClinicalTrials.gov number, NCT00643188.)	[Marrouche, Nassir F.] Univ Utah Hlth, Comprehens Arrhythmia Res & Management Ctr, Div Cardiovasc Med, Sch Med, Salt Lake City, UT 84132 USA; [Brachmann, Johannes] Klinikum Coburg, Coburg, Germany; [Andresen, Dietrich] Kardiol Ev Elisabeth Kliniken, Berlin, Germany; [Proff, Jochen] Biotronik, Berlin, Germany; [Vogt, Juergen] Klin Rotes Kreuz, Frankfurt, Germany; [Siebels, Juergen] Klinikum Links Weser, Bremen, Germany; [Schunkert, Heribert] Deutsch Herzzentrum Munich, Munich, Germany; [Christ, Hildegard] Inst Med Stat & Computat Biol, Cologne, Germany; [Baensch, Dietmar] KMG Klinikum, Gustrow, Germany; [Boersma, Lucas] Antonius Ziekenhuis Nieuwegein, Nieuwegein, Netherlands; [Jordaens, Luc] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Merkely, Bela] Semmelweis Univ, Budapest, Hungary; [Pokushalov, Evgeny] State Res Inst Circulat Pathol, Novosibirsk, Russia	Utah System of Higher Education; University of Utah; Klinikum Coburg; German Heart Centre Munich; University of Cologne; Erasmus University Rotterdam; Erasmus MC; Semmelweis University; Meshalkin National Medical Research Center	Marrouche, NF (corresponding author), Univ Utah Hlth, Div Cardiovasc Med, Comprehens Arrhythmia Res & Management Ctr, Salt Lake City, UT 84132 USA.	nassir.marrouche@carma.utah.edu	Brachmann, Johannes/AAD-1499-2021; Pokushalov, Evgeny A/L-7993-2014; Pokushalov, Evgeny/ABA-6205-2020; Jordaens, Luc/AAI-6541-2020; Sanders, Prashanthan/D-7641-2013	Pokushalov, Evgeny A/0000-0002-2560-5167; Jordaens, Luc/0000-0002-1407-7186; Braunschweig, Frieder/0000-0002-4966-1315; Christ, Hildegard/0000-0003-3235-2994; Wieneke, Heinrich/0000-0002-6709-0982; Boersma, Lucas/0000-0003-4591-4220; Sanders, Prashanthan/0000-0003-3803-8429	Biotronik	Biotronik	Funded by Biotronik; CASTLE-AF ClinicalTrials.gov number, NCT00643188.	Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Chen MS, 2004, J AM COLL CARDIOL, V43, P1004, DOI 10.1016/j.jacc.2003.09.056; Di Biase L, 2016, CIRCULATION, V133, P1637, DOI 10.1161/CIRCULATIONAHA.115.019406; Doyle JF, 2009, MAYO CLIN PROC, V84, P234, DOI 10.1016/S0025-6196(11)61140-3; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Glanz A, 2013, NEW ENGL J MED, V368, P477, DOI 10.1056/NEJMc1214193; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunter RJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P31, DOI 10.1161/CIRCEP.113.000806; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Jones DG, 2013, J AM COLL CARDIOL, V61, P1894, DOI 10.1016/j.jacc.2013.01.069; Khan MN, 2008, NEW ENGL J MED, V359, P1778, DOI 10.1056/NEJMoa0708234; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; MacDonald MR, 2011, HEART, V97, P740, DOI 10.1136/hrt.2010.207340; Marrouche NF, 2009, PACE, V32, P987, DOI 10.1111/j.1540-8159.2009.02428.x; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Muller HH, 2004, STAT MED, V23, P2497, DOI 10.1002/sim.1852; Nieuwlaat R, 2009, J AM COLL CARDIOL, V53, P1690, DOI 10.1016/j.jacc.2009.01.055; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Santhanakrishnan R, 2016, CIRCULATION, V133, P484, DOI 10.1161/CIRCULATIONAHA.115.018614; Strickberger SA, 2003, J AM COLL CARDIOL, V41, P1707, DOI 10.1016/S0735-1097(03)00297-3; Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201; Verma A, 2017, CIRCULATION, V135, P1547, DOI 10.1161/CIRCULATIONAHA.116.026054; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	31	1094	1127	2	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					417	427		10.1056/NEJMoa1707855	http://dx.doi.org/10.1056/NEJMoa1707855			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU3WP	29385358	Bronze			2022-12-28	WOS:000423783200006
J	Mitja, O; Godornes, C; Houinei, W; Kapa, A; Paru, R; Abel, H; Gonzalez-Beiras, C; Bieb, SV; Wangi, J; Barry, AE; Sanz, S; Bassat, Q; Lukehart, SA				Mitja, Oriol; Godornes, Charmie; Houinei, Wendy; Kapa, August; Paru, Raymond; Abel, Haina; Gonzalez-Beiras, Camila; Bieb, Sibauk V.; Wangi, James; Barry, Alyssa E.; Sanz, Sergi; Bassat, Quique; Lukehart, Sheila A.			Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study	LANCET			English	Article							PAPUA-NEW-GUINEA; TREPONEMA-PALLIDUM; MACROLIDE RESISTANCE; HAEMOPHILUS-DUCREYI; DOSE AZITHROMYCIN; POINT MUTATION; UNITED-STATES; SKIN ULCERS; PREVALENCE; CHILDREN	Background Yaws is a substantial cause of chronic disfiguring ulcers in children in at least 14 countries in the tropics. WHO's newly adopted strategy for yaws eradication uses a single round of mass azithromycin treatment followed by targeted treatment programmes, and data from pilot studies have shown a short-term significant reduction of yaws. We assessed the long-term efficacy of the WHO strategy for yaws eradication. Methods Between April 15, 2013, and Oct 24, 2016, we did a longitudinal study on a Papua New Guinea island (Lihir; 16 092 population) in which yaws was endemic. In the initial study, the participants were followed for 12 months; in this extended follow-up study, clinical, serological, and PCR surveys were continued every 6 months for 42 months. We used genotyping and travel history to identify importation events. Active yaws confirmed by PCR specific for Treponema pallidum was the primary outcome indicator. The study is registered with ClinicalTrials.gov, number NCT01955252. Findings Mass azithromycin treatment (coverage rate of 84%) followed by targeted treatment programmes reduced the prevalence of active yaws from 1.8% to a minimum of 0.1% at 18 months (difference from baseline -1.7%, 95% CI, -1.9 to -1.4; p<0.0001), but the infection began to re-emerge after 24 months with a significant increase to 0.4% at 42 months (difference from 18 months 0.3%, 95% CI 0.1 to 0.4; p<0.0001). At each timepoint after baseline, more than 70% of the total community burden of yaws was found in individuals who had not had the mass treatment or as new infections in non-travelling residents. At months 36 and 42, five cases of active yaws, all from the same village, showed clinical failure following azithromycin treatment, with PCR-detected mutations in the 23S ribosomal RNA genes conferring resistance to azithromycin. A sustained decrease in the prevalence of high-titre latent yaws from 13.7% to <1.5% in asymptomatic children aged 1-5 years old and of genetic diversity of yaws strains from 0.139 to less than 0.046 between months 24 and 42 indicated a reduction in transmission of infection. Interpretation The implementation of the WHO strategy did not, in the long-term, achieve elimination in a high-endemic community mainly due to the individuals who were absent at the time of mass treatment in whom yaws reactivated; repeated mass treatment might be necessary to eliminate yaws. To our knowledge, this is the first report of the emergence of azithromycin-resistant T p pertenue and spread within one village. Communities' surveillance should be strengthened to detect any possible treatment failure and biological markers of resistance.	[Mitja, Oriol; Gonzalez-Beiras, Camila; Sanz, Sergi; Bassat, Quique] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth, Barcelona, Spain; [Mitja, Oriol] Univ Papua New Guinea, Sch Med & Hlth Sci, Div Publ Hlth, Port Moresby, Papua N Guinea; [Mitja, Oriol; Kapa, August; Paru, Raymond; Abel, Haina] Int SOS Newcrest Min, Lihir Med Ctr, Lihir Isl, Papua N Guinea; [Godornes, Charmie; Lukehart, Sheila A.] Univ Washington, Dept Med, Seattle, WA USA; [Lukehart, Sheila A.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Houinei, Wendy; Bieb, Sibauk V.] Natl Dept Hlth, Dis Control Branch, Port Moresby, Papua N Guinea; [Gonzalez-Beiras, Camila] Lisbon Inst Hyg & Trop Med, Lisbon, Portugal; [Wangi, James] WHO, Off World Hlth Org WHO Representat Papua New Guin, Port Moresby, Papua N Guinea; [Barry, Alyssa E.] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia; [Barry, Alyssa E.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Bassat, Quique] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Bassat, Quique] Ctr Invest Saude Manhica, Maputo, Mozambique; [Sanz, Sergi] Univ Barcelona, Dept Publ Hlth, Biostat Unit, Fac Med, Barcelona, Spain; [Bassat, Quique] Hosp St Joan de Deu, Dept Paediat, Paediat Infect Dis Unit, Barcelona, Spain	ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Papua New Guinea; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; World Health Organization; Walter & Eliza Hall Institute; University of Melbourne; ICREA; Centro de Investigacao em Saude de Manhica; University of Barcelona; University of Barcelona	Mitja, O (corresponding author), Lihir Med Ctr, Dept Community Hlth, POB 34, Lihir Isl, New Ireland Pro, Papua N Guinea.	oriol.mitja@isglobal.org	Mitjà, Oriol/W-4181-2018; Sanz, Sergi/AAY-7211-2020; Bassat, Quique/P-2341-2016	Mitjà, Oriol/0000-0003-3266-8868; Bassat, Quique/0000-0003-0875-7596; Barry, Alyssa/0000-0002-1189-2310; Gonzalez-Beiras, Camila/0000-0001-6617-0748; Sanz Bravo, Sergi/0000-0001-5010-4527	ISDIN laboratories; Newcrest Mining Limited; US Public Health Service National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042143] Funding Source: NIH RePORTER	ISDIN laboratories; Newcrest Mining Limited; US Public Health Service National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	ISDIN laboratories, Newcrest Mining Limited, and US Public Health Service National Institutes of Health.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P189; Chi KH, 2015, AM J TROP MED HYG, V92, P134, DOI 10.4269/ajtmh.14-0459; Ghinai R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003496; Godornes C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006113; Grillova L, 2014, J CLIN MICROBIOL, V52, P3693, DOI 10.1128/JCM.01292-14; Grimes M, 2012, SEX TRANSM DIS, V39, P954, DOI 10.1097/OLQ.0b013e31826ae7a8; HACKETT C J, 1956, Bull World Health Organ, V15, P869; Hinman AR, 1988, ERADICATION INFECT D, P19; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwakye-Maclean C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005154; Lee SY, 2002, FEMS MICROBIOL LETT, V207, P39, DOI 10.1111/j.1574-6968.2002.tb11025.x; Li Z, 2013, J CLIN MICROBIOL, V51, P4270, DOI 10.1128/JCM.01261-13; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Marks M, 2017, EMERG INFECT DIS, V23, P22, DOI 10.3201/eid2301.160487; Marks M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004927; Marks M, 2015, LANCET INFECT DIS, V15, P1220, DOI 10.1016/S1473-3099(15)00136-X; Marks M, 2014, EMERG INFECT DIS, V20, P1705, DOI 10.3201/eid2010.140573; Marra CM, 2006, J INFECT DIS, V194, P1771, DOI 10.1086/509512; Matejkova P, 2009, J MED MICROBIOL, V58, P832, DOI 10.1099/jmm.0.007542-0; Mitja O, 2015, NEW ENGL J MED, V372, P703, DOI 10.1056/NEJMoa1408586; Mitja O, 2014, LANCET GLOB HEALTH, V2, pE235, DOI 10.1016/S2214-109X(14)70019-1; Mitja O, 2012, LANCET, V379, P342, DOI 10.1016/S0140-6736(11)61624-3; Mitja O, 2011, EMERG INFECT DIS, V17, P1083, DOI [10.3201/eid1706.101575, 10.3201/eid/1706.101575]; Muldoon EG, 2012, SEX TRANSM DIS, V39, P784, DOI 10.1097/OLQ.0b013e318269995f; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; REIN C R, 1949, J Natl Med Assoc, V41, P60; Samajs D, 2015, AM J TROP MED HYG, V93, P678, DOI 10.4269/ajtmh.15-0316; Su JR, 2012, SEX TRANSM DIS, V39, P794, DOI 10.1097/OLQ.0b013e31826f36de; WHO, 2012, SUMM REP CONS ER YAW; ZAHRA A, 1956, Bull World Health Organ, V15, P911	30	41	41	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1599	1607		10.1016/S0140-6736(18)30204-6	http://dx.doi.org/10.1016/S0140-6736(18)30204-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD5JG	29428183	Green Accepted, Green Submitted			2022-12-28	WOS:000430542700029
J	Bergenstal, RM				Bergenstal, Richard M.			Continuous glucose monitoring: transforming diabetes management step by step	LANCET			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; GLYCEMIC CONTROL; HYPOGLYCEMIA; ADULTS; SYSTEM		[Bergenstal, Richard M.] Int Diabet Ctr Pk Nicollet, Minneapolis, MN 55416 USA	International Diabetes Center	Bergenstal, RM (corresponding author), Int Diabet Ctr Pk Nicollet, Minneapolis, MN 55416 USA.	richard.bergenstal@parknicollet.com			National Institute of Diabetes and Digestive and Kidney Diseases (NIH) [DK108611]; Abbott Diabetes Care; DexCom; Johnson Johnson; Medtronic; Onduo; Roche; Sanofi; United Healthcare	National Institute of Diabetes and Digestive and Kidney Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Abbott Diabetes Care(Abbott Laboratories); DexCom; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Medtronic(Medtronic); Onduo; Roche(Roche Holding); Sanofi; United Healthcare	I have received research support, consulted, or been on the scientific advisory board for Abbott Diabetes Care, DexCom, Johnson & Johnson, Medtronic, Onduo, Roche, Sanofi, and United Healthcare. My technology research is partly funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIH grant DK108611). I am a volunteer for the American Diabetes Association, American Association of Clinical Endocrinologists, and JDRF. My employer, non-profit HealthPartners Institute, contracts for my services and I receive no personal income. I have inherited Merck stock. Merck does not manufacture or distribute any products related to the Article being discussed in this Comment.	Aleppo G, 2017, J ENDOCR SOC, V1, P1445, DOI 10.1210/js.2017-00388; Beck RW, 2017, DIABETES CARE, V40, P994, DOI 10.2337/dc17-0636; Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975; Bergenstal RM, 2016, JAMA-J AM MED ASSOC, V316, P1407, DOI 10.1001/jama.2016.11708; Bergenstal RM, 2015, DIABETES CARE, V38, P1615, DOI 10.2337/dc15-0099; Carlson AL, 2017, DIABETES TECHNOL THE, V19, pS4, DOI 10.1089/dia.2017.0024; Cryer PE, 2014, DIABETES, V63, P2188, DOI 10.2337/db14-0059; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; Feig DS, 2017, LANCET, V390, P2347, DOI 10.1016/S0140-6736(17)32400-5; Fradkin JE, 2016, DIABETES CARE, V39, P1080, DOI 10.2337/dc16-0541; Frier BM, 2014, NAT REV ENDOCRINOL, V10, P711, DOI 10.1038/nrendo.2014.170; Heinemann L, 2018, LANCET; Ly TT, 2013, JAMA-J AM MED ASSOC, V310, P1240, DOI 10.1001/jama.2013.277818; van Beers CAJ, 2016, LANCET DIABETES ENDO, V4, P893, DOI 10.1016/S2213-8587(16)30193-0	14	17	17	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2018	391	10128					1334	1336		10.1016/S0140-6736(18)30290-3	http://dx.doi.org/10.1016/S0140-6736(18)30290-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GB8RK	29459022				2022-12-28	WOS:000429342800005
J	Swanson, RL; Hampton, S; Green-McKenzie, J; Diaz-Arrastia, R; Grady, MS; Verma, R; Biester, R; Duda, D; Wolf, RL; Smith, DH				Swanson, Randel L., II; Hampton, Stephen; Green-McKenzie, Judith; Diaz-Arrastia, Ramon; Grady, M. Sean; Verma, Ragini; Biester, Rosette; Duda, Diana; Wolf, Ronald L.; Smith, Douglas H.			Neurological Manifestations Among US Government Personnel Reporting Directional Audible and Sensory Phenomena in Havana, Cuba	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; BALANCE; VALIDITY; CONSISTENCY; DISORDERS; INVENTORY; ILLNESS	IMPORTANCE From late 2016 through August 2017, US government personnel serving on diplomatic assignment in Havana, Cuba, reported neurological symptoms associated with exposure to auditory and sensory phenomena. OBJECTIVE To describe the neurological manifestations that followed exposure to an unknown energy source associated with auditory and sensory phenomena. DESIGN, SETTING, AND PARTICIPANTS Preliminary results from a retrospective case series of US government personnel in Havana, Cuba. Following reported exposure to auditory and sensory phenomena in their homes or hotel rooms, the individuals reported a similar constellation of neurological symptoms resembling brain injury. These individuals were referred to an academic brain injury center for multidisciplinary evaluation and treatment. EXPOSURES Report of experiencing audible and sensory phenomena emanating from a distinct direction (directional phenomena) associated with an undetermined source, while serving on US government assignments in Havana, Cuba, since 2016. MAIN OUTCOMES AND MEASURES Descriptions of the exposures and symptoms were obtained from medical record review of multidisciplinary clinical interviews and examinations. Additional objective assessments included clinical tests of vestibular (dynamic and static balance, vestibulo-ocular reflex testing, caloric testing), oculomotor (measurement of convergence, saccadic, and smooth pursuit eye movements), cognitive (comprehensive neuropsychological battery), and audiometric (pure tone and speech audiometry) functioning. Neuroimaging was also obtained. RESULTS Of 24 individuals with suspected exposure identified by the US Department of State, 21 completed multidisciplinary evaluation an average of 203 days after exposure. Persistent symptoms (>3 months after exposure) were reported by these individuals including cognitive (n = 17, 81%), balance (n = 15, 71%), visual (n = 18, 86%), and auditory (n = 15, 68%) dysfunction, sleep impairment (n = 18, 86%), and headaches (n = 16, 76%). Objective findings included cognitive (n = 16, 76%), vestibular (n = 17, 81%), and oculomotor (n = 15, 71%) abnormalities. Moderate to severe sensorineural hearing loss was identified in 3 individuals. Pharmacologic intervention was required for persistent sleep dysfunction (n = 15, 71%) and headache (n = 12, 57%). Fourteen individuals (67%) were held from work at the time of multidisciplinary evaluation. Of those, 7 began graduated return to work with restrictions in place, home exercise programs, and higher-level work-focused cognitive rehabilitation. CONCLUSIONS AND RELEVANCE In this preliminary report of a retrospective case series, persistent cognitive, vestibular, and oculomotor dysfunction, as well as sleep impairment and headaches, were observed among US government personnel in Havana, Cuba, associated with reports of directional audible and/or sensory phenomena of unclear origin. These individuals appeared to have sustained injury to widespread brain networks without an associated history of head trauma.	[Grady, M. Sean; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Dept Neurosurg, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA; [Swanson, Randel L., II; Hampton, Stephen; Biester, Rosette] Univ Penn, Dept Phys Med & Rehabil, Perelman Sch Med, Philadelphia, PA 19104 USA; [Swanson, Randel L., II; Hampton, Stephen; Green-McKenzie, Judith; Diaz-Arrastia, Ramon; Grady, M. Sean; Verma, Ragini; Biester, Rosette; Duda, Diana; Wolf, Ronald L.; Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Green-McKenzie, Judith] Univ Penn, Div Occupat & Environm Med, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Verma, Ragini; Wolf, Ronald L.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Duda, Diana] Univ Penn, Penn Therapy & Fitness, Good Shepherd Penn Partners, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Smith, DH (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosurg, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA.; Smith, DH (corresponding author), Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA.	smithdou@upenn.edu	Swanson, Randel/AFJ-8066-2022	McKenzie, Judith/0000-0003-3994-6568	Health Resources and Services Administration; National Institute for Occupational Safety and Health	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Green-McKenzie reported receiving grants from Health Resources and Services Administration and the National Institute for Occupational Safety and Health. No other disclosures were reported.	Alahmari KA, 2014, ARCH PHYS MED REHAB, V95, P65, DOI 10.1016/j.apmr.2013.09.011; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Barin K., BALANCE FUNCTION ASS, V2008, P229; Beck A., 1993, BECK ANXIETY INVENTO; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, PSYCHOL ASSESS; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brown SG, 2004, BRAIN COGNITION, V55, P283, DOI 10.1016/j.bandc.2004.02.010; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Chlebowski C, 2011, WECHSLER MEMORY SCAL; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Goodglass H., 2001, TEST BOSTON DIAGNOST, V3a; Grace J, 2002, FRONTAL SYSTEMS BEHA; Horn Linda B, 2015, Arch Phys Med Rehabil, V96, P1747; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones TF, 2000, NEW ENGL J MED, V342, P96, DOI 10.1056/NEJM200001133420206; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; McCutchan PK, 2016, MIL MED, V181, P1002, DOI 10.7205/MILMED-D-15-00444; McInnes K, 2017, PLOS ONE, V12; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nashner LM, 1993, HDB BALANCE FUNCTION, P280; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Scheiman M., 2014, CLIN MANAGEMENT BINO; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shepard NT., 1996, PRACTICAL MANAGEMENT; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Weathers F. W., 1991, PCL C FOR DSM 4; Wechsler, 2008, WAIS 4 TECHNICAL MAN; Weir E, 2005, CAN MED ASSOC J, V172, P36, DOI 10.1503/cmaj.045027; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	37	43	44	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1125	1133		10.1001/jama.2018.1742	http://dx.doi.org/10.1001/jama.2018.1742			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ8LL	29450484	Bronze, Green Published			2022-12-28	WOS:000427860200017
J	Wiese, AD; Griffin, MR; Schaffner, W; Stein, CM; Greevy, RA; Mitchel, EF; Grijalva, CG				Wiese, Andrew D.; Griffin, Marie R.; Schaffner, William; Stein, C. Michael; Greevy, Robert A.; Mitchel, Edward F., Jr.; Grijalva, Carlos G.			Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases A Nested Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; ADVISORY-COMMITTEE; OPIATE ANALGESICS; OLDER-ADULTS; CHRONIC PAIN; MORTALITY; INFECTIONS; MORPHINE	Background: Although certain opioid analgesics have immunosuppressive properties and increase the risk for infections in animals, the clinical effects of prescription opioid use on infection risk among humans are unknown. Objective: To test the hypothesis that prescription opioid use is an independent risk factor for invasive pneumococcal disease (IPD). Design: Nested case-control study. Setting: Tennessee Medicaid database linked to Medicare and Active Bacterial Core surveillance system databases (1995 to 2014). Patients: 1233 case patients with IPD aged 5 years and older matched to 24 399 control participants by diagnosis date, age, and county of residence. Measurements: Opioid use was measured on the basis of pharmacy prescription fills. Invasive pneumococcal disease was defined by the isolation of Streptococcus pneumoniae from a normally sterile site. The odds of current opioid use were compared between the case and control groups, accounting for known IPD risk factors. Secondary analyses categorized opioid use by opioid characteristics, applied an IPD risk score to assure comparability between exposure groups, and analyzed pneumonia and nonpneumonia lPD cases separately. Results: Persons in the case group had greater odds than control participants of being current opioid users (adjusted odds ratio [aOR], 1.62 [95% Cl, 1.36 to 1.92]). Associations were strongest for opioids that were long acting (aOR, 1.87 [Cl, 1.24 to 2.82]), of high potency (aOR, 1.72 [Cl, 1.32 to 2.25]), or were used at high dosages (50 to 90 morphine milligram equivalents [MME]/d: aOR, 1.71 [Cl, 1.22 to 2.39]; >= 90 MME/d: aOR, 1.75 [Cl, 1.33 to 2.29]). Results were consistent when the IPD risk score was taken into account and pneumonia and nonpneumonia IPD were analyzed separately. Limitations: Unmeasured confounding and measurement error, although sensitivity analyses suggested that neither was likely to affect results. Actual opioid use and other nonprescription use (such as illicit opioid use) were not measured. Conclusion: Opioid use is associated with an increased risk for IPD and represents a novel risk factor for these diseases.	[Wiese, Andrew D.; Griffin, Marie R.; Schaffner, William; Mitchel, Edward F., Jr.; Grijalva, Carlos G.] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Suite 2600,1500 21 St Ave South, Nashville, TN 37212 USA; [Stein, C. Michael] Vanderbilt Univ, Med Ctr, Dept Med, 2222 Pierce Ave,Robinson Res Bldg,Suite 542, Nashville, TN 37232 USA; [Greevy, Robert A.] Vanderbilt Univ, Med Ctr, Dept Biostat, 2525 West End,Suite 11000, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Wiese, AD (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Suite 2600,1500 21 St Ave South, Nashville, TN 37212 USA.	andrew.d.wiese.l@vanderbilt.edu; carlos.grijalva@vanderbilt.edu	Wiese, Andrew D/U-9745-2017; Wiese, Andrew/D-2200-2019	Wiese, Andrew D/0000-0002-0699-4224; Wiese, Andrew/0000-0002-0699-4224; Grijalva, Carlos/0000-0002-2329-7797	NIH, National Institute on Aging [R03 AG042981, R01 AG043471, TL1TR000447]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043471] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By NIH, National Institute on Aging, through grants R03 AG042981, R01 AG043471, and TL1TR000447.	Arbogast PG, 2011, AM J EPIDEMIOL, V174, P613, DOI 10.1093/aje/kwr143; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Arbogast PG, 2012, 33 AG HEALTHC RES QA; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Berterame S, 2016, LANCET, V387, P1644, DOI 10.1016/S0140-6736(16)00161-6; Breslow JM, 2011, J NEUROIMMUNE PHARM, V6, P551, DOI 10.1007/s11481-011-9303-6; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Dublin S, 2011, J AM GERIATR SOC, V59, P1899, DOI 10.1111/j.1532-5415.2011.03586.x; Ekstrom MP, 2014, BMJ-BRIT MED J, V348, pg445, DOI DOI 10.1136/BMJ.G445; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Inagi T, 2015, J HOSP INFECT, V89, P61, DOI 10.1016/j.jhin.2014.10.001; Kim DH, 2014, PHARMACOEPIDEM DR S, V23, P891, DOI 10.1002/pds.3674; Larochelle MR, 2016, ANN INTERN MED, V164, P1, DOI 10.7326/M15-0038; McCann DJ, 2015, NEW ENGL J MED, V372, P1572, DOI 10.1056/NEJMc1501822; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789; Roy S, 2011, J NEUROIMMUNE PHARM, V6, P442, DOI 10.1007/s11481-011-9292-5; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Schwacha MG, 2006, AM J SURG, V192, P82, DOI 10.1016/j.amjsurg.2006.01.001; Shao YJ, 2017, CLIN J PAIN, V33, P295, DOI 10.1097/AJP.0000000000000405; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Suissa S., 2002, PHARMACOEPIDEM DR S, P785; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; Veldhuizen S, 2014, ANN EPIDEMIOL, V24, P620, DOI 10.1016/j.annepidem.2014.06.001; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Vozoris NT, 2016, BRIT J CLIN PHARMACO, V81, P161, DOI 10.1111/bcp.12762; Wang JH, 2005, J IMMUNOL, V174, P426, DOI 10.4049/jimmunol.174.1.426; Wang JH, 2008, J IMMUNOL, V180, P3594, DOI 10.4049/jimmunol.180.5.3594; Wiese AD, 2016, ARTHRITIS RHEUMATOL, V68, P323, DOI 10.1002/art.39462; Wolfe S, 2015, EPIDEMIOLOGY PREVENT	39	61	62	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					396	+		10.7326/M17-1907	http://dx.doi.org/10.7326/M17-1907			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29435555	Green Accepted			2022-12-28	WOS:000427827400014
J	Dillon, A; Landells, LJ				Dillon, Andrew; Landells, Linda J.			NICE, the NHS, and Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dillon, Andrew; Landells, Linda J.] Natl Inst Hlth & Care Excellence, 10 Spring Gardens, London SW1A 2BU, England	National Institute for Health & Care Excellence	Dillon, A (corresponding author), Natl Inst Hlth & Care Excellence, 10 Spring Gardens, London SW1A 2BU, England.	andrew.dillon@nice.org.uk						[Anonymous], PMG19 ADD FIN AM NIC; Collins M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1363; European Medicines Agency, FIN REP AD P ATHW PI; Hwang TJ, 2017, JAMA-J AM MED ASSOC, V318, P609, DOI 10.1001/jama.2017.8255; Mailankody S, 2016, JAMA-J AM MED ASSOC, V316, P271, DOI 10.1001/jama.2016.5998; National Health Service England, 2016, NEW DEAL PAT TAXP IN; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence (NICE), 2014, GUID PROC TECHN APPR	8	10	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2018	319	8					767	768		10.1001/jama.2017.20552	http://dx.doi.org/10.1001/jama.2017.20552			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX6GK	29387883				2022-12-28	WOS:000426181300015
J	Taubert, F; Fischer, R; Groeneveld, J; Lehmann, S; Muller, MS; Rodig, E; Wiegand, T; Huth, A				Taubert, Franziska; Fischer, Rico; Groeneveld, Juergen; Lehmann, Sebastian; Mueller, Michael S.; Roedig, Edna; Wiegand, Thorsten; Huth, Andreas			Global patterns of tropical forest fragmentation	NATURE			English	Article							HABITAT FRAGMENTATION	Remote sensing enables the quantification of tropical deforestation with high spatial resolution(1,2). This in-depth mapping has led to substantial advances in the analysis of continent-wide fragmentation of tropical forests(1-4). Here we identified approximately 130 million forest fragments in three continents that show surprisingly similar power-law size and perimeter distributions as well as fractal dimensions. Power-law distributions(5-7) have been observed in many natural phenomena(8,9) such as wildfires, landslides and earthquakes. The principles of percolation theory(7,10,11) provide one explanation for the observed patterns, and suggest that forest fragmentation is close to the critical point of percolation; simulation modelling also supports this hypothesis. The observed patterns emerge not only from random deforestation, which can be described by percolation theory(10,11), but also from a wide range of deforestation and forest-recovery regimes. Our models predict that additional forest loss will result in a large increase in the total number of forest fragments-at maximum by a factor of 33 over 50 years-as well as a decrease in their size, and that these consequences could be partly mitigated by reforestation and forest protection.	[Taubert, Franziska; Fischer, Rico; Groeneveld, Juergen; Lehmann, Sebastian; Mueller, Michael S.; Roedig, Edna; Wiegand, Thorsten; Huth, Andreas] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Permoserstr 15, D-04318 Leipzig, Germany; [Groeneveld, Juergen] Tech Univ Dresden, Inst Forest Growth & Forest Comp Sci, PO 1117, D-01735 Tharandt, Germany; [Wiegand, Thorsten; Huth, Andreas] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Huth, Andreas] Univ Osnabruck, Inst Environm Syst Res, Barbarastr 12, D-49076 Osnabruck, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technische Universitat Dresden; University Osnabruck	Taubert, F (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Permoserstr 15, D-04318 Leipzig, Germany.	franziska.taubert@ufz.de	Bagher, Saeed/U-1068-2019; Wiegand, Thorsten/AAP-9709-2021; Groeneveld, Juergen/N-2420-2016; Wiegand, Thorsten/H-5877-2016; Fischer, Rico/AAI-4543-2021	Wiegand, Thorsten/0000-0002-3721-2248; Wiegand, Thorsten/0000-0002-3721-2248; Fischer, Rico/0000-0002-0482-0095; Rodig, Edna/0000-0002-6248-8844; Taubert, Franziska/0000-0001-7594-8152	Helmholtz Alliance Remote Sensing and Earth System Dynamics; European Research Council Advanced Grant [233066]	Helmholtz Alliance Remote Sensing and Earth System Dynamics; European Research Council Advanced Grant(European Research Council (ERC))	The project has been supported by the Helmholtz Alliance Remote Sensing and Earth System Dynamics. A.H. and T.W. were supported by the European Research Council Advanced Grant 233066. We thank A. Hein and A. Bogdanowski for assistance, A. Hartmann for discussion, M. Dantas de Paula for data handling, and S. Paulick and F. Bohn for technical support.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2018, NATURE, V554, P52; Bak P., 1996, NATURE WORKS SCI SEL; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Bascompte J., 2006, SELF ORG COMPLEX ECO, V42; Brinck K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14855; Chaplin-Kramer R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10158; Christensen K, 2005, COMPLEXITY CRITICALI, V1; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HOUGHTON RA, 1994, BIOSCIENCE, V44, P305, DOI 10.2307/1312380; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P47, DOI 10.5194/essd-7-47-2015; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Milne BT, 1996, ECOLOGY, V77, P805, DOI 10.2307/2265503; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Saberi AA, 2015, PHYS REP, V578, P1, DOI 10.1016/j.physrep.2015.03.003; Sornette D, 2006, CRITICAL PHENOMENA N; South A, 2011, R J, V3, P35; STAUFFER D, 1994, INTRO PERCOLATION TH; Storch D., 2007, SCALING BIODIVERSITY; Team RC., 2013, R LANG ENV STAT COMP; Turcotte DL, 2004, PHYSICA A, V340, P580, DOI 10.1016/j.physa.2004.05.009; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; ZIFF RM, 1986, PHYS REV LETT, V56, P545, DOI 10.1103/PhysRevLett.56.545	33	256	264	45	405	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					519	+		10.1038/nature25508	http://dx.doi.org/10.1038/nature25508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29443966				2022-12-28	WOS:000425597400045
J	Kremen, C				Kremen, Claire			The value of pollinator species diversity	SCIENCE			English	Editorial Material							ECOLOGICAL INTENSIFICATION; CROP POLLINATION; BIODIVERSITY; SERVICES; DELIVERY; IMPACTS		[Kremen, Claire] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kremen, C (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.							Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Daily GC., 1997, ISSUES ECOL, V2, P1; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Geldmann J, 2018, SCIENCE, V359, P392, DOI 10.1126/science.aar2269; Isbell F, 2017, NATURE, V546, P65, DOI 10.1038/nature22899; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Kovacs-Hostyanszki A, 2017, ECOL LETT, V20, P673, DOI 10.1111/ele.12762; Kremen C, 2005, FRONT ECOL ENVIRON, V3, P540, DOI 10.1890/1540-9295(2005)003[0540:ACTEMA]2.0.CO;2; Kremen C, 2012, ECOL SOC, V17, DOI 10.5751/ES-05035-170440; Lohbeck M, 2016, ECOLOGY, V97, P2772, DOI 10.1002/ecy.1499; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Tallis H, 2014, NATURE, V515, P27, DOI 10.1038/515027a; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Winfree R, 2018, SCIENCE, V359, P791, DOI 10.1126/science.aao2117; Winfree R, 2015, ECOL LETT, V18, P626, DOI 10.1111/ele.12424	15	16	20	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					741	742	aar7614	10.1126/science.aar7614	http://dx.doi.org/10.1126/science.aar7614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449477				2022-12-28	WOS:000425116200026
J	Sherman, DJ; Xie, R; Taylor, RJ; George, AH; Okuda, S; Foster, PJ; Needleman, DJ; Kahne, D				Sherman, David J.; Xie, Ran; Taylor, Rebecca. J.; George, Alexander H.; Okuda, Suguru; Foster, Peter J.; Needleman, Daniel J.; Kahne, Daniel			Lipopolysaccharide is transported to the cell surface by a membrane-to-membrane protein bridge	SCIENCE			English	Article							BACTERIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; FLOW-CYTOMETRY; CONTACT SITES; COMPLEX; EXPORT; IDENTIFICATION	Gram-negative bacteria have an outer membrane that serves as a barrier to noxious agents in the environment. This protective function is dependent on lipopolysaccharide, a large glycolipid located in the outer leaflet of the outer membrane. Lipopolysaccharide is synthesized at the cytoplasmic membrane and must be transported to the cell surface. To understand this transport process, we reconstituted membrane-to-membrane movement of lipopolysaccharide by incorporating purified inner and outer membrane transport complexes into separate proteoliposomes. Transport involved stable association between the inner and outer membrane proteoliposomes. Our results support a model in which lipopolysaccharide molecules are pushed one after the other in a PEZ dispenser-like manner across a protein bridge that connects the inner and outer membranes.	[Sherman, David J.; Xie, Ran; Taylor, Rebecca. J.; George, Alexander H.; Okuda, Suguru; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Foster, Peter J.; Needleman, Daniel J.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Foster, Peter J.; Needleman, Daniel J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Foster, Peter J.; Needleman, Daniel J.; Kahne, Daniel] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Kahne, D (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Kahne, D (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kahne@chemistry.harvard.edu	Okuda, Suguru/K-6571-2017; Xie, Ran/O-9268-2017	Okuda, Suguru/0000-0002-9184-5601; Sherman, David/0000-0002-2120-0971; Xie, Ran/0000-0001-5170-2940; Foster, Peter/0000-0003-1818-5886; Kahne, Daniel/0000-0002-8296-1424; George, Alexander/0000-0001-5200-5055; Taylor, Rebecca/0000-0001-8147-3130	National Science Foundation Graduate Research Fellowship; Kavli Institute for Bionano Science and Technology at Harvard University; Blavatnik Biomedical Accelerator at Harvard University; National Science Foundation [DMR-0820484]; National Institute of Allergy and Infectious Diseases [AI081059, AI109764]; National Institute of General Medical Sciences [GM066174]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059, U19AI109764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066174] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Kavli Institute for Bionano Science and Technology at Harvard University; Blavatnik Biomedical Accelerator at Harvard University; National Science Foundation(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation Graduate Research Fellowship (to D.J.S. and R.J.T.), the Kavli Institute for Bionano Science and Technology at Harvard University, the Blavatnik Biomedical Accelerator at Harvard University, National Science Foundation grant DMR-0820484 (to D.J.N.), the National Institute of Allergy and Infectious Diseases award numbers AI081059 and AI109764 (to D.K.), and the National Institute of General Medical Sciences award no. GM066174 (to D.K.).	Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; Kormelink TG, 2016, CYTOM PART A, V89A, P135, DOI 10.1002/cyto.a.22644; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11883; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Murley A, 2016, MOL CELL, V61, P648, DOI 10.1016/j.molcel.2016.01.031; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; OSBORN MJ, 1972, J BIOL CHEM, V247, P3973; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Saheki Y, 2017, ANNU REV BIOCHEM, V86, P659, DOI 10.1146/annurev-biochem-061516-044932; Sherman DJ, 2014, P NATL ACAD SCI USA, V111, P4982, DOI 10.1073/pnas.1323516111; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Tefsen B, 2005, J BIOL CHEM, V280, P4504, DOI 10.1074/jbc.M409259200; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	32	75	75	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					798	+	aar1886	10.1126/science.aar1886	http://dx.doi.org/10.1126/science.aar1886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449493	Green Accepted			2022-12-28	WOS:000425116200046
J	El-Jawahri, AR; Schaefer, PW; El Khoury, JB; Martinez-Lage, M				El-Jawahri, Areej R.; Schaefer, Pamela W.; El Khoury, Joseph B.; Martinez-Lage, Maria			Case 5-2018: A 63-Year-Old Man with Confusion after Stem-Cell Transplantation Human herpesvirus 6-related meningoencephalitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSIBLE ENCEPHALOPATHY SYNDROME; NERVOUS-SYSTEM COMPLICATIONS; BONE-MARROW; INFECTIOUS COMPLICATIONS; RISK-FACTORS; RECIPIENTS; REACTIVATION; FUNGAL; BLOOD; LEUKOENCEPHALOPATHY		[El-Jawahri, Areej R.; El Khoury, Joseph B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Martinez-Lage, Maria] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [El-Jawahri, Areej R.; El Khoury, Joseph B.] Harvard Med Sch, Dept Med, Boston, MA USA; [Schaefer, Pamela W.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Martinez-Lage, Maria] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	El-Jawahri, AR (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; El-Jawahri, AR (corresponding author), Harvard Med Sch, Dept Med, Boston, MA USA.		Schaefer, Pamela/AAA-1323-2019; Martinez-Lage, Maria/S-6665-2019	Martinez-Lage, Maria/0000-0002-5859-7562				Agut H, 2015, CLIN MICROBIOL REV, V28, P313, DOI 10.1128/CMR.00122-14; Alsharif M, 2009, AM J CLIN PATHOL, V132, P746, DOI 10.1309/AJCPV9DC4HGPANKR; Bachanova V, 2009, BONE MARROW TRANSPL, V43, P237, DOI 10.1038/bmt.2008.313; Baddley JW, 2002, CLIN TRANSPLANT, V16, P419, DOI 10.1034/j.1399-0012.2002.02033.x; Bartynski WS, 2004, AM J NEURORADIOL, V25, P261; Beitinjaneh A, 2011, BIOL BLOOD MARROW TR, V17, P300, DOI 10.1016/j.bbmt.2010.04.003; CARRIGAN DR, 1994, BLOOD, V84, P3307; Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313; CONE RW, 1993, NEW ENGL J MED, V329, P156, DOI 10.1056/NEJM199307153290302; Fukae S, 2000, INTERNAL MED, V39, P632, DOI 10.2169/internalmedicine.39.632; Galvin R, 2010, EUR J NEUROL, V17, P1408, DOI 10.1111/j.1468-1331.2010.03153.x; George JN, 2004, J CLIN APHERESIS, V19, P63, DOI 10.1002/jca.20008; GREEN R, 1995, NEUROLOGY, V45, P1435, DOI 10.1212/WNL.45.8.1435; Hill JA, 2014, TRANSPL INFECT DIS, V16, P477, DOI 10.1111/tid.12208; Hill JA, 2014, HAND CLINIC, V123, P327, DOI 10.1016/B978-0-444-53488-0.00016-X; Ho VT, 2005, BIOL BLOOD MARROW TR, V11, P571, DOI 10.1016/j.bbmt.2005.06.001; Ljungman P, 2000, BRIT J HAEMATOL, V111, P774, DOI 10.1046/j.1365-2141.2000.02422.x; Moazzam AA, 2012, J NEURO-ONCOL, V106, P185, DOI 10.1007/s11060-011-0636-z; Ogata M, 2013, CLIN INFECT DIS, V57, P671, DOI 10.1093/cid/cit358; Robin M, 2007, BIOL BLOOD MARROW TR, V13, P1304, DOI 10.1016/j.bbmt.2007.07.007; Schmidt V, 2016, ACTA HAEMATOL-BASEL, V135, P1, DOI 10.1159/000430489; Siegal D, 2007, BIOL BLOOD MARROW TR, V13, P1369, DOI 10.1016/j.bbmt.2007.07.013; Srinivasan A, 2013, BIOL BLOOD MARROW TR, V19, P94, DOI 10.1016/j.bbmt.2012.08.012; Syed FI, 2016, HEMATOL ONCOL CLIN N, V30, P887, DOI 10.1016/j.hoc.2016.03.009; Tan IL, 2011, NEUROLOGY, V77, P297, DOI 10.1212/WNL.0b013e318225ab3f; Teira P, 2016, BLOOD, V127, P2427, DOI 10.1182/blood-2015-11-679639; Tomblyn M, 2009, BONE MARROW TRANSPL, V44, P453, DOI 10.1038/bmt.2009.254; Tomblyn M, 2010, BIOL BLOOD MARROW TR, V16, P1155, DOI 10.1016/j.bbmt.2010.02.024; van Burik JAH, 2007, BIOL BLOOD MARROW TR, V13, P1487, DOI 10.1016/j.bbmt.2007.08.049; Wong R, 2003, BRIT J HAEMATOL, V122, P128, DOI 10.1046/j.1365-2141.2003.04447.x; Yoshikawa T, 2002, J INFECT DIS, V185, P847, DOI 10.1086/339411; Young JAH, 2016, BIOL BLOOD MARROW TR, V22, P359, DOI 10.1016/j.bbmt.2015.09.013; Zerr DM, 2005, CLIN INFECT DIS, V40, P932, DOI 10.1086/428060	33	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					659	669		10.1056/NEJMcpc1707556	http://dx.doi.org/10.1056/NEJMcpc1707556			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW0QK	29443669				2022-12-28	WOS:000425000000012
J	Mercuri, E; Darras, BT; Chiriboga, CA; Day, JW; Campbell, C; Connolly, AM; Iannaccone, ST; Kirschner, J; Kuntz, NL; Saito, K; Shieh, PB; Tulinius, M; Mazzone, ES; Montes, J; Bishop, KM; Yang, Q; Foster, R; Gheuens, S; Bennett, CF; Farwell, W; Schneider, E; De Vivo, DC; Finkel, RS; Bradley, WG; Kaufmann, P; Dickson, PI; Reingold, SC; Davis, CS; Arredondo, K; Castro, D; Cowie, M; Farrow-Gillespie, A; Hebert, A; Kauk, M; Miller, N; Nelson, L; Spain, T; Cappell, J; Constantinescu, A; Cruz, R; Dastgir, J; De Vivo, D; Dunaway, S; Engelstad, K; Khandji, AG; Kramer, S; Marra, J; Popolizio, M; Salazar, R; Weimer, LH; Aziz-Zaman, S; LaMarca, N; Ghosh, P; Al-Ghamdi, F; Liew, W; Graham, R; Berde, C; Sethna, N; Koka, A; Wang, L; Laine, R; Souris, M; Ordonez, G; Harrington, T; Szelag, H; Pasternak, A; Mirek, E; Quigley, J; Finkel, R; Berry, D; Civitello, M; Endsley, JD; Eden, C; Leon, W; O'Reardon, K; Sigurdardottir, L; Johnson, C; Turner, J; Vega, M; Weber-Guzman, F; Zinn, M; Rocha, ACT; Watson, K; D'Souza, G; Ramamurthi, RJ; Gee, R; Kitsuwa-Lowe, J; Hagerman, K; Crasta, S; Welsh, L; Paulose, S; McFall, D; Perez, J; Patnaik, S; Sanjanwala, B; Sakamuri, S; Proud, C; Purse, BP; Duong, TT; Sampson, J; Tennekoon, G; Brandsema, J; Glanzman, A; Flickinger, J; Toms, M; Adang, L; Stanford, D; Mayer, O; Zigmont, J; Chadehumbe, M; Kichula, E; Finanger, E; Russman, B; Roberts, C; Frank, A; Benjamin, D; Zilke, K; Golumbek, PT; Zaidman, CM; Anand, P; Gadeken, R; Siener, C; Kuntz, N; Epstein, L; Krueger, J; Goldman, S; Krosschell, K; Blomgren, C; Choi, HW; Kurz, J; Parsons, J; Janas, J; Yang, M; Ballard, A; Carry, T; Shea, S; Bielsky, A; Booker, K; Camuto, A; Lord-Halvorson, S; Gibbons, M; Zimmerman, C; Allen, V; Fuhr, P; Kelley, C; Johnson, H; Tran, V; VanderVeen, G; Shieh, P; Fowler, E; Parziale, N; Rao, L; Skura, C; Kelley, C; Shu, F; Oskoui, M; Zielinski, D; Poulin, C; Ingelmo, PM; Desilets, ST; Dinunzio, P; Rivera, G; Srour, M; Arpin, S; Goobie, S; Gibson, P; Scholtes, C; McDonald, W; Zapata, E; Nguyen, CTE; Servais, L; Gargaun, E; Le Moing, AG; Gidaro, T; Vialle, R; Guye, ML; Lilien, C; Olliver, G; Gilabert, S; Borell, S; Wider, S; Stein, S; Vogt, S; Kruger, M; Pechmann, A; Rippberger, B; Eckenweiler, M; Schara, U; Koelbel, H; Andres, B; Rupprich, K; Gangfuss, A; Jachertz, P; Della Marina, A; Sponemann, N; Pane, M; Palermo, C; Piastra, M; Fanelli, L; De Sanctis, R; Genovese, O; Antonaci, L; Pera, MC; Lamendola, P; Messina, S; Vita, G; Di Bella, V; Sframeli, M; la Rosa, M; Barcellona, C; Distefano, MG; Cavallaro, F; Versaci, A; De Luca, F; Vita, G; Osorio, AN; Tizzano, E; Gonzalez, CIO; Escobar, JDO; Oferil, JC; Cantillo, JM; Rotger, AF; Morancho, MV; Eldblom, J; Darin, N; Kroksmark, AK; Lindstedt, A; Michael, E; Kimber, E; Wahlgren, L; Chan, SHS; Chim, S; Chiu, J; Ho, ACC; Ip, JKJ; Lam, WWM; Ng, MCS; Wan, C; Wong, VCN; Yue, Y; Arakawa, R; Yamauchi, A; Nagata, S; Ito, Y; Nakatsukasa, H; Takeshita, A; Hirasawa, K; Ikai, T; Eto, K; Otamni, Y; Takeshima, Y; Fukuda, N; Tanaka, Y; Shimomura, H; Lee, T; Shibano, T; Tachikawa, T; Chae, JH; Lim, BC; Shin, HI; Kim, SY; Choi, SA; Son, WS; Jo, H; Chun, SM; Kim, H				Mercuri, E.; Darras, B. T.; Chiriboga, C. A.; Day, J. W.; Campbell, C.; Connolly, A. M.; Iannaccone, S. T.; Kirschner, J.; Kuntz, N. L.; Saito, K.; Shieh, P. B.; Tulinius, M.; Mazzone, E. S.; Montes, J.; Bishop, K. M.; Yang, Q.; Foster, R.; Gheuens, S.; Bennett, C. F.; Farwell, W.; Schneider, E.; De Vivo, D. C.; Finkel, R. S.; Bradley, Walter G.; Kaufmann, Petra; Dickson, Patricia I.; Reingold, Stephen C.; Davis, Charles S.; Arredondo, Kristen; Castro, Diana; Cowie, Margaret; Farrow-Gillespie, Alan; Hebert, Andrew; Kauk, Melissa; Miller, Nancy; Nelson, Leslie; Spain, Thomas, Jr.; Cappell, Joshua; Constantinescu, Andrei; Cruz, Rosangel; Dastgir, Jahannaz; De Vivo, Darryl; Dunaway, Sally; Engelstad, Kristin; Khandji, Alexander G.; Kramer, Samantha; Marra, Jonathan; Popolizio, Molly; Salazar, Rachel; Weimer, Louis H.; Aziz-Zaman, Sonya; LaMarca, Nicole; Ghosh, Partha; Al-Ghamdi, Fouad; Liew, Wendy; Graham, Robert; Berde, Charles; Sethna, Navil; Koka, Anjali; Wang, Luke; Laine, Regina; Souris, Michelle; Ordonez, Grace; Harrington, Timothy; Szelag, Heather; Pasternak, Amy; Mirek, Elizabeth; Quigley, Janet; Finkel, Richard; Berry, Debbie; Civitello, Matthew; Endsley, Julie Duke; Eden, Candace; Leon, Wendy; O'Reardon, Kathleen; Sigurdardottir, Laufey; Johnson, Craig; Turner, Jenna; Vega, Melisa; Weber-Guzman, Fabiola; Zinn, Matthias; Rocha, Ana Carolina Tesi; Watson, Karolina; D'Souza, Genevieve; Ramamurthi, R. J.; Gee, Richard; Kitsuwa-Lowe, Janis; Hagerman, Katharine; Crasta, Sheela; Welsh, Lesly; Paulose, Shirley; McFall, Danielle; Perez, Jennifer; Patnaik, Swetapadma; Sanjanwala, Bharati; Sakamuri, Sarada; Proud, Crystal; Purse, Bona Park; Duong, Trinh Tina; Sampson, Jacinda; Tennekoon, Gihan; Brandsema, John; Glanzman, Allan; Flickinger, Jean; Toms, Michele; Adang, Laura; Stanford, Delores; Mayer, Oscar; Zigmont, Joshua; Chadehumbe, Madeline; Kichula, Elizabeth; Finanger, Erika; Russman, Barry; Roberts, Colin; Frank, Andrea; Benjamin, Danielle; Zilke, Kirsten; Golumbek, Paul T.; Zaidman, Craig M.; Anand, Pallavi; Gadeken, Rebecca; Siener, Catherine; Kuntz, Nancy; Epstein, Leon; Krueger, Jena; Goldman, Stewart; Krosschell, Kristin; Blomgren, Colleen; Choi, Hyoung Won; Kurz, Jonathan; Parsons, Julie; Janas, Joanne; Yang, Michele; Ballard, Alison; Carry, Terri; Shea, Stephanie; Bielsky, Alan; Booker, Kaylee; Camuto, Alicia; Lord-Halvorson, Sierra; Gibbons, Melissa; Zimmerman, Carl; Allen, Victoria; Fuhr, Peter; Kelley, Carolyn; Johnson, Hannah; Tran, Vi; VanderVeen, Gina; Shieh, Perry; Fowler, Eileen; Parziale, Nicholas; Rao, Lekha; Skura, Christy; Kelley, Carolyn; Shu, Francy; Oskoui, Maryam; Zielinski, David; Poulin, Chantal; Ingelmo, Pablo Mauricio; Desilets, Sarah Turgeon; Dinunzio, Pamela; Rivera, Gonzalo; Srour, Myriam; Arpin, Stephanie; Goobie, Sharan; Gibson, Paul; Scholtes, Cheryl; McDonald, Wendy; Zapata, Eugenio; Nguyen, Cam-Tu Emilie; Servais, Laurent; Gargaun, Elena; Le Moing, Anne-Gaelle; Gidaro, Teresa; Vialle, Raphael; Guye, Marie-Laurence; Lilien, Charlotte; Olliver, Gwenn; Gilabert, Stephanie; Borell, Sabine; Wider, Sabine; Stein, Sabine; Vogt, Sibylle; Krueger, Marcus; Pechmann, Astrid; Rippberger, Bianca; Eckenweiler, Matthias; Schara, Ulrike; Koelbel, Heike; Andres, Barbara; Rupprich, Katrin; Gangfuss, Andrea; Jachertz, Philipp; Della Marina, Adela; Sponemann, Nina; Pane, Markia; Palermo, Concetta; Piastra, Marco; Fanelli, Lavinia; De Sanctis, Roberto; Genovese, Orazio; Antonaci, Laura; Pera, Maria Carmela; Lamendola, Priscilla; Messina, Sonia; Vita, Gianluca; Di Bella, Vincenzo; Sframeli, Maria; la Rosa, Matteo; Barcellona, Costanza; Distefano, Maria Grazia; Cavallaro, Filippo; Versaci, Antonio; De Luca, Francesco; Vita, Giuseppe; Nacimento Osorio, Andres; Tizzano, Eduardo; Ortez Gonzalez, Carlos Ignacio; Ortigoza Escobar, Juan Dario; Colomer Oferil, Juame; Medina Cantillo, Julita; Febrer Rotger, Anna; Vigo Morancho, Meritxell; Eldblom, Johanneh; Darin, Niklas; Kroksmark, Anna Karin; Lindstedt, Asa; Michael, Eva; Kimber, Eva; Wahlgren, Lisa; Chan, Sophelia Hoi-Shan; Chim, Stella; Chiu, Joseph; Ho, Alvin Chi Chung; Ip, Jing Kun Janice; Lam, Wendy Wai Man; Ng, Maggie Chui-San; Wan, Connie; Wong, Virginia Chun Nei; Yue, Yvonne; Arakawa, Reiko; Yamauchi, Akemi; Nagata, Satoru; Ito, Yasushi; Nakatsukasa, Hidetsugu; Takeshita, Akiko; Hirasawa, Kyoko; Ikai, Tetsuo; Eto, Kaoru; Otamni, Yui; Takeshima, Yasuhiro; Fukuda, Noroki; Tanaka, Yasuhiro; Shimomura, Hideki; Lee, Tomoko; Shibano, Takayuki; Tachikawa, Tomohiro; Chae, Jong-Hee; Lim, Byung Chan; Shin, Hyung-Ik; Kim, Soo Yeon; Choi, Sun Ah; Son, Woo Sung; Jo, Hyemi; Chun, Seong Min; Kim, Hyuna		CHERISH Study Grp	Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FUNCTIONAL MOTOR SCALE; LUMBAR PUNCTURE; HEADACHE; CHILDREN; SEVERITY; BACKACHE; PROTEIN; TRIAL	BACKGROUND Nusinersen is an antisense oligonucleotide drug that modulates pre-messenger RNA splicing of the survival motor neuron 2 (SMN2) gene. It has been developed for the treatment of spinal muscular atrophy (SMA). METHODS We conducted a multicenter, double-blind, sham-controlled, phase 3 trial of nusinersen in 126 children with SMA who had symptom onset after 6 months of age. The children were randomly assigned, in a 2: 1 ratio, to undergo intrathecal administration of nusinersen at a dose of 12 mg (nusinersen group) or a sham procedure (control group) on days 1, 29, 85, and 274. The primary end point was the least-squares mean change from baseline in the Hammersmith Functional Motor Scale-Expanded (HFMSE) score at 15 months of treatment; HFMSE scores range from 0 to 66, with higher scores indicating better motor function. Secondary end points included the percentage of children with a clinically meaningful increase from baseline in the HFMSE score (>= 3 points), an outcome that indicates improvement in at least two motor skills. RESULTS In the prespecified interim analysis, there was a least-squares mean increase from baseline to month 15 in the HFMSE score in the nusinersen group (by 4.0 points) and a least-squares mean decrease in the control group (by -1.9 points), with a significant between-group difference favoring nusinersen (least-squares mean difference in change, 5.9 points; 95% confidence interval, 3.7 to 8.1; P< 0.001). This result prompted early termination of the trial. Results of the final analysis were consistent with results of the interim analysis. In the final analysis, 57% of the children in the nusinersen group as compared with 26% in the control group had an increase from baseline to month 15 in the HFMSE score of at least 3 points (P< 0.001), and the overall incidence of adverse events was similar in the nusinersen group and the control group (93% and 100%, respectively). CONCLUSIONS Among children with later-onset SMA, those who received nusinersen had significant and clinically meaningful improvement in motor function as compared with those in the control group. (Funded by Biogen and Ionis Pharmaceuticals; CHERISH ClinicalTrials. gov number, NCT02292537.)	[Mercuri, E.; Mazzone, E. S.] Catholic Univ, Dept Pediat Neurol, Rome, Italy; [Darras, B. T.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Foster, R.; Gheuens, S.; Farwell, W.] Biogen, Cambridge, MA USA; [Chiriboga, C. A.; Montes, J.; De Vivo, D. C.] Columbia Univ Med Ctr, Dept Neurol, New York, NY USA; [Chiriboga, C. A.; De Vivo, D. C.] Columbia Univ Med Ctr, Dept Pediat, New York, NY USA; [Montes, J.] Columbia Univ Med Ctr, Dept Rehabil & Regenerat Med, New York, NY USA; [Day, J. W.] Stanford Sch Med, Dept Neurol, Stanford, CA USA; [Shieh, P. B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bishop, K. M.; Yang, Q.; Bennett, C. F.; Schneider, E.] Ionis Pharmaceut, Carlsbad, CA USA; [Campbell, C.] Childrens Hosp, London Hlth Sci Ctr, London, ON, Canada; [Connolly, A. M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Iannaccone, S. T.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Kirschner, J.] Univ Freiburg, Med Ctr, Fac Med, Dept Neuropediat & Muscle Disorders, Freiburg, Germany; [Kuntz, N. L.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA; [Saito, K.] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan; [Saito, K.] Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan; [Tulinius, M.] Gothenburg Univ, Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden; [Finkel, R. S.] Nemours Childrens Hosp, Dept Pediat, Div Neurol, Orlando, FL USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Harvard University; Boston Children's Hospital; Biogen; Columbia University; Columbia University; Columbia University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ionis Pharmaceuticals, Inc.; London Health Sciences Centre; Western University (University of Western Ontario); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Freiburg; Ann & Robert H. Lurie Children's Hospital of Chicago; Tokyo Women's Medical University; Tokyo Women's Medical University; Queen Silvia Children's Hospital; University of Gothenburg	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Largo Gemelli 8, I-00168 Rome, Italy.	eugeniomaria.mercuri@unicatt.it	Vita, Gianluca/AAR-4587-2020; Graham, Robert J/AAJ-9835-2021; Antonaci, Laura/AAC-3274-2022; Kirschner, Janbernd/H-7418-2016; Ortigoza-Escobar, Juan Dario/AAP-8165-2021; Connolly, Anne/GYD-3128-2022; Darin, Niklas/AAL-6345-2020; Kauk-Kuusik, Marit/I-8163-2015; Chan, Sophelia/AAZ-5026-2021; Ramamurthi, Radhamangalam J/AFK-7113-2022; Mazzone, Elena/AAF-4444-2020; D'souza, Genevieve/AAX-9296-2020; Servais, Laurent/AAL-7384-2020; Kirschner, Janbernd/Q-1493-2019; Pera, Maria Carmela/J-6068-2018; Mercuri, Eugenio/G-1351-2015	Vita, Gianluca/0000-0003-4190-8042; Graham, Robert J/0000-0002-8659-6313; Kirschner, Janbernd/0000-0003-1618-7386; Ortigoza-Escobar, Juan Dario/0000-0002-6320-2641; Kauk-Kuusik, Marit/0000-0003-0071-8568; Chan, Sophelia/0000-0002-2990-0163; Kirschner, Janbernd/0000-0003-1618-7386; D'souza, Genevieve/0000-0003-4801-6215; Tesi Rocha, Carolina/0000-0002-7224-0754; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Pera, Maria Carmela/0000-0001-6777-1721; Antonaci, Laura/0000-0003-4753-8441; Darras, Basil/0000-0002-1536-8145; Saito, Kayoko/0000-0003-2632-0873; Kuntz, Nancy L/0000-0003-2253-5156; Day, John/0000-0002-0086-9529; Mercuri, Eugenio/0000-0002-9851-5365; Ramamurthi, Radhamangalam/0000-0002-8518-5985; Shin, Hyungik/0000-0001-8805-3104; Reingold, Stephen/0000-0003-4485-8634	Biogen and Ionis Pharmaceuticals; CHERISH	Biogen and Ionis Pharmaceuticals; CHERISH	Funded by Biogen and Ionis Pharmaceuticals; CHERISH ClinicalTrials.gov number, NCT02292537.	Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Crock C, 2014, ARCH DIS CHILD, V99, P203, DOI 10.1136/archdischild-2013-305145; Darras BT, 2015, PEDIATR CLIN N AM, V62, P743, DOI 10.1016/j.pcl.2015.03.010; Darras BT, 21 INT C WORLD MUS S; Darras BT, 2017, SWAIMANS PEDIAT NEUR, V6, P1057, DOI [10.1016/B978-0-323-37101-8.00139-9, DOI 10.1016/B978-0-323-37101-8.00139-9]; Ebinger F, 2004, PEDIATRICS, V113, P1588, DOI 10.1542/peds.113.6.1588; Ellenby Miles S, 2006, N Engl J Med, V355, pe12, DOI 10.1056/NEJMvcm054952; Evans RW, 2000, NEUROLOGY, V55, P909, DOI 10.1212/WNL.55.7.909; Faravelli I, 2015, NAT REV NEUROL, V11, P351, DOI 10.1038/nrneurol.2015.77; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finkel R, 2015, NEUROMUSCULAR DISORD, V25, P593, DOI 10.1016/j.nmd.2015.04.009; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Glanzman A, 2017, NEUROLOGY, V88; Glanzman AM, 2011, J CHILD NEUROL, V26, P1499, DOI 10.1177/0883073811420294; Glimm E, 2010, STAT MED, V29, P219, DOI 10.1002/sim.3748; Hache M, 2016, J CHILD NEUROL, V31, P899, DOI 10.1177/0883073815627882; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kaufmann P, 2012, NEUROLOGY, V79, P1889, DOI 10.1212/WNL.0b013e318271f7e4; Keidan I, 2005, J PEDIAT HEMATOL ONC, V27, P307, DOI 10.1097/01.mph.0000168729.32463.7b; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lowery S, 2008, PEDIATR ANESTH, V18, P230, DOI 10.1111/j.1460-9592.2008.02414.x; Markowitz JA, 2012, PEDIATR NEUROL, V46, P1, DOI 10.1016/j.pediatrneurol.2011.09.001; Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563; Mazzone ES, 2017, MUSCLE NERVE, V55, P869, DOI 10.1002/mus.25430; Mercuri Eugenio, 2012, Lancet Neurol, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26, P126, DOI 10.1016/j.nmd.2015.10.006; Morgenlander J C, 1994, Postgrad Med, V95, P125; O'Hagen JM, 2007, NEUROMUSCULAR DISORD, V17, P693, DOI 10.1016/j.nmd.2007.05.009; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Pera MC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0790-9; Rouault F, 2017, NEUROMUSCULAR DISORD, V27, P428, DOI 10.1016/j.nmd.2017.01.018; Rudnik-Schoneborn S, 2001, EUR NEUROL, V45, P174, DOI 10.1159/000052118; Swoboda KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012140; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	38	651	669	3	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					625	635		10.1056/NEJMoa1710504	http://dx.doi.org/10.1056/NEJMoa1710504			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0QK	29443664	Green Published, Bronze			2022-12-28	WOS:000425000000008
J	Thomas, K				Thomas, Kim			TECHNOLOGY Wanted: a WhatsApp alternative for clinicians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kimthomas@ntlworld.com						Commontime, 2017, PAG IN THE NHS; Crouch H., 2017, DIGITAL HLTH NE 1204; Gulland A, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4309; Mobasheri M.H., 2015, BMJ INNOV, V1, P174, DOI [DOI 10.1136/BMJINNOV-2015-000062, 10.1136/bmjinnov-2015-000062]; NHS Digital, 2018, DOS DONTS IND US INS; RIMMER A, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J489629074520	6	37	37	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2018	360								k622	10.1136/bmj.k622	http://dx.doi.org/10.1136/bmj.k622			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KT	29440047	Green Published			2022-12-28	WOS:000425581700003
J	Akhilesh, K; Pappu, S; Rajapara, HM; Gunnell, Y; Shukla, AD; Singhvi, AK				Akhilesh, Kumar; Pappu, Shanti; Rajapara, Haresh M.; Gunnell, Yanni; Shukla, Anil D.; Singhvi, Ashok K.			Early Middle Palaeolithic culture in India around 385-172 ka reframes Out of Africa models	NATURE			English	Article							STONE-AGE; KAPTHURIN FORMATION; TECHNOLOGY; RECORD; BEHAVIOR; ORIGINS; KENYA; ASIA	Luminescence dating at the stratified prehistoric site of Attirampakkam, India, has shown that processes signifying the end of the Acheulian culture and the emergence of a Middle Palaeolithic culture occurred at 385 +/- 64 thousand years ago (ka), much earlier than conventionally presumed for South Asia(1). The Middle Palaeolithic continued at Attirampakkam until 172 +/- 41 ka. Chronologies of Middle Palaeolithic technologies in regions distant from Africa and Europe are crucial for testing theories about the origins and early evolution of these cultures, and for understanding their association with modern humans or archaic hominins, their links with preceding Acheulian cultures and the spread of Levallois lithic technologies(2-20). The geographic location of India and its rich Middle Palaeolithic record are ideally suited to addressing these issues, but progress has been limited by the paucity of excavated sites and hominin fossils as well as by geochronological constraints(1,8). At Attirampakkam, the gradual disuse of bifaces, the predominance of small tools, the appearance of distinctive and diverse Levallois flake and point strategies, and the blade component all highlight a notable shift away from the preceding Acheulian large-flake technologies(9). These findings document a process of substantial behavioural change that occurred in India at 385 +/- 64 ka and establish its contemporaneity with similar processes recorded in Africa and Europe(2-8,10-13). This suggests complex interactions between local developments and ongoing global transformations. Together, these observations call for a re-evaluation of models that restrict the origins of Indian Middle Palaeolithic culture to the incidence of modern human dispersals after approximately 125 ka(19,21).				pappu.shanti@gmail.com	Rajapara, H M/O-9545-2019; Rajapara, H M/C-3453-2018; Shukla, Anil D/L-7858-2016	Rajapara, H M/0000-0001-7740-2903; Rajapara, H M/0000-0001-7740-2903; Shukla, Anil D/0000-0002-4969-0204; Pappu, Shanti/0000-0003-4786-4968	Sharma Centre for Heritage Education; L. S. B. Leakey Foundation; Earthwatch Institute; Homi Bhabha Fellowships Council; ISRO-GBP program; Institut Universitaire de France grant; Department of Science and Technology; Department of Atomic Energy, India; J. C. Bose fellowship	Sharma Centre for Heritage Education; L. S. B. Leakey Foundation; Earthwatch Institute; Homi Bhabha Fellowships Council; ISRO-GBP program; Institut Universitaire de France grant; Department of Science and Technology(Department of Science & Technology (India)); Department of Atomic Energy, India(Department of Atomic Energy (DAE)); J. C. Bose fellowship(Department of Science & Technology (India))	S.P. and K.A. thank the Sharma Centre for Heritage Education, the L. S. B. Leakey Foundation, the Earthwatch Institute, the Homi Bhabha Fellowships Council (S.P.: 2000-2002; K.A.: 2014-2016) and the ISRO-GBP program for funding various aspects of the research project, and the Archaeological Survey of India and Department of Archaeology, Government of Tamil Nadu, for issuing licenses. Y.G. benefited from an Institut Universitaire de France grant for field and analytical work. A.K.S. acknowledges the Department of Science and Technology and the Department of Atomic Energy, India, for a J. C. Bose national fellowship and for Raja Ramanna fellowships, respectively. H.M.R. was supported by the contingency grant of the J. C. Bose fellowship awarded to A.K.S. S.P. and K.A. thank M. Taieb for his encouragement.	Adler DS, 2014, SCIENCE, V345, P1609, DOI 10.1126/science.1256484; Alvarez-Alonso D, 2014, QUATERN INT, V326, P288, DOI 10.1016/j.quaint.2012.12.023; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Berger LR, 2017, ELIFE, V6, DOI 10.7554/eLife.24234; Blinkhom J., 2014, SO ASIA AUSTR SEARCH, P64; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; DeBono H, 2001, J ISRAEL PREHISTORIC, V31, P9; Haslam M, 2011, QUATERNARY RES, V75, P670, DOI 10.1016/j.yqres.2011.02.001; James HVA, 2005, CURR ANTHROPOL, V46, pS3, DOI 10.1086/444365; McBrearty S., 2001, FARMING, V3, P1; McBrearty S, 2006, INTERD CONTRIB ARCH, P257, DOI 10.1007/0-387-24661-4_14; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Mishra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069280; Pappu S., 2004, MAN ENV, VXXIX, P1; Pappu S., 2001, BAR INT SERIES; Pappu S, 2011, SCIENCE, V331, P1596, DOI 10.1126/science.1200183; Pappu S, 2010, J ARCHAEOL SCI, V37, P2316, DOI 10.1016/j.jas.2010.04.005; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Raynaud D, 2005, NATURE, V436, P39, DOI 10.1038/43639b; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Sahle Y, 2014, QUATERN INT, V331, P6, DOI 10.1016/j.quaint.2013.03.010; Sehlebusch CM, 2017, SCIENCE, V358, P652, DOI 10.1126/science.aao6266; Sharon G., 2007, ARCHAEOPRESS BAR INT, V1701; Singhvi AK, 2010, QUATERNARY SCI REV, V29, P3095, DOI 10.1016/j.quascirev.2010.08.003; Tryon C. A., 2003, ACHEULIAN MIDDLE STO; Tryon C. A., 2005, AFR ARCHAEOL REV, V22, P199, DOI [10.1007/s10437-006-9002-5, DOI 10.1007/S10437-006-9002-5]; Tryon CA, 2006, CURR ANTHROPOL, V47, P367, DOI 10.1086/503066; Warrier AK, 2011, J ARCHAEOL SCI, V38, P3681, DOI 10.1016/j.jas.2011.08.039; White M, 2006, J QUATERNARY SCI, V21, P525, DOI 10.1002/jqs.1034; Williams MAJ, 2009, PALAEOGEOGR PALAEOCL, V284, P295, DOI 10.1016/j.palaeo.2009.10.009	31	40	42	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					97	+		10.1038/nature25444	http://dx.doi.org/10.1038/nature25444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU7QX	29388951				2022-12-28	WOS:000424048900038
J	Marsicek, J; Shuman, BN; Bartlein, PJ; Shafer, SL; Brewer, S				Marsicek, Jeremiah; Shuman, Bryan N.; Bartlein, Patrick J.; Shafer, Sarah L.; Brewer, Simon			Reconciling divergent trends and millennial variations in Holocene temperatures	NATURE			English	Article							LOCALLY WEIGHTED REGRESSION; AFRICAN HUMID PERIOD; GLOBAL LAND AREAS; NORTH-AMERICA; MODERN ANALOGS; FOSSIL POLLEN; ICE-AGE; CLIMATE; MODEL; ASSEMBLAGES	Cooling during most of the past two millennia has been widely recognized(1,2) and has been inferred to be the dominant global temperature trend of the past 11,700 years (the Holocene epoch)(3). However, long-term cooling has been difficult to reconcile with global forcing(4), and climate models consistently simulate long-term warming(4). The divergence between simulations and reconstructions emerges primarily for northern mid-latitudes, for which pronounced cooling has been inferred from marine and coastal records using multiple approaches(3). Here we show that temperatures reconstructed from sub-fossil pollen from 642 sites across North America and Europe closely match simulations, and that long-term warming, not cooling, defined the Holocene until around 2,000 years ago. The reconstructions indicate that evidence of long-term cooling was limited to North Atlantic records. Early Holocene temperatures on the continents were more than two degrees Celsius below those of the past two millennia, consistent with the simulated effects of remnant ice sheets in the climate model Community Climate System Model(3) (CCSM3)(5). CCSM3 simulates increases in 'growing degree days'-a measure of the accumulated warmth above five degrees Celsius per year-of more than 300 kelvin days over the Holocene, consistent with inferences from the pollen data. It also simulates a decrease in mean summer temperatures of more than two degrees Celsius, which correlates with reconstructed marine trends and highlights the potential importance of the different subseasonal sensitivities of the records. Despite the differing trends, pollen-and marine-based reconstructions are correlated at millennial-tocentennial scales, probably in response to ice-sheet and meltwater dynamics, and to stochastic dynamics similar to the temperature variations produced by CCSM3. Although our results depend on a single source of palaeoclimatic data (pollen) and a single climatemodel simulation, they reinforce the notion that climate models can adequately simulate climates for periods other than the present-day. They also demonstrate that amplified warming in recent decades increased temperatures above the mean of any century during the past 11,000 years.				jmarsicek@wisc.edu	Bartlein, Patrick J./E-4643-2011	Bartlein, Patrick J./0000-0001-7657-5685; Shuman, Bryan/0000-0002-8149-8925; Marsicek, Jeremiah/0000-0002-6444-5207; Brewer, Simon/0000-0002-6810-1911	NCAR; NSF P2C2 programme; DOE Abrupt Change and EaSM programmes; Wyoming NASA Space Grant [NNX10AO95H]; EPA STAR [FP-91763201-0]; NSF [DEB-1146297, EAR-1003848, ATM-06202409]; US Geological Survey Climate Research and Development Program; Division Of Environmental Biology [1146297] Funding Source: National Science Foundation	NCAR(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF P2C2 programme; DOE Abrupt Change and EaSM programmes; Wyoming NASA Space Grant; EPA STAR(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); US Geological Survey Climate Research and Development Program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank T. Webb, S. Marcott, J. Shinker, T. Minckley, B. McElroy and E. Currano for comments. Data were obtained from the Neotoma and European Pollen Databases, and we acknowledge the work of the data contributors and the Neotoma and European Pollen Database communities. TraCE-21ka was made possible by the DOE INCITE computing programme, and supported by NCAR, the NSF P2C2 programme, and the DOE Abrupt Change and EaSM programmes. Funding was provided by Wyoming NASA Space Grant (#NNX10AO95H) and EPA STAR (FP-91763201-0) to J.M., and NSF support to B.N.S. (DEB-1146297), S.B. (EAR-1003848) and P.J.B. (ATM-06202409). S.L.S. was supported by the US Geological Survey Climate Research and Development Program.	Argus DF, 2014, GEOPHYS J INT, V198, P537, DOI 10.1093/gji/ggu140; Bartlein PJ, 2011, CLIM DYNAM, V37, P775, DOI 10.1007/s00382-010-0904-1; Bartlein P. J., 2016, AGU FALL M; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Blois JL, 2011, QUATERNARY SCI REV, V30, P1926, DOI 10.1016/j.quascirev.2011.04.017; Cheddadi R, 1996, CLIM DYNAM, V13, P1, DOI 10.1007/s003820050148; Chen GS, 2011, CLIM DYNAM, V37, P1949, DOI 10.1007/s00382-010-0944-6; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Davis BAS, 2013, VEG HIST ARCHAEOBOT, V22, P521, DOI 10.1007/s00334-012-0388-5; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; EPSTEIN ES, 1991, J CLIMATE, V4, P365, DOI 10.1175/1520-0442(1991)004<0365:OODCVF>2.0.CO;2; Fyfe RM, 2009, VEG HIST ARCHAEOBOT, V18, P417, DOI 10.1007/s00334-009-0215-9; Goring S., 2015, OPEN QUAT, V1; Gouhier T. C., 2016, BIWAVELET CONDUCT UN; Grimm EC, 2009, QUATERNARY RES, V72, P301, DOI 10.1016/j.yqres.2009.05.006; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Harrison SP, 1998, J CLIMATE, V11, P2721, DOI 10.1175/1520-0442(1998)011<2721:IOSGVD>2.0.CO;2; He F., 2011, THESIS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Joussaume S, 1997, J GEOPHYS RES-ATMOS, V102, P1943, DOI 10.1029/96JD01989; Juggins S., 2016, RIOJA ANAL QUATERNAR; KUTZBACH JE, 1988, J GEOPHYS RES-ATMOS, V93, P803, DOI 10.1029/JD093iD01p00803; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Liu ZY, 2014, P NATL ACAD SCI USA, V111, pE3501, DOI 10.1073/pnas.1407229111; Lorenz SJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001152; Lotter AF, 2000, PALAEOGEOGR PALAEOCL, V159, P349, DOI 10.1016/S0031-0182(00)00093-6; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Marsicek JP, 2013, QUATERNARY SCI REV, V80, P129, DOI 10.1016/j.quascirev.2013.09.001; Mauri A, 2015, QUATERNARY SCI REV, V112, P109, DOI 10.1016/j.quascirev.2015.01.013; Muschitiello F, 2015, QUATERNARY SCI REV, V125, P91, DOI 10.1016/j.quascirev.2015.08.012; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; PAGES 2k Consortium, 2013, NATURE GEOSCIENCE, V6, P339, DOI DOI 10.1038/NGE01797; Peltier WR, 2015, J GEOPHYS RES-SOL EA, V120, P450, DOI 10.1002/2014JB011176; Pollard D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002126; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Renssen H, 2009, NAT GEOSCI, V2, P410, DOI 10.1038/NGEO513; Sachs JP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028495; Samartin S, 2017, NAT GEOSCI, V10, P207, DOI [10.1038/ngeo2891, 10.1038/NGEO2891]; Schurer AP, 2017, NAT CLIM CHANGE, V7, P563, DOI [10.1038/NCLIMATE3345, 10.1038/nclimate3345]; Shuman BN, 2016, QUATERNARY SCI REV, V141, P38, DOI 10.1016/j.quascirev.2016.03.009; Telford R., 2015, PALAEOSIG SIGNIFICAN; Telford RJ, 2011, QUATERNARY SCI REV, V30, P1272, DOI 10.1016/j.quascirev.2011.03.002; Timm O, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001461; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Viau AE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006031; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; WEBB T, 1986, VEGETATIO, V67, P75, DOI 10.1007/BF00037359; Whitmore J, 2005, QUATERNARY SCI REV, V24, P1828, DOI 10.1016/j.quascirev.2005.03.005; Williams JW, 2008, QUATERNARY SCI REV, V27, P669, DOI 10.1016/j.quascirev.2008.01.004; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045	55	189	200	11	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					92	+		10.1038/nature25464	http://dx.doi.org/10.1038/nature25464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29388952				2022-12-28	WOS:000424048900037
J	Rigotti, NA				Rigotti, Nancy A.			Balancing the Benefits and Harms of E-Cigarettes: A National Academies of Science, Engineering, and Medicine Report	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES		[Rigotti, Nancy A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rigotti, Nancy A.] Harvard Med Sch, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Gen Internal Med, 100 Cambridge St,Suite 1600, Boston, MA 02114 USA.	nrigotti@partners.org						[Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P1177, DOI 10.15585/mmwr.mm6542a7; Food and Drug Administration HHS, 2016, Fed Regist, V81, P28973; Glynn TJ, 2014, CA-CANCER J CLIN, V64, P164, DOI 10.3322/caac.21226; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Jamal A, 2017, MMWR-MORBID MORTAL W, V66, P597, DOI 10.15585/mmwr.mm6623a1; Kasza KA, 2017, NEW ENGL J MED, V376, P342, DOI 10.1056/NEJMsa1607538; National Academies of Sciences Engineering and Medicine, 2018, PUBL HLTH CONS E CIG; Shahab L, 2017, ANN INTERN MED, V166, P390, DOI 10.7326/M16-1107; Singh Binu, 2017, Prev Med Rep, V8, P25, DOI 10.1016/j.pmedr.2017.07.012; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G	10	30	30	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					666	667		10.7326/M18-0251	http://dx.doi.org/10.7326/M18-0251			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3BZ	29435573				2022-12-28	WOS:000434247300009
J	Shekelle, PG; Cook, IA; Miake-Lye, IM; Booth, MS; Beroes, JM; Mak, S				Shekelle, Paul G.; Cook, Ian A.; Miake-Lye, Isomi M.; Booth, Marika Suttorp; Beroes, Jessica M.; Mak, Selene			Benefits and Harms of Cranial Electrical Stimulation for Chronic Painful Conditions, Depression, Anxiety, and Insomnia A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							NONINVASIVE BRAIN-STIMULATION; ELECTROTHERAPY STIMULATION; TRANSCRANIAL ELECTROSTIMULATION; ELECTROSLEEP THERAPY; EFFICACY; SAFETY; INDIVIDUALS; HEADACHE; DISORDER	Background: Cranial electrical stimulation (CES) is increasingly popular as a treatment, yet its clinical benefit is unclear. Purpose: To review evidence about the benefits and harms of CES for adult patients with chronic painful conditions, depression, anxiety, and insomnia. Data Sources: Several databases from inception to 10 October 2017 without language restrictions and references from experts, prior reviews, and manufacturers. Study Selection: Randomized controlled trials of CES versus usual care or sham CES that reported pain, depression, anxiety, or sleep outcomes in any language. Data Extraction: Single-reviewer extraction checked by another; dual independent quality assessment; strength-of-evidence grading by the first author with subsequent group discussion. Data Synthesis: Twenty-eight articles from 26 randomized trials met eligibility criteria. The 2 trials that compared CES with usual care were small, and neither reported a statistically significant benefit in pain or anxiety outcomes for patients with fibromyalgia or anxiety, respectively. Fourteen trials with sham or placebo controls involving patients with painful conditions, such as headache, neuromuscular pain, or musculoskeletal pain, had conflicting results. Four trials done more than 40 years ago and 1 from 2014 provided low-strength evidence of a possible modest benefit compared with sham treatments in patients with anxiety and depression. Trials in patients with insomnia (n = 2), insomnia and anxiety (n = 1), or depression (n = 3) had inconclusive or conflicting results. Low-strength evidence suggested that CES does not cause serious side effects. Limitation: Most trials had small sample sizes and short durations; all had high risk of bias due to inadequate blinding. Conclusion: Evidence is insufficient that CES has clinically important effects on fibromyalgia, headache, neuromusculoskeletal pain, degenerative joint pain, depression, or insomnia; low-strength evidence suggests modest benefit in patients with anxiety and depression.	[Shekelle, Paul G.; Miake-Lye, Isomi M.; Beroes, Jessica M.] West Los Angeles Vet Affairs Med Ctr, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA; [Cook, Ian A.] Univ Calif Los Angeles, David Geffen Sch Med, 10833 Le Conte Ave, Santa Monica, CA 90401 USA; [Booth, Marika Suttorp] RAND Corp, Southern Calif Evidence Based Practice Ctr, 1776 Main St, Santa Monica, CA 90401 USA; [Mak, Selene] Univ Calif Los Angeles, Fielding Sch Publ Hlth, 650 Charles E Young Dr South, Los Angeles, CA 90095 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation; University of California System; University of California Los Angeles	Shekelle, PG (corresponding author), West Los Angeles Vet Affairs Med Ctr, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	paul.shekelle@va.gov						Boldt I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009177.pub2; Bystritsky A, 2008, J CLIN PSYCHIAT, V69, P412, DOI 10.4088/JCP.v69n0311; CARTWRIGHT RD, 1975, J NERV MENT DIS, V161, P134, DOI 10.1097/00005053-197508000-00008; Cork RC, 2004, INTERNET J ANESTHESI, V8; FEIGHNER JP, 1973, J NERV MENT DIS, V157, P121, DOI 10.1097/00005053-197308000-00004; Feusner JD, 2012, BRAIN BEHAV, V2, P211, DOI 10.1002/brb3.45; Gabis L, 2003, AM J PHYS MED REHAB, V82, P81, DOI 10.1097/00002060-200302000-00001; Gabis L, 2009, J REHABIL MED, V41, P256, DOI 10.2340/16501977-0315; Gibson TH., 1987, AM J ELECTROMED, V4, P18; Guleyupoglu B, 2013, J NEUROSCI METH, V219, P297, DOI 10.1016/j.jneumeth.2013.07.016; HEARST ED, 1974, ARCH GEN PSYCHIAT, V30, P463; Heffernan M., 1996, CANADIAN J CLIN MED, V4, P4; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Katsnelson Y, 2004, P ANN INT IEEE EMBS, V26, P4087; Kavirajan HC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010521.pub2; KLAWANSKY S, 1995, J NERV MENT DIS, V183, P478, DOI 10.1097/00005053-199507000-00010; Lichtbroun AS, 2001, JCR-J CLIN RHEUMATOL, V7, P72, DOI 10.1097/00124743-200104000-00003; Lisanby SH, 2017, NEW ENGL J MED, V376, P2593, DOI 10.1056/NEJMe1702492; Masson SC, 2013, J CLIN EPIDEMIOL, V66, P805, DOI 10.1016/j.jclinepi.2013.01.010; McClure D, 2015, J NERV MENT DIS, V203, P827, DOI 10.1097/NMD.0000000000000378; Mindes J, 2015, CRANIAL ELECT STIMUL; Mischoulon D, 2015, J PSYCHIATR RES, V70, P98, DOI 10.1016/j.jpsychires.2015.08.016; Moncrieff J, 2015, CONTEMP CLIN TRIALS, V43, P60, DOI 10.1016/j.cct.2015.05.005; MOORE JA, 1975, BIOL PSYCHIAT, V10, P59; Moreno-Duarte I, 2014, NEUROIMAGE, V85, P1003, DOI 10.1016/j.neuroimage.2013.05.097; O'Connell NE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub3; Rintala DH, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/569154; ROSENTHAL SH, 1972, BIOL PSYCHIAT, V4, P179; Scallet A, 1976, COMPLEMENT THER MED, V37, P347, DOI DOI 10.1016/J.CTIM.2012.11.007; Shekelle PG, 2016, EFFECTIVENESS RISKS; SOLOMON S, 1989, HEADACHE, V29, P445, DOI 10.1111/j.1526-4610.1989.hed2907445.x; SOLOMON S, 1985, HEADACHE, V25, P12, DOI 10.1111/j.1526-4610.1985.hed2501012.x; Tan G, 2000, AM J PAIN MANAG, V10, P35; Tan G, 2006, J REHABIL RES DEV, V43, P461, DOI 10.1682/JRRD.2005.04.0066; Tan G, 2011, J SPINAL CORD MED, V34, P285, DOI 10.1179/2045772311Y.0000000008; Taylor AG, 2013, PAIN MANAG NURS, V14, P327, DOI 10.1016/j.pmn.2011.07.002; Taylor AG, 2013, EXPLORE-NY, V9, P32, DOI 10.1016/j.explore.2012.10.006; Tietjen G, 2013, CEPHALALGIA, V33, P963; Turner MD, 2016, J AFFECT DISORDERS, V76, DOI DOI 10.1016/J.JAD.2014.04.029; Wang W, 2000, PSYCHIAT RES, V96, P149, DOI 10.1016/S0165-1781(00)00194-3; WEISS MF, 1973, J NERV MENT DIS, V157, P108, DOI 10.1097/00005053-197308000-00003; Zaghi S, 2010, NEUROSCIENTIST, V16, P285, DOI 10.1177/1073858409336227	42	25	29	5	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					414	+		10.7326/M17-1970	http://dx.doi.org/10.7326/M17-1970			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ8AM	29435567				2022-12-28	WOS:000427827400016
J	Mure, LS; Le, HD; Benegiamo, G; Chang, MW; Rios, L; Jillani, N; Ngotho, M; Kariuki, T; Dkhissi-Benyahya, O; Cooper, HM; Panda, S				Mure, Ludovic S.; Le, Hiep D.; Benegiamo, Giorgia; Chang, Max W.; Rios, Luis; Jillani, Ngalla; Ngotho, Maina; Kariuki, Thomas; Dkhissi-Benyahya, Ouria; Cooper, Howard M.; Panda, Satchidananda			Diurnal transcriptome atlas of a primate across major neural and peripheral tissues	SCIENCE			English	Article							CIRCADIAN GENE-EXPRESSION; LIVER		[Mure, Ludovic S.; Le, Hiep D.; Benegiamo, Giorgia; Chang, Max W.; Rios, Luis; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Chang, Max W.] Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Jillani, Ngalla; Ngotho, Maina; Kariuki, Thomas] Natl Museums Kenya, IPR, Nairobi, Kenya; [Dkhissi-Benyahya, Ouria; Cooper, Howard M.] Univ Claude Bernard Lyon 1, Univ Lyon, Stem Cell & Brain Res Inst U1208, INSERM, F-69500 Bron, France	Salk Institute; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Panda, S (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Cooper, HM (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, Stem Cell & Brain Res Inst U1208, INSERM, F-69500 Bron, France.	howard.cooper@inserm.fr; satchin@salk.edu	Mure, Ludovic/AAR-9132-2021; Dkhissi-Benyahya, Ouria/M-5665-2014; COOPER, HOWARD/M-7304-2014	Mure, Ludovic/0000-0002-2485-1032; Dkhissi-Benyahya, Ouria/0000-0001-9168-3801; Rios, Luis/0000-0003-1537-0701; Benegiamo, Giorgia/0000-0001-7164-6771; Chang, Max/0000-0002-4526-489X; COOPER, Howard/0000-0002-1942-1855	Salk Institute Innovation; U.S. Department of Defense [W81XWH-15-1-0169]; Next Generation Sequencing Core Facility of the Salk Institute; NIHNational Cancer Institute Cancer Center Support Grant [P30 014195]; Chapman Foundation; Helmsley Charitable Trust; Glenn Center for Aging Research; Fyssen foundation; Catharina foundation;  [ANR-09-MNPS-040-01]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Salk Institute Innovation; U.S. Department of Defense(United States Department of Defense); Next Generation Sequencing Core Facility of the Salk Institute; NIHNational Cancer Institute Cancer Center Support Grant; Chapman Foundation; Helmsley Charitable Trust; Glenn Center for Aging Research; Fyssen foundation; Catharina foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The data discussed in this study have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) and are accessible through GEO Series accession no. GSE98965. Peripheral tissue samples are available from S.P. under a materials transfer agreement with Salk Institute. This work was supported by the Salk Institute Innovation and U.S. Department of Defense grant W81XWH-15-1-0169 to S.P.; Next Generation Sequencing Core Facility of the Salk Institute, with funding from NIHNational Cancer Institute Cancer Center Support Grant P30 014195; the Chapman Foundation and the Helmsley Charitable Trust grant; and ANR-09-MNPS-040-01 to H.M.C. G.B. was partly supported by Glenn Center for Aging Research, and L.M. was partially supported by Fyssen and Catharina foundations. We thank the veterinarians and animal technicians at the IPR for their assistance and J. A. Cooper for custom designing a baboon brain matrix for sectioning the brain, D. O'Keefe for manuscript editing, and J. Simon for his help with the illustrations.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hatori M, 2014, ELIFE, V3, DOI 10.7554/eLife.03357; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Oster H, 2017, ENDOCR REV, V38, P3, DOI 10.1210/er.2015-1080; Pipes L, 2013, NUCLEIC ACIDS RES, V41, pD906, DOI 10.1093/nar/gks1268; SCHWARTZ WJ, 1983, BRAIN RES, V274, P184, DOI 10.1016/0006-8993(83)90538-3; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wang GZ, 2015, CELL REP, V13, P1868, DOI 10.1016/j.celrep.2015.10.043; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang R, 2016, J BIOL RHYTHM, V31, P244, DOI 10.1177/0748730416631895; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	19	324	333	13	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2018	359	6381					1232	+	eaao0318	10.1126/science.aao0318	http://dx.doi.org/10.1126/science.aao0318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3QN	29439024	Green Accepted			2022-12-28	WOS:000427504900034
J	Lopez, S; Tejos, N; Ledoux, C; Barrientos, LF; Sharon, K; Rigby, JR; Gladders, MD; Bayliss, MB; Pessa, I				Lopez, Sebastian; Tejos, Nicolas; Ledoux, Cedric; Felipe Barrientos, L.; Sharon, Keren; Rigby, Jane R.; Gladders, Michael D.; Bayliss, Matthew B.; Pessa, Ismael			A clumpy and anisotropic galaxy halo at redshift 1 from gravitational-arc tomography	NATURE			English	Article							SMALL-SCALE STRUCTURE; MG II ABSORPTION; INTERGALACTIC MEDIUM; BINARY QUASARS; GALACTIC WINDS; STAR-FORMATION; STELLAR MASS; SPECTRA; SYSTEMS; GAS	Every star-forming galaxy has a halo of metal-enriched gas that extends out to at least 100 kiloparsecs(1-3), as revealed by the absorption lines that this gas imprints on the spectra of background quasars(4). However, quasars are sparse and typically probe only one narrow beam of emission through the intervening galaxy. Close quasar pairs(5-7) and gravitationally lensed quasars(8-11) have been used to circumvent this inherently one-dimensional technique, but these objects are rare and the structure of the circumgalactic medium remains poorly constrained. As a result, our understanding of the physical processes that drive the recycling of baryons across the lifetime of a galaxy is limited(12,13). Here we report integral-field (tomographic) spectroscopy of an extended background source-a bright, giant gravitational arc. We can thus coherently map the spatial and kinematic distribution of Mg II absorption-a standard tracer of enriched gas-in an intervening galaxy system at redshift 0.98 (around 8 billion years ago). Our gravitational-arc tomography unveils a dumpy medium in which the absorption strength decreases with increasing distance from the galaxy system, in good agreement with results for quasars. Furthermore, we find strong evidence that the gas is not distributed isotropically. Interestingly, we detect little kinematic variation over a projected area of approximately 600 square kiloparsecs, with all line-of-sight velocities confined to within a few tens of kilometres per second of each other. These results suggest that the detected absorption originates from entrained recycled material, rather than in a galactic outflow.	[Lopez, Sebastian] Univ Chile, Dept Astron, Casilla 36-D, Santiago, Chile; [Tejos, Nicolas] Pontificia Univ Catolica Valparaiso, Inst Fis, Valparaiso 4059, Chile; [Ledoux, Cedric] European Southern Observ, Alonso Cordova 3107,Casilla 19001, Santiago 19, Chile; [Felipe Barrientos, L.; Pessa, Ismael] Pontificia Univ Catolica Chile, Inst Astrofis, Vicuna Mackenna 4860, Santiago, Chile; [Sharon, Keren] Univ Michigan, Dept Astron, 500 Church St, Ann Arbor, MI 48109 USA; [Rigby, Jane R.] NASA Goddard Space Flight Ctr, Observat Cosmol Lab, 8800 Greenbelt Rd, Greenbelt, MD 20771 USA; [Gladders, Michael D.] Univ Chicago, Dept Astron & Astrophys, 5640 South Ellis Ave, Chicago, IL 60637 USA; [Gladders, Michael D.] Univ Chicago, Kavli Inst Cosmol Phys, 5640 South Ellis Ave, Chicago, IL 60637 USA; [Bayliss, Matthew B.] MIT, Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Universidad de Chile; Pontificia Universidad Catolica de Valparaiso; European Southern Observatory; Pontificia Universidad Catolica de Chile; University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Chicago; University of Chicago; Massachusetts Institute of Technology (MIT)	Lopez, S (corresponding author), Univ Chile, Dept Astron, Casilla 36-D, Santiago, Chile.	slopez@das.uchile.cl	Lopez, Sebastian/I-5657-2016	Lopez, Sebastian/0000-0003-0389-0902; Pessa Gutierrez, Ismael/0000-0002-0873-5744; Ledoux, Cedric/0000-0002-7864-3327; Barrientos, Felipe/0000-0003-0151-0718; Tejos, Nicolas/0000-0002-1883-4252; Bayliss, Matthew/0000-0003-1074-4807	FONDECYT [1140838]; CONICYT [PAI/82140055];  [PFB-06 CATA]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); 	This work has benefitted from discussions with A. Smette, N. Nielsen and G. Kacprzak. S.L. thanks the European Southern Observatory Scientific Visitor Selection Committee for supporting a research stay at the ESO headquarters in Santiago, where part of this work was done. S.L. has been supported by FONDECYT grant number 1140838. This work has also been partially supported by PFB-06 CATA. N. T acknowledges support from CONICYT PAI/82140055.	Bacon R, 2010, PROC SPIE, V7735, DOI 10.1117/12.856027; Bacon R., 2016, ASTROPHYSICS SOURCE; Bergeron J, 2017, ASTRON ASTROPHYS, V604, DOI 10.1051/0004-6361/201730906; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Bordoloi R, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/108; Bouche N, 2012, MON NOT R ASTRON SOC, V426, P801, DOI 10.1111/j.1365-2966.2012.21114.x; Cappellari M, 2003, MON NOT R ASTRON SOC, V342, P345, DOI 10.1046/j.1365-8711.2003.06541.x; Charlton JC, 1996, ASTROPHYS J, V465, P631, DOI 10.1086/177448; Chen HW, 2017, ASTROPHYS SPACE SC L, V434, P291, DOI 10.1007/978-3-319-56570-5_9; Chen HW, 2014, MON NOT R ASTRON SOC, V438, P1435, DOI 10.1093/mnras/stt2288; Chen HW, 2010, ASTROPHYS J, V714, P1521, DOI 10.1088/0004-637X/714/2/1521; Churchill CW, 2000, ASTROPHYS J SUPPL S, V130, P91, DOI 10.1086/317343; COLEMAN GD, 1980, ASTROPHYS J SUPPL S, V43, P393, DOI 10.1086/190674; Dahle H, 2016, ASTRON ASTROPHYS, V590, DOI 10.1051/0004-6361/201628297; Ellison SL, 2006, MON NOT R ASTRON SOC, V368, P335, DOI 10.1111/j.1365-2966.2006.10098.x; Hennawi JF, 2006, ASTRON J, V131, P1, DOI 10.1086/498235; Hidalgo PR, 2012, MON NOT R ASTRON SOC, V427, P1801, DOI 10.1111/j.1365-2966.2012.21586.x; Ho SH, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/2/267; Johnson TL, 2016, ASTROPHYS J, V832, DOI 10.3847/0004-637X/832/1/82; Jullo E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/447; Kacprzak GG, 2017, ASTROPHYS SPACE SC L, V430, P145, DOI 10.1007/978-3-319-52512-9_7; Kacprzak GG, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/1/L7; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Lopez S, 2007, ASTRON ASTROPHYS, V469, P61, DOI 10.1051/0004-6361:20065301; Lopez S, 2005, ASTROPHYS J, V626, P767, DOI 10.1086/429956; Martin CL, 2010, ASTROPHYS J, V721, P174, DOI 10.1088/0004-637X/721/1/174; Moster BP, 2010, ASTROPHYS J, V710, P903, DOI 10.1088/0004-637X/710/2/903; Moustakas J, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/50; Muratov AL, 2017, MON NOT R ASTRON SOC, V468, P4170, DOI 10.1093/mnras/stx667; Nielsen NM, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/115; Nielsen NM, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/114; Rauch M, 2001, ASTROPHYS J, V562, P76, DOI 10.1086/323523; Rigby JR, 2015, ASTROPHYS J LETT, V814, DOI 10.1088/2041-8205/814/1/L6; Rigby JR, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/59; Rigby J. R., ASTROPHYS J IN PRESS; ROBERTSON JG, 1986, PUBL ASTRON SOC PAC, V98, P1220, DOI 10.1086/131925; Robitaille T., 2012, ASTROPHYSICS SOURCE; Rubin K. H. R., 2017, PREPRINT; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Sharon K, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/161; Soto KT, 2016, MON NOT R ASTRON SOC, V458, P3210, DOI 10.1093/mnras/stw474; Steidel CC, 1995, ESO ASTROPHY SYMP, P139; Tumlinson J, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/59; Tytler D, 2009, MON NOT R ASTRON SOC, V392, P1539, DOI 10.1111/j.1365-2966.2008.14159.x; Willmer CNA, 2006, ASTROPHYS J, V647, P853, DOI 10.1086/505455; Wuyts E, 2010, ASTROPHYS J, V724, P1182, DOI 10.1088/0004-637X/724/2/1182	48	45	45	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					493	+		10.1038/nature25436	http://dx.doi.org/10.1038/nature25436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29414939	Green Submitted			2022-12-28	WOS:000425597400039
J	Singer, M; Shankar-Hari, M				Singer, Mervyn; Shankar-Hari, Manu			qSOFA, Cue Confusion	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERNATIONAL CONSENSUS DEFINITIONS; INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK SEPSIS-3		[Singer, Mervyn] UCL, London, England; [Shankar-Hari, Manu] Guys & St Thomas NHS Fdn Trust, London, England; [Shankar-Hari, Manu] Kings Coll London, London, England; [Singer, Mervyn] UCL, Bloomsbury Inst Intens Care Med, Gower St, London WC1E 6BT, England; [Shankar-Hari, Manu] Guys & St Thomas Hosp NHS Trust, ICU Offices, Westminster Bridge Rd, London SE1 7EH, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Singer, M (corresponding author), UCL, Bloomsbury Inst Intens Care Med, Gower St, London WC1E 6BT, England.	m.singer@ucl.ac.uk	Shankar-Hari, Manu/I-6948-2012; Singer, Mervyn/Q-6142-2019	Shankar-Hari, Manu/0000-0002-5338-2538; Singer, Mervyn/0000-0002-1042-6350	National Institute for Health Research Clinician Scientist Award [NIHR-CS-2016-16-011]	National Institute for Health Research Clinician Scientist Award	Dr Shankar-Hari is supported by the National Institute for Health Research Clinician Scientist Award (NIHR-CS-2016-16-011).	Bhattacharjee P, 2017, CHEST, V151, P898, DOI 10.1016/j.chest.2016.06.020; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Churpek MM, 2015, AM J RESP CRIT CARE, V192, P958, DOI 10.1164/rccm.201502-0275OC; Duckitt RW, 2007, BRIT J ANAESTH, V98, P769, DOI 10.1093/bja/aem097; Fernando SM, 2018, ANN INTERN MED, V168, P266, DOI 10.7326/M17-2820; LEE A, 1995, ANAESTH INTENS CARE, V23, P183, DOI 10.1177/0310057X9502300210; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	8	12	12	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					293	+		10.7326/M17-3415	http://dx.doi.org/10.7326/M17-3415			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29404580				2022-12-28	WOS:000425434000021
J	Liang, QY; Venkatramani, AV; Cantu, SH; Nicholson, TL; Gullans, MJ; Gorshkov, AV; Thompson, JD; Chin, C; Lukin, MD; Vuletic, V				Liang, Qi-Yu; Venkatramani, Aditya V.; Cantu, Sergio H.; Nicholson, Travis L.; Gullans, Michael J.; Gorshkov, Alexey V.; Thompson, Jeff D.; Chin, Cheng; Lukin, Mikhail D.; Vuletic, Vladan			Observation of three-photon bound states in a quantum nonlinear medium	SCIENCE			English	Article							STRONGLY INTERACTING PHOTONS; OPTICAL-FIBERS; GAS; SOLITONS; ATOMS	Bound states of massive particles, such as nuclei, atoms, or molecules, constitute the bulk of the visible world around us. By contrast, photons typically only interact weakly. We report the observation of traveling three-photon bound states in a quantum nonlinear medium where the interactions between photons are mediated by atomic Rydberg states. Photon correlation and conditional phase measurements reveal the distinct bunching and phase features associated with three-photon and two-photon bound states. Such photonic trimers and dimers possess shape-preserving wave functions that depend on the constituent photon number. The observed bunching and strongly nonlinear optical phase are described by an effective field theory of Rydberg-induced photon-photon interactions. These observations demonstrate the ability to realize and control strongly interacting quantum many-body states of light.	[Liang, Qi-Yu; Nicholson, Travis L.; Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA; [Liang, Qi-Yu; Nicholson, Travis L.; Vuletic, Vladan] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Venkatramani, Aditya V.; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Cantu, Sergio H.; Gullans, Michael J.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Gullans, Michael J.; Gorshkov, Alexey V.] NIST, Joint Quantum Inst, College Pk, MD 20742 USA; [Gullans, Michael J.; Gorshkov, Alexey V.] NIST, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA; [Gullans, Michael J.; Gorshkov, Alexey V.] Univ Maryland, College Pk, MD 20742 USA; [Thompson, Jeff D.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Chin, Cheng] Univ Chicago, James Franck Inst, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Chin, Cheng] Univ Chicago, Dept Phys, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Princeton University; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Princeton University; University of Chicago; University of Chicago	Vuletic, V (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Vuletic, V (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.; Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu; vuletic@mit.edu	Venkatramani, Aditya/GOK-0191-2022; Vuletic, Vladan/M-8736-2019; Gorshkov, Alexey V/A-9848-2008; Nicholson, Travis L/O-1573-2018	Venkatramani, Aditya/0000-0002-0984-5654; Gorshkov, Alexey V/0000-0003-0509-3421; Nicholson, Travis L/0000-0002-0503-7991; /0000-0002-9786-0538; Cantu, Sergio/0000-0002-9530-2559; Thompson, Jeff/0000-0001-8673-052X; /0000-0002-2430-7248	NSF; NSF Center for Ultracold Atoms; U.S. Army Research Office (ARO); U.S. Air Force Office of Scientific Research; ARO Multidisciplinary University Research Initiative; Bush Fellowship; U.S. Army Research Laboratory Center for Distributed Quantum Information; NSF Quantum Information Science program; NSF Physics Frontiers Center at the Joint Quantum Institute; NSF [PHY-1511696]; Alexander von Humboldt Foundation; Direct For Mathematical & Physical Scien [1505862, 1430094, 1506284] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF Center for Ultracold Atoms(National Science Foundation (NSF)); U.S. Army Research Office (ARO); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ARO Multidisciplinary University Research Initiative; Bush Fellowship; U.S. Army Research Laboratory Center for Distributed Quantum Information; NSF Quantum Information Science program; NSF Physics Frontiers Center at the Joint Quantum Institute; NSF(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank O. Firstenberg for help with the early stages of this work and S. Choi for discussions. M.J.G. and A.V.G. thank H. P. Buchler for many insightful discussions and comments on the theoretical analysis. This work has been supported by the NSF, the NSF Center for Ultracold Atoms, the U.S. Army Research Office (ARO), the U.S. Air Force Office of Scientific Research, the ARO Multidisciplinary University Research Initiative, and a Bush Fellowship. A.V.G. and M.J.G. acknowledge additional support by the U.S. Army Research Laboratory Center for Distributed Quantum Information, the NSF Quantum Information Science program, and the NSF Physics Frontiers Center at the Joint Quantum Institute. C.C. acknowledges funding support from NSF grant PHY-1511696 and the Alexander von Humboldt Foundation. All data needed to evaluate the conclusions in the paper are present in the paper and the supplementary materials.	Bienias P, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.053804; Bienias P, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/aa50c3; Braaten E, 2007, ANN PHYS-NEW YORK, V322, P120, DOI 10.1016/j.aop.2006.10.011; Chang DE, 2008, NAT PHYS, V4, P884, DOI 10.1038/nphys1074; CHENG Z, 1995, PHYS REV LETT, V75, P3430, DOI 10.1103/PhysRevLett.75.3430; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; DEUTSCH IH, 1992, PHYS REV LETT, V69, P3627, DOI 10.1103/PhysRevLett.69.3627; DRUMMOND PD, 1993, NATURE, V365, P307, DOI 10.1038/365307a0; Drummond PD, 1997, PHYS REV A, V56, pR1107, DOI 10.1103/PhysRevA.56.R1107; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Firstenberg O, 2013, NATURE, V502, P71, DOI 10.1038/nature12512; Fleischhauer M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.163601; Friedler I, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.043803; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133602; Gullans MJ, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.233601; Gullans MJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.113601; Jachymski K, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.053601; Kraemer T, 2006, NATURE, V440, P315, DOI 10.1038/nature04626; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; LAI Y, 1989, PHYS REV A, V40, P854, DOI 10.1103/PhysRevA.40.854; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13618; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; Maghrebi MF, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.033838; Maxwell D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.103001; MCGUIRE JB, 1964, J MATH PHYS, V5, P622, DOI 10.1063/1.1704156; Pan JW, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.777; Petrosyan D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.213601; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Schauss P, 2012, NATURE, V491, P87, DOI 10.1038/nature11596; Sevincli S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.153001; Shen JT, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153003; Shen YC, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.033803; Thaicharoen N, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.133401; Thompson JD, 2017, NATURE, V542, P206, DOI 10.1038/nature20823	34	73	73	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					783	786	aao7293	10.1126/science.aao7293	http://dx.doi.org/10.1126/science.aao7293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449489	Green Submitted, Green Accepted			2022-12-28	WOS:000425116200042
J	Taler, SJ				Taler, Sandra J.			Initial Treatment of Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE CONTROL; ALCOHOL-CONSUMPTION; CLINICAL-TRIAL; METAANALYSIS; REDUCTION; WEIGHT; PROGRESSION; INHIBITION; DISEASE; RISK	A 56-year-old woman presents for elevated blood pressure, which was noted at a job-site screening. She has gained 20 lb (9.1 kg) during the past 5 years and takes naproxen sodium (at a dose of 220 mg daily) for joint pain. She has never smoked, and she consumes one or two alcoholic drinks daily. Both of her parents received a diagnosis of hypertension in their 50s. On examination, the blood pressure is 162/94 mm Hg in both arms while the patient is seated and 150/96 mm Hg while the patient is standing. The body-mass index (the weight in kilograms divided by the square of the height in meters) is 29. Her examination is notable only for abdominal obesity without bruits or masses. The serum level of sodium is 138 mmol per liter, potassium 3.8 mmol per liter, calcium 9.4 mg per deciliter (2.35 mmol per liter), fasting glucose 105 mg per deciliter (5.8 mmol per liter), and creatinine 0.8 mg per deciliter (71 mu mol per liter). Urinalysis is negative. How would you further evaluate and treat this patient?	[Taler, Sandra J.] Mayo Clin, Div Nephrol & Hypertens, 200 First St SW, Rochester, MN 55905 USA	Mayo Clinic	Taler, SJ (corresponding author), Mayo Clin, Div Nephrol & Hypertens, 200 First St SW, Rochester, MN 55905 USA.	taler.sandra@mayo.edu						Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Bangalore S, 2010, AM J MED, V123, P1016, DOI 10.1016/j.amjmed.2010.06.014; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bennett A, 2017, HYPERTENSION, V70, P85, DOI 10.1161/HYPERTENSIONAHA.117.09202; Berlowitz DR, 2017, NEW ENGL J MED, V377, P733, DOI 10.1056/NEJMoa1611179; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; Carlson DJ, 2014, MAYO CLIN PROC, V89, P327, DOI 10.1016/j.mayocp.2013.10.030; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Egan BM, 2009, AM J HYPERTENS, V22, P792, DOI 10.1038/ajh.2009.63; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Garovic VD, 2010, J HYPERTENS, V28, P826, DOI 10.1097/HJH.0b013e328335c29a; He F. J., 2013, BMJ, V346; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kiers HD, 2008, NETH J MED, V66, P474; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Muntner P, 2018, CIRCULATION, V137, P109, DOI 10.1161/CIRCULATIONAHA.117.032582; Myers MG, 2012, J HYPERTENS, V30, P1894, DOI 10.1097/HJH.0b013e3283577b05; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Roerecke M, 2017, LANCET PUBLIC HEALTH, V2, pE108, DOI 10.1016/S2468-2667(17)30003-8; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Sharabi Y, 2002, J HUM HYPERTENS, V16, P631, DOI 10.1038/sj.jhh.1001458; Siu AL, 2015, ANN INTERN MED, V163, P778, DOI 10.7326/M15-2223; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Veterans Administration Cooperative Study Group, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.1970.03170330025003; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; Whelton PK, 2017, HYPERTENSION, DOI 10.1016/j.jacc.2017.11.006; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Yi SS, 2015, CIRC-CARDIOVASC QUAL, V8, P138, DOI 10.1161/CIRCOUTCOMES.114.000950	48	30	31	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					636	644		10.1056/NEJMcp1613481	http://dx.doi.org/10.1056/NEJMcp1613481			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0QK	29443671				2022-12-28	WOS:000425000000009
J	Fiolet, T; Srour, B; Sellem, L; Kesse-Guyo, E; Alles, B; Mejean, C; Deschasaux, M; Fassier, P; Latino-Martel, P; Beslay, M; Hercberg, S; Lavalette, C; Monteiro, CA; Julia, C; Touvier, M				Fiolet, Thibault; Srour, Bernard; Sellem, Laury; Kesse-Guyo, Emmanuelle; Alles, Benjamin; Mejean, Caroline; Deschasaux, Melanie; Fassier, Philippine; Latino-Martel, Paule; Beslay, Marie; Hercberg, Serge; Lavalette, Celine; Monteiro, Carlos A.; Julia, Chantal; Touvier, Mathilde			Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRODUCTS; OBESITY; DIET; QUALITY; TRENDS	OBJECTIVE To assess the prospective associations between consumption of ultra-processed food and risk of cancer. DESIGN Population based cohort study. SETTING AND PARTICIPANTS 104 980 participants aged at least 18 years (median age 42.8 years) from the French NutriNet-Sante cohort (2009-17). Dietary intakes were collected using repeated 24 hour dietary records, designed to register participants' usual consumption for 3300 different food items. These were categorised according to their degree of processing by the NOVA classification. MAIN OUTCOME MEASURES Associations between ultra-processed food intake and risk of overall, breast, prostate, and colorectal cancer assessed by multivariable Cox proportional hazard models adjusted for known risk factors. RESULTS Ultra-processed food intake was associated with higher overall cancer risk (n=2228 cases; hazard ratio for a 10% increment in the proportion of ultrap-rocessed food in the diet 1.12 (95% confidence interval 1.06 to 1.18); P for trend<0.001) and breast cancer risk (n=739 cases; hazard ratio 1.11 (1.02 to 1.22); P for trend=0.02). These results remained statistically significant after adjustment for several markers of the nutritional quality of the diet (lipid, sodium, and carbohydrate intakes and/or a Western pattern derived by principal component analysis). CONCLUSIONS In this large prospective study, a 10% increase in the proportion of ultra-processed foods in the diet was associated with a significant increase of greater than 10% in risks of overall and breast cancer. Further studies are needed to better understand the relative effect of the various dimensions of processing (nutritional composition, food additives, contact materials, and neoformed contaminants) in these associations.	[Fiolet, Thibault; Srour, Bernard; Sellem, Laury; Kesse-Guyo, Emmanuelle; Alles, Benjamin; Deschasaux, Melanie; Fassier, Philippine; Latino-Martel, Paule; Beslay, Marie; Hercberg, Serge; Lavalette, Celine; Julia, Chantal; Touvier, Mathilde] Paris 13 Univ, Nutr Epidemiol Res Team EREN, Sorbonne Paris Cite,Cnam, Epidemiol & Stat Res Ctr CRESS,INSERM,U1153,Inra, Bobigny, France; [Mejean, Caroline] INRA, MOISA, UMR 1110, F-34000 Montpellier, France; [Monteiro, Carlos A.] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil; [Hercberg, Serge; Julia, Chantal] Avicenne Hosp, AP HP, Publ Hlth Dept, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Srour, B (corresponding author), Paris 13 Univ, Nutr Epidemiol Res Team EREN, Sorbonne Paris Cite,Cnam, Epidemiol & Stat Res Ctr CRESS,INSERM,U1153,Inra, Bobigny, France.	b.srour@eren.smbh.univ-paris13.fr	Alles, Benjamin/F-1006-2017; Deschasaux, Mélanie/AAK-9116-2020; Fassier, Philippine/F-5918-2018; Touvier, Mathilde/E-8817-2017; Fiolet, Thibault/AAX-6808-2020; Srour, Bernard/X-8652-2019; Latino-Martel, Paule/O-1549-2019; Chantal, Julia/F-2805-2017; Monteiro, Carlos Augusto/F-9892-2012	Alles, Benjamin/0000-0002-7970-171X; Deschasaux, Mélanie/0000-0002-3359-420X; Fassier, Philippine/0000-0001-8130-8485; Touvier, Mathilde/0000-0002-8322-8857; Srour, Bernard/0000-0002-1277-3380; Latino-Martel, Paule/0000-0003-4581-852X; Chantal, Julia/0000-0003-2006-5269; Monteiro, Carlos Augusto/0000-0002-3777-1533; Fiolet, Thibault/0000-0002-0292-9863; Sellem, Laury/0000-0002-2697-997X; Lavalette, Celine/0000-0002-4332-4318	Ministere de la Sante; Institut National de la Prevention et de l'Education pour la Sante (INPES); Region Ile-de-France (CORDDIM); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13; Canceropole Ile de France/Region Ile de France; French National Cancer Institute [INCa_8085]; Institut de Veille Sanitaire (InVS)	Ministere de la Sante; Institut National de la Prevention et de l'Education pour la Sante (INPES); Region Ile-de-France (CORDDIM)(Region Ile-de-France); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13; Canceropole Ile de France/Region Ile de France(Region Ile-de-France); French National Cancer Institute(Institut National du Cancer (INCA) France); Institut de Veille Sanitaire (InVS)	The NutriNet-Sante study was supported by the following public institutions: Ministere de la Sante, Institut de Veille Sanitaire (InVS), Institut National de la Prevention et de l'Education pour la Sante (INPES), Region Ile-de-France (CORDDIM), Institut National de la Sante et de la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Metiers (CNAM), and Universite Paris 13. MD and PF were funded by a PhD grant from the Canceropole Ile de France/Region Ile de France (public funding). BS was funded by the French National Cancer Institute (grant number INCa_8085). Researchers were independent from funders. Funders had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication.	Adams J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0317-y; Andreeva VA, 2015, J EPIDEMIOL COMMUN H, V69, P893, DOI 10.1136/jech-2014-205263; [Anonymous], 2017, CANC PREV EST DIET N; ANSES (French Agency for Food Environmental and Occupational Health & Safety), 2017, ET IND NAT CONS AL; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752; Cediel G, 2018, PUBLIC HEALTH NUTR, V21, P125, DOI 10.1017/S1368980017001161; Chang XH, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-51; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Louzada MLD, 2015, PREV MED, V81, P9, DOI 10.1016/j.ypmed.2015.07.018; Louzada MLD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006132; Mendonca RD, 2017, AM J HYPERTENS, V30, P358, DOI 10.1093/ajh/hpw137; Mendonca RD, 2016, AM J CLIN NUTR, V104, P1433, DOI 10.3945/ajcn.116.135004; Etude Nutrinet-Sante, 2013, TABL COMP AL ET NUTR; European Union, 2008, DAT AUTH FOOD ADD; Fardet A, 2016, FOOD FUNCT, V7, P2338, DOI [10.1039/c6fo00107f, 10.1039/C6FO00107F]; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Haut Conseil de la sante publique, 2017, AV REL REV REP AL AD; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V93, P1; Institut National du Cancer, 2014, LES CANC EN FRANC; Julia C, 2018, PUBLIC HEALTH NUTR, V21, P27, DOI 10.1017/S1368980017001367; Juul F, 2015, PUBLIC HEALTH NUTR, V18, P3096, DOI 10.1017/S1368980015000506; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Lassale C, 2016, J ACAD NUTR DIET, V116, P427, DOI 10.1016/j.jand.2015.09.017; Lassale C, 2015, BRIT J NUTR, V113, P953, DOI 10.1017/S0007114515000057; Lassale C, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2575; Latino-Martel P, 2016, CRIT REV ONCOL HEMAT, V99, P308, DOI 10.1016/j.critrevonc.2016.01.002; Luiten CM, 2016, PUBLIC HEALTH NUTR, V19, P539, DOI 10.1017/S1368980015002840; Ministry of Health of Brazil, 2014, DIET GUID BRAZ POP; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro CA., 2016, WORLD NUTR, V7, P28; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P5, DOI 10.1017/S1368980017000234; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moubarac JC, 2017, APPETITE, V108, P512, DOI 10.1016/j.appet.2016.11.006; Moubarac JC, 2014, CURR OBES REP, V3, P256, DOI 10.1007/s13679-014-0092-0; Moubarac JC, 2014, CAN J DIET PRACT RES, V75, P15, DOI 10.3148/75.1.2014.15; Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Muncke J, 2011, J STEROID BIOCHEM, V127, P118, DOI 10.1016/j.jsbmb.2010.10.004; Panel on Contaminants in the Food Chain, 2015, EFSA J, V13, P4104, DOI [10.2903/j.efsa.2015.4104, DOI 10.2903/J.EFSA.2015.4104]; Panel on Food Additives and Nutrient Sources Added to Food, 2013, EFSA J, V11, P3496; Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.113.071928; Rauber F, 2015, NUTR METAB CARDIOVAS, V25, P116, DOI 10.1016/j.numecd.2014.08.001; Santarelli RL, 2010, CANCER PREV RES, V3, P852, DOI 10.1158/1940-6207.CAPR-09-0160; Slimani N, 2009, EUR J CLIN NUTR, V63, pS206, DOI 10.1038/ejcn.2009.82; Steele EM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009892; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; US Food and Drug Administration, 2017, FOOD ADD STAT LIST; Venn D, 2017, PUBLIC HEALTH NUTR, V20, P2549, DOI [10.1017/s136898001600255x, 10.1017/S136898001600255X]; Vergnaud AC, 2011, INT J PUBLIC HEALTH, V56, P407, DOI 10.1007/s00038-011-0257-5; Virk-Baker MK, 2014, NUTR CANCER, V66, P774, DOI 10.1080/01635581.2014.916323; World Health Organization (WHO), 2017, FOOD ADDITIVES	57	393	401	14	110	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2018	360								k322	10.1136/bmj.k322	http://dx.doi.org/10.1136/bmj.k322			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KZ	29444771	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000425582700002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The NHS shouldn't have to pick up the bill for private screening tests	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2018	360						17	18	k598	10.1136/bmj.k598	http://dx.doi.org/10.1136/bmj.k598			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KW	29440048	Bronze, Green Published			2022-12-28	WOS:000425582200003
J	Gandal, MJ; Haney, JR; Parikshak, NN; Leppa, V; Ramaswami, G; Hartl, C; Schork, AJ; Appadurai, V; Buil, A; Werge, TM; Liu, C; White, KP; Horvath, S; Geschwind, DH				Gandal, Michael J.; Haney, Jillian R.; Parikshak, Neelroop N.; Leppa, Virpi; Ramaswami, Gokul; Hartl, Chris; Schork, Andrew J.; Appadurai, Vivek; Buil, Alfonso; Werge, Thomas M.; Liu, Chunyu; White, Kevin P.; Horvath, Steve; Geschwind, Daniel H.		CommonMind Consortium; PsychENCODE Consortium; iPSYCH-BROAD Working Grp	Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; DE-NOVO MUTATIONS; GENE-EXPRESSION; COEXPRESSION NETWORKS; BIPOLAR DISORDER; HIGH-RISK; AUTISM; SCHIZOPHRENIA; BRAIN; MICRODELETIONS	The predisposition to neuropsychiatric disease involves a complex, polygenic, and pleiotropic genetic architecture. However, little is known about how genetic variants impart brain dysfunction or pathology. We used transcriptomic profiling as a quantitative readout of molecular brain-based phenotypes across five major psychiatric disorders-autism, schizophrenia, bipolar disorder, depression, and alcoholism-compared with matched controls. We identified patterns of shared and distinct gene-expression perturbations across these conditions. The degree of sharing of transcriptional dysregulation is related to polygenic (single-nucleotide polymorphism-based) overlap across disorders, suggesting a substantial causal genetic component. This comprehensive systems-level view of the neurobiological architecture of major neuropsychiatric illness demonstrates pathways of molecular convergence and specificity.	[Gandal, Michael J.; Haney, Jillian R.; Parikshak, Neelroop N.; Leppa, Virpi; Ramaswami, Gokul; Hartl, Chris; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA; [Gandal, Michael J.; Haney, Jillian R.; Parikshak, Neelroop N.; Leppa, Virpi; Ramaswami, Gokul; Hartl, Chris; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Res & Treatment,Dept Neurol, 695 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Gandal, Michael J.; Haney, Jillian R.; Parikshak, Neelroop N.; Leppa, Virpi; Ramaswami, Gokul; Hartl, Chris; Horvath, Steve; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Gandal, Michael J.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Psychiat, 695 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Schork, Andrew J.; Appadurai, Vivek; Buil, Alfonso; Werge, Thomas M.] Mental Hlth Serv Copenhagen, Inst Biol Psychiat, Copenhagen, Denmark; [Werge, Thomas M.] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Werge, Thomas M.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Liu, Chunyu] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Liu, Chunyu] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [White, Kevin P.] Tempus Labs, 600 W Chicago Ave, Chicago, IL 60654 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Central South University; University of Chicago	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Res & Treatment,Dept Neurol, 695 Charles E Young Dr South, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu	Pinto, Dalila/C-4218-2016; Jaffe, Andrew/GPF-5693-2022; Liu, Chunyu/G-7561-2012; Gandal, Michael/AAE-4282-2020; Agerbo, Esben/A-2645-2012; Domenici, Enrico/K-8194-2016	Pinto, Dalila/0000-0002-8769-0846; Jaffe, Andrew/0000-0001-6886-1454; Liu, Chunyu/0000-0002-5986-4415; Gandal, Michael/0000-0001-5800-5128; Hartl, Christopher/0000-0003-3352-4356; Buil, Alfonso/0000-0002-3097-1014; Borglum, Anders/0000-0001-8627-7219; Mangravite, Lara/0000-0001-7841-3612; Agerbo, Esben/0000-0002-2849-524X; Leppa, Virpi/0000-0003-2942-2656; Parikshak, Neel/0000-0003-2027-1871; Haney, Jillian/0000-0001-5847-9892; Ramaswami, Gokul/0000-0003-3246-5622; APPADURAI, VIVEK/0000-0002-2148-6201; Schork, Andrew/0000-0003-4164-9335; Domenici, Enrico/0000-0001-7436-6919; Buxbaum, Joseph/0000-0001-8898-8313	U.S. National Institute of Mental Health (NIMH) [P50-MH106438, R01-MH094714, U01-MH103339, R01-MH110927, R01-MH100027, R01-MH110920, U01-MH103340]; Simons Foundation for Autism Research Initiative (SFARI) [206733]; Stephen R. Mallory schizophrenia research award at the University of California, Los Angeles, (UCLA); Lundbeck Foundation Initiative for Integrative Psychiatric Research [R102-A9118]; Novo Nordisk Foundation; NIH [R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, MH06692]; Takeda Pharmaceuticals Company; F. Hoffman-La Roche; Simons Foundation for Autism Research Initiative (SFARI) (SFARI Bridge to Independence Award);  [U01MH103339];  [U01MH103365];  [U01MH103392];  [U01MH103340];  [U01MH103346];  [R01MH105472];  [R01MH094714];  [R01MH105898];  [R21MH102791];  [R21MH105881];  [R21MH103877];  [P50MH106934]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105472, R01MH094714, P50MH106934, R01MH110927, R01MH085542, U01MH103346, U01MH103340, R01MH093725, R03MH066923, P50MH066392, R01MH097276, R37MH057881, P50MH096891, R21MH103877, R01MH105898, P50MH096890, R01MH100027, R01MH110920, R21MH105881, U01MH103392, U01MH103339, P50MH084051, P50MH106438, R01MH080405, R01MH109912, U01MH103365, R21MH102791, R01MH075916, P50MH084053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG022193, P01AG002219, P50AG005138, F31AG051381] Funding Source: NIH RePORTER; Lundbeck Foundation [R155-2014-1724, R248-2017-2003] Funding Source: researchfish	U.S. National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation for Autism Research Initiative (SFARI); Stephen R. Mallory schizophrenia research award at the University of California, Los Angeles, (UCLA); Lundbeck Foundation Initiative for Integrative Psychiatric Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Pharmaceuticals Company(Takeda Pharmaceutical Company Ltd); F. Hoffman-La Roche; Simons Foundation for Autism Research Initiative (SFARI) (SFARI Bridge to Independence Award); ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Lundbeck Foundation(Lundbeckfonden)	The work is funded by the U.S. National Institute of Mental Health (NIMH) (grants P50-MH106438, D.H.G.; R01-MH094714, D.H.G.; U01-MH103339, D.H.G.; R01-MH110927, D.H.G.; R01-MH100027, D.H.G.; R01-MH110920, C.L.; and U01-MH103340, C.L.), the Simons Foundation for Autism Research Initiative (SFARI) (SFARI grant 206733, D.H.G., and SFARI Bridge to Independence Award, M.J.G.), and the Stephen R. Mallory schizophrenia research award at the University of California, Los Angeles, (UCLA) (M.J.G.). The study was supported by The Lundbeck Foundation Initiative for Integrative Psychiatric Research (grant R102-A9118) and by the Novo Nordisk Foundation. Published microarray data sets analyzed in this study are available on Gene Expression Omnibus (accession nos. GSE28521, GSE28475, GSE35978, GSE53987, GSE17612, GSE12649, GSE21138, GSE54567, GSE54568, GSE54571, GSE54572, GSE29555, and GSE11223), ArrayExpress (accession no. E-MTAB-184), or directly from the study authors (4). New RNA-seq data (available on Synapse with accession numbers syn4590909 and syn458/609, with access governed by NIMH Repository and Genomics Resource) were generated as part of the PsychENCODE Consortium, supported by grants U01MH103339, U01MH103365, U01MH103392, U01MH103340, U01MH103346, R01MH105472, R01MH094714, R01MH105898, R21MH102791, R21MH105881, R21MH103877, and P50MH106934 awarded to Schahram Akbarian (Icahn School of Medicine at Mount Sinai), Gregory Crawford (Duke), Stella Dracheva (Icahn School of Medicine at Mount Sinai), Peggy Farnham (USC), Mark Gerstein (Yale), Daniel Geschwind (UCLA), Thomas M. Hyde (LIBD), Andrew Jaffe (LIBD), James A. Knowles (USC), Chunyu Liu (UIC), Dalila Pinto (Icahn School of Medicine at Mount Sinai), Nenad Sestan (Yale), Pamela Sklar (Icahn School of Medicine at Mount Sinai), Matthew State (UCSF), Patrick Sullivan (UNC), Flora Vaccarino (Yale), Sherman Weissman (Yale), Kevin White (UChicago), and Peter Zandi (JHU). RNA-seq data from the CommonMind Consortium used in this study (Synapse accession no. syn2759792) was supported by funding from Takeda Pharmaceuticals Company, F. Hoffman-La Roche and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, and MH06692. Brain tissue for the study was obtained from the following brain bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimer's Disease Core Center, the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories, the Harvard Brain Bank as part of the Autism Tissue Project (ATP), the Stanley Medical Research Institute, and the NIMH Human Brain Collection Core. Summary statistics for the ASD GWAS performed on data from the iPSYCH consortium are available in data table S5. Data and analysis code are available at https://github.com/mgandal/Shared-molecular-neuropathology-across-majorpsychiatric-disorders-parallels-polygenic-overlap. The authors thank S. Parhami, H. Won, J. Stein, D. Poliodakis, J. Flint, R. Ophoff, and members of the D. H. G. laboratory for critical reading of earlier versions of this manuscript. The authors also thank B. Pasaniuc for his helpful comments and for assistance with module heritability analyses.	Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Anney RJL, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0137-9; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chang LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090980; Chen C, 2013, MOL PSYCHIATR, V18, P1308, DOI 10.1038/mp.2012.146; Chow ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002592; Cope L., 2004, STAT APPL GENET MOL, V3, pe29; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gandal MJ, 2016, NAT NEUROSCI, V19, P1397, DOI 10.1038/nn.4409; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geschwind DH, 2015, SCIENCE, V349, P1489, DOI 10.1126/science.aaa8954; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Glessner JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015463; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gold PW, 2015, MOL PSYCHIATR, V20, P32, DOI 10.1038/mp.2014.163; Green EK, 2016, MOL PSYCHIATR, V21, P89, DOI 10.1038/mp.2014.174; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jaffe AE, 2017, P NATL ACAD SCI USA, V114, P7130, DOI 10.1073/pnas.1617384114; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin Maureen V, 2015, Mol Neuropsychiatry, V1, P82; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046128; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Moreno-De-Luca D, 2013, MOL PSYCHIATR, V18, P1090, DOI 10.1038/mp.2012.138; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Narayan S, 2008, BRAIN RES, V1239, P235, DOI 10.1016/j.brainres.2008.08.023; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pedersen CB, 2018, MOL PSYCHIATR, V23, P6, DOI 10.1038/mp.2017.196; Pedersen CB, 2014, JAMA PSYCHIAT, V71, P573, DOI 10.1001/jamapsychiatry.2014.16; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Prilutsky D, 2014, TRENDS MOL MED, V20, P91, DOI 10.1016/j.molmed.2013.11.004; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Reinhart V, 2015, NEUROBIOL DIS, V77, P220, DOI 10.1016/j.nbd.2015.03.011; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; van Granlund A. B., 2013, PLOS ONE, V8; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu XX, 2014, J NEUROSCI, V34, P1420, DOI 10.1523/JNEUROSCI.4488-13.2014; Yao P, 2015, NAT NEUROSCI, V18, P1168, DOI 10.1038/nn.4063; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	97	503	509	11	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					693	697		10.1126/science.aad6469	http://dx.doi.org/10.1126/science.aad6469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439242	Green Accepted, Green Submitted			2022-12-28	WOS:000425117700042
J	Osterwalder, M; Barozzi, I; Tissieres, V; Fukuda-Yuzawa, Y; Mannion, BJ; Afzal, SY; Lee, EA; Zhu, YW; Plajzer-Frick, I; Pickle, CS; Kato, M; Garvin, TH; Pham, QT; Harrington, AN; Akiyama, JA; Afzal, V; Lopez-Rios, J; Dickel, DE; Visel, A; Pennacchio, LA				Osterwalder, Marco; Barozzi, Iros; Tissieres, Virginie; Fukuda-Yuzawa, Yoko; Mannion, Brandon J.; Afzal, Sarah Y.; Lee, Elizabeth A.; Zhu, Yiwen; Plajzer-Frick, Ingrid; Pickle, Catherine S.; Kato, Momoe; Garvin, Tyler H.; Pham, Quan T.; Harrington, Anne N.; Akiyama, Jennifer A.; Afzal, Veena; Lopez-Rios, Javier; Dickel, Diane E.; Visel, Axel; Pennacchio, Len A.			Enhancer redundancy provides phenotypic robustness in mammalian development	NATURE			English	Article							VERTEBRATE LIMB BUD; SHADOW ENHANCERS; TRANSCRIPTIONAL ENHANCERS; GENE-EXPRESSION; DATABASE 2016; HUMAN GENOME; MOUSE MODEL; IN-VIVO; EVOLUTION; REVEALS	Distant-acting tissue-specific enhancers, which regulate gene expression, vastly outnumber protein-coding genes in mammalian genomes, but the functional importance of this regulatory complexity remains unclear(1,2). Here we show that the pervasive presence of multiple enhancers with similar activities near the same gene confers phenotypic robustness to loss-of-function mutations in individual enhancers. We used genome editing to create 23 mouse deletion lines and inter-crosses, including both single and combinatorial enhancer deletions at seven distinct loci required for limb development. Unexpectedly, none of the ten deletions of individual enhancers caused noticeable changes in limb morphology. By contrast, the removal of pairs of limb enhancers near the same gene resulted in discernible phenotypes, indicating that enhancers function redundantly in establishing normal morphology. In a genetic background sensitized by reduced baseline expression of the target gene, even single enhancer deletions caused limb abnormalities, suggesting that functional redundancy is conferred by additive effects of enhancers on gene expression levels. A genome-wide analysis integrating epigenomic and transcriptomic data from 29 developmental mouse tissues revealed that mammalian genes are very commonly associated with multiple enhancers that have similar spatiotemporal activity. Systematic exploration of three representative developmental structures (limb, brain and heart) uncovered more than one thousand cases in which five or more enhancers with redundant activity patterns were found near the same gene. Together, our data indicate that enhancer redundancy is a remarkably widespread feature of mammalian genomes that provides an effective regulatory buffer to prevent deleterious phenotypic consequences upon the loss of individual enhancers.	[Osterwalder, Marco; Barozzi, Iros; Fukuda-Yuzawa, Yoko; Mannion, Brandon J.; Afzal, Sarah Y.; Lee, Elizabeth A.; Zhu, Yiwen; Plajzer-Frick, Ingrid; Pickle, Catherine S.; Kato, Momoe; Garvin, Tyler H.; Pham, Quan T.; Harrington, Anne N.; Akiyama, Jennifer A.; Afzal, Veena; Dickel, Diane E.; Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Tissieres, Virginie; Lopez-Rios, Javier] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Tissieres, Virginie; Lopez-Rios, Javier] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, CSIC, JA, Seville 41013, Spain; [Visel, Axel; Pennacchio, Len A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Pennacchio, Len A.] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced; University of California System; University of California Berkeley	Dickel, DE; Visel, A; Pennacchio, LA (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA.; Visel, A; Pennacchio, LA (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.; Visel, A (corresponding author), Univ Calif, Sch Nat Sci, Merced, CA 95343 USA.; Pennacchio, LA (corresponding author), Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA.	dedickel@lbl.gov; avisel@lbl.gov; lapennacchio@lbl.gov	Lopez-Rios, Javier/D-8094-2014; Osterwalder, Marco/AAU-4478-2021; Tissières, Virginie/B-1435-2017; Visel, Axel/A-9398-2009; Barozzi, Iros/GLQ-8907-2022; Osterwalder, Marco/T-1817-2018	Lopez-Rios, Javier/0000-0001-6731-3798; Tissières, Virginie/0000-0003-4276-5514; Visel, Axel/0000-0002-4130-7784; Barozzi, Iros/0000-0003-0690-3473; Afzal, Sarah Yasmeen/0000-0002-3682-5536; Osterwalder, Marco/0000-0002-1969-2313; Dickel, Diane/0000-0001-5497-6824; Pennacchio, Len/0000-0002-8748-3732; Mannion, Brandon/0000-0002-1149-3790; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820	National Institutes of Health [R01HG003988, U54HG006997, R24HL123879, UM1HL098166]; University of Basel; Novartis Foundation for Biomedical Research; Swiss National Science Foundation (SNSF) fellowship; Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123879, UM1HL098166] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997, R01HG003988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Basel; Novartis Foundation for Biomedical Research; Swiss National Science Foundation (SNSF) fellowship; Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grants R01HG003988, U54HG006997, R24HL123879 and UM1HL098166 (to A.V. and L.A.P.) and the University of Basel and the Novartis Foundation for Biomedical Research (to J.L.-R.). M.O. was supported by a Swiss National Science Foundation (SNSF) fellowship. We thank B. Ren for providing access to the ChIP-seq and RNA-seq data from ENCODE; J. Doudna for providing a plasmid containing a human-optimized Cas9 gene; W. Ye and Y. Chen for sharing the image of a Shox2-deficient limb skeleton (Fig. 3b); and the members of the L.A.P., A.V. and D.E.D. groups for technical advice and comments on the manuscript, in particular C. Spurrell and E. Kvon. Research was conducted at the E. O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrey G, 2017, DEVELOPMENT, V144, P3646, DOI 10.1242/dev.148304; Andrey G, 2017, GENOME RES, V27, P223, DOI 10.1101/gr.213066.116; Antosova B, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006441; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bult CJ, 2016, NUCLEIC ACIDS RES, V44, pD840, DOI 10.1093/nar/gkv1211; Cannavo E, 2016, CURR BIOL, V26, P38, DOI 10.1016/j.cub.2015.11.034; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Dickel DE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12923; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gordon CT, 2014, HUM MUTAT, V35, P1011, DOI 10.1002/humu.22606; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Jalili V, 2015, BIOINFORMATICS, V31, P2761, DOI 10.1093/bioinformatics/btv293; Kawakami Y, 2009, DEVELOPMENT, V136, P585, DOI 10.1242/dev.027748; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kvon EZ, 2016, CELL, V167, P633, DOI 10.1016/j.cell.2016.09.028; Lam DD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004935; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lettice LA, 2008, HUM MOL GENET, V17, P978, DOI 10.1093/hmg/ddm370; Li Q, 2014, DEVELOPMENT, V141, P1906, DOI 10.1242/dev.104299; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Menke DB, 2008, DEVELOPMENT, V135, P2543, DOI 10.1242/dev.017384; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Osterwalder M, 2014, DEV CELL, V31, P345, DOI 10.1016/j.devcel.2014.09.018; Ovchinnikov D, 2009, COLD SPRING HARB PRO, V2009; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Petit F, 2017, NAT REV GENET, V18, P245, DOI 10.1038/nrg.2016.167; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosin JM, 2013, HUM MOL GENET, V22, P3063, DOI 10.1093/hmg/ddt163; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Will AJ, 2017, NAT GENET, V49, P1539, DOI 10.1038/ng.3939; Yanagisawa H, 2003, DEVELOPMENT, V130, P1069, DOI 10.1242/dev.00337; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yao Y, 2016, NAT GENET, V48, P575, DOI 10.1038/ng.3542; Ye WD, 2016, DEVELOPMENT, V143, P2548, DOI 10.1242/dev.138750; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	65	272	274	5	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					239	+		10.1038/nature25461	http://dx.doi.org/10.1038/nature25461			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420474	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000424332600039
J	Owen, SF; Berke, JD; Kreitzer, AC				Owen, Scott F.; Berke, Joshua D.; Kreitzer, Anatol C.			Fast-Spiking Interneurons Supply Feedforward Control of Bursting, Calcium, and Plasticity for Efficient Learning	CELL			English	Article							GABAERGIC INTERNEURONS; BASAL GANGLIA; PROJECTION NEURONS; TOURETTE-SYNDROME; DORSAL STRIATUM; SYNAPTIC-TRANSMISSION; DENDRITIC SPINES; VISUAL-CORTEX; IN-VIVO; INHIBITION	Fast-spiking interneurons (FSIs) are a prominent class of forebrain GABAergic cells implicated in two seemingly independent network functions: gain control and network plasticity. Little is known, however, about how these roles interact. Here, we use a combination of cell-type-specific ablation, optogenetics, electrophysiology, imaging, and behavior to describe a unified mechanism by which striatal FSIs control burst firing, calciuminflux, and synaptic plasticity in neighboring medium spiny projection neurons (MSNs). In vivo silencing of FSIs increased bursting, calcium transients, and AMPA/NMDA ratios in MSNs. In a motor sequence task, FSI silencing increased the frequency of calcium transients but reduced the specificity with which transients aligned to individual task events. Consistent with this, ablation of FSIs disrupted the acquisition of striatum-dependent egocentric learning strategies. Together, our data support a model in which feedforward inhibition from FSIs temporally restricts MSN bursting and calcium-dependent synaptic plasticity to facilitate striatum-dependent sequence learning.	[Owen, Scott F.; Kreitzer, Anatol C.] Gladstone Inst, San Francisco, CA 94158 USA; [Berke, Joshua D.; Kreitzer, Anatol C.] UCSF, Dept Neurol, San Francisco, CA 94158 USA; [Berke, Joshua D.; Kreitzer, Anatol C.] UCSF, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA; [Berke, Joshua D.; Kreitzer, Anatol C.] UCSF, UCSF Weill Inst Neurosci, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] UCSF, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreitzer, AC (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), UCSF, Dept Neurol, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), UCSF, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), UCSF, UCSF Weill Inst Neurosci, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), UCSF, Dept Physiol, San Francisco, CA 94158 USA.	anatol.kreitzer@gladstone.ucsf.edu	Core, Vector/CAF-4832-2022	Owen, Scott/0000-0001-6294-7513	NIH [R01 NS078435, R01 NS064984, F32 NS083369, K99 MH110597, RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH110597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS083369, R01NS064984, R01NS078435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Delanie Shulte and Benjamin Margolin for assistance with genotyping, histology, and microscopy and the A.C.K. laboratory for comments on the manuscript. The authors wish to acknowledge Inscopix for scientific collaboration and providing access to nVoke integrated imaging and optogenetics system. Thank you to Michael Gill and the Gladstone Behavioral Core and Nikon Imaging Core at UCSF for assistance with specific experiments. This work was funded by the NIH (R01 NS078435 and R01 NS064984 to A.C.K.; F32 NS083369 and K99 MH110597 to S.F.O.; and RR018928 to the Gladstone Institutes).	Agetsuma M, 2017, CEREB CORTEX; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bakhurin KI, 2016, J NEUROPHYSIOL, V115, P1521, DOI 10.1152/jn.01037.2015; Barbera G, 2016, NEURON, V92, P202, DOI 10.1016/j.neuron.2016.08.037; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bronfeld M, 2013, NEUROSCIENTIST, V19, P101, DOI 10.1177/1073858412444466; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; BUZSAKI G, 1981, BRAIN RES, V230, P346, DOI 10.1016/0006-8993(81)90413-3; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gernert M, 2000, J NEUROSCI, V20, P7052, DOI 10.1523/JNEUROSCI.20-18-07052.2000; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kerr JND, 2002, J NEUROSCI, V22, P1499, DOI 10.1523/JNEUROSCI.22-05-01499.2002; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Klaus A, 2017, NEURON, V95, P1171, DOI 10.1016/j.neuron.2017.08.015; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Kuo SP, 2011, NEURON, V71, P306, DOI 10.1016/j.neuron.2011.05.039; Lee K, 2017, NEURON, V93, P1451, DOI 10.1016/j.neuron.2017.02.033; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Packard MG, 1999, P NATL ACAD SCI USA, V96, P12881, DOI 10.1073/pnas.96.22.12881; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Rapanelli M, 2017, BIOL PSYCHIAT, V82, P194, DOI 10.1016/j.biopsych.2017.01.020; Rothwell PE, 2015, NEURON, V88, P345, DOI 10.1016/j.neuron.2015.09.035; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smeal RM, 2007, J NEUROSCI METH, V159, P224, DOI 10.1016/j.jneumeth.2006.07.007; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Straub C, 2016, NEURON, V92, P84, DOI 10.1016/j.neuron.2016.09.007; Tecuapetla F, 2016, CELL, V166, P703, DOI 10.1016/j.cell.2016.06.032; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu M, 2016, NEUROSCIENCE, V324, P321, DOI 10.1016/j.neuroscience.2016.02.074; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Zhou P., 2016, ARXIV160507266V2; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	65	75	77	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					683	+		10.1016/j.cell.2018.01.005	http://dx.doi.org/10.1016/j.cell.2018.01.005			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425490	Green Accepted, Bronze			2022-12-28	WOS:000424648800010
J	Shoji, K; Saitoh, A				Shoji, Kensuke; Saitoh, Akihiko			Herpetic Whitlow	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shoji, Kensuke] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Saitoh, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan	National Center for Child Health & Development - Japan; Niigata University	Shoji, K (corresponding author), Natl Ctr Child Hlth & Dev, Tokyo, Japan.	shoji-k@ncchd.go.jp	Shoji, Kensuke/J-3316-2019						0	2	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					563	563		10.1056/NEJMicm1711479	http://dx.doi.org/10.1056/NEJMicm1711479			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OX	29414271				2022-12-28	WOS:000424335200011
J	Zhou, X; Franklin, RA; Adler, M; Jacox, JB; Bailis, W; Shyer, JA; Flavell, RA; Mayo, A; Alon, U; Medzhitov, R				Zhou, Xu; Franklin, Ruth A.; Adler, Miri; Jacox, Jeremy B.; Bailis, Will; Shyer, Justin A.; Flavell, Richard A.; Mayo, Avi; Alon, Uri; Medzhitov, Ruslan			Circuit Design Features of a Stable Two-Cell System	CELL			English	Article							TISSUE-RESIDENT MACROPHAGES; NERVE GROWTH-FACTOR; SIZE CONTROL; HOMEOSTASIS; NEURONS; CANCER; CELLS; INFLAMMATION; MECHANISM; PLATFORM	Cell communication within tissues is mediated by multiple paracrine signals including growth factors, which control cell survival and proliferation. Cells and the growth factors they produce and receive constitute a circuit with specific properties that ensure homeostasis. Here, we used computational and experimental approaches to characterize the features of cell circuits based on growth factor exchange between macrophages and fibroblasts, two cell types found in most mammalian tissues. We found that the macrophage-fibroblast cell circuit is stable and robust to perturbations. Analytical screening of all possible two-cell circuit topologies revealed the circuit features sufficient for stability, including environmental constraint and negative-feedback regulation. Moreover, we found that cell-cell contact is essential for the stability of the macrophage-fibroblast circuit. These findings illustrate principles of cell circuit design and provide a quantitative perspective on cell interactions.	[Zhou, Xu; Franklin, Ruth A.; Jacox, Jeremy B.; Bailis, Will; Shyer, Justin A.; Flavell, Richard A.; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Adler, Miri; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Jacox, Jeremy B.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Weizmann Institute of Science; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06510 USA.; Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.	uri.alon@weizmann.ac.il; ruslan.medzhitov@yale.edu	Franklin, Ruth/AAG-4161-2022; Franklin, Ruth/AFK-5723-2022; Zhou, Xu/AAI-9269-2020; mayo, avi/N-3756-2019	mayo, avi/0000-0002-4479-3423; Zhou, Xu/0000-0002-1692-6823; Jacox, Jeremy/0000-0001-9187-7374	Blavatnik Family Foundation; Else Kroner-Fresenius Foundation; Scleroderma Research Foundation; Biogen; Howard Hughes Medical Institute (HHMI); Jane Coffin Childs Memorial Fund postdoctoral fellowship; CRI Donald Gogel postdoctoral fellowship; NIH MSTP [T32GM007205]; NRSA NCI fellowship [1F30CA189926-01]; CRI Irvington postdoctoral fellowship; NIH [F31AI133855]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI133855, T32AI007019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Blavatnik Family Foundation; Else Kroner-Fresenius Foundation; Scleroderma Research Foundation; Biogen(Biogen); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Jane Coffin Childs Memorial Fund postdoctoral fellowship; CRI Donald Gogel postdoctoral fellowship; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA NCI fellowship; CRI Irvington postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the R.M. lab was supported by the Blavatnik Family Foundation, the Else Kroner-Fresenius Foundation, the Scleroderma Research Foundation, a grant from Biogen, and the Howard Hughes Medical Institute (HHMI). X.Z. is supported by the Jane Coffin Childs Memorial Fund postdoctoral fellowship. R.A. Franklin is supported by the CRI Donald Gogel postdoctoral fellowship. J.B.J. is supported by an NIH MSTP T32 training grant (T32GM007205) and an NRSA NCI fellowship (1F30CA189926-01). W.B. is supported by a CRI Irvington postdoctoral fellowship. J.S. is supported by NIH (F31AI133855). R.A. Flavell is supported in part by the HHMI. U.A. is the incumbent of the Abisch-Frenkel chair. We want to thank all current and former members of the Medzhitov and Alon labs for discussions.	Adler M., 2018, P NATL ACAD SCI US; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ben-Zvi D, 2011, CURR BIOL, V21, P1391, DOI 10.1016/j.cub.2011.07.015; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Damm EW, 2017, NAT CELL BIOL, V19, P457, DOI 10.1038/ncb3508; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Decker M, 2017, NAT CELL BIOL, V19, P677, DOI 10.1038/ncb3530; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Gotelli NJ, 2008, PRIMER ECOLOGY, V4th; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Hart Y, 2014, CELL, V158, P1022, DOI 10.1016/j.cell.2014.07.033; Hart Y, 2012, P NATL ACAD SCI USA, V109, P8346, DOI 10.1073/pnas.1117475109; HAWLEY RG, 1992, J EXP MED, V176, P1149, DOI 10.1084/jem.176.4.1149; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Karin O, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177599; Karin O, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167216; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Krieger T, 2015, DEVELOPMENT, V142, P1396, DOI 10.1242/dev.101063; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lo WC, 2009, MATH BIOSCI ENG, V6, P59, DOI 10.3934/mbe.2009.6.59; Majno G., 2004, CELLS TISSUES DIS PR; MAY RM, 1973, ECOLOGY, V54, P638, DOI 10.2307/1935352; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Payne S, 2014, ADV BIOCHEM ENG BIOT, V146, P97, DOI 10.1007/10_2013_249; Raff MC, 1996, CELL, V86, P173, DOI 10.1016/S0092-8674(00)80087-2; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044	49	138	139	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					744	+		10.1016/j.cell.2018.01.015	http://dx.doi.org/10.1016/j.cell.2018.01.015			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29398113	Green Accepted, Bronze			2022-12-28	WOS:000424648800015
J	Jessiman, S				Jessiman, Sarah			Patient Commentary: "I don't want to go to Switzerland, and I don't want to attempt suicide"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Ellie.Ball@dignityindying.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2018	360								k542	10.1136/bmj.k542	http://dx.doi.org/10.1136/bmj.k542			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HY	29437692				2022-12-28	WOS:000424975900011
J	Burki, T				Burki, Talha			Developing countries in the digital revolution	LANCET			English	Editorial Material																			0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					417	417		10.1016/S0140-6736(18)30191-0	http://dx.doi.org/10.1016/S0140-6736(18)30191-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407022				2022-12-28	WOS:000424333600014
J	Moberly, T				Moberly, Tom			BRIEFING Moving to accountable care in the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tmoberly@bmj.com						Charles A, 2018, KINGS FUND 0118; Moberly T, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4105	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2018	360								k442	10.1136/bmj.k442	http://dx.doi.org/10.1136/bmj.k442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TQ	29386324				2022-12-28	WOS:000423845900005
J	Mohammed, AJ				Mohammed, Amina J.			A call to action: improving women's, children's, and adolescents' health in the Muslim world	LANCET			English	Editorial Material									[Mohammed, Amina J.] United Nations Headquarters, New York, NY 10017 USA		Mohammed, AJ (corresponding author), United Nations Headquarters, New York, NY 10017 USA.	kuot@un.org						Akseer N, 2018, LANCET, V391, P1493, DOI 10.1016/S0140-6736(18)30183-1; Every Woman Every Child, 2015, GLOB STRAT WOM CHILD; OIC, 2016, OIC 2025 PROGR ACT; Pew Research Centre, 2017, CHANG GLOB REL LANDS; UNICEF, 2019, CHILDR FOOD NUTR	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1458	1460		10.1016/S0140-6736(18)30182-X	http://dx.doi.org/10.1016/S0140-6736(18)30182-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29395270				2022-12-28	WOS:000429926000005
J	Nabhan, AN; Brownfield, DG; Harbury, PB; Krasnow, MA; Desai, TJ				Nabhan, Ahmad N.; Brownfield, Douglas G.; Harbury, Pehr B.; Krasnow, Mark A.; Desai, Tushar J.			Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells	SCIENCE			English	Article							EPITHELIAL SELF-RENEWAL; BETA-CATENIN; LUNG; PROTEINS; PROGRESSION; PROGENITOR	Alveoli, the lung's respiratory units, are tiny sacs where oxygen enters the bloodstream. They are lined by flat alveolar type 1 (AT1) cells, which mediate gas exchange, and AT2 cells, which secrete surfactant. Rare AT2s also function as alveolar stem cells. We show that AT2 lung stem cells display active Wnt signaling, and many of them are near single, Wnt-expressing fibroblasts. Blocking Wnt secretion depletes these stem cells. Daughter cells leaving the Wnt niche transdifferentiate into AT1s: Maintaining Wnt signaling prevents transdifferentiation, whereas abrogating Wnt signaling promotes it. Injury induces AT2 autocrine Wnts, recruiting "bulk" AT2s as progenitors. Thus, individual AT2 stem cells reside in single-cell fibroblast niches providing juxtacrine Wnts that maintain them, whereas injury induces autocrine Wnts that transiently expand the progenitor pool. This simple niche maintains the gas exchange surface and is coopted in cancer.	[Nabhan, Ahmad N.; Brownfield, Douglas G.; Harbury, Pehr B.; Krasnow, Mark A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Nabhan, Ahmad N.; Brownfield, Douglas G.; Krasnow, Mark A.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Desai, Tushar J.] Stanford Univ, Sch Med, Div Pulm & Crit Care, Dept Internal Med, Stanford, CA 94305 USA; [Desai, Tushar J.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.; Krasnow, MA (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.; Desai, TJ (corresponding author), Stanford Univ, Sch Med, Div Pulm & Crit Care, Dept Internal Med, Stanford, CA 94305 USA.; Desai, TJ (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	krasnow@stanford.edu; tdesai@stanford.edu		Nabhan, Ahmad/0000-0002-4959-9590; Krasnow, Mark/0000-0002-1976-5471; Brownfield, Doug/0000-0003-4769-1518	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL127471, U01HL099995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [U01 HL099995, R56 HL127471] Funding Source: Medline; NIGMS NIH HHS [T32 GM007276] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMSON IYR, 1990, AM J PATHOL, V137, P385; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; BOWDEN DH, 1968, ARCH PATHOL, V86, P671; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Frank DB, 2016, CELL REP, V17, P2312, DOI 10.1016/j.celrep.2016.11.001; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalez Robert F, 2013, Methods Mol Biol, V945, P145, DOI 10.1007/978-1-62703-125-7_10; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Juan J, 2014, GENE DEV, V28, P561, DOI 10.1101/gad.233627.113; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lee JH, 2017, CELL, V170, P1149, DOI 10.1016/j.cell.2017.07.028; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053817; Logan CY, 2015, BIOESSAYS, V37, P1028, DOI 10.1002/bies.201500031; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Nagendran M, 2018, ELIFE, V7, DOI 10.7554/eLife.30510; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Rompolas P, 2014, SEMIN CELL DEV BIOL, V25, P34, DOI 10.1016/j.semcdb.2013.12.005; Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013; Sheikh AQ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9712; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034	39	328	336	8	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1118	1123		10.1126/science.aam6603	http://dx.doi.org/10.1126/science.aam6603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29420258	Green Accepted			2022-12-28	WOS:000426835900037
J	Gelinas, L; Largent, EA; Cohen, IG; Kornetsky, S; Bierer, BE; Lynch, HF				Gelinas, Luke; Largent, Emily A.; Cohen, I. Glenn; Kornetsky, Susan; Bierer, Barbara E.; Lynch, Holly Fernandez			A Framework for Ethical Payment to Research Participants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; UNDUE; INCENTIVES; COERCION; PAY		[Gelinas, Luke; Cohen, I. Glenn; Lynch, Holly Fernandez] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA; [Gelinas, Luke; Cohen, I. Glenn; Bierer, Barbara E.; Lynch, Holly Fernandez] Harvard Med Sch, Harvard Catalyst Harvard Clin & Translat Sci Ctr, Cambridge, MA USA; [Kornetsky, Susan] Boston Childrens Hosp, Boston, MA USA; [Bierer, Barbara E.] Brigham & Womens Hosp, Multireg Clin Trials Ctr, 75 Francis St, Boston, MA 02115 USA; [Bierer, Barbara E.] Harvard Univ, Cambridge, MA 02138 USA; [Bierer, Barbara E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Bierer, Barbara E.] Harvard Med Sch, Boston, MA USA; [Largent, Emily A.; Lynch, Holly Fernandez] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Largent, Emily A.; Lynch, Holly Fernandez] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Bierer, BE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	bbierer@bwh.harvard.edu		Largent, Emily/0000-0002-7536-5077; Bierer, Barbara/0000-0001-6448-8170				[Anonymous], 2011, ETH IMP STD RES GUAT; Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594; Carlisle B, 2015, CLIN TRIALS, V12, P77, DOI 10.1177/1740774514558307; Council for International Organizations of Medical Sciences, 2016, INT ETH GUID HLTH RE; Cryder CE, 2010, SOC SCI MED, V70, P455, DOI 10.1016/j.socscimed.2009.10.047; Devine EG, 2013, CLIN TRIALS, V10, P935, DOI 10.1177/1740774513492917; Dickert N, 2002, ANN INTERN MED, V136, P368, DOI 10.7326/0003-4819-136-5-200203050-00009; Dickert N, 1999, NEW ENGL J MED, V341, P198, DOI 10.1056/NEJM199907153410312; Dominguez D, 2012, CONTEMP CLIN TRIALS, V33, P860, DOI 10.1016/j.cct.2012.05.001; Elliott C, 2011, WHITE COAT BLACK HAT; Emanuel EJ, 2005, AM J BIOETHICS, V5, P9, DOI 10.1080/15265160500244959; Emanuel EJ, 2004, J LAW MED ETHICS, V32, P100, DOI 10.1111/j.1748-720X.2004.tb00453.x; Food and Drug Administration, PAYM REIMB RES SUBJ; Gelinas L, 2017, J MED ETHICS, V43, P803, DOI 10.1136/medethics-2016-103680; Grady C, 2005, CONTEMP CLIN TRIALS, V26, P365, DOI 10.1016/j.cct.2005.02.003; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Keating NL, 2008, MED CARE, V46, P878, DOI 10.1097/MLR.0b013e318178eb1d; Klitzman R, 2013, J MED ETHICS, V39, P224, DOI 10.1136/medethics-2011-100439; Largent E. A., 2017, YALE J HLTH POLICY L, V17, P61; Largent EA, 2017, PAYING RES PARTICI P; Largent E, 2013, BIOETHICS, V27, P500, DOI 10.1111/j.1467-8519.2012.01972.x; Largent Emily A, 2012, IRB, V34, P1; Lynch Holly Fernandez, 2014, Yale J Health Policy Law Ethics, V14, P122; Macklin Ruth, 1981, IRB, V3, P1, DOI 10.2307/3564136; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979, BELM REP C; Ripley E, 2010, J EMPIR RES HUM RES, V5, P43, DOI 10.1525/jer.2010.5.3.43; Ulrich CM, 2005, NURS RES, V54, P178; Ulrich Connie M, 2005, IRB, V27, P17, DOI 10.2307/3563957; United States Office for Human Research Protections, INF CONS FAQS DOES C; United States Office for Human Research Protections, INF CONS FAQS WHAT D; Wertheimer A, 2008, J MED ETHICS, V34, P389, DOI 10.1136/jme.2007.021857; Wertheimer A, 2013, BIOETHICS, V27, P105, DOI 10.1111/j.1467-8519.2011.01892.x; Wertheimer Alan, 1987, COERCION	34	69	69	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2018	378	8					766	771		10.1056/NEJMsb1710591	http://dx.doi.org/10.1056/NEJMsb1710591			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW8VA	29466147				2022-12-28	WOS:000425613900016
J	Lavoie, H; Sahmi, M; Maisonneuve, P; Marullo, SA; Thevakumaran, N; Jin, T; Kurinov, I; Sicheri, F; Therrien, M				Lavoie, Hugo; Sahmi, Malha; Maisonneuve, Pierre; Marullo, Sara A.; Thevakumaran, Neroshan; Jin, Ting; Kurinov, Igor; Sicheri, Frank; Therrien, Marc			MEK drives BRAF activation through allosteric control of KSR proteins	NATURE			English	Article							SEQUENCE ALIGNMENT EDITOR; RAF KINASE; SYSTEM; DOMAIN; MODEL; PHOSPHORYLATION; MUTATION	RAF family kinases have prominent roles in cancer(1). Their activation is dependent on dimerization of their kinase domains, which has emerged as a hindrance for drug development(2,3). In mammals, RAF family kinases include three catalytically competent enzymes (ARAF, BRAF and CRAF) and two pseudokinases (KSR1 and KSR2) that have been described as scaffolds owing to their apparent ability to bridge RAF isoforms and their substrate, mitogen-activated protein kinase kinase (MEK)(4). Kinase suppressor of Ras (KSR) pseudokinases were also shown to dimerize with kinase-competent RAFs to stimulate catalysis allosterically(5). Although GTP-bound RAS can modulate the dimerization of RAF isoforms by engaging their RAS-binding domains, KSR1 and KSR2 lack an RAS-binding domain and therefore the regulatory principles underlying their dimerization with other RAF family members remain unknown. Here we show that the selective heterodimerization of BRAF with KSR1 is specified by direct contacts between the amino-terminal regulatory regions of each protein, comprising in part a novel domain called BRS in BRAF and the coiled-coil-sterile alpha motif (CC-SAM) domain in KSR1. We also discovered that MEK binding to the kinase domain of KSR1 asymmetrically drives BRAF-KSR1 heterodimerization, resulting in the concomitant stimulation of BRAF catalytic activity towards free MEK molecules. These findings demonstrate that KSR-MEK complexes allosterically activate BRAF through the action of N-terminal regulatory region and kinase domain contacts and challenge the accepted role of KSR as a scaffold for MEK recruitment to RAF.	[Lavoie, Hugo; Sahmi, Malha; Marullo, Sara A.; Jin, Ting; Therrien, Marc] Univ Montreal, Immunol Res Inst, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Lavoie, Hugo; Sahmi, Malha; Marullo, Sara A.; Jin, Ting; Therrien, Marc] Univ Montreal, Canc Lab Intracellular Signaling, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Maisonneuve, Pierre; Thevakumaran, Neroshan; Sicheri, Frank] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Thevakumaran, Neroshan; Sicheri, Frank] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kurinov, Igor] Argonne Natl Lab, NE CAT APS, Bldg 436E,9700 S Cass Ave, Argonne, IL 60439 USA; [Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Therrien, Marc] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; University of Toronto; Universite de Montreal	Therrien, M (corresponding author), Univ Montreal, Immunol Res Inst, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Therrien, M (corresponding author), Univ Montreal, Canc Lab Intracellular Signaling, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Sicheri, F (corresponding author), Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.; Sicheri, F (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.; Sicheri, F (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.; Therrien, M (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada.	sicheri@lunenfeld.ca; marc.therrien@umontreal.ca	Marullo, Sara/ABE-9348-2021	Marullo, Sara/0000-0001-9609-343X; Lavoie, Hugo/0000-0003-0560-2409; Maisonneuve, Pierre/0000-0001-8292-5741	Canadian Institutes for Health Research (CIHR) Banting fellowship; CIHR scholarship; Canadian Cancer Society [702319, 704116]; CIHR [MOP119443, PJT152873, FDN143277]; National Institutes of Health [P41 GM 103403, SI0 RR029205]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR) Banting fellowship(Canadian Institutes of Health Research (CIHR)); CIHR scholarship(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Volpon, M. Osborne, G. Seabrook, and the Institute for Research in Immunology and Cancer High-Throughput Screening and Proteomics facilities for experimental assistance. H.L. was supported by a Canadian Institutes for Health Research (CIHR) Banting fellowship. N.T. was supported by a CIHR scholarship. Research was supported by Impact Grants from the Canadian Cancer Society (702319 to M.T. and 704116 to F.S.) and by CIHR operating grants (MOP119443 and PJT152873 to M.T. and FDN143277 to F.S.). M.T and ES. hold Canada Research Chairs in Intracellular Signaling and in Structural Biology of Signaling. Synchrotron work at the Northeastern Collaborative Access Team beamlines was supported by National Institutes of Health grants (P41 GM 103403 and SI0 RR029205).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; James P, 1996, GENETICS, V144, P1425; James P, 2001, METH MOL B, V177, P41; Jin T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01274-0; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karoulia Z, 2017, NAT REV CANCER, V17, P676, DOI 10.1038/nrc.2017.79; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Koveal D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003289; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lavoie H, 2013, NAT CHEM BIOL, V9, P428, DOI [10.1038/NCHEMBIO.1257, 10.1038/nchembio.1257]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Sammito M, 2015, ACTA CRYSTALLOGR D, V71, P1921, DOI 10.1107/S1399004715010846; Schrodinger, 2015, PYMOL MOL GRAPH SYST; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SPEE JH, 1993, NUCLEIC ACIDS RES, V21, P777, DOI 10.1093/nar/21.3.777; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	40	65	65	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					549	+		10.1038/nature25478	http://dx.doi.org/10.1038/nature25478			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29433126	Green Accepted			2022-12-28	WOS:000425597400051
J	McDonald, BC; de Gouw, JA; Gilman, JB; Jathar, SH; Akherati, A; Cappa, CD; Jimenez, JL; Lee-Taylor, J; Hayes, PL; McKeen, SA; Cui, YY; Kim, SW; Gentner, DR; Isaacman-VanWertz, G; Goldstein, AH; Harley, RA; Frost, GJ; Roberts, JM; Ryerson, TB; Trainer, M				McDonald, Brian C.; de Gouw, Joost A.; Gilman, Jessica B.; Jathar, Shantanu H.; Akherati, Ali; Cappa, Christopher D.; Jimenez, Jose L.; Lee-Taylor, Julia; Hayes, Patrick L.; McKeen, Stuart A.; Cui, Yu Yan; Kim, Si-Wan; Gentner, Drew R.; Isaacman-VanWertz, Gabriel; Goldstein, Allen H.; Harley, Robert A.; Frost, Gregory J.; Roberts, James M.; Ryerson, Thomas B.; Trainer, Michael			Volatile chemical products emerging as largest petrochemical source of urban organic emissions	SCIENCE			English	Article							MOTOR-VEHICLE EMISSIONS; LONG-TERM TRENDS; COAST AIR BASIN; AEROSOL FORMATION; LOS-ANGELES; AMBIENT CONCENTRATIONS; CLEANING PRODUCTS; VAPOR-PRESSURE; WALL LOSSES; CALNEX 2010	A gap in emission inventories of urban volatile organic compound (VOC) sources, which contribute to regional ozone and aerosol burdens, has increased as transportation emissions in the United States and Europe have declined rapidly. A detailed mass balance demonstrates that the use of volatile chemical products (VCPs)-including pesticides, coatings, printing inks, adhesives, cleaning agents, and personal care products-now constitutes half of fossil fuel VOC emissions in industrialized cities. The high fraction of VCP emissions is consistent with observed urban outdoor and indoor air measurements. We show that human exposure to carbonaceous aerosols of fossil origin is transitioning away from transportation-related sources and toward VCPs. Existing U.S. regulations on VCPs emphasize mitigating ozone and air toxics, but they currently exempt many chemicals that lead to secondary organic aerosols.	[McDonald, Brian C.; de Gouw, Joost A.; Jimenez, Jose L.; Lee-Taylor, Julia; McKeen, Stuart A.; Cui, Yu Yan; Kim, Si-Wan] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [McDonald, Brian C.; de Gouw, Joost A.; Gilman, Jessica B.; McKeen, Stuart A.; Cui, Yu Yan; Kim, Si-Wan; Frost, Gregory J.; Roberts, James M.; Ryerson, Thomas B.; Trainer, Michael] NOAA, Chem Sci Div, Earth Syst Res Lab, Boulder, CO 80305 USA; [Jathar, Shantanu H.; Akherati, Ali] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA; [Cappa, Christopher D.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Jimenez, Jose L.] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; [Lee-Taylor, Julia] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Hayes, Patrick L.] Univ Montreal, Dept Chem, Montreal, PQ, Canada; [Gentner, Drew R.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT USA; [Gentner, Drew R.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Isaacman-VanWertz, Gabriel] Virginia Polytech Inst & State Univ, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA; [Goldstein, Allen H.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Goldstein, Allen H.; Harley, Robert A.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Cui, Yu Yan] Calif Air Resources Board, Sacramento, CA USA; [Kim, Si-Wan] Yonsei Univ, Dept Atmospher Sci, Seoul, South Korea	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; Colorado State University; University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder; National Center Atmospheric Research (NCAR) - USA; Universite de Montreal; Yale University; Yale University; Virginia Polytechnic Institute & State University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Yonsei University	McDonald, BC (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.; McDonald, BC (corresponding author), NOAA, Chem Sci Div, Earth Syst Res Lab, Boulder, CO 80305 USA.	brian.mcdonald@noaa.gov	Frost, Gregory J/I-1958-2013; Lee-Taylor, Julia M/B-7409-2008; Roberts, James M./A-1082-2009; Akherati, Ali/AAH-4607-2020; Ryerson, Tom/AAA-8399-2021; Trainer, Michael/H-5168-2013; Gilman, Jessica B/E-7751-2010; Goldstein, Allen H/A-6857-2011; KIM, SI-WAN/GPC-7160-2022; Jimenez, Jose L/A-5294-2008; Roberts, James/AAI-3283-2020; Kim, Si-Wan/I-3979-2013; McKeen, Stuart A/H-9516-2013; McDonald, Brian/B-5897-2015; Ryerson, Thomas/C-9611-2009; de Gouw, Joost/A-9675-2008; Jathar, Shantanu/A-2966-2015	Lee-Taylor, Julia M/0000-0003-0989-1113; Roberts, James M./0000-0002-8485-8172; Akherati, Ali/0000-0002-2919-2179; Trainer, Michael/0000-0002-1668-2961; Gilman, Jessica B/0000-0002-7899-9948; Goldstein, Allen H/0000-0003-4014-4896; KIM, SI-WAN/0000-0002-7889-189X; Jimenez, Jose L/0000-0001-6203-1847; Roberts, James/0000-0002-2671-3207; Kim, Si-Wan/0000-0002-7889-189X; McKeen, Stuart A/0000-0001-9700-6166; McDonald, Brian/0000-0001-8600-5096; Ryerson, Thomas/0000-0003-2800-7581; de Gouw, Joost/0000-0002-0385-1826; Jathar, Shantanu/0000-0003-4106-2358; Cappa, Christopher/0000-0002-3528-3368	CIRES Visiting Postdoctoral Fellowship; NOAA grant [NA17OAR4310003]; NSF [AGS-1151062, AGS-1360834]; Sloan Foundation [2016-7173, G-2016-7050]; NSERC [RGPIN/05002-2014]; FRQNT grant [2016-PR-192364]; NASA ROSES ACMAP grant [NNH14AX01I]; Div Atmospheric & Geospace Sciences [1151062] Funding Source: National Science Foundation	CIRES Visiting Postdoctoral Fellowship; NOAA grant(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQNT grant; NASA ROSES ACMAP grant; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	J.A.d.G. was associated as a consultant with Aerodyne Research Inc. during part of the preparation phase. Supported by a CIRES Visiting Postdoctoral Fellowship (B.C.M.); NOAA grant NA17OAR4310003 (S.H.J.); NSF grant AGS-1151062 (C.D.C.); NSF grant AGS-1360834 and Sloan Foundation grant 2016-7173 (J.L.J. and J.L.-T.); NSERC grant RGPIN/05002-2014 and FRQNT grant 2016-PR-192364 (P.L.H.); Sloan Foundation grant G-2016-7050 (A.H.G.); and NASA ROSES ACMAP grant NNH14AX01I (S.-W.K.). We thank W. Nazaroff at UC Berkeley, P. Ziemann at the University of Colorado, and M. Coggon, A. Koss, W. Kuster, B. Lerner, A. Middlebrook, J. Peischl, A. Perring, C. Warneke, and others at the NOAA Earth System Research Laboratory's Chemical Sciences Division for their helpful comments and technical insights.	Ahmadov R, 2015, ATMOS CHEM PHYS, V15, P411, DOI 10.5194/acp-15-411-2015; American Chemistry Council, 2016, 2016 GUID BUS CHEM; Borbon A, 2013, J GEOPHYS RES-ATMOS, V118, P2041, DOI 10.1002/jgrd.50059; California Air Resources Board, 2015, CAL CONS PROD REG; Cappa CD, 2012, ATMOS CHEM PHYS, V12, P9505, DOI 10.5194/acp-12-9505-2012; Cappa CD, 2016, ATMOS CHEM PHYS, V16, P3041, DOI 10.5194/acp-16-3041-2016; Chan AWH, 2009, ATMOS CHEM PHYS, V9, P3049, DOI 10.5194/acp-9-3049-2009; de Gouw JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052109; Derwent RG, 2010, SCI TOTAL ENVIRON, V408, P3374, DOI 10.1016/j.scitotenv.2010.04.013; Di Q, 2017, NEW ENGL J MED, V376, P2513, DOI 10.1056/NEJMoa1702747; Dollard GJ, 2007, ATMOS ENVIRON, V41, P2559, DOI 10.1016/j.atmosenv.2006.11.020; Ensberg JJ, 2014, ATMOS CHEM PHYS, V14, P2383, DOI 10.5194/acp-14-2383-2014; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gentner DR, 2017, ENVIRON SCI TECHNOL, V51, P1074, DOI 10.1021/acs.est.6b04509; Griffith SM, 2016, J GEOPHYS RES-ATMOS, V121, P4211, DOI 10.1002/2015JD024358; HARLEY RA, 1992, ENVIRON SCI TECHNOL, V26, P2395, DOI 10.1021/es00036a010; Harley RA, 1997, ENVIRON SCI TECHNOL, V31, P2829, DOI 10.1021/es9700562; Hayes PL, 2015, ATMOS CHEM PHYS, V15, P5773, DOI 10.5194/acp-15-5773-2015; Hayes PL, 2013, J GEOPHYS RES-ATMOS, V118, P9233, DOI 10.1002/jgrd.50530; Hossaini R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15962; Huijbregts MAJ, 2005, INTEGR ENVIRON ASSES, V1, P181, DOI 10.1897/2004-007R.1; Jathar SH, 2014, P NATL ACAD SCI USA, V111, P10473, DOI 10.1073/pnas.1323740111; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Johansson JKE, 2014, J GEOPHYS RES-ATMOS, V119, P1973, DOI 10.1002/2013JD020485; Kim SW, 2016, J GEOPHYS RES-ATMOS, V121, P1340, DOI 10.1002/2015JD024292; Kim SW, 2011, ATMOS CHEM PHYS, V11, P11361, DOI 10.5194/acp-11-11361-2011; Klein F, 2016, ENVIRON SCI TECHNOL, V50, P1243, DOI 10.1021/acs.est.5b04618; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Langford B, 2010, ATMOS CHEM PHYS, V10, P627, DOI 10.5194/acp-10-627-2010; Lee A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007050; Li WH, 2018, ATMOS ENVIRON, V178, P109, DOI 10.1016/j.atmosenv.2017.12.019; Logue JM, 2011, INDOOR AIR, V21, P92, DOI 10.1111/j.1600-0668.2010.00683.x; Ma PK, 2017, ATMOS CHEM PHYS, V17, P9237, DOI 10.5194/acp-17-9237-2017; Mackay D, 2014, ENVIRON SCI TECHNOL, V48, P10259, DOI 10.1021/es5029074; McDonald BC, 2015, ENVIRON SCI TECHNOL, V49, P5178, DOI 10.1021/es505912b; McDonald BC, 2013, ENVIRON SCI TECHNOL, V47, P10022, DOI 10.1021/es401034z; National Research Council, 2004, AIR QUAL MAN US; Nazaroff WW, 2004, ATMOS ENVIRON, V38, P2841, DOI 10.1016/j.atmosenv.2004.02.040; Ng NL, 2007, ATMOS CHEM PHYS, V7, P3909, DOI 10.5194/acp-7-3909-2007; Niedojadlo A, 2007, ATMOS ENVIRON, V41, P7108, DOI 10.1016/j.atmosenv.2007.04.056; Ortega AM, 2016, ATMOS CHEM PHYS, V16, P7411, DOI 10.5194/acp-16-7411-2016; Peischl J, 2013, J GEOPHYS RES-ATMOS, V118, P4974, DOI 10.1002/jgrd.50413; Petron G, 2014, J GEOPHYS RES-ATMOS, V119, P6836, DOI 10.1002/2013JD021272; Platt SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03714-9; Pollack IB, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016772; Presto AA, 2010, ENVIRON SCI TECHNOL, V44, P2029, DOI 10.1021/es903712r; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; Shin HM, 2016, CHEMOSPHERE, V153, P130, DOI 10.1016/j.chemosphere.2016.02.131; Shin HM, 2015, ATMOS ENVIRON, V108, P98, DOI 10.1016/j.atmosenv.2015.02.067; Steinemann AC, 2011, ENVIRON IMPACT ASSES, V31, P328, DOI 10.1016/j.eiar.2010.08.002; U. S. Environmental Protection Agency, 2016, CHEM DAT ACC TOOL CD; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; von Schneidemesser E, 2016, ATMOS ENVIRON, V135, P59, DOI 10.1016/j.atmosenv.2016.03.057; von Schneidemesser E, 2010, ATMOS ENVIRON, V44, P5053, DOI 10.1016/j.atmosenv.2010.09.010; Warneke C, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017899; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Wu XM, 2011, ENVIRON SCI TECHNOL, V45, P9075, DOI 10.1021/es202132u; Wu Y, 2017, ENVIRON SCI TECHNOL, V51, P4445, DOI 10.1021/acs.est.7b00655; Yang YD, 2016, ATMOS ENVIRON, V134, P147, DOI 10.1016/j.atmosenv.2016.03.010; Zhao YL, 2014, ENVIRON SCI TECHNOL, V48, P13743, DOI 10.1021/es5035188; Zotter P, 2014, J GEOPHYS RES-ATMOS, V119, P6818, DOI 10.1002/2013JD021114	62	468	479	53	523	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					760	764	aaq0524	10.1126/science.aaq0524	http://dx.doi.org/10.1126/science.aaq0524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449485				2022-12-28	WOS:000425116200037
J	Kitagawa, K; Takayama, T; Matsumoto, Y; Kato, A; Takano, R; Kishimoto, Y; Bette, S; Dinnebier, R; Jackeli, G; Takagi, H				Kitagawa, K.; Takayama, T.; Matsumoto, Y.; Kato, A.; Takano, R.; Kishimoto, Y.; Bette, S.; Dinnebier, R.; Jackeli, G.; Takagi, H.			A spin-orbital-entangled quantum liquid on a honeycomb lattice	NATURE			English	Article							STATE; EXCITATIONS	The honeycomb lattice is one of the simplest lattice structures. Electrons and spins on this simple lattice, however, often form exotic phases with non-trivial excitations. Massless Dirac fermions can emerge out of itinerant electrons, as demonstrated experimentally in graphene(1), and a topological quantum spin liquid with exotic quasiparticles can be realized in spin-1/2 magnets, as proposed theoretically in the Kitaev model(2). The quantum spin liquid is a long-sought exotic state of matter, in which interacting spins remain quantum-disordered without spontaneous symmetry breaking(3). The Kitaev model describes one example of a quantum spin liquid, and can be solved exactly by introducing two types of Majorana fermion(2). Realizing a Kitaev model in the laboratory, however, remains a challenge in materials science. Mott insulators with a honeycomb lattice of spin-orbital-entangled pseudospin-1/2 moments have been proposed(4), including the 5d-electron systems alpha-Na2IrO3 (ref. 5) and alpha-Li2IrO3 (ref. 6) and the 4d-electron system alpha-RuCl3 (ref.7). However, these candidates were found to magnetically order rather than form a liquid at sufficiently low temperatures(8-10), owing to non-Kitaev interactions(6,11-13). Here we report a quantum-liquid state of pseudospin-1/2 moments in the 5d-electron honeycomb compound H3LiIr2O6. This iridate does not display magnetic ordering down to 0.05 kelvin, despite an interaction energy of about 100 kelvin. We observe signatures of low-energy fermionic excitations that originate from a small number of spin defects in the nuclear-magnetic-resonance relaxation and the specific heat. We therefore conclude that H3LiIr2O6 is a quantum spin liquid. This result opens the door to finding exotic quasiparticles in a strongly spin-orbit-coupled 5d-electron transition-metal oxide.	[Kitagawa, K.; Kato, A.; Takano, R.; Takagi, H.] Univ Tokyo, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan; [Takayama, T.; Matsumoto, Y.; Bette, S.; Dinnebier, R.; Jackeli, G.; Takagi, H.] Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany; [Kishimoto, Y.] Kochi Univ, Grad Sch Integrated Arts & Sci, Akebonocho 2-5-1, Kochi 7808520, Japan; [Jackeli, G.; Takagi, H.] Univ Stuttgart, Inst Funct Matter & Quantum Technol, Pfaffenwaldring 57, D-70569 Stuttgart, Germany	University of Tokyo; Max Planck Society; Kochi University; University of Stuttgart	Takagi, H (corresponding author), Univ Tokyo, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.; Takagi, H (corresponding author), Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.; Takagi, H (corresponding author), Univ Stuttgart, Inst Funct Matter & Quantum Technol, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	h.takagi@fkf.mpg.de	Matsumoto, Yosuke/N-6566-2018; Jackeli, George/A-8637-2013; Takagi, Hidenori/B-2935-2010; TAKAGI, HIDENORI/Q-1041-2019; Kitagawa, Kentaro/AAI-5811-2021; Dinnebier, Robert/B-5642-2015	Matsumoto, Yosuke/0000-0001-8522-7113; Jackeli, George/0000-0002-1286-8718; TAKAGI, HIDENORI/0000-0001-5700-3761; Kitagawa, Kentaro/0000-0002-9535-0710; Dinnebier, Robert/0000-0003-2778-2113; Kato, Akihiko/0000-0001-5556-3845; Bette, Sebastian/0000-0003-3575-0517	Japan Society for the Promotion of Science (JSPS) [24224010, 26707018, 15K13523, JP15H05852, JP15K21717, 17H01140]; Alexander von Humboldt foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	We thank Y. Motome, M. Udagawa, R. Valenti, A. Gibbs, Y.B. Kim, A. Smerald and N. Shannon for discussions, and U. Wedig, Y. Ishikuro, T. Nishioka and S. Nakatsuji for experimental support and discussions. This work was partly supported by the Japan Society for the Promotion of Science (JSPS) KAKAENHI (numbers 24224010, 26707018, 15K13523, JP15H05852, JP15K21717 and 17H01140) and the Alexander von Humboldt foundation.	Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Banerjee A, 2016, NAT MATER, V15, P733, DOI [10.1038/NMAT4604, 10.1038/nmat4604]; Bette S, 2017, DALTON T, V46, P15216, DOI 10.1039/c7dt02978k; Bette S, 2015, J APPL CRYSTALLOGR, V48, P1706, DOI 10.1107/S1600576715017719; Chaloupka J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.027204; Choi SK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127204; Chun SH, 2015, NAT PHYS, V11, P462, DOI [10.1038/NPHYS3322, 10.1038/nphys3322]; Fu MX, 2015, SCIENCE, V350, P655, DOI 10.1126/science.aab2120; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; Harris RK, 2008, PURE APPL CHEM, V80, P59, DOI 10.1351/pac200880010059; Itou T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104413; Jackeli G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017205; Johnson RD, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.235119; Khuntia P, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.107203; Kim BJ, 2009, SCIENCE, V323, P1329, DOI 10.1126/science.1167106; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Mendels P, 2000, PHYS REV LETT, V85, P3496, DOI 10.1103/PhysRevLett.85.3496; Momma K, 2008, J APPL CRYSTALLOGR, V41, P653, DOI 10.1107/S0021889808012016; Nasu J, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.115122; O'Malley MJ, 2012, J MATER CHEM, V22, P7782, DOI [10.1039/c2jm16791, 10.1039/c2jm16791c]; Olariu A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.087202; Olariu A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167203; Plumb KW, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.041112; Rau JG, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.077204; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Singh Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127203; Singh Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064412; Takeya H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.054429; Tsujii H, 2003, PHYSICA B, V329, P1552, DOI 10.1016/S0921-4526(02)02291-3; Willans AJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115146; Williams SC, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.195158; Winter SM, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.214431; Yamashita M, 2010, SCIENCE, V328, P1246, DOI 10.1126/science.1188200; Ye F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180403; Yoshitake J, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.157203	36	214	219	16	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					341	+		10.1038/nature25482	http://dx.doi.org/10.1038/nature25482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29446382				2022-12-28	WOS:000424996300034
J	Ushio, M; Hsieh, CH; Masuda, R; Deyle, ER; Ye, H; Chang, CW; Sugihara, G; Kondoh, M				Ushio, Masayuki; Hsieh, Chih-hao; Masuda, Reiji; Deyle, Ethan R.; Ye, Hao; Chang, Chun-Wei; Sugihara, George; Kondoh, Michio			Fluctuating interaction network and time-varying stability of a natural fish community	NATURE			English	Article							FOOD-WEB; COMPLEX ECOSYSTEMS; WEAK-INTERACTIONS; POPULATION; DIVERSITY; STRENGTH; DYNAMICS; BEHAVIOR; SYSTEM; SERIES	Ecological theory suggests that large-scale patterns such as community stability can be influenced by changes in interspecific interactions that arise from the behavioural and/or physiological responses of individual species varying over time(1-3). Although this theory has experimental support(2,4,5),evidence from natural ecosystems is lacking owing to the challenges of tracking rapid changes in interspecific interactions (known to occur on timescales much shorter than a generation time)6 and then identifying the effect of such changes on large-scale community dynamics. Here, using tools for analysing nonlinear time series(6-9) and a 12-year-long dataset of fortnightly collected observations on a natural marine fish community in Maizuru Bay, Japan, we show that short-term changes in interaction networks influence overall community dynamics. Among the 15 dominant species, we identify 14 interspecific interactions to construct a dynamic interaction network. We show that the strengths, and even types, of interactions change with time; we also develop a time-varying stability measure based on local Lyapunov stability for attractor dynamics in non-equilibrium nonlinear systems. We use this dynamic stability measure to examine the link between the time-varying interaction network and community stability. We find seasonal patterns in dynamic stability for this fish community that broadly support expectations of current ecological theory. Specifically, the dominance of weak interactions and higher species diversity during summer months are associated with higher dynamic stability and smaller population fluctuations. We suggest that interspecific interactions, community network structure and community stability are dynamic properties, and that linking fluctuating interaction networks to community-level dynamic properties is key to understanding the maintenance of ecological communities in nature.	[Ushio, Masayuki; Kondoh, Michio] Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, Otsu, Shiga 5202194, Japan; [Ushio, Masayuki] Ryukoku Univ, Joint Res Ctr Sci & Technol, Otsu, Shiga 5202194, Japan; [Ushio, Masayuki] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Ushio, Masayuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Inst Ecol & Evolutionary Biol, Taipei 10617, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Dept Life Sci, Taipei 10617, Taiwan; [Hsieh, Chih-hao; Chang, Chun-Wei] Acad Sinica, Taiwan Int Grad Program, Earth Syst Sci Program, Taipei 11529, Taiwan; [Hsieh, Chih-hao; Chang, Chun-Wei] Natl Cent Univ, Taipei 11529, Taiwan; [Hsieh, Chih-hao] Natl Ctr Theoret Sci, Taipei 10617, Taiwan; [Masuda, Reiji] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto 6250086, Japan; [Deyle, Ethan R.; Ye, Hao; Sugihara, George] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Ye, Hao] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	Ryukoku University; Ryukoku University; Kyoto University; Japan Science & Technology Agency (JST); National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Central University; Kyoto University; University of California System; University of California San Diego; Scripps Institution of Oceanography; State University System of Florida; University of Florida	Ushio, M; Kondoh, M (corresponding author), Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, Otsu, Shiga 5202194, Japan.; Ushio, M (corresponding author), Ryukoku Univ, Joint Res Ctr Sci & Technol, Otsu, Shiga 5202194, Japan.; Ushio, M (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.; Ushio, M (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan.	ong8181@gmail.com; kondohmjp@icloud.com	Ushio, Masayuki/F-8667-2010; Ye, Hao/HGD-5399-2022; Kondoh, Michio/AAE-4332-2019; Deyle, Ethan R/AAR-8749-2021; Chang, Chun-Wei/ABF-3354-2021; Hsieh, Chih-hao/B-3797-2008	Ushio, Masayuki/0000-0003-4831-7181; Chang, Chun-Wei/0000-0002-9817-2956; Hsieh, Chih-hao/0000-0001-5935-7272; Ye, Hao/0000-0002-8630-1458	CREST, Japan Science and Technology Agency [JPMJCR13A2]; Japan Society for the Promotion of Science [15K14610, 16H04846]; Foundation for the Advancement of Outstanding Scholarship (Ministry of Science and Technology, Taiwan); DoD-Strategic Environmental Research and Development Program [15 RC-2509]; Lenfest Ocean Program [00028335]; NSF [DBI-1667584, DEB-1655203]; McQuown Fund; McQuown Chair in Natural Sciences (University of California, San Diego); Grants-in-Aid for Scientific Research [15K14610] Funding Source: KAKEN	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for the Advancement of Outstanding Scholarship (Ministry of Science and Technology, Taiwan); DoD-Strategic Environmental Research and Development Program; Lenfest Ocean Program; NSF(National Science Foundation (NSF)); McQuown Fund; McQuown Chair in Natural Sciences (University of California, San Diego); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank members of the Kondoh laboratory in Ryukoku University; F. Grziwotz, A. Telschow and T. Miki for discussions; S.-I. Nakayama for advice on the twin surrogate method; and T. Yoshida and M. Kasada for providing time series of the algae-rotifer system. This research was supported by CREST, grant number JPMJCR13A2, Japan Science and Technology Agency; KAKENHI grant number 15K14610 and 16H04846, Japan Society for the Promotion of Science; Foundation for the Advancement of Outstanding Scholarship (Ministry of Science and Technology, Taiwan); DoD-Strategic Environmental Research and Development Program 15 RC-2509; Lenfest Ocean Program 00028335; NSF DBI-1667584; NSF DEB-1655203; the McQuown Fund and the McQuown Chair in Natural Sciences (University of California, San Diego).	Allesina S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8842; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Chang CW, 2017, ECOL RES, V32, P785, DOI 10.1007/s11284-017-1469-9; Deyle ER, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2258; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; Deyle ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018295; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Downing AL, 2014, ECOLOGY, V95, P173, DOI 10.1890/12-1406.1; Gratton C, 2003, OECOLOGIA, V134, P487, DOI 10.1007/s00442-002-1137-8; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Jost C, 2000, P ROY SOC B-BIOL SCI, V267, P1611, DOI 10.1098/rspb.2000.1186; Kasada M, 2014, P NATL ACAD SCI USA, V111, P16035, DOI 10.1073/pnas.1406357111; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Masuda R, 2011, J FISH BIOL, V78, P1323, DOI 10.1111/j.1095-8649.2011.02936.x; Masuda R, 2010, FISH B-NOAA, V108, P162; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McMeans BC, 2015, TRENDS ECOL EVOL, V30, P662, DOI 10.1016/j.tree.2015.09.001; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Navarrete SA, 2006, ECOL LETT, V9, P526, DOI 10.1111/j.1461-0248.2006.00899.x; Reynolds PL, 2013, ECOL MONOGR, V83, P119, DOI 10.1890/11-2284.1; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; Tang S, 2014, ECOL LETT, V17, P1094, DOI 10.1111/ele.12312; Team RC., 2013, R LANG ENV STAT COMP; Thiel M, 2006, EUROPHYS LETT, V75, P535, DOI 10.1209/epl/i2006-10147-0; Veilleux B. G., 1976, THESIS; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; Wootton KL, 2016, THEOR ECOL-NETH, V9, P185, DOI 10.1007/s12080-015-0279-3; Ye H, 2015, P NATL ACAD SCI USA, V112, pE1569, DOI 10.1073/pnas.1417063112	34	100	105	22	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					360	+		10.1038/nature25504	http://dx.doi.org/10.1038/nature25504			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29414940				2022-12-28	WOS:000424996300038
J	Holen, SR; Demere, TA; Fisher, DC; Fullagar, R; Paces, JB; Jefferson, GT; Beeton, JM; Cerutti, RA; Rountrey, AN; Vescera, L; Holen, KA				Holen, Steven R.; Demere, Thomas A.; Fisher, Daniel C.; Fullagar, Richard; Paces, James B.; Jefferson, George T.; Beeton, Jared M.; Cerutti, Richard A.; Rountrey, Adam N.; Vescera, Lawrence; Holen, Kathleen A.			Contesting early archaeology in California Reply	NATURE			English	Letter							HAMMERSTONE PERCUSSION; BONES; TAPHONOMY; USA		[Holen, Steven R.; Demere, Thomas A.; Cerutti, Richard A.; Holen, Kathleen A.] San Diego Nat Hist Museum, Dept Paleontol, San Diego, CA 92101 USA; [Holen, Steven R.; Holen, Kathleen A.] Ctr Amer Paleolith Res, 27930 Cascade Rd, Hot Springs, SD USA; [Fisher, Daniel C.; Rountrey, Adam N.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Fisher, Daniel C.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Fullagar, Richard] Univ Wollongong, Fac Sci Med & Hlth, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW, Australia; [Paces, James B.] US Geol Survey, Geosci & Environm Change Sci Ctr, Box 25046, Denver, CO 80225 USA; [Jefferson, George T.; Vescera, Lawrence] Calif Dept Pk & Recreat, Stout Res Ctr, Borrego Springs, CA USA; [Beeton, Jared M.] Adams State Univ, Dept Earth Sci, Alamosa, CO USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Wollongong; United States Department of the Interior; United States Geological Survey	Demere, TA (corresponding author), San Diego Nat Hist Museum, Dept Paleontol, San Diego, CA 92101 USA.	tdemere@sdnhm.org	Fullagar, Richard/AAT-1155-2020	Demere, Thomas/0000-0001-5464-3528; Fullagar, Richard/0000-0003-1047-1466				CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Ferraro JV, 2018, NATURE, V554, pE1, DOI 10.1038/nature25165; Haynes G, 2017, QUATERN INT, V445, P171, DOI 10.1016/j.quaint.2016.02.034; Holen S. R., 2017, PALEOAMERICA; Holen SR, 2017, NATURE, V544, P479, DOI 10.1038/nature22065; Karr LP, 2015, QUATERN INT, V361, P332, DOI 10.1016/j.quaint.2013.12.017; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Wiest LA, 2016, PALAIOS, V31, P592, DOI 10.2110/palo.2016.053	8	2	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					E3	E3		10.1038/nature25166	http://dx.doi.org/10.1038/nature25166			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420475				2022-12-28	WOS:000424332600002
J	Farsides, B				Farsides, Bobbie			Commentary: Palliative care and assisted dying are not mutually exclusive	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Farsides, Bobbie] Univ Sussex, Clin & Biomed Eth, Brighton, E Sussex, England	University of Sussex	Farsides, B (corresponding author), Univ Sussex, Clin & Biomed Eth, Brighton, E Sussex, England.	B.Farsides@bsms.ac.uk		Farsides, Bobbie/0000-0002-5477-0612				Farsides B, 1998, J MED ETHICS, V24, P149, DOI 10.1136/jme.24.3.149; Ipsos MORI, 2015, PUBL ATT ASS DYING	2	3	3	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2018	360								k544	10.1136/bmj.k544	http://dx.doi.org/10.1136/bmj.k544			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HY	29437643				2022-12-28	WOS:000424975900012
J	Lee, JH				Lee, Je H.			Tracing single-cell histories	SCIENCE			English	Editorial Material							MUTATIONAL PROCESSES		[Lee, Je H.] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Lee, JH (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	jlee@cshl.edu			NCI NIH HHS [P30 CA045508] Funding Source: Medline; NIGMS NIH HHS [R35 GM119772] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119772] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Bae T, 2018, SCIENCE, V359, P550, DOI 10.1126/science.aan8690; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Chen CY, 2017, SCIENCE, V356, P189, DOI 10.1126/science.aak9787; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Lodato MA, 2018, SCIENCE, V359, P555, DOI 10.1126/science.aao4426; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Shipman SL, 2017, NATURE, V547, P345, DOI 10.1038/nature23017	15	1	1	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					521	522		10.1126/science.aar6335	http://dx.doi.org/10.1126/science.aar6335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420280	Green Accepted			2022-12-28	WOS:000423795800025
J	Mall, A; Sobotta, J; Huber, C; Tschirner, C; Kowarschik, S; Bacnik, K; Mergelsberg, M; Boll, M; Hugler, M; Eisenreich, W; Berg, IA				Mall, Achim; Sobotta, Jessica; Huber, Claudia; Tschirner, Carolin; Kowarschik, Stefanie; Bacnik, Katarina; Mergelsberg, Mario; Boll, Matthias; Huegler, Michael; Eisenreich, Wolfgang; Berg, Ivan A.			Reversibility of citrate synthase allows autotrophic growth of a thermophilic bacterium	SCIENCE			English	Article							DESULFUROMONAS-ACETOXIDANS; DESULFURELLA-ACETIVORANS; CLEAVAGE REACTION; LYASE; FIXATION; ACETATE; ENZYME; CYCLE; ATP; CATABOLISM	Biological inorganic carbon fixation proceeds through a number of fundamentally different autotrophic pathways that are defined by specific key enzymatic reactions. Detection of the enzymatic genes in (meta) genomes is widely used to estimate the contribution of individual organisms or communities to primary production. Here we show that the sulfur-reducing anaerobic deltaproteobacterium Desulfurella acetivorans is capable of both acetate oxidation and autotrophic carbon fixation, with the tricarboxylic acid cycle operating either in the oxidative or reductive direction, respectively. Under autotrophic conditions, the enzyme citrate synthase cleaves citrate adenosine triphosphate independently into acetyl coenzyme A and oxaloacetate, a reaction that has been regarded as impossible under physiological conditions. Because this overlooked, energetically efficient carbon fixation pathway lacks key enzymes, it may function unnoticed in many organisms, making bioinformatical predictions difficult, if not impossible.	[Mall, Achim; Tschirner, Carolin; Kowarschik, Stefanie; Bacnik, Katarina; Mergelsberg, Mario; Boll, Matthias; Berg, Ivan A.] Albert Ludwigs Univ Freiburg, Fak Biol, Mikrobiol, D-79104 Freiburg, Germany; [Mall, Achim; Berg, Ivan A.] Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany; [Sobotta, Jessica; Huber, Claudia; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85748 Munich, Germany; [Huegler, Michael] DVGW Technol Zentrum Wasser TZW, Dept Microbiol & Mol Biol, D-76139 Karlsruhe, Germany	University of Freiburg; University of Munster; Technical University of Munich	Berg, IA (corresponding author), Albert Ludwigs Univ Freiburg, Fak Biol, Mikrobiol, D-79104 Freiburg, Germany.; Berg, IA (corresponding author), Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany.; Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Biochem, D-85748 Munich, Germany.	wolfgang.eisenreich@mytum.de; ivan.berg@uni-muenster.de	Eisenreich, Wolfgang/A-1258-2013; Hügler, Michael/A-9155-2018; Berg, Ivan/AAZ-3917-2020	Eisenreich, Wolfgang/0000-0002-9832-8279; Hügler, Michael/0000-0002-2820-0333; Tschirner, Carolin/0000-0002-5557-2044; Mall, Achim/0000-0002-6681-2381; Bacnik, Katarina/0000-0002-2092-2518	Deutsche Forschungsgemeinschaft [BE 4822/5-1]; Deutsche Forschungsgemeinschaft (Heisenberg Fellowship) [BE 4822/1-2]; Hans-Fischer Gesellschaft (Munich)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Heisenberg Fellowship)(German Research Foundation (DFG)); Hans-Fischer Gesellschaft (Munich)	We thank G. Fuchs, Albert-Ludwigs-Universitat Freiburg, for his support, discussions, and suggestions during this work and for critical reading of the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (grant BE 4822/5-1 and Heisenberg Fellowship BE 4822/1-2 to I.A.B.). We also thank the Hans-Fischer Gesellschaft (Munich) for financial support. All data to understand and assess the conclusions of this research are available in the main text, supplementary materials, and the GenBank database (www.ncbi.nlm.nih.gov/Genbank/). The genome sequences of D. acetivorans and D. multipotens are deposited under GenBank accession numbers CP007051.1 and PRJNA262210, respectively. Amino acid sequences of candidate enzymes are available under their respective GenBank accession numbers (see Table 1 and table S1).	Aoshima M, 2004, MOL MICROBIOL, V52, P763, DOI 10.1111/j.1365-2958.2004.04010.x; Aoshima M, 2004, MOL MICROBIOL, V52, P751, DOI 10.1111/j.1365-2958.2004.04009.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; BONCHOSMOLOVSKAYA EA, 1990, ARCH MICROBIOL, V153, P151, DOI 10.1007/BF00247813; Chernyh NA, 2015, EXTREMOPHILES, V19, P1157, DOI 10.1007/s00792-015-0787-5; Florentino AP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00222; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; GUYNN RW, 1973, J BIOL CHEM, V248, P6957; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; IVANOVSKY RN, 1980, ARCH MICROBIOL, V128, P239, DOI 10.1007/BF00406165; Keller MA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0083; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; MOLLER D, 1987, ARCH MICROBIOL, V148, P202, DOI 10.1007/BF00414812; PAULSEN J, 1986, ARCH MICROBIOL, V144, P78, DOI 10.1007/BF00454960; Pradella S, 1998, FEMS MICROBIOL LETT, V159, P137, DOI 10.1111/j.1574-6968.1998.tb12852.x; Proudfoot Alex T, 2006, Toxicol Rev, V25, P213, DOI 10.2165/00139709-200625040-00002; SCHMITZ RA, 1990, ARCH MICROBIOL, V154, P274, DOI 10.1007/BF00248967; SIESS EA, 1984, BIOCHEM J, V218, P171, DOI 10.1042/bj2180171; SIESS EA, 1978, H-S Z PHYSIOL CHEM, V359, P785, DOI 10.1515/bchm2.1978.359.2.785; Smith E, 2004, P NATL ACAD SCI USA, V101, P13168, DOI 10.1073/pnas.0404922101; Tang KH, 2010, J BIOL CHEM, V285, P35848, DOI 10.1074/jbc.M110.157834; THAUER RK, 1989, ANNU REV MICROBIOL, V43, P43, DOI 10.1146/annurev.mi.43.100189.000355; THAUER RK, 1970, FEBS LETT, V9, P271, DOI 10.1016/0014-5793(70)80374-X; Turova T P, 2014, Mikrobiologiia, V83, P72; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200	28	79	82	13	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					563	567		10.1126/science.aao2410	http://dx.doi.org/10.1126/science.aao2410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420287				2022-12-28	WOS:000423795800039
J	Nobeli, I				Nobeli, Irene			In praise of slow	SCIENCE			English	Editorial Material								I huff and puff my way up the moderate slope. Even by my own abysmal standards, this is a poor run. In the past hour, I have been overtaken by both an octogenarian and a mum pushing her toddlers in a buggy. Yet I am smiling. I am a happy runner, despite my utter mediocrity at this sport. But at work, happiness had become elusive. After a relatively relaxed Ph.D. and postdoc, I had been thrilled when I landed a tenured job. But as I worked to establish myself as a group leader, I began to feel intense pressure to be more competitive and publish more. Recently, as I wondered why I felt so discontented at my job, I realized that I could apply some lessons from running to my research.	[Nobeli, Irene] Birkbeck Univ London, London, England	University of London; Birkbeck University London	Nobeli, I (corresponding author), Birkbeck Univ London, London, England.	SciCareerEditor@aaas.org		Nobeli, Irene/0000-0001-8616-170X					0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					602	602		10.1126/science.359.6375.602	http://dx.doi.org/10.1126/science.359.6375.602			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420294				2022-12-28	WOS:000423795800047
J	Adelborg, K; Szepligeti, SK; Holland-Bill, L; Ehrenstein, V; Horvath-Puho, E; Henderson, VW; Sorensen, HT				Adelborg, Kasper; Szepligeti, Szimonetta Komjathine; Holland-Bill, Louise; Ehrenstein, Vera; Horvath-Puho, Erzsebet; Henderson, Victor W.; Sorensen, Henrik Toft			Migraine and risk of cardiovascular diseases: Danish population based matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VENOUS THROMBOEMBOLISM; HEART-DISEASE; STROKE; HEADACHE; BURDEN; EPIDEMIOLOGY; METAANALYSIS; PREVALENCE; QUALITY; UPDATE	OBJECTIVE To examine the risks of myocardial infarction, stroke (ischaemic and haemorrhagic), peripheral artery disease, venous thromboembolism, atrial fibrillation or atrial flutter, and heart failure in patients with migraine and in a general population comparison cohort. DESIGN Nationwide, population based cohort study. SETTING All Danish hospitals and hospital outpatient clinics from 1995 to 2013. PARTICIPANTS 51 032 patients with migraine and 510 320 people from the general population matched on age, sex, and calendar year. MAIN OUTCOME MEASURES Comorbidity adjusted hazard ratios of cardiovascular outcomes based on Cox regression analysis. RESULTS Higher absolute risks were observed among patients with incident migraine than in the general population across most outcomes and follow-up periods. After 19 years of follow-up, the cumulative incidences per 1000 people for the migraine cohort compared with the general population were 25 v 17 for myocardial infarction, 45 v 25 for ischaemic stroke, 11 v 6 for haemorrhagic stroke, 13 v 11 for peripheral artery disease, 27 v 18 for venous thromboembolism, 47 v 34 for atrial fibrillation or atrial flutter, and 19 v 18 for heart failure. Correspondingly, migraine was positively associated with myocardial infarction (adjusted hazard ratio 1.49, 95% confidence interval 1.36 to 1.64), ischaemic stroke (2.26, 2.11 to 2.41), and haemorrhagic stroke (1.94, 1.68 to 2.23), as well as venous thromboembolism (1.59, 1.45 to 1.74) and atrial fibrillation or atrial flutter (1.25, 1.16 to 1.36). No meaningful association was found with peripheral artery disease (adjusted hazard ratio 1.12, 0.96 to 1.30) or heart failure (1.04, 0.93 to 1.16). The associations, particularly for stroke outcomes, were stronger during the short term (0-1 years) after diagnosis than the long term (up to 19 years), in patients with aura than in those without aura, and in women than in men. In a subcohort of patients, the associations persisted after additional multivariable adjustment for body mass index and smoking. CONCLUSIONS Migraine was associated with increased risks of myocardial infarction, ischaemic stroke, haemorrhagic stroke, venous thromboembolism, and atrial fibrillation or atrial flutter. Migraine may be an important risk factor for most cardiovascular diseases.	[Adelborg, Kasper; Szepligeti, Szimonetta Komjathine; Holland-Bill, Louise; Ehrenstein, Vera; Horvath-Puho, Erzsebet; Henderson, Victor W.; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Henderson, Victor W.; Sorensen, Henrik Toft] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Henderson, Victor W.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Aarhus University; Stanford University; Stanford University	Adelborg, K (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	kade@clin.au.dk	Henderson, V/AAW-4744-2021; Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Holland-Bill, Louise/0000-0002-6329-4566; Ehrenstein, Vera/0000-0002-3415-3254; Horvath-Puho, Erzsebet/0000-0002-3594-2212	Aarhus University; Program for Clinical Research Infrastructure (PROCRIN); Novo Nordisk Foundation	Aarhus University; Program for Clinical Research Infrastructure (PROCRIN); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Aarhus University and the Program for Clinical Research Infrastructure (PROCRIN), established by the Lundbeck Foundation and the Novo Nordisk Foundation, funded the study. The sponsors had no role in study design, data collection, analysis or interpretation of the data, or writing of the manuscript or in the decision to submit the paper for publication. All authors had full access to the study data and had final responsibility for the decision to submit for publication.	Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2009, NEUROLOGY, V72, P1864, DOI 10.1212/WNL.0b013e3181a71220; Bigal Marcelo E, 2004, Curr Neurol Neurosci Rep, V4, P98, DOI 10.1007/s11910-004-0022-8; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Bushnell CD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b664; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Eikermann-Haerter K, 2012, CIRCULATION, V125, P335, DOI 10.1161/CIRCULATIONAHA.111.045096; Harriott AM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0530-8; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Jesurum JT, 2012, HEADACHE, V52, P1207, DOI 10.1111/j.1526-4610.2012.02143.x; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Knudsen LB, 1998, DAN MED BULL, V45, P320; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Kurth T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a636; Kurth T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2610; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Leonardi Matilde, 2005, J Headache Pain, V6, P429, DOI 10.1007/s10194-005-0252-4; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; National Institute for Health and Care Excellence, 2015, HEAD 12S DIAGN MAN; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Peng KP, 2016, HEADACHE, V56, P1290, DOI 10.1111/head.12885; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; Roberto G, 2015, CEPHALALGIA, V35, P118, DOI 10.1177/0333102414550416; Sacco S, 2015, EUR J NEUROL, V22, P1001, DOI 10.1111/ene.12701; Sacco S, 2008, J HEADACHE PAIN, V9, P237, DOI 10.1007/s10194-008-0048-4; Sacco S, 2013, STROKE, V44, P3032, DOI 10.1161/STROKEAHA.113.002465; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schmidt M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3450; Schurks Markus, 2009, BMJ, V339, pb3914, DOI 10.1136/bmj.b3914; Schwaiger J, 2008, NEUROLOGY, V71, P937, DOI 10.1212/01.wnl.0000325918.48056.75; Schwerzmann M, 2005, NEUROLOGY, V65, P1415, DOI 10.1212/01.wnl.0000179800.73706.20; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Tietjen GE, 2009, CEPHALALGIA, V29, P989, DOI 10.1111/j.1468-2982.2009.01937.x; Timm FP, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6635; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Ungprasert P, 2015, RHEUMATOLOGY, V54, P736, DOI 10.1093/rheumatology/keu408; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	40	129	132	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2018	360								k96	10.1136/bmj.k96	http://dx.doi.org/10.1136/bmj.k96			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TQ	29386181	hybrid, Green Published			2022-12-28	WOS:000423845900017
J	Pollock, AM; Roderick, P				Pollock, Allyson M.; Roderick, Peter			Why we should be concerned about accountable care organisations in England's NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pollock, Allyson M.; Roderick, Peter] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Pollock, AM (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.	allyson.pollock@newcastle.ac.uk						[Anonymous], 2000, NON TRADITIONAL REF; Blackstone EA, 2016, AM HEALTH DRUG BENEF, V9, P11; Department of Health, 2017, ACC CAR MOD CONTR PR; Douven R, 2015, HEALTH AFFAIR, V34, P143, DOI 10.1377/hlthaff.2014.0444; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Gifford GA, 2004, HEALTH CARE FINANC R, V26, P21; Iacobucci G, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k412; Moberly T, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4105; NHS, COMM HDB LIB COMM CY; NHS England, NHS STAND C IN PRESS; NHS England, 2017, PARAGRAPH; NHS England, 2016, TECHN GUID ALL FORM; NHS England, 2013, TACKL LIST INFL PRIM; NHS England, 2017, WHOL POP MOD PROV ES; RCGP, PRINC COMM; SUTARIA S, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J4279.28954738; UK Government, CONTR FIND MULT COMM; UK Government, 2012, STAT GUID JOINT STRA	18	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2018	360								k343	10.1136/bmj.k343	http://dx.doi.org/10.1136/bmj.k343			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TM	29382656	Green Published			2022-12-28	WOS:000423845500001
J	Gootenberg, JS; Abudayyeh, OO; Kellner, MJ; Joung, J; Collins, JJ; Zhang, F				Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Kellner, Max J.; Joung, Julia; Collins, James J.; Zhang, Feng			Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6	SCIENCE			English	Article							THERMOPHILUS; CRISPR-CAS13; CLEAVAGE; IMMUNITY; SYSTEMS	Rapid detection of nucleic acids is integral for clinical diagnostics and biotechnological applications. We recently developed a platform termed SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) that combines isothermal preamplification with Cas13 to detect single molecules of RNA or DNA. Through characterization of CRISPR enzymology and application development, we report here four advances integrated into SHERLOCK version 2 (SHERLOCKv2) (i) four-channel single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar; (iii) 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme; and (iv) lateral-flow readout. SHERLOCKv2 can detect Dengue or Zika virus single-stranded RNA as well as mutations in patient liquid biopsy samples via lateral flow, highlighting its potential as a multiplexable, portable, rapid, and quantitative detection platform of nucleic acids.	[Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Kellner, Max J.; Joung, Julia; Collins, James J.; Zhang, Feng] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Joung, Julia; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Joung, Julia; Zhang, Feng] MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Joung, Julia; Collins, James J.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Abudayyeh, Omar O.; Collins, James J.] MIT, Dept Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Zhang, F (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org	Joung, Julia/HCH-8944-2022; Macrae, Rhiannon/AAX-1536-2020; Gootenberg, Jonathan/AAY-8174-2021; Abudayyeh, Omar/ABF-1746-2020	Gootenberg, Jonathan/0000-0003-2757-2175; Abudayyeh, Omar/0000-0002-7979-3220	Paul and Daisy Soros Fellowship; NIH F30 National Research Service Award [1F30-CA210382]; Defense Threat Reduction Agency [HDTRA1-14-1-0006]; Paul G. Allen Frontiers Group; Wyss Institute; NIH [1R01-HG009761, 1R01-MH110049, 1DP1-HL141201]; Howard Hughes Medical Institute; New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Poitras Center for Affective Disorders Research at MIT; Hock E. Tan and K. Lisa Yang Center for Autism Research at MIT; Skolkovo Institute of Science and Technology; NATIONAL CANCER INSTITUTE [F30CA210382] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL141201] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009761, RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049] Funding Source: NIH RePORTER	Paul and Daisy Soros Fellowship; NIH F30 National Research Service Award; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Paul G. Allen Frontiers Group; Wyss Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Poitras Center for Affective Disorders Research at MIT; Hock E. Tan and K. Lisa Yang Center for Autism Research at MIT; Skolkovo Institute of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	O.O.A. is supported by a Paul and Daisy Soros Fellowship and a NIH F30 National Research Service Award 1F30-CA210382. J.J.C. is supported by the Defense Threat Reduction Agency grant HDTRA1-14-1-0006, the Paul G. Allen Frontiers Group, and the Wyss Institute. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by NIH grants (1R01-HG009761, 1R01-MH110049, and 1DP1-HL141201); the Howard Hughes Medical Institute; the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; the Poitras Center for Affective Disorders Research at MIT; the Hock E. Tan and K. Lisa Yang Center for Autism Research at MIT; the Skolkovo Institute of Science and Technology; and J. and P. Poitras, R. Metcalfe, and D. Cheng.	Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Barletta JM, 2004, AM J CLIN PATHOL, V122, P20, DOI 10.1309/529T2WDNEB6X8VUN; Chen J. S., 2017, BIORXIV PREPRINT; COTTRELL S, 1992, LANCET, V340, P626, DOI 10.1016/0140-6736(92)92169-G; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; UNAIDS WHO., 2009, GUID US HIV TEST TEC, P42; Zhao WA, 2008, ANAL CHEM, V80, P8431, DOI 10.1021/ac801008q; Zhao WA, 2008, SMALL, V4, P810, DOI 10.1002/smll.200700757	24	944	1023	145	886	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					439	+		10.1126/science.aaq0179	http://dx.doi.org/10.1126/science.aaq0179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29449508	Green Accepted, Green Submitted			2022-12-28	WOS:000430949600043
J	Kudo, M; Finn, RS; Qin, S; Han, KH; Ikeda, K; Piscaglia, F; Baron, A; Park, JW; Han, G; Jassem, J; Blanc, JF; Vogel, A; Komov, D; Evans, TRJ; Lopez, C; Dutcus, C; Guo, M; Saito, K; Kraljevic, S; Tamai, T; Ren, M; Cheng, AL				Kudo, Masatoshi; Finn, Richard S.; Qin, Shukui; Han, Kwang-Hyub; Ikeda, Kenji; Piscaglia, Fabio; Baron, Ari; Park, Joong-Won; Han, Guohong; Jassem, Jacek; Blanc, Jean Frederic; Vogel, Arndt; Komov, Dmitry; Evans, T. R. Jeffry; Lopez, Carlos; Dutcus, Corina; Guo, Matthew; Saito, Kenichi; Kraljevic, Silvija; Tamai, Toshiyuki; Ren, Min; Cheng, Ann-Lii			Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial	LANCET			English	Article							HEPATIC ARTERIAL INFUSION; KINASE INHIBITOR; SOLID TUMORS; LIVER-CANCER; III TRIAL; MRECIST; E7080; CHEMOTHERAPY; VALIDATION; SURVIVAL	Background In a phase 2 trial, lenvatinib, an inhibitor of VEGF receptors 1-3, FGF receptors 1-4, PDGF receptor a, RET, and KIT, showed activity in hepatocellular carcinoma. We aimed to compare overall survival in patients treated with lenvatinib versus sorafenib as a first-line treatment for unresectable hepatocellular carcinoma. Methods This was an open-label, phase 3, multicentre, non-inferiority trial that recruited patients with unresectable hepatocellular carcinoma, who had not received treatment for advanced disease, at 154 sites in 20 countries throughout the Asia-Pacific, European, and North American regions. Patients were randomly assigned (1:1) via an interactive voice-web response system-with region; macroscopic portal vein invasion, extrahepatic spread, or both; Eastern Cooperative Oncology Group performance status; and bodyweight as stratification factors-to receive oral lenvatinib (12 mg/day for bodyweight >= 60 kg or 8 mg/day for bodyweight <60 kg) or sorafenib 400 mg twice-daily in 28-day cycles. The primary endpoint was overall survival, measured from the date of randomisation until the date of death from any cause. The efficacy analysis followed the intention-to-treat principle, and only patients who received treatment were included in the safety analysis. The non-inferiority margin was set at 1.08. The trial is registered with ClinicalTrials. gov, number NCT01761266. Findings Between March 1, 2013 and July 30, 2015, 1492 patients were recruited. 954 eligible patients were randomly assigned to lenvatinib (n=478) or sorafenib (n=476). Median survival time for lenvatinib of 13.6 months (95% CI 12.1-14.9) was non-inferior to sorafenib (12.3 months, 10.4-13.9; hazard ratio 0.92, 95% CI 0.79-1.06), meeting criteria for non-inferiority. The most common any-grade adverse events were hypertension (201 [42%]), diarrhoea (184 [39%]), decreased appetite (162 [34%]), and decreased weight (147 [31%]) for lenvatinib, and palmar-plantar erythrodysaesthesia (249 [52%]), diarrhoea (220 [46%]), hypertension (144 [30%]), and decreased appetite (127 [27%]) for sorafenib. Interpretation Lenvatinib was non-inferior to sorafenib in overall survival in untreated advanced hepatocellular carcinoma. The safety and tolerability profiles of lenvatinib were consistent with those previously observed. Funding Eisai Inc.	[Kudo, Masatoshi] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 337-2 Ohno Higashi, Osaka, Japan; [Finn, Richard S.] Univ Calif Los Angeles, Geffen Sch Med, Santa Monica, CA USA; [Qin, Shukui] Nanjing Bayi Hosp, Nanjing, Jiangsu, Peoples R China; [Han, Kwang-Hyub] Yonsei Univ, Severance Hosp, Seoul, South Korea; [Ikeda, Kenji] Toranomon Gen Hosp, Tokyo, Japan; [Piscaglia, Fabio] Univ Bologna, Bologna, Italy; [Baron, Ari] Calif Pacific Med Ctr, San Francisco, CA USA; [Park, Joong-Won] Natl Canc Ctr Korea, Goyang Si, South Korea; [Han, Guohong] Fourth Mil Med Univ, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Jassem, Jacek] Med Univ Gdansk, Gdansk, Poland; [Blanc, Jean Frederic] Univ Bordeaux, Bordeaux, France; [Vogel, Arndt] Hannover Med Sch, Hannover, Germany; [Komov, Dmitry] NN Blokhin Canc Res Ctr, Moscow, Russia; [Evans, T. R. Jeffry] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Lopez, Carlos] Marques de Valdecilla Univ Hosp, Santander, Spain; [Dutcus, Corina; Guo, Matthew; Saito, Kenichi; Tamai, Toshiyuki; Ren, Min] Eisai, Woodcliff Lake, NJ USA; [Kraljevic, Silvija] Eisai, Hatfield, Herts, England; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Taipei, Taiwan	Kindai University (Kinki University); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nanjing University of Chinese Medicine; Yonsei University; Yonsei University Health System; Toranomon Hospital; University of Bologna; California Pacific Medical Center; National Cancer Center - Korea (NCC); Air Force Military Medical University; Fahrenheit Universities; Medical University Gdansk; UDICE-French Research Universities; Universite de Bordeaux; Hannover Medical School; N.N. Blokhin Russian Cancer Research Center; Beatson Oncology Centre; University of Glasgow; Hospital Universitario Marques de Valdecilla (HUMV); Eisai Co Ltd; Eisai Co Ltd; National Taiwan University; National Taiwan University Hospital	Kudo, M (corresponding author), Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 337-2 Ohno Higashi, Osaka, Japan.	m-kudo@med.kindai.ac.jp	Piscaglia, Fabio/GRY-4468-2022; Kudo, Masatoshi/AAA-9744-2019; Vogel, Arndt/A-8437-2012; Piscaglia, Fabio/AAC-6899-2022	Piscaglia, Fabio/0000-0001-8264-1845; Kudo, Masatoshi/0000-0002-4102-3474; Piscaglia, Fabio/0000-0001-8264-1845; LOPEZ LOPEZ, CARLOS/0000-0002-8901-741X; Jassem, Jacek/0000-0002-8875-6747; Vogel, Arndt/0000-0003-0560-5538	Eisai Inc.; Eisai Inc; Cancer Research UK [11650, 12946] Funding Source: researchfish; Versus Arthritis [20409] Funding Source: researchfish	Eisai Inc.(Eisai Co Ltd); Eisai Inc(Eisai Co Ltd); Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis)	Eisai Inc.; We thank the patients, their families, the investigators, and the teams who participated in this trial, and Terri Binder (Eisai Inc., Woodcliff Lake, NJ, USA) for overseeing the independent image review. Editorial assistance was provided by Nicolette Belletier of Oxford PharmaGenesis (funded by Eisai Inc).	Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Boss DS, 2012, BRIT J CANCER, V106, P1598, DOI 10.1038/bjc.2012.154; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chie WC, 2012, HEPATOLOGY, V55, P1122, DOI 10.1002/hep.24798; Cocks K, 2011, J CLIN ONCOL, V29, P89, DOI 10.1200/JCO.2010.28.0107; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Giesinger JM, 2016, J CLIN EPIDEMIOL, V69, P79, DOI 10.1016/j.jclinepi.2015.08.007; Ikeda K, 2017, J GASTROENTEROL, V52, P512, DOI 10.1007/s00535-016-1263-4; Ikeda M, 2016, CLIN CANCER RES, V22, P1385, DOI 10.1158/1078-0432.CCR-15-1354; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kudo M, 2014, LIVER CANCER, V3, P458, DOI 10.1159/000343875; Lencioni R, 2017, J HEPATOL, V66, P1166, DOI 10.1016/j.jhep.2017.01.012; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Matsui J, 2008, CLIN CANCER RES, V14, P5459, DOI 10.1158/1078-0432.CCR-07-5270; Matsui J, 2008, INT J CANCER, V122, P664, DOI 10.1002/ijc.23131; Meyer T, 2017, LIVER INT, V37, P1047, DOI 10.1111/liv.13359; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; National Cancer Institute, PROT DEV CANC THER E; NCCN, 2017, CLIN PRACT GUID ONC; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Shao YY, 2013, LIVER INT, V33, P1413, DOI 10.1111/liv.12207; Tamai T, 2017, J CLIN PHARMACOL, V57, P1138, DOI 10.1002/jcph.917; Terashima T, 2014, HEPATOL RES, V44, P1179, DOI 10.1111/hepr.12266; Tohyama O, 2014, J THROID RES, V2014, DOI 10.1155/2014/638747; Yamamoto Y, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-18; Zhu AX, 2015, J CLIN ONCOL, V33, P559, DOI 10.1200/JCO.2013.53.7746	33	2298	2434	38	330	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1163	1173		10.1016/S0140-6736(18)30207-1	http://dx.doi.org/10.1016/S0140-6736(18)30207-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA2MF	29433850	Green Accepted			2022-12-28	WOS:000428156100028
J	Holbrook, A				Holbrook, Anne			In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK		[Holbrook, Anne] McMaster Univ, Hamilton, ON, Canada	McMaster University	Holbrook, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Ho LJ, 2015, BIOCHEM PHARMACOL, V97, P16, DOI 10.1016/j.bcp.2015.06.009; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Solomon DH, 2012, ARTHRITIS RHEUM-US, V64, P21, DOI 10.1002/art.30653	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC23	JC23		10.7326/ACPJC-2018-168-4-023	http://dx.doi.org/10.7326/ACPJC-2018-168-4-023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459960				2022-12-28	WOS:000425434000011
J	Patel, T; Patel, V				Patel, Tejas; Patel, Vihas			Review: DOACs reduce intracranial hemorrhage more than warfarin in AF with chronic kidney disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Patel, Tejas] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Patel, Vihas] Zucker Sch Med Hofstra Northwell, New Hyde Pk, NY USA	Icahn School of Medicine at Mount Sinai	Patel, T (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Charytan DM, 2016, CLIN J AM SOC NEPHRO, V11, P721, DOI 10.2215/CJN.09350915; Nigwekar SU, 2017, J AM SOC NEPHROL, V28, P1717, DOI 10.1681/ASN.2016060651	2	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC18	JC18		10.7326/ACPJC-2018-168-4-018	http://dx.doi.org/10.7326/ACPJC-2018-168-4-018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459955				2022-12-28	WOS:000425434000006
J	Zar, FA				Zar, Fred Arthur			Guideline: Recommendations are provided for antiretroviral therapies in pregnant women with HIV	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSMISSION; PREVENTION		[Zar, Fred Arthur] Univ Illinois, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zar, FA (corresponding author), Univ Illinois, Chicago, IL 60607 USA.							Chaisilwattana P, 2002, CLIN INFECT DIS, V35, P1405, DOI 10.1086/344274; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Nachega JB, 2017, JAIDS-J ACQ IMM DEF, V76, P1, DOI 10.1097/QAI.0000000000001359; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG AD AD; Panel on Treatment of HIV-lnfected Pregnant Women and Prevention of Perinatal Transmission, 2016, REC US ANT DRUGS PRE; World Health Organization, 2016, CONS GUID US ANT DRU	7	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC14	JC14		10.7326/ACPJC-2018-168-4-014	http://dx.doi.org/10.7326/ACPJC-2018-168-4-014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459951				2022-12-28	WOS:000425434000002
J	Johns, DM; Oppenheimer, GM				Johns, David Merritt; Oppenheimer, Gerald M.			Was there ever really a "sugar conspiracy"?	SCIENCE			English	Editorial Material							INDUSTRY; NUTRITION; COMMITTEE; DISEASE		[Johns, David Merritt; Oppenheimer, Gerald M.] Columbia Univ, Dept Sociomed Sci, New York, NY 10027 USA; [Oppenheimer, Gerald M.] CUNY, Sch Publ Hlth, New York, NY 10021 USA	Columbia University; City University of New York (CUNY) System	Johns, DM (corresponding author), Columbia Univ, Dept Sociomed Sci, New York, NY 10027 USA.	dmj2119@columbia.edu						Glantz SA, 1998, CIGARETTE PAPERS; Jacobson M. F., 1981, J SPRATS LEGACY SCI, P16; Johns D. M., 2016, COMMUNICATION; Kearns CE, 2016, JAMA INTERN MED, V176, P1680, DOI 10.1001/jamainternmed.2016.5394; Leslie I., 2016, GUARDIAN; Lustig R. H., 2013, PURE WHITE DEADLY SU, P12; MCGANDY RB, 1967, NEW ENGL J MED, V277, P186, DOI 10.1056/NEJM196707272770405; Nestle M, 2016, JAMA INTERN MED, V176, P1685, DOI 10.1001/jamainternmed.2016.5400; Oppenheimer GM, 2014, AM J PUBLIC HEALTH, V104, P59, DOI 10.2105/AJPH.2013.301464; PAGE IH, 1961, CIRCULATION, V23, P133, DOI 10.1161/01.CIR.23.1.133; Platt L., 1970, LANCET, V7686, P1265; Stare F. J., 1991, ADVENTURES NUTR; Taubes G., 2017, LIVIN VIDA LOW CARB; YUDKIN J, 1964, LANCET, V2, P6	14	24	24	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					747	750	aaq1618	10.1126/science.aaq1618	http://dx.doi.org/10.1126/science.aaq1618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449481				2022-12-28	WOS:000425116200030
J	Winfree, R; Reilly, JR; Bartomeus, I; Cariveau, DP; Williams, NM; Gibbs, J				Winfree, Rachael; Reilly, James R.; Bartomeus, Ignasi; Cariveau, Daniel P.; Williams, Neal M.; Gibbs, Jason			Species turnover promotes the importance of bee diversity for crop pollination at regional scales	SCIENCE			English	Article							ECOSYSTEM SERVICES; BIODIVERSITY LOSS; PLANT DIVERSITY; ABUNDANCE; COMMUNITIES; DOMINANCE; RICHNESS; DELIVERY; LINKING; DEPEND	Ecologists have shown through hundreds of experiments that ecological communities with more species produce higher levels of essential ecosystem functions such as biomass production, nutrient cycling, and pollination, but whether this finding holds in nature (that is, in large-scale and unmanipulated systems) is controversial. This knowledge gap is troubling because ecosystem services have been widely adopted as a justification for global biodiversity conservation. Here we show that, to provide crop pollination in natural systems, the number of bee species must increase by at least one order of magnitude compared with that in field experiments. This increase is driven by species turnover and its interaction with functional dominance, mechanisms that emerge only at large scales. Our results show that maintaining ecosystem services in nature requires many species, including relatively rare ones.	[Winfree, Rachael; Reilly, James R.; Bartomeus, Ignasi; Cariveau, Daniel P.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Bartomeus, Ignasi] CSIC, Donana Biol Stn, Seville, Spain; [Cariveau, Daniel P.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Williams, Neal M.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Gibbs, Jason] Univ Manitoba, Dept Entomol, Winnipeg, MB, Canada	Rutgers State University New Brunswick; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of Manitoba	Winfree, R (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	rwinfree.rutgers@gmail.com	Cariveau, Daniel/AAB-9336-2020; Gibbs, Jason/H-6963-2012	Gibbs, Jason/0000-0002-4945-5423; Cariveau, Daniel/0000-0002-3064-0071; Bartomeus, Ignasi/0000-0001-7893-4389; Reilly, James/0000-0002-2355-3535	U.S. Department of Agriculture [National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative] [2009-65104-05782]; NSF [1556629]	U.S. Department of Agriculture [National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative]; NSF(National Science Foundation (NSF))	Data collection was funded by the U.S. Department of Agriculture [National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative grant 2009-65104-05782 to R.W. and N.M.W.]. R.W. and N.M.W. also received funding from the NSF (grant 1556629).	Albrecht M, 2012, P ROY SOC B-BIOL SCI, V279, P4845, DOI 10.1098/rspb.2012.1621; Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Dangles O, 2004, ECOL LETT, V7, P395, DOI 10.1111/j.1461-0248.2004.00591.x; Fauset S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7857; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Isbell F, 2017, NATURE, V546, P65, DOI 10.1038/nature22899; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lohbeck M, 2016, ECOLOGY, V97, P2772, DOI 10.1002/ecy.1499; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Ricketts TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13106; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Turnbull LA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0536; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Wardle DA, 2016, J VEG SCI, V27, P646, DOI 10.1111/jvs.12399; Winfree R, 2015, ECOL LETT, V18, P626, DOI 10.1111/ele.12424	24	159	166	12	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					791	793	aao2117	10.1126/science.aao2117	http://dx.doi.org/10.1126/science.aao2117			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449491				2022-12-28	WOS:000425116200044
J	Ellenberg, SS				Ellenberg, Susan S.			The Stepped-Wedge Clinical Trial Evaluation by Rolling Deployment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLUSTER; RANDOMIZATION; DESIGN		[Ellenberg, Susan S.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, 423 Guardian Dr,Blockley 611, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Ellenberg, SS (corresponding author), Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, 423 Guardian Dr,Blockley 611, Philadelphia, PA 19104 USA.	sellenbe@pennmedicine.upenn.edu						Baio G, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0840-9; CORNFIELD J, 1978, AM J EPIDEMIOL, V108, P100, DOI 10.1093/oxfordjournals.aje.a112592; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6; Huffman MD, 2018, JAMA-J AM MED ASSOC, V319, P567, DOI 10.1001/jama.2017.21906; Huffman MD, 2017, AM HEART J, V185, P154, DOI 10.1016/j.ahj.2016.10.026; Meurer WJ, 2015, JAMA-J AM MED ASSOC, V313, P2068, DOI 10.1001/jama.2015.5199; Moberg J, 2015, J ROY SOC MED, V108, P192, DOI 10.1177/0141076815582303; Taljaard M, 2017, CLIN TRIALS, V14, P333, DOI 10.1177/1740774517703057	9	18	18	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					607	608		10.1001/jama.2017.21993	http://dx.doi.org/10.1001/jama.2017.21993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450512				2022-12-28	WOS:000424908400021
J	Hughes, MP; Sawaya, MR; Boyer, DR; Goldschmidt, L; Rodriguez, JA; Cascio, D; Chong, L; Gonen, T; Eisenberg, DS				Hughes, Michael P.; Sawaya, Michael R.; Boyer, David R.; Goldschmidt, Lukasz; Rodriguez, Jose A.; Cascio, Duilio; Chong, Lisa; Gonen, Tamir; Eisenberg, David S.			Atomic structures of low-complexity protein segments reveal kinked beta sheets that assemble networks	SCIENCE			English	Article							RNA-BINDING PROTEINS; AMYLOID-LIKE FIBRILS; PRION-LIKE DOMAINS; PHASE-SEPARATION; LIQUID DROPLETS; BENZENE DIMER; SEQUENCES; HYDROGELS; DISEASE; TRANSITION	Subcellular membraneless assemblies are a reinvigorated area of study in biology, with spirited scientific discussions on the forces between the low-complexity protein domains within these assemblies. To illuminate these forces, we determined the atomic structures of five segments from protein low-complexity domains associated with membraneless assemblies. Their common structural feature is the stacking of segments into kinked beta sheets that pair into protofilaments. Unlike steric zippers of amyloid fibrils, the kinked sheets interact weakly through polar atoms and aromatic side chains. By computationally threading the human proteome on our kinked structures, we identified hundreds of low-complexity segments potentially capable of forming such interactions. These segments are found in proteins as diverse as RNA binders, nuclear pore proteins, and keratins, which are known to form networks and localize to membraneless assemblies.	[Hughes, Michael P.; Sawaya, Michael R.; Boyer, David R.; Goldschmidt, Lukasz; Cascio, Duilio; Chong, Lisa; Eisenberg, David S.] UCLA, HHMI, UCLA Dept Energy DOE Inst Genom & Prote, Dept Biol Chem, Los Angeles, CA 90095 USA; [Hughes, Michael P.; Sawaya, Michael R.; Boyer, David R.; Goldschmidt, Lukasz; Cascio, Duilio; Chong, Lisa; Eisenberg, David S.] UCLA, HHMI, UCLA Dept Energy DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Rodriguez, Jose A.] UCLA, UCLA DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Gonen, Tamir] UCLA, HHMI, Los Angeles, CA 90095 USA; [Gonen, Tamir] UCLA, Dept Physiol, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eisenberg, DS (corresponding author), UCLA, HHMI, UCLA Dept Energy DOE Inst Genom & Prote, Dept Biol Chem, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), UCLA, HHMI, UCLA Dept Energy DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Eisenberg, David/0000-0003-2432-5419; Chong, Lisa/0000-0001-7667-9441; Hughes, Michael/0000-0002-6239-4151; Sawaya, Michael/0000-0003-0874-9043	National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; NSF [MCB-1616265]; NIH [AG-054022]; DOE; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054022] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); DOE Office of Science(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D.S.E. is on the scientific advisory board and holds equity in ADRx, Inc. X-ray diffraction data were collected at the Northeastern Collaborative Access Team beamline 24-ID-E, which is funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. We thank NSF MCB-1616265, NIH AG-054022, DOE, and HHMI for support. Atomic coordinates and structure factors have been deposited in the PDB with the following accession codes: SYSGYS (6BWZ), SYSSYGQS (6BXV), STGGYG (6BZP), GYNGFG (6BXX), and GFGNFGTS (6BZM).	Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; ARUNAN E, 1993, J CHEM PHYS, V98, P4294, DOI 10.1063/1.465035; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Elbaum-Garfinkle S, 2015, DEV CELL, V35, P531, DOI 10.1016/j.devcel.2015.11.014; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hennig S, 2015, J CELL BIOL, V210, P529, DOI 10.1083/jcb.201504117; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kumari B, 2015, MOL BIOSYST, V11, P585, DOI 10.1039/c4mb00425f; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schwartz JC, 2015, ANNU REV BIOCHEM, V84, P355, DOI 10.1146/annurev-biochem-060614-034325; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; Sinnokrot MO, 2002, J AM CHEM SOC, V124, P10887, DOI 10.1021/ja025896h; Toretsky JA, 2014, J CELL BIOL, V206, P579, DOI 10.1083/jcb.201404124; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040	35	224	225	7	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					698	701		10.1126/science.aan6398	http://dx.doi.org/10.1126/science.aan6398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439243	Green Accepted, Green Submitted			2022-12-28	WOS:000425117700043
J	Jewell, J; McCollum, D; Emmerling, J; Bertram, C; Gernaat, DEHJ; Krey, V; Paroussos, L; Berger, L; Fragkiadakis, K; Keppo, I; Saadi, N; Tavoni, M; van Vuuren, D; Vinichenko, V; Riahi, K				Jewell, Jessica; McCollum, David; Emmerling, Johannes; Bertram, Christoph; Gernaat, David E. H. J.; Krey, Volker; Paroussos, Leonidas; Berger, Loic; Fragkiadakis, Kostas; Keppo, Ilkka; Saadi, Nawfal; Tavoni, Massimo; van Vuuren, Detlef; Vinichenko, Vadim; Riahi, Keywan			Limited emission reductions from fuel subsidy removal except in energy-exporting regions	NATURE			English	Article								Hopes are high that removing fossil fuel subsidies could help to mitigate climate change by discouraging inefficient energy consumption and levelling the playing field for renewable energy(1-3). In September 2016, the G20 countries re-affirmed their 2009 commitment (at the G20 Leaders' Summit) to phase out fossil fuel subsidies(4,5) and many national governments are using today's low oil prices as an opportunity to do so(6-9). In practical terms, this means abandoning policies that decrease the price of fossil fuels and electricity generated from fossil fuels to below normal market prices(10,11). However, whether the removal of subsidies, even if implemented worldwide, would have a large impact on climate change mitigation has not been systematically explored. Here we show that removing fossil fuel subsidies would have an unexpectedly small impact on global energy demand and carbon dioxide emissions and would not increase renewable energy use by 2030. Subsidy removal would reduce the carbon price necessary to stabilize greenhouse gas concentration at 550 parts per million by only 2-12 per cent under low oil prices. Removing subsidies in most regions would deliver smaller emission reductions than the Paris Agreement (2015) climate pledges and in some regions global subsidy removal may actually lead to an increase in emissions, owing to either coal replacing subsidized oil and natural gas or natural-gas use shifting from subsidizing, energy-exporting regions to non-subsidizing, importing regions. Our results show that subsidy removal would result in the largest CO2 emission reductions in high-income oil-and gas-exporting regions, where the reductions would exceed the climate pledges of these regions and where subsidy removal would affect fewer people living below the poverty line than in lower-income regions.	[Jewell, Jessica; McCollum, David; Krey, Volker; Riahi, Keywan] Int Inst Appl Syst Anal, Energy Program, A-2361 Laxenburg, Austria; [Jewell, Jessica] Univ Bergen, Ctr Climate & Energy Transformat, N-5020 Bergen, Norway; [Jewell, Jessica] Univ Bergen, Dept Geog, N-5020 Bergen, Norway; [McCollum, David] Univ Tennessee, Howard H Baker Jr Ctr Publ Policy, Knoxville, TN 37996 USA; [Emmerling, Johannes; Berger, Loic; Tavoni, Massimo] Fdn Eni Enrico Mattei, I-20123 Milan, Italy; [Emmerling, Johannes; Berger, Loic; Tavoni, Massimo] Ctr Euromediterraneo Cambiamenti Climat, I-73100 Lecce, Italy; [Bertram, Christoph] Leibniz Assoc, Potsdam Inst Climate Impact Res, POB 60 12 03, D-14473 Potsdam, Germany; [Gernaat, David E. H. J.; van Vuuren, Detlef] Univ Utrecht, Copernicus Inst Sustainable Dev, NL-3584 CS Utrecht, Netherlands; [Gernaat, David E. H. J.; van Vuuren, Detlef] PBL Netherlands Environm Assessment Agcy, The Hague, Netherlands; [Paroussos, Leonidas; Fragkiadakis, Kostas] Natl Tech Univ Athens, Sch Elect & Comp Engn, Dept Elect Power, GR-15773 Athens, Greece; [Berger, Loic] CNRS, IESEG Sch Management, Dept Econ & Quantitat Methods, LEM, F-59000 Lille, France; [Keppo, Ilkka; Saadi, Nawfal] UCL, UCL Energy Inst, London WC1H 0NN, England; [Tavoni, Massimo] Politecn Milan, Dept Management Econ & Ind Engn, I-20156 Milan, Italy; [Vinichenko, Vadim] Cent European Univ, Dept Environm Sci & Policy, H-1051 Budapest, Hungary; [Riahi, Keywan] Graz Univ Technol, Inst Thermal Engn, A-8010 Graz, Austria	International Institute for Applied Systems Analysis (IIASA); University of Bergen; University of Bergen; University of Tennessee System; University of Tennessee Knoxville; Fondazione Mattei; Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); Potsdam Institut fur Klimafolgenforschung; Utrecht University; National Technical University of Athens; Centre National de la Recherche Scientifique (CNRS); IESEG School of Management; University of London; University College London; Polytechnic University of Milan; Central European University; Graz University of Technology	Jewell, J (corresponding author), Int Inst Appl Syst Anal, Energy Program, A-2361 Laxenburg, Austria.; Jewell, J (corresponding author), Univ Bergen, Ctr Climate & Energy Transformat, N-5020 Bergen, Norway.; Jewell, J (corresponding author), Univ Bergen, Dept Geog, N-5020 Bergen, Norway.	jewell@iiasa.ac.at	EMMERLING, Johannes/K-8283-2019; Bertram, Christoph/AAT-9651-2020; Krey, Volker/ABD-5070-2021; Fragkiadakis, Kostas/AAG-9660-2020; van Vuuren, Detlef P./A-4764-2009; Berger, Loic/E-7060-2016; Riahi, Keywan/B-6426-2011	EMMERLING, Johannes/0000-0003-0916-9913; Bertram, Christoph/0000-0002-0933-4395; Fragkiadakis, Kostas/0000-0002-1129-0360; van Vuuren, Detlef P./0000-0003-0398-2831; tavoni, massimo/0000-0001-5069-4707; Paroussos, Leonidas/0000-0001-8251-7270; Krey, Volker/0000-0003-0307-3515; Berger, Loic/0000-0002-0696-9387; McCollum, David/0000-0003-1293-0179; Riahi, Keywan/0000-0001-7193-3498; Jewell, Jessica/0000-0003-2846-9081	European Union [308329]	European Union(European Commission)	The research leading to these results received funding from the European Union's Seventh Programme FP7/2007-2013 under grant agreement number 308329 (ADVANCE). We thank the International Institute for Applied Systems Analysis, Energy Program for hosting the online database with the scenario data as well as P. Kolp, L. Groihofer and D. Garcia-Carbrera for data and database support; the International Energy Agency (in particular A. Bromhead, L. Cozzi, N. Selmet, G. Zazias and T. Shirai) for providing data and support related to their energy subsidy database; G. Luderer for contributing to the study design; and A. Cherp for commenting on the manuscript.	[Anonymous], 2015, ECONOMIST; [Anonymous], 2016, G20 LEAD COMM HANGZH; Bast E., 2015, EMPTY PROMISES G20 S; British Petroleum (BP), 2021, STAT REV WORLD EN 20; Burniaux J. -M., 2011, OECD EC DEP WORKING; Burniaux J-M., 2014, INT EC, V140, P71, DOI [10.1016/j.inteco.2014.05.002, DOI 10.1016/J.INTECO.2014.05.002]; Cameron C, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2015.10, 10.1038/NENERGY.2015.10]; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Coady D., 2015, LARGE ARE GLOBAL ENE; Friends of Fossil Fuel Subsidy Reform (FFSR), 2015, FOSS FUEL SUBS REF C; Gerasimchuk I., 2017, ZOMBIE ENERGY CLIMAT; IEA, 2011, WORLD EN OUTL 2011; IEA, EN SUBS; IEA, 2014, WORLD EN OUTL 2014; IEA, 2016, 20 YEARS CARB CAPT S; IEA OPEC OECD and World Bank, 2011, JOINT REP IEA OPEC O; IEA-International Energy Agency, 2015, WORLD EN OUTL 2015; Inchauste G., 2017, POLITICAL EC ENERGY, P1; International Energy Agency (IEA), 2015, EN CLIM CHANG WEO SP; Lam NL, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/044014; Lockwood M, 2015, NEW POLIT ECON, V20, P475, DOI 10.1080/13563467.2014.923826; Matsuo T, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5384; Merrill L., 2015, TACKLING FOSSIL FUEL, DOI 10.6027/TN2015-575; OECD, 2015, OECD INV SUPP MEAS F; Rogelj J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15748; Russell C, 2015, OIL PRICE PLUNGE SHO; Schwanitz VJ, 2014, ENERG POLICY, V67, P882, DOI 10.1016/j.enpol.2013.12.015; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P33; Wagner A., 2014, INT FUEL PRICES 2012	29	67	68	24	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					229	233		10.1038/nature25467	http://dx.doi.org/10.1038/nature25467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420477	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000424332600037
J	Atun, R; Cavalli, F				Atun, Rifat; Cavalli, Franco			The global fight against cancer: challenges and opportunities	LANCET			English	Editorial Material							HEALTH		[Atun, Rifat] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Atun, Rifat] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Cavalli, Franco] Univ Svizzera Italiana, European Sch Oncol, Lugano, Switzerland; [Cavalli, Franco] Univ Svizzera Italiana, Biomed Fac, Inst Oncol Res, Lugano, Switzerland	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Universita della Svizzera Italiana; Universita della Svizzera Italiana	Atun, R (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Atun, R (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.	ratun@hsph.harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				Adams C, 2017, LANCET ONCOL, V18, P286, DOI 10.1016/S1470-2045(17)30083-9; Atun R, 2017, LANCET GLOB HEALTH, V5, pE720, DOI [10.1016/S2214-109X(17)30198-5, 10.1016/s2214-109x(17)30198-5]; Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cavalli F, 2015, LANCET ONCOL, V16, P133, DOI 10.1016/S1470-2045(15)70012-4; Cavalli F, 2013, LANCET, V381, P425, DOI 10.1016/S0140-6736(13)60059-8; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Knaul FM, 2013, LANCET, V381, P2238, DOI 10.1016/S0140-6736(13)60176-2; Knaul FM, 2017, LANCET; Ministry of Health and Social Welfare, 2017, HLTH FIN POL 2017 20; National Cancer Institute, 2016, CANC MOONSH; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5	15	17	17	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					412	413		10.1016/S0140-6736(18)30156-9	http://dx.doi.org/10.1016/S0140-6736(18)30156-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407018				2022-12-28	WOS:000424333600010
J	Horton, R				Horton, Richard			Offline: Adolescent health-vulnerable and under threat	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					414	414		10.1016/S0140-6736(18)30184-3	http://dx.doi.org/10.1016/S0140-6736(18)30184-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407019	Bronze			2022-12-28	WOS:000424333600011
J	Boylston, AW				Boylston, Arthur W.			HISTORY OF MEDICINE The Myth of the Milkmaid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Boylston, Arthur W.] Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England	University of Oxford	Boylston, AW (corresponding author), Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England.							BARON J, 1838, LIFE E JENNER, V1; Jenner Edward, 1801, ORIGIN VACCINE INOCU; Moore JC, 1817, HIST PRACTICE VACCIN; Pearson George, 1798, INQUIRY HIST COWPOX	4	8	8	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					414	415		10.1056/NEJMp1715349	http://dx.doi.org/10.1056/NEJMp1715349			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29385360				2022-12-28	WOS:000423783200005
J	Capewell, S; Cairney, P; Clarke, A				Capewell, Simon; Cairney, Paul; Clarke, Aileen			Should action take priority over further research on public health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS; DISEASE; ADULTS		[Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Publ Hlth & Policy, Liverpool, Merseyside, England; [Cairney, Paul] Univ Stirling, Stirling, Scotland; [Clarke, Aileen] Warwick Med Sch, Warwick, England	University of Liverpool; University of Stirling; University of Warwick	Capewell, S (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Publ Hlth & Policy, Liverpool, Merseyside, England.; Clarke, A (corresponding author), Warwick Med Sch, Warwick, England.	Capewell@liverpool.ac.uk; Clarke@warwick.ac.uk	Clarke, Aileen/I-5679-2012	Clarke, Aileen/0000-0001-8299-3146	NIHR CLAHRC West Midlands initiative; Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI	NIHR CLAHRC West Midlands initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. AC is partly supported by the NIHR CLAHRC West Midlands initiative. The views expressed here are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Cairney P, 2012, GLOBAL TOBACCO CONTR, DOI [10.1057/9780230361249, DOI 10.1057/9780230361249]; Cairney P, 2016, PUBLIC ADMIN REV, V76, P399, DOI 10.1111/puar.12555; Capewell S, 2018, BR MED B IN PRESS; Capewell S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6341; Chan M., 2013, WHO DIRECTOR GEN OPE; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Friedl Karl E, 2009, J Diabetes Sci Technol, V3, P761; He F. J., 2013, BMJ, V346; House of Lords Science and Technology Select Committee, 2011, BEHAV CHANGE; Kelly MP, 2018, SOCIOL HEALTH ILL, V40, P82, DOI 10.1111/1467-9566.12621; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mackenzie G., PUBLIC HLTH CENTURY; Marteau T, 2006, BMJ-BRIT MED J, V332, P437, DOI 10.1136/bmj.332.7539.437; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; National Statistics, 2017, NAT CHILD MEAS PROGR; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; Nowotny H., 2003, SCI PUBL POLICY, V30, P151, DOI 10.3152/147154303781780461; Public Health England, 2017, HLTH PROF ENGL; Public Health England, 2017, 10 MIN BRISK WALK EA; Wynne B, 2010, NATURE, V466, P441, DOI 10.1038/466441a	22	5	5	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2018	360								k292	10.1136/bmj.k292	http://dx.doi.org/10.1136/bmj.k292			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TT	29419385	Green Published			2022-12-28	WOS:000423846200005
J	Morley, RL; Sharma, A; Horsch, AD; Hinchliffe, RJ				Morley, Rachael L.; Sharma, Anita; Horsch, Alexander D.; Hinchliffe, Robert J.			CLINICAL UPDATES Peripheral artery disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR RISK-FACTORS; INTER-SOCIETY CONSENSUS; INTERMITTENT CLAUDICATION; ANTITHROMBOTIC THERAPY; NAFTIDROFURYL OXALATE; ETHNIC-DIFFERENCES; SMOKING-CESSATION; AMERICAN-COLLEGE; VASCULAR-DISEASE; STATIN THERAPY		[Morley, Rachael L.; Horsch, Alexander D.; Hinchliffe, Robert J.] North Bristol NHS Trust, Bristol, Avon, England; [Morley, Rachael L.; Hinchliffe, Robert J.] Univ Bristol, Bristol Ctr Surg Res, NIHR Bristol BRC, Bristol, Avon, England; [Sharma, Anita] South Chadderton Hlth Ctr, Oldham, England	North Bristol NHS Trust; University of Bristol	Hinchliffe, RJ (corresponding author), North Bristol NHS Trust, Bristol, Avon, England.; Hinchliffe, RJ (corresponding author), Univ Bristol, Bristol Ctr Surg Res, NIHR Bristol BRC, Bristol, Avon, England.	robert.hinchliffe@bristol.ac.uk	Horsch, Alexander D./U-3330-2019; Miller, Rachael Lucia/ABC-1500-2020	Miller, Rachael Lucia/0000-0001-7918-4196; Horsch, Alexander/0000-0001-8213-2784				Adler AI, 2002, DIABETES CARE, V25, P894, DOI 10.2337/diacare.25.5.894; Alahdab F, 2015, J VASC SURG, V61, p42S, DOI 10.1016/j.jvs.2014.12.008; Alonso-Coello P, 2012, CHEST, V141, pE669S, DOI 10.1378/chest.11-2307; [Anonymous], 2017, ISRCTN27728689 BYP V; Antoniou GA, 2017, COCHRANE DB SYST REV, V4; Antoniou GA, 2014, VASC PHARMACOL, V63, P79, DOI 10.1016/j.vph.2014.09.001; Armstrong David G, 2011, J Diabetes Sci Technol, V5, P1591; Armstrong EJ, 2014, J VASC SURG, V60, P1565, DOI 10.1016/j.jvs.2014.08.064; ARONOW WS, 1994, AM J CARDIOL, V74, P64, DOI 10.1016/0002-9149(94)90493-6; Aronow WS, 2003, AM J CARDIOL, V92, P711, DOI 10.1016/S0002-9149(03)00833-6; Barrons RW, 2016, AM J THER, V23, pE7, DOI 10.1097/MJT.0000000000000011; Bedenis R, 2014, COCHRANE DB SYST REV; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Boyko EJ, 1997, J CLIN EPIDEMIOL, V50, P659, DOI 10.1016/S0895-4356(97)00005-X; Cahill K, COCHRANE DATABASE SY; Crawford F, COCHRANE DATABASE SY; Criqui MH, 2005, CIRCULATION, V112, P2703, DOI 10.1161/CIRCULATIONAHA.105.546507; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; Ebbert JO, 2010, PATIENT PREFER ADHER, V4, P355, DOI 10.2147/PPA.S10620; FAULKNER KW, 1983, MED J AUSTRALIA, V1, P217, DOI 10.5694/j.1326-5377.1983.tb99395.x; Fokkenrood HJP, 2013, COCHRANE DB SYST REV, V23; Frans FA, 2012, BRIT J SURG, V99, P16, DOI 10.1002/bjs.7656; Garcia LA, 2006, J ENDOVASC THER, V13, P3, DOI 10.1583/05-1751.1; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Hennion DR, 2013, AM FAM PHYSICIAN, V88, P306; Hess CN, 2017, CIRCULATION, V135, P2534, DOI 10.1161/CIRCULATIONAHA.117.024469; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Huisstede BM, 2011, ARCH PHYS MED REHAB, V92, P1166, DOI 10.1016/j.apmr.2011.01.022; Jaff MR, 2015, CATHETER CARDIO INTE, V86, P611, DOI 10.1002/ccd.26122; Jones WS, 2013, AM HEART J, V165, P809, DOI 10.1016/j.ahj.2012.12.002; Joosten MM, 2012, JAMA-J AM MED ASSOC, V308, P1660, DOI 10.1001/jama.2012.13415; Jude EB, 2001, DIABETES CARE, V24, P1433, DOI 10.2337/diacare.24.8.1433; Katsanos K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135692; Khan NA, 2006, JAMA-J AM MED ASSOC, V295, P536, DOI 10.1001/jama.295.5.536; Khan S, 2007, EUR J VASC ENDOVASC, V33, P442, DOI 10.1016/j.ejvs.2006.11.010; Kullo IJ, 2003, VASC MED, V8, P237, DOI 10.1191/1358863x03vm511oa; Lane R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000990.pub3; LASSILA R, 1988, ACTA CHIR SCAND, V154, P635; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Lyu XF, 2016, J DIABETES, V8, P363, DOI 10.1111/1753-0407.12304; Meng Y, 2014, ANGIOLOGY, V65, P190, DOI 10.1177/0003319712474335; Mohler ER, 2003, CIRCULATION, V108, P1481, DOI 10.1161/01.CIR.0000090686.57897.F5; Mondillo S, 2003, AM J MED, V114, P359, DOI 10.1016/S0002-9343(03)00010-X; Moulik PK, 2003, DIABETES CARE, V26, P491, DOI 10.2337/diacare.26.2.491; National Institute for Health and Care Excellence, 2017, CARDIOVASCULAR DIS; National Institute for Health and Care Excellence, 2015, CLIN KNOWL SUMM PER; National Institute for Health and Care Excellence, 2016, DIAB FOOT PROBL PREV; National Institute for Health and Care Excellence, 2016, NICE QUAL OUTC FRAM; NHS Employers, 2016, GEN MED SERV GMS CON; Norgren L, 2007, INT ANGIOL, V26, P81; Osborne NH, 2009, J VASC SURG, V50, P709, DOI 10.1016/j.jvs.2009.05.020; Patnode CD, 2015, ANN INTERN MED, V163, P608, DOI 10.7326/M15-0171; Pope J, COCHRANE DATABASE SY; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Selvin E, 2006, DIABETES CARE, V29, P877, DOI 10.2337/diacare.29.04.06.dc05-2018; Shahin Y, 2011, INT J SURG, V9, P209, DOI 10.1016/j.ijsu.2010.12.006; Stevens JW, 2012, BRIT J SURG, V99, P1630, DOI 10.1002/bjs.8895; Suckow BD, 2015, J VASC SURG, V61, P126, DOI 10.1016/j.jvs.2014.05.093; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van de Graaf RC, NED TIJDSCHR GENEESK; Vitalis A, 2017, EXPERT REV CARDIOVAS, V15, P327, DOI 10.1080/14779072.2017.1305890; Willigendael EM, 2004, J VASC SURG, V40, P1158, DOI 10.1016/j.jvs.2004.08.049; Willigendael EM, 2005, J VASC SURG, V42, P67, DOI 10.1016/j.jvs.2005.03.024; 1995, AM J CARDIOL, V75, P894, DOI DOI 10.1016/S0002-9149(99)80683-37732997	67	63	63	3	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2018	360								j5842	10.1136/bmj.j5842	http://dx.doi.org/10.1136/bmj.j5842			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TT	29419394	Green Published			2022-12-28	WOS:000423846200001
J	Wang, ZF; Herraiz, AG; del Hoyo, AM; Suero, MG				Wang, Zhaofeng; Herraiz, Ana G.; del Hoyo, Ana M.; Suero, Marcos G.			Generating carbyne equivalents with photoredox catalysis	NATURE			English	Article							C-H FUNCTIONALIZATION; DIETHYL MERCURYBISDIAZOACETATE; ETHYL DIAZOACETATE; COUPLING REACTIONS; ORGANIC-SYNTHESIS; AQUEOUS-SOLUTION; DIAZO-COMPOUNDS; DECOMPOSITION; ALKYLATION; MOLECULES	Carbon has the unique ability to bind four atoms and form stable tetravalent structures that are prevalent in nature. The lack of one or two valences leads to a set of species-carbocations, carbanions, radicals and carbenes-that is fundamental to our understanding of chemical reactivity(1). In contrast, the carbyne-a monovalent carbon with three non-bonded electrons-is a relatively unexplored reactive intermediate(2-6); the design of reactions involving a carbyne is limited by challenges associated with controlling its extreme reactivity and the lack of efficient sources(7-9). Given the innate ability of carbynes to form three new covalent bonds sequentially, we anticipated that a catalytic method of generating carbynes or related stabilized species would allow what we term an 'assembly point' disconnection approach for the construction of chiral centres. Here we describe a catalytic strategy that generates diazomethyl radicals as direct equivalents of carbyne species using visible-light photoredox catalysis. The ability of these carbyne equivalents to induce site-selective carbon-hydrogen bond cleavage in aromatic rings enables a useful diazomethylation reaction, which underpins sequencing control for the late-stage assembly-point functionalization of medically relevant agents. Our strategy provides an efficient route to libraries of potentially bioactive molecules through the installation of tailored chiral centres at carbon-hydrogen bonds, while complementing current translational late-stage functionalization processes(10). Furthermore, we exploit the dual radical and carbene character of the generated carbyne equivalent in the direct transformation of abundant chemical feedstocks into valuable chiral molecules.	[Wang, Zhaofeng] Barcelona Inst Sci & Technol, Inst Chem Res Catalonia ICIQ, Avinguda Paisos Catalans 16, Tarragona 43007, Spain	Barcelona Institute of Science & Technology; Universitat Rovira i Virgili; Institute of Chemical Research of Catalonia	Wang, ZF (corresponding author), Barcelona Inst Sci & Technol, Inst Chem Res Catalonia ICIQ, Avinguda Paisos Catalans 16, Tarragona 43007, Spain.	mgsuero@iciq.es	Garcia Herraiz, Ana/I-7054-2017; Wang, Zhaofeng/J-2118-2015	Garcia Herraiz, Ana/0000-0003-0028-1132; Wang, Zhaofeng/0000-0002-0547-8172; Garcia Suero, Marcos/0000-0001-9796-7768	ICIQ Foundation; CERCA Programme (Generalitat de Catalunya); MINECO [CTQ2016-75311-P, SEV-2013-0319]; CELLEX Foundation through the CELLEX-ICIQ high-throughput experimentation platform; European Union; CELLEX Foundation	ICIQ Foundation(Foundation CELLEX); CERCA Programme (Generalitat de Catalunya); MINECO(Spanish Government); CELLEX Foundation through the CELLEX-ICIQ high-throughput experimentation platform(Foundation CELLEX); European Union(European Commission); CELLEX Foundation(Foundation CELLEX)	This work was funded by the ICIQ Foundation, the CERCA Programme (Generalitat de Catalunya), MINECO (CTQ2016-75311-P, AEI/FEDER-EU; Severo Ochoa Excellence Accreditation 2014-2018, SEV-2013-0319), the CELLEX Foundation through the CELLEX-ICIQ high-throughput experimentation platform. We thank the European Union for a Marie Curie-COFUND post-doctoral fellowship (to Z.W.) and the CELLEX Foundation for pre-doctoral (to A.G.H.) and post-doctoral fellowships (to A.M.d.H.). We thank the ICIQ Research Support Area, and F. Bravo for LC/MS instrumentation. M.G.S. is a Junior Group Leader of the ICIQ Starting Career Programme 2014-2019.	Bino A, 2005, SCIENCE, V308, P234, DOI 10.1126/science.1109965; Bogoslavsky B, 2012, ANGEW CHEM INT EDIT, V51, P90, DOI 10.1002/anie.201103652; Boursalian GB, 2016, NAT CHEM, V8, P810, DOI [10.1038/NCHEM.2529, 10.1038/nchem.2529]; Caballero A, 2011, SCIENCE, V332, P835, DOI 10.1126/science.1204131; Cernak T, 2016, CHEM SOC REV, V45, P546, DOI 10.1039/c5cs00628g; Ford A, 2015, CHEM REV, V115, P9981, DOI 10.1021/acs.chemrev.5b00121; Fu LB, 2017, CHEM-EUR J, V23, P3272, DOI 10.1002/chem.201700101; Furstner A, 2013, ANGEW CHEM INT EDIT, V52, P2794, DOI 10.1002/anie.201204513; Landau E., 2016, BUILDING BLOCKS LIFE; Le C, 2017, NATURE, V547, P79, DOI 10.1038/nature22813; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Morris PW, 2016, ASTROPHYS J, V829, DOI 10.3847/0004-637X/829/1/15; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Panish R, 2015, ORG LETT, V17, P3978, DOI 10.1021/acs.orglett.5b01836; PATRICK TB, 1978, J ORG CHEM, V43, P1506, DOI 10.1021/jo00402a004; PATRICK TB, 1975, J ORG CHEM, V40, P1527, DOI 10.1021/jo00898a043; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qin T, 2016, SCIENCE, V352, P801, DOI 10.1126/science.aaf6123; RYDBECK OEH, 1973, NATURE, V246, P466, DOI 10.1038/246466a0; Schnaars C, 2013, J ORG CHEM, V78, P7488, DOI 10.1021/jo401050c; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; STRAUSZ OP, 1974, J AM CHEM SOC, V96, P5723, DOI 10.1021/ja00825a007; STRAUSZ OP, 1968, J AM CHEM SOC, V90, P1930, DOI 10.1021/ja01009a063; Swings P, 1937, ASTROPHYS J, V86, P483, DOI 10.1086/143880; Thap D. M., 1967, J AM CHEM SOC, V89, P6785; Trost B. M., 1991, COMPREHENSIVE ORGANI; Wang LJ, 2016, EUR J ORG CHEM, V2016, P1813, DOI 10.1002/ejoc.201501490; WEISS R, 1994, ANGEW CHEM INT EDIT, V33, P1952, DOI 10.1002/anie.199419521; Ye F, 2015, J AM CHEM SOC, V137, P4435, DOI 10.1021/ja513275c; Yoshimura A, 2016, CHEM REV, V116, P3328, DOI 10.1021/acs.chemrev.5b00547; Zhu ZD, 1999, J AM CHEM SOC, V121, P2863, DOI 10.1021/ja983277w	31	93	93	7	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					86	91		10.1038/nature25185	http://dx.doi.org/10.1038/nature25185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29388953				2022-12-28	WOS:000424048900036
J	Olival, KJ; Hosseini, PR; Zambrana-Torrelio, C; Ross, N; Bogich, TL; Daszak, P				Olival, Kevin J.; Hosseini, Parviez R.; Zambrana-Torrelio, Carlos; Ross, Noam; Bogich, Tiffany L.; Daszak, Peter			Host and viral traits predict zoonotic spillover from mammals (vol 546, pg 646, 2017)	NATURE			English	Correction													daszak, peter/U-4588-2017; Zambrana-Torrelio, Carlos/AAH-3911-2020	daszak, peter/0000-0002-2046-5695; Zambrana-Torrelio, Carlos/0000-0002-5614-7496; Bogich, Tiffany/0000-0002-8143-5289				Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975	1	7	7	4	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669								10.1038/nature23660	http://dx.doi.org/10.1038/nature23660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	29411779	Green Published, Bronze			2022-12-28	WOS:000408703100045
J	Bai, G; Sen, AP; Anderson, GF				Bai, Ge; Sen, Aditi P.; Anderson, Gerard F.			Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bai, Ge] Johns Hopkins Carey Business Sch, 100 Int Dr, Baltimore, MD 21202 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Sen, Aditi P.; Anderson, Gerard F.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 North Broadway, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bai, G (corresponding author), Johns Hopkins Carey Business Sch, 100 Int Dr, Baltimore, MD 21202 USA.	gbai@jhu.edu						Anderson GF, 2017, TESTIMONY SENATE COM; Balto DA, 2015, STATE COMPETITION PH; Barrett P, 2017, BLOOMBERG BUSIN 0629; Fein AJ, 2017, 2017 EC REPORT US PH; IQVIA Institute for Human Data Science, 2019, MED US SPEND US REV; Walker J, 2016, WALL STREET J; Weinberg N, 2017, BLOOMBERG BUSINESSWE	7	17	17	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					436	+		10.7326/M17-2506	http://dx.doi.org/10.7326/M17-2506			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29435565				2022-12-28	WOS:000427827400019
J	Perez, FF; Fontela, M; Garcia-Ibanez, MI; Mercier, H; Velo, A; Lherminier, P; Zunino, P; de la Paz, M; Alonso-Perez, F; Guallart, EE; Padin, XA				Perez, Fiz F.; Fontela, Marcos; Garcia-Ibanez, Maribel I.; Mercier, Herle; Velo, Anton; Lherminier, Pascale; Zunino, Patricia; de la Paz, Mercedes; Alonso-Perez, Fernando; Guallart, Elisa E.; Padin, Xose A.			Meridional overturning circulation conveys fast acidification to the deep Atlantic Ocean	NATURE			English	Article							ANTHROPOGENIC CO2; SEAWATER; CARBON; SEA; CHEMISTRY; CALCITE; SYSTEM	Since the Industrial Revolution, the North Atlantic Ocean has been accumulating anthropogenic carbon dioxide (CO2) and experiencing ocean acidification(1), that is, an increase in the concentration of hydrogen ions (a reduction in pH) and a reduction in the concentration of carbonate ions. The latter causes the 'aragonite saturation horizon'-below which waters are undersaturated with respect to a particular calcium carbonate, aragonite-to move to shallower depths (to shoal), exposing corals to corrosive waters(2,3). Here we use a database analysis to show that the present rate of supply of acidified waters to the deep Atlantic could cause the aragonite saturation horizon to shoal by 1,000-1,700 metres in the subpolar North Atlantic within the next three decades. We find that, during 1991-2016, a decrease in the concentration of carbonate ions in the Irminger Sea caused the aragonite saturation horizon to shoal by about 10-15 metres per year, and the volume of aragonite-saturated waters to reduce concomitantly. Our determination of the transport of the excess of carbonate over aragonite saturation ((XC)[CO32-])-an indicator of the availability of aragonite to organisms-by the Atlantic meridional overturning circulation shows that the present-day transport of carbonate ions towards the deep ocean is about 44 per cent lower than it was in preindustrial times. We infer that a doubling of atmospheric anthropogenic CO2 levels-which could occur within three decades according to a 'business-as-usual scenario' for climate change 4-could reduce the transport of (XC)[CO32-] by 64-79 per cent of that in preindustrial times, which could severely endanger cold-water coral habitats. The Atlantic meridional overturning circulation would also export this acidified deep water southwards, spreading corrosive waters to the world ocean.	[Perez, Fiz F.; Fontela, Marcos; Garcia-Ibanez, Maribel I.; Velo, Anton; de la Paz, Mercedes; Alonso-Perez, Fernando; Guallart, Elisa E.; Padin, Xose A.] CSIC, IIM, Calle Eduardo Cabello 6, Vigo 36208, Spain; [Mercier, Herle; Lherminier, Pascale; Zunino, Patricia] Univ Brest, CNRS,Ifremer, Inst Rech Dev, LOPS,Ctr Ifremer Bretagne, F-29280 Plouzane, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Perez, FF (corresponding author), CSIC, IIM, Calle Eduardo Cabello 6, Vigo 36208, Spain.	fiz.perez@iim.csic.es	de la Paz, Mercedes/Y-4285-2019; Alonso-Pérez, Fernando/P-8679-2014; MERCIER, Herle/L-4161-2015; Fontela, Marcos/ABB-3099-2021; Velo, Anton/B-4172-2019; Lherminier, Pascale/L-3181-2014; Padin, X.A./AAA-1305-2019; Guallart, Elisa Fernández/AAB-2049-2020; Fernandez Perez, Fiz/B-9001-2011; García-Ibáñez, Maribel I./AAE-1798-2019	de la Paz, Mercedes/0000-0002-9267-930X; Alonso-Pérez, Fernando/0000-0002-4434-0360; MERCIER, Herle/0000-0002-1940-617X; Fontela, Marcos/0000-0002-7486-0922; Velo, Anton/0000-0002-7598-5700; Lherminier, Pascale/0000-0001-9007-2160; Guallart, Elisa Fernández/0000-0003-2965-6671; Fernandez Perez, Fiz/0000-0003-4836-8974; García-Ibáñez, Maribel I./0000-0001-5218-0064; Zunino, Patricia/0000-0001-7057-7049; PADIN, XOSE ANTONIO/0000-0002-4277-3410	Institut Frangais de Recherche pour I'Exploitation de la Mer (IFREMER); CNRS/Institut National des Sciences de I'Univers (INSU)/Les Enveloppes Fluides et I'Environnement (LEFE); CNRS; European Union's Horizon research and innovation programme [633211]; Spanish Ministry of Economy and Competitiveness [CTM2013-41048-P]; Fondo Europeo de Desarrollo Regional (FEDER)	Institut Frangais de Recherche pour I'Exploitation de la Mer (IFREMER); CNRS/Institut National des Sciences de I'Univers (INSU)/Les Enveloppes Fluides et I'Environnement (LEFE); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union's Horizon research and innovation programme; Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government)	The OVIDE research project was co-funded by the Institut Frangais de Recherche pour I'Exploitation de la Mer (IFREMER) and CNRS/Institut National des Sciences de I'Univers (INSU)/Les Enveloppes Fluides et I'Environnement (LEFE). H.M. was supported by CNRS. This is a contribution to the AtlantOS project funded by the European Union's Horizon 2020 research and innovation programme under grant agreement 633211. This study is also a contribution to the BOCATS project (CTM2013-41048-P) supported by the Spanish Ministry of Economy and Competitiveness and co-funded by the Fondo Europeo de Desarrollo Regional 2014-2020 (FEDER). We thank the captain of the research vessel Sarmiento Gamboa-A. Campos-and her crew for help that made possible the success of the BOCATS cruise. We thank D. Barton for revision of the manuscript.	Daniault N, 2011, J PHYS OCEANOGR, V41, P437, DOI 10.1175/2010JPO4428.1; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fontela M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26931; Freiwald A., 2004, UNEP WCMC BIODIVERSI; Freiwald A, 2017, GLOBAL DISTRIBUTION; Garcia H. E., 2014, WORLD OCEAN ATLAS 20, V4; Garcia HE, 2013, WORLD OCEAN ATLAS 20, V3, DOI [10.7289/V5XG9P2W, DOI 10.7289/V5XG9P2W]; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Gehlen M, 2014, BIOGEOSCIENCES, V11, P6955, DOI 10.5194/bg-11-6955-2014; Gourcuff C, 2011, J ATMOS OCEAN TECH, V28, P1324, DOI 10.1175/2011JTECHO818.1; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hall-Spencer J, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P135; Hennige SJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0990; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; IPCC, 2014, WORKING GROUP 1 CONT; Jackson EL, 2014, ICES J MAR SCI, V71, P2621, DOI 10.1093/icesjms/fsu099; Jeansson E, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003961; Jiang LQ, 2015, GLOBAL BIOGEOCHEM CY, V29, P1656, DOI 10.1002/2015GB005198; Key R. M., 2015, GLOBAL OCEAN DATA AN; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Kriegler E, 2017, GLOBAL ENVIRON CHANG, V42, P297, DOI 10.1016/j.gloenvcha.2016.05.015; Le Quere C, 2016, PUBLIC HEALTH REV, V37, DOI 10.1186/s40985-016-0038-z; Lewis E., 1998, PROGRAM DEV CO2 SYST; Lherminier P, 2010, DEEP-SEA RES PT I, V57, P1374, DOI 10.1016/j.dsr.2010.07.009; Locarnini R. A., 2013, WORLD OCEAN ATLAS 20, V1; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; Matsumoto K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002397; Mercier H, 2015, PROG OCEANOGR, V132, P250, DOI 10.1016/j.pocean.2013.11.001; Millero FJ, 2008, DEEP-SEA RES PT I, V55, P50, DOI 10.1016/j.dsr.2007.10.001; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Olsen A, 2016, EARTH SYST SCI DATA, V8, P297, DOI 10.5194/essd-8-297-2016; Perez FF, 2008, BIOGEOSCIENCES, V5, P1669, DOI 10.5194/bg-5-1669-2008; Perez FF, 2013, NAT GEOSCI, V6, P146, DOI [10.1038/ngeo1680, 10.1038/NGEO1680]; Pickart R.S., 2008, ARCTIC SUBARCTIC OCE, P629, DOI [DOI 10.1007/978-1-4020-6774-7, 10.1007/978-1%2D4020-6774-7%5F27, DOI 10.1007/978-1%2D4020-6774-7%5F27]; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Resplandy L, 2013, GEOPHYS RES LETT, V40, P3091, DOI 10.1002/grl.50414; Riahi K, 2017, GLOBAL ENVIRON CHANG, V42, P153, DOI 10.1016/j.gloenvcha.2016.05.009; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; ROGERS AD, 2007, SEAMOUNTS ECOLOGY FI, P141; Steinfeldt R, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003311; Subhas AV, 2015, GEOCHIM COSMOCHIM AC, V170, P51, DOI 10.1016/j.gca.2015.08.011; Tagklis F, 2017, GLOBAL BIOGEOCHEM CY, V31, P1218, DOI 10.1002/2016GB005617; Tanhua T, GLOB BIOGEOCHEM CYCL, V20; Tanhua T, 2007, P NATL ACAD SCI USA, V104, P3037, DOI 10.1073/pnas.0606574104; Thresher RE, 2011, MAR ECOL PROG SER, V442, P87, DOI 10.3354/meps09400; Tittensor DP, 2010, MAR ECOL-EVOL PERSP, V31, P212, DOI 10.1111/j.1439-0485.2010.00393.x; van Heuven S., 2009, MATLAB PROGRAM DEV C; Vazquez-Rodriguez M, 2009, BIOGEOSCIENCES, V6, P439, DOI 10.5194/bg-6-439-2009; Velo A, 2010, SCI MAR, V74, P21, DOI 10.3989/scimar.2010.74s1021; Yashayaev I, 2017, GEOPHYS RES LETT, V44, P1429, DOI 10.1002/2016GL071668; Zweng MM, 2013, WORLD OCEAN ATLAS 20, V2, P74	54	50	50	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					515	+		10.1038/nature25493	http://dx.doi.org/10.1038/nature25493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29433125	Green Submitted, Green Published			2022-12-28	WOS:000425597400044
J	Fernando, SM; Tran, A; Taljaard, M; Cheng, W; Rochwerg, B; Seely, AJE; Perry, JJ				Fernando, Shannon M.; Tran, Alexandre; Taljaard, Monica; Cheng, Wei; Rochwerg, Bram; Seely, Andrew J. E.; Perry, Jeffrey J.			Prognostic Accuracy of the Quick Sequential Organ Failure Assessment for Mortality in Patients With Suspected Infection A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							INFLAMMATORY RESPONSE SYNDROME; INTERNATIONAL CONSENSUS DEFINITIONS; IN-HOSPITAL MORTALITY; INTENSIVE-CARE-UNIT; EMERGENCY-DEPARTMENT; QSOFA SCORE; PREDICTIVE PERFORMANCE; CLINICAL-CRITERIA; SIRS CRITERIA; SEPSIS	Background: The quick Sequential Organ Failure Assessment (qSOFA) has been proposed for prediction of mortality in patients with suspected infection. Purpose: To summarize and compare the prognostic accuracy of qSOFA and the systemic inflammatory response syndrome (SIRS) criteria for prediction of mortality in adult patients with suspected infection. Data Sources: Four databases from inception through November 2017. Study Selection: English-language studies using qSOFA for prediction of mortality (in-hospital, 28-day, or 30-day) in adult patients with suspected infection in the intensive care unit (ICU), emergency department (ED), or hospital wards. Data Extraction: Two investigators independently extracted data and assessed study quality using standard criteria. Data Synthesis: Thirty-eight studies were included (n = 385 333). qSOFA was associated with a pooled sensitivity of 60.8% (95% CI, 51.4% to 69.4%) and a pooled specificity of 72.0% (CI, 63.4% to 79.2%) for mortality. The SIRS criteria were associated with a pooled sensitivity of 88.1% (CI, 82.3% to 92.1%) and a pooled specificity of 25.8% (CI, 17.1% to 36.9%). The pooled sensitivity of qSOFA was higher in the ICU population (87.2% [CI, 75.8% to 93.7%]) than the non-ICU population (51.2% [CI, 43.6% to 58.7%]). The pooled specificity of qSOFA was higher in the non-ICU population (79.6% [CI, 73.3% to 84.7%]) than the ICU population (33.3% [CI, 23.8% to 44.4%]). Limitation: Potential risk of bias in inCIuded studies due to qSOFA interpretation and patient selection. Conclusion: qSOFA had poor sensitivity and moderate specificity for short-term mortality. The SIRS criteria had sensitivity superior to that of qSOFA, supporting their use for screening of patients and as a prompt for treatment initiation.	[Fernando, Shannon M.] Univ Ottawa, Dept Emergency Med, Ottawa Hosp, Civ Campus,Room EM-206,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada; [Fernando, Shannon M.] Univ Ottawa, Dept Med, Ottawa Hosp, Div Crit Care, Civ Campus,Room EM-206,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada; Ottawa Hosp, Res Inst, Ottawa, ON, Canada; McMaster Univ, Hamilton, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; McMaster University	Fernando, SM (corresponding author), Univ Ottawa, Dept Emergency Med, Ottawa Hosp, Civ Campus,Room EM-206,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.; Fernando, SM (corresponding author), Univ Ottawa, Dept Med, Ottawa Hosp, Div Crit Care, Civ Campus,Room EM-206,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	sfernando@qmed.ca	Rochwerg, Bram/AAE-7606-2020; Cheng, Wei/AAE-4605-2022; Fernando, Shannon/I-9570-2019	Cheng, Wei/0000-0002-1475-4079; Fernando, Shannon/0000-0003-4549-4289; Taljaard, Monica/0000-0002-3978-8961	Canadian Association of Emergency Physicians [PROSPERO: CRD42017075964]	Canadian Association of Emergency Physicians	Canadian Association of Emergency Physicians. (PROSPERO: CRD42017075964)	Amland RC, 2018, AM J MED QUAL, V33, P50, DOI 10.1177/1062860617692034; April MD, 2017, J EMERG MED, V52, P622, DOI 10.1016/j.jemermed.2016.10.012; Askim A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0399-4; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Beynon R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000022.pub3; Bhattacharjee P, 2017, CHEST, V151, P898, DOI 10.1016/j.chest.2016.06.020; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Burnham JP, 2018, J CRIT CARE, V43, P143, DOI 10.1016/j.jcrc.2017.09.011; Chen YX, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1351-0; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Churpek MM, 2017, CRIT CARE MED, V45, P1677, DOI 10.1097/CCM.0000000000002620; de Groot B, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0436-3; Deeks JJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000127; Donnelly JP, 2017, LANCET INFECT DIS, V17, P661, DOI 10.1016/S1473-3099(17)30117-2; Finkelsztein EJ, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1658-5; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Forward E, 2017, INTENS CARE MED, V43, P945, DOI 10.1007/s00134-017-4776-2; Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329; Giamarellos-Bourboulis EJ, 2017, CLIN MICROBIOL INFEC, V23, P104, DOI 10.1016/j.cmi.2016.11.003; del Castillo JG, 2017, EUR J CLIN MICROBIOL, V36, P2361, DOI 10.1007/s10096-017-3068-7; Guirgis FW, 2020, J INTENSIVE CARE MED, V35, P270, DOI 10.1177/0885066617741284; Haydar S, 2017, AM J EMERG MED, V35, P1730, DOI 10.1016/j.ajem.2017.07.001; Henning DJ, 2017, ANN EMERG MED, V70, P544, DOI 10.1016/j.annemergmed.2017.01.008; Huson MAM, 2017, INFECTION, V45, P893, DOI 10.1007/s15010-017-1057-5; Huson MAM, 2017, TRAVEL MED INFECT DI, V15, P76, DOI 10.1016/j.tmaid.2016.10.014; Hwang S, 2017, ANN EMERG MED, V70, pS109, DOI 10.1016/j.annemergmed.2017.07.254; Johnson A, 2016, CRIT CARE MED, V44, P91; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Khwannimit B, 2018, J CRIT CARE, V44, P156, DOI 10.1016/j.jcrc.2017.10.023; Kim M, 2017, SUPPORT CARE CANCER, V25, P1557, DOI 10.1007/s00520-016-3567-6; KNAUS WA, 1992, CHEST, V101, P1656, DOI 10.1378/chest.101.6.1656; Kolditz M, 2016, INTENS CARE MED, V42, P2108, DOI 10.1007/s00134-016-4517-y; Lamontagne F, 2017, JAMA-J AM MED ASSOC, V317, P267, DOI 10.1001/jama.2016.19684; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; LeGuen M, 2018, RESUSCITATION, V122, P13, DOI 10.1016/j.resuscitation.2017.11.036; Levy MM, 2014, INTENS CARE MED, V40, P1623, DOI 10.1007/s00134-014-3496-0; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Marik PE, 2017, J THORAC DIS, V9, P943, DOI 10.21037/jtd.2017.03.125; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moskowitz A, 2017, CRIT CARE MED, V45, P1813, DOI 10.1097/CCM.0000000000002622; Park HK, 2017, J CRIT CARE, V42, P12, DOI 10.1016/j.jcrc.2017.06.020; Piano S, 2018, GUT, V67, P1892, DOI 10.1136/gutjnl-2017-314324; Quinten VM, 2018, EUR J EMERG MED, V25, P328, DOI 10.1097/MEJ.0000000000000460; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ranzani OT, 2017, AM J RESP CRIT CARE, V196, P1287, DOI [10.1164/rccm.201611-2262OC, 10.1164/rccm.201611-2262oc]; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sampson M, 2008, J CLIN EPIDEMIOL, V61, P755, DOI 10.1016/j.jclinepi.2007.10.003; Scott MC, 2017, EMERG MED CLIN N AM, V35, P1, DOI 10.1016/j.emc.2016.08.002; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Siddiqui S, 2017, J CRIT CARE, V41, P191, DOI 10.1016/j.jcrc.2017.05.017; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sprung CL, 2006, INTENS CARE MED, V32, P421, DOI 10.1007/s00134-005-0039-8; Sterling SA, 2017, CRIT CARE MED, V45, P1436, DOI 10.1097/CCM.0000000000002512; Takwoingi Y, 2010, QUICK REFERENCE WORK, V1; Umemura Y, 2017, J INFECT CHEMOTHER, V23, P757, DOI 10.1016/j.jiac.2017.07.005; Vincent JL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1389-z; Vincent JL, 1997, CRIT CARE MED, V25, P372, DOI 10.1097/00003246-199702000-00029; Wang AY, 2018, AM J EMERG MED, V36, P949, DOI 10.1016/j.ajem.2017.10.056; Wang HE, 2017, CRIT CARE MED, V45, P1443, DOI 10.1097/CCM.0000000000002538; Wang JY, 2016, AM J EMERG MED, V34, P1788, DOI 10.1016/j.ajem.2016.06.015; Weigle H, 2016, ANN EMERG MED, V68, pS132, DOI DOI 10.1016/j.annemergmed.2016.08.361; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Williams JM, 2017, CHEST, V151, P586, DOI 10.1016/j.chest.2016.10.057	66	141	150	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					266	+		10.7326/M17-2820	http://dx.doi.org/10.7326/M17-2820			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29404582				2022-12-28	WOS:000425434000015
J	Ugurlar, D; Howes, SC; de Kreuk, BJ; Koning, RI; de Jong, RN; Beurskens, FJ; Schuurman, J; Koster, AJ; Sharp, TH; Parren, PWHI; Gros, P				Ugurlar, Deniz; Howes, Stuart C.; de Kreuk, Bart-Jan; Koning, Roman I.; de Jong, Rob N.; Beurskens, Frank J.; Schuurman, Janine; Koster, Abraham J.; Sharp, Thomas H.; Parren, Paul W. H. I.; Gros, Piet			Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement	SCIENCE			English	Article							C1Q BINDING-SITE; CRYSTAL-STRUCTURE; GLOBULAR HEAD; HUMAN-IGG; RECRUIT COMPLEMENT; CATALYTIC DOMAIN; IMMUNOGLOBULIN-G; PROTEASE C1R; C-CHAIN; B-CHAIN	Danger patterns on microbes or damaged host cells bind and activate C1, inducing innate immune responses and clearance through the complement cascade. How these patterns trigger complement initiation remains elusive. Here, we present cryo-electron microscopy analyses of C1 bound to monoclonal antibodies in which we observed heterogeneous structures of single and clustered C1-immunoglobulin G1 (IgG1) hexamer complexes. Distinct C1q binding sites are observed on the two Fc-CH2 domains of each IgG molecule. These are consistent with known interactions and also reveal additional interactions, which are supported by functional IgG1-mutant analysis. Upon antibody binding, the C1q arms condense, inducing rearrangements of the C1r(2)s(2) proteases and tilting C1q's cone-shaped stalk. The data suggest that C1r may activate C1s within single, strained C1 complexes or between neighboring C1 complexes on surfaces.	[Ugurlar, Deniz; Gros, Piet] Univ Utrecht, Bijvoet Ctr Biomol Res, Crystal & Struct Chem, Dept Chem,Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Howes, Stuart C.; Koning, Roman I.; Koster, Abraham J.; Sharp, Thomas H.] Leiden Univ, Sect Electron Microscopy, Dept Mol Cell Biol, Med Ctr, Einthovenweg 20, NL-2300 RC Leiden, Netherlands; [de Kreuk, Bart-Jan; de Jong, Rob N.; Beurskens, Frank J.; Schuurman, Janine; Parren, Paul W. H. I.] Genmab, Yalelaan 60, NL-3584 CM Utrecht, Netherlands; [Koning, Roman I.; Koster, Abraham J.] Leiden Univ, NeCEN, Gorlaeus Labs, NL-2333 CC Leiden, Netherlands; [Parren, Paul W. H. I.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Genmab; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gros, P (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Crystal & Struct Chem, Dept Chem,Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.; Sharp, TH (corresponding author), Leiden Univ, Sect Electron Microscopy, Dept Mol Cell Biol, Med Ctr, Einthovenweg 20, NL-2300 RC Leiden, Netherlands.; Parren, PWHI (corresponding author), Genmab, Yalelaan 60, NL-3584 CM Utrecht, Netherlands.; Parren, PWHI (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	t.sharp@lumc.nl; p.w.h.i.parren@lumc.nl; p.gros@uu.nl	Gros, Piet/AAD-6452-2019; Koster, Abraham/I-7665-2017	Gros, Piet/0000-0002-7782-2585; Beurskens, Frank/0000-0002-7165-5771; Ugurlar, Deniz/0000-0001-8841-3851; Parren, Paul/0000-0002-4365-3859; Sharp, Thomas/0000-0002-1990-2333; Schuurman, Janine/0000-0002-9738-9926; Koning, Roman/0000-0001-6736-7147; Koster, Abraham/0000-0003-1717-2549; de Jong, Rob N./0000-0002-9300-6633	Netherlands Organization for Scientific Research (NWO) [CW 714.013.002, 700.57.010, STW 13711]; Institute of Chemical Immunology [NWO 024.002.009]; European Research Council [233229]; Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden [NWO 175.010.2009.001]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Institute of Chemical Immunology; European Research Council(European Research Council (ERC)European Commission); Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden	Electron density maps are deposited in the Electron Microscopy Data Bank (EMDB). We gratefully acknowledge helpful discussions with L. van Bezouwen, D. Meijer, F. Forster (Utrecht, Netherlands), and S. Scheres (Cambridge, UK), and technical assistance from C. Schneijdenberg and H. Meeldijk (EM-square, Utrecht). This research was supported by grants from the Netherlands Organization for Scientific Research (NWO) (projects CW 714.013.002, 700.57.010, and STW 13711), the Institute of Chemical Immunology (WO 024.002.009), and the European Research Council (project 233229). This work was supported by the Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden (NWO 175.010.2009.001).	Arlaud GJ, 2001, IMMUNOL REV, V180, P136, DOI 10.1034/j.1600-065X.2001.1800112.x; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; BURTON DR, 1980, NATURE, V288, P338, DOI 10.1038/288338a0; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Davies AM, 2014, MOL IMMUNOL, V62, P46, DOI 10.1016/j.molimm.2014.05.015; de Jong RN, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002344; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gaboriaud C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00565; Gingras AR, 2011, STRUCTURE, V19, P1635, DOI 10.1016/j.str.2011.08.014; Girija UV, 2013, P NATL ACAD SCI USA, V110, P13916, DOI 10.1073/pnas.1311113110; HUGHESJONES NC, 1979, MOL IMMUNOL, V16, P697, DOI 10.1016/0161-5890(79)90010-5; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Idusogie EE, 2001, J IMMUNOL, V166, P2571, DOI 10.4049/jimmunol.166.4.2571; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; Kojouharova MS, 2004, J IMMUNOL, V172, P4351, DOI 10.4049/jimmunol.172.7.4351; Kojouharova MS, 2003, BBA-PROTEINS PROTEOM, V1652, P64, DOI 10.1016/j.bbapap.2003.08.003; Michaelsen TE, 2006, EUR J IMMUNOL, V36, P129, DOI 10.1002/eji.200535178; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Mortensen SA, 2017, P NATL ACAD SCI USA, V114, P986, DOI 10.1073/pnas.1616998114; Perry AJ, 2013, J BIOL CHEM, V288, P15821, DOI 10.1074/jbc.M113.464545; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sharp TH, 2017, J STRUCT BIOL, V197, P155, DOI 10.1016/j.jsb.2016.09.008; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Wang G, 2016, MOL CELL, V63, P135, DOI 10.1016/j.molcel.2016.05.016	32	89	90	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					794	797	aao4988	10.1126/science.aao4988	http://dx.doi.org/10.1126/science.aao4988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449492	Green Submitted			2022-12-28	WOS:000425116200045
J	Berns, DS; DeNardo, LA; Pederick, DT; Luo, LQ				Berns, Dominic S.; DeNardo, Laura A.; Pederick, Daniel T.; Luo, Liqun			Teneurin-3 controls topographic circuit assembly in the hippocampus	NATURE			English	Article							CELL-CELL ADHESION; ENTORHINAL CORTEX; LAMINAR ORGANIZATION; GENE-EXPRESSION; THALAMIC NUCLEI; SPATIAL MAP; PROJECTIONS; NEURONS; CA1; CONNECTIONS	Brain functions rely on specific patterns of connectivity. Teneurins are evolutionarily conserved transmembrane proteins that instruct synaptic partner matching in Drosophila and are required for vertebrate visual system development. The roles of vertebrate teneurins in connectivity beyond the visual system remain largely unknown and their mechanisms of action have not been demonstrated. Here we show that mouse teneurin-3 is expressed in multiple topographically interconnected areas of the hippocampal region, including proximal CA1, distal subiculum, and medial entorhinal cortex. Viral-genetic analyses reveal that teneurin-3 is required in both CA1 and subicular neurons for the precise targeting of proximal CA1 axons to distal subiculum. Furthermore, teneurin-3 promotes homophilic adhesion in vitro in a splicing isoform-dependent manner. These findings demonstrate striking genetic heterogeneity across multiple hippocampal areas and suggest that teneurin-3 may orchestrate the assembly of a complex distributed circuit in the mammalian brain via matching expression and homophilic attraction.	[Berns, Dominic S.; DeNardo, Laura A.; Pederick, Daniel T.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Berns, Dominic S.; DeNardo, Laura A.; Pederick, Daniel T.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Berns, Dominic S.] Stanford Univ, Neurosci Grad Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Luo, LQ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Pederick, Daniel/0000-0003-1870-9475	National Institute on Deafness and Other Communication Disorders [F31DC013240]; National Institute of Neurological Disorders and Stroke [F32NS087860]; National Institutes of Health [R01-NS050580]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC013240] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Guo and the Howard Hughes Medical Institute/Janelia Research Campus for producing the Ten3<SUP>cre</SUP> and Ten3<SUP>fl</SUP> alleles, M. Sur for providing the Ten3<SUP>Delta 4</SUP> allele, the Neuroscience Gene Vector and Virus Core at Stanford for producing viruses, K. DeLoach for technical assistance, T. Mosca and W. Hong for advice and inspiration, members of the Luo laboratory for discussion and support, P. Thomas for the dual transcription unit vector, T. Sudhof for advice and the latrophilin-3 construct, and K. Shen, L. Giocomo, T. Mosca, H. Li, J. Li, J. Lui, E. Richman and A. Shuster for critiques of the manuscript. D.S.B. was supported by a National Institute on Deafness and Other Communication Disorders predoctoral fellowship (F31DC013240), L.A.D. was supported by an National Institute of Neurological Disorders and Stroke postdoctoral fellowship (F32NS087860) and L. L. is an investigator of Howard Hughes Medical Institute. This work was supported by a National Institutes of Health grant (R01-NS050580 to L.L.).	Aldahmesh MA, 2012, GENET MED, V14, P900, DOI 10.1038/gim.2012.71; Alkelai A, 2016, CLIN GENET, V90, P211, DOI 10.1111/cge.12782; Amaral D G, 1991, Hippocampus, V1, P415, DOI 10.1002/hipo.450010410; Antinucci P, 2016, CURR BIOL, V26, P1802, DOI 10.1016/j.cub.2016.05.035; Antinucci P, 2013, CELL REP, V5, P582, DOI 10.1016/j.celrep.2013.09.045; Beckmann J, 2013, NANO LETT, V13, P2937, DOI 10.1021/nl4013248; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Boucard AA, 2014, J BIOL CHEM, V289, P387, DOI 10.1074/jbc.M113.504779; CABALLEROBLEDA M, 1993, J COMP NEUROL, V328, P115, DOI 10.1002/cne.903280109; Cembrowski MS, 2016, NEURON, V89, P351, DOI 10.1016/j.neuron.2015.12.013; Croarkin PE, 2017, J CLIN PSYCHIAT, V78, P1337, DOI 10.4088/JCP.15m10314; Dharmaratne N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043083; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Green EK, 2013, MOL PSYCHIATR, V18, P1302, DOI 10.1038/mp.2012.142; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Honda Y, 2004, J COMP NEUROL, V473, P463, DOI 10.1002/cne.20093; Honda Y, 2015, NEUROSCI RES, V92, P1, DOI 10.1016/j.neures.2014.11.011; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Igarashi KM, 2014, FEBS LETT, V588, P2470, DOI 10.1016/j.febslet.2014.06.004; Ishizuka N, 2001, J COMP NEUROL, V435, P89, DOI 10.1002/cne.1195; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Kolodkin AL, 2011, COLD SPRING HARB PER, V3, P1, DOI DOI 10.1101/CSHPERSPECT.A001727; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Leamey CA, 2008, CEREB CORTEX, V18, P53, DOI 10.1093/cercor/bhm031; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Loh KH, 2016, CELL, V166, P1295, DOI 10.1016/j.cell.2016.07.041; Lu YC, 2015, STRUCTURE, V23, P1678, DOI 10.1016/j.str.2015.06.024; Ivorra JL, 2014, SCHIZOPHR RES, V159, P107, DOI 10.1016/j.schres.2014.07.004; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; MEIBACH RC, 1977, BRAIN RES, V124, P197, DOI 10.1016/0006-8993(77)90880-0; Mosca TJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03726; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Muraoka D, 2007, DEV NEUROSCI-BASEL, V29, P59, DOI 10.1159/000096211; Naber PA, 2001, HIPPOCAMPUS, V11, P99, DOI 10.1002/hipo.1028; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; O'Reilly KC, 2013, J COMP NEUROL, V521, P4284, DOI 10.1002/cne.23417; O'Sullivan ML, 2012, NEURON, V73, P903, DOI 10.1016/j.neuron.2012.01.018; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Rubin BP, 2002, DEVELOPMENT, V129, P4697; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Sisino G, 2006, ANAL BIOCHEM, V359, P283, DOI 10.1016/j.ab.2006.09.002; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; TAMAMAKI N, 1990, J COMP NEUROL, V291, P509, DOI 10.1002/cne.902910403; TAMAMAKI N, 1995, J COMP NEUROL, V353, P379, DOI 10.1002/cne.903530306; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Triplett JW, 2011, P NATL ACAD SCI USA, V108, P19060, DOI 10.1073/pnas.1102834108; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Weissbourd B, 2014, NEURON, V83, P645, DOI 10.1016/j.neuron.2014.06.024; Witter M, 2012, MOUSE NERVOUS SYSTEM, P112, DOI 10.1016/B978-0-12-369497-3.10005-6; WITTER MP, 1990, PROG BRAIN RES, V83, P47; Wright NF, 2013, J COMP NEUROL, V521, P2966, DOI 10.1002/cne.23325; Wright NF, 2010, J COMP NEUROL, V518, P2334, DOI 10.1002/cne.22336	64	76	76	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					328	+		10.1038/nature25463	http://dx.doi.org/10.1038/nature25463			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29414938	Green Accepted			2022-12-28	WOS:000424996300031
J	Rubin, R				Rubin, Rita			State Restrictions of e-Cigarette Use Has Slowed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					540	540		10.1001/jama.2018.0121	http://dx.doi.org/10.1001/jama.2018.0121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450532				2022-12-28	WOS:000424908400006
J	Dakin, R; Segre, PS; Straw, AD; Altshuler, DL				Dakin, Roslyn; Segre, Paolo S.; Straw, Andrew D.; Altshuler, Douglas L.			Morphology, muscle capacity, skill, and maneuvering ability in hummingbirds	SCIENCE			English	Article							PREDATOR-PREY INTERACTIONS; BODY-MASS; FLIGHT PERFORMANCE; FLYING ANIMALS; BIRDS; MANEUVERABILITY; SPEED; STRATEGIES; LOCOMOTION; ENERGETICS	How does agility evolve? This question is challenging because natural movement has many degrees of freedom and can be influenced by multiple traits. We used computer vision to record thousands of translations, rotations, and turns from more than 200 hummingbirds from 25 species, revealing that distinct performance metrics are correlated and that species diverge in their maneuvering style. Our analysis demonstrates that the enhanced maneuverability of larger species is explained by their proportionately greater muscle capacity and lower wing loading. Fast acceleration maneuvers evolve by recruiting changes in muscle capacity, whereas fast rotations and sharp turns evolve by recruiting changes in wing morphology. Both species and individuals use turns that play to their strengths. These results demonstrate how both skill and biomechanical traits shape maneuvering behavior.	[Dakin, Roslyn; Segre, Paolo S.; Altshuler, Douglas L.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Straw, Andrew D.] Univ Freiburg, Dept Anim Physiol Neurobiol & Behav, Fac Biol, D-79104 Freiburg, Germany; [Dakin, Roslyn] Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA; [Segre, Paolo S.] Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	University of British Columbia; University of Freiburg; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Stanford University	Altshuler, DL (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada.	doug@zoology.ubc.ca	Straw, Andrew D/A-1244-2007; Altshuler, Douglas L./E-5786-2011	Straw, Andrew D/0000-0001-8381-0858; Altshuler, Douglas L./0000-0002-1364-3617	NSF [IOS 0923849]; Natural Sciences and Engineering Research Council of Canada [402677]	NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank the Los Amigos and La Selva Biological Stations, La Georgina restaurant, Hacienda Guaytara, L. Darkhovsky, A. Quinonez, C. Andrade, J. Saucier, A. Ryskiewicz, S. Chang, E. Kim, M. Van Vlaardingen, C. Witt, O. Ramirez, R. Vargas, A. Camacho, M. Pennell, V. Careau, and three anonymous reviewers. This research was funded by NSF (IOS 0923849) and the Natural Sciences and Engineering Research Council of Canada (402677 and PDF). Data and scripts are available on figshare at https://doi.org/10.6084/m9.figshare.5307136.v3. R.D., P.S.S., and D.L.A. designed the research. A.D.S. and P.S.S. developed the data acquisition techniques. P.S.S. and D.L.A. collected the data. R.D. developed the analysis and figures. R.D. and D.L.A. wrote the manuscript. All authors approved the manuscript.	Alerstam T, 2007, PLOS BIOL, V5, P1656, DOI 10.1371/journal.pbio.0050197; Altshuler DL, 2010, J EXP BIOL, V213, P725, DOI 10.1242/jeb.037002; Arnold S. J., 1983, INTEGR COMP BIOL, V23, P347, DOI DOI 10.1093/ICB/23.2.347; Burns JG, 2002, BEHAV ECOL SOCIOBIOL, V52, P128, DOI 10.1007/s00265-002-0494-y; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; CARPENTER FL, 1983, P NATL ACAD SCI-BIOL, V80, P7259, DOI 10.1073/pnas.80.23.7259; Chai P, 1997, J EXP BIOL, V200, P1527; Cheng B, 2016, J EXP BIOL, V219, P3518, DOI 10.1242/jeb.137539; Cheverud JM, 1996, AM ZOOL, V36, P44; Clark CJ, 2009, P ROY SOC B-BIOL SCI, V276, P3047, DOI 10.1098/rspb.2009.0508; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Dial KP, 2008, TRENDS ECOL EVOL, V23, P394, DOI 10.1016/j.tree.2008.03.005; Dudley R, 2002, INTEGR COMP BIOL, V42, P135, DOI 10.1093/icb/42.1.135; GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051; GREENEWALT CH, 1975, T AM PHILOS SOC, V65, P5; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Hedrick TL, 2007, J EXP BIOL, V210, P1897, DOI 10.1242/jeb.002055; HOWLAND HC, 1974, J THEOR BIOL, V47, P333, DOI 10.1016/0022-5193(74)90202-1; Kruyt JW, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0585; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Lilliendahl K, 2002, J AVIAN BIOL, V33, P212, DOI 10.1034/j.1600-048X.2002.330302.x; Lindstrom A, 2000, J EXP BIOL, V203, P913; MARDEN JH, 1987, J EXP BIOL, V130, P235; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; Moore TY, 2015, INTEGR COMP BIOL, V55, P1188, DOI 10.1093/icb/icv074; PENNYCUICK CJ, 1978, OIKOS, V30, P165, DOI 10.2307/3543476; Read TJG, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0110; Ros IG, 2011, P NATL ACAD SCI USA, V108, P19990, DOI 10.1073/pnas.1107519108; SAVILE DBO, 1957, EVOLUTION, V11, P212, DOI 10.2307/2406051; Sefati S, 2013, P NATL ACAD SCI USA, V110, P18798, DOI 10.1073/pnas.1309300110; Segre PS, 2016, CURR BIOL, V26, P3368, DOI 10.1016/j.cub.2016.10.028; Segre PS, 2015, ELIFE, V4, DOI 10.7554/eLife.11159; Sholtis KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125659; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Skandalis DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01223-x; SRYGLEY RB, 1993, J EXP BIOL, V174, P155; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Warrick DR, 1998, CAN J ZOOL, V76, P1063, DOI 10.1139/cjz-76-6-1063; Welch KC, 2009, COMP BIOCHEM PHYS B, V152, P324, DOI 10.1016/j.cbpb.2008.12.013; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson RP, 2015, ELIFE, V4, DOI 10.7554/eLife.06487; Wright NA, 2016, P NATL ACAD SCI USA, V113, P4765, DOI 10.1073/pnas.1522931113	42	35	35	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					653	657		10.1126/science.aao7104	http://dx.doi.org/10.1126/science.aao7104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439237				2022-12-28	WOS:000425117700032
J	Meschede, D				Meschede, Dieter			Superradiators created atom by atom	SCIENCE			English	Editorial Material									[Meschede, Dieter] Univ Bonn, Inst Angew Phys, D-53115 Bonn, Germany	University of Bonn	Meschede, D (corresponding author), Univ Bonn, Inst Angew Phys, D-53115 Bonn, Germany.	meschede@uni-bonn.de						DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Kim J, 2018, SCIENCE, V359, P662, DOI 10.1126/science.aar2179; PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37; Reimann R, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.023601; Scully MO, 2009, SCIENCE, V325, P1510, DOI 10.1126/science.1176695	5	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					641	641	aas9067	10.1126/science.aas9067	http://dx.doi.org/10.1126/science.aas9067			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439232				2022-12-28	WOS:000425117700025
J	Merrill, TG; Lopez, W; Perl, SB; Bassett, MT				Merrill, Thomas G.; Lopez, Wilfredo; Perl, Sarah B.; Bassett, Mary T.			The Judicial Threat to Public Health Innovation - The Sword of Boreali	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Merrill, Thomas G.; Perl, Sarah B.; Bassett, Mary T.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; [Merrill, Thomas G.; Bassett, Mary T.] New York City Board Hlth, New York, NY 10013 USA; [Lopez, Wilfredo] Dept Hlth & Mental Hyg, New York, NY USA; [Lopez, Wilfredo] Board Hlth, New York, NY USA	New York City Department of Health & Mental Hygiene	Merrill, TG (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.; Merrill, TG (corresponding author), New York City Board Hlth, New York, NY 10013 USA.							Duffy John, 1968, HIST PUBLIC HLTH NEW; Grynbaum Michael M., 2014, NY TIMES	2	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					499	501		10.1056/NEJMp1712636	http://dx.doi.org/10.1056/NEJMp1712636			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OX	29414275				2022-12-28	WOS:000424335200003
J	Rule, ARL				Rule, Amy R. L.			I Am That Parent	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rule, Amy R. L.] Hosp Med, Perinatal Inst, 3333 Burnet Ave, Cincinnati, OH 45229 USA		Rule, ARL (corresponding author), Hosp Med, Perinatal Inst, CCHMC, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	amy.rule@cchmc.org							0	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					445	445		10.1001/jama.2017.21048	http://dx.doi.org/10.1001/jama.2017.21048			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411036				2022-12-28	WOS:000424224500011
J	Sun, X; Tan, J; Tang, L; Guo, JJ; Li, XL				Sun, Xin; Tan, Jing; Tang, Li; Guo, Jeff Jianfei; Li, Xinling			Real world evidence: experience and lessons from China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS		[Sun, Xin; Tan, Jing; Tang, Li] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China; [Sun, Xin; Tan, Jing; Tang, Li] Sichuan Univ, West China Hosp, CREAT Grp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Guo, Jeff Jianfei] Univ Cincinnati, Coll Pharm, Cincinnati, OH USA; [Li, Xinling] Chinese State Food & Drug Adm, Ctr Adverse Drug React Monitoring, Beijing 100000, Peoples R China	Sichuan University; Sichuan University; University System of Ohio; University of Cincinnati	Sun, X (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China.; Sun, X (corresponding author), Sichuan Univ, West China Hosp, CREAT Grp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.	sunx79@hotmail.com		Tang, Li/0000-0001-8536-7538; Tan, Jing/0000-0001-8839-6705	National Natural Science Foundation of China [81590955, 71573183, 71704122]; Thousand Youth Talents Plan of China [D1024002]; National Science Foundation for Post-doctoral Scientists of China [2016M602699]; US Center of Medicaid and Medicare Services; PCORI; Novartis; AstraZeneca; Bristol-Myers Squibb; Janssen Ortho-McNeil; Roche; Eli Lilly	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Youth Talents Plan of China; National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); US Center of Medicaid and Medicare Services; PCORI(Patient-Centered Outcomes Research Institute - PCORI); Novartis(Novartis); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen Ortho-McNeil(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); Eli Lilly(Eli Lilly)	We have read and understood BMJ policy on declaration of interests and declare that the study was supported by the National Natural Science Foundation of China (grant number 81590955; 71573183; 71704122), Thousand Youth Talents Plan of China (grant number D1024002), and The National Science Foundation for Post-doctoral Scientists of China (grant number 2016M602699). JJG is supported by the US Center of Medicaid and Medicare Services, PCORI, and unrestricted educational research grants sponsored by Novartis, AstraZeneca, Bristol-Myers Squibb, Janssen Ortho-McNeil, Roche, and Eli Lilly. None is related to this article.	Aljunid SM, 2012, VALUE HEALTH, V15, pS132, DOI 10.1016/j.jval.2011.11.004; Charter R, 2016, VALUE HEALTH, V19, pA703, DOI 10.1016/j.jval.2016.09.2046; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Guo JJLG, 2003, CONNECTIONS, V9, P14; [黄卓山 Huang Zhuoshan], 2014, [循证医学, The Journal of Evidence-Based Medicine], V14, P364; Ko CY, 2015, JT COMM J QUAL PATIE, V41, P199, DOI 10.1016/S1553-7250(15)41026-8; Kwong JSW, 2017, HEART ASIA, V9, DOI 10.1136/heartasia-2017-010903; Li GW, 2016, J CLIN EPIDEMIOL, V80, P16, DOI 10.1016/j.jclinepi.2016.08.003; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Makady A, 2017, VALUE HEALTH, V20, P858, DOI 10.1016/j.jval.2017.03.008; Makady A, 2017, VALUE HEALTH, V20, P520, DOI 10.1016/j.jval.2016.12.003; Oyinlola JO, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1562-8; Ross JS, 2014, JAMA INTERN MED, V174, P1557, DOI 10.1001/jamainternmed.2014.3366; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Shu T, 2014, INT J MED INFORM, V83, P113, DOI 10.1016/j.ijmedinf.2013.08.008; [孙鑫 Sun Xin], 2017, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V17, P126; [唐立 Tang Li], 2017, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V17, P999; Tian Feng, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P301, DOI 10.3736/jcim20100401; TU JT, 1983, J NATL CANCER I, V70, P589; U.S. Food and Drug Administration, 2017, US REAL WORLD EV SUP; US Food and Drug Administration, 2016, FDAS SENT IN; Wang YZ, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/034301; Wei XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183169; Wu Xi, 2006, Zhonghua Nei Ke Za Zhi, V45, P661; Xie Q, 2014, WORLD CHINESE MEDICI, V9, P28; ZENG ZS, 1993, SURG ONCOL, V2, P311; Zhang Yan-Hong, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P161	27	37	46	8	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2018	360								j5262	10.1136/bmj.j5262	http://dx.doi.org/10.1136/bmj.j5262			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HP	29437644	Green Published, Green Submitted			2022-12-28	WOS:000424974800002
J	Bonan, GB; Doney, SC				Bonan, Gordon B.; Doney, Scott C.			Climate, ecosystems, and planetary futures: The challenge to predict life in Earth system models	SCIENCE			English	Review							MOUNTAIN PINE-BEETLE; LAND-USE; 21ST-CENTURY PROJECTIONS; BIOGEOCHEMISTRY MODELS; OCEAN ECOSYSTEMS; CHANGE IMPACTS; GLOBAL CARBON; DRIVERS; UNCERTAINTIES; EMERGENCE	Many global change stresses on terrestrial and marine ecosystems affect not only ecosystem services that are essential to humankind, but also the trajectory of future climate by altering energy and mass exchanges with the atmosphere. Earth system models, which simulate terrestrial and marine ecosystems and biogeochemical cycles, offer a common framework for ecological research related to climate processes; analyses of vulnerability, impacts, and adaptation; and climate change mitigation. They provide an opportunity to move beyond physical descriptors of atmospheric and oceanic states to societally relevant quantities such as wildfire risk, habitat loss, water availability, and crop, fishery, and timber yields. To achieve this, the science of climate prediction must be extended to a more multifaceted Earth system prediction that includes the biosphere and its resources.	[Bonan, Gordon B.] NCAR, Boulder, CO 80307 USA; [Doney, Scott C.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA	National Center Atmospheric Research (NCAR) - USA; University of Virginia	Bonan, GB (corresponding author), NCAR, Boulder, CO 80307 USA.; Doney, SC (corresponding author), Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA.	bonan@ucar.edu; sdoney@virginia.edu	Doney, Scott C/F-9247-2010	Doney, Scott C/0000-0002-3683-2437; Bonan, Gordon/0000-0003-0830-6437	National Institute of Food and Agriculture/U.S. Department of Agriculture [2015-67003-23485]; NASA Ocean Biology and Biogeochemistry Program [NNX14AL86G]; National Science Foundation	National Institute of Food and Agriculture/U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NASA Ocean Biology and Biogeochemistry Program(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	We acknowledge funding from the National Institute of Food and Agriculture/U.S. Department of Agriculture (2015-67003-23485) and the NASA Ocean Biology and Biogeochemistry Program (NNX14AL86G). We thank C. Tebaldi and J. Kleypas (NCAR) for comments on the manuscript and figures. NCAR is sponsored by the National Science Foundation.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson GB, 2018, CLIMATIC CHANGE, V146, P455, DOI 10.1007/s10584-016-1779-x; Bonan G. B., 2016, ECOLOGICAL CLIMATOLO; Bonan GB, 2016, ANNU REV ECOL EVOL S, V47, P97, DOI 10.1146/annurev-ecolsys-121415-032359; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Bright BC, 2013, J GEOPHYS RES-BIOGEO, V118, P974, DOI 10.1002/jgrg.20078; Buitenwerf R, 2015, NAT CLIM CHANGE, V5, P364, DOI 10.1038/nclimate2533; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Caldeira K, 2013, ANNU REV EARTH PL SC, V41, P231, DOI 10.1146/annurev-earth-042711-105548; Campbell JE, 2017, NATURE, V544, P84, DOI 10.1038/nature22030; Carman JC, 2017, B AM METEOROL SOC, V98, P239, DOI 10.1175/BAMS-D-16-0002.1; Chen Y, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4968042; Chisholm SW, 2000, NATURE, V407, P685, DOI 10.1038/35037696; Collins WD, 2015, GEOSCI MODEL DEV, V8, P2203, DOI 10.5194/gmd-8-2203-2015; Constable AJ, 2014, GLOBAL CHANGE BIOL, V20, P3004, DOI 10.1111/gcb.12623; Davin EL, 2014, P NATL ACAD SCI USA, V111, P9757, DOI 10.1073/pnas.1317323111; de Noblet-Ducoudre N, 2012, J CLIMATE, V25, P3261, DOI 10.1175/JCLI-D-11-00338.1; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Edburg SL, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001786; Eyring V, 2016, GEOSCI MODEL DEV, V9, P1937, DOI 10.5194/gmd-9-1937-2016; Field C.B., 2014, CONTRIBUTION WORKING; Fisher RA, 2015, GEOSCI MODEL DEV, V8, P3593, DOI 10.5194/gmd-8-3593-2015; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Follows MJ, 2011, ANNU REV MAR SCI, V3, P427, DOI 10.1146/annurev-marine-120709-142848; Frank D, 2015, GLOBAL CHANGE BIOL, V21, P2861, DOI 10.1111/gcb.12916; Friedlingstein P, 2014, J CLIMATE, V27, P511, DOI 10.1175/JCLI-D-12-00579.1; Frolicher TL, 2016, GLOBAL BIOGEOCHEM CY, V30, P1224, DOI 10.1002/2015GB005338; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gattuso J-P, 2011, OCEAN ACIDIFICATION; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Hantson S, 2016, BIOGEOSCIENCES, V13, P3359, DOI 10.5194/bg-13-3359-2016; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Hawkins E, 2016, CLIM DYNAM, V46, P3807, DOI 10.1007/s00382-015-2806-8; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hazeleger W, 2010, B AM METEOROL SOC, V91, P1357, DOI 10.1175/2010BAMS2877.1; Henson SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14682; Henson SA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005139; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Hood RR, 2006, DEEP-SEA RES PT II, V53, P459, DOI 10.1016/j.dsr2.2006.01.025; Huang XY, 2016, J ADV MODEL EARTH SY, V8, P345, DOI 10.1002/2015MS000559; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; IPCC, 2013, CLIMATE CHANGE 2022; Irvine PJ, 2017, EARTHS FUTURE, V5, P93, DOI 10.1002/2016EF000389; Ito T, 2017, GEOPHYS RES LETT, V44, P4214, DOI 10.1002/2017GL073613; Jahn A, 2016, GEOPHYS RES LETT, V43, P9113, DOI 10.1002/2016GL070067; Jochum M, 2010, J CLIMATE, V23, P2916, DOI 10.1175/2010JCLI3254.1; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kleypas JA, 2016, GLOBAL CHANGE BIOL, V22, P3539, DOI 10.1111/gcb.13347; Krishnamurthy A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003440; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Laufkotter C, 2015, BIOGEOSCIENCES, V12, P6955, DOI 10.5194/bg-12-6955-2015; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Levis S., 2016, CLIM CHANGE; Levis S, 2012, J CLIMATE, V25, P4839, DOI 10.1175/JCLI-D-11-00446.1; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lombardozzi D, 2015, J CLIMATE, V28, P292, DOI 10.1175/JCLI-D-14-00223.1; Lombardozzi D, 2014, NAT CLIM CHANGE, V4, P796, DOI [10.1038/nclimate2323, 10.1038/NCLIMATE2323]; Lovenduski NS, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa66b8; Lovenduski NS, 2016, GLOBAL BIOGEOCHEM CY, V30, P1276, DOI 10.1002/2016GB005426; Luo YQ, 2015, GLOBAL CHANGE BIOL, V21, P1737, DOI 10.1111/gcb.12766; Luyssaert S, 2014, NAT CLIM CHANGE, V4, P389, DOI [10.1038/nclimate2196, 10.1038/NCLIMATE2196]; Mahowald NM, 2017, CURR CLIM CHANGE REP, V3, P16, DOI 10.1007/s40641-017-0056-z; Maness H, 2013, NAT GEOSCI, V6, P65, DOI [10.1038/NGEO1642, 10.1038/ngeo1642]; McKinley GA, 2016, NATURE, V530, P469, DOI 10.1038/nature16958; Meehl GA, 2014, B AM METEOROL SOC, V95, P243, DOI 10.1175/BAMS-D-12-00241.1; Meehl GA, 2009, B AM METEOROL SOC, V90, P1467, DOI 10.1175/2009BAMS2778.1; MELILLO JM, 1995, GLOBAL BIOGEOCHEM CY, V9, P407; Melton JR, 2013, BIOGEOSCIENCES, V10, P753, DOI 10.5194/bg-10-753-2013; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Moore JK, 2013, J CLIMATE, V26, P9291, DOI 10.1175/JCLI-D-12-00566.1; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mueller ND, 2016, NAT CLIM CHANGE, V6, P317, DOI [10.1038/nclimate2825, 10.1038/NCLIMATE2825]; National Academies of Sciences Engineering and Medicine, 2016, NEXT GEN EARTH SYST, P350; National Research Council, 2015, CLIM INT CARB DIOX R, DOI [10.17226/18805, DOI 10.17226/18805]; Ordonez A, 2016, NAT CLIM CHANGE, V6, P1104, DOI [10.1038/nclimate3127, 10.1038/NCLIMATE3127]; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Pinder RW, 2012, P NATL ACAD SCI USA, V109, P7671, DOI 10.1073/pnas.1114243109; Polavarapu SM, 2016, ATMOS CHEM PHYS, V16, P12005, DOI 10.5194/acp-16-12005-2016; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Rhoades AM, 2016, J APPL METEOROL CLIM, V55, P173, DOI 10.1175/JAMC-D-15-0156.1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rodgers KB, 2015, BIOGEOSCIENCES, V12, P3301, DOI 10.5194/bg-12-3301-2015; Rosenzweig Cynthia, 2014, Proc Natl Acad Sci U S A, V111, P3268, DOI 10.1073/pnas.1222463110; Ruane AC, 2016, GEOSCI MODEL DEV, V9, P3493, DOI 10.5194/gmd-9-3493-2016; Russell LM, 2012, AMBIO, V41, P350, DOI 10.1007/s13280-012-0258-5; Sarmiento J. L., 2006, OCEAN BIOGEOCHEMICAL, pxii; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; Schewe J, 2014, P NATL ACAD SCI USA, V111, P3245, DOI 10.1073/pnas.1222460110; Shindell DT, 2013, ATMOS CHEM PHYS, V13, P2653, DOI 10.5194/acp-13-2653-2013; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Smith P, 2016, NAT CLIM CHANGE, V6, P42, DOI [10.1038/NCLIMATE2870, 10.1038/nclimate2870]; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stock CA, 2017, P NATL ACAD SCI USA, V114, pE1441, DOI 10.1073/pnas.1610238114; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Stocker T., 2013, COMPUTATIONAL GEOMET, DOI 10.1017/ CBO9781107415324; Sun Q, 2017, OCEAN MODEL, V112, P139, DOI 10.1016/j.ocemod.2017.03.004; Swann ALS, 2016, P NATL ACAD SCI USA, V113, P10019, DOI 10.1073/pnas.1604581113; Sweeney C, 2005, J PHYS OCEANOGR, V35, P1103, DOI 10.1175/JPO2740.1; Tagliabue A, 2016, GLOBAL BIOGEOCHEM CY, V30, P149, DOI 10.1002/2015GB005289; Tommasi D, 2017, PROG OCEANOGR, V152, P15, DOI 10.1016/j.pocean.2016.12.011; Unger N, 2014, NAT CLIM CHANGE, V4, P907, DOI 10.1038/nclimate2347; Ward DS, 2012, ATMOS CHEM PHYS, V12, P10857, DOI 10.5194/acp-12-10857-2012; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/NCLIMATE3004, 10.1038/nclimate3004]	113	250	264	81	506	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					533	+	eaam8328	10.1126/science.aam8328	http://dx.doi.org/10.1126/science.aam8328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420265				2022-12-28	WOS:000423795800032
J	Ergecen, E; Gedik, N				Ergecen, Emre; Gedik, Nuh			Lighting up superconducting stripes	SCIENCE			English	Editorial Material									[Ergecen, Emre; Gedik, Nuh] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gedik, N (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	gedik@mit.edu						Berg E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.127003; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hamidian MH, 2016, NATURE, V532, P343, DOI 10.1038/nature17411; Hucker M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.104506; Li Q, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067001; Rajasekaran S, 2018, SCIENCE, V359, P575, DOI 10.1126/science.aan3438; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0	7	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					519	519		10.1126/science.aar5254	http://dx.doi.org/10.1126/science.aar5254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420278				2022-12-28	WOS:000423795800023
J	Han, AP				Han, Andrew P.			SCIENTIFIC PUBLISHING Judge orders unmasking of anonymous peer reviewers	SCIENCE			English	News Item									[Han, Andrew P.] Retraction Watch, New York, NY 10036 USA		Han, AP (corresponding author), Retraction Watch, New York, NY 10036 USA.								0	2	2	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					504	505		10.1126/science.359.6375.504	http://dx.doi.org/10.1126/science.359.6375.504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420269				2022-12-28	WOS:000423795800014
J	Nwadiuko, J; Varadaraj, V; Ranjit, A				Nwadiuko, Joseph; Varadaraj, Varshini; Ranjit, Anju			International Medical Graduates-A Critical Component of the Global Health Workforce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOME		[Nwadiuko, Joseph] Johns Hopkins Sch Med, Dept Med, 5200 Eastern Ave, Baltimore, MD 21224 USA; [Varadaraj, Varshini] Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA; [Ranjit, Anju] Howard Univ Hosp, Washington, DC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard University	Nwadiuko, J (corresponding author), Johns Hopkins Sch Med, Dept Med, 5200 Eastern Ave, Baltimore, MD 21224 USA.	jnwadiu1@jhu.edu		Nwadiuko, Joseph/0000-0002-2498-2972				Clemens MA, 2011, DIASPORA FOR DEVELOPMENT IN AFRICA, P165; Crush J, 2014, BRAIN DRAIN REGAIN M; Educational Commission for Foreign Medical Graduates, IMG PERF 2017 MATCH; GAVIRIA M, 1975, J MED EDUC, V50, P167; Hagander LE, 2013, WORLD J SURG, V37, P14, DOI 10.1007/s00268-012-1795-6; Nwadiuko J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0165-9; Tankwanchi ABS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124734; The Saudi Arabian Cultural Bureau (SACB) in Canada, SAUD AR CULT BUR SAC; World Health Organization (WHO), 2016, 69 WORLD HLTH ASS MA	9	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2018	319	8					765	766		10.1001/jama.2017.17961	http://dx.doi.org/10.1001/jama.2017.17961			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX6GK	29423516				2022-12-28	WOS:000426181300014
J	Lewis, AC				Lewis, Alastair C.			The changing face of urban air pollution	SCIENCE			English	Editorial Material							SECONDARY ORGANIC AEROSOL; DIESEL; CARBON		[Lewis, Alastair C.] Univ York, Natl Ctr Atmospher Sci, York YO10 5DD, N Yorkshire, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of York - UK	Lewis, AC (corresponding author), Univ York, Natl Ctr Atmospher Sci, York YO10 5DD, N Yorkshire, England.	ally.lewis@york.ac.uk	Lewis, Alastair C/A-6721-2008	Lewis, Alastair C/0000-0002-4075-3651	NERC [ncas10003] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Dunmore RE, 2015, ATMOS CHEM PHYS, V15, P9983, DOI 10.5194/acp-15-9983-2015; Gentner DR, 2012, P NATL ACAD SCI USA, V109, P18318, DOI 10.1073/pnas.1212272109; Gligorovski S, 2018, SCIENCE, V359, P631, DOI 10.1126/science.aar6837; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Haagen-Smit A.J., 1954, AIR REPAIR, V4, P105, DOI DOI 10.1080/00966665.1954.10467649; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Helmig D, 2016, NAT GEOSCI, V9, P490, DOI [10.1038/NGEO2721, 10.1038/ngeo2721]; Jenkin ME, 2015, ATMOS CHEM PHYS, V15, P11433, DOI 10.5194/acp-15-11433-2015; McDonald BC, 2018, SCIENCE, V359, P760, DOI 10.1126/science.aaq0524; Tang XC, 2015, ENVIRON SCI TECH LET, V2, P303, DOI 10.1021/acs.estlett.5b00256; Wang CM, 2017, ENVIRON SCI-PROC IMP, V19, P528, DOI 10.1039/c6em00569a; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229	12	56	60	11	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					744	745	aar4925	10.1126/science.aar4925	http://dx.doi.org/10.1126/science.aar4925			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449479	Green Accepted			2022-12-28	WOS:000425116200028
J	Morinaka, BI; Lakis, E; Verest, M; Helf, MJ; Scalvenzi, T; Vagstad, AL; Sims, J; Sunagawa, S; Gugger, M; Piel, J				Morinaka, Brandon I.; Lakis, Edgars; Verest, Marjan; Helf, Maximilian J.; Scalvenzi, Thibault; Vagstad, Anna L.; Sims, James; Sunagawa, Shinichi; Gugger, Muriel; Piel, Jorn			Natural noncanonical protein splicing yields products with diverse beta-amino acid residues	SCIENCE			English	Article							S-ADENOSYLMETHIONINE PROTEIN; ESCHERICHIA-COLI; THIAMINE BIOSYNTHESIS; THIAZOLE SYNTHASE; ALPHA-KETOAMIDES; POLYTHEONAMIDE-B; MARINE SPONGE; GENETIC-CODE; IN-VITRO; ENZYMES	Current textbook knowledge holds that the structural scope of ribosomal biosynthesis is based exclusively on alpha-amino acid backbone topology. Here we report the genome-guided discovery of bacterial pathways that posttranslationally create beta-amino acid-containing products. The transformation is widespread in bacteria and is catalyzed by an enzyme belonging to a previously uncharacterized radical S-adenosylmethionine family. We show that the beta-amino acids result from an unusual protein splicing process involving backbone carbon-carbon bond cleavage and net excision of tyramine. The reaction can be used to incorporate diverse and multiple beta-amino acids into genetically encoded precursors in Escherichia coli. In addition to enlarging the set of basic amino acid components, the excision generates keto functions that are useful as orthogonal reaction sites for chemical diversification.	[Morinaka, Brandon I.; Lakis, Edgars; Verest, Marjan; Helf, Maximilian J.; Vagstad, Anna L.; Sunagawa, Shinichi; Piel, Jorn] ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland; [Scalvenzi, Thibault; Gugger, Muriel] Inst Pasteur, Collect Cyanobacteries, Dept Microbiol, 28 Rue Docteur Roux, F-75015 Paris 15, France; [Sims, James] ETH, Inst Agr Sci, Schmelzbergstr 9, CH-8092 Zurich, Switzerland; [Morinaka, Brandon I.] Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore; [Helf, Maximilian J.] Cornell Univ, Boyce Thompson Inst, 533 Tower Rd, Ithaca, NY 14853 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore; Cornell University; Boyce Thompson Institute for Plant Research	Piel, J (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	jpiel@ethz.th	Sunagawa, Shinichi/Q-5950-2019	Sunagawa, Shinichi/0000-0003-3065-0314; Vagstad, Anna Lisa/0000-0001-8074-0137; Lakis, Edgars/0000-0002-9371-5560; Gugger, Muriel/0000-0001-6728-1976; Verest, Marjan/0000-0003-0446-8981; Sims, James/0000-0003-3472-1642; Morinaka, Brandon/0000-0001-8239-619X	Swiss National Science Foundation [31003A_146992/1]; European Union (SYNPEPTIDE); European Union (European Research Council Advanced Grant "SynPlex"); Helmut Horten Foundation; Alexander von Humboldt Fellowship; ETH Postdoctoral Fellowship; Institut Pasteur	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union (SYNPEPTIDE); European Union (European Research Council Advanced Grant "SynPlex"); Helmut Horten Foundation; Alexander von Humboldt Fellowship(Alexander von Humboldt Foundation); ETH Postdoctoral Fellowship; Institut Pasteur(European Commission)	J.P. thanks the Swiss National Science Foundation (31003A_146992/1) and the European Union (SYNPEPTIDE and European Research Council Advanced Grant "SynPlex") for support. S.S. is grateful for financial support by the Helmut Horten Foundation. B.I.M. was the recipient of an Alexander von Humboldt Fellowship. A.L.V. was the recipient of an ETH Postdoctoral Fellowship. We thank D. Seebach and A. Eschenmoser for discussion and J. Keller, A. Geers, and C. Klaus for assistance with protein purification. M.G. thanks the P2M team of the Institut Pasteur for the novel cyanobacterial genomes and the Institut Pasteur for funding the Pasteur Culture Collection of Cyanobacteria. All data are contained in the main text and supplementary materials. New sequence data are archived in GenBank under accession numbers MG373765 to MG373783. B.I.M. and J.P. are inventors on patent application #EP17150498.8 submitted by the ETH Zurich that covers the use of radical S-adenosyl methionine enzymes for introducing alpha-keto-beta-3-amino acids into (poly)peptides.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Carrico IS, 2007, NAT CHEM BIOL, V3, P321, DOI 10.1038/nchembio878; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Cortina NS, 2012, ANGEW CHEM INT EDIT, V51, P811, DOI 10.1002/anie.201106305; Czekster CM, 2016, J AM CHEM SOC, V138, P5194, DOI 10.1021/jacs.6b01023; De Risi C, 2016, CHEM REV, V116, P3241, DOI 10.1021/acs.chemrev.5b00443; Freeman MF, 2017, NAT CHEM, V9, P387, DOI [10.1038/NCHEM.2666, 10.1038/nchem.2666]; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Fujino T, 2016, J AM CHEM SOC, V138, P1962, DOI 10.1021/jacs.5b12482; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Hamada T, 2005, J AM CHEM SOC, V127, P110, DOI 10.1021/ja045749e; Hamada T, 2010, J AM CHEM SOC, V132, P12941, DOI 10.1021/ja104616z; Han W, 2000, BIOORG MED CHEM LETT, V10, P711, DOI 10.1016/S0960-894X(00)00074-3; HARBESON SL, 1994, J MED CHEM, V37, P2918, DOI 10.1021/jm00044a013; Hartman MCT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000972; Hartman MCT, 2006, P NATL ACAD SCI USA, V103, P4356, DOI 10.1073/pnas.0509219103; Howe AYM, 2013, J CLIN TRANSL HEPATO, V1, P22, DOI 10.14218/JCTH.2013.002XX; Jamison MT, 2016, J NAT PROD, V79, P2243, DOI 10.1021/acs.jnatprod.6b00336; Khaliullin B, 2017, J BIOL CHEM, V292, P13022, DOI 10.1074/jbc.M117.795682; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Kuchenreuther JM, 2014, SCIENCE, V343, P424, DOI 10.1126/science.1246572; Kudo F, 2014, NAT PROD REP, V31, P1056, DOI 10.1039/c4np00007b; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Mahanta N, 2017, BIOCHEMISTRY-US, V56, P5229, DOI 10.1021/acs.biochem.7b00771; Maini R, 2015, BIOCHEMISTRY-US, V54, P3694, DOI 10.1021/acs.biochem.5b00389; Maini R, 2013, BIOORGAN MED CHEM, V21, P1088, DOI 10.1016/j.bmc.2013.01.002; Morinaka BI, 2017, ANGEW CHEM INT EDIT, V56, P762, DOI 10.1002/anie.201609469; Morinaka BI, 2014, ANGEW CHEM INT EDIT, V53, P8503, DOI 10.1002/anie.201400478; Philmus B, 2015, J AM CHEM SOC, V137, P5406, DOI 10.1021/ja513287k; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Tang WX, 2012, BIOCHEMISTRY-US, V51, P4271, DOI 10.1021/bi300255s; Venkatraman S, 2006, J MED CHEM, V49, P6074, DOI 10.1021/jm060325b; Wakimoto T, 2014, NAT CHEM BIOL, V10, P648, DOI [10.1038/NCHEMBIO.1573, 10.1038/nchembio.1573]; Walsh C., 2006, POSTTRANSLATIONAL MO; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Zhang Q, 2011, J BIOL CHEM, V286, P21287, DOI 10.1074/jbc.M111.224832; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	42	54	54	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					779	782	aao0157	10.1126/science.aao0157	http://dx.doi.org/10.1126/science.aao0157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449488				2022-12-28	WOS:000425116200041
J	Serwadda, D; Ndebele, P; Grabowski, MK; Bajunirwe, F; Wanyenze, RK				Serwadda, David; Ndebele, Paul; Grabowski, M. Kate; Bajunirwe, Francis; Wanyenze, Rhoda K.			Open data sharing and the Global South-Who benefits?	SCIENCE			English	Editorial Material							PUBLIC-HEALTH RESEARCH; RESEARCH STAKEHOLDERS; VIEWS; EXPERIENCES		[Serwadda, David; Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Serwadda, David; Grabowski, M. Kate] Rakai Hlth Sci Program, Kalisizo, Uganda; [Ndebele, Paul] Med Res Council Zimbabwe, Harare, Zimbabwe; [Grabowski, M. Kate] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda	Makerere University; Rakai Health Sciences Program; Johns Hopkins University; Mbarara University of Science & Technology	Serwadda, D (corresponding author), Makerere Univ, Sch Publ Hlth, Kampala, Uganda.; Serwadda, D (corresponding author), Rakai Hlth Sci Program, Kalisizo, Uganda.	dserwada@imul.com		Ndebele, Paul/0000-0001-9669-1544				Allen L, 2014, NATURE, V508, P312, DOI 10.1038/508312a; Bull S, 2015, J EMPIR RES HUM RES, V10, P225, DOI 10.1177/1556264615594767; Cheah PY, 2015, J EMPIR RES HUM RES, V10, P278, DOI 10.1177/1556264615592388; Council for International Organizations of Medical Sciences, 2016, INT ETH GUID HLTH RE; Denny SG, 2015, J EMPIR RES HUM RES, V10, P290, DOI 10.1177/1556264615592386; Hate K, 2015, J EMPIR RES HUM RES, V10, P239, DOI 10.1177/1556264615592383; Jao I, 2015, J EMPIR RES HUM RES, V10, P264, DOI 10.1177/1556264615592385	7	32	32	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					642	643		10.1126/science.aap8395	http://dx.doi.org/10.1126/science.aap8395			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2FH	29439233				2022-12-28	WOS:000425117700026
J	Dyer, C; Cohen, D				Dyer, Clare; Cohen, Deborah			LEGAL How should doctors use e-portfolios in the wake of the Bawa-Garba case?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												claredyer4@gmail.com						Academy of Medical Royal Colleges, 2016, AC GUID E PORTF; Cohen D, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5534; Health Education England, 2016, REP STAT TRAIN WRITT	3	11	11	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2018	360								k572	10.1136/bmj.k572	http://dx.doi.org/10.1136/bmj.k572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0IA	29437673				2022-12-28	WOS:000424976200005
J	Guo, Q; Lehmer, C; Martinez-Sanchez, A; Rudack, T; Beck, F; Hartmann, H; Perez-Berlanga, M; Frottin, F; Hipp, MS; Hartl, FU; Edbauer, D; Baumeister, W; Fernandez-Busnadiego, R				Guo, Qiang; Lehmer, Carina; Martinez-Sanchez, Antonio; Rudack, Till; Beck, Florian; Hartmann, Hannelore; Perez-Berlanga, Manuela; Frottin, Frederic; Hipp, Mark S.; Hartl, F. Ulrich; Edbauer, Dieter; Baumeister, Wolfgang; Fernandez-Busnadiego, Ruben			In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment	CELL			English	Article							DIPEPTIDE REPEAT PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; HUMAN 26S PROTEASOME; HEXANUCLEOTIDE REPEAT; MOLECULAR-DYNAMICS; RNA FOCI; CRYO-EM; CLINICOPATHOLOGICAL CORRELATIONS; FRONTOTEMPORAL DEMENTIA; CRYOELECTRON TOMOGRAPHY	Protein aggregation and dysfunction of the ubiquitin-proteasome system are hallmarks of many neuro-degenerative diseases. Here, we address the elusive link between these phenomena by employing cryo-electron tomography to dissect the molecular architecture of protein aggregates within intact neurons at high resolution. We focus on the poly-Gly-Ala (poly-GA) aggregates resulting from aberrant translation of an expanded GGGGCC repeat in C9orf72, the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. We find that poly-GA aggregates consist of densely packed twisted ribbons that recruit numerous 26S proteasome complexes, while other macromolecules are largely excluded. Proximity to poly-GA ribbons stabilizes a transient substrate-processing conformation of the 26S proteasome, suggesting stalled degradation. Thus, poly-GA aggregates may compromise neuronal proteostasis by driving the accumulation and functional impairment of a large fraction of cellular proteasomes.	[Guo, Qiang; Martinez-Sanchez, Antonio; Beck, Florian; Baumeister, Wolfgang; Fernandez-Busnadiego, Ruben] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Lehmer, Carina; Hartmann, Hannelore; Edbauer, Dieter] German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany; [Lehmer, Carina; Hartmann, Hannelore; Hipp, Mark S.; Hartl, F. Ulrich; Edbauer, Dieter] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Rudack, Till] Ruhr Univ Bochum, Dept Biophys, D-44780 Bochum, Germany; [Rudack, Till] Univ Illinois, Beckman Inst Adv Sci & Technol, NIH Ctr Macromol Modeling & Bioinformat, Champaign, IL 61801 USA; [Perez-Berlanga, Manuela; Frottin, Frederic; Hipp, Mark S.; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Edbauer, Dieter] Ludwig Maximilians Univ Munchen, D-81377 Munich, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Ruhr University Bochum; University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; University of Munich	Baumeister, W; Fernandez-Busnadiego, R (corresponding author), Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany.; Edbauer, D (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany.; Edbauer, D (corresponding author), Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany.; Edbauer, D (corresponding author), Ludwig Maximilians Univ Munchen, D-81377 Munich, Germany.	dieter.edbauer@dzne.de; baumeist@biochem.mpg.de; ruben@biochem.mpg.de	Edbauer, Dieter/M-9906-2019; Guo, Qiang/J-7542-2019; Hipp, Mark/AAA-4238-2022; Martinez-Sanchez, Antonio/A-6968-2019; Hartl, F. Ulrich/Y-8206-2019	Edbauer, Dieter/0000-0002-7186-4653; Martinez-Sanchez, Antonio/0000-0002-5865-2138; Guo, Qiang/0000-0003-3520-5439; Frottin, Frederic/0000-0002-2756-7838; Hipp, Mark/0000-0002-0497-3016; Fernandez-Busnadiego, Ruben/0000-0002-8366-7622	EMBO [EMBO ALTF 73-2015]; Alexander von Humboldt Foundation; Seneca Foundation; European Commission [FP7 GA ERC-2012-SyG_318987-ToPAG, FP7 GA ERC-2013-CoG_617198 DPR-MODELS]; German Science Foundation (Excellence Cluster Center for Integrated Protein Science Munich [CIPSM]); Munich Cluster for Systems Neurology (SyNergy) [SFB-1035]; NOMIS Foundation; Helmholtz Association; NIH (Center for Macromolecular Modeling and Bioinformatics) [9P41GM104601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Seneca Foundation(Fundacion Seneca); European Commission(European CommissionEuropean Commission Joint Research Centre); German Science Foundation (Excellence Cluster Center for Integrated Protein Science Munich [CIPSM]); Munich Cluster for Systems Neurology (SyNergy); NOMIS Foundation; Helmholtz Association(Helmholtz Association); NIH (Center for Macromolecular Modeling and Bioinformatics)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Radostin Danev, Gunter Pfeifer, Jurgen Plitzko, and Miroslava Schaffer for electron microscopy support, as well as Irina Dudanova and Eri Sakata for helpful discussions. The psPAX2 plasmid (Addgene plasmid # 12260) was a gift from Didier Trono. Q.G. is the recipient of postdoctoral fellowships from EMBO (EMBO ALTF 73-2015) and the Alexander von Humboldt Foundation. A.M.-S. is the recipient of a postdoctoral fellowship from the Seneca Foundation. This research has received funding from the European Commission (FP7 GA ERC-2012-SyG_318987-ToPAG and FP7 GA ERC-2013-CoG_617198 DPR-MODELS), the German Science Foundation (Excellence Cluster Center for Integrated Protein Science Munich [CIPSM]), Munich Cluster for Systems Neurology (SyNergy) (SFB-1035/Project A01), the NOMIS Foundation, the Helmholtz Association, and the NIH (Center for Macromolecular Modeling and Bioinformatics, grant 9P41GM104601).	Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Beck M, 2016, TRENDS CELL BIOL, V26, P825, DOI 10.1016/j.tcb.2016.08.006; Chang YJ, 2016, J BIOL CHEM, V291, P4903, DOI 10.1074/jbc.M115.694273; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; De Smet F, 2017, J PATHOL, V242, P24, DOI 10.1002/path.4872; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deriziotis P, 2011, EMBO J, V30, P3065, DOI 10.1038/emboj.2011.224; Edbauer D, 2016, CURR OPIN NEUROBIOL, V36, P99, DOI 10.1016/j.conb.2015.10.009; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Fernandez JJ, 2016, BIOPHYS J, V110, P850, DOI 10.1016/j.bpj.2015.10.043; Freibaum BD, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00035; Gendron T.F., 2017, COLD SPRING HARB PER; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Goh BC, 2016, ANNU REV BIOPHYS, V45, P253, DOI 10.1146/annurev-biophys-062215-011113; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Hipp MS, 2012, METHODS MOL BIOL, V832, P463, DOI 10.1007/978-1-61779-474-2_33; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Hrabe T, 2012, J STRUCT BIOL, V178, P177, DOI 10.1016/j.jsb.2011.12.003; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Khatter H, 2015, NATURE, V520, P640, DOI 10.1038/nature14427; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Knight WE, 2016, P NATL ACAD SCI USA, V113, pE7116, DOI 10.1073/pnas.1607728113; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kraut DA, 2013, J BIOL CHEM, V288, P34729, DOI 10.1074/jbc.M113.512533; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lin G, 2017, CURR TOP DEV BIOL, V121, P111, DOI 10.1016/bs.ctdb.2016.07.004; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; Mackenzie IRA, 2015, ACTA NEUROPATHOL, V130, P845, DOI 10.1007/s00401-015-1476-2; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Martinez-Sanchez A, 2014, J STRUCT BIOL, V186, P49, DOI 10.1016/j.jsb.2014.02.015; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ribeiro JV, 2016, SCI REP-UK, V6, DOI 10.1038/srep26536; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Schroeder W., 2006, VISUALIZATION TOOLKI, V4th; Schweitzer A, 2016, P NATL ACAD SCI USA, V113, P7816, DOI 10.1073/pnas.1608050113; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wehmer M, 2017, P NATL ACAD SCI USA, V114, P1305, DOI 10.1073/pnas.1621129114; Yamakawa M, 2015, HUM MOL GENET, V24, P1630, DOI 10.1093/hmg/ddu576; Zang YX, 2016, NAT STRUCT MOL BIOL, V23, P1083, DOI 10.1038/nsmb.3309; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	85	208	212	5	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					696	+		10.1016/j.cell.2017.12.030	http://dx.doi.org/10.1016/j.cell.2017.12.030			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29398115	Green Accepted, Bronze			2022-12-28	WOS:000424648800011
J	Uggenti, C; Crow, YJ				Uggenti, Carolina; Crow, Yanick J.			Sort Your Self Out!	CELL			English	Editorial Material							AUTOIMMUNITY; IFIH1; TREX1	Discrimination between viral and self-derived nucleic acid species is crucial in maintaining effective antiviral immunity whilst avoiding autoinflammation. Ahmad et al. and Chung et al. delineate the consequences of MDA5 gain of function and loss of ADAR1 activity, highlighting the blurring of the concept of self and non-self when considering endogenous retroelements.	[Uggenti, Carolina; Crow, Yanick J.] INSERM, Inst Imagine, Lab Neurogenet & Neuroinflammat, UMR1163, Paris, France; [Crow, Yanick J.] Paris Descartes Univ, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Crow, Yanick J.] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Dept Genet, F-75015 Paris, France; [Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Evolut & Genom Sci, Sch Biol Sci,Fac Biol Med & Hlth, Manchester, Lancs, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Manchester	Crow, YJ (corresponding author), INSERM, Inst Imagine, Lab Neurogenet & Neuroinflammat, UMR1163, Paris, France.; Crow, YJ (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France.; Crow, YJ (corresponding author), Hop Necker Enfants Malad, Assistance Publ Hop Paris, Dept Genet, F-75015 Paris, France.; Crow, YJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Evolut & Genom Sci, Sch Biol Sci,Fac Biol Med & Hlth, Manchester, Lancs, England.	yanickcrow@mac.com		Uggenti, Carolina/0000-0003-2673-5120	European Research Council [GA 309449]; National Research Agency (ANR, France) under the "Investments for the Future'' [ANR-10-IAHU-01]; ERA-NET Neuron [MR/M501803/1]; ANR [CE17001002]; Medical Research Council [MR/M501803/1] Funding Source: researchfish; MRC [MR/M501803/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); National Research Agency (ANR, France) under the "Investments for the Future''(French National Research Agency (ANR)); ERA-NET Neuron; ANR(French National Research Agency (ANR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Y.J.C. acknowledges funding from the European Research Council (GA 309449: Fellowship to Y.J.C.), a state subsidy managed by the National Research Agency (ANR, France) under the "Investments for the Future'' (ANR-10-IAHU-01), funding from ERA-NET Neuron (MR/M501803/1), and an ANR grant (CE17001002).	[Anonymous], TITLE ERROR; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Gorman JA, 2017, NAT IMMUNOL, V18, P744, DOI 10.1038/ni.3766; Mu X, 2016, ADV IMMUNOL, V132, P47, DOI 10.1016/bs.ai.2016.07.001; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009	7	2	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					640	642		10.1016/j.cell.2018.01.023	http://dx.doi.org/10.1016/j.cell.2018.01.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425484	Bronze			2022-12-28	WOS:000424648800004
J	Urnavicius, L; Lau, CK; Elshenawy, MM; Morales-Rios, E; Motz, C; Yildiz, A; Carter, AP				Urnavicius, Linas; Lau, Clinton K.; Elshenawy, Mohamed M.; Morales-Rios, Edgar; Motz, Carina; Yildiz, Ahmet; Carter, Andrew P.			Cryo-EM shows how dynactin recruits two dyneins for faster movement	NATURE			English	Article							TUG-OF-WAR; CYTOPLASMIC DYNEIN; COMPLEX; ADAPTER; MOTILITY; KINESIN; ORGANIZATION; ACTIVATION; PREDICTION; TRANSPORT	Dynein and its cofactor dynactin form a highly processive microtubule motor in the presence of an activating adaptor, such as BICD2. Different adaptors link dynein and dynactin to distinct cargoes. Here we use electron microscopy and single-molecule studies to show that adaptors can recruit a second dynein to dynactin. Whereas BICD2 is biased towards recruiting a single dynein, the adaptors BICDR1 and HOOK3 predominantly recruit two dyneins. We find that the shift towards a double dynein complex increases both the force and speed of the microtubule motor. Our 3.5 A resolution cryoelectron microscopy reconstruction of a dynein tail-dynactin-BICDR1 complex reveals how dynactin can act as a scaffold to coordinate two dyneins side-by-side. Our work provides a structural basis for understanding how diverse adaptors recruit different numbers of dyneins and regulate the motile properties of the dynein-dynactin transport machine.	[Urnavicius, Linas; Lau, Clinton K.; Motz, Carina; Carter, Andrew P.] MRC, Mol Biol Lab, Div Struct Studies, Francis Crick Ave, Cambridge CB2 0QH, England; [Elshenawy, Mohamed M.; Yildiz, Ahmet] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Morales-Rios, Edgar] CINVESTAV, Dept Biochem, Mexico City, DF, Mexico; [Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Motz, Carina] TUM, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany	MRC Laboratory Molecular Biology; University of California System; University of California Berkeley; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of California System; University of California Berkeley; Technical University of Munich	Carter, AP (corresponding author), MRC, Mol Biol Lab, Div Struct Studies, Francis Crick Ave, Cambridge CB2 0QH, England.	cartera@mrc-lmb.cam.ac.uk	Elshenawy, Mohamed/AAA-6812-2020; Yildiz, Ahmet/E-6167-2015	Morales-Rios, Edgar/0000-0003-1139-2292; Lau, Clinton/0000-0003-1083-2989; Yildiz, Ahmet/0000-0003-4792-174X; Carter, Andrew/0000-0001-7292-5430	Wellcome Trust [WT100387]; MRC [MC_UP_A025_1011]; NIH [GM094522]; NSF [MCB-1055017, MCB-1617028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118773, R01GM094522] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A025_1011] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Scheres, X. Bai, K. Vinothkumar and R. Leiro for cryo-EM advice; S. Chen, G. McMullan, C. Savva, G. Cannone, J. Grimmett and T. Darling for technical support; S. Bullock for SNAPf-dynein (1-1074-GST); M. Yu for crystallography support and the European Synchrotron Radiation Facility (beamline ID29) for data collection; T. Croll for model building; S. Bullock, L. Passmore, S. Lacey and H. Foster for manuscript comments; and G. Lander for discussions. This work was funded by Wellcome Trust (WT100387) and MRC grants (MC_UP_A025_1011) to A.P.C.; and NIH (GM094522) and NSF (MCB-1055017, MCB-1617028) grants to A.Y.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baumbach J, 2017, ELIFE, V6, DOI 10.7554/eLife.21768; Belyy V, 2016, NAT CELL BIOL, V18, P1018, DOI 10.1038/ncb3393; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bharat TAM, 2015, STRUCTURE, V23, P1743, DOI 10.1016/j.str.2015.06.026; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Cianfrocco MA, 2015, ANNU REV CELL DEV BI, V31, P83, DOI 10.1146/annurev-cellbio-100814-125438; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Driller-Colangelo AR, 2016, CYTOSKELETON, V73, P693, DOI 10.1002/cm.21339; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gama JB, 2017, J CELL BIOL, V216, P943, DOI 10.1083/jcb.201610108; Grotjahn D. A., 2018, NAT STRUCT MOL BIOL; Gutierrez PA, 2017, J BIOL CHEM, V292, P12245, DOI 10.1074/jbc.M117.790048; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hendricks AG, 2012, P NATL ACAD SCI USA, V109, P18447, DOI 10.1073/pnas.1215462109; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; Klinman E, 2016, METHOD CELL BIOL, V131, P409, DOI 10.1016/bs.mcb.2015.06.011; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olenick MA, 2016, J BIOL CHEM, V291, P18239, DOI 10.1074/jbc.M116.738211; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2017, ELIFE, V6, DOI 10.7554/eLife.28257; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Schlager MA, 2014, CELL REP, V8, P1248, DOI 10.1016/j.celrep.2014.07.052; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder CM, 2016, J CELL BIOL, V214, P309, DOI 10.1083/jcb.201604002; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zheng WJ, 2017, BIOCHEMISTRY-US, V56, P313, DOI 10.1021/acs.biochem.6b01002	54	127	127	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					202	+		10.1038/nature25462	http://dx.doi.org/10.1038/nature25462			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420470	Green Accepted, Green Submitted			2022-12-28	WOS:000424332600031
J	Park, JH; Riviere, I; Gonen, M; Wang, XY; Senechal, B; Curran, KJ; Sauter, C; Wang, YZ; Santomasso, B; Mead, E; Roshal, M; Maslak, P; Davila, M; Brentjens, RJ; Sadelain, M				Park, Jae H.; Riviere, Isabelle; Gonen, Mithat; Wang, Xiuyan; Senechal, Brigitte; Curran, Kevin J.; Sauter, Craig; Wang, Yongzeng; Santomasso, Bianca; Mead, Elena; Roshal, Mikhail; Maslak, Peter; Davila, Marco; Brentjens, Renier J.; Sadelain, Michel			Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; ACUTE LYMPHOCYTIC-LEUKEMIA; T-CELLS; B-CELL; FREE SURVIVAL; CHEMOTHERAPY; ADULTS; BLINATUMOMAB; SALVAGE; ANTIGEN	BACKGROUND CD19-specific chimeric antigen receptor (CAR) T cells induce high rates of initial response among patients with relapsed B-cell acute lymphoblastic leukemia (ALL) and long-term remissions in a subgroup of patients. METHODS We conducted a phase 1 trial involving adults with relapsed B-cell ALL who received an infusion of autologous T cells expressing the 19-28z CAR at the Memorial Sloan Kettering Cancer Center (MSKCC). Safety and long-term outcomes were assessed, as were their associations with demographic, clinical, and disease characteristics. RESULTS A total of 53 adults received 19-28z CAR T cells that were manufactured at MSKCC. After infusion, severe cytokine release syndrome occurred in 14 of 53 patients (26%; 95% confidence interval [CI], 15 to 40); 1 patient died. Complete remission was observed in 83% of the patients. At a median follow-up of 29 months (range, 1 to 65), the median event-free survival was 6.1 months (95% CI, 5.0 to 11.5), and the median overall survival was 12.9 months (95% CI, 8.7 to 23.4). Patients with a low disease burden (<5% bone marrow blasts) before treatment had markedly enhanced remission duration and survival, with a median event-free survival of 10.6 months (95% CI, 5.9 to not reached) and a median overall survival of 20.1 months (95% CI, 8.7 to not reached). Patients with a higher burden of disease (>= 5% bone marrow blasts or extramedullary disease) had a greater incidence of the cytokine release syndrome and neurotoxic events and shorter long-term survival than did patients with a low disease burden. CONCLUSIONS In the entire cohort, the median overall survival was 12.9 months. Among patients with a low disease burden, the median overall survival was 20.1 months and was accompanied by a markedly lower incidence of the cytokine release syndrome and neurotoxic events after 19-28z CAR T-cell infusion than was observed among patients with a higher disease burden. (Funded by the Commonwealth Foundation for Cancer Research and others; ClinicalTrials.gov number, NCT01044069.)	[Park, Jae H.; Sauter, Craig; Maslak, Peter; Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10065 USA; [Riviere, Isabelle; Wang, Xiuyan; Senechal, Brigitte; Wang, Yongzeng] Mem Sloan Kettering Canc Ctr, Michael G Harris Cell Therapy & Cell Engn Facil, New York, NY 10065 USA; [Park, Jae H.; Riviere, Isabelle; Wang, Xiuyan; Brentjens, Renier J.; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Curran, Kevin J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Santomasso, Bianca] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Mead, Elena] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care Med, New York, NY 10065 USA; [Roshal, Mikhail] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Park, Jae H.; Sauter, Craig; Brentjens, Renier J.] Cornell Univ, Dept Med, Joan & Sanford Weill Med Coll, New York, NY 10021 USA; [Davila, Marco] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; H Lee Moffitt Cancer Center & Research Institute	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave,Box 184, New York, NY 10065 USA.	m-sadelain@ski.mskcc.org	Gonen, Mithat/E-4826-2012	Gonen, Mithat/0000-0001-8683-8477; Santomasso, Bianca/0000-0001-9423-4059	Commonwealth Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA076292, P30CA008748] Funding Source: NIH RePORTER	Commonwealth Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Commonwealth Foundation for Cancer Research and others; ClinicalTrials.gov number, NCT01044069.	Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gardner R, 2016, BLOOD, V127, P2406, DOI 10.1182/blood-2015-08-665547; Gokbuget N, 2017, HAEMATOLOGICA, V102, pE132, DOI 10.3324/haematol.2016.153957; Gokbuget N, 2012, BLOOD, V120, P2032, DOI 10.1182/blood-2011-12-399287; Hollyman D, 2009, J IMMUNOTHER, V32, P169, DOI 10.1097/CJI.0b013e318194a6e8; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Kantarjian HM, 2016, NEW ENGL J MED, V375, P740, DOI 10.1056/NEJMoa1509277; Kantarjian HM, 2010, CANCER-AM CANCER SOC, V116, P5568, DOI 10.1002/cncr.25354; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; O'Brien S, 2008, CANCER-AM CANCER SOC, V113, P3186, DOI 10.1002/cncr.23919; Park JH, 2016, BLOOD, V127, P3312, DOI 10.1182/blood-2016-02-629063; Tavernier E, 2007, LEUKEMIA, V21, P1907, DOI 10.1038/sj.leu.2404824; Theunissen P, 2017, BLOOD, V129, P347, DOI 10.1182/blood-2016-07-726307; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; van der Stegen SJC, 2015, NAT REV DRUG DISCOV, V14, P499, DOI 10.1038/nrd4597; van Dongen JJM, 2015, BLOOD, V125, P3996, DOI 10.1182/blood-2015-03-580027; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	24	1329	1388	9	165	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					449	459		10.1056/NEJMoa1709919	http://dx.doi.org/10.1056/NEJMoa1709919			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU3WP	29385376	Green Accepted, Bronze			2022-12-28	WOS:000423783200009
J	Yu, C; Tang, H; Guo, Y; Bian, Z; Yang, L; Chen, Y; Tang, A; Zhou, X; Yang, X; Chen, J; Chen, Z; Lv, J; Li, L				Yu, C.; Tang, H.; Guo, Y.; Bian, Z.; Yang, L.; Chen, Y.; Tang, A.; Zhou, X.; Yang, X.; Chen, J.; Chen, Z.; Lv, J.; Li, L.			Hot Tea Consumption and the Risk for Esophageal Cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	1	1	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2018	168	7					I18	I18		10.7326/P17-9054	http://dx.doi.org/10.7326/P17-9054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4AB	29404566				2022-12-28	WOS:000429000900001
J	Grant, PJ; Eagle, KA				Grant, Paul J.; Eagle, Kim A.			Inpatient Notes: Perioperative Medicine-The Past, Present, and Future of Cardiovascular Risk Assessment and Risk Reduction Strategies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NONCARDIAC SURGERY; GUIDELINES		[Grant, Paul J.; Eagle, Kim A.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Grant, PJ (corresponding author), Univ Michigan, Div Hosp Med, 1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	paulgran@umich.edu						Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Duceppe E, 2017, CAN J CARDIOL, V33, P17, DOI 10.1016/j.cjca.2016.09.008; Eagle KA, 1996, CIRCULATION, V93, P1278; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					HO2	HO3		10.7326/M18-0109	http://dx.doi.org/10.7326/M18-0109			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459972				2022-12-28	WOS:000425434000001
J	Dierickx, D; Habermann, TM				Dierickx, Daan; Habermann, Thomas M.			Post-Transplantation Lymphoproliferative Disorders in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							EPSTEIN-BARR-VIRUS; SOLID-ORGAN TRANSPLANTATION; B-CELL LYMPHOMA; BLOOD MONONUCLEAR-CELLS; KIDNEY-TRANSPLANTATION; INITIAL THERAPY; RISK-FACTORS; WHOLE-BLOOD; VIRAL LOAD; EBV	POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PTLDs) are defined as lymphomas that occur after transplantation (Fig. 1). Recipients of solid-organ or allogeneic hematopoietic stem-cell transplants have an increased risk of cancers related to immunosuppression and the Epstein-Barr virus (EBV) - in particular, lymphomas. 1,2 Although lymphoproliferative disorders were initially reported to be a rare complication of transplantation, observations during the past decade have shown that they are not uncommon and are associated with poor outcomes. Lymphoma accounts for 21% of all cancers in recipients of solidorgan transplants, as compared with 4% among women and 5% among men in an immunocompetent population. 3 Important advances in diagnosis and treatment have been made after two consensus conferences. 4,5 This review outlines our current understanding of the epidemiology of and risk factors for PTLD, the pathogenesis of these disorders, and current approaches to diagnosis, staging, and treatment.	[Dierickx, Daan] Univ Hosp Leuven, Dept Hematol, Herestr 49, B-3000 Leuven, Belgium; [Dierickx, Daan] Univ Leuven, Dept Oncol, Lab Expt Hematol, Leuven, Belgium; [Habermann, Thomas M.] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA	KU Leuven; University Hospital Leuven; KU Leuven; Mayo Clinic	Dierickx, D (corresponding author), Univ Hosp Leuven, Dept Hematol, Herestr 49, B-3000 Leuven, Belgium.	daan.dierickx@uzleuven.be			National Clinical Trials Network; Lymphoma Epidemiology of Outcomes consortium; Lymphoma SPORE	National Clinical Trials Network; Lymphoma Epidemiology of Outcomes consortium; Lymphoma SPORE	Dr. Habermann reports serving as a study representative for and receiving food from Celgene, serving on the National Comprehensive Cancer Network Lymphoma Guideline Committee, receiving grant support from the National Clinical Trials Network, receiving grant support from and serving as cochair of the clinical core for the Lymphoma Epidemiology of Outcomes consortium, receiving grant support from Lymphoma SPORE, and receiving an honorarium from the American Society of Clinical Oncology. No other potential conflict of interest relevant to this article was reported.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Aull MJ, 2004, TRANSPLANTATION, V78, P1676, DOI 10.1097/01.TP.0000144333.19106.58; Barnett R, 2017, NEW ENGL J MED, V376, P191, DOI 10.1056/NEJMc1614298; Batchelor Tracy T, 2016, Am Soc Clin Oncol Educ Book, V35, pe354, DOI 10.14694/EDBK_159030; Blaes AH, 2005, CANCER-AM CANCER SOC, V104, P1661, DOI 10.1002/cncr.21391; Brunstein CG, 2006, BLOOD, V108, P2874, DOI 10.1182/blood-2006-03-011791; Buell JF, 2005, TRANSPL P, V37, P956, DOI 10.1016/j.transproceed.2004.12.124; Caillard S, 2017, CLIN J AM SOC NEPHRO, V12, P1663, DOI 10.2215/CJN.03790417; Caillard S, 2013, J CLIN ONCOL, V31, P1302, DOI 10.1200/JCO.2012.43.2344; Cho YU, 2014, AM J CLIN PATHOL, V141, P268, DOI 10.1309/AJCP9WYEXKOL9YUV; Choquet S, 2006, BLOOD, V107, P3053, DOI 10.1182/blood-2005-01-0377; Choquet S, 2014, AM J TRANSPLANT, V14, P857, DOI 10.1111/ajt.12640; Choquet S, 2007, ANN HEMATOL, V86, P599, DOI 10.1007/s00277-007-0298-2; Choquet S, 2007, HAEMATOLOGICA, V92, P273, DOI 10.3324/haematol.10595; Cockfield S M, 2001, Transpl Infect Dis, V3, P70; Courville EL, 2016, MODERN PATHOL, V29, P1200, DOI 10.1038/modpathol.2016.130; de Fijter JW, 2017, TRANSPLANTATION, V101, P45, DOI 10.1097/TP.0000000000001447; Dharnidharka VR, 2015, NEW ENGL J MED, V372, P569, DOI 10.1056/NEJMcibr1415117; Dierickx D, 2015, BLOOD, V126, P2274, DOI 10.1182/blood-2015-05-615872; Dierickx D, 2013, LEUKEMIA LYMPHOMA, V54, P2433, DOI 10.3109/10428194.2013.780655; Dierickx D, 2013, J CLIN ONCOL, V31, P3443, DOI 10.1200/JCO.2013.50.3326; Dierickx D, 2013, HAEMATOLOGICA, V98, P771, DOI 10.3324/haematol.2012.074500; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; Evens AM, 2013, AM J TRANSPLANT, V13, P1512, DOI 10.1111/ajt.12211; Evens AM, 2010, J CLIN ONCOL, V28, P1038, DOI 10.1200/JCO.2009.25.4961; Ferreiro JF, 2016, AM J TRANSPLANT, V16, P414, DOI 10.1111/ajt.13558; Fink SEK, 2014, AM J TRANSPLANT, V14, P2577, DOI 10.1111/ajt.12858; Furukawa S, 2013, AM J TRANSPLANT, V13, P2035, DOI 10.1111/ajt.12328; Ghobrial IM, 2005, TRANSPLANTATION, V79, P244, DOI 10.1097/01.TP.0000144335.39913.5C; Glotz D, SEVILLE EXPERT WORKS, V94, P784; Gonzalez-Barca E, 2007, HAEMATOLOGICA, V92, P1489, DOI 10.3324/haematol.11360; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Habermann Thomas M., 2008, V142, P273; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Johnson SR, 2006, AM J TRANSPLANT, V6, P2743, DOI 10.1111/j.1600-6143.2006.01543.x; Kanakry JA, 2016, BLOOD, V127, P2007, DOI 10.1182/blood-2015-09-672030; Kanakry JA, 2013, BIOL BLOOD MARROW TR, V19, P1514, DOI 10.1016/j.bbmt.2013.07.013; Kinch A, 2014, ACTA ONCOL, V53, P669, DOI 10.3109/0284186X.2013.844853; Landgren O, 2009, BLOOD, V113, P4992, DOI 10.1182/blood-2008-09-178046; Lee TC, 2005, AM J TRANSPLANT, V5, P2222, DOI 10.1111/j.1600-6143.2005.01002.x; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Luskin MR, 2015, AM J TRANSPLANT, V15, P2665, DOI 10.1111/ajt.13324; Mahale P, 2017, AM J TRANSPLANT; Maksten EF, 2016, TRANSPL INT, V29, P483, DOI 10.1111/tri.12744; Margolskee E, 2016, ONCOTARGET, V7, P37636, DOI 10.18632/oncotarget.9400; Menter T, 2017, BRIT J HAEMATOL, V178, P48, DOI 10.1111/bjh.14633; Merlo A, 2010, HAEMATOL-HEMATOL J, V95, P1769, DOI 10.3324/haematol.2010.023689; Morscio J, 2013, AM J TRANSPLANT, V13, P1305, DOI 10.1111/ajt.12196; Morscio J, 2017, MODERN PATHOL, V30, P370, DOI 10.1038/modpathol.2016.199; Morton M, 2013, TRANSPLANTATION, V95, P470, DOI 10.1097/TP.0b013e318276a237; Oertel SHK, 2005, AM J TRANSPLANT, V5, P2901, DOI 10.1111/j.1600-6143.2005.01098.x; Opelz G, 2004, AM J TRANSPLANT, V4, P222, DOI 10.1046/j.1600-6143.2003.00325.x; PAPADOPOULOS EB, 1994, NEW ENGL J MED, V330, P1185, DOI 10.1056/NEJM199404283301703; Parker A, 2010, BRIT J HAEMATOL, V149, P675, DOI 10.1111/j.1365-2141.2010.08161.x; Parker A, 2010, BRIT J HAEMATOL, V149, P693, DOI 10.1111/j.1365-2141.2010.08160.x; Paya CV, 1999, TRANSPLANTATION, V68, P1517, DOI 10.1097/00007890-199911270-00015; PENN I, 1969, TRANSPLANT P, V1, P106; Quinlan SC, 2011, AM J HEMATOL, V86, P206, DOI 10.1002/ajh.21911; Rasche L, 2014, BONE MARROW TRANSPL, V49, P163, DOI 10.1038/bmt.2013.96; Reshef R, 2011, AM J TRANSPLANT, V11, P336, DOI 10.1111/j.1600-6143.2010.03387.x; Rosenberg AS, 2016, CL LYMPH MYELOM LEUK, V16, P684, DOI 10.1016/j.clml.2016.09.002; Rosenberg AS, 2016, AM J HEMATOL, V91, P560, DOI 10.1002/ajh.24346; Rossignol J, 2015, AM J TRANSPLANT, V15, P1976, DOI 10.1111/ajt.13244; Schober T, 2013, TRANSPLANTATION, V95, P240, DOI 10.1097/TP.0b013e318277e344; Schutt SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137641; Semenova T, 2016, J CLIN MICROBIOL, V54, P1746, DOI 10.1128/JCM.03336-15; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stevens SJC, 2001, BLOOD, V97, P1165, DOI 10.1182/blood.V97.5.1165; Styczynski J, 2016, HAEMATOLOGICA, V101, P803, DOI 10.3324/haematol.2016.144428; Styczynski J, 2013, CLIN INFECT DIS, V57, P794, DOI 10.1093/cid/cit391; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Swinnen LJ, 2008, TRANSPLANTATION, V86, P215, DOI 10.1097/TP.0b013e3181761659; Thiele J, 2017, WHO CLASSIFICATION T, V4th, P453; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Trappe RU, 2015, AM J TRANSPLANT, V15, P1091, DOI 10.1111/ajt.13086; Trappe R, 2012, LANCET ONCOL, V13, P196, DOI 10.1016/S1470-2045(11)70300-X; Trappe RU, 2017, J CLIN ONCOL, V35, P536, DOI 10.1200/JCO.2016.69.3564; Tsai DE, 2008, AM J TRANSPLANT, V8, P1016, DOI 10.1111/j.1600-6143.2008.02183.x; Tsai DE, 2001, TRANSPLANTATION, V71, P1076, DOI 10.1097/00007890-200104270-00012; van Esser JWJ, 2001, BLOOD, V98, P972, DOI 10.1182/blood.V98.4.972; Vase MO, 2015, LEUKEMIA LYMPHOMA, V56, P1677, DOI 10.3109/10428194.2014.966242; Wagner HJ, 2001, TRANSPLANTATION, V72, P1012, DOI 10.1097/00007890-200109270-00006; WALKER RC, 1995, CLIN INFECT DIS, V20, P1346, DOI 10.1093/clinids/20.5.1346; Weisenburger DD, 2017, BRIT J HAEMATOL, V179, P854, DOI 10.1111/bjh.14274; Worth A, 2011, BRIT J HAEMATOL, V155, P377, DOI 10.1111/j.1365-2141.2011.08855.x; Zimmermann H, 2013, HEMATOL-AM SOC HEMAT, P95, DOI 10.1182/asheducation-2013.1.95	87	179	187	4	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					549	562		10.1056/NEJMra1702693	http://dx.doi.org/10.1056/NEJMra1702693			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV1OX	29414277				2022-12-28	WOS:000424335200010
J	Godlee, F				Godlee, Fiona			Assisted dying: it's time to poll UK doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												fgodlee@bmj.com							0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2018	360								k593	10.1136/bmj.k593	http://dx.doi.org/10.1136/bmj.k593			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0IA	29440046	Green Published, Bronze			2022-12-28	WOS:000424976200006
J	Huelsken, J; Hanahan, D				Huelsken, Joerg; Hanahan, Douglas			A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance	CELL			English	Editorial Material							PANCREATIC-CANCER	While functional heterogeneity of fibroblastic cells populating the tumor microenvironment is increasingly recognized, lack of definitive markers complicates elucidation of roles among ostensibly distinctive fibroblastic states. In this issue of Cell, Su et al. characterize a new pro-tumorigenic cancer-associated fibroblast subset mediating chemoresistance defined and driven by a novel signaling pathway.	[Huelsken, Joerg] Swiss Fed Inst Technol Lausanne EPFL, ISREC Swiss Inst Expt Canc Res, Sch Life Sci, Lab Tumor Heterogene & Stemness Canc, CH-1015 Lausanne, Switzerland; [Hanahan, Douglas] Swiss Fed Inst Technol Lausanne EPFL, ISREC Swiss Inst Expt Canc Res, Sch Life Sci, Lab Translat Oncol, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Huelsken, J (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, ISREC Swiss Inst Expt Canc Res, Sch Life Sci, Lab Tumor Heterogene & Stemness Canc, CH-1015 Lausanne, Switzerland.	joerg.huelsken@epfl.ch	Huelsken, Joerg/AAC-9581-2021	Huelsken, Joerg/0000-0003-3105-9606				[Anonymous], TITLE ERROR; Brechbuhl HM, 2017, CLIN CANCER RES, V23, P1710, DOI 10.1158/1078-0432.CCR-15-2851; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Maris P, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001871; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021	8	50	51	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					643	644		10.1016/j.cell.2018.01.028	http://dx.doi.org/10.1016/j.cell.2018.01.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425485	Bronze			2022-12-28	WOS:000424648800005
J	Kimsey, IJ; Szymanski, ES; Zahurancik, WJ; Shakya, A; Xue, Y; Chu, CC; Sathyamoorthy, B; Suo, ZC; Al-Hashimi, HM				Kimsey, Isaac J.; Szymanski, Eric S.; Zahurancik, Walter J.; Shakya, Anisha; Xue, Yi; Chu, Chia-Chieh; Sathyamoorthy, Bharathwaj; Suo, Zucai; Al-Hashimi, Hashim M.			Dynamic basis for dG.dT misincorporation via tautomerization and ionization	NATURE			English	Article							DNA-POLYMERASE EPSILON; MISPAIRING FREQUENCIES; STRUCTURAL INSIGHTS; CHEMICAL-EXCHANGE; KINETIC MECHANISM; NMR-SPECTROSCOPY; FIDELITY; REPLICATION; RNA; SELECTION	Tautomeric and anionic Watson-Crick-like mismatches have important roles in replication and translation errors through mechanisms that are not fully understood. Here, using NMR relaxation dispersion, we resolve a sequence-dependent kinetic network connecting G center dot T/U wobbles with three distinct Watson-Crick mismatches: two rapidly exchanging tautomeric species (G(enol)center dot T/U reversible arrow G center dot T-enol/U-enol; population less than 0.4%) and one anionic species (G center dot T-/U-; population around 0.001% at neutral pH). The sequence-dependent tautomerization or ionization step was inserted into a minimal kinetic mechanism for correct incorporation during replication after the initial binding of the nucleotide, leading to accurate predictions of the probability of dG center dot dT misincorporation across different polymerases and pH conditions and for a chemically modified nucleotide, and providing mechanisms for sequence-dependent misincorporation. Our results indicate that the energetic penalty for tautomerization and/or ionization accounts for an approximately 10(-2) to 10(-3)-fold discrimination against misincorporation, which proceeds primarily via tautomeric dG(enol)center dot dT and dG center dot dT(enol), with contributions from anionic dG center dot dT(-) dominant at pH 8.4 and above or for some mutagenic nucleotides.	[Kimsey, Isaac J.; Szymanski, Eric S.; Xue, Yi; Chu, Chia-Chieh; Sathyamoorthy, Bharathwaj; Al-Hashimi, Hashim M.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Zahurancik, Walter J.; Suo, Zucai] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Zahurancik, Walter J.; Suo, Zucai] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Shakya, Anisha] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Al-Hashimi, Hashim M.] Duke Univ, Dept Chem, Durham, NC 27710 USA; [Kimsey, Isaac J.] Nymirum, Durham, NC 27713 USA; [Shakya, Anisha] Ctr Soft & Living Matter, Inst Basic Sci, Ulsan, South Korea; [Xue, Yi] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Sathyamoorthy, Bharathwaj] Indian Inst Sci Educ & Res Bhopal, Dept Chem, Bhopal 462066, India	Duke University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Duke University; Institute for Basic Science - Korea (IBS); Tsinghua University; Indian Institute of Science Education & Research (IISER) - Bhopal	Al-Hashimi, HM (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; Suo, ZC (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.; Suo, ZC (corresponding author), Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA.; Al-Hashimi, HM (corresponding author), Duke Univ, Dept Chem, Durham, NC 27710 USA.	suo.3@osu.edu; hashim.al.hashimi@duke.edu	Shakya, A./AAA-2098-2020; Shakya, A./AAB-1860-2021; Sathyamoorthy, Bharathwaj/ABG-2715-2020	Shakya, A./0000-0002-8411-1458; Sathyamoorthy, Bharathwaj/0000-0002-1568-2599; Zahurancik, Walter/0000-0002-0084-3644	National Institutes of Health (NIH) [R01GM089846, P01GM0066275, P50GM103297]; Agilent Thought Leader Award; National Science Foundation [MCB-1716168]; Pelotonia Graduate Fellowship from The Ohio State University Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089846, P50GM103297, P01GM066275] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agilent Thought Leader Award; National Science Foundation(National Science Foundation (NSF)); Pelotonia Graduate Fellowship from The Ohio State University Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Al-Hashimi laboratory and T. Oas for discussions and input. We acknowledge technical support and resources from the Duke Magnetic Resonance Spectroscopy Center and the Duke Shared Cluster Resource. This work was supported by grants from the National Institutes of Health (NIH R01GM089846, P01GM0066275 and P50GM103297) and an Agilent Thought Leader Award to H.M.A., and a grant from the National Science Foundation (MCB-1716168) to Z.S. W.J.Z. was supported by a Pelotonia Graduate Fellowship from The Ohio State University Comprehensive Cancer Center.	Balbo PB, 2011, BIOCHEMISTRY-US, V50, P9865, DOI 10.1021/bi200954r; Ban D, 2012, J MAGN RESON, V221, P1, DOI 10.1016/j.jmr.2012.05.005; Bebenek K, 2011, P NATL ACAD SCI USA, V108, P1862, DOI 10.1073/pnas.1012825108; Brovarets' OO, 2015, J BIOMOL STRUCT DYN, V33, P925, DOI 10.1080/07391102.2014.924879; Delaney JC, 2001, BIOCHEMISTRY-US, V40, P14968, DOI 10.1021/bi015578f; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; DOSANJH MK, 1991, BIOCHEMISTRY-US, V30, P11595, DOI 10.1021/bi00113a015; ECKERT KA, 1993, J BIOL CHEM, V268, P13462; Freudenthal BD, 2015, NAT STRUCT MOL BIOL, V22, P924, DOI 10.1038/nsmb.3105; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P11233, DOI 10.1093/nar/gku789; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Korzhnev DM, 2005, J AM CHEM SOC, V127, P713, DOI 10.1021/ja0446855; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; Loveland AB, 2017, NATURE, V546, P113, DOI 10.1038/nature22397; Maximoff SN, 2017, J PHYS CHEM B, V121, P7813, DOI 10.1021/acs.jpcb.7b04874; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Nomura K., 2013, J MOD PHYS, V4, P422, DOI DOI 10.4236/JMP.2013.43A059; Oertell K, 2016, P NATL ACAD SCI USA, V113, pE2277, DOI 10.1073/pnas.1600279113; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Orozco M, 1998, J PHYS CHEM B, V102, P5228, DOI 10.1021/jp981005+; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rozov A, 2016, TRENDS BIOCHEM SCI, V41, P798, DOI 10.1016/j.tibs.2016.06.001; Rozov A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8251; Sekhar A, 2015, ELIFE, V4, DOI 10.7554/eLife.07296; Singh V, 2015, RNA, V21, P1, DOI 10.1261/rna.048371.114; Szymanski ES, 2017, J AM CHEM SOC, V139, P4326, DOI 10.1021/jacs.7b01156; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0; TOPAL MD, 1976, NATURE, V263, P285, DOI 10.1038/263285a0; Trott O, 2004, J MAGN RESON, V170, P104, DOI 10.1016/j.jmr.2004.06.005; Trott O, 2003, MOL PHYS, V101, P753, DOI 10.1080/0026897021000054826; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vallurupalli P, 2016, CHEM SCI, V7, P3602, DOI 10.1039/c5sc03886c; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020; Xia SL, 2014, PROTEIN SCI, V23, P508, DOI 10.1002/pro.2434; YU H, 1993, J BIOL CHEM, V268, P15935; Zahurancik WJ, 2014, NUCLEIC ACIDS RES, V42, P13853, DOI 10.1093/nar/gku1184; Zahurancik WJ, 2013, BIOCHEMISTRY-US, V52, P7041, DOI 10.1021/bi400803v; Zhang JJ, 2015, P NATL ACAD SCI USA, V112, P9602, DOI 10.1073/pnas.1506823112	49	71	71	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					195	+		10.1038/nature25487	http://dx.doi.org/10.1038/nature25487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420478	Green Accepted			2022-12-28	WOS:000424332600030
J	Lopez-Garrido, J; Ojkic, N; Khanna, K; Wagner, FR; Villa, E; Endres, RG; Pogliano, K				Lopez-Garrido, Javier; Ojkic, Nikola; Khanna, Kanika; Wagner, Felix R.; Villa, Elizabeth; Endres, Robert G.; Pogliano, Kit			Chromosome Translocation Inflates Bacillus Forespores and Impacts Cellular Morphology	CELL			English	Article							SUBTILIS SPORULATION; ESCHERICHIA-COLI; CRYOELECTRON TOMOGRAPHY; MEMBRANE DYNAMICS; DNA TRANSLOCATION; OSMOTIC-PRESSURE; BACTERIAL SHAPE; SPOIIIE; GROWTH; DIVISION	The means by which the physicochemical properties of different cellular components together determine bacterial cell shape remain poorly understood. Here, we investigate a programmed cell-shape change during Bacillus subtilis sporulation, when a rod-shaped vegetative cell is transformed to an ovoid spore. Asymmetric cell division generates a bigger mother cell and a smaller, hemispherical forespore. The septum traps the forespore chromosome, which is translocated to the forespore by SpoIIIE. Simultaneously, forespore size increases as it is reshaped into an ovoid. Using genetics, timelapse microscopy, cryo-electron tomography, and mathematical modeling, we demonstrate that forespore growth relies on membrane synthesis and SpoIIIE-mediated chromosome translocation, but not on peptidoglycan or protein synthesis. Our data suggest that the hydrated nucleoid swells and inflates the forespore, displacing ribosomes to the cell periphery, stretching septal peptidoglycan, and reshaping the forespore. Our results illustrate how simple biophysical interactions between core cellular components contribute to cellular morphology.	[Lopez-Garrido, Javier; Khanna, Kanika; Wagner, Felix R.; Villa, Elizabeth; Pogliano, Kit] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ojkic, Nikola; Endres, Robert G.] Imperial Coll, Dept Life Sci, London SW7 2AZ, England; [Ojkic, Nikola; Endres, Robert G.] Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England; [Ojkic, Nikola] Univ Edinburgh, Sch Phys & Astron, Edinburgh EN9 3FD, Midlothian, Scotland	University of California System; University of California San Diego; Imperial College London; University of Edinburgh	Pogliano, K (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.; Endres, RG (corresponding author), Imperial Coll, Dept Life Sci, London SW7 2AZ, England.; Endres, RG (corresponding author), Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England.	r.endres@imperial.ac.uk; kpogliano@ucsd.edu	Villa, Elizabeth/D-1811-2010	Villa, Elizabeth/0000-0003-4677-9809; Lopez-Garrido, Javier/0000-0002-8907-502X; Khanna, Kanika/0000-0001-7150-0350; Ojkic, Nikola/0000-0003-2793-9440	ERC [280492-PPHPI]; NIH [R01-GM57045, 1DP2GM123494-01, R01-GM33050]; EMBO Long Term Fellowship [ALTF 1274-2011]; Agouron Institute; NSF [ECCS-1542148]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033050, R01GM057045, DP2GM123494] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Agouron Institute(Pfizer); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Davide Marenduzzo, Rudi Podgornik, and Rosalind Allen for discussion. This work was supported by ERC starting grant 280492-PPHPI (N.O. and R.G.E.), NIH grant R01-GM57045 (K.P.), NIH Director's New Innovator Award 1DP2GM123494-01 (E.V.), and EMBO Long Term Fellowship ALTF 1274-2011 (J.L.-G). We used the UCSD Cryo-EM Facility (supported by NIH grant R01-GM33050 to Dr. Timothy S. Baker and the Agouron Institute) and the San Diego Nanotechnology Infrastructure of UCSD (supported by the NSF grant ECCS-1542148).	Amir A, 2012, P NATL ACAD SCI USA, V109, P9833, DOI 10.1073/pnas.1207105109; Bartlett TM, 2017, CELL, V168, P172, DOI 10.1016/j.cell.2016.12.019; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Becker EC, 2007, MOL MICROBIOL, V66, P1066, DOI 10.1111/j.1365-2958.2007.05992.x; Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017; Castellana M, 2016, P NATL ACAD SCI USA, V113, P9286, DOI 10.1073/pnas.1604995113; Castelnovo M, 2006, EUROPHYS LETT, V73, P635, DOI 10.1209/epl/i2005-10425-3; Deng Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.158101; Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006; DOBRYNIN AV, 1995, MACROMOLECULES, V28, P1859, DOI 10.1021/ma00110a021; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fleming TC, 2010, GENE DEV, V24, P1160, DOI 10.1101/gad.1925210; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hansen PL, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021907; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Holt J., 1994, BERGEYS MANUAL DETER; KAY D, 1968, BIOCHEM J, V109, P819, DOI 10.1042/bj1090819; Kempes CP, 2016, ISME J, V10, P2145, DOI 10.1038/ismej.2016.21; Lamsa A, 2016, ACS CHEM BIOL, V11, P2222, DOI 10.1021/acschembio.5b01050; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Liu NN, 2015, ELIFE, V4, DOI 10.7554/eLife.09224; Lo CJ, 2006, BIOPHYS J, V90, P357, DOI 10.1529/biophysj.105.071332; LOPEZDIAZ I, 1986, J GEN MICROBIOL, V132, P341; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Manning GS, 2006, BIOPHYS J, V91, P3607, DOI 10.1529/biophysj.106.089029; Martinez-Sanchez A, 2014, J STRUCT BIOL, V186, P49, DOI 10.1016/j.jsb.2014.02.015; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Meyer P, 2010, MOL MICROBIOL, V76, P956, DOI 10.1111/j.1365-2958.2010.07155.x; Nguyen LT, 2015, P NATL ACAD SCI USA, V112, pE3689, DOI 10.1073/pnas.1504281112; Ojkic N, 2016, ELIFE, V5, DOI 10.7554/eLife.18657; Ojkic N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003912; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Pelletier J, 2012, P NATL ACAD SCI USA, V109, pE2649, DOI 10.1073/pnas.1208689109; Pereira MCF, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4995992; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Podgornik R, 2016, J PHYS CHEM B, V120, P6051, DOI 10.1021/acs.jpcb.6b02017; Pogliano J, 2002, J BACTERIOL, V184, P1743, DOI 10.1128/JB.184.4.1743-1749.2002; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Purohit PK, 2003, P NATL ACAD SCI USA, V100, P3173, DOI 10.1073/pnas.0737893100; Raspaud E, 2000, PHYS REV LETT, V84, P2533, DOI 10.1103/PhysRevLett.84.2533; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; Rojas E, 2014, P NATL ACAD SCI USA, V111, P7807, DOI 10.1073/pnas.1402591111; RYTER A, 1965, ANN I PASTEUR PARIS, V108, P40; SANDMAN K, 1987, GENETICS, V117, P603; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; SMITH K, 1993, J BACTERIOL, V175, P3607, DOI 10.1128/jb.175.11.3607-3617.1993; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; Tan IS, 2014, ENV MICROBIOL REP, V6, P212, DOI 10.1111/1758-2229.12130; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor CV, 1923, J EXP ZOOL, V37, P259, DOI 10.1002/jez.1400370302; Tocheva EI, 2013, MOL MICROBIOL, V88, P673, DOI 10.1111/mmi.12201; Ursell TS, 2014, P NATL ACAD SCI USA, V111, pE1025, DOI 10.1073/pnas.1317174111; Villa E, 2013, CURR OPIN STRUC BIOL, V23, P771, DOI 10.1016/j.sbi.2013.08.006; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; Yen Shin J., 2015, ELIFE, V4; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443	67	24	24	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					758	+		10.1016/j.cell.2018.01.027	http://dx.doi.org/10.1016/j.cell.2018.01.027			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425492	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000424648800016
J	Nakamura, A; Kaneko, N; Villemagne, VL; Kato, T; Doecke, J; Dore, V; Fowler, C; Li, QX; Martins, R; Rowe, C; Tomita, T; Matsuzaki, K; Ishii, K; Ishii, K; Arahata, Y; Iwamoto, S; Ito, K; Tanaka, K; Masters, CL; Yanagisawa, K				Nakamura, Akinori; Kaneko, Naoki; Villemagne, Victor L.; Kato, Takashi; Doecke, James; Dore, Vincent; Fowler, Chris; Li, Qiao-Xin; Martins, Ralph; Rowe, Christopher; Tomita, Taisuke; Matsuzaki, Katsumi; Ishii, Kenji; Ishii, Kazunari; Arahata, Yutaka; Iwamoto, Shinichi; Ito, Kengo; Tanaka, Koichi; Masters, Colin L.; Yanagisawa, Katsuhiko			High performance plasma amyloid-beta biomarkers for Alzheimer's disease	NATURE			English	Article							MILD COGNITIVE IMPAIRMENT; BLOOD-BASED BIOMARKERS; CEREBROSPINAL-FLUID; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; QUANTIFICATION; PET; RECOMMENDATIONS; PEPTIDES	To facilitate clinical trials of disease-modifying therapies for Alzheimer's disease, which are expected to be most efficacious at the earliest and mildest stages of the disease(1,2), supportive biomarker information is necessary. The only validated methods for identifying amyloid-beta deposition in the brain-the earliest pathological signature of Alzheimer's disease-are amyloid-beta positron-emission tomography (PET) imaging or measurement of amyloid-beta in cerebrospinal fluid. Therefore, a minimally invasive, cost-effective blood-based biomarker is desirable(3,4). Despite much effort(3-7), to our knowledge, no study has validated the clinical utility of blood-based amyloid-beta markers. Here we demonstrate the measurement of high-performance plasma amyloid-beta biomarkers by immunoprecipitation coupled with mass spectrometry. The ability of amyloid-beta precursor protein (APP)(669-711)/amyloid-beta (A beta)(1-42) and A beta(1-40)/A beta(1-42) ratios, and their composites, to predict individual brain amyloid-beta-positive or -negative status was determined by amyloid-beta-PET imaging and tested using two independent data sets: a discovery data set (Japan, n = 121) and a validation data set (Australia, n = 252 including 111 individuals diagnosed using C-11-labelled Pittsburgh compound-B (PIB)-PET and 141 using other ligands). Both data sets included cognitively normal individuals, individuals with mild cognitive impairment and individuals with Alzheimer's disease. All test biomarkers showed high performance when predicting brain amyloid-beta burden. In particular, the composite biomarker showed very high areas under the receiver operating characteristic curves (AUCs) in both data sets (discovery, 96.7%, n = 121 and validation, 94.1%, n = 111) with an accuracy approximately equal to 90% when using PIB-PET as a standard of truth. Furthermore, test biomarkers were correlated with amyloid-beta-PET burden and levels of A beta(1-42) in cerebrospinal fluid. These results demonstrate the potential clinical utility of plasma biomarkers in predicting brain amyloid-beta burden at an individual level. These plasma biomarkers also have cost-benefit and scalability advantages over current techniques, potentially enabling broader clinical access and efficient population screening.	[Nakamura, Akinori; Kato, Takashi; Ito, Kengo; Yanagisawa, Katsuhiko] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Obu, Aichi 4748511, Japan; [Kaneko, Naoki; Iwamoto, Shinichi; Tanaka, Koichi] Shimadzu Co Ltd, Koichi Tanaka Mass Spectrometry Res Lab, Kyoto 6048511, Japan; [Villemagne, Victor L.; Dore, Vincent; Rowe, Christopher] Austin Hlth, Dept Mol Imaging & Therapy, Ctr PET, Heidelberg, Vic 3084, Australia; [Villemagne, Victor L.; Fowler, Chris; Li, Qiao-Xin; Rowe, Christopher; Masters, Colin L.] Univ Melbourne, Florey Inst, Parkville, Vic 3010, Australia; [Kato, Takashi; Arahata, Yutaka; Ito, Kengo] Natl Hosp Geriatr Med, Natl Ctr Geriatr & Gerontol, Obu, Aichi 4748511, Japan; [Doecke, James; Dore, Vincent] CSIRO, Hlth & Biosecur, Brisbane, Qld 4029, Australia; [Martins, Ralph] Edith Cowan Univ, Joondalup, WA 6027, Australia; [Tomita, Taisuke] Univ Tokyo, Lab Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Matsuzaki, Katsumi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Ishii, Kenji] Tokyo Metropolitan Inst Gerontol, Team Neuroimaging Res, Tokyo 1730015, Japan; [Ishii, Kazunari] Kindai Univ, Fac Med, Dept Radiol, Osaka 5898511, Japan	National Center for Geriatrics & Gerontology; Shimadzu Corporation; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne; National Center for Geriatrics & Gerontology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Edith Cowan University; University of Tokyo; Kyoto University; Tokyo Metropolitan Institute of Gerontology; Kindai University (Kinki University)	Yanagisawa, K (corresponding author), Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Obu, Aichi 4748511, Japan.	katuhiko@ncgg.go.jp	Tomita, Taisuke/L-5427-2015; Kaneko, Naoki/AAT-2477-2021; Rowe, Christopher/AAX-8748-2021; Villemagne, Victor/AAC-5406-2019; Dore, Vincent/A-7750-2011	Tomita, Taisuke/0000-0002-0075-5943; Villemagne, Victor/0000-0002-5832-9875; Dore, Vincent/0000-0002-8051-0558; Fowler, Christopher/0000-0003-1397-0359; Masters, Colin/0000-0003-3072-7940; Martins, Ralph/0000-0002-4828-9363; Nakamura, Akinori/0000-0002-4259-1297; Ishii, Kazunari/0000-0001-6601-952X	National Center for Geriatrics and Gerontology [25-24, 26-30]; Japan Agency for Medical Research and Development, AMED; UMIN [000016144]; Alzheimer's Association (US); Alzheimer's Drug Discovery Foundation; Cooperative Research Centre for Mental Health; CSIRO Science and Industry Endowment Fund; Dementia Collaborative Research Centres; Victorian Government Operational Infrastructure Support program; McCusker Alzheimer's Research Foundation; National Health and Medical Research Council; Yulgilbar Foundation; Grants-in-Aid for Scientific Research [15H02492] Funding Source: KAKEN	National Center for Geriatrics and Gerontology; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); UMIN; Alzheimer's Association (US)(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Cooperative Research Centre for Mental Health(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); CSIRO Science and Industry Endowment Fund; Dementia Collaborative Research Centres; Victorian Government Operational Infrastructure Support program; McCusker Alzheimer's Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Yulgilbar Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The NCGG study group thank all participants of the study, clinicians who referred patients, and all the staff who supported the MULNIAD project. We thank N. Sugimoto for conducting statistical analyses, S. Niida and the NCGG Biobank members for the management of plasma samples and M. Kawakage for data monitoring. This study was supported by The Research Funding for Longevity Sciences (25-24 and 26-30) from the National Center for Geriatrics and Gerontology, and partially supported by Research and Development Grants for Dementia from the Japan Agency for Medical Research and Development, AMED. This study is registered under UMIN ID: 000016144. The AIBL study would like to thank all participants of the study and the clinicians who referred participants. The AIBL study (https://aibl.csiro.au/) is a consortium between Austin Health, CSIRO, Edith Cowan University and the Florey Institute, The University of Melbourne. Partial financial support was provided by the Alzheimer's Association (US), the Alzheimer's Drug Discovery Foundation, an anonymous foundation, the Cooperative Research Centre for Mental Health, CSIRO Science and Industry Endowment Fund, the Dementia Collaborative Research Centres, the Victorian Government Operational Infrastructure Support program, the McCusker Alzheimer's Research Foundation, the National Health and Medical Research Council, and the Yulgilbar Foundation. Funding sources had no role in study design, data collection, data analyses or data interpretation.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Boccardi M, 2016, JAMA NEUROL, V73, P1417, DOI 10.1001/jamaneurol.2016.3751; Bourgeat P, 2015, NEUROBIOL AGING, V36, pS159, DOI 10.1016/j.neurobiolaging.2014.04.033; Caselli RJ, 2016, JAMA NEUROL, V73, P1396, DOI 10.1001/jamaneurol.2016.3792; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Fagan AM, 2011, ARCH NEUROL-CHICAGO, V68, P1137, DOI 10.1001/archneurol.2011.105; Gelfanova Valentina, 2007, Briefings in Functional Genomics & Proteomics, V6, P149, DOI 10.1093/bfgp/elm010; Henriksen K, 2014, ALZHEIMERS DEMENT, V10, P115, DOI 10.1016/j.jalz.2013.01.013; Irwin DJ, 2012, ARCH NEUROL-CHICAGO, V69, P1018, DOI 10.1001/archneurol.2012.26; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Janelidze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26801; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Kaneko N, 2014, P JPN ACAD B-PHYS, V90, P353, DOI 10.2183/pjab.90.353; Kaneko N, 2014, P JPN ACAD B-PHYS, V90, P104, DOI 10.2183/pjab.90.104; Landau SM, 2014, EUR J NUCL MED MOL I, V41, P1398, DOI 10.1007/s00259-014-2753-3; Li QX, 2015, J ALZHEIMERS DIS, V48, P175, DOI 10.3233/JAD-150247; Lovheim H, 2017, ALZHEIMERS DEMENT, V13, P778, DOI 10.1016/j.jalz.2016.12.004; Lundqvist R, 2013, J NUCL MED, V54, P1472, DOI 10.2967/jnumed.112.115006; Manzoni C, 2009, AMYLOID, V16, P71, DOI 10.1080/13506120902879848; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mormino EC, 2014, NEUROLOGY, V82, P1760, DOI 10.1212/WNL.0000000000000431; O'Bryant SE, 2017, ALZHEIMERS DEMENT, V13, P45, DOI 10.1016/j.jalz.2016.09.014; O'Bryant SE, 2015, ALZHEIMERS DEMENT, V11, P549, DOI 10.1016/j.jalz.2014.08.099; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; Pannee J, 2013, J ALZHEIMERS DIS, V33, P1021, DOI 10.3233/JAD-2012-121471; Patterson BW, 2015, ANN NEUROL, V78, P439, DOI 10.1002/ana.24454; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rembach A, 2014, J ALZHEIMERS DIS, V40, P95, DOI 10.3233/JAD-131802; Rembach A, 2014, ALZHEIMERS DEMENT, V10, P53, DOI 10.1016/j.jalz.2012.12.006; Rogers M. B, 2017, ARE CSF ASSAYS FINAL; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Swaminathan Shanker, 2014, Alzheimers Dement, V10, pe9, DOI 10.1016/j.jalz.2013.01.007; Tanaka S, 2014, J PROTEOME RES, V13, P3846, DOI 10.1021/pr500155z; Toombs J, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt236; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; Villemagne V.L., 2014, ADV RES, V2, P723, DOI DOI 10.9734/AIR/2014/11599; Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	47	776	794	32	542	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					249	+		10.1038/nature25456	http://dx.doi.org/10.1038/nature25456			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420472				2022-12-28	WOS:000424332600041
J	Jha, AK				Jha, Ashish K.			To Fix the Hospital Readmissions Program, Prioritize What Matters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Global Hlth & Hlth Policy, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA	Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard TH Chan Sch Publ Hlth, Global Hlth & Hlth Policy, Boston, MA 02115 USA.; Jha, AK (corresponding author), Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA.	ajha@hsph.harvard.edu							0	18	18	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					431	433		10.1001/jama.2017.21623	http://dx.doi.org/10.1001/jama.2017.21623			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29411022	Bronze			2022-12-28	WOS:000424224500003
J	Nunoura, T; Chikaraishi, Y; Izaki, R; Suwa, T; Sato, T; Harada, T; Mori, K; Kato, Y; Miyazaki, M; Shimamura, S; Yanagawa, K; Shuto, A; Ohkouchi, N; Fujita, N; Takaki, Y; Atomi, H; Takai, K				Nunoura, Takuro; Chikaraishi, Yoshito; Izaki, Rikihisa; Suwa, Takashi; Sato, Takaaki; Harada, Takeshi; Mori, Koji; Kato, Yumiko; Miyazaki, Masayuki; Shimamura, Shigeru; Yanagawa, Katsunori; Shuto, Aya; Ohkouchi, Naohiko; Fujita, Nobuyuki; Takaki, Yoshihiro; Atomi, Haruyuki; Takai, Ken			A primordial and reversible TCA cycle in a facultatively chemolithoautotrophic thermophile	SCIENCE			English	Article							ATP-CITRATE LYASE; AUTOTROPHIC CARBON FIXATION; PURIFICATION; EVOLUTION; SYNTHASE; ENZYME; ACID	Inorganic carbon fixation is essential to sustain life on Earth, and the reductive tricarboxylic acid (rTCA) cycle is one of the most ancient carbon fixation metabolisms. A combination of genomic, enzymatic, and metabolomic analyses of a deeply branching chemolithotrophic Thermosulfidibacter takaii ABI70S6(T) revealed a previously unknown reversible TCA cycle whose direction was controlled by the available carbon source(s). Under a chemolithoautotrophic condition, a rTCA cycle occurred with the reverse reaction of citrate synthase (CS) and not with the adenosine 5'-triphosphate-dependent citrate cleavage reactions that had been regarded as essential for the conventional rTCA cycle. Phylometabolic evaluation suggests that the TCA cycle with reversible CS may represent an ancestral mode of the rTCA cycle and raises the possibility of a facultatively chemolithomixotrophic origin of life.	[Nunoura, Takuro; Chikaraishi, Yoshito; Miyazaki, Masayuki; Shuto, Aya; Takaki, Yoshihiro] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res & Dev Ctr Marine Biosci, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan; [Chikaraishi, Yoshito; Ohkouchi, Naohiko] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Biogeochem, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan; [Chikaraishi, Yoshito] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Kita 19,Nishi 8, Sapporo, Hokkaido 0600819, Japan; [Izaki, Rikihisa; Suwa, Takashi; Sato, Takaaki; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Harada, Takeshi; Mori, Koji; Kato, Yumiko; Fujita, Nobuyuki] NITE, NBRC, Shibuya Ku, 2-49-10 Nishihara, Tokyo 1510066, Japan; [Miyazaki, Masayuki; Shimamura, Shigeru; Yanagawa, Katsunori; Takaki, Yoshihiro; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan; [Atomi, Haruyuki] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, 7 Goban Cho, Tokyo 1020076, Japan; [Yanagawa, Katsunori] Univ Kitakyushu, Fac Environm Engn, Kitakyushu, Fukuoka, Japan; [Fujita, Nobuyuki] Tokyo Univ Agr, Fac Life Sci, Tokyo, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Hokkaido University; Kyoto University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Science & Technology Agency (JST); University of Kitakyushu; Tokyo University of Agriculture	Nunoura, T (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res & Dev Ctr Marine Biosci, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	takuron@jamstec.go.jp	Chikaraishi, Yoshito/O-5250-2019; Nunoura, Takuro/AAL-6266-2020	Chikaraishi, Yoshito/0000-0002-7506-1524; Nunoura, Takuro/0000-0003-2323-0880; Atomi, Haruyuki/0000-0001-9687-6426; Yanagawa, Katsunori/0000-0003-0431-3322; Ohkouchi, Naohiko/0000-0002-6355-7469				ANTRANIKIAN G, 1982, J BACTERIOL, V152, P1284; Aoshima M, 2004, MOL MICROBIOL, V52, P763, DOI 10.1111/j.1365-2958.2004.04010.x; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; BOULTON CA, 1983, J GEN MICROBIOL, V129, P2863; Braakman R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002455; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Cody GD, 2001, GEOCHIM COSMOCHIM AC, V65, P3557, DOI 10.1016/S0016-7037(01)00674-3; Feng XY, 2010, J BIOL CHEM, V285, P39544, DOI 10.1074/jbc.M110.162958; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; GUYNN RW, 1973, J BIOL CHEM, V248, P6957; Hugler M, 2007, ENVIRON MICROBIOL, V9, P81, DOI 10.1111/j.1462-2920.2006.01118.x; ISHII M, 1989, J BACTERIOL, V171, P1788, DOI 10.1128/jb.171.4.1788-1792.1989; Kanao T, 2001, EUR J BIOCHEM, V268, P1670, DOI 10.1046/j.1432-1033.2001.02034.x; Keller MA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0083; Lazcano A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002089; MAHLEN A, 1973, EUR J BIOCHEM, V36, P342, DOI 10.1111/j.1432-1033.1973.tb02918.x; Mall A, 2018, SCIENCE, V359, P563, DOI 10.1126/science.aao2410; Nunoura T., 2014, PROKARYOTES PROKARYO, P617; Nunoura T, 2008, INT J SYST EVOL MICR, V58, P659, DOI 10.1099/ijs.0.65349-0; PAULSEN J, 1986, ARCH MICROBIOL, V144, P78, DOI 10.1007/BF00454960; Ramos-Vera WH, 2009, J BACTERIOL, V191, P4286, DOI 10.1128/JB.00145-09; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; Smith E, 2004, P NATL ACAD SCI USA, V101, P13168, DOI 10.1073/pnas.0404922101; Smith E, 2010, ORIGINS LIFE EVOL B, V40, P397; Srinivasan V, 2009, BIOL BULL-US, V216, P126; Takeda Y., 1969, METHOD ENZYMOL, V13, P153, DOI [DOI 10.1016/0076-6879(69)13032-3, 10.1016/0076-6879(69)13032-3]; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200	27	90	96	18	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					559	562		10.1126/science.aao3407	http://dx.doi.org/10.1126/science.aao3407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420286				2022-12-28	WOS:000423795800038
J	Maude, SL; Laetsch, TW; Buechner, J; Rives, S; Boyer, M; Bittencourt, H; Bader, P; Verneris, MR; Stefanski, HE; Myers, GD; Qayed, M; De Moerloose, B; Hiramatsu, H; Schlis, K; Davis, KL; Martin, PL; Nemecek, ER; Yanik, GA; Peters, C; Baruchel, A; Boissel, N; Mechinaud, F; Balduzzi, A; Krueger, J; June, CH; Levine, BL; Wood, P; Taran, T; Leung, M; Mueller, KT; Zhang, Y; Sen, K; Lebwohl, D; Pulsipher, MA; Grupp, SA				Maude, S. L.; Laetsch, T. W.; Buechner, J.; Rives, S.; Boyer, M.; Bittencourt, H.; Bader, P.; Verneris, M. R.; Stefanski, H. E.; Myers, G. D.; Qayed, M.; De Moerloose, B.; Hiramatsu, H.; Schlis, K.; Davis, K. L.; Martin, P. L.; Nemecek, E. R.; Yanik, G. A.; Peters, C.; Baruchel, A.; Boissel, N.; Mechinaud, F.; Balduzzi, A.; Krueger, J.; June, C. H.; Levine, B. L.; Wood, P.; Taran, T.; Leung, M.; Mueller, K. T.; Zhang, Y.; Sen, K.; Lebwohl, D.; Pulsipher, M. A.; Grupp, S. A.			Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAR-T-CELLS; PEDIATRIC-PATIENTS	BACKGROUND In a single-center phase 1-2a study, the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel produced high rates of complete remission and was associated with serious but mainly reversible toxic effects in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). METHODS We conducted a phase 2, single-cohort, 25-center, global study of tisagenlecleucel in pediatric and young adult patients with CD19+ relapsed or refractory B-cell ALL. The primary end point was the overall remission rate (the rate of complete remission or complete remission with incomplete hematologic recovery) within 3 months. RESULTS For this planned analysis, 75 patients received an infusion of tisagenlecleucel and could be evaluated for efficacy. The overall remission rate within 3 months was 81%, with all patients who had a response to treatment found to be negative for minimal residual disease, as assessed by means of flow cytometry. The rates of event-free survival and overall survival were 73% (95% confidence interval [CI], 60 to 82) and 90% (95% CI, 81 to 95), respectively, at 6 months and 50% (95% CI, 35 to 64) and 76% (95% CI, 63 to 86) at 12 months. The median duration of remission was not reached. Persistence of tisagenlecleucel in the blood was observed for as long as 20 months. Grade 3 or 4 adverse events that were suspected to be related to tisagenlecleucel occurred in 73% of patients. The cytokine release syndrome occurred in 77% of patients, 48% of whom received tocilizumab. Neurologic events occurred in 40% of patients and were managed with supportive care, and no cerebral edema was reported. CONCLUSIONS In this global study of CAR T-cell therapy, a single infusion of tisagenlecleucel provided durable remission with long-term persistence in pediatric and young adult patients with relapsed or refractory B-cell ALL, with transient high-grade toxic effects. (Funded by Novartis Pharmaceuticals; ClinicalTrials.gov number, NCT02435849.)	[Maude, S. L.; Grupp, S. A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [June, C. H.; Levine, B. L.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [June, C. H.; Levine, B. L.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Maude, S. L.; Grupp, S. A.] Childrens Hosp Philadelphia, Div Oncol, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Maude, S. L.; Grupp, S. A.] Childrens Hosp Philadelphia, Canc Immunotherapy Program, Philadelphia, PA 19104 USA; [Laetsch, T. W.] Univ Texas Dallas, Southwestern Med Ctr, Dept Pediat, Dallas, TX USA; Pauline Allen Gill Ctr Canc & Blood Disorders, Childrens Hlth, Dallas, TX USA; [Buechner, J.] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway; [Rives, S.] Hosp St Joan Deu Barcelona, Dept Pediat Hematol & Oncol, Barcelona, Spain; [Boyer, M.] Univ Utah, Dept Pediat & Internal Med, Salt Lake City, UT USA; [Bittencourt, H.] Univ Montreal, Dept Pediat, Fac Med, Montreal, PQ, Canada; [Bittencourt, H.] CHU Sainte Justine, Res Ctr, Hematol Oncol Div, Montreal, PQ, Canada; [Bittencourt, H.] CHU Sainte Justine, Res Ctr, Charles Bruneau Canc Ctr, Montreal, PQ, Canada; [Krueger, J.] Hosp Sick Children, Div Haematol Oncol Bone Marrow Transplantat, Toronto, ON, Canada; [Bader, P.] Univ Hosp Frankfurt, Hosp Children & Adolescents, Div Stem Cell Transplantat & Immunol, Frankfurt, Germany; [Verneris, M. R.; Stefanski, H. E.] Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN USA; [Myers, G. D.] Childrens Mercy Hosp & Clin, Kansas City, MO USA; [Qayed, M.] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [De Moerloose, B.] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium; [De Moerloose, B.] CRIG, Ghent, Belgium; [Hiramatsu, H.] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; [Schlis, K.; Davis, K. L.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Pulsipher, M. A.] USC Keck Sch Med, Childrens Hosp Los Angeles, Div Hematol Oncol Blood & Marrow Transplant, Los Angeles, CA USA; [Martin, P. L.] Duke Univ, Med Ctr, Div Pediat Blood & Marrow Transplant, Durham, NC USA; [Nemecek, E. R.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Yanik, G. A.] CS Mott Childrens Hosp, Ann Arbor, MI USA; [Peters, C.] St Anna Childrens Hosp, Stem Cell Transplantat Unit, Vienna, Austria; [Baruchel, A.] Univ Hosp Robert Debre, Paris, France; [Baruchel, A.; Boissel, N.] Univ Paris Diderot, Paris, France; [Boissel, N.] St Louis Hop, Paris, France; [Mechinaud, F.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Balduzzi, A.] Univ Milano Bicocca, Clin Pediat, Monza, Italy; [Wood, P.; Taran, T.; Leung, M.; Zhang, Y.; Sen, K.; Lebwohl, D.] Novartis Pharmaceut, E Hanover, NJ USA; [Mueller, K. T.] Novartis Inst Biomed Res, E Hanover, NJ USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oslo; Utah System of Higher Education; University of Utah; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Minnesota System; University of Minnesota Twin Cities; Children's Mercy Hospital; Emory University; Ghent University; Ghent University Hospital; Ghent University; Kyoto University; Stanford University; Children's Hospital Los Angeles; University of Southern California; Duke University; Oregon Health & Science University; Saint Anna Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Children's Hospital Melbourne; University of Milano-Bicocca; Novartis; Novartis	Maude, SL (corresponding author), 3012 Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	maude@email.chop.edu	Rives, Susana/AHA-6765-2022; De+Moerloose, Barbara/AAN-3298-2020; Grupp, Stephan A/D-1145-2009; Boissel, Nicolas/P-2190-2018; BALDUZZI, Adriana/AAC-1033-2019	Rives, Susana/0000-0002-5658-1831; Balduzzi, Adriana Cristina/0000-0002-5879-0610; Peters, Christina/0000-0003-0369-8515; Buechner, Jochen/0000-0001-5848-4501; Boissel, Nicolas/0000-0003-2091-7927; De Moerloose, Barbara/0000-0002-2449-539X	Novartis Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002381, UL1TR002378] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Novartis Pharmaceuticals; ClinicalTrials.gov number, NCT02435849.	Abramson JS, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.7513; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; GARDNER R, 2016, BLOOD, V128; Gardner RA, 2017, BLOOD, V129, P3322, DOI 10.1182/blood-2017-02-769208; GRUPP SA, 2016, BLOOD, V128; Grupp SA, 2015, BLOOD, V126, P681, DOI DOI 10.1158/1078-0432.CCR-08-0144; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Jeha S, 2006, J CLIN ONCOL, V24, P1917, DOI 10.1200/JCO.2005.03.8554; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee DW, 2015, BLOOD, V126, P684; Lee S, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.5500.5500; Liu ZG, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.255.255; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Maude SL, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3011; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; SHAH B, 2016, BLOOD, V128; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; von Stackelberg A, 2016, J CLIN ONCOL, V34, P4381, DOI 10.1200/JCO.2016.67.3301	20	2423	2501	32	275	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					439	448		10.1056/NEJMoa1709866	http://dx.doi.org/10.1056/NEJMoa1709866			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU3WP	29385370	Green Accepted, Bronze			2022-12-28	WOS:000423783200008
J	Tang, WX; Liu, DR				Tang, Weixin; Liu, David R.			Rewritable multi-event analog recording in bacterial and mammalian cells	SCIENCE			English	Article							MOLECULAR-MECHANISM; GENOMIC DNA; BASE; MEMORY; ACTIVATION; EXPRESSION; CIRCUITS; LOGIC; RICE	We present two CRISPR-mediated analog multi-event recording apparatus (CAMERA) systems that use base editors and Cas9 nucleases to record cellular events in bacteria and mammalian cells. The devices record signal amplitude or duration as changes in the ratio of mutually exclusive DNA sequences (CAMERA 1) or as single-base modifications (CAMERA 2). We achieved recording of multiple stimuli in bacteria or mammalian cells, including exposure to antibiotics, nutrients, viruses, light, and changes in Wnt signaling. When recording to multicopy plasmids, reliable readout requires as few as 10 to 100 cells. The order of stimuli can be recorded through an overlapping guide RNA design, and memories can be erased and re-recorded over multiple cycles. CAMERA systems serve as "cell data recorders" that write a history of endogenous or exogenous signaling events into permanent DNA sequence modifications in living cells.	[Liu, David R.] Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	Tang, Weixin/0000-0002-5739-5416	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [RM1 HG009490] Funding Source: Medline; NIBIB NIH HHS [R01 EB022376] Funding Source: Medline; NIGMS NIH HHS [R35 GM118062] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG009490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118062] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x; Boehr DD, 2001, J BIOL CHEM, V276, P23929, DOI 10.1074/jbc.M100540200; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Carlson JC, 2014, NAT CHEM BIOL, V10, P216, DOI [10.1038/NCHEMBIO.1453, 10.1038/nchembio.1453]; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Hubbard BP, 2015, NAT METHODS, V12, P939, DOI [10.1038/NMETH.3515, 10.1038/nmeth.3515]; Inniss MC, 2013, CURR BIOL, V23, pR812, DOI 10.1016/j.cub.2013.06.047; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuscu C, 2017, NAT METHODS, V14, P710, DOI 10.1038/nmeth.4327; LEWENDON A, 1994, BIOCHEMISTRY-US, V33, P1944, DOI 10.1021/bi00173a043; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ohlendorf R, 2012, J MOL BIOL, V416, P534, DOI 10.1016/j.jmb.2012.01.001; Packer MS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01055-9; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Purcell O, 2014, CURR OPIN BIOTECH, V29, P146, DOI 10.1016/j.copbio.2014.04.009; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sheth RU, 2017, SCIENCE, V358, P1457, DOI 10.1126/science.aao0958; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; TOMAN Z, 1985, J MOL BIOL, V186, P97, DOI 10.1016/0022-2836(85)90260-8; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/nmeth.3147, 10.1038/NMETH.3147]; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	50	119	124	7	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385							eaap8992	10.1126/science.aap8992	http://dx.doi.org/10.1126/science.aap8992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29449507	Green Accepted			2022-12-28	WOS:000429805400037
J	Manson, JE; Bassuk, SS				Manson, Joann E.; Bassuk, Shari S.			Vitamin and Mineral Supplements What Clinicians Need to Know	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION; DISEASE; CANCER		[Manson, Joann E.; Bassuk, Shari S.] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA; [Manson, Joann E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu			National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA138962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Manson and Bassuk reported that their research division conducts randomized clinical trials of several vitamins and minerals. The Vitamin D and Omega-3 Trial (VITAL) is sponsored by the National Institutes of Health but the vitamin D is donated by Pharmavite. In COSMOS, the multivitamins are donated by Pfizer. Both authors collaborate on these studies.	ACOG, NUTR PREGN; American Academy of Pediatrics, VIT D IR SUPPL BAB A; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P1871, DOI 10.1001/jama.2012.14641; Institute of Medicine, 2011, DIETARY REFERENCE IN; Institute of Medicine, 1998, DIET REF INT THIAM R; Kantor ED, 2016, JAMA-J AM MED ASSOC, V316, P1464, DOI 10.1001/jama.2016.14403; Marra MV, 2009, J AM DIET ASSOC, V109, P2073, DOI 10.1016/j.jada.2009.10.020; Moyer VA, 2014, ANN INTERN MED, V160, P558, DOI 10.7326/M14-0198; Rautiainen S, 2016, NAT REV ENDOCRINOL, V12, P407, DOI 10.1038/nrendo.2016.54	9	27	31	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2018	319	9					859	860		10.1001/jama.2017.21012	http://dx.doi.org/10.1001/jama.2017.21012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY3FW	29404568				2022-12-28	WOS:000426705100008
J	He, L; Si, G; Huang, JH; Samuel, ADT; Perrimon, N				He, Li; Si, Guangwei; Huang, Jiuhong; Samuel, Aravinthan D. T.; Perrimon, Norbert			Mechanical regulation of stem-cell differentiation by the stretch-activated Piezo channel	NATURE			English	Article							DROSOPHILA-MELANOGASTER; ENTEROENDOCRINE CELLS; MIDGUT; REGENERATION; INTEGRATION; PROTEINS; DIVISION	Somatic stem cells constantly adjust their self-renewal and lineage commitment by integrating various environmental cues to maintain tissue homeostasis. Although numerous chemical and biological signals have been identified that regulate stem-cell behaviour, whether stem cells can directly sense mechanical signals in vivo remains unclear(1). Here we show that mechanical stress regulates stem-cell differentiation in the adult Drosophila midgut through the stretch-activated ion channel Piezo. We find that Piezo is specifically expressed in previously unidentified enteroendocrine precursor cells, which have reduced proliferation ability and are destined to become enteroendocrine cells. Loss of Piezo activity reduces the generation of enteroendocrine cells in the adult midgut. In addition, ectopic expression of Piezo in all stem cells triggers both cell proliferation and enteroendocrine cell differentiation. Both the Piezo mutant and overexpression phenotypes can be rescued by manipulation of cytosolic Ca2+ levels, and increases in cytosolic Ca2+ resemble the Piezo overexpression phenotype, suggesting that Piezo functions through Ca2+ signalling. Further studies suggest that Ca2+ signalling promotes stem-cell proliferation and differentiation through separate pathways. Finally, Piezo is required for both mechanical activation of stem cells in a gut expansion assay and the increase of cytosolic Ca2+ in response to direct mechanical stimulus in a gut compression assay. Thus, our study demonstrates the existence of a specific group of stem cells in the fly midgut that can directly sense mechanical signals through Piezo.	[He, Li; Perrimon, Norbert] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Si, Guangwei; Samuel, Aravinthan D. T.] Harvard Univ, Dept Phys, Ctr Brain Sci, Cambridge, MA 02142 USA; [Huang, Jiuhong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Perrimon, Norbert] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Tongji University; Howard Hughes Medical Institute	He, L; Perrimon, N (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Perrimon, N (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	lihe@genetics.med.harvard.edu; perrimon@rascal.med.harvard.edu		HE, LI/0000-0003-2155-606X	Damon Runyon Cancer Research Foundation; National Institutes of Health [R21DA039582, P01GM103770]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM103770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA039582] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Binari, W. Song and C. Villalta for technical support; C. Xu, S. Mohr and D. Doupe for comments on the manuscript; and G. Hasan for sharing reagents. This work was supported by the Damon Runyon Cancer Research Foundation (L.H.) and a grant from the National Institutes of Health (R21DA039582). N.P. is an investigator of the Howard Hughes Medical Institute. G. S. and A.D.T.S. are supported by the National Institutes of Health (P01GM103770).	Amcheslavsky A, 2014, CELL REP, V9, P32, DOI 10.1016/j.celrep.2014.08.052; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Cinar E, 2015, P NATL ACAD SCI USA, V112, P11783, DOI 10.1073/pnas.1507309112; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dai W, 2016, METHODS MOL BIOL, V1407, P153, DOI 10.1007/978-1-4939-3480-5_12; De Ford C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.413; Deng HS, 2015, NATURE, V528, P212, DOI 10.1038/nature16170; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guo Z, 2015, SCIENCE, V350, DOI 10.1126/science.aab0988; Harrison E, 2013, CURR OPIN PHARMACOL, V13, P941, DOI 10.1016/j.coph.2013.09.012; Housden BE, 2016, COLD SPRING HARB PRO; Housden BE, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3729; Housden BE, 2014, METHOD ENZYMOL, V546, P415, DOI 10.1016/B978-0-12-801185-0.00019-2; Hubin EA, 2017, ELIFE, V6, DOI 10.7554/eLife.22520; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Li HJ, 2016, DIS MODEL MECH, V9, P487, DOI 10.1242/dmm.024232; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Micchelli CA, 2011, GENE EXPR PATTERNS, V11, P12, DOI 10.1016/j.gep.2010.08.005; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Salle J, 2017, EMBO J, V36, P1928, DOI 10.15252/embj.201695622; Suslak TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130969; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Vining KH, 2017, NAT REV MOL CELL BIO, V18, P728, DOI 10.1038/nrm.2017.108; Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z; Wang CH, 2015, DEVELOPMENT, V142, P3321, DOI 10.1242/dev.123208; Wen Q, 2012, NEURON, V76, P750, DOI 10.1016/j.neuron.2012.08.039; Zeng XK, 2010, GENESIS, V48, P607, DOI 10.1002/dvg.20661; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	43	164	166	11	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2018	555	7694					103	+		10.1038/nature25744	http://dx.doi.org/10.1038/nature25744			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7DN	29414942	Green Accepted			2022-12-28	WOS:000426247600040
J	Cobo, I; Martinelli, P; Flandez, M; Bakiri, L; Zhang, MF; Carrillo-de-Santa-Pau, E; Jia, JP; Lobo, VJSA; Megias, D; Felipe, I; del Pozo, N; Millan, I; Thommesen, L; Bruland, T; Olson, SH; Smith, J; Schoonjans, K; Bamlet, WR; Petersen, GM; Malats, N; Amundadottir, LT; Wagner, EF; Real, FX				Cobo, Isidoro; Martinelli, Paola; Flandez, Marta; Bakiri, Latifa; Zhang, Mingfeng; Carrillo-de-Santa-Pau, Enrique; Jia, Jinping; Sanchez-Arevalo Lobo, Victor J.; Megias, Diego; Felipe, Irene; del Pozo, Natalia; Millan, Irene; Thommesen, Liv; Bruland, Torunn; Olson, Sara H.; Smith, Jill; Schoonjans, Kristina; Bamlet, William R.; Petersen, Gloria M.; Malats, Nuria; Amundadottir, Laufey T.; Wagner, Erwin F.; Real, Francisco X.			Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas	NATURE			English	Article							GLUCOCORTICOID SYNTHESIS; GENE-EXPRESSION; C-JUN; LRH-1; AP-1	Chronic inflammation increases the risk of developing one of several types of cancer. Inflammatory responses are currently thought to be controlled by mechanisms that rely on transcriptional networks that are distinct from those involved in cell differentiation(1-3). The orphan nuclear receptor NR5A2 participates in a wide variety of processes, including cholesterol and glucose metabolism in the liver, resolution of endoplasmic reticulum stress, intestinal glucocorticoid production, pancreatic development and acinar differentiation(4-8). In genome-wide association studies(9,10), single nucleotide polymorphisms in the vicinity of NR5A2 have previously been associated with the risk of pancreatic adenocarcinoma. In mice, Nr5a2 heterozygosity sensitizes the pancreas to damage, impairs regeneration and cooperates with mutant Kras in tumour progression(11). Here, using a global transcriptomic analysis, we describe an epithelial-cell- autonomous basal pre-inflammatory state in the pancreas of Nr5a2(+/-) mice that is reminiscent of the early stages of pancreatitis-induced inflammation and is conserved in histologically normal human pancreases with reduced expression of NR5A2 mRNA. In Nr5a2(+/-) mice, NR5A2 undergoes a marked transcriptional switch, relocating from differentiation-specific to inflammatory genes and thereby promoting gene transcription that is dependent on the AP-1 transcription factor. Pancreatic deletion of Jun rescues the pre-inflammatory phenotype, as well as binding of NR5A2 to inflammatory gene promoters and the defective regenerative response to damage. These findings support the notion that, in the pancreas, the transcriptional networks involved in differentiation-specific functions also suppress inflammatory programmes. Under conditions of genetic or environmental constraint, these networks can be subverted to foster inflammation.	[Cobo, Isidoro; Martinelli, Paola; Flandez, Marta; Carrillo-de-Santa-Pau, Enrique; Sanchez-Arevalo Lobo, Victor J.; Felipe, Irene; del Pozo, Natalia; Millan, Irene; Real, Francisco X.] Spanish Natl Canc Res Ctr CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain; [Bakiri, Latifa; Wagner, Erwin F.] Spanish Natl Canc Res Ctr CNIO, Genes Dev & Dis Grp, Madrid, Spain; [Zhang, Mingfeng; Jia, Jinping; Amundadottir, Laufey T.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Megias, Diego] Spanish Natl Canc Res Ctr CNIO, Confocal Microscopy Unit, Madrid, Spain; [del Pozo, Natalia; Millan, Irene; Real, Francisco X.] CIBERONC, Epithelial Carcinogenesis Grp, Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Thommesen, Liv] Norwegian Univ Sci & Technol NTNU, Dept Biomed Sci, Trondheim, Norway; [Bruland, Torunn] St Olavs Univ Hosp, Med Clin, Trondheim, Norway; [Bruland, Torunn] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Trondheim, Norway; [Olson, Sara H.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Smith, Jill] Georgetown Univ, Dept Gastroenterol, Washington, DC 20007 USA; [Smith, Jill] Georgetown Univ, Dept Hepatol, Washington, DC 20007 USA; [Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Bamlet, William R.; Petersen, Gloria M.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN 55905 USA; [Malats, Nuria] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Malats, Nuria] CIBERONC, Genet & Mol Epidemiol Grp, Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Martinelli, Paola] Med Univ Vienna, Inst Canc Res, Dept Med 1, Vienna, Austria; [Flandez, Marta] Spanish Natl Cardiovasc Res Ctr CNIC, Tissue Regenerat Lab, Madrid, Spain; [Sanchez-Arevalo Lobo, Victor J.] Univ Francisco Vitoria, Fac Ciencias Biosanitarias, Dept Biotechnol, Pozuelo De Alarcon, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Memorial Sloan Kettering Cancer Center; Georgetown University; Georgetown University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Mayo Clinic; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Pompeu Fabra University; Medical University of Vienna; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Francisco de Vitoria	Real, FX (corresponding author), Spanish Natl Canc Res Ctr CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain.; Real, FX (corresponding author), CIBERONC, Epithelial Carcinogenesis Grp, Spanish Natl Canc Res Ctr CNIO, Madrid, Spain.; Real, FX (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain.	preal@cnio.es	Arribas, Francisco X Real/H-5275-2015; FELIPE, IRENE/ABF-9743-2021; Lobo, Victor Javier Sanchez-Arevalo/N-8641-2019; Canet, Marta Flández/E-2681-2019; Megías, Diego/L-6008-2014; Bluland, Torunn/AAT-5730-2021; de Santa Pau, Enrique Carrillo/AAV-7544-2021; Lobo, Victor Javier vjsal Sanchez-Arevalo/H-1069-2011; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Bakiri, Latifa/AAP-1674-2020; Malats, Nuria/H-7041-2015	Arribas, Francisco X Real/0000-0001-9501-498X; FELIPE, IRENE/0000-0001-7781-1459; Lobo, Victor Javier Sanchez-Arevalo/0000-0002-4561-1505; Canet, Marta Flández/0000-0002-9096-2267; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; Lobo, Victor Javier vjsal Sanchez-Arevalo/0000-0002-4561-1505; Malats, Nuria/0000-0003-2538-3784; bakiri, latifa/0000-0002-6300-2420; Bruland, Torunn/0000-0002-1568-2476; Wagner, Erwin F/0000-0001-7872-0196; Megias, Diego/0000-0003-0755-0518; Millan, Irene/0000-0002-7537-2955; Schoonjans, Kristina/0000-0003-1247-4265; Martinelli, Paola/0000-0002-1643-8731	Ministerio de Economia y Competitividad (ERDF-EU) [SAF2011-29530, SAF2015-70553-R, BFU 2012-40230, SAF2015-70857]; RTICC from the Instituto de Salud Carlos III [RD 12/0036/0034, RD12/0036/0050]; European Union Seventh Framework Program [256974, 289737]; Worldwide Cancer Research [13-0216]; Fondo de Investigaciones Sanitarias [PI12/00815, PI1501573]; Instituto de Salud Carlos III, Spain; EUPancreas COST Action [BM 1204]; US NIH, National Cancer Institute [P30CA008748]; Intramural Research Program of the NIH, National Cancer Institute; National Cancer Institute [P50 CA102701]; Department of Technology, Norwegian University of Science and Technology; Central Norway Regional Health Authority; European Science Foundation; Juan de la Cierva and Beca de Formacion del Personal Investigador; Ministerio de Economia y Competitividad; 'Juegaterapia-Amigos del CNIO' Postdoctoral Fellowship; Asociacion Espanola Contra el Cancer; Ministerio de Economia y Competitividad (ERDF-EU) [SAF2011-29530, SAF2015-70553-R, BFU 2012-40230, SAF2015-70857]; RTICC from the Instituto de Salud Carlos III [RD 12/0036/0034, RD12/0036/0050]; European Union Seventh Framework Program [256974, 289737]; Worldwide Cancer Research [13-0216]; Fondo de Investigaciones Sanitarias [PI12/00815, PI1501573]; Instituto de Salud Carlos III, Spain; EUPancreas COST Action [BM 1204]; US NIH, National Cancer Institute [P30CA008748]; Intramural Research Program of the NIH, National Cancer Institute; National Cancer Institute [P50 CA102701]; Department of Technology, Norwegian University of Science and Technology; Central Norway Regional Health Authority; European Science Foundation; Juan de la Cierva and Beca de Formacion del Personal Investigador; Ministerio de Economia y Competitividad; 'Juegaterapia-Amigos del CNIO' Postdoctoral Fellowship; Asociacion Espanola Contra el Cancer; NATIONAL CANCER INSTITUTE [ZIACP010201, P50CA102701, P30CA008748] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad (ERDF-EU); RTICC from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Union Seventh Framework Program(European Commission); Worldwide Cancer Research; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); EUPancreas COST Action(European Cooperation in Science and Technology (COST)); US NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Technology, Norwegian University of Science and Technology; Central Norway Regional Health Authority; European Science Foundation(European Science Foundation (ESF)European Commission); Juan de la Cierva and Beca de Formacion del Personal Investigador; Ministerio de Economia y Competitividad(Spanish Government); 'Juegaterapia-Amigos del CNIO' Postdoctoral Fellowship; Asociacion Espanola Contra el Cancer; Ministerio de Economia y Competitividad (ERDF-EU); RTICC from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Union Seventh Framework Program(European Commission); Worldwide Cancer Research; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); EUPancreas COST Action(European Cooperation in Science and Technology (COST)); US NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Technology, Norwegian University of Science and Technology; Central Norway Regional Health Authority; European Science Foundation(European Science Foundation (ESF)European Commission); Juan de la Cierva and Beca de Formacion del Personal Investigador; Ministerio de Economia y Competitividad(Spanish Government); 'Juegaterapia-Amigos del CNIO' Postdoctoral Fellowship; Asociacion Espanola Contra el Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank O. Dominguez, J. Herranz, T Lobato, L. Martinez, and Y. Cecilia, as well as members of the CNIO core facilities, Epithelial Carcinogenesis Group, and Genes, Development and Disease Group; L. Montuenga, C. Rodrfguez-Ortigosa, B. Breant and cited investigators for providing antibodies; and E. Batlle and R Munoz-Cnoves for critical comments. This study used the high-performance computational capabilities of the Biowulf Linux cluster (https://hpc.nih.gov/). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, US National Institutes of Health (NIH), nor does mention of trade names, commercial products or organizations imply endorsement by the US government. This work was supported in part by grants SAF2011-29530 and SAF2015-70553-R from the Ministerio de Economia y Competitividad (co-funded by the ERDF-EU), RTICC from the Instituto de Salud Carlos III (RD 12/0036/0034, RD12/0036/0050) and grants 256974 and 289737 from the European Union Seventh Framework Program to EX. R.; grants BFU 2012-40230 and SAF2015-70857 from the Ministerio de Economia y Competitividad (co-funded by the ERDF-EU) and Worldwide Cancer Research (13-0216) to E.F.W.; grants PI12/00815 and PI1501573 from the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain and EUPancreas COST Action BM 1204 to N.M.; grant P30CA008748 from the US NIH, National Cancer Institute to S.H.O.; the Intramural Research Program of the NIH, National Cancer Institute; and Mayo Clinic SPORE in Pancreatic Cancer funded by National Cancer Institute grant P50 CA102701. LT. and TB. were supported by the Department of Technology, Norwegian University of Science and Technology, the Central Norway Regional Health Authority and by the European Science Foundation. PM. and I. C. are recipients of Juan de la Cierva and Beca de Formacion del Personal Investigador, respectively, from Ministerio de Economia y Competitividad. IF. is the recipient of a 'Juegaterapia-Amigos del CNIO' Postdoctoral Fellowship. EX. R. acknowledges the support of Asociacion Espanola Contra el Cancer.	Amundadottir LT, 2016, INT J BIOL SCI, V12, P314, DOI 10.7150/ijbs.15001; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Cendrowski J, 2015, GUT, V64, P937, DOI 10.1136/gutjnl-2013-306068; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Flandez M, 2014, GUT, V63, P647, DOI 10.1136/gutjnl-2012-304381; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hale MA, 2014, DEVELOPMENT, V141, P3123, DOI 10.1242/dev.109405; Headland SE, 2015, SEMIN IMMUNOL, V27, P149, DOI 10.1016/j.smim.2015.03.014; Holmstrom SR, 2011, GENE DEV, V25, P1674, DOI 10.1101/gad.16860911; Hoskins JW, 2014, CARCINOGENESIS, V35, P2670, DOI 10.1093/carcin/bgu193; Huang SC, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004786; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mamrosh JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01694; Molero X, 2012, GUT, V61, P1187, DOI 10.1136/gutjnl-2011-300360; Oiwa A, 2007, BIOCHEM BIOPH RES CO, V353, P895, DOI 10.1016/j.bbrc.2006.12.131; PAPAVASSILIOU AG, 1992, P NATL ACAD SCI USA, V89, P11562, DOI 10.1073/pnas.89.23.11562; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Stein S, 2015, CURR OPIN CELL BIOL, V33, P26, DOI 10.1016/j.ceb.2014.10.007; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Zhang M., 2017, GUT	29	60	61	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					533	+		10.1038/nature25751	http://dx.doi.org/10.1038/nature25751			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29443959	Green Submitted, Green Accepted			2022-12-28	WOS:000425597400048
J	Kawai, Y; Mickiewicz, K; Errington, J				Kawai, Yoshikazu; Mickiewicz, Katarzyna; Errington, Jeff			Lysozyme Counteracts beta-Lactam Antibiotics by Promoting the Emergence of L-Form Bacteria	CELL			English	Article							PENICILLIN-BINDING PROTEINS; BACILLUS-SUBTILIS; CELL-WALL; STAPHYLOCOCCUS-AUREUS; WIDESPREAD FAMILY; ESCHERICHIA-COLI; PEPTIDOGLYCAN; EXPRESSION; DIVISION; PERSISTENCE	beta-lactam antibiotics inhibit bacterial cell wall assembly and, under classical microbiological culture conditions that are generally hypotonic, induce explosive cell death. Here, we show that under more physiological, osmoprotective conditions, for various Gram-positive bacteria, lysis is delayed or abolished, apparently because inhibition of class A penicillin-binding protein leads to a block in autolytic activity. Although these cells still then die by other mechanisms, exogenous lytic enzymes, such as lysozyme, can rescue viability by enabling the escape of cell wall-deficient "L-form" bacteria. This protective L-form conversion was also observed in macrophages and in an animal model, persumably due to the production of host lytic activities, including lysozyme. Our results demonstrate the potential for L-form switching in the host environment and highlight the unexpected effects of innate immune effectors, such as lysozyme, on antibiotic activity. Unlike previously described dormant persisters, L-forms can continue to proliferate in the presence of antibiotic.	[Kawai, Yoshikazu; Mickiewicz, Katarzyna; Errington, Jeff] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK	Errington, J (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	jeff.errington@ncl.ac.uk	Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388; Mickiewicz, Katarzyna/0000-0001-9109-2120	European Research Council [670980]	European Research Council(European Research Council (ERC)European Commission)	We thank Frances Davison for excellent technical assistance. We thank Robert Lightowlers and Rawaa Al-Faresi for sharing the Flp-ln 293 cell line. This work was funded by the European Research Council (670980).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Allan EJ, 2009, ADV APPL MICROBIOL, V68, P1, DOI 10.1016/S0065-2164(09)01201-5; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; CLASENER H, 1972, ANNU REV MICROBIOL, V26, P55, DOI 10.1146/annurev.mi.26.100172.000415; Dorr T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004850; Domingue GJ, 2010, DISCOV MED, V10, P234; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Dominguez-Cuevas P, 2012, MOL MICROBIOL, V83, P52, DOI 10.1111/j.1365-2958.2011.07920.x; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Dziarski R., 2017, CURR GENET; Emami K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.253; Errington J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0494; Ferguson CMJ, 2000, LETT APPL MICROBIOL, V31, P390, DOI 10.1046/j.1472-765x.2000.00834.x; Fisher RA, 2017, NAT REV MICROBIOL, V15, P453, DOI 10.1038/nrmicro.2017.42; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Han J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108325; Harms A, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4268; Hashimoto M, 2012, J BACTERIOL, V194, P796, DOI 10.1128/JB.05569-11; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Kawai Y, 2015, CURR BIOL, V25, P1613, DOI 10.1016/j.cub.2015.04.031; Kawai Y, 2014, CURR BIOL, V24, P863, DOI 10.1016/j.cub.2014.02.053; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Klieneberger E, 1935, J PATHOL BACTERIOL, V40, P93, DOI 10.1002/path.1700400108; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; Mak P, 2010, DEV COMP IMMUNOL, V34, P1129, DOI 10.1016/j.dci.2010.06.005; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Mercier R, 2014, ELIFE, V3, DOI 10.7554/eLife.04629; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Onwuamaegbu M, 2005, J INT MED RES, V33, P1, DOI 10.1177/147323000503300101; Ragland SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006512; RODRIGUEZTEBAR A, 1982, EUR J BIOCHEM, V126, P161, DOI 10.1111/j.1432-1033.1982.tb06761.x; Sassine J, 2017, MOL MICROBIOL, V106, P304, DOI 10.1111/mmi.13765; Steele VR, 2011, MOL MICROBIOL, V80, P542, DOI 10.1111/j.1365-2958.2011.07591.x; THORNEWELL SJ, 1993, GENE, V133, P47, DOI 10.1016/0378-1119(93)90223-P; Tsai CJY, 2016, VIRULENCE, V7, P214, DOI 10.1080/21505594.2015.1135289; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VANHEIJENOORT Y, 1987, J GEN MICROBIOL, V133, P667; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Wu JA, 2003, ANTIMICROB AGENTS CH, V47, P3407, DOI 10.1128/AAC.47.11.3407-3414.2003	46	57	61	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2018	172	5					1038	+		10.1016/j.cell.2018.01.021	http://dx.doi.org/10.1016/j.cell.2018.01.021			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FX2ZG	29456081	Green Published, hybrid			2022-12-28	WOS:000425937100014
J	Saito, F; Hirayasu, K; Satoh, T; Wang, CW; Lusingu, J; Arimori, T; Shida, K; Palacpac, NMQ; Itagaki, S; Iwanaga, S; Takashima, E; Tsuboi, T; Kohyama, M; Suenaga, T; Colonna, M; Takagi, J; Lavstsen, T; Horii, T; Arase, H				Saito, Fumiji; Hirayasu, Kouyuki; Satoh, Takeshi; Wang, Christian W.; Lusingu, John; Arimori, Takao; Shida, Kyoko; Palacpac, Nirianne Marie Q.; Itagaki, Sawako; Iwanaga, Shiroh; Takashima, Eizo; Tsuboi, Takafumi; Kohyama, Masako; Suenaga, Tadahiro; Colonna, Marco; Takagi, Junichi; Lavstsen, Thomas; Horii, Toshihiro; Arase, Hisashi			Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors (vol 552, pg 101, 2017)	NATURE			English	Correction													Lusingu, John P. A./GSJ-3228-2022; Tsuboi, Takafumi/AAK-6145-2021	Takashima, Eizo/0000-0001-9070-8499; Lusingu, John P. A./0000-0002-9407-0602; Lavstsen, Thomas/0000-0002-3044-4249				Saito F, 2017, NATURE, V552, P101, DOI 10.1038/nature24994	1	1	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693								10.1038/nature25498	http://dx.doi.org/10.1038/nature25498			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29443969	Bronze			2022-12-28	WOS:000425597400053
J	Nelson, SM; Haig, C; McConnachie, A; Sattar, N; Ring, SM; Smith, GD; Lawlor, DA; Lindsay, RS				Nelson, Scott M.; Haig, Caroline; McConnachie, Alex; Sattar, Naveed; Ring, Susan M.; Smith, George D.; Lawlor, Debbie A.; Lindsay, Robert S.			Maternal thyroid function and child educational attainment: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUBCLINICAL HYPOTHYROIDISM; EARLY-PREGNANCY; NEUROPSYCHOLOGICAL DEVELOPMENT; HYPOTHYROXINEMIA; MANAGEMENT; WOMEN; DIAGNOSIS; ASSOCIATION; PERFORMANCE; DYSFUNCTION	OBJECTIVE To determine if first trimester maternal thyroid dysfunction is a critical determinant of child scholastic performance and overall educational attainment. DESIGN Prospective cohort study. SETTING Avon Longitudinal Study of Parents and Children cohort in the UK. PARTICIPANTS 4615 mother-child pairs with an available first trimester sample (median 10 weeks gestation, interquartile range 8-12). EXPOSURES Free thyroxine, thyroid stimulating hormone, and thyroid peroxidase antibodies assessed as continuous measures and the seven clinical categories of maternal thyroid function. MAIN OUTCOME MEASURES Five age-specific national curriculum assessments in 3580 children at entry stage assessment at 54 months, increasing up to 4461 children at their final school assessment at age 15. RESULTS No strong evidence of clinically meaningful associations of first trimester free thyroxine and thyroid stimulating hormone levels with entry stage assessment score or Standard Assessment Test scores at any of the key stages was found. Associations of maternal free thyroxine or thyroid stimulating hormone with the total number of General Certificates of Secondary Education (GCSEs) passed (range 0-16) were all close to the null: free thyroxine, rate ratio per pmol/L 1.00 (95% confidence interval 1.00 to 1.01); and thyroid stimulating hormone, rate ratio 0.98 (0.94 to 1.02). No important relationship was observed when more detailed capped scores of GCSEs allowing for both the number and grade of pass or when language, mathematics, and science performance were examined individually or when all educational assessments undertaken by an individual from school entry to leaving were considered. 200 (4.3%) mothers were newly identified as having hypothyroidism or subclinical hypothyroidism and 97 (2.1%) subclinical hyperthyroidism or hyperthyroidism. Children of mothers with thyroid dysfunction attained an equivalent number of GCSEs and equivalent grades as children of mothers with euthyroidism. CONCLUSIONS Maternal thyroid dysfunction in early pregnancy does not have a clinically important association with impaired child performance at school or educational achievement.	[Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow Royal Infirm, Room 2-52 Level 2,New Lister Bldg, Glasgow G31 2ER, Lanark, Scotland; [Nelson, Scott M.; Lawlor, Debbie A.] Natl Inst Hlth Res, Bristol Biomed Res Ctr, Bristol, Avon, England; [Haig, Caroline; McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Level 11,Boyd Orr Bldg, Glasgow, Lanark, Scotland; [Sattar, Naveed; Lindsay, Robert S.] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ring, Susan M.; Smith, George D.; Lawlor, Debbie A.] Univ Bristol, Med Res Council, Integrat Epidemiol Unit, Oakfield House, Bristol, Avon, England; [Ring, Susan M.; Smith, George D.; Lawlor, Debbie A.] Univ Bristol, Populat Hlth Sci, Bristol Med Sch, Oakfield House, Bristol, Avon, England	University of Glasgow; University of Glasgow; University of Glasgow; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; University of Bristol	Nelson, SM (corresponding author), Univ Glasgow, Sch Med, Glasgow Royal Infirm, Room 2-52 Level 2,New Lister Bldg, Glasgow G31 2ER, Lanark, Scotland.; Nelson, SM (corresponding author), Natl Inst Hlth Res, Bristol Biomed Res Ctr, Bristol, Avon, England.	Scott.Nelson@glasgow.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Nelson, Scott/0000-0002-9099-3047; Lawlor, Debbie A/0000-0002-6793-2262; Lindsay, Robert/0000-0002-9868-5217	Wellcome Trust [102215/2/13/2]; Chief Scientist Office [ETM/97/90357/130024782]; UK Medical Research Council [MC_UU_12013/1, MC_UU_12013/5]; National Institute of Health Research Senior Investigator Award [NF-SI-0611-10196]; National Institute of Health Research Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust; University of Bristol; MRC [G0600705, MC_UU_12013/1, MC_UU_12013/5] Funding Source: UKRI; Medical Research Council [G0600705, G9815508, MC_UU_12013/1, MC_PC_15018, MC_UU_12013/5] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10196] Funding Source: researchfish; Chief Scientist Office [ETM/97] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Chief Scientist Office; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Senior Investigator Award; National Institute of Health Research Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust; University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The UK Medical Research Council and the Wellcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for the Avon Longitudinal Study of Parents and Children. This research was specifically funded by the Chief Scientist Office (ETM/97/90357/130024782). SMR, GDS, and DAL work in a unit that receives funds from the UK Medical Research Council (MC_UU_12013/1 and MC_UU_12013/5). DAL has a National Institute of Health Research Senior Investigator Award (NF-SI-0611-10196). SMN and DAL are supported by the National Institute of Health Research Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol.	Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; [Anonymous], 2017, ED GLANC 2017 OECD I; Berbel P, 2009, THYROID, V19, P511, DOI 10.1089/thy.2008.0341; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Blatt AJ, 2012, J CLIN ENDOCR METAB, V97, P777, DOI 10.1210/jc.2011-2038; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brent GA, 2012, NEW ENGL J MED, V366, P562, DOI 10.1056/NEJMe1112591; Casey BM, 2017, NEW ENGL J MED, V376, P815, DOI 10.1056/NEJMoa1606205; Chevrier J, 2011, J THROID RES, V2011, DOI 10.4061/2011/426427; Cooper DS, 2017, NEW ENGL J MED, V376, P876, DOI 10.1056/NEJMe1615312; de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Education Df, TEST EX POINT SCOR U; Endendijk JJ, 2017, HORM BEHAV, V94, P84, DOI 10.1016/j.yhbeh.2017.06.007; Finken MJJ, 2013, J CLIN ENDOCR METAB, V98, P1417, DOI 10.1210/jc.2012-3389; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hegedus L, 2017, NEW ENGL J MED, V377, P700, DOI 10.1056/NEJMc1707415; Henrichs J, 2010, J CLIN ENDOCR METAB, V95, P4227, DOI 10.1210/jc.2010-0415; Julvez J, 2013, EPIDEMIOLOGY, V24, P150, DOI 10.1097/EDE.0b013e318276ccd3; Korevaar TIM, 2016, LANCET DIABETES ENDO, V4, P35, DOI 10.1016/S2213-8587(15)00327-7; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; Li Y, 2010, CLIN ENDOCRINOL, V72, P825, DOI 10.1111/j.1365-2265.2009.03743.x; MAN EB, 1971, AM J OBSTET GYNECOL, V111, P905, DOI 10.1016/0002-9378(71)90945-8; Mannisto T, 2007, CLIN CHEM, V53, P1986, DOI 10.1373/clinchem.2007.091371; Maraka S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6865; Nazarpour S, 2017, EUR J ENDOCRINOL, V176, P253, DOI 10.1530/EJE-16-0548; Negro R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4929; Negro R, 2010, J CLIN ENDOCR METAB, V95, P1699, DOI 10.1210/jc.2009-2009; Noten AME, 2015, EUR J ENDOCRINOL, V173, P563, DOI 10.1530/EJE-15-0397; Obregon M. J., 2007, V10, P86, DOI 10.1159/000106821; Oken E, 2009, J CLIN ENDOCR METAB, V94, P497, DOI 10.1210/jc.2008-0936; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Pakkila F, 2015, THYROID, V25, P1363, DOI 10.1089/thy.2015.0197; Pakkila F, 2014, J CLIN ENDOCR METAB, V99, pE1, DOI 10.1210/jc.2013-2943; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; Reid SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007752.pub3; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Smit BJ, 2000, ACTA PAEDIATR, V89, P291; Stagnaro-Green A, 2015, JAMA-J AM MED ASSOC, V313, P565, DOI 10.1001/jama.2014.17226; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Stricker R, 2007, EUR J ENDOCRINOL, V157, P509, DOI 10.1530/EJE-07-0249; UN, GOAL 4 ENS INCL QUAL	49	24	26	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2018	360								k452	10.1136/bmj.k452	http://dx.doi.org/10.1136/bmj.k452			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX1EN	29463525	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000425791700001
J	Cho, A				Cho, Adrian			A weight limit emerges for neutron stars	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					724	725						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449468				2022-12-28	WOS:000425116200017
J	Cui, YH; Yang, Y; Ni, ZY; Dong, YY; Cai, GH; Foncelle, A; Ma, SS; Sang, KN; Tang, SY; Li, YZ; Shen, Y; Berry, H; Wu, SX; Hu, HL				Cui, Yihui; Yang, Yan; Ni, Zheyi; Dong, Yiyan; Cai, Guohong; Foncelle, Alexandre; Ma, Shuangshuang; Sang, Kangning; Tang, Siyang; Li, Yuezhou; Shen, Ying; Berry, Hugues; Wu, Shengxi; Hu, Hailan			Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression	NATURE			English	Article							RECTIFYING POTASSIUM CHANNELS; ASTROCYTES; DYSFUNCTION; INHIBITION; PHENOTYPES; NETWORKS; DISEASE; REWARD; INPUT; MODEL	Enhanced bursting activity of neurons in the lateral habenula (LHb) is essential in driving depression-like behaviours, but the cause of this increase has been unknown. Here, using a high-throughput quantitative proteomic screen, we show that an astroglial potassium channel (Kir4.1) is upregulated in the LHb in rat models of depression. Kir4.1 in the LHb shows a distinct pattern of expression on astrocytic membrane processes that wrap tightly around the neuronal soma. Electrophysiology and modelling data show that the level of Kir4.1 on astrocytes tightly regulates the degree of membrane hyperpolarization and the amount of bursting activity of LHb neurons. Astrocyte-specific gain and loss of Kir4.1 in the LHb bidirectionally regulates neuronal bursting and depression-like symptoms. Together, these results show that a glia-neuron interaction at the perisomatic space of LHb is involved in setting the neuronal firing mode in models of a major psychiatric disease. Kir4.1 in the LHb might have potential as a target for treating clinical depression.	[Cui, Yihui; Yang, Yan; Ni, Zheyi; Dong, Yiyan; Ma, Shuangshuang; Sang, Kangning; Tang, Siyang; Li, Yuezhou; Shen, Ying; Hu, Hailan] Zhejiang Univ, Interdisciplinary Inst Neurosci & Technol, Qiushi Acad Adv Studies,Ctr Neurosci, Key Lab Med Neurobiol,Minist Hlth China,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Cui, Yihui; Yang, Yan; Hu, Hailan] Zhejiang Univ, Sch Med, Mental Hlth Ctr, Hangzhou 310013, Zhejiang, Peoples R China; [Cai, Guohong; Wu, Shengxi] Fourth Mil Med Univ, Sch Basic Med, Dept Neurobiol, Xian 710032, Shaanxi, Peoples R China; [Foncelle, Alexandre; Berry, Hugues] INRIA, F-69603 Lyon, France; [Foncelle, Alexandre; Berry, Hugues] Univ Lyon, CNRS, UMR 5205, LIRIS, F-69622 Lyon, France	Zhejiang University; Zhejiang University; Air Force Military Medical University; Inria; Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Hu, HL (corresponding author), Zhejiang Univ, Interdisciplinary Inst Neurosci & Technol, Qiushi Acad Adv Studies,Ctr Neurosci, Key Lab Med Neurobiol,Minist Hlth China,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Hu, HL (corresponding author), Zhejiang Univ, Sch Med, Mental Hlth Ctr, Hangzhou 310013, Zhejiang, Peoples R China.	huhailan@zju.edu.cn	shen, ying/HHS-5635-2022; Cui, Yihui/AAB-9328-2022	Hu, Hailan/0000-0002-0425-5057; Dong, Yiyan/0000-0002-4664-4579; Cui, Yihui/0000-0002-7362-6237; Berry, Hugues/0000-0003-3470-683X; Wu, Shengxi/0000-0002-3210-9567; Foncelle, Alexandre/0000-0002-4679-6601	National Key R&D Program of China [2016YFA0501000]; National Natural Science Foundation of China [91432108, 31225010, 81527901, 81701335, 81730035]; Strategic Priority Research Program (B) of the Chinese Academy of Sciences [XDB02030004]; 111 project [B13026]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program (B) of the Chinese Academy of Sciences(Chinese Academy of Sciences); 111 project(Ministry of Education, China - 111 Project)	We thank K. McCarthy for Kir4.1 floxed mice; B. Khakh for the GFAP-Kir4.1 plasmid; T. Xue for advice on dn-Kir4.1 design; Y.-Y. Liu for technical support on electromicroscopy; C. Liu and C.-J. Shen for help with immunohistochemistry; S.-M. Duan, Y.-D. Zhou, J.-W. Zhao, X.-H. Zhang and B. MacVicar for advice on experimental design; and C. Giaum and P. Magistretti for comments on the manuscript. This work was supported by grants from the National Key R&D Program of China (2016YFA0501000), the National Natural Science Foundation of China (91432108, 31225010, and 81527901 to H.H., 81701335 to Y.C., and 81730035 to S.W.), the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB02030004) and 111 project (B13026) to H.H.	Adzic M, 2015, BEHAV BRAIN RES, V291, P130, DOI 10.1016/j.bbr.2015.05.029; Amedee T, 1997, GLIA, V21, P46, DOI 10.1002/(SICI)1098-1136(199709)21:1<46::AID-GLIA5>3.0.CO;2-#; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Cui W, 2014, J NEUROSCI, V34, P16273, DOI 10.1523/JNEUROSCI.1465-14.2014; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Kettenmann H., 2013, NEUROGLIA; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lecca S, 2016, NAT MED, V22, P254, DOI 10.1038/nm.4037; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Powell TR, 2011, DEPRESSION RELATED B; Proulx CD, 2014, NAT NEUROSCI, V17, P1146, DOI 10.1038/nn.3779; RANSOM CB, 1995, J NEUROPHYSIOL, V73, P333, DOI 10.1152/jn.1995.73.1.333; Rojas L, 1999, GLIA, V25, P199, DOI 10.1002/(SICI)1098-1136(19990115)25:2<199::AID-GLIA10>3.0.CO;2-B; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Shabel SJ, 2014, SCIENCE, V345, P1494, DOI 10.1126/science.1250469; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Verkhratskii A. N, 2007, GLIAL NEUROBIOLOGY T; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Woo DH, 2012, CELL, V151, P25, DOI 10.1016/j.cell.2012.09.005; Yang Y., 2018, NATURE; Yang Y, 2018, CURR OPIN NEUROBIOL, V48, P90, DOI 10.1016/j.conb.2017.10.024	35	226	247	28	286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					323	+		10.1038/nature25752	http://dx.doi.org/10.1038/nature25752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29446379	Green Submitted			2022-12-28	WOS:000424996300030
J	Massey, C				Massey, Charlie			RESPONSE GMC responds to concerns raised by Bawa-Garba case	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Massey, Charlie] Gen Med Council, London, England		Massey, C (corresponding author), Gen Med Council, London, England.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2018	360								k660	10.1136/bmj.k660	http://dx.doi.org/10.1136/bmj.k660			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0IE	29439146				2022-12-28	WOS:000424976600007
J	Bann, M; Kaul, DR; Haider, MZ; Saint, S; Goldberger, ZD				Bann, Maralyssa; Kaul, Daniel R.; Haider, Mahri Z.; Saint, Sanjay; Goldberger, Zachary D.			Home Sweet Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TYPHOID-FEVER; UNITED-STATES		[Bann, Maralyssa; Haider, Mahri Z.; Goldberger, Zachary D.] Univ Washington, Harborview Med Ctr, Sch Med, Dept Med, Seattle, WA 98104 USA; [Bann, Maralyssa; Haider, Mahri Z.] Univ Washington, Harborview Med Ctr, Sch Med, Div Gen Internal Med, Seattle, WA 98104 USA; [Goldberger, Zachary D.] Univ Washington, Harborview Med Ctr, Sch Med, Div Cardiol, Seattle, WA 98104 USA; [Kaul, Daniel R.; Saint, Sanjay] Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA; [Kaul, Daniel R.] Univ Michigan, Med Sch, Div Infect Dis, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Hlth Serv Res, Dept Vet Affairs, Ann Arbor, MI USA; [Saint, Sanjay] Dev Ctr Excellence, Ann Arbor, MI USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Goldberger, ZD (corresponding author), Harborview Med Ctr, Box 359748, Seattle, WA 98104 USA.	zgoldber@uw.edu	Saint, Sanjay/AAF-5126-2019	Bann, Maralyssa/0000-0002-5893-950X	Doximity; Jvion	Doximity; Jvion	Dr. Saint reports receiving consulting fees from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	Anwar E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub3; Azmatullah A, 2015, J GLOB HEALTH, V5, P107, DOI 10.7189/jogh.05.020407; BUTLER T, 1985, REV INFECT DIS, V7, P244; Date KA, 2016, CLIN INFECT DIS, V63, P322, DOI 10.1093/cid/ciw232; Ebell MH, 2016, JAMA-J AM MED ASSOC, V315, P1502, DOI 10.1001/jama.2016.2111; GILMAN RH, 1975, LANCET, V1, P1211; HOFFMAN SL, 1984, NEW ENGL J MED, V310, P82, DOI 10.1056/NEJM198401123100203; Jackson BR, 2015, MMWR-MORBID MORTAL W, V64, P305; Mahon BE, 2014, VACCINE, V32, P3577, DOI 10.1016/j.vaccine.2014.04.055; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Olopoenia LA, 2000, POSTGRAD MED J, V76, P80, DOI 10.1136/pmj.76.892.80; Parry CM, 2007, ANTIMICROB AGENTS CH, V51, P819, DOI 10.1128/AAC.00447-06; Puca E, 2016, TRAVEL MED INFECT DI, V14, P143, DOI 10.1016/j.tmaid.2015.11.011; Thwaites GE, 2017, NEW ENGL J MED, V376, P548, DOI 10.1056/NEJMra1508435; van den Bergh ETAM, 1999, TROP MED INT HEALTH, V4, P211	15	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					461	466		10.1056/NEJMcps1704731	http://dx.doi.org/10.1056/NEJMcps1704731			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29385373				2022-12-28	WOS:000423783200011
J	Burgos-Barragan, G; Wit, N; Meiser, J; Dingler, FA; Pietzke, M; Mulderrig, L; Pontel, LB; Rosado, IV; Brewer, TF; Cordell, RL; Monks, PS; Chang, CJ; Vazquez, A; Patel, KJ				Burgos-Barragan, Guillermo; Wit, Niek; Meiser, Johannes; Dingler, Felix A.; Pietzke, Matthias; Mulderrig, Lee; Pontel, Lucas B.; Rosado, Ivan V.; Brewer, Thomas F.; Cordell, Rebecca L.; Monks, Paul S.; Chang, Christopher J.; Vazquez, Alexei; Patel, Ketan J.			Mammals divert endogenous genotoxic formaldehyde into one-carbon metabolism (vol 548, pg 549, 2017)	NATURE			English	Correction															NIEHS NIH HHS [P42 ES004705] Funding Source: Medline; NIGMS NIH HHS [R01 GM079465, T32 GM066698] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM079465] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burgos-Barragan G, 2017, NATURE, V548, P549, DOI 10.1038/nature23481	1	4	4	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					612	612		10.1038/nature23904	http://dx.doi.org/10.1038/nature23904			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	29411778	Green Accepted, Bronze			2022-12-28	WOS:000408703100031
J	Rudd, P				Rudd, Peter			Review: In primary prevention, BP-Iowering treatment reduces major CV events in patients with SBP >= 140 mm Hg	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOOD-PRESSURE		[Rudd, Peter] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Rudd, P (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Cifu AS, 2017, JAMA-J AM MED ASSOC, V318, P2132, DOI 10.1001/jama.2017.18706; Greenland P, 2017, JAMA-J AM MED ASSOC, V318, P2083, DOI 10.1001/jama.2017.18605; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P115, DOI 10.1001/jama.2017.19672; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					JC15	JC15		10.7326/ACPJC-2018-168-4-015	http://dx.doi.org/10.7326/ACPJC-2018-168-4-015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29459952				2022-12-28	WOS:000425434000003
J	McArthur, JW; Rasmussen, K; Yamey, G				McArthur, John W.; Rasmussen, Krista; Yamey, Gavin			How many lives are at stake? Assessing 2030 sustainable development goal trajectories for maternal and child health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; COUNTRIES; WOMENS		[McArthur, John W.; Rasmussen, Krista] Brookings Inst, Global Econ & Dev Program, Washington, DC 20036 USA; [Yamey, Gavin] Duke Univ, Duke Global Hlth Inst, Ctr Policy Impact Global Hlth, Durham, NC USA	Brookings Institution; Duke University	McArthur, JW (corresponding author), Brookings Inst, Global Econ & Dev Program, Washington, DC 20036 USA.	JMcArthur@brookings.edu						Ahmed SM, 2016, B WORLD HEALTH ORGAN, V94, P351, DOI 10.2471/BLT.15.168450; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2017, WORLD DEV IND; Black RE, 2016, DIS CONTROL PRIORITI, V9; Innovation Countdown, REIM GLOB HLTH 30 HI; Jamison DT, 2016, J HEALTH ECON, V48, P16, DOI 10.1016/j.jhealeco.2016.03.002; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kuruvilla S, 2014, B WORLD HEALTH ORGAN, V92, P533, DOI [10.2471/BLT.14.13813125110379, DOI 10.2471/BLT.14.13813125110379]; Kuruvilla S, 2016, B WORLD HEALTH ORGAN, V94, P398, DOI 10.2471/BLT.16.170431; Lange S, 2017, WORLD DEV, V90, P128, DOI 10.1016/j.worlddev.2016.09.002; McArthur JW, 2018, WORLD DEV, V105, P132, DOI 10.1016/j.worlddev.2017.12.030; McArthur JW, 2014, 78 BROOK GLOB EC DEV; Stenberg K, 2017, LANCET GLOB HEALTH, V5, pE875, DOI [10.1016/S2214-109X(17)30263-2, 10.1016/s2214-109x(17)30263-2]; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; United Nations, 2017, WORLD POPULATION PRO; United Nations Inter-agency Group for Child Mortality Estimation, 2017, LEV TRENDS CHILD MOR; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	17	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2018	360								k373	10.1136/bmj.k373	http://dx.doi.org/10.1136/bmj.k373			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8LG	29449222	hybrid, Green Published			2022-12-28	WOS:000425583900001
J	Jones, TR; Roberts, WHG; Steig, EJ; Cuffey, KM; Markle, BR; White, JWC				Jones, T. R.; Roberts, W. H. G.; Steig, E. J.; Cuffey, K. M.; Markle, B. R.; White, J. W. C.			Southern Hemisphere climate variability forced by Northern Hemisphere ice-sheet topography	NATURE			English	Article							LAST GLACIAL MAXIMUM; HIGH-LATITUDE CLIMATE; WEST ANTARCTICA; SEA-LEVEL; EL-NINO; ISOTOPIC DIFFUSION; TROPICAL PACIFIC; LATE PLEISTOCENE; COUPLED MODEL; PART 2	The presence of large Northern Hemisphere ice sheets and reduced greenhouse gas concentrations during the Last Glacial Maximum fundamentally altered global ocean-atmosphere climate dynamics(1). Model simulations and palaeoclimate records suggest that glacial boundary conditions affected the El Nino-Southern Oscillation(2,3), a dominant source of short-term global climate variability. Yet little is known about changes in short-term climate variability at mid-to high latitudes. Here we use a high-resolution water isotope record from West Antarctica to demonstrate that interannual to decadal climate variability at high southern latitudes was almost twice as large at the Last Glacial Maximum as during the ensuing Holocene epoch (the past 11,700 years). Climate model simulations indicate that this increased variability reflects an increase in the teleconnection strength between the tropical Pacific and West Antarctica, owing to a shift in the mean location of tropical convection. This shift, in turn, can be attributed to the influence of topography and albedo of the North American ice sheets on atmospheric circulation. As the planet deglaciated, the largest and most abrupt decline in teleconnection strength occurred between approximately 16,000 years and 15,000 years ago, followed by a slower decline into the early Holocene.	[Jones, T. R.; White, J. W. C.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Roberts, W. H. G.] Univ Bristol, Sch Geog Sci, Bristol Res Initiat Dynam Global Environm, Bristol BS8 1SS, Avon, England; [Roberts, W. H. G.] Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; [Steig, E. J.; Markle, B. R.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Cuffey, K. M.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [White, J. W. C.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Bristol; University of Bristol; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder	Jones, TR (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	tyler.jones@colorado.edu	Steig, Eric J/G-9088-2015; White, James W.C./A-7845-2009; Markle, Bradley R/I-6132-2019	Steig, Eric J/0000-0002-8191-5549; White, James W.C./0000-0001-6041-4684; Roberts, William/0000-0002-8249-1901; Markle, Bradley/0000-0002-2282-6546	US National Science Foundation (NSF) [0537593, 0537661, 0537930, 0539232, 1043092, 1043167, 1043518, 1142166]; NSF [0230396, 0440817, 0944266, 0944348]; NSF Division of Polar Programs; Leverhulme Trust	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NSF Division of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Leverhulme Trust(Leverhulme Trust)	This work was supported by US National Science Foundation (NSF) grants 0537593, 0537661, 0537930, 0539232, 1043092, 1043167, 1043518 and 1142166. Field and logistical activities were managed by the WAIS Divide Science Coordination Office at the Desert Research Institute, USA, and the University of New Hampshire, USA (NSF grants 0230396, 0440817, 0944266 and 0944348). The NSF Division of Polar Programs funded the Ice Drilling Program Office (IDPO), the Ice Drilling Design and Operations (IDDO) group, the National Ice Core Laboratory (NICL), the Antarctic Support Contractor, and the 109th New York Air National Guard. W.H.G.R. was funded by a Leverhulme Trust Research Project Grant. All HadCM3 model simulations were carried out using the computational facilities of the Advanced Computing Research Centre, University of Bristol (http://www.bris.ac.uk/acrc/). We thank P.J. Valdes and J.S. Singarayer for providing their model simulations, as well as the groups that provided climate model data as part of the PMIP2/3.	Abe-Ouchi A, 2015, GEOSCI MODEL DEV, V8, P3621, DOI 10.5194/gmd-8-3621-2015; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; Carolin SA, 2013, SCIENCE, V340, P1564, DOI 10.1126/science.1233797; Cuffey KM, 1998, J GLACIOL, V44, P273, DOI 10.3189/S0022143000002616; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; Di Nezio PN, 2016, PALEOCEANOGRAPHY, V31, P866, DOI 10.1002/2015PA002890; DiNezio PN, 2013, NAT GEOSCI, V6, P485, DOI [10.1038/ngeo1823, 10.1038/NGEO1823]; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Ding QH, 2013, J CLIMATE, V26, P7570, DOI 10.1175/JCLI-D-12-00729.1; Ding QH, 2012, J CLIMATE, V25, P6330, DOI 10.1175/JCLI-D-11-00523.1; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; Fogt RL, 2006, J CLIMATE, V19, P979, DOI 10.1175/JCLI3671.1; Fogt RL, 2011, CLIM DYNAM, V36, P1555, DOI 10.1007/s00382-010-0905-0; Ford HL, 2015, SCIENCE, V347, P255, DOI 10.1126/science.1258437; Fudge TJ, 2016, GEOPHYS RES LETT, V43, P3795, DOI 10.1002/2016GL068356; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; Gkinis V, 2014, EARTH PLANET SC LETT, V405, P132, DOI 10.1016/j.epsl.2014.08.022; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Johnsen S. J., 1977, IAHS-AISH PUBL, V118, P210; Johnsen S.J., 2000, PHYS ICE CORE RECORD, V159, P121; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Jones TR, 2017, J GEOPHYS RES-EARTH, V122, P290, DOI 10.1002/2016JF003938; Jones TR, 2017, ATMOS MEAS TECH, V10, P617, DOI 10.5194/amt-10-617-2017; Lachlan-Cope T, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006386; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Markle BR, 2017, NAT GEOSCI, V10, P36, DOI [10.1038/NGEO2848, 10.1038/ngeo2848]; Merkel U, 2010, QUATERNARY SCI REV, V29, P86, DOI 10.1016/j.quascirev.2009.11.006; Nicolas JP, 2011, J CLIMATE, V24, P49, DOI 10.1175/2010JCLI3522.1; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Percival D., 1993, SPECTRAL ANAL PHYS A, P1, DOI [10.1017/CBO9780511622762.004, DOI 10.1017/CBO9780511622762.004]; Porter SC, 1998, QUATERNARY RES, V50, P205, DOI 10.1006/qres.1998.2004; Roberts WHG, 2014, P NATL ACAD SCI USA, V111, P16688, DOI 10.1073/pnas.1414882111; Russell JM, 2014, P NATL ACAD SCI USA, V111, P5100, DOI 10.1073/pnas.1402373111; Sadekov AY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3692; Schneider DP, 2012, J CLIMATE, V25, P4048, DOI 10.1175/JCLI-D-11-00273.1; Sigl M, 2016, CLIM PAST, V12, P769, DOI 10.5194/cp-12-769-2016; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Steig EJ, 2012, ANN GLACIOL, V53, P19, DOI 10.3189/2012AoG60A110; Steig EJ, 2013, NAT GEOSCI, V6, P372, DOI [10.1038/ngeo1778, 10.1038/NGEO1778]; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Stern JV, 2013, GEOPHYS RES LETT, V40, P3693, DOI 10.1002/grl.50679; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Turney CSM, 2004, NATURE, V428, P306, DOI 10.1038/nature02386; Ullman DJ, 2014, CLIM PAST, V10, P487, DOI 10.5194/cp-10-487-2014; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Valdes PJ, 2017, GEOSCI MODEL DEV, V10, P3715, DOI 10.5194/gmd-10-3715-2017; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Welhouse LJ, 2016, J CLIMATE, V29, P1797, DOI 10.1175/JCLI-D-15-0108.1; WHILLANS IM, 1985, J GEOPHYS RES-ATMOS, V90, P3910, DOI 10.1029/JD090iD02p03910; Yanase W, 2010, J CLIMATE, V23, P135, DOI 10.1175/2009JCLI3148.1; Yin JH, 2001, J CLIMATE, V14, P565, DOI 10.1175/1520-0442(2001)014<0565:TIOTSS>2.0.CO;2; Zhang X, 2014, NATURE, V512, P290, DOI 10.1038/nature13592; Zheng W, 2008, CLIM DYNAM, V30, P745, DOI 10.1007/s00382-007-0320-3; Zhu J, 2014, GEOPHYS RES LETT, V41, P6252, DOI 10.1002/2014GL060891	63	33	35	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					351	+		10.1038/nature24669	http://dx.doi.org/10.1038/nature24669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29400700	Green Submitted			2022-12-28	WOS:000424996300036
J	Zhang, ZM; Lu, R; Wang, PC; Yu, Y; Chen, DL; Gao, LF; Liu, S; Ji, DB; Rothbart, SB; Wang, YS; Wang, GG; Song, JK				Zhang, Zhi-Min; Lu, Rui; Wang, Pengcheng; Yu, Yang; Chen, Dongliang; Gao, Linfeng; Liu, Shuo; Ji, Debin; Rothbart, Scott B.; Wang, Yinsheng; Wang, Gang Greg; Song, Jikui			Structural basis for DNMT3A-mediated de novo DNA methylation	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; METHYLTRANSFERASE DNMT3A; MUTATIONS; COMPLEX; MODEL; AUTOINHIBITION; MAINTENANCE; IMPRINTS; SOFTWARE; DISEASE	DNA methylation by de novo DNA methyltransferases 3A (DNMT3A) and 3B (DNMT3B) at cytosines is essential for genome regulation and development(1,2). Dysregulation of this process is implicated in various diseases, notably cancer. However, the mechanisms underlying DNMT3 substrate recognition and enzymatic specificity remain elusive. Here we report a 2.65-angstrom crystal structure of the DNMT3A-DNMT3L-DNA complex in which two DNMT3A monomers simultaneously attack two cytosine-phosphate-guanine (CpG) dinucleotides, with the target sites separated by 14 base pairs within the same DNA duplex. The DNMT3A-DNA interaction involves a target recognition domain, a catalytic loop, and DNMT3A homodimeric interface. Arg836 of the target recognition domain makes crucial contacts with CpG, ensuring DNMT3A enzymatic preference towards CpG sites in cells. Haematological cancer-associated somatic mutations of the substrate-binding residues decrease DNMT3A activity, induce CpG hypomethylation, and promote transformation of haematopoietic cells. Together, our study reveals the mechanistic basis for DNMT3A-mediated DNA methylation and establishes its aetiological link to human disease.	[Zhang, Zhi-Min; Song, Jikui] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Lu, Rui; Chen, Dongliang; Wang, Gang Greg] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Lu, Rui; Chen, Dongliang; Rothbart, Scott B.; Wang, Gang Greg] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [Wang, Pengcheng; Yu, Yang; Gao, Linfeng; Liu, Shuo; Wang, Yinsheng; Song, Jikui] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Ji, Debin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Rothbart, Scott B.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Zhang, Zhi-Min] Jinan Univ, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China	University of California System; University of California Riverside; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Riverside; University of California System; University of California Riverside; Van Andel Institute; Jinan University	Song, JK (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.; Wang, GG (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA.; Wang, GG (corresponding author), Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA.; Song, JK (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.	greg_wang@med.unc.edu; jikui.song@ucr.edu	Wang, Yin/HCI-9352-2022; Wang, G Greg/L-6666-2014	Wang, G Greg/0000-0002-7210-9940; , Shuo/0000-0003-3225-3910; Lu, Rui/0000-0003-1593-2612; Gao, Linfeng/0000-0001-6194-5145; Wang, Pengcheng/0000-0003-4581-983X	University of North Carolina facilities including Genomics Core - UNC Cancer Center Core Support Grant [P30-CA016086]; Kimmel Scholar Awards; March of Dimes Foundation [1-FY15-345]; DoD Peer-reviewed Cancer Research Program [W81XWH-14-1-0232]; Gabrielle's Angel Foundation for Cancer Research; Gilead Sciences Research Scholars Program in haematology/oncology; University Cancer Research Fund of the N.C. state; National Institutes of Health [1R35GM119721, R35GM124736, 5R21ES025392, 1R01CA215284, 1R01CA218600, 1R01CA211336]; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA218600, R01CA215284, P30CA016086, R01CA211336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119721, R35GM124736] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	University of North Carolina facilities including Genomics Core - UNC Cancer Center Core Support Grant; Kimmel Scholar Awards; March of Dimes Foundation(March of Dimes); DoD Peer-reviewed Cancer Research Program; Gabrielle's Angel Foundation for Cancer Research; Gilead Sciences Research Scholars Program in haematology/oncology; University Cancer Research Fund of the N.C. state; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Cheng for comments on the manuscript, M. Okano, J. Wang, and J.-A. Losman for providing reagents used in the study, and staff members at the Advanced Light Source, Lawrence Berkeley National Laboratory, and at the Advanced Photo Source, Argonne National Laboratory, for access to X-ray beamlines. We are also grateful for the support of University of North Carolina facilities including Genomics Core, which are partly supported by UNC Cancer Center Core Support Grant P30-CA016086. This work was supported by Kimmel Scholar Awards (to J.S. and G.G.W.), the March of Dimes Foundation (1-FY15-345 to J.S.), the DoD Peer-reviewed Cancer Research Program (W81XWH-14-1-0232 to G.G.W.), Gabrielle's Angel Foundation for Cancer Research (to G.G.W.), Gilead Sciences Research Scholars Program in haematology/oncology (to G.G.W.), University Cancer Research Fund of the N.C. state (to G.G.W.), and the National Institutes of Health (1R35GM119721 to J.S.; R35GM124736 to S.B.R.; 5R21ES025392 to Y.W.; and 1R01CA215284, 1R01CA218600, and 1R01CA211336 to G.G.W.). G.G.W. is a Research Scholar of American Cancer Society and a Junior Faculty Scholar of American Society of Haematology. R.L. was supported by a Lymphoma Research Foundation postdoctoral fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Hata K, 2002, DEVELOPMENT, V129, P1983; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu R, 2016, CANCER CELL, V30, P92, DOI 10.1016/j.ccell.2016.05.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Volz DC, 2016, ENVIRON SCI TECHNOL, V50, P10255, DOI 10.1021/acs.est.6b03656; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397; Yu Y, 2016, MOL CELL PROTEOMICS, V15, P810, DOI 10.1074/mcp.M115.052696; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	39	134	141	4	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					387	+		10.1038/nature25477	http://dx.doi.org/10.1038/nature25477			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29414941	Green Accepted, Green Submitted			2022-12-28	WOS:000424996300044
J	Matharu, GS; Judge, A; Pandit, HG; Murray, DW				Matharu, Gulraj S.; Judge, Andrew; Pandit, Hemant G.; Murray, David W.			Follow-up for patients with metal-on-metal hip replacements: are the new MHRA recommendations justified?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NATIONAL JOINT REGISTRY; ADVERSE-REACTIONS; ION LEVELS; ASYMPTOMATIC PSEUDOTUMORS; IDENTIFY PATIENTS; NATURAL-HISTORY; ARTHROPLASTY; FAILURE; RISK; REVISION		[Matharu, Gulraj S.; Judge, Andrew; Pandit, Hemant G.; Murray, David W.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Matharu, Gulraj S.; Judge, Andrew] Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Musculoskeletal Res Unit, Bristol, Avon, England; [Judge, Andrew] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Pandit, Hemant G.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England	University of Oxford; University of Bristol; University of Southampton; University of Leeds	Matharu, GS (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.; Matharu, GS (corresponding author), Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	gsm@doctors.org.uk		Matharu, Gulraj/0000-0003-1098-9230; Judge, Andrew/0000-0003-3015-0432	Arthritis Research UK; Orthopaedics Trust; Royal College of Surgeons of England; Royal Orthopaedic Hospital Hip Research and Education Charitable Fund; Servier; UK Renal Registry; Oxford Craniofacial Unit; IDIAP Jordi Gol; Freshfields Bruckhaus Deringer; ROCHE; Kennedys Law; Bristol Myers Squibb; Depuy Synthes; Medacta Int; Meril Life; UKIERI; Charnley Trust; GSK; NIHR; Zimmer-Biomet; Stryker; Depuy; Smith Nephew; Wright Medical	Arthritis Research UK(Versus Arthritis); Orthopaedics Trust; Royal College of Surgeons of England; Royal Orthopaedic Hospital Hip Research and Education Charitable Fund; Servier(Servier); UK Renal Registry; Oxford Craniofacial Unit; IDIAP Jordi Gol; Freshfields Bruckhaus Deringer; ROCHE(Roche Holding); Kennedys Law; Bristol Myers Squibb(Bristol-Myers Squibb); Depuy Synthes; Medacta Int; Meril Life; UKIERI(UK Research & Innovation (UKRI)); Charnley Trust; GSK(GlaxoSmithKline); NIHR(National Institute for Health Research (NIHR)); Zimmer-Biomet; Stryker; Depuy; Smith Nephew; Wright Medical	We have read and understood BMJ policy on declaration of interests and declare the following interests: GSM has received financial support for other research work from Arthritis Research UK, the Orthopaedics Trust, Royal College of Surgeons of England, and Royal Orthopaedic Hospital Hip Research and Education Charitable Fund. GSM has also received personal fees for undertaking medicolegal work for Leigh Day, which includes work relating to metal-on-metal hip replacements. AJ has received consultancy, lecture fees, and honorariums from Servier, UK Renal Registry, Oxford Craniofacial Unit, IDIAP Jordi Gol, and Freshfields Bruckhaus Deringer; he is a paid member of the data safety and monitoring board for Anthera Pharmaceuticals, and received consortium research grants from ROCHE. HGP is a paid consultant for Kennedys Law, Bristol Myers Squibb, Depuy Synthes, Medacta Int and Meril Life. He has received institutional research grants from UKIERI, Charnley Trust, Depuy Synthes, GSK and NIHR. HGP and DWM are paid consultants and speakers for Zimmer-Biomet, and both receive institutional research funding from Zimmer-Biomet and Stryker. DWM has received research funding related to metal-on-metal hip replacements from Depuy, Smith & Nephew, Wright Medical, and Zimmer-Biomet, and has been a consultant related to metal-on-metal hip replacements for Herbert Smith Freehills Lawyers and Wright Medical.	Almousa SA, 2013, CLIN ORTHOP RELAT R, V471, P3814, DOI 10.1007/s11999-013-2944-4; [Anonymous], MED DEV AL MDA 2017; Australian Department of Health, 2012, MET ON MET HIP REPL; Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), 2016, HIP KNEE SHOULD ARTH; Bisseling P, 2015, BONE JOINT J, V97B, P1175, DOI 10.1302/0301-620X.97B9.35247; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P1614, DOI 10.2106/JBJS.H.01220; Bradberry SM, 2014, CLIN TOXICOL, V52, P837, DOI 10.3109/15563650.2014.944977; British Orthopaedic Association British Hip Society, 2017, BOA BHS JOINT STAT M; Carr A, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3387; Cheung AC, 2016, BONE JOINT J, V98B, P6, DOI 10.1302/0301-620X.98B1.36374; Cohen D, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3246; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; De Smet KA, 2011, ORTHOP CLIN N AM, V42, P259, DOI 10.1016/j.ocl.2011.01.003; Ebreo D, 2013, BONE JOINT J, V95B, P1035, DOI 10.1302/0301-620X.95B8.31377; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Hannemann F, 2013, ORTHOP TRAUMATOL-SUR, V99, P263, DOI 10.1016/j.otsr.2013.01.005; Hart AJ, 2014, J BONE JOINT SURG AM, V96A, P1091, DOI 10.2106/JBJS.M.00957; Hart AJ, 2011, J BONE JOINT SURG BR, V93B, P1308, DOI 10.1302/0301-620X.93B10.26249; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P738, DOI 10.1302/0301-620X.91B6.21682; Health Canada, 2012, MET ON MET HIP IMPL; Hoffman RM, 2011, NEW ENGL J MED, V365, P2013, DOI 10.1056/NEJMcp1103642; Kendal AR, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6549; Kwon Young-Min, 2014, J Bone Joint Surg Am, V96, pe4, DOI 10.2106/JBJS.M.00160; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Langton DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001541; Liddle AD, 2013, ACTA ORTHOP, V84, P237, DOI 10.3109/17453674.2013.797313; Low AK, 2016, J ARTHROPLASTY, V31, P146, DOI 10.1016/j.arth.2015.08.007; Makela KT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4646; Matharu GS, 2017, BONE JOINT J, V99B, P1020, DOI 10.1302/0301-620X.99B8.BJJ-2016-0889.R1; Matharu GS, 2016, BONE JOINT J, V98B, P1455, DOI 10.1302/0301-620X.98B11.38042; Matharu GS, 2013, BONE JOINT J, V95B, P1172, DOI 10.1302/0301-620X.95B9.31711; Matharu GS, 2018, CLIN ORTHOP RELAT R, V476, P245, DOI 10.1007/s11999.0000000000000029; Matharu GS, 2017, J BONE JOINT SURG AM, V99, P1532, DOI 10.2106/JBJS.16.01568; Matharu GS, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1329-8; Matharu GS, 2016, HIP INT, V26, P522, DOI 10.5301/hipint.5000387; Matharu GS, 2016, J BONE JOINT SURG AM, V98, P1444, DOI 10.2106/JBJS.15.01234; Matharu GS, 2016, J BONE JOINT SURG AM, V98, P617, DOI 10.2106/JBJS.15.00340; Matharu GS, 2015, J ARTHROPLASTY, V30, P1317, DOI 10.1016/j.arth.2015.03.009; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; Medicines & Healthcare products Regulatory Agency, 2012, MDA2012036 MED HEALT; MHRA, 2010, MED DEV AL ASR HIP R; Murray DW, 2007, J BONE JOINT SURG BR, V89B, P1010, DOI 10.1302/0301-620X.89B8; National Health Service, 2017, HIP REPL MET ON MET; National Joint Registry for England Wales Northern Ireland and the Isle of Man, 2016, 13 NAT JOINT REG ENG; National Joint Registry for England Wales Northern Ireland and the Isle of Man, 2012, 9 NAT JOINT REG ENGL; Reito A, 2016, ORTHOP TRAUMATOL-SUR, V102, P167, DOI 10.1016/j.otsr.2015.12.015; Reito A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147872; Reito A, 2014, ACTA ORTHOP, V85, P570, DOI 10.3109/17453674.2014.961868; Reito A, 2014, INT ORTHOP, V38, P1353, DOI 10.1007/s00264-014-2300-7; Sabah SA, 2018, BONE JOINT J, V100B, P20, DOI 10.1302/0301-620X.100B1.BJJ-2017-1065.R1; Smith AJ, 2012, LANCET, V380, P1759, DOI 10.1016/S0140-6736(12)60989-1; Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Tower SS, 2010, J BONE JOINT SURG AM, V92A, P2847, DOI 10.2106/JBJS.J.00125; US Food and Drug Administration, 2013, MED DEV MET ON MET H; Van der Straeten C, 2013, BONE JOINT J, V95B, P1332, DOI 10.1302/0301-620X.95B10.32022; Van der Straeten C, 2013, CLIN ORTHOP RELAT R, V471, P377, DOI 10.1007/s11999-012-2526-x; van der Veen HC, 2015, BONE JOINT J, V97B, P1481, DOI 10.1302/0301-620X.97B11.34541; van der Weegen W, 2013, BONE JOINT J, V95B, P1626, DOI 10.1302/0301-620X.95B12.32248	59	11	11	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2018	360						12	16	k566	10.1136/bmj.k566	http://dx.doi.org/10.1136/bmj.k566			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KW	29440064	Green Submitted			2022-12-28	WOS:000425582200002
J	Godlee, F				Godlee, Fiona			Assisted dying: it's time to poll UK doctors (vol 360, k593, 2018)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Godlee F, 2018, BMJ-BRIT MED J, V360, DOI [10.1136/bmj.k694, 10.1136/bmj.k593]	1	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2018	360								k694	10.1136/bmj.k694	http://dx.doi.org/10.1136/bmj.k694			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KT	29440046	Green Published, Bronze			2022-12-28	WOS:000425581700012
J	Kim, DK; Riley, LE; Hunter, P				Kim, David K.; Riley, Laura E.; Hunter, Paul		Advisory Comm Immunization Practic	Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2018	ANNALS OF INTERNAL MEDICINE			English	Article							ZOSTER SUBUNIT VACCINE; INFORMATION-SYSTEMS; ADVISORY-COMMITTEE; HERPES-ZOSTER; PRACTICES ACIP; PROGRESS; POPULATIONS; EFFICACY; COVERAGE; POLICY		[Kim, David K.; Riley, Laura E.; Hunter, Paul; Advisory Comm Immunization Practic] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Kim, DK (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop A-19, Atlanta, GA 30329 USA.	dkim@cdc.gov	Epling, John W/J-1097-2019	Epling, John W/0000-0001-9445-8669; Belongia, Edward/0000-0001-7478-0415				Advisory Committee on Immunization Practices, UPD 2017 ACIP STAT O; Advisory Committee on Immunization Practices, 2018, REC IMM SCHED CHILDR; Almquist J., 2014, AAP NEWS, V35, P33; American Academy of Family Physicians, COD VACC ADM 2016; American College of Obstetricians and Gynecologists, IMM COD OBST GYN 201; American College of Physicians, BILL COD AD IMM; Bhatt A, 2014, PUBLIC HEALTH REP, V129, P115; Bridges CB, 2015, AM J PREV MED, V49, pS455, DOI 10.1016/j.amepre.2015.08.014; Cardemil C, 2013, MMWR-MORBID MORTAL W, V62, P1005; Centers for Disease Control and Prevention, IMM INF SYST ANN REP; Centers for Disease Control and Prevention, IMM INF SYST; Centers for Medicare & Medicaid Services, QUAL PAYM PROGR; Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800; Groom H, 2015, J PUBLIC HEALTH MAN, V21, P227, DOI 10.1097/PHH.0000000000000069; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hurley LP, 2017, VACCINE, V35, P647, DOI 10.1016/j.vaccine.2016.12.007; Hurley LP, 2014, ANN INTERN MED, V160, P161, DOI 10.7326/M13-2332; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Kelly J., 2010, Morbidity and Mortality Weekly Report, V59, P133; Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184; Lu PJ, 2015, AM J PREV MED, V48, P647, DOI 10.1016/j.amepre.2014.12.008; Marin M, 2018, MMWR-MORBID MORTAL W, V67, P33, DOI 10.15585/mmwr.mm6701a7; Martin DW, 2015, J PUBLIC HEALTH MAN, V21, P296, DOI 10.1097/PHH.0000000000000040; Meites E, 2016, MMWR-MORBID MORTAL W, V65, P1405, DOI 10.15585/mmwr.mm6549a5; Murthy N, 2017, MMWR-MORBID MORTAL W, V66, P1178, DOI 10.15585/mmwr.mm6643a4; Smith JC, 2010, VACCINE, V28, pA68, DOI 10.1016/j.vaccine.2010.02.037; Stewart AM, 2014, VACCINE, V32, P618, DOI 10.1016/j.vaccine.2013.11.050; US Task Force on Community Preventive Services, 2005, GUIDE COMMUNITY PREV; Williams WW, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6611a1	29	34	34	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					210	+		10.7326/M17-3439	http://dx.doi.org/10.7326/M17-3439			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29404596				2022-12-28	WOS:000424224300010
J	Patorno, E; Goldfine, AB; Schneeweiss, S; Everett, BM; Glynn, RJ; Liu, J; Kim, SC				Patorno, Elisabetta; Goldfine, Allison B.; Schneeweiss, Sebastian; Everett, Brendan M.; Glynn, Robert J.; Liu, Jun; Kim, Seoyoung C.			Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MYOCARDIAL-INFARCTION; HEART-FAILURE; EMPAGLIFLOZIN; SAFETY; HEALTH; RISK; INHIBITORS; ACCURACY; EFFICACY; DEATH	OBJECTIVE To evaluate the cardiovascular safety of canagliflozin, a sodium-glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus, in direct comparisons with DPP-4 inhibitors (DPP-4i), GLP-1 receptor agonists (GLP-1RA), or sulfonylureas, as used in routine practice. DESIGN Population based retrospective cohort study. SETTING Nationwide sample of patients with type 2 diabetes from a large de-identified US commercial healthcare database (Optum Clinformatics Datamart). PARTICIPANTS Three pairwise 1: 1 propensity score matched cohorts of patients with type 2 diabetes 18 years and older who initiated canagliflozin or a comparator non-gliflozin antidiabetic agent (ie, a DPP-4i, a GLP-1RA, or a sulfonylurea) between April 2013 and September 2015. MAIN OUTCOME MEASURES The primary outcomes were heart failure admission to hospital and a composite cardiovascular endpoint (comprised of being admitted to hospital for acute myocardial infarction, ischemic stroke, or hemorrhagic stroke). Hazard ratios and 95% confidence intervals were estimated in each propensity score matched cohort controlling for more than 100 baseline characteristics. RESULTS During a 30 month period, the hazard ratio for heart failure admission to hospital associated with canagliflozin was 0.70 (95% confidence interval 0.54 to 0.92) versus a DPP-4i (n=17 667 pairs), 0.61 (0.47 to 0.78) versus a GLP-1RA (20 539), and 0.51 (0.38 to 0.67) versus a sulfonylurea (17 354). The hazard ratio for the composite cardiovascular endpoint associated with canagliflozin was 0.89 (0.68 to 1.17) versus a DPP-4i, 1.03 (0.79 to 1.35) versus a GLP-1RA, and 0.86 (0.65 to 1.13) versus a sulfonylurea. Results were similar in sensitivity analyses further adjusting for baseline hemoglobin A1c levels and in subgroups of patients with and without prior cardiovascular disease or heart failure. CONCLUSIONS In this large cohort study, canagliflozin was associated with a lower risk of heart failure admission to hospital and with a similar risk of myocardial infarction or stroke in direct comparisons with three different classes of non-gliflozin diabetes treatment alternatives as used in routine care.	[Patorno, Elisabetta; Schneeweiss, Sebastian; Glynn, Robert J.; Liu, Jun; Kim, Seoyoung C.] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Goldfine, Allison B.] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA USA; [Everett, Brendan M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA USA; [Everett, Brendan M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA USA; [Kim, Seoyoung C.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Patorno, E (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	epatorno@bwh.harvard.edu	Kim, Seoyoung/L-6561-2019; Schneeweiss, Sebastian/C-2125-2013	Kim, Seoyoung/0000-0002-2517-3579; Schneeweiss, Sebastian/0000-0003-2575-467X; Goldfine, Allison/0000-0002-0345-1048	Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; National Institute on Aging [K08AG055670]; NATIONAL INSTITUTE ON AGING [K08AG055670] Funding Source: NIH RePORTER	Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. EP was supported by a career development grant (K08AG055670) from the National Institute on Aging.	[Anonymous], 2011, IMPORTANT NOTICE CHA; [Anonymous], 2008, GUIDANCE IND DIABETE; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Everett BM, 2016, CIRCULATION, V134, P773, DOI 10.1161/CIRCULATIONAHA.116.024512; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Haring HU, 2013, DIABETES CARE, V36, P3396, DOI 10.2337/dc12-2673; Hsia DS, 2017, CURR OPIN ENDOCRINOL, V24, P73, DOI 10.1097/MED.0000000000000311; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kleinbaum DG, 2012, STAT BIOL HEALTH, P161, DOI 10.1007/978-1-4419-6646-9_4; Kosiborod M, 2017, CIRCULATION, V136, P249, DOI 10.1161/CIRCULATIONAHA.117.029190; MacDonald MR, 2008, EUR HEART J, V29, P1377, DOI 10.1093/eurheartj/ehn153; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patorno E, 2018, DIABETES OBES METAB, V20, P974, DOI 10.1111/dom.13184; Persson F, 2018, DIABETES OBES METAB, V20, P344, DOI 10.1111/dom.13077; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Zaccardi F, 2016, DIABETES OBES METAB, V18, P783, DOI 10.1111/dom.12670; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	27	109	111	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2018	360								k119	10.1136/bmj.k119	http://dx.doi.org/10.1136/bmj.k119			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HT	29437648	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000424975300001
J	Berger, Z; Rubenstein, LS; DeCamp, M				Berger, Zackary; Rubenstein, Leonard S.; DeCamp, Matthew			Clinical care and complicity with torture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTORS		[Berger, Zackary; DeCamp, Matthew] Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Berger, Zackary; Rubenstein, Leonard S.; DeCamp, Matthew] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Rubenstein, Leonard S.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Berger, Z (corresponding author), Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD 21205 USA.; Berger, Z (corresponding author), Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA.	zberger1@jhmi.edu	Berger, Zackary/AAW-5761-2020; Berger, Zackary/I-7032-2013	Berger, Zackary/0000-0002-5871-0342				Ackerman S., 2015, GUARDIAN; [Anonymous], 2018, PRESIDENTIAL EXECUTI; BMA, 1986, WORK PART BRIT MED A; Brotherton S, 2016, JAMA-J AM MED ASSOC, V316, P1041, DOI 10.1001/jama.2016.9752; Central Intelligence Agency Office of Medical Services, OMS GUID MED PSYCH S; Charatan F, 1999, BRIT MED J, V318, P757, DOI 10.1136/bmj.318.7186.757a; CIA Cable, EYES ONL DET RE 06 A; Danish Medical Association, 1987, DAN MED B, V34, P185; Feinstein D., 2014, SENATE INTELLIGENCE; Hall P, 2004, BRIT MED J, V329, P66, DOI 10.1136/bmj.329.7457.66; Hoffman D., 2015, REPORT SPECIAL COMMI; Indian Medical Association, 1996, REP KNOWL ATT PRACT; Lifton RJ, 2004, NEW ENGL J MED, V351, P415, DOI 10.1056/NEJMp048065; McColl H, 2012, J ROY SOC MED, V105, P464, DOI 10.1258/jrsm.2012.120100; Miles Steven H, 2015, AMA J Ethics, V17, P945, DOI 10.1001/journalofethics.2015.17.10.pfor1-1510; Miles SH, 2009, LANCET, V373, P344, DOI 10.1016/S0140-6736(09)60097-0; Nathanson V, 1999, BRIT MED J, V319, P397, DOI 10.1136/bmj.319.7207.397; Rubenstein LS, 2010, JAMA-J AM MED ASSOC, V304, P569, DOI 10.1001/jama.2010.1057; UN General Assembly, 1984, CONV TORT OTH CRUEL; United Nations, PRINC MED ETH REL RO; World Medical Association, 2016, DECL TOK GUID PHYS T; World Medical Association, 2017, WMA DECL MALT HUNG S	22	0	0	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2018	360								k449	10.1136/bmj.k449	http://dx.doi.org/10.1136/bmj.k449			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV4JV	29420187	Green Published			2022-12-28	WOS:000424540400002
J	Rajasekaran, S; Okamoto, J; Mathey, L; Fechner, M; Thampy, V; Gu, GD; Cavalleri, A				Rajasekaran, S.; Okamoto, J.; Mathey, L.; Fechner, M.; Thampy, V.; Gu, G. D.; Cavalleri, A.			Probing optically silent superfluid stripes in cuprates	SCIENCE			English	Article							DENSITY-WAVE; 3RD-HARMONIC GENERATION; SUPERCONDUCTORS; SUSCEPTIBILITY; EXCITATION	Unconventional superconductivity in the cuprates coexists with other types of electronic order. However, some of these orders are invisible to most experimental probes because of their symmetry. For example, the possible existence of superfluid stripes is not easily validated with linear optics, because the stripe alignment causes interlayer superconducting tunneling to vanish on average. Here we show that this frustration is removed in the nonlinear optical response. A giant terahertz third harmonic, characteristic of nonlinear Josephson tunneling, is observed in La1.885Ba0.115CuO4 above the transition temperature T-c = 13 kelvin and up to the charge-ordering temperature T-co = 55 kelvin. We model these results by hypothesizing the presence of a pair density wave condensate, in which nonlinear mixing of optically silent tunneling modes drives large dipole-carrying supercurrents.	[Rajasekaran, S.; Fechner, M.; Cavalleri, A.] Max Planck Inst Struct & Dynam Matter, Hamburg, Germany; [Okamoto, J.; Mathey, L.] Univ Hamburg, Ctr Opt Quantum Technol, Hamburg, Germany; [Okamoto, J.; Mathey, L.] Univ Hamburg, Inst Laser Phys, Hamburg, Germany; [Thampy, V.; Gu, G. D.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Cavalleri, A.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England	Max Planck Society; University of Hamburg; University of Hamburg; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Oxford	Rajasekaran, S; Cavalleri, A (corresponding author), Max Planck Inst Struct & Dynam Matter, Hamburg, Germany.; Cavalleri, A (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England.	srivats.rajasekaran@mpsd.mpg.de; andrea.cavalleri@mpsd.mpg.de	Cavalleri, Adriano/D-3264-2015; Okamoto, Junichi/B-9409-2017; Fechner, Michael/J-7198-2018	Cavalleri, Adriano/0000-0003-4163-6745; Okamoto, Junichi/0000-0002-2537-3343; Cavalleri, Andrea/0000-0002-3143-0850; Thampy, Vivek/0000-0003-3983-3109; Fechner, Michael/0000-0003-2774-7684	European Research Council under the European Union's Seventh Framework Programme; ERC [319286]; U.S. Department of Energy, Division of Materials Science [DE-AC02-98CH10886]	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); U.S. Department of Energy, Division of Materials Science(United States Department of Energy (DOE))	We thank S. A. Kivelson and J. M. Tranquada for helpful feedback on the manuscript. We thank D. Nicoletti for providing us with the linear reflectivity data of the x = 11.5% sample. The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) and ERC grant agreement no. 319286 [Frontiers in Quantum Materials' Control (Q-MAC)]. Work performed at Brookhaven was supported by the U.S. Department of Energy, Division of Materials Science under contract no. DE-AC02-98CH10886. The data from the terahertz measurements and the simulations are kept at the Cavalleri Laboratory at Max Planck Institute of Structure and Dynamics, Hamburg, and are available from the authors upon request.	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Berg E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.127003; Berg E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115004; Bilbro LS, 2011, NAT PHYS, V7, P298, DOI [10.1038/nphys1912, 10.1038/NPHYS1912]; Boyd RW, 2014, OPT COMMUN, V326, P74, DOI 10.1016/j.optcom.2014.03.005; BUCHALTER B, 1982, APPL OPTICS, V21, P3221, DOI 10.1364/AO.21.003221; CHEN T, 1987, PHYS REV B, V36, P2931, DOI 10.1103/PhysRevB.36.2931; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; Dienst A, 2013, NAT MATER, V12, P535, DOI [10.1038/NMAT3580, 10.1038/nmat3580]; Dienst A, 2011, NAT PHOTONICS, V5, P485, DOI [10.1038/nphoton.2011.124, 10.1038/NPHOTON.2011.124]; Fujita K, 2014, P NATL ACAD SCI USA, V111, pE3026, DOI 10.1073/pnas.1406297111; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hamidian MH, 2016, NATURE, V532, P343, DOI 10.1038/nature17411; Hebling J, 2008, J OPT SOC AM B, V25, pB6, DOI 10.1364/JOSAB.25.0000B6; Homes CC, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.134510; Hucker M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.104506; JOSEPHSON BD, 1964, REV MOD PHYS, V36, P216, DOI 10.1103/RevModPhys.36.216; Laplace Y, 2016, ADV PHYS-X, V1, P387, DOI 10.1080/23746149.2016.1212671; Lee PA, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031017; Li Q, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067001; Rajasekaran S, 2016, NAT PHYS, V12, P1012, DOI [10.1038/NPHYS3819, 10.1038/nphys3819]; Savel'ev S, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/2/026501; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0	26	48	48	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					575	578		10.1126/science.aan3438	http://dx.doi.org/10.1126/science.aan3438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420290	Green Submitted			2022-12-28	WOS:000423795800042
J	Snyder, A				Snyder, Alison			Chesmal Siriwardhana Obituary	LANCET			English	Biographical-Item									[Snyder, Alison] Axios, Washington, DC 20036 USA		Snyder, A (corresponding author), Axios, Washington, DC 20036 USA.	amsnyder@alum.mit.edu						SIRIWARDHANA C, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2017	389	10082					1878	1878		10.1016/S0140-6736(17)31219-9	http://dx.doi.org/10.1016/S0140-6736(17)31219-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU4AZ	29407038	Bronze			2022-12-28	WOS:000400973500014
J	Venkataramani, AS; Gandhavadi, M; Jena, AB				Venkataramani, Atheendar S.; Gandhavadi, Maheer; Jena, Anupam B.			Association Between Playing American Football in the National Football League and Long-term Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; LIFE EXPECTANCY; TIME-SCALE; PLAYERS; DEATH; INJURIES; CHOICE; IMPACT; INDEX	IMPORTANCE Studies of the longevity of professional American football players have demonstrated lower mortality relative to the general population but they may have been susceptible to selection bias. OBJECTIVE To examine the association between career participation in professional American football and mortality risk in retirement. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study involving 3812 retired US National Football League (NFL) players who debuted in the NFL between 1982 and 1992, including regular NFL players (n = 2933) and NFL "replacement players" (n = 879) who were temporarily hired to play during a 3-game league-wide player strike in 1987. Follow-up ended on December 31, 2016. EXPOSURES NFL participation as a career player or as a replacement player. MAIN OUTCOMES AND MEASURES The primary outcome was all-cause mortality by December 31, 2016. Cox proportional hazards models were estimated to compare the observed number of years from age 22 years until death (or censoring), adjusted for birth year, body mass index, height, and position played. Information on player death and cause of death was ascertained from a search of the National Death Index and web-based sources. RESULTS Of the 3812 men included in this study (mean [SD] age at first NFL activity, 23.4 [1.5] years), there were 2933 career NFL players (median NFL tenure, 5 seasons [interquartile range {IQR}, 2-8]; median follow-up, 30 years [IQR, 27-33]) and 879 replacement players (median NFL tenure, 1 season [IQR, 1-1]; median follow-up, 31 years [IQR, 30-33]). At the end of follow-up, 144 NFL players (4.9%) and 37 replacement players (4.2%) were deceased (adjusted absolute risk difference, 1.0%[95% CI, -0.7% to 2.7%]; P =.25). The adjusted mortality hazard ratio for NFL players relative to replacements was 1.38 (95% CI, 0.95 to 1.99; P =.09). Among career NFL players, the most common causes of death were cardiometabolic disease (n = 51; 35.4%), transportation injuries (n = 20; 13.9%), unintentional injuries (n = 15; 10.4%), and neoplasms (n = 15; 10.4%). Among NFL replacement players, the leading causes of death were cardiometabolic diseases (n = 19; 51.4%), self-harm and interpersonal violence (n = 5; 13.5%), and neoplasms (n = 4; 10.8%). CONCLUSIONS AND RELEVANCE Among NFL football players who began their careers between 1982 and 1992, career participation in the NFL, compared with limited NFL exposure obtained primarily as an NFL replacement player during a league-wide strike, was not associated with a statistically significant difference in long-term all-cause mortality. Given the small number of events, analysis of longer periods of follow-up may be informative.	[Venkataramani, Atheendar S.] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Blockley Hall 1102,423 Guardian Dr, Philadelphia, PA 19104 USA; [Venkataramani, Atheendar S.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Gandhavadi, Maheer] Everett Clin, Clin Cardiac Electrophys, Dept Heart & Vasc Cardiol, Everett, WA USA; [Gandhavadi, Maheer] Providence Reg Med Ctr, Everett, WA USA; [Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Venkataramani, AS (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Blockley Hall 1102,423 Guardian Dr, Philadelphia, PA 19104 USA.	atheenv@pennmedicine.upenn.edu			NIH HHS [DP5 OD017897] Funding Source: Medline; NIMH NIH HHS [K23 MH106362] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH106362] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baron S, 1994, 88085 HETA CTR DIS C; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Boublik M, 2013, AM J SPORT MED, V41, P1841, DOI 10.1177/0363546513490655; C- SPAN, CONC RES TREATM; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Chetty R, 2016, AM ECON REV, V106, P855, DOI 10.1257/aer.20150572; Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645; Fillenbaum GG, 2009, AM J EPIDEMIOL, V170, P515, DOI 10.1093/aje/kwp155; FOGEL RW, 1994, AM ECON REV, V84, P369; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Holstein J, 2015, THERE LIFE FOOTBALL; Horn S, 2009, AM J PHYS MED REHAB, V88, P192, DOI 10.1097/PHM.0b013e318198b622; Kluck T., 2015, 3 WEEK PROFESSIONALS; Koning R, 2014, INT J FINANC STUD, V2, P168, DOI 10.3390/ijfs2010168; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Merrill E., 2011, NFL REPLACEMENTS PAR; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; National Center for Health Statistics, 2013, NAT DEATH IND US GUI; National Football League, PLAYERS; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parekh Selene G, 2009, Foot Ankle Spec, V2, P283, DOI 10.1177/1938640009351138; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Pincivero DM, 1997, SPORTS MED, V23, P247, DOI 10.2165/00007256-199723040-00004; Pro Football Reference, FOOTB STATS HIST; Smith RS, 2013, SLEEP, V36, P1999, DOI 10.5665/sleep.3248; Troan J., NFL ROSTERS; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Weir DR., 2009, NATL FOOTBALL LEAGUE; Williams T., 2012, LONG TERM MORTALITY	33	24	24	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2018	319	8					800	806		10.1001/jama.2018.0140	http://dx.doi.org/10.1001/jama.2018.0140			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX6GK	29392304	Green Published, Bronze			2022-12-28	WOS:000426181300022
J	Scharfman, HE				Scharfman, Helen E.			Controlling learning and epilepsy together	SCIENCE			English	Editorial Material							DENTATE GYRUS; MOSSY CELL		[Scharfman, Helen E.] NYU, Dept Child & Adolescent Psychiat, Langone Hlth, New York, NY 10003 USA; [Scharfman, Helen E.] NYU, Dept Neurosci & Physiol, Langone Hlth, New York, NY 10003 USA; [Scharfman, Helen E.] NYU, Dept Psychiat, Langone Hlth, 550 1St Ave, New York, NY 10016 USA; [Scharfman, Helen E.] NYU, Neurosci Inst, Langone Hlth, 550 1St Ave, New York, NY 10003 USA; [Scharfman, Helen E.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA	New York University; New York University; New York University; New York University; Nathan Kline Institute for Psychiatric Research	Scharfman, HE (corresponding author), NYU, Dept Child & Adolescent Psychiat, Langone Hlth, New York, NY 10003 USA.; Scharfman, HE (corresponding author), NYU, Dept Neurosci & Physiol, Langone Hlth, New York, NY 10003 USA.; Scharfman, HE (corresponding author), NYU, Dept Psychiat, Langone Hlth, 550 1St Ave, New York, NY 10016 USA.; Scharfman, HE (corresponding author), NYU, Neurosci Inst, Langone Hlth, 550 1St Ave, New York, NY 10003 USA.; Scharfman, HE (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG055328] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG055328] Funding Source: Medline; NIMH NIH HHS [R01 MH109305] Funding Source: Medline; NINDS NIH HHS [R01 NS106983] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bui AD, 2018, SCIENCE, V359, P787, DOI 10.1126/science.aan4074; Clasadonte J., 2012, JASPERS BASIC MECH E; Dengler CG, 2016, PROG BRAIN RES, V226, P155, DOI 10.1016/bs.pbr.2016.04.005; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Jaffe DB, 2007, PROG BRAIN RES, V163, P109, DOI 10.1016/S0079-6123(07)63006-4; Kesner RP, 2013, BEHAV BRAIN RES, V254, P1, DOI 10.1016/j.bbr.2013.01.012; Krook-Magnuson E, 2015, J PHYSIOL-LONDON, V593, P2379, DOI 10.1113/JP270056; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scharfman HE, 2018, CELL TISSUE RES, V373, P643, DOI 10.1007/s00441-017-2750-5; Scharfman HE, 2016, NAT REV NEUROSCI, V17, P562, DOI 10.1038/nrn.2016.87; Scharfman HE, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00112; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Yuan M, 2017, ELIFE, V6, DOI 10.7554/eLife.21105; Zappone CA, 2001, J COMP NEUROL, V441, P324, DOI 10.1002/cne.1415	14	5	5	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					740	741		10.1126/science.aas8993	http://dx.doi.org/10.1126/science.aas8993			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449476	Green Accepted			2022-12-28	WOS:000425116200025
J	de Iongh, A				de Iongh, Anya			WHAT YOUR PATIENT IS THINKING Appointment day-the tip of an iceberg	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adeiongh@bmj.com							0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2018	360								k430	10.1136/bmj.k430	http://dx.doi.org/10.1136/bmj.k430			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KZ	29444882	Bronze, Green Published			2022-12-28	WOS:000425582700004
J	Naudet, F; Sakarovitch, C; Janiaud, P; Cristea, I; Fanelli, D; Moher, D; Ioannidis, JPA				Naudet, Florian; Sakarovitch, Charlotte; Janiaud, Perrine; Cristea, Ioana; Fanelli, Daniele; Moher, David; Ioannidis, John P. A.			Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAJOR DEPRESSION; CLINICAL-TRIALS; DOUBLE-BLIND; EFFICACY; MULTICENTER; PAROXETINE	OBJECTIVES To explore the effectiveness of data sharing by randomized controlled trials (RCTs) in journals with a full data sharing policy and to describe potential difficulties encountered in the process of performing reanalyses of the primary outcomes. DESIGN Survey of published RCTs. SETTING PubMed/Medline. ELIGIBILITY CRITERIA RCTs that had been submitted and published by The BMJ and PLOS Medicine subsequent to the adoption of data sharing policies by these journals. MAIN OUTCOME MEASURE The primary outcome was data availability, defined as the eventual receipt of complete data with clear labelling. Primary outcomes were reanalyzed to assess to what extent studies were reproduced. Difficulties encountered were described. RESULTS 37 RCTs (21 from The BMJ and 16 from PLOS Medicine) published between 2013 and 2016 met the eligibility criteria. 17/37 (46%, 95% confidence interval 30% to 62%) satisfied the definition of data availability and 14 of the 17 (82%, 59% to 94%) were fully reproduced on all their primary outcomes. Of the remaining RCTs, errors were identified in two but reached similar conclusions and one paper did not provide enough information in the Methods section to reproduce the analyses. Difficulties identified included problems in contacting corresponding authors and lack of resources on their behalf in preparing the datasets. In addition, there was a range of different data sharing practices across study groups. CONCLUSIONS Data availability was not optimal in two journals with a strong policy for data sharing. When investigators shared data, most reanalyses largely reproduced the original results. Data sharing practices need to become more widespread and streamlined to allow meaningful reanalyses and reuse of data.	[Naudet, Florian; Janiaud, Perrine; Cristea, Ioana; Fanelli, Daniele; Moher, David; Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Sakarovitch, Charlotte] Stanford Univ, Dept Med, Div Biomed Informat Res, Quantitat Sci Unit, Stanford, CA 94305 USA; [Cristea, Ioana] Babes Bolyai Univ, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania; [Fanelli, Daniele] London Sch Econ & Polit Sci, Dept Methodol, London, England; [Moher, David] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Babes Bolyai University from Cluj; University of London; London School Economics & Political Science; University of Ottawa; Ottawa Hospital Research Institute; Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011; Cristea, Ioana Alina/E-7490-2011; Naudet, Florian/H-5644-2019	Cristea, Ioana Alina/0000-0002-9854-7076; Naudet, Florian/0000-0003-3760-3801; Ioannidis, John P./0000-0003-3118-6859; , Cuenta de ejemplo/0000-0002-0951-3000	Laura and John Arnold Foundation; La Fondation Pierre Deniker, Rennes University Hospital, France (CORECT: COmite de la Recherche Clinique et Translationelle); Agence Nationale de la Recherche (ANR); Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI [PN-II-RU-TE-2014-4-1316]	Laura and John Arnold Foundation; La Fondation Pierre Deniker, Rennes University Hospital, France (CORECT: COmite de la Recherche Clinique et Translationelle); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	METRICS has been funded by Laura and John Arnold Foundation but there was no direct funding for this study. FN received grants from La Fondation Pierre Deniker, Rennes University Hospital, France (CORECT: COmite de la Recherche Clinique et Translationelle) and Agence Nationale de la Recherche (ANR), PJ is supported by a postdoctoral fellowship from the Laura and John Arnold Foundation, IC was supported by the Laura and John Arnold Foundation and the Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI, project number PN-II-RU-TE-2014-4-1316 (awarded to IC), and the work of JI is supported by an unrestricted gift from Sue and Bob O'Donnell. The sponsors had no role concerning preparation, review, or approval of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Adrion C, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6816; [Anonymous], 2017, INT C PEER REV SCI P; Atukunda EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001752; Bloom T, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001797; Bousema T, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001993; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chesterton LS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5160; Cohen SP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1748; Devereaux PJ, 2016, NEW ENGL J MED, V375, P405, DOI 10.1056/NEJMp1605654; Ebrahim S, 2014, JAMA-J AM MED ASSOC, V312, P1024, DOI 10.1001/jama.2014.9646; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7888; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Gysin-Maillart A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001968; Hanson C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001881; Harris T, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001783; Haug CJ, 2017, NEW ENGL J MED, V376, P2203, DOI 10.1056/NEJMp1704485; Hopkins C, 2016, J CLIN EPIDEMIOL, V70, P17, DOI 10.1016/j.jclinepi.2015.07.002; Hrynaszkiewicz Iain, 2010, BMJ, V340, pc181, DOI [10.1186/1745-6215-11-9, 10.1136/bmj.c181]; Hyttel-Sorensen S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7635; Iqbal SA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002333; Kalager M, 2016, NEW ENGL J MED, V374, P1898, DOI 10.1056/NEJMc1603789; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Kidwell MC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002456; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Lewandowsky S, 2016, NATURE, V529, P459, DOI 10.1038/529459a; Liu XQ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001876; Loder E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2373; Lombard C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001941; Luedtke K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1640; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Navar AM, 2016, JAMA-J AM MED ASSOC, V315, P1283, DOI 10.1001/jama.2016.2374; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ormerod AD, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2958; Paul M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2219; Platt R, 2016, NEW ENGL J MED, V374, P1897, DOI 10.1056/NEJMc1602016; Polyak CS, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001934; Robinson LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001891; Rockhold F, 2016, NEW ENGL J MED, V375, P1115, DOI 10.1056/NEJMp1608086; Rosenbaum L, 2017, NEW ENGL J MED, V376, P2201, DOI 10.1056/NEJMp1704482; Rowhani-Farid A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011784; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Selak V, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3318; Smith CT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0532-z; Stodden V, 2016, SCIENCE, V354, P1240, DOI 10.1126/science.aah6168; Sydes MR, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0604-6; Taichman DB, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2372; Taichman DB, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001950; Zarin DA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001946	52	107	108	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2018	360						1	11	k400	10.1136/bmj.k400	http://dx.doi.org/10.1136/bmj.k400			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KW	29440066	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000425582200001
J	Hyman, DM; Piha-Paul, SA; Won, H; Rodon, J; Saura, C; Shapiro, GI; Juric, D; Quinn, DI; Moreno, V; Doger, B; Mayer, IA; Boni, V; Calvo, E; Loi, S; Lockhart, AC; Erinjeri, JP; Scaltriti, M; Ulaner, GA; Patel, J; Tang, JB; Beer, H; Selcuklu, SD; Hanrahan, AJ; Bouvier, N; Melcer, M; Murali, R; Schram, AM; Smyth, LM; Jhaveri, K; Li, BT; Drilon, A; Harding, JJ; Iyer, G; Taylor, BS; Berger, MF; Cutler, RE; Xu, F; Butturini, A; Eli, LD; Mann, G; Farrell, C; Lalani, AS; Bryce, RP; Arteaga, CL; Meric-Bernstam, F; Baselga, J; Solit, DB				Hyman, David M.; Piha-Paul, Sarina A.; Won, Helen; Rodon, Jordi; Saura, Cristina; Shapiro, Geoffrey I.; Juric, Dejan; Quinn, David I.; Moreno, Victor; Doger, Bernard; Mayer, Ingrid A.; Boni, Valentina; Calvo, Emiliano; Loi, Sherene; Lockhart, Albert C.; Erinjeri, Joseph P.; Scaltriti, Maurizio; Ulaner, Gary A.; Patel, Juber; Tang, Jiabin; Beer, Hannah; Selcuklu, S. Duygu; Hanrahan, Aphrothiti J.; Bouvier, Nancy; Melcer, Myra; Murali, Rajmohan; Schram, Alison M.; Smyth, Lillian M.; Jhaveri, Komal; Li, Bob T.; Drilon, Alexander; Harding, James J.; Iyer, Gopa; Taylor, Barry S.; Berger, Michael F.; Cutler, Richard E., Jr.; Xu, Feng; Butturini, Anna; Eli, Lisa D.; Mann, Grace; Farrell, Cynthia; Lalani, Alshad S.; Bryce, Richard P.; Arteaga, Carlos L.; Meric-Bernstam, Funda; Baselga, Jose; Solit, David B.			HER kinase inhibition in patients with HER2-and HER3-mutant cancers	NATURE			English	Article							BREAST-CANCER; MONOCLONAL-ANTIBODY; HIGH-FREQUENCY; SOLID TUMORS; PHASE-II; MUTATIONS; TRASTUZUMAB; LAPATINIB; TARGETS; PERTUZUMAB	Somatic mutations of ERBB2 and ERBB3 (which encode HER2 and HER3, respectively) are found in a wide range of cancers. Preclinical modelling suggests that a subset of these mutations lead to constitutive HER2 activation, but most remain biologically uncharacterized. Here we define the biological and therapeutic importance of known oncogenic HER2 and HER3 mutations and variants of unknown biological importance by conducting a multi-histology, genomically selected, 'basket' trial using the pan-HER kinase inhibitor neratinib (SUMMIT; clinicaltrials.gov identifier NCT01953926). Efficacy in HER2-mutant cancers varied as a function of both tumour type and mutant allele to a degree not predicted by preclinical models, with the greatest activity seen in breast, cervical and biliary cancers and with tumours that contain kinase domain missense mutations. This study demonstrates how a molecularly driven clinical trial can be used to refine our biological understanding of both characterized and new genomic alterations with potential broad applicability for advancing the paradigm of genome-driven oncology.	[Hyman, David M.; Won, Helen; Erinjeri, Joseph P.; Scaltriti, Maurizio; Ulaner, Gary A.; Patel, Juber; Tang, Jiabin; Beer, Hannah; Selcuklu, S. Duygu; Hanrahan, Aphrothiti J.; Bouvier, Nancy; Melcer, Myra; Murali, Rajmohan; Schram, Alison M.; Smyth, Lillian M.; Jhaveri, Komal; Li, Bob T.; Drilon, Alexander; Harding, James J.; Iyer, Gopa; Taylor, Barry S.; Berger, Michael F.; Baselga, Jose; Solit, David B.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Piha-Paul, Sarina A.; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Rodon, Jordi; Saura, Cristina] Vall Hebron Univ Hosp, VHIO, Barcelona, Spain; [Shapiro, Geoffrey I.] Dana Faber Canc Inst, Boston, MA USA; [Juric, Dejan] Massachusetts Hosp, Canc Ctr, Boston, MA USA; [Quinn, David I.] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Moreno, Victor; Doger, Bernard] START Madrid Fdn Jimenez Diaz, Madrid, Spain; [Mayer, Ingrid A.; Arteaga, Carlos L.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Boni, Valentina; Calvo, Emiliano] CIOCC, START Madrid, Madrid, Spain; [Loi, Sherene] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Lockhart, Albert C.] Washington Univ, Sch Med, St Louis, MO USA; [Cutler, Richard E., Jr.; Xu, Feng; Butturini, Anna; Eli, Lisa D.; Mann, Grace; Farrell, Cynthia; Lalani, Alshad S.; Bryce, Richard P.] Puma Biotechnol Inc, Los Angeles, CA USA	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Harvard University; Dana-Farber Cancer Institute; University of Southern California; Vanderbilt University; Peter Maccallum Cancer Center; Washington University (WUSTL)	Hyman, DM (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	hymand@mskcc.org	Quinn, David/N-3730-2019; Moreno, Victor/GNN-0449-2022; Miquel, Josep Maria/AAG-3508-2019; Solit, David B./AAC-5309-2019; Loi, Sherene/H-1979-2016	Quinn, David/0000-0002-1411-0417; Moreno, Victor/0000-0001-6099-4236; Harding, James/0000-0002-7029-4310; Eli, Lisa/0000-0003-3896-0966; Schram, Alison/0000-0002-6070-2413; Solit, David/0000-0002-6614-802X; Calvo, Emiliano/0000-0003-4921-829X; Loi, Sherene/0000-0001-6137-9171; Saura, Cristina/0000-0001-8296-5065; Piha-Paul, Sarina/0000-0001-9455-1660	Puma Biotechnology; National Institutes of Health [P30 CA008748, P30 CA016672, P30 CA014089, R01 CA204749, R01 CA80195, T32 CA009207, 1U01 CA180964, UL1 TR000371]; National Institutes of Health/National Cancer Institute (Breast SPORE grant) [P50 CA098131]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Cancer Prevention and Research Institute of Texas [RP1100584]; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; Nellie B. Connally Breast Cancer Research Endowment; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA204749, T32CA009207, R01CA080195, P30CA008748, P30CA014089, U01CA180964, R25CA020449, P30CA016672, P50CA098131] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	Puma Biotechnology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute (Breast SPORE grant); Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Cancer Prevention and Research Institute of Texas; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; Nellie B. Connally Breast Cancer Research Endowment; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank patients and their families for participating in this study. Editorial support, not including writing, was provided by L. Miller. This work was funded by Puma Biotechnology, and supported by grants from the National Institutes of Health (grants P30 CA008748, P30 CA016672, P30 CA014089, R01 CA204749, R01 CA80195, T32 CA009207, 1U01 CA180964 and UL1 TR000371), the National Institutes of Health/National Cancer Institute (Breast SPORE grant P50 CA098131), Cycle for Survival, Marie-Josee and Henry R. Kravis Center for Molecular Oncology, The Cancer Prevention and Research Institute of Texas (RP1100584), the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, Nellie B. Connally Breast Cancer Research Endowment, and the Breast Cancer Research Foundation.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bang YJ, 2010, LANCET, V376, P1302; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Baselga J, 2014, J CLIN ONCOL, V32, P3753, DOI 10.1200/JCO.2013.54.5384; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chakravarty D, 2017, JCO PRECIS ONCOL, V1; Chang M. T, 2017, CANC DISCOV; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Chmielecki J, 2015, ONCOLOGIST, V20, P7, DOI 10.1634/theoncologist.2014-0234; Chumsri S, 2015, J NATL COMPR CANC NE, V13, P1066, DOI 10.6004/jnccn.2015.0132; Freedman RA, 2016, J CLIN ONCOL, V34, P945, DOI 10.1200/JCO.2015.63.0343; Hyman D.M., 2017, J CLIN ONCOL, V35, pLBA2501; Hyman DM, 2017, J CLIN ONCOL, V35, P2251, DOI 10.1200/JCO.2017.73.0143; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jordan EJ, 2017, CANCER DISCOV, V7, P596, DOI 10.1158/2159-8290.CD-16-1337; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kavuri SM, 2015, CANCER DISCOV, V5, P832, DOI 10.1158/2159-8290.CD-14-1211; Kosaka T, 2017, CANCER RES, V77, P2712, DOI 10.1158/0008-5472.CAN-16-3404; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Loibl S, 2016, ANN ONCOL, V27, P1519, DOI 10.1093/annonc/mdw197; Ma CX, 2017, CLIN CANCER RES, V23, P5687, DOI 10.1158/1078-0432.CCR-17-0900; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Middha S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00084; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Ross JS, 2014, CLIN CANCER RES, V20, P68, DOI 10.1158/1078-0432.CCR-13-1992; Ross JS, 2013, CLIN CANCER RES, V19, P2668, DOI 10.1158/1078-0432.CCR-13-0295; Sartore-Bianchi A, 2016, LANCET ONCOL, V17, P738, DOI 10.1016/S1470-2045(16)00150-9; Schram A, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-LB-103; Schram AM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002242; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shi W, 2017, ANN ONCOL, V28, P128, DOI 10.1093/annonc/mdw434; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yasuda H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007205; Zabransky DJ, 2015, P NATL ACAD SCI USA, V112, pE6205, DOI 10.1073/pnas.1516853112; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhou X, 2016, NAT GENET, V48, P4, DOI 10.1038/ng.3466	49	411	419	7	126	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					189	194		10.1038/nature25475	http://dx.doi.org/10.1038/nature25475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420467	Green Accepted			2022-12-28	WOS:000424332600029
J	Lau, CY; Wong, HT				Lau, Chin-Yee; Wong, Hui-Tong			Branchial-Cleft Sinus Manifesting as Recurrent Neck Abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lau, Chin-Yee] Hosp Miri, Miri, Malaysia; [Wong, Hui-Tong] Univ Malaya, Kuala Lumpur, Malaysia	Universiti Malaya	Lau, CY (corresponding author), Hosp Miri, Miri, Malaysia.	chinyeelau@gmail.com	Wong, Hui Tong/A-5861-2018	Wong, Hui Tong/0000-0003-1649-2575					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					E9	E9		10.1056/NEJMicm1710539	http://dx.doi.org/10.1056/NEJMicm1710539			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OX	29414266				2022-12-28	WOS:000424335200001
J	Liu, XS; Wu, H; Krzisch, M; Wu, XB; Graef, J; Muffat, J; Hnisz, D; Li, CH; Yuan, BB; Xu, CY; Li, Y; Vershkov, D; Cacace, A; Young, RA; Jaenisch, R				Liu, X. Shawn; Wu, Hao; Krzisch, Marine; Wu, Xuebing; Graef, John; Muffat, Julien; Hnisz, Denes; Li, Charles H.; Yuan, Bingbing; Xu, Chuanyun; Li, Yun; Vershkov, Dan; Cacace, Angela; Young, Richard A.; Jaenisch, Rudolf			Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene	CELL			English	Article							EMBRYONIC STEM-CELLS; MOUSE MODEL; MOLECULAR-MECHANISMS; SYNAPTIC FUNCTION; MESSENGER-RNA; KNOCKOUT MICE; KO MICE; INHIBITION; CRISPR-CAS9; EXPRESSION	Fragile X syndrome (FXS), the most common genetic form of intellectual disability in males, is caused by silencing of the FMR1 gene associated with hypermethylation of the CGG expansion mutation in the 5' UTR of FMR1 in FXS patients. Here, we applied recently developed DNA methylation editing tools to reverse this hypermethylation event. Targeted demethylation of the CGG expansion by dCas9-Tet1/single guide RNA (sgRNA) switched the heterochromatin status of the upstream FMR1 promoter to an active chromatin state, restoring a persistent expression of FMR1 in FXS iPSCs. Neurons derived from methylation-edited FXS iPSCs rescued the electrophysiological abnormalities and restored a wild-type phenotype upon the mutant neurons. FMR1 expression in edited neurons was maintained in vivo after engrafting into the mouse brain. Finally, demethylation of the CGG repeats in post-mitotic FXS neurons also reactivated FMR1. Our data establish that demethylation of the CGG expansion is sufficient for FMR1 reactivation, suggesting potential therapeutic strategies for FXS.	[Liu, X. Shawn; Wu, Hao; Krzisch, Marine; Wu, Xuebing; Muffat, Julien; Hnisz, Denes; Li, Charles H.; Yuan, Bingbing; Xu, Chuanyun; Li, Yun; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Li, Charles H.; Young, Richard A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Wu, Hao; Graef, John; Cacace, Angela] Fulcrum Therapeut, One Kendall Sq,Binney St b7102, Cambridge, MA 02139 USA; [Vershkov, Dan] Hebrew Univ Jerusalem, Edmond J Safra Campus, IL-91904 Jerusalem, Israel; [Xu, Chuanyun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Stanford University	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.; Jaenisch, R (corresponding author), MIT, Dept Biol, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Hnisz, Denes/AAE-9592-2019; Wu, Xuebing/C-9152-2013; Young, Richard A/F-6495-2012; Li, Yun/C-3367-2011	Hnisz, Denes/0000-0002-6256-1693; Wu, Xuebing/0000-0003-0369-5269; Young, Richard A/0000-0001-8855-8647; Li, Yun/0000-0002-5849-5910; Li, Charles/0000-0001-8091-6112; Muffat, Julien/0000-0003-1889-7023	NIH [HD045022, MH104610, R01NS088538, R01GM123511]; Damon Runyon Cancer Foundation postdoctoral fellowship; Rett Syndrome Research Trust; NARSAD Young Investigator Fellowship; Helen Hay Whitney Foundation postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM087237, R01GM123511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Foundation postdoctoral fellowship; Rett Syndrome Research Trust; NARSAD Young Investigator Fellowship(NARSAD); Helen Hay Whitney Foundation postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Patti Wisniewski, Patrick Autissier, and Hanna Aharonov for FACS and Maisam Mitalipova, Dongdong Fu, Robert Plasschaert, Malkiel Cohen, Carrie Ng, and Vivian Villegas for reagents, technical assistance, and input on the manuscript. We thank Steve Warren at Emory University for providing FXS_SW isogenic iPSC lines. This study was supported by NIH grants HD045022, MH104610, R01NS088538, and R01GM123511. X.S.L. is supported by a Damon Runyon Cancer Foundation postdoctoral fellowship and funding from the Rett Syndrome Research Trust. H.W. was supported by a NARSAD Young Investigator Fellowship. X.W. is supported by a Helen Hay Whitney Foundation postdoctoral fellowship.	Avitzour M, 2014, STEM CELL REP, V3, P699, DOI 10.1016/j.stemcr.2014.09.001; BAKKER CE, 1994, CELL, V78, P23; Berman RF, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-25; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Brick DJ, 2014, STEM CELL TRANSL MED, V3, P1275, DOI 10.5966/sctm.2014-0073; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Colak D, 2014, SCIENCE, V343, P1002, DOI 10.1126/science.1245831; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Esch CEF, 2014, STEM CELL REP, V3, P548, DOI 10.1016/j.stemcr.2014.07.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Erickson CA, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9186-9; Gholizadeh S, 2014, NEUROPSYCHOPHARMACOL, V39, P3100, DOI 10.1038/npp.2014.167; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Halevy T, 2015, STEM CELL REP, V4, P37, DOI 10.1016/j.stemcr.2014.10.015; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Huai C, 2017, HUM GENET, V136, P875, DOI 10.1007/s00439-017-1801-z; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kumari D, 2016, HUM MOL GENET, V25, P3689, DOI 10.1093/hmg/ddw215; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Park CY, 2015, CELL REP, V13, P234, DOI 10.1016/j.celrep.2015.08.084; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pugin A, 2017, NEUROLOGIA, V32, P241, DOI 10.1016/j.nrl.2014.10.009; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Smith LN, 2014, NEURON, V82, P645, DOI 10.1016/j.neuron.2014.03.028; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Windrem MS, 2014, J NEUROSCI, V34, P16153, DOI 10.1523/JNEUROSCI.1510-14.2014; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xie N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153845; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Zeier Z, 2009, GENE THER, V16, P1122, DOI 10.1038/gt.2009.83; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	68	220	234	3	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2018	172	5					979	+		10.1016/j.cell.2018.01.012	http://dx.doi.org/10.1016/j.cell.2018.01.012			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FX2ZG	29456084	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000425937100010
J	Vanlandewijck, M; He, LQ; Mae, MAA; Andrae, J; Ando, K; Del Gaudio, F; Nahar, K; Lebouvier, T; Lavina, B; Gouveia, L; Sun, Y; Raschperger, E; Rasanen, M; Zarb, Y; Mochizuki, N; Keller, A; Lendahl, U; Betsholtz, C				Vanlandewijck, Michael; He, Liqun; Mae, Maarj A. Andaloussi; Andrae, Johanna; Ando, Koji; Del Gaudio, Francesca; Nahar, Khayrun; Lebouvier, Thibaud; Lavina, Barbara; Gouveia, Leonor; Sun, Ying; Raschperger, Elisabeth; Rasanen, Markus; Zarb, Yvette; Mochizuki, Naoki; Keller, Annika; Lendahl, Urban; Betsholtz, Christer			A molecular atlas of cell types and zonation in the brain vasculature	NATURE			English	Article							MESENCHYMAL STEM-CELLS; BMX TYROSINE KINASE; ENDOTHELIAL-CELLS; GENE-EXPRESSION; BARRIER TRANSPORT; BLOOD-FLOW; RNA-SEQ; PERICYTES; ORIGIN; EFFLUX	Cerebrovascular disease is the third most common cause of death in developed countries, but our understanding of the cells that compose the cerebral vasculature is limited. Here, using vascular single-cell transcriptomics, we provide molecular definitions for the principal types of blood vascular and vessel-associated cells in the adult mouse brain. We uncover the transcriptional basis of the gradual phenotypic change (zonation) along the arteriovenous axis and reveal unexpected cell type differences: a seamless continuum for endothelial cells versus a punctuated continuum for mural cells. We also provide insight into pericyte organotypicity and define a population of perivascular fibroblast-like cells that are present on all vessel types except capillaries. Our work illustrates the power of single-cell transcriptomics to decode the higher organizational principles of a tissue and may provide the initial chapter in a molecular encyclopaedia of the mammalian vasculature.	[Vanlandewijck, Michael; Raschperger, Elisabeth; Betsholtz, Christer] Karolinska Inst, AstraZeneca Integrated Cardio Metab Ctr KI AZ ICM, Blickagangen 6, SE-14157 Huddinge, Sweden; [He, Liqun] Tianjin Med Univ, Key Lab Postneuroinjury Neurorepair & Regenerat C, Dept Neurosurg,Gen Hosp, Tianjin Neurol Inst,Minist Educ & Tianjin City, Tianjin 300052, Peoples R China; [Vanlandewijck, Michael; Mae, Maarj A. Andaloussi; Andrae, Johanna; Ando, Koji; Nahar, Khayrun; Lebouvier, Thibaud; Lavina, Barbara; Gouveia, Leonor; Betsholtz, Christer] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Dag Hammarskjolds Vag 20, SE-75185 Uppsala, Sweden; [Del Gaudio, Francesca; Lendahl, Urban] Karolinska Inst, Dept Cell & Mol Biol, Von Eulers Vag 3, SE-17177 Stockholm, Sweden; [Lebouvier, Thibaud] Univ Lille, CHU,Memory Ctr, Distalz, Inserm,U1171, F-59000 Lille, France; [Sun, Ying] Zhongyuan Union Genet Technol Co Ltd, Dept Bioinformat, Tianjin Airport Econ Area, 45 9th East Rd, Tianjin 300304, Peoples R China; [Rasanen, Markus] Univ Helsinki, Wihuri Res Inst, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland; [Rasanen, Markus] Univ Helsinki, Translat Canc Biol Program, Biomedicum Helsinki, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland; [Zarb, Yvette; Keller, Annika] Zurich Univ, Univ Zurich Hosp, Div Neurosurg, CH-8091 Zurich, Switzerland; [Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Res Inst, Suita, Osaka, Japan; [Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, AMED CREST, Suita, Osaka, Japan	Karolinska Institutet; Tianjin Medical University; Uppsala University; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Helsinki; Wihuri Research Institute; University of Helsinki; University of Zurich; University Zurich Hospital; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Betsholtz, C (corresponding author), Karolinska Inst, AstraZeneca Integrated Cardio Metab Ctr KI AZ ICM, Blickagangen 6, SE-14157 Huddinge, Sweden.; Betsholtz, C (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Dag Hammarskjolds Vag 20, SE-75185 Uppsala, Sweden.	christer.betsholtz@ki.se	Gouveia, Leonor/P-4285-2018; Del Gaudio, Francesca/AAD-3685-2022; Andrae, Johanna/L-3875-2014; Andaloussi Mäe, Maarja/AAA-9215-2022; Lebouvier, Thibaud/G-7053-2018	Gouveia, Leonor/0000-0002-3825-8571; Del Gaudio, Francesca/0000-0001-8342-1377; Lebouvier, Thibaud/0000-0002-4386-6045; Zarb, Yvette/0000-0001-5107-0701; Markus, Rasanen/0000-0003-4048-4591; He, Liqun/0000-0003-2127-7597; Keller, Annika/0000-0003-1466-3633; Vanlandewijck, Michael/0000-0002-0709-7808	AstraZeneca AB; Swedish Research Council [2015-00550, K2014-64X-20097-09-5]; European Research Council [AdG294556]; Leducq Foundation [14CVD02]; Swedish Cancer Society [150735, CAN 2016/271]; Knut and Alice Wallenberg Foundation [2015.0030]; Hjarnfonden; Swiss National Science Foundation [31003A_159514/1]; Synapsis Foundation; AstraZeneca AB; Swedish Research Council [2015-00550, K2014-64X-20097-09-5]; European Research Council [AdG294556]; Leducq Foundation [14CVD02]; Swedish Cancer Society [150735, CAN 2016/271]; Knut and Alice Wallenberg Foundation [2015.0030]; Hjarnfonden; Swiss National Science Foundation [31003A_159514/1]; Synapsis Foundation	AstraZeneca AB(AstraZeneca); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Leducq Foundation(Leducq Foundation); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Hjarnfonden; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Synapsis Foundation; AstraZeneca AB(AstraZeneca); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Leducq Foundation(Leducq Foundation); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Hjarnfonden; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Synapsis Foundation	This study was supported by AstraZeneca AB (C.B., U.L), the Swedish Research Council (C.B.: 2015-00550; U.L.: K2014-64X-20097-09-5), the European Research Council (C.B.: AdG294556), the Leducq Foundation (C.B., A.K.: 14CVD02), Swedish Cancer Society (C.B.: 150735; U.L.: CAN 2016/271), Knut and Alice Wallenberg Foundation (C.B.: 2015.0030), Hjarnfonden (U.L.), Swiss National Science Foundation (A. K.: 31003A_159514/1) and the Synapsis Foundation (A.K.). We thank C. Olsson, H. Leksell, P Peterson, J. Chmielniakova, K. Gaengel, BioVis (Uppsala), Center for Microscopy and Image Analysis (Zurich) and Eukaryotic Single Cell Genomics facility (Science for Life Laboratory) for technical help, and K. Alitalo, P. Soriano, D. Silver and L. Sorokin for reagents.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Agarwal S, 2012, MOL CANCER THER, V11, P2183, DOI 10.1158/1535-7163.MCT-12-0552; Ando K, 2016, DEVELOPMENT, V143, P1328, DOI 10.1242/dev.132654; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; de Lange ECM, 2015, CLIN PHARMACOL THER, V97, P380, DOI 10.1002/cpt.76; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Dieterich LC, 2012, J PATHOL, V228, P378, DOI 10.1002/path.4072; Do TM, 2013, J ALZHEIMERS DIS, V36, P555, DOI 10.3233/JAD-121891; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ekman N, 1997, CIRCULATION, V96, P1729, DOI 10.1161/01.CIR.96.6.1729; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fukuhara S, 2014, DEV BIOL, V393, P10, DOI 10.1016/j.ydbio.2014.06.015; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guimaraes-Camboa N, 2017, CELL STEM CELL, V20, P345, DOI 10.1016/j.stem.2016.12.006; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; He LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35108; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hirashima M, 2006, ENDOTHELIUM-J ENDOTH, V13, P137, DOI 10.1080/10623320600698078; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kutschera S, 2011, ARTERIOSCL THROM VAS, V31, P151, DOI 10.1161/ATVBAHA.110.215871; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; Phoenix TN, 2016, CANCER CELL, V29, P508, DOI 10.1016/j.ccell.2016.03.002; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Rajantie I, 2001, MOL CELL BIOL, V21, P4647, DOI 10.1128/MCB.21.14.4647-4655.2001; Ramskold D, 2012, METHODS MOL BIOL, V802, P259, DOI 10.1007/978-1-61779-400-1_17; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SIMIONESCU M, 1975, J CELL BIOL, V67, P863, DOI 10.1083/jcb.67.3.863; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Storvall H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053822; Tarlungeanu DC, 2016, CELL, V167, P1481, DOI 10.1016/j.cell.2016.11.013; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Vanlandewijck M., 2018, PROTOC EXCH; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong HQ, 2009, J NEUROSCI, V29, P5463, DOI 10.1523/JNEUROSCI.5103-08.2009; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	63	746	754	17	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					475	+		10.1038/nature25739	http://dx.doi.org/10.1038/nature25739			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29443965	Green Published			2022-12-28	WOS:000425597400036
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Do we want an NHS that depends on outsourcing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Campbell D, 2016, GUARDIAN; Matthews-King A, 2017, PULSE, P27; National Audit Office, 2018, NHS ENGL MAN PRIM CA; Plimmer G, 2017, FINANCIAL TIMES; Plimmer G, 2015, FINANCIAL TIMES; Plimmer G, 2013, FINANCIAL TIMES; Roberts N, 2016, GPONLINE        0825	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2018	360								k670	10.1136/bmj.k670	http://dx.doi.org/10.1136/bmj.k670			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX1ED	29459490	Bronze, Green Published			2022-12-28	WOS:000425790700002
J	Sushkevich, VL; Palagin, D; Ranocchiari, M; van Bokhoven, JA				Sushkevich, Vitaly L.; Palagin, Dennis; Ranocchiari, Marco; van Bokhoven, Jeroen A.			Response to Comment on "Selective anaerobic oxidation of methane enables direct synthesis of methanol"	SCIENCE			English	Editorial Material									[Sushkevich, Vitaly L.; Palagin, Dennis; Ranocchiari, Marco; van Bokhoven, Jeroen A.] Paul Scherrer Inst, Lab Catalysis & Sustainable Chem, CH-5232 Villigen, Switzerland; [van Bokhoven, Jeroen A.] ETH, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sushkevich, VL; van Bokhoven, JA (corresponding author), Paul Scherrer Inst, Lab Catalysis & Sustainable Chem, CH-5232 Villigen, Switzerland.; van Bokhoven, JA (corresponding author), ETH, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland.	vitaly.sushkevich@psi.ch; jeroen.vanbokhoven@chem.ethz.ch	li, shangkun/AAB-3035-2019; Ranocchiari, Marco/C-3931-2011; Palagin, Dennis/E-1726-2015; Sushkevich, Vitaly/Z-4603-2019; van Bokhoven, Jeroen A/B-1677-2014	Ranocchiari, Marco/0000-0002-4460-8742; Palagin, Dennis/0000-0001-5251-3471; Sushkevich, Vitaly/0000-0002-3788-8969; van Bokhoven, Jeroen A/0000-0002-4166-2284				Labinger JA, 2018, SCIENCE, V359, DOI 10.1126/science.aar4968; Lange JP, 2001, CATTECH, V5, P82, DOI 10.1023/A:1011944622328; Periana RA, 2017, SCIENCE, V358, DOI 10.1126/science.aan5970; Sushkevich VL, 2017, SCIENCE, V358, DOI 10.1126/science.aan6083; Sushkevich VL, 2017, SCIENCE, V356, P523, DOI 10.1126/science.aam9035	5	0	0	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377								10.1126/science.aar6868	http://dx.doi.org/10.1126/science.aar6868			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449464	Green Accepted			2022-12-28	WOS:000425116200002
J	Jaynes, AN				Jaynes, Allison N.			SPACE PHYSICS The origin of pulsating auroras	NATURE			English	Editorial Material							ELECTRON; MAGNETOSPHERE		[Jaynes, Allison N.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA	University of Iowa	Jaynes, AN (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.	allison-n-jaynes@uiowa.edu	JAYNES, ALLISON N/F-7876-2018	JAYNES, ALLISON N/0000-0002-1470-4266				CORONITI FV, 1970, J GEOPHYS RES, V75, P1279, DOI 10.1029/JA075i007p01279; DAVIDSON GT, 1979, J GEOPHYS RES-SPACE, V84, P6517, DOI 10.1029/JA084iA11p06517; Jaynes AN, 2013, J GEOPHYS RES-SPACE, V118, P4884, DOI 10.1002/jgra.50434; Kasahara S, 2018, NATURE, V554, P337, DOI 10.1038/nature25505; MCEWEN DJ, 1981, CAN J PHYS, V59, P1106, DOI 10.1139/p81-146; Mende SB, 2008, SPACE SCI REV, V141, P357, DOI 10.1007/s11214-008-9380-x; Miyoshi Y, 2017, J PHYS CONF SER, V869, DOI 10.1088/1742-6596/869/1/012095; Nishimura Y., 2011, J GEOPHYS RES SPACE; Pulkkinen TI, 1996, J GEOPHYS RES-SPACE, V101, P27431, DOI 10.1029/96JA02489	9	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					302	303		10.1038/d41586-018-01669-z	http://dx.doi.org/10.1038/d41586-018-01669-z			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW0PD	29446411	Bronze			2022-12-28	WOS:000424996300022
J	Lai, HT; Huang, SH				Lai, Hsin-Ti; Huang, Shu-Hung			Phlegmasia Cerulea Dolens with Compartment Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lai, Hsin-Ti] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Huang, Shu-Hung] Kaohsiung Med Univ, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Huang, SH (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.	huangsh63@gmail.com	Huang, Shu-Hung/AAA-3445-2021	Huang, Shu-Hung/0000-0002-2903-1703; Lai, Hsin-Ti/0000-0002-6735-4888					0	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					658	658		10.1056/NEJMicm1704996	http://dx.doi.org/10.1056/NEJMicm1704996			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW0QK	29443665				2022-12-28	WOS:000425000000011
J	Rehfeld, K; Munch, T; Ho, SL; Laepple, T				Rehfeld, Kira; Muench, Thomas; Ho, Sze Ling; Laepple, Thomas			Global patterns of declining temperature variability from the Last Glacial Maximum to the Holocene	NATURE			English	Article							HIGH-RESOLUTION RECORD; SEA-ICE; CLIMATE-CHANGE; CENTRAL GREENLAND; CORE; RECONSTRUCTION; ACCUMULATION; CALIBRATION; GRIP; CONSTRAINTS	Changes in climate variability are as important for society to address as are changes in mean climate(1). Contrasting temperature variability during the Last Glacial Maximum and the Holocene can provide insights into the relationship between the mean state of the climate and its variability(2,3). However, although glacial-interglacial changes in variability have been quantified for Greenland(2), a global view remains elusive. Here we use a network of marine and terrestrial temperature proxies to show that temperature variability decreased globally by a factor of four as the climate warmed by 3-8 degrees Celsius from the Last Glacial Maximum (around 21,000 years ago) to the Holocene epoch (the past 11,500 years). This decrease had a clear zonal pattern, with little change in the tropics (by a factor of only 1.6-2.8) and greater change in the mid-latitudes of both hemispheres (by a factor of 3.3-14). By contrast, Greenland ice-core records show a reduction in temperature variability by a factor of 73, suggesting influences beyond local temperature or a decoupling of atmospheric and global surface temperature variability for Greenland. The overall pattern of reduced variability can be explained by changes in the meridional temperature gradient, a mechanism that points to further decreases in temperature variability in a warmer future.	[Rehfeld, Kira; Muench, Thomas; Ho, Sze Ling; Laepple, Thomas] Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Telegrafenberg A43, D-14473 Potsdam, Germany; [Rehfeld, Kira] British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England; [Muench, Thomas] Univ Potsdam, Inst Phys & Astron, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany; [Ho, Sze Ling] Univ Bergen, Allegaten 41, N-5007 Bergen, Norway; [Ho, Sze Ling] Bjerknes Ctr Climate Res, Allegaten 41, N-5007 Bergen, Norway	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Potsdam; University of Bergen; Bjerknes Centre for Climate Research	Rehfeld, K (corresponding author), Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Telegrafenberg A43, D-14473 Potsdam, Germany.; Rehfeld, K (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.	krehfeld@awi.de	Münch, Thomas/AAC-9281-2019; Rehfeld, Kira/G-9945-2013; Rehfeld, Kira/O-1781-2019	Münch, Thomas/0000-0002-5492-7544; Rehfeld, Kira/0000-0002-9442-5362; Rehfeld, Kira/0000-0002-9442-5362; Ho, Sze Ling/0000-0002-4898-9036	Initiative and Networking Fund of the Helmholtz Association [VG-900NH]; German Science Foundation (DFG) [RE 3994/1-1]; European Research Council (ERC) under the European Union [716092]; CEA; CNRS; NERC [bas0100034] Funding Source: UKRI	Initiative and Networking Fund of the Helmholtz Association; German Science Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC) under the European Union(European Research Council (ERC)); CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Initiative and Networking Fund of the Helmholtz Association grant no. VG-900NH. K.R. acknowledges funding by the German Science Foundation (DFG, code RE 3994/1-1). This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 716092). We acknowledge P. Huybers, L. Sime, M. Holloway and T. Kunz for comments on the manuscript. We thank all original data contributors who made their proxy data available, and acknowledge the World Climate Research Programmes Working Group on Coupled Modelling, which is responsible for CMIP, and thank the climate modelling groups for producing and making available their model output. The US Department of Energy Programme for Climate Model Diagnosis and Intercomparison provided coordinating support for CMIP5 and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. The PMIP3 data archives are supported by CEA and CNRS.	Anand P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000846; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Annan JD, 2013, CLIM PAST, V9, P367, DOI 10.5194/cp-9-367-2013; Beltrami H, 1995, GLOBAL PLANET CHANGE, V11, P127, DOI 10.1016/0921-8181(95)00006-2; BERGER WH, 1968, J MAR RES, V26, P134; Bromwich DH, 2013, NAT GEOSCI, V6, P139, DOI [10.1038/ngeo1671, 10.1038/NGEO1671]; Chatfield C., 2004, ANAL TIME SERIES INT; CUFFEY KM, 1994, J GLACIOL, V40, P341, DOI 10.3189/S0022143000007425; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; CUFFEY KM, 1995, SCIENCE, V270, P455, DOI 10.1126/science.270.5235.455; de Vernal A, 2006, QUATERNARY SCI REV, V25, P2820, DOI 10.1016/j.quascirev.2006.06.006; Ditlevsen PD, 1996, NATURE, V379, P810, DOI 10.1038/379810a0; Fisher D. A., 1985, ANN GLACIOL, V7, P76, DOI DOI 10.1017/S0260305500005942; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Hilbrecht H., 1996, TECHNICAL REPORT; Ho SL, 2016, NAT GEOSCI, V9, P606, DOI [10.1038/ngeo2763, 10.1038/NGEO2763]; Hoff U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12247; Holmes CR, 2016, J CLIMATE, V29, P2221, DOI 10.1175/JCLI-D-14-00735.1; Huntingford C, 2013, NATURE, V500, P327, DOI 10.1038/nature12310; Johnsen SJ, 1997, J GEOPHYS RES-OCEANS, V102, P26397, DOI 10.1029/97JC00167; JOHNSEN SJ, 1995, TELLUS B, V47, P624, DOI 10.1034/j.1600-0889.47.issue5.9.x; Jouzel J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002677; Jouzel J, 1997, J GEOPHYS RES-OCEANS, V102, P26471, DOI 10.1029/97JC01283; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Kindler P, 2014, CLIM PAST, V10, P887, DOI 10.5194/cp-10-887-2014; Kobashi T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049444; Koutavas A, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002378; Laepple T, 2014, P NATL ACAD SCI USA, V111, P16682, DOI 10.1073/pnas.1412077111; Laepple T, 2011, NATURE, V471, P91, DOI 10.1038/nature09825; Li C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023492; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Masson-Delmotte V, 2008, J CLIMATE, V21, P3359, DOI 10.1175/2007JCLI2139.1; Masson-Delmotte V, 2006, CLIM DYNAM, V26, P513, DOI [10.1007/s00382-005-0081-9, 10.1007/S00382-005-0081-9]; Masson-Delmotte V, 2005, SCIENCE, V309, P118, DOI 10.1126/science.1108575; Mix A.C., 1987, N AM ADJACENT OCEANS, P111; Mohtadi M, 2014, NATURE, V509, P76, DOI 10.1038/nature13196; Muller J, 2014, EARTH PLANET SC LETT, V403, P446, DOI 10.1016/j.epsl.2014.07.016; Munch T, 2017, CRYOSPHERE, V11, P2175, DOI 10.5194/tc-11-2175-2017; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Myhre G., 2013, CONTRIBUTION WORKING; Rasmussen SO, 2008, QUATERNARY SCI REV, V27, P18, DOI 10.1016/j.quascirev.2007.01.016; Rhines A, 2014, J CLIMATE, V27, P8902, DOI 10.1175/JCLI-D-14-00075.1; Rhines A, 2013, P NATL ACAD SCI USA, V110, pE546, DOI 10.1073/pnas.1218748110; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Rypdal K, 2015, J CLIMATE, V28, P8379, DOI 10.1175/JCLI-D-15-0183.1; Schneider T, 2015, J CLIMATE, V28, P2312, DOI 10.1175/JCLI-D-14-00632.1; Sevellec F, 2015, EARTH PLANET SC LETT, V429, P60, DOI 10.1016/j.epsl.2015.07.022; Shakun JD, 2010, QUATERNARY SCI REV, V29, P1801, DOI 10.1016/j.quascirev.2010.03.016; Shao ZG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10951; SHUMAN CA, 1995, J GEOPHYS RES-ATMOS, V100, P9165, DOI 10.1029/95JD00560; Sjolte J, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015287; Steen-Larsen HC, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014311; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Vinther BM, 2009, NATURE, V461, P385, DOI 10.1038/nature08355; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Wunsch C, 2006, QUATERNARY RES, V65, P191, DOI 10.1016/j.yqres.2005.10.006	58	56	57	4	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					356	+		10.1038/nature25454	http://dx.doi.org/10.1038/nature25454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29400701	Green Accepted, Green Submitted			2022-12-28	WOS:000424996300037
J	Daw, JR; Sommers, BD				Daw, Jamie R.; Sommers, Benjamin D.			Association of the Affordable Care Act Dependent Coverage Provision With Prenatal Care Use and Birth Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-INSURANCE; MEDICAID EXPANSIONS; YOUNG-ADULTS; PREVENTIVE CARE; PREGNANT-WOMEN; ACCESS; WEIGHT; REFORM; IMPACT; CHILDBIRTH	IMPORTANCE The effect of the Affordable Care Act (ACA) dependent coverage provision on pregnancy-related health care and health outcomes is unknown. OBJECTIVE To determine whether the dependent coverage provision was associated with changes in payment for birth, prenatal care, and birth outcomes. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study, using a differences-indifferences analysis of individual-level birth certificate data comparing live births among US women aged 24 to 25 years (exposure group) and women aged 27 to 28 years (control group) before (2009) and after (2011-2013) enactment of the dependent coverage provision. Results were stratified by marital status. MAIN EXPOSURES The dependent coverage provision of the ACA, which allowed young adults to stay on their parent's health insurance until age 26 years. MAIN OUTCOMES AND MEASURES Primary outcomes were payment source for birth, early prenatal care (first visit in first trimester), and adequate prenatal care (a first trimester visit and 80% of expected visits). Secondary outcomes were cesarean delivery, premature birth, low birth weight, and infant neonatal intensive care unit (NICU) admission. RESULTS The study population included 1 379 005 births among women aged 24 to 25 years (exposure: 299024 in 2009; 1079 981 in 2011-2013), and 1 551 192 births among women aged 27 to 28 years (control: 325 564 in 2009; 1 225 628 in 2011-2013). From 2011-2013, compared with 2009, private insurance payment for births increased in the exposure group vs the control group; Medicaid payment and self-payment decreased. Early and adequate prenatal care increased and preterm birth decreased. There were no significant changes in low birth weight, NICU admission, or cesarean delivery. In stratified analyses, changes in payment for birth, prenatal care, and preterm birth were concentrated among unmarried women [GRAPHICS] CONCLUSIONS AND RELEVANCE In this study of nearly 3 million births among women aged 24 to 25 years vs those aged 27 to 28 years, the Affordable Care Act dependent coverage provision was associated with increased private insurance payment for birth, increased use of prenatal care, and modest reduction in preterm births, but was not associated with changes in cesarean delivery rates, low birth weight, or NICU admission.	[Daw, Jamie R.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Sommers, Benjamin D.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Hlth Policy & Econ, Boston, MA USA; [Sommers, Benjamin D.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Daw, JR (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	jdaw@fas.harvard.edu			AHRQ; Commonwealth Fund; RobertWood Johnson Foundation; John Hopkins University; University of Pennsylvania; University of Chicago; MetroHealth/CaseWestern University; AcademyHealth; American Economic Association	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Commonwealth Fund; RobertWood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); John Hopkins University; University of Pennsylvania; University of Chicago(University of Chicago); MetroHealth/CaseWestern University; AcademyHealth; American Economic Association	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sommers reported receiving grant funding from AHRQ, Commonwealth Fund, and RobertWood Johnson Foundation; personal fees from John Hopkins University, University of Pennsylvania, University of Chicago, MetroHealth/CaseWestern University, AcademyHealth, and the American Economic Association; travel expenses from America's Health Insurance Plan, John Hopkins University, University of Pennsylvania, University of Chicago, MetroHealth/CaseWestern University, AcademyHealth, Institute for Medicaid Innovation, and Milbank Memorial Fund; and serving as a senior advisor in the US Department of Health and Human Services from September 2011 to June 2016. Ms Daw reported no disclosures.	Akosa Antwi Y, 2015, ANN EMERG MED, V65; Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; [Anonymous], 2015, N Engl J Med, V373, P782, DOI 10.1056/NEJMx150009; Antwi YA, 2016, NEW ENGL J MED, V374, P194, DOI 10.1056/NEJMc1507847; Aron DC, 2000, MED CARE, V38, P35, DOI 10.1097/00005650-200001000-00005; Bernstein AB, 2007, NCHS DATA BRIEF, P1; Braveman P, 2000, OBSTET GYNECOL, V95, P874, DOI 10.1016/S0029-7844(00)00780-8; Bureau of Labor Statistics US Department of Labor, LAB FORC STAT CURR P; Centers for Medicare & Medicaid Services, EL; Chua KP, 2014, JAMA-J AM MED ASSOC, V311, P2437, DOI 10.1001/jama.2014.2202; Currie J, 1996, J POLIT ECON, V104, P1263, DOI 10.1086/262059; Currie J, 2001, J PUBLIC ECON, V82, P63, DOI 10.1016/S0047-2727(00)00140-7; Daw JR, 2017, HEALTH AFFAIR, V36, P598, DOI 10.1377/hlthaff.2016.1241; de Jongh BE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-97; Epstein AM, 1998, HEALTH CARE FINANC R, V19, P85; FISCELLA K, 1995, OBSTET GYNECOL, V85, P468, DOI 10.1016/0029-7844(94)00408-6; Han XS, 2014, NEW ENGL J MED, V371, P2341, DOI 10.1056/NEJMc1406586; Hernandez-Boussard T, 2014, HEALTH AFFAIR, V33, P1648, DOI 10.1377/hlthaff.2014.0103; Howell EM, 2001, MED CARE RES REV, V58, P3, DOI 10.1177/107755870105800101; Huesch Marco D, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2011.300333; Issel LM, 2011, JOGNN-J OBST GYN NEO, V40, P157, DOI 10.1111/j.1552-6909.2011.01219.x; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Krans EE, 2012, AM J OBSTET GYNECOL, V206, P398, DOI 10.1016/j.ajog.2011.06.082; Markus AR, 2013, WOMEN HEALTH ISS, V23, pE273, DOI 10.1016/j.whi.2013.06.006; Miller S, 2017, NEW ENGL J MED, V376, P947, DOI 10.1056/NEJMsa1612890; MURRAY JL, 1988, NEW ENGL J MED, V319, P1385, DOI 10.1056/NEJM198811243192105; Partridge S, 2012, AM J PERINAT, V29, P787, DOI 10.1055/s-0032-1316439; Rosenberg D, 2007, MATERN CHILD HLTH J, V11, P11, DOI 10.1007/s10995-006-0077-z; Ryan AM, 2015, HEALTH SERV RES, V50, P1211, DOI 10.1111/1475-6773.12270; SHOWSTACK JA, 1984, AM J PUBLIC HEALTH, V74, P1003, DOI 10.2105/AJPH.74.9.1003; Slusky DJG, 2017, EAST ECON J, V43, P580, DOI 10.1057/eej.2015.49; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P913, DOI 10.1001/jama.307.9.913; Turienzo CF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009044; Wallace J, 2016, AM J PREV MED, V50, pS27, DOI 10.1016/j.amepre.2016.01.003; Wherry LR, 2017, HEALTH AFFAIR, V36, P607, DOI 10.1377/hlthaff.2016.1198; Wherry LR, 2016, ANN INTERN MED, V164, P795, DOI 10.7326/M15-2234; Wise PH, 2008, WOMEN HEALTH ISS, V18, pS13, DOI 10.1016/j.whi.2008.07.014	40	32	32	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					579	587		10.1001/jama.2018.0030	http://dx.doi.org/10.1001/jama.2018.0030			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV9LD	29450525	Bronze, Green Published			2022-12-28	WOS:000424908400018
J	Riano, NS; Linos, E; Accurso, EC; Sung, D; Linos, E; Simard, JF; Mangurian, C				Riano, Nicholas S.; Linos, Eleni; Accurso, Erin C.; Sung, Dawn; Linos, Elizabeth; Simard, Julia F.; Mangurian, Christina			Paid Family and Childbearing Leave Policies at Top US Medical Schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Riano, Nicholas S.; Accurso, Erin C.; Sung, Dawn; Mangurian, Christina] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94110 USA; [Linos, Eleni] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94110 USA; [Linos, Elizabeth] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Simard, Julia F.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Stanford University	Mangurian, C (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Psychiat, Weill Inst Neurosci, 1001 Potrero Ave,Ste 7M, San Francisco, CA 94110 USA.	christina.mangurian@ucsf.edu			NIH NIAMS [K01-AR066878]; National Institutes of Health [K76AG054631, R21CA212201, DP2OD024079];  [K23MH093689];  [R01MH112420];  [R03DK101857]; NATIONAL CANCER INSTITUTE [R21CA212201, DP2CA225433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K76AG054631] Funding Source: NIH RePORTER	NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was unfunded, although salary support was received from grants K23MH093689, R01MH112420, and R03DK101857 (Dr Mangurian); NIH NIAMS K01-AR066878 (Dr Simard); K76AG054631, R21CA212201, and DP2OD024079 (Dr Linos) from the National Institutes of Health.	Aitken Z, 2015, SOC SCI MED, V130, P32, DOI 10.1016/j.socscimed.2015.02.001; American Academy of Pediatrics, MAJ PED ASS CALL C A; Bohnet I., 2016, WHAT WORKS GENDER EQ; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; Nandi A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001985; Schuster MA, 2014, NEW ENGL J MED, V371, P493, DOI 10.1056/NEJMp1404860	6	52	52	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					611	614		10.1001/jama.2017.19519	http://dx.doi.org/10.1001/jama.2017.19519			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450516	Green Published, Bronze			2022-12-28	WOS:000424908400023
J	Persson, M; Razaz, N; Tedroff, K; Joseph, KS; Cnattingius, S				Persson, Martina; Razaz, Neda; Tedroff, Kristina; Joseph, K. S.; Cnattingius, Sven			Five and 10 minute Apgar scores and risks of cerebral palsy and epilepsy: population based cohort study in Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TERM; ASSOCIATION; DEATH; ENCEPHALOPATHY; EPIDEMIOLOGY; SURVEILLANCE; HYPOTHERMIA; PREGNANCY; NEWBORNS	OBJECTIVE To investigate associations between Apgar score at five and 10 minutes across the entire range of score values (from 0 to 10) and risks of childhood cerebral palsy or epilepsy, and to analyse the effect of changes in Apgar scores from five to 10 minutes after birth in infants born >= 37 completed weeks. DESIGN, SETTING, AND PARTICIPANTS Population based cohort study in Sweden, including 1 213 470 non-malformed live singleton infants, born at term between 1999 and 2012. Data on maternal and pregnancy characteristics and diagnoses of cerebral palsy and epilepsy were obtained by individual record linkages of nationwide Swedish registries. EXPOSURES Apgar scores at five and 10 minutes. MAIN OUTCOME MEASURE Cerebral palsy and epilepsy diagnosed up to 16 years of age. Adjusted hazard ratios were calculated, along with 95% confidence intervals. RESULTS 1221 (0.1%) children were diagnosed as having cerebral palsy and 3975 (0.3%) as having epilepsy. Compared with children with an Apgar score of 10 at five minutes, the adjusted hazard ratio for cerebral palsy increased steadily with decreasing Apgar score: from 1.9 (95% confidence interval 1.6 to 2.2) for an Apgar score of 9 to 277.7 (154.4 to 499.5) for an Apgar score of 0. Similar and even stronger associations were obtained between Apgar scores at 10 minutes and cerebral palsy. Associations between Apgar scores and epilepsy were less pronounced, but increased hazard ratios were noted in infants with a five minute Apgar score of 7 or less and a 10 minute Apgar score of 8 or less. Compared with infants with an Apgar of 9-10 at both five and 10 minutes, hazard ratios of cerebral palsy and epilepsy were higher among infants with a five minute Apgar score of 7-8 and a 10 minute Apgar score of 9-10. CONCLUSION Risks of cerebral palsy and epilepsy are inversely associated with five minute and 10 minute Apgar scores across the entire range of Apgar scores.	[Persson, Martina; Razaz, Neda; Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Tedroff, Kristina] Karolinska Inst, Dept Womens & Childrens Hlth, Neuropediat Unit, Stockholm, Sweden; [Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Joseph, K. S.] Childrens & Womens Hosp British Columbia, Vancouver, BC, Canada	Karolinska Institutet; Karolinska Institutet; University of British Columbia	Persson, M (corresponding author), Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden.	Martina.Persson@ki.se	Persson, Martina/B-7667-2015; Tedroff, Kristina/AAD-7620-2022	Persson, Martina/0000-0003-2268-3159; Tedroff, Kristina/0000-0002-0456-8029; Joseph, K.S./0000-0003-2317-5607	Swedish Research Council for Health, Working Life and Welfare [2014-0073]; Stockholm County Council [20150118]; Karolinska Institutet [2368/10-221]; Canadian Institutes of Health Research (CIHR); BC Children's Hospital Research Institute; CIHR [APR-126338]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Children's Hospital Research Institute; CIHR(Canadian Institutes of Health Research (CIHR))	This study was funded by the Swedish Research Council for Health, Working Life and Welfare (grant No 2014-0073), by the Stockholm County Council (ALF project 20150118 and a clinical postdoc position to MP), and by an unrestricted grant from Karolinska Institutet (No 2368/10-221, distinguished professor award to SC). NR is supported by a postdoctoral fellowship award from the Canadian Institutes of Health Research (CIHR). KSJ is supported by the BC Children's Hospital Research Institute and a chair award from the CIHR (APR-126338). Funders were not involved in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	APGAR V, 1953, Curr Res Anesth Analg, V32, P260; Berglund S, 2010, BJOG-INT J OBSTET GY, V117, P968, DOI 10.1111/j.1471-0528.2010.02565.x; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; CATLIN EA, 1986, J PEDIATR-US, V109, P865, DOI 10.1016/S0022-3476(86)80715-6; Dan B, 2014, CEREBRAL PALSY SCI C; Ellenberg JH, 2013, DEV MED CHILD NEUROL, V55, P210, DOI 10.1111/dmcn.12016; Eun S, 2016, SEIZURE-EUR J EPILEP, V37, P48, DOI 10.1016/j.seizure.2016.03.001; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Graham HK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.82; Guerrini R, 2006, LANCET, V367, P499, DOI 10.1016/S0140-6736(06)68182-8; Hegyi T, 1998, PEDIATRICS, V101, P77, DOI 10.1542/peds.101.1.77; Helmers SL, 2015, EPILEPSIA, V56, P942, DOI 10.1111/epi.13001; Hogan L, 2007, EUR J OBSTET GYN R B, V130, P169, DOI 10.1016/j.ejogrb.2006.03.002; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Lai S, 2017, EUR J OBSTET GYN R B, V210, P251, DOI 10.1016/j.ejogrb.2017.01.008; Laptook AR, 2017, JAMA-J AM MED ASSOC, V318, P1550, DOI 10.1001/jama.2017.14972; Lie KK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4990; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; NELSON KB, 1981, PEDIATRICS, V68, P36; Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Painter B., 1998, NEUROLOGY, P717; Persson M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001648; Razaz N, 2017, JAMA NEUROL, V74, P668, DOI 10.1001/jamaneurol.2016.6130; Rouse DJ, 2004, AM J OBSTET GYNECOL, V191, P211, DOI 10.1016/j.ajog.2004.03.003; Shankar R, 2017, EPILEPTIC DISORD, V19, P1, DOI 10.1684/epd.2017.0891; Statistics Sweden, 2006, EV SWED REG ED; Sun YL, 2006, EPIDEMIOLOGY, V17, P296, DOI 10.1097/01.ede.0000208478.47401.b6; Swedish National Board of Health and Welfare, 2009, QUAL CONT SWED PAT R; Swedish National Board of Health and Welfare, 2003, SWED MED BIRTH REF S; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Villamor E, 2017, JAMA-J AM MED ASSOC, V317, P925, DOI 10.1001/jama.2017.0945; Walsh S, 2017, NEUROTOXICOLOGY, V61, P64, DOI 10.1016/j.neuro.2016.03.011; Whitehead E, 2006, PEDIATRICS, V117, P1298, DOI 10.1542/peds.2005-1660; Wong L, 2011, AUST NZ J OBSTET GYN, V51, P17, DOI 10.1111/j.1479-828X.2010.01275.x; World Health Organization, GLOB DAT BOD MASS IN	41	49	54	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2018	360								k207	10.1136/bmj.k207	http://dx.doi.org/10.1136/bmj.k207			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0IA	29437691	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000424976200002
J	Davis, J				Davis, Jacky			PERSONAL VIEW Most UK doctors support assisted dying, a new poll shows: the BMA's opposition does not represent members	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Davis, Jacky] Whittington Hosp, London, England; [Davis, Jacky] BMA Council, London, England; [Davis, Jacky] Healthcare Profess Assisted Dying, London, England	University of London; University College London	Davis, J (corresponding author), Whittington Hosp, London, England.; Davis, J (corresponding author), BMA Council, London, England.; Davis, J (corresponding author), Healthcare Profess Assisted Dying, London, England.	drjcdavis@hotmail.com						[Anonymous], 2017, IS IT TIME LEGALISE; British Medical Association, 2017, PHYS ASS DYING BMA P; British Medical Association, 2014, ASS DYING BILL PARL; Campaign for Dignity in Dying, 2015, LARG EV POLL ASS DYI; Campaign for Dignity in Dying, 2015, PAT WOULD TRUST DOCT; Davis J., 2016, BMA SHOULD MOVE NEUT; Hartropp P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3274; Nicholl D, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3566; Oregon Hospice and Palliative Care Association, HOSP OR DEATH DIGN A; RCGP, 2014, ASS DYING CONS AN; Royal College of Physicians of London, RCP REAFF POS ASS DY	11	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2018	360								k301	10.1136/bmj.k301	http://dx.doi.org/10.1136/bmj.k301			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HY	29437652				2022-12-28	WOS:000424975900003
J	Calvert, M; Kyte, D; Mercieca-Bebber, R; Slade, A; Chan, AW; King, MT				Calvert, Melanie; Kyte, Derek; Mercieca-Bebber, Rebecca; Slade, Anita; Chan, An-Wen; King, Madeleine T.		Spirit-Pro Grp	Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols The SPIRIT-PRO Extension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TASK-FORCE; PERSPECTIVE	IMPORTANCE Patient-reported outcome (PRO) data from clinical trials can provide valuable evidence to inform shared decision making, labeling claims, clinical guidelines, and health policy; however, the PRO content of clinical trial protocols is often suboptimal. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement was published in 2013 and aims to improve the completeness of trial protocols by providing evidence-based recommendations for the minimum set of items to be addressed, but it does not provide PRO-specific guidance. OBJECTIVE To develop international, consensus-based, PRO-specific protocol guidance (the SPIRIT-PRO Extension). DESIGN, SETTING, AND PARTICIPANTS The SPIRIT-PRO Extension was developed following the Enhancing Quality and Transparency of Health Research (EQUATOR) Network's methodological framework for guideline development. This included (1) a systematic review of existing PRO-specific protocol guidance to generate a list of potential PRO-specific protocol items (published in 2014); (2) refinements to the list and removal of duplicate items by the International Society for Quality of Life Research (ISOQOL) Protocol Checklist Taskforce; (3) an international stakeholder survey of clinical trial research personnel, PRO methodologists, health economists, psychometricians, patient advocates, funders, industry representatives, journal editors, policy makers, ethicists, and researchers responsible for evidence synthesis (distributed by 38 international partner organizations in October 2016); (4) an international Delphi exercise (n = 137 invited; October 2016 to February 2017); and (5) consensus meeting (n = 30 invited; May 2017). Prior to voting, consensus meeting participants were informed of the results of the Delphi exercise and given data from structured reviews evaluating the PRO protocol content of 3 defined samples of trial protocols. RESULTS The systematic review identified 162 PRO-specific protocol recommendations from 54 sources. The ISOQOL Taskforce (n = 21) reduced this to 56 items, which were considered by 138 international stakeholder survey participants and 99 Delphi panelists. The final wording of the SPIRIT-PRO Extension was agreed on at a consensus meeting (n = 29 participants) and reviewed by external group of experts during a consultation period. Eleven extensions and 5 elaborations to the SPIRIT 2013 checklist were recommended for inclusion in clinical trial protocols in which PROs are a primary or key secondary outcome. Extension items focused on PRO-specific issues relating to the trial rationale, objectives, eligibility criteria, concepts used to evaluate the intervention, time points for assessment, PRO instrument selection and measurement properties, data collection plan, translation to other languages, proxy completion, strategies to minimize missing data, and whether PRO data will be monitored during the study to inform clinical care. CONCLUSIONS AND RELEVANCE The SPIRIT-PRO guidelines provide recommendations for items that should be addressed and included in clinical trial protocols in which PROs are a primary or key secondary outcome. Improved design of clinical trials including PROs could help ensure high-quality data that may inform patient-centered care.	[Calvert, Melanie; Kyte, Derek; Slade, Anita] Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcome Res, Birmingham B15 2TT, W Midlands, England; [Mercieca-Bebber, Rebecca; King, Madeleine T.] Univ Sydney, Fac Med, Sydney Med Sch, Sydney, NSW, Australia; [Mercieca-Bebber, Rebecca; King, Madeleine T.] Univ Sydney, Fac Sci, Sch Psychol, Sydney, NSW, Australia; [Chan, An-Wen] Univ Toronto, Dept Med, Womens Coll Res Inst, Toronto, ON, Canada	University of Birmingham; University of Sydney; University of Sydney; University of Toronto; University Toronto Affiliates; Womens College Hospital	Calvert, M (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcome Res, Birmingham B15 2TT, W Midlands, England.	m.calvert@bham.ac.uk	Slade, Anita/M-3246-2017; Calvert, Melanie/F-7055-2011; Groves, Trish/A-9119-2009	Slade, Anita/0000-0003-2827-7741; Calvert, Melanie/0000-0002-1856-837X; Coast, Joanna/0000-0002-3537-5166; Hunn, Amanda/0000-0003-2156-7279; Mercieca-Bebber, Rebecca/0000-0003-3708-9099; Groves, Trish/0000-0001-7915-6419; Haywood, Kirstie/0000-0002-5405-187X; brown, julia/0000-0002-2719-7064; Blazeby, Jane/0000-0002-3354-3330	Macmillan Cancer Support [5592105]; University of Birmingham; NIHR Birmingham Biomedical Research Centre; NIHR Surgical Reconstruction and Microbiology Research Centre; Australian government through Cancer Australia; MRC ConDuCT-II Hub for Trials Methodology Research; MRC [G0800800] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114, PDF-2016-09-009, SPCR-017] Funding Source: researchfish	Macmillan Cancer Support; University of Birmingham; NIHR Birmingham Biomedical Research Centre; NIHR Surgical Reconstruction and Microbiology Research Centre; Australian government through Cancer Australia(Australian Government); MRC ConDuCT-II Hub for Trials Methodology Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by Macmillan Cancer Support (grant 5592105) and the University of Birmingham and was sponsored by the University of Birmingham. Drs Calvert, Kyte, and Slade are funded by the NIHR Birmingham Biomedical Research Centre and the NIHR Surgical Reconstruction and Microbiology Research Centre. Dr King is supported by the Australian government through Cancer Australia. Dr Blazeby is partially supported by the MRC ConDuCT-II Hub for Trials Methodology Research.	Bernhard J, 1998, STAT MED, V17, P517, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<517::AID-SIM799>3.0.CO;2-S; Bottomley A, 2016, LANCET ONCOL, V17, pE510, DOI 10.1016/S1470-2045(16)30510-1; Calvert M, 2015, LANCET, V385, P1073, DOI 10.1016/S0140-6736(15)60599-2; Calvert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110216; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Centre for Patient Reported Outcome Research, 2017, INT CONS GUID INCL P; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x; Doward LC, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-89; European Medicines Agency, 2016, EMACHMP2924642014; Fairclough DL, 2010, DESIGN AND ANALYSIS OF QUALITY OF LIFE STUDIES IN CLINICAL TRIALS, SECOND EDITION, P1, DOI 10.1201/9781420061185; Fayers PM, 1997, EUR J CANCER, V33, P20, DOI 10.1016/S0959-8049(96)00412-1; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Haywood K, 2017, QUAL LIFE RES, V26, P1393, DOI 10.1007/s11136-016-1465-5; King MT, 2011, EXPERT REV PHARM OUT, V11, P171, DOI [10.1586/ERP.11.9, 10.1586/erp.11.9]; Kluetz Paul G, 2016, Am Soc Clin Oncol Educ Book, V35, P67, DOI 10.14694/EDBK_159514; Kyle D, 2016, PLOS ONE, V11; Kyte D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012281; Kyte D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110229; Kyte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076625; Kyte D, 2013, JAMA-J AM MED ASSOC, V310, P1229, DOI 10.1001/jama.2013.277222; Kyte DG, 2017, QUAL LIFE RES, V26, P55; Leidy N K, 1999, Value Health, V2, P113, DOI 10.1046/j.1524-4733.1999.02210.x; Mercieca-Bebber R, 2018, CONT CLIN TRIAL COMM, V9, P23, DOI 10.1016/j.conctc.2017.11.009; Mercieca-Bebber R, 2016, QUAL LIFE RES, V25, P2457, DOI 10.1007/s11136-016-1339-x; Mercieca-Bebber R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010938; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Prinsen CAC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1555-2; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Rothrock NE, 2011, CLIN PHARMACOL THER, V90, P737, DOI 10.1038/clpt.2011.195; Rutherford C, 2016, QUAL LIFE RES, V25, P559, DOI 10.1007/s11136-015-1110-8; Sloan JA, 2007, VALUE HEALTH, V10, pS106, DOI 10.1111/j.1524-4733.2007.00273.x; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; US Department of Health and Human Services . Food and Drug Administration, 2009, GUID IND PAT REP OUT; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132	38	332	341	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					483	494		10.1001/jama.2017.21903	http://dx.doi.org/10.1001/jama.2017.21903			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV0CW	29411037	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000424224500018
J	Watts, G				Watts, Geoff			Prospects for dementia research	LANCET			English	Editorial Material																			0	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					416	416		10.1016/S0140-6736(18)30190-9	http://dx.doi.org/10.1016/S0140-6736(18)30190-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407021				2022-12-28	WOS:000424333600013
J	Setvin, M; Reticcioli, M; Poelzleitner, F; Hulva, J; Schmid, M; Boatner, LA; Franchini, C; Diebold, U				Setvin, Martin; Reticcioli, Michele; Poelzleitner, Flora; Hulva, Jan; Schmid, Michael; Boatner, Lynn A.; Franchini, Cesare; Diebold, Ulrike			Polarity compensation mechanisms on the perovskite surface KTaO3(001)	SCIENCE			English	Article							STABILITY; OXIDES; SRTIO3	The stacking of alternating charged planes in ionic crystals creates a diverging electrostatic energy-a "polar catastrophe"-that must be compensated at the surface. We used scanning probe microscopies and density functional theory to study compensation mechanisms at the perovskite potassium tantalate (KTaO3) ( 001) surface as increasing degrees of freedom were enabled. The as-cleaved surface in vacuum is frozen in place but immediately responds with an insulator-to-metal transition and possibly ferroelectric lattice distortions. Annealing in vacuum allows the formation of isolated oxygen vacancies, followed by a complete rearrangement of the top layers into an ordered pattern of KO and TaO2 stripes. The optimal solution is found after exposure to water vapor through the formation of a hydroxylated overlayer with ideal geometry and charge.	[Setvin, Martin; Poelzleitner, Flora; Hulva, Jan; Schmid, Michael; Diebold, Ulrike] Tech Univ Wien, Inst Appl Phys, Vienna, Austria; [Reticcioli, Michele; Franchini, Cesare] Univ Vienna, Fac Phys, Vienna, Austria; [Reticcioli, Michele; Franchini, Cesare] Univ Vienna, Ctr Computat Mat Sci, Vienna, Austria; [Boatner, Lynn A.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA	Technische Universitat Wien; University of Vienna; University of Vienna; United States Department of Energy (DOE); Oak Ridge National Laboratory	Setvin, M (corresponding author), Tech Univ Wien, Inst Appl Phys, Vienna, Austria.	setvin@iap.tuwien.ac.at	Setvin, Martin/G-4879-2016; Reticcioli, Michele/V-1218-2018; Franchini, Cesare/B-2084-2009; Diebold, Ulrike/A-3681-2010; Boatner, Lynn/I-6428-2013	Setvin, Martin/0000-0002-1210-7740; Reticcioli, Michele/0000-0001-8223-9928; Franchini, Cesare/0000-0002-7990-2984; Diebold, Ulrike/0000-0003-0319-5256; Schmid, Michael/0000-0003-3373-9357; Boatner, Lynn/0000-0002-0235-7594	European Research Council (ERC) advanced grant "Oxide Surfaces" [ERC-2011-ADG-20110209]; Austrian Science Fund (FWF) Project Wittgenstein Prize [Z 250]; FOXSI; FWF-SFB project VICOM [F41]; U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division	European Research Council (ERC) advanced grant "Oxide Surfaces"; Austrian Science Fund (FWF) Project Wittgenstein Prize(Austrian Science Fund (FWF)); FOXSI; FWF-SFB project VICOM; U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	This work was supported by European Research Council (ERC) advanced grant "Oxide Surfaces" (ERC-2011-ADG-20110209), Austrian Science Fund (FWF) Project Wittgenstein Prize (Z 250), Project F45 (FOXSI), and the FWF-SFB project VICOM (grant no. F41). Research at the Oak Ridge National Laboratory for one author (L.A.B.) was supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division. All data are reported in the main text and supplement.	Bruix A, 2014, ANGEW CHEM INT EDIT, V53, P10525, DOI 10.1002/anie.201402342; Deacon-Smith DEE, 2014, ADV MATER, V26, P7252, DOI 10.1002/adma.201401858; Dulub O, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.016102; Grabowska E, 2016, APPL CATAL B-ENVIRON, V186, P97, DOI 10.1016/j.apcatb.2015.12.035; Grinberg I, 2013, NATURE, V503, P509, DOI 10.1038/nature12622; Gross L, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155455; Haeni JH, 2004, NATURE, V430, P758, DOI 10.1038/nature02773; Kato H, 2003, J AM CHEM SOC, V125, P3082, DOI 10.1021/ja027751g; King PDC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.117602; Meyer B, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045416; Noguera C, 2000, J PHYS-CONDENS MAT, V12, pR367, DOI 10.1088/0953-8984/12/31/201; Santander-Syro AF, 2011, NATURE, V469, P189, DOI 10.1038/nature09720; Setvin M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.086402; Singh DJ, 1996, PHYS REV B, V53, P176, DOI 10.1103/PhysRevB.53.176; Szot K, 2000, J PHYS-CONDENS MAT, V12, P4687, DOI 10.1088/0953-8984/12/22/302; TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Trelenberg TW, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/30/304009; Willmott PR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155502	19	58	58	18	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					572	+		10.1126/science.aar2287	http://dx.doi.org/10.1126/science.aar2287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420289				2022-12-28	WOS:000423795800041
J	Pepper, DJ; Jaswal, D; Sun, JF; Welsh, J; Natanson, C; Eichacker, PQ				Pepper, Dominique J.; Jaswal, Dharmvir; Sun, Junfeng; Welsh, Judith; Natanson, Charles; Eichacker, Peter Q.			Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1) A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							GOAL-DIRECTED RESUSCITATION; THERAPY; LACTATE; QUALITY; IMPLEMENTATION; MULTICENTER; SURVIVAL; CARE; HYPOTENSION; GUIDELINES	Background: The Severe Sepsis and Septic Shock Early Management Bundle (SEP-1), the sepsis performance measure introduced in 2015 by the Centers for Medicare & Medicaid Services (CMS), requires the reporting of up to 5 hemodynamic interventions, as many as 141 tasks, and 3 hours to document for a single patient. Purpose: To evaluate whether moderate-or high-level evidence shows that use of the 2015 SEP-1 or its hemodynamic interventions improves survival in adults with sepsis. Data Sources: PubMed, Embase, Scopus, Web of Science, and ClinicalTrials.gov from inception to 28 November 2017 with no language restrictions. Study Selection: Randomized and observational studies of death among adults with sepsis who received versus those who did not receive either the entire SEP-1 bundle or 1 or more SEP-1 hemodynamic interventions, including serial lactate measurements; a fluid infusion of 30 mL/kg of body weight; and assessment of volume status and tissue perfusion with a focused examination, bedside cardiovascular ultrasonography, or fluid responsiveness testing. Data Extraction: Two investigators independently extracted study data and assessed each study's risk of bias; 4 authors rated level of evidence by consensus using CMS criteria published in 2013. High-or moderate-level evidence required studies to have no confounders and low risk of bias. Data Synthesis: Of 56 563 references, 20 studies (18 reports) met inclusion criteria. One single-center observational study reported lower in-hospital mortality after implementation of the SEP-1 bundle. Sixteen studies (2 randomized and 14 observational) reported increased survival with serial lactate measurements or 30-mL/kg fluid infusions. None of the 17 studies were free of confounders or at low risk of bias. In 3 randomized trials, fluid responsiveness testing did not alter survival. Limitation: Few trials, poor-quality and confounded studies, and no studies (with survival outcomes) of the focused examination or bedside cardiovascular ultrasonography. Use of the 2015 version of SEP-1 and 2013 version of CMS evidence criteria, both of which were updated in 2017. Conclusion: No high-or moderate-level evidence shows that SEP-1 or its hemodynamic interventions improve survival in adults with sepsis. Annals.org	[Pepper, Dominique J.; Jaswal, Dharmvir; Sun, Junfeng; Welsh, Judith; Natanson, Charles; Eichacker, Peter Q.] NIH, 10 Ctr Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Eichacker, PQ (corresponding author), NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.; Eichacker, PQ (corresponding author), NIH, Dept Crit Care Med, Bldg 10,Room 2C145, Bethesda, MD 20892 USA.	peichacker@cc.nih.gov			National Institutes of Health [PROSPERO: CRD42016052716]; CLINICAL CENTER [ZIACL090050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	National Institutes of Health. (PROSPERO: CRD42016052716)	Aaronson EL, 2017, J EMERG MED, V52, P109, DOI 10.1016/j.jemermed.2016.08.009; [Anonymous], [No title captured]; [Anonymous], SPEC MAN NAT HOSP IN; Bakker J, 2015, CRIT CARE MED, V43, P705, DOI 10.1097/CCM.0000000000000870; Barochia AV, 2010, CRIT CARE MED, V38, P668, DOI 10.1097/CCM.0b013e3181cb0ddf; Centers for Medicare and Medicaid Services (CMS) HHS, 2016, Fed Regist, V81, P56761; Dettmer M, 2015, SHOCK, V43, P55, DOI 10.1097/SHK.0000000000000260; Faust JS, 2017, EMERG MED CLIN N AM, V35, P219, DOI 10.1016/j.emc.2016.09.006; Amez JMF, 2017, EMERGENCIAS, V29, P154; Grek A, 2017, AM J MED QUAL, V32, P500, DOI 10.1177/1062860616676887; Hayden GE, 2016, AM J EMERG MED, V34, P1, DOI 10.1016/j.ajem.2015.08.039; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hou PC, 2016, SHOCK, V46, P132, DOI 10.1097/SHK.0000000000000564; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Kalil AC, 2017, CRIT CARE MED, V45, P607, DOI 10.1097/CCM.0000000000002235; Klompas M, 2016, ANN INTERN MED, V165, P517, DOI 10.7326/M16-0588; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LaRosa JA, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/980369; Leisman DE, 2017, CRIT CARE MED, V45, P395, DOI 10.1097/CCM.0000000000002184; Liu VX, 2016, AM J RESP CRIT CARE, V193, P1264, DOI 10.1164/rccm.201507-1489OC; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; McColl T, 2017, CAN J EMERG MED, V19, P112, DOI 10.1017/cem.2016.351; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; National Health Foundation, 2016, MEAS SET SEPS VERS 5; National Institute for Health and Care Excellence, 2016, SEPS REC DIAGN EARL, pNG51; National Quality Forum, 2013, TECHNICAL REPORT; Nguyen HB, 2007, CRIT CARE MED, V35, P1105, DOI 10.1097/01.CCM.0000259463.33848.3D; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; PEPPER DJ, 2017, AM J RESP CRIT CARE, V195; Pepper DJ, 2018, ANN INTERN MED, V168, P610, DOI 10.7326/L18-0140; Ramsdell Taylor H, 2017, Hosp Pharm, V52, P177, DOI 10.1310/hpj5203-177; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rhodes A, 2015, INTENS CARE MED, V41, P1620, DOI 10.1007/s00134-015-3906-y; Rowan KM, 2017, NEW ENGL J MED, V376, P2223, DOI 10.1056/NEJMoa1701380; Sen Kuan W, 2016, ANN EMERG MED, V67, P367, DOI 10.1016/j.annemergmed.2015.09.010; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Siontis B, 2015, PEERJ, V3, DOI 10.7717/peerj.1290; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Teles F, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0231-2; Townsend SR, 2018, ANN INTERN MED, V168, P609, DOI 10.7326/L18-0139; Venkatesh AK, 2018, ANN EMERG MED, V71, P10, DOI 10.1016/j.annemergmed.2017.06.032; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Xiaochun L, 2015, NATL MED J CHINA, V95, P496; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	44	50	51	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					558	+		10.7326/M17-2947	http://dx.doi.org/10.7326/M17-2947			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29459977				2022-12-28	WOS:000430083100016
J	Casassus, B				Casassus, Barbara			PHARMACOVIGILANCE Risks of reformulation: French patients complain after Merck modifies levothyroxine pills	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												barbara.casassus@gmail.com						[Anonymous], 2018, LE PARISIEN     0129; ANSM, POINT ACT LEV AUTR M; Association Francaise des Malades de la Thyroid, 2017, COMMUNICATION; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; Levothyrox, 2017, MONDE; Robache S., 2017, NOUVEAU LEVOTHYROX D	6	15	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2018	360								k714	10.1136/bmj.k714	http://dx.doi.org/10.1136/bmj.k714			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8LG	29453193	Green Published			2022-12-28	WOS:000425583900008
J	Zhao, P; Wong, KI; Sun, XL; Reilly, SM; Uhm, M; Liao, ZJ; Skorobogatko, Y; Saltiel, AR				Zhao, Peng; Wong, Kai In; Sun, Xiaoli; Reilly, Shannon M.; Uhm, Maeran; Liao, Zhongji; Skorobogatko, Yuliya; Saltiel, Alan R.			TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue	CELL			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; DIET-INDUCED THERMOGENESIS; CALORIE RESTRICTION; BODY-WEIGHT; MITOCHONDRIAL BIOGENESIS; METABOLIC DISEASE; SIGNALING PATHWAY	The noncanonical IKK family member TANK-binding kinase 1 (TBK1) is activated by pro-inflammatory cytokines, but its role in controlling metabolism remains unclear. Here, we report that the kinase uniquely controls energy metabolism. Tbk1 expression is increased in adipocytes of HFD-fed mice. Adipocyte-specific TBK1 knockout (ATKO) attenuates HFD-induced obesity by increasing energy expenditure; further studies show that TBK1 directly inhibits AMPK to repress respiration and increase energy storage. Conversely, activation of AMPK under catabolic conditions can increase TBK1 activity through phosphorylation, mediated by AMPK's downstream target ULK1. Surprisingly, ATKO also exaggerates adipose tissue inflammation and insulin resistance. TBK1 suppresses inflammation by phosphorylating and inducing the degradation of the IKK kinase NIK, thus attenuating NF-kappa B activity. Moreover, TBK1 mediates the negative impact of AMPK activity on NF-kappa B activation. These data implicate a unique role for TBK1 in mediating bidirectional crosstalk between energy sensing and inflammatory signaling pathways in both over-and undernutrition.	[Zhao, Peng; Wong, Kai In; Sun, Xiaoli; Reilly, Shannon M.; Liao, Zhongji; Skorobogatko, Yuliya; Saltiel, Alan R.] Univ Calif San Diego, Dept Med, Div Metab & Endocrinol, La Jolla, CA 92093 USA; [Zhao, Peng; Reilly, Shannon M.; Uhm, Maeran; Skorobogatko, Yuliya; Saltiel, Alan R.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Calif San Diego, Dept Med, Div Metab & Endocrinol, La Jolla, CA 92093 USA.; Saltiel, AR (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.	asaltiel@ucsd.edu	Reilly, Shannon Marie/ABB-6473-2021; Zhao, Peng/G-3562-2019; Sun, Xiaoli/G-3554-2019; Saltiel, Alan/L-3632-2019	Reilly, Shannon Marie/0000-0003-0412-2446; 	NIH [P30DK06349, R01DK100319, R01DK60597, R01DK60591]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100319, P30DK063491, R01DK060597, K01DK105075, R01DK060591] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021724] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Saltiel lab for helpful discussions. We thank Kate Fitzgerald for sharing TBK1 floxed mice. We thank Ken Inoki for sharing AMPK alpha 1 and alpha 2 floxed mice and AMPK alpha-, beta-, and gamma-expressing plasmids. We thank Michael Karin and Jerry Wong for providing the NIK CRISPR/Cas9 KO plasmid. We thank Majid Ghassemian and the Biomolecular and Proteomics Mass Spectrometry Facility for the mass spectrometry study. We thank Marilyn Hardee and the Animal Phenotyping Core for support of CLAMs indirect calorimetry and DEXA studies. We thank the UCSD histology core for tissue sectioning and staining. This work was supported by grants from the NIH (P30DK06349, R01DK100319, R01DK60597, and R01DK60591) (to A.R.S.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Choi MS, 2015, BRIT J NUTR, V113, P867, DOI 10.1017/S0007114515000100; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang BP, 2015, DNA CELL BIOL, V34, P133, DOI 10.1089/dna.2014.2630; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jin J, 2012, NAT IMMUNOL, V13, P1101, DOI 10.1038/ni.2423; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kazak L, 2017, CELL METAB, V26, P660, DOI 10.1016/j.cmet.2017.08.009; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lohman AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8965; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Oral EA, 2017, CELL METAB, V26, P157, DOI 10.1016/j.cmet.2017.06.006; Pazos P, 2015, SCI REP-UK, V5, DOI 10.1038/srep17977; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rasmussen LG, 2007, AM J CLIN NUTR, V85, P1014, DOI 10.1093/ajcn/85.4.1014; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Roberts SB, 1998, INT J OBESITY, V22, P385, DOI 10.1038/sj.ijo.0800640; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Schnurr M, 2000, J IMMUNOL, V165, P4704, DOI 10.4049/jimmunol.165.8.4704; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XJ, 2012, J LIPID RES, V53, P792, DOI 10.1194/jlr.P022905; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zhao P, 2013, MOL METAB, V2, P161, DOI 10.1016/j.molmet.2013.04.003	68	141	144	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					731	+		10.1016/j.cell.2018.01.007	http://dx.doi.org/10.1016/j.cell.2018.01.007			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425491	Green Accepted, Bronze			2022-12-28	WOS:000424648800014
J	Moore, W				Moore, Wendy			The medical suffragettes	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					422	423		10.1016/S0140-6736(18)30111-9	http://dx.doi.org/10.1016/S0140-6736(18)30111-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407026				2022-12-28	WOS:000424333600018
J	Silvi, M; Melchiorre, P				Silvi, Mattia; Melchiorre, Paolo			Enhancing the potential of enantioselective organocatalysis with light	NATURE			English	Review							2+2 PHOTOCYCLOADDITION REACTIONS; PHASE-TRANSFER CATALYSIS; CHIRAL BRONSTED ACID; PHOTOREDOX CATALYSIS; ELECTRON-TRANSFER; ALPHA-ALKYLATION; VISIBLE-LIGHT; PHOTOCHEMICAL ACTIVITY; ASYMMETRIC CATALYSIS; THIOUREA DERIVATIVES	Organocatalysis-catalysis mediated by small chiral organic molecules-is a powerful technology for enantioselective synthesis, and has extensive applications in traditional ionic, two-electron-pair reactivity domains. Recently, organocatalysis has been successfully combined with photochemical reactivity to unlock previously inaccessible reaction pathways, thereby creating new synthetic opportunities. Here we describe the historical context, scientific reasoning and landmark discoveries that were essential in expanding the functions of organocatalysis to include one-electronmediated chemistry and excited-state reactivity.	[Silvi, Mattia] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Melchiorre, Paolo] Barcelona Inst Sci & Technol, Inst Chem Res Catalonia, ICIQ, Ave Paisos Catalans 16, Tarragona 43007, Spain; [Melchiorre, Paolo] Catalan Inst Res & Adv Studies, ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain	University of Bristol; Barcelona Institute of Science & Technology; Universitat Rovira i Virgili; Institute of Chemical Research of Catalonia; ICREA	Melchiorre, P (corresponding author), Barcelona Inst Sci & Technol, Inst Chem Res Catalonia, ICIQ, Ave Paisos Catalans 16, Tarragona 43007, Spain.; Melchiorre, P (corresponding author), Catalan Inst Res & Adv Studies, ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain.	pmelchiorre@iciq.es	Melchiorre, Paolo/K-9301-2014	Melchiorre, Paolo/0000-0001-8722-4602; Silvi, Mattia/0000-0002-0728-7193	Generalitat de Catalunya (CERCA Program); Agencia Estatal de Investigacion (AEI) [CTQ2016-75520-P]; European Research Council (ERC) [681840-CATA-LUX]; EU [744242]	Generalitat de Catalunya (CERCA Program); Agencia Estatal de Investigacion (AEI); European Research Council (ERC)(European Research Council (ERC)European Commission); EU(European Commission)	P.M. thanks the Generalitat de Catalunya (CERCA Program), Agencia Estatal de Investigacion (AEI) (CTQ2016-75520-P), and the European Research Council (ERC 681840-CATA-LUX) for financial support. M.S. thanks the EU for a Horizon 2020 Marie Sklodowska-Curie Fellowship (grant 744242).	Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Albini A., 2010, HDB SYNTHETIC PHOTOC; Alonso R, 2014, ANGEW CHEM INT EDIT, V53, P4368, DOI 10.1002/anie.201310997; Arceo E, 2014, CHEM SCI, V5, P2438, DOI 10.1039/c4sc00315b; Arceo E, 2013, NAT CHEM, V5, P750, DOI [10.1038/NCHEM.1727, 10.1038/nchem.1727]; Bach T, 2002, J AM CHEM SOC, V124, P7982, DOI 10.1021/ja0122288; Bahamonde A, 2017, J AM CHEM SOC, V139, P4559, DOI 10.1021/jacs.7b01446; Bahamonde A, 2016, J AM CHEM SOC, V138, P8019, DOI 10.1021/jacs.6b04871; Balzani V., 2014, PHOTOCHEMISTRY PHOTO; Bauer A, 2005, NATURE, V436, P1139, DOI 10.1038/nature03955; Beeson TD, 2007, SCIENCE, V316, P582, DOI 10.1126/science. 1142696; Bergonzini G, 2014, CHEM SCI, V5, P112, DOI [10.1039/C3SC52265B, 10.1039/c3sc52265b]; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Brimioulle R, 2013, SCIENCE, V342, P840, DOI 10.1126/science.1244809; Brimioulle R, 2015, ANGEW CHEM INT EDIT, V54, P3872, DOI 10.1002/anie.201411409; Cambie D, 2016, CHEM REV, V116, P10276, DOI 10.1021/acs.chemrev.5b00707; Capacci AG, 2017, NAT CHEM, V9, P1073, DOI 10.1038/nchem.2797; Cecere G, 2013, J AM CHEM SOC, V135, P11521, DOI 10.1021/ja406181e; Chatgilialoglu, 2014, ENCY RADICALS CHEM B; Cismesia MA, 2015, CHEM SCI, V6, P5426, DOI 10.1039/c5sc02185e; Curran D. P., 1996, STEREOCHEMISTRY RADI; Dai X, 2008, J AM CHEM SOC, V130, P3302, DOI 10.1021/ja8009428; Dalko PI, 2013, COMPREHENSIVE ENANTIOSELECTIVE ORGANOCATALYSIS: CATALYSTS, REACTIONS, AND APPLICATIONS, VOLS 1-3, P1, DOI 10.1002/9783527658862; DiRocco DA, 2012, J AM CHEM SOC, V134, P8094, DOI 10.1021/ja3030164; DOLLING UH, 1984, J AM CHEM SOC, V106, P446, DOI 10.1021/ja00314a045; Doyle AG, 2005, J AM CHEM SOC, V127, P62, DOI 10.1021/ja043601p; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; Emmanuel MA, 2016, NATURE, V540, P414, DOI 10.1038/nature20569; Enders D, 2002, ANGEW CHEM INT EDIT, V41, P1743, DOI 10.1002/1521-3773(20020517)41:10<1743::AID-ANIE1743>3.0.CO;2-Q; Enders D, 2007, CHEM REV, V107, P5606, DOI 10.1021/cr068372z; Evans DA., 1984, ASYMMETRIC SYNTHESIS, V3, P1; Filippini G, 2017, ANGEW CHEM INT EDIT, V56, P4447, DOI 10.1002/anie.201612045; Fischer H, 2001, ANGEW CHEM INT EDIT, V40, P1340, DOI 10.1002/1521-3773(20010417)40:8<1340::AID-ANIE1340>3.0.CO;2-#; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; FUKUZUMI S, 1983, J AM CHEM SOC, V105, P4722, DOI 10.1021/ja00352a034; Giese B., 1986, RADICALS ORGANIC SYN; Grondal C, 2010, NAT CHEM, V2, P167, DOI [10.1038/NCHEM.539, 10.1038/nchem.539]; Gualandi A, 2015, ACS CATAL, V5, P5927, DOI 10.1021/acscatal.5b01573; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; HIEMSTRA H, 1981, J AM CHEM SOC, V103, P417, DOI 10.1021/ja00392a029; Huisman GW, 2010, CURR OPIN CHEM BIOL, V14, P122, DOI 10.1016/j.cbpa.2009.12.003; Huo HH, 2014, NATURE, V515, P100, DOI 10.1038/nature13892; IrelAND, 1969, ORGANIC SYNTHESIS; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; JAKOBSEN HJ, 1966, J CHEM SOC B, P940, DOI 10.1039/j29660000940; Jones SB, 2011, NATURE, V475, P183, DOI 10.1038/nature10232; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; Koike T, 2009, CHEM LETT, V38, P166, DOI 10.1246/cl.2009.166; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; Lian MM, 2012, CHEM-ASIAN J, V7, P2019, DOI 10.1002/asia.201200358; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; List B, 2014, ANGEW CHEM INT EDIT, V53, P282, DOI 10.1002/anie.201306037; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Madarasz A, 2016, ACS CATAL, V6, P4379, DOI 10.1021/acscatal.6b00618; MARIANO PS, 1983, ACCOUNTS CHEM RES, V16, P130, DOI 10.1021/ar00088a003; Mayer JM, 2011, ACCOUNTS CHEM RES, V44, P36, DOI 10.1021/ar100093z; Melchiorre P, 2009, ANGEW CHEM INT EDIT, V48, P1360, DOI 10.1002/anie.200804995; Miller DC, 2016, TOPICS CURR CHEM, V374, DOI 10.1007/s41061-016-0030-6; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; MULLIKEN RS, 1952, J AM CHEM SOC, V74, P811, DOI 10.1021/ja01123a067; Murphy JJ, 2016, NATURE, V532, P218, DOI 10.1038/nature17438; Nagib DA, 2009, J AM CHEM SOC, V131, P10875, DOI 10.1021/ja9053338; Narayanam JMR, 2009, J AM CHEM SOC, V131, P8756, DOI 10.1021/ja9033582; Neumann M, 2011, ANGEW CHEM INT EDIT, V50, P951, DOI 10.1002/anie.201002992; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Ojima I., 2010, CATALYTIC ASYMMETRIC; Parmar D, 2014, CHEM REV, V114, P9047, DOI 10.1021/cr5001496; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Rathore R, 2000, ADV PHYS ORG CHEM, V35, P193, DOI 10.1016/S0065-3160(00)35014-6; Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m; Rono LJ, 2013, J AM CHEM SOC, V135, P17735, DOI 10.1021/ja4100595; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Shaw MH, 2016, J ORG CHEM, V81, P6898, DOI 10.1021/acs.joc.6b01449; SHEEHAN JC, 1974, J ORG CHEM, V39, P1196, DOI 10.1021/jo00923a006; Shih HW, 2010, J AM CHEM SOC, V132, P13600, DOI 10.1021/ja106593m; Shirakawa S, 2013, ANGEW CHEM INT EDIT, V52, P4312, DOI 10.1002/anie.201206835; Sibi MP, 2003, CHEM REV, V103, P3263, DOI 10.1021/cr020044l; Sigman MS, 1998, J AM CHEM SOC, V120, P4901, DOI 10.1021/ja980139y; Silvi M, 2017, NAT CHEM, V9, P868, DOI [10.1038/nchem.2748, 10.1038/NCHEM.2748]; Silvi M, 2015, J AM CHEM SOC, V137, P6120, DOI 10.1021/jacs.5b01662; STORK G, 1963, J AM CHEM SOC, V85, P207, DOI 10.1021/ja00885a021; Studer A, 2001, CHEM-EUR J, V7, P1159, DOI 10.1002/1521-3765(20010316)7:6<1159::AID-CHEM1159>3.0.CO;2-I; Studer A, 2016, ANGEW CHEM INT EDIT, V55, P58, DOI 10.1002/anie.201505090; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Turro N. J., 2010, MODERN MOL PHOTOCHEM; Twilton J, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0052; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533; Uraguchi D, 2015, J AM CHEM SOC, V137, P13768, DOI 10.1021/jacs.5b09329; Vallavoju N, 2014, ANGEW CHEM INT EDIT, V53, P5604, DOI 10.1002/anie.201310940; VANBERGEN TJ, 1979, J ORG CHEM, V44, P4953, DOI 10.1021/jo00394a044; Welin ER, 2015, ANGEW CHEM INT EDIT, V54, P9668, DOI 10.1002/anie.201503789; Wozniak L, 2015, J AM CHEM SOC, V137, P5678, DOI 10.1021/jacs.5b03243; Yoon TP, 2016, ACCOUNTS CHEM RES, V49, P2307, DOI 10.1021/acs.accounts.6b00280; Zhu YB, 2014, J AM CHEM SOC, V136, P14642, DOI 10.1021/ja508605a	99	322	321	36	514	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					40	48		10.1038/nature25175	http://dx.doi.org/10.1038/nature25175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29388950	Green Accepted, Green Submitted			2022-12-28	WOS:000424048900028
J	Horton, R				Horton, Richard			Offline: Why we must learn to love economists	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2018	391	10118					296	296		10.1016/S0140-6736(18)30139-9	http://dx.doi.org/10.1016/S0140-6736(18)30139-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU5CE	29413033				2022-12-28	WOS:000423869500013
J	Kahn, R				Kahn, Richard			A Cautionary Tale of Warning Messages on Food Products: The Case of Sugar-Sweetened Beverages	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kahn, Richard] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kahn, R (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA.	rak6200@gmail.com						Kahn R, 2014, DIABETES CARE, V37, P957, DOI 10.2337/dc13-2506; Sievenpiper JL, 2016, NO CAN J DIABETES, V40, P287, DOI [10.1016/j.jcjd.2016.05.006, DOI 10.1016/J.JCJD.2016.05.006]	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2018	168	9					668	+		10.7326/M17-2659	http://dx.doi.org/10.7326/M17-2659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GI3BZ	29435584				2022-12-28	WOS:000434247300010
J	Smith, MR; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, BA; Graff, JN; Olmos, D; Mainwaring, PN; Lee, JY; Uemura, H; Lopez-Gitlitz, A; Trudel, GC; Espina, BM; Shu, Y; Park, YC; Rackoff, WR; Yu, MK; Small, EJ				Smith, Matthew R.; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris A.; Graff, Julie N.; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Lopez-Gitlitz, Angela; Trudel, Geralyn C.; Espina, Byron M.; Shu, Youyi; Park, Youn C.; Rackoff, Wayne R.; Yu, Margaret K.; Small, Eric J.		SPARTAN Investigators	Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE METASTASES; ANTIGEN; THERAPY; LIGANDS; ARN-509; MEN	BACKGROUND Apalutamide, a competitive inhibitor of the androgen receptor, is under development for the treatment of prostate cancer. We evaluated the efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer who were at high risk for the development of metastasis. METHODS We conducted a double-blind, placebo-controlled, phase 3 trial involving men with nonmetastatic castration-resistant prostate cancer and a prostate-specific antigen doubling time of 10 months or less. Patients were randomly assigned, in a 2:1 ratio, to receive apalutamide (240 mg per day) or placebo. All the patients continued to receive androgen-deprivation therapy. The primary end point was metastasis-free survival, which was defined as the time from randomization to the first detection of distant metastasis on imaging or death. RESULTS A total of 1207 men underwent randomization (806 to the apalutamide group and 401 to the placebo group). In the planned primary analysis, which was performed after 378 events had occurred, median metastasis-free survival was 40.5 months in the apalutamide group as compared with 16.2 months in the placebo group (hazard ratio for metastasis or death, 0.28; 95% confidence interval [CI], 0.23 to 0.35; P<0.001). Time to symptomatic progression was significantly longer with apalutamide than with placebo (hazard ratio, 0.45; 95% CI, 0.32 to 0.63; P<0.001). The rate of adverse events leading to discontinuation of the trial regimen was 10.6% in the apalutamide group and 7.0% in the placebo group. The following adverse events occurred at a higher rate with apalutamide than with placebo: rash (23.8% vs. 5.5%), hypothyroidism (8.1% vs. 2.0%), and fracture (11.7% vs. 6.5%). CONCLUSIONS Among men with nonmetastatic castration-resistant prostate cancer, metastasis-free survival and time to symptomatic progression were significantly longer with apalutamide than with placebo.	[Smith, Matthew R.] Massachusetts Gen Hosp, Ctr Canc, Yawkey 7030,55 Fruit St, Boston, MA 02114 USA; [Smith, Matthew R.] Harvard Med Sch, Boston, MA USA; [Saad, Fred] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Chowdhury, Simon] Guys Hosp, London, England; [Chowdhury, Simon] Kings Hosp, London, England; [Chowdhury, Simon] St Thomas Hosp, London, England; [Oudard, Stephane] Georges Pompidou Hosp, Paris, France; [Hadaschik, Boris A.] Univ Duisburg Essen, Essen, Germany; [Hadaschik, Boris A.] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany; [Graff, Julie N.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [Graff, Julie N.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Olmos, David] Spanish Natl Canc Res Ctr, Madrid, Spain; [Olmos, David] Hosp Univ Virgen de la Victoria & Reg, Inst Biomed Res Malaga, Malaga, Spain; [Mainwaring, Paul N.] Univ Queensland, Ctr Personalised Nanomed, Brisbane, Qld, Australia; [Lee, Ji Youl] Catholic Univ, St Marys Hosp, Seoul, South Korea; [Uemura, Hiroji] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan; [Lopez-Gitlitz, Angela; Trudel, Geralyn C.; Espina, Byron M.; Shu, Youyi; Park, Youn C.; Rackoff, Wayne R.; Yu, Margaret K.] Janssen Res & Dev, Los Angeles, CA USA; [Small, Eric J.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Universite de Montreal; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Queensland; Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Yokohama City University; Johnson & Johnson; Janssen Pharmaceuticals; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Smith, MR (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Yawkey 7030,55 Fruit St, Boston, MA 02114 USA.	smith.matthew@mgh.harvard.edu	Izmailov, Adel/AAF-6394-2019; Gravis, Gwenaelle/CAG-3019-2022; Olmos, David/L-5664-2015; Mulders, Peter F.A./H-8076-2014; Shu, Youyi/AAJ-4450-2020; Sanchez Sanchez, Ernesto/N-5071-2018; Perez-Gracia, Jose Luis/I-8372-2017; VILLERS, Arnauld/K-6629-2016	Izmailov, Adel/0000-0002-8461-9243; Gravis, Gwenaelle/0000-0002-3127-1554; Drewa, Tomasz/0000-0002-5529-4320; MAROTO REY, PABLO/0000-0002-0030-0412; OUDARD, Stephane/0000-0003-0893-285X; Angulo, Javier/0000-0002-1735-8792; Olmos Hidalgo, David/0000-0002-7003-4826; Sanchez Sanchez, Ernesto/0000-0003-3162-4409; Horvath, Lisa/0000-0001-6842-9223; Ribal, Maria J./0000-0001-8142-5382; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Lacombe, Louis/0000-0003-4811-0308; Kjellman, Anders/0000-0002-9080-9027; Bompas, Emmanuelle/0000-0003-4414-7760; VILLERS, Arnauld/0000-0002-6298-7758; joly, florence/0000-0001-6168-4942; Slojewski, Marcin/0000-0003-3679-7325; Ferrer Albiach, Carlos/0000-0001-9122-7646; MAHAMMEDI, Hakim/0000-0002-7596-2357; Ellard, Susan/0000-0001-5757-9787; Hadaschik, Boris/0000-0002-1052-2692	Janssen Research and Development; Astellas; Bayer; Janssen; Sanofi; Johnson Johnson; Clovis Oncology; Bristol-Myers Squibb; Profound Medical; Merck; Dendreon; Genentech; AstraZeneca; Ipsen; Novartis; Pfizer; Roche; Xing Technologies; Takeda	Janssen Research and Development; Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sanofi; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Clovis Oncology; Bristol-Myers Squibb(Bristol-Myers Squibb); Profound Medical; Merck(Merck & Company); Dendreon; Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); Ipsen(Ipsen); Novartis(Novartis); Pfizer(Pfizer); Roche(Roche Holding); Xing Technologies; Takeda(Takeda Pharmaceutical Company Ltd)	Supported by Janssen Research and Development. (Aragon Pharmaceuticals is a wholly owned subsidiary of Johnson & Johnson. Janssen Research and Development is part of the Janssen Pharmaceutical Companies of Johnson & Johnson and provides various services to its affiliated company, Aragon Pharmaceuticals.); Dr. Smith reports consulting fees from Astellas and Bayer; Dr. Saad, receiving grant support, honoraria, consulting fees, lecture fees, and writing assistance from Janssen, Astellas, Sanofi, and Bayer; Dr. Chowdhury, receiving honoraria, consulting fees, fees for serving on a speakers' bureau, and travel support from Johnson & Johnson and Astellas, honoraria, consulting fees, and fees for serving on a speakers' bureau from Sanofi, and grant support, honoraria, consulting fees, and fees for serving on a speakers' bureau from Clovis Oncology; Dr. Oudard, receiving honoraria and lecture fees from Sanofi, Astellas, and Bayer; Dr. Hadaschik, receiving grant support, consulting fees, and travel support from Janssen and Astellas, grant support and consulting fees from Bristol-Myers Squibb, consulting fees and travel support from Bayer, and grant support from Profound Medical; Dr. Graff, receiving grant support and consulting fees from Janssen and Astellas, consulting fees and lecture fees from Bayer, grant support and consulting fees from Sanofi, grant support from Merck and Bristol-Myers Squibb, and consulting fees from Dendreon; Dr. Olmos, receiving grant support and consulting fees from Janssen, Astellas, Bayer, Sanofi, and Genentech and grant support from AstraZeneca; Dr. Mainwaring, receiving honoraria, consulting fees, fees for serving on a speakers' bureau, and travel support from Ipsen, Janssen, Novartis, Pfizer, and Roche, grant support, honoraria, consulting fees, fees for serving on a speakers' bureau, and travel support from Merck, and fees for leadership and travel support from Xing Technologies, owning stock in Xing Technologies, and holding a pending patent (WO2014093357) on cell-free biofragment compositions and related systems, devices, and methods, a pending patent (WO2014127409) on a device and method for the detection of target entities, and a pending patent (WO2015095929) on a nucleic-acid detection method and kit; Dr. Uemura, receiving honoraria and travel support from Janssen, Sanofi, and Bayer, honoraria from Astellas, honoraria, consulting fees, and travel support from Takeda, and consulting fees from AstraZeneca; Dr. Lopez-Gitlitz, Dr. Trudel, Mr. Espina, Mr. Shu, Dr. Park, and Dr. Yu, being employed by Janssen Research and Development and owning stock in Johnson & Johnson; and Dr. Rackoff, being employed by and owning stock in Johnson & Johnson. No other potential conflict of interest relevant to this article was reported.	Beheshti M, 2016, J NUCL MED, V57, p55S, DOI 10.2967/jnumed.115.169730; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452; Eiber M, 2017, J NUCL MED, V58, p67S, DOI 10.2967/jnumed.116.186767; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gartrell BA, 2014, NAT REV CLIN ONCOL, V11, P335, DOI 10.1038/nrclinonc.2014.70; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139440; Schwarzenboeck SM, 2017, J NUCL MED, V58, P1545, DOI 10.2967/jnumed.117.191031; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; Smith MR, 2016, EUR UROL, V70, P963, DOI 10.1016/j.eururo.2016.04.023; Smith MR, 2013, J CLIN ONCOL, V31, P3800, DOI 10.1200/JCO.2012.44.6716; Smith MR, 2005, J CLIN ONCOL, V23, P2918, DOI 10.1200/JCO.2005.01.529	13	707	728	5	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2018	378	15					1408	1418		10.1056/NEJMoa1715546	http://dx.doi.org/10.1056/NEJMoa1715546			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC3YA	29420164	Green Published, Bronze			2022-12-28	WOS:000429718500007
J	Mi, X; Benito, M; Putz, S; Zajac, DM; Taylor, JM; Burkard, G; Petta, JR				Mi, X.; Benito, M.; Putz, S.; Zajac, D. M.; Taylor, J. M.; Burkard, Guido; Petta, J. R.			A coherent spin-photon interface in silicon	NATURE			English	Article							CIRCUIT QUANTUM ELECTRODYNAMICS; SINGLE-ELECTRON; CAVITY; QUBIT; DOTS; STORAGE	Electron spins in silicon quantum dots are attractive systems for quantum computing owing to their long coherence times and the promise of rapid scaling of the number of dots in a system using semiconductor fabrication techniques. Although nearest-neighbour exchange coupling of two spins has been demonstrated, the interaction of spins via microwave-frequency photons could enable long-distance spin-spin coupling and connections between arbitrary pairs of qubits ('all-to-all' connectivity) in a spin-based quantum processor. Realizing coherent spin-photon coupling is challenging because of the small magnetic-dipole moment of a single spin, which limits magnetic-dipole coupling rates to less than 1 kilohertz. Here we demonstrate strong coupling between a single spin in silicon and a single microwave-frequency photon, with spin-photon coupling rates of more than 10 megahertz. The mechanism that enables the coherent spin-photon interactions is based on spin-charge hybridization in the presence of a magnetic-field gradient. In addition to spin-photon coupling, we demonstrate coherent control and dispersive readout of a single spin. These results open up a direct path to entangling single spins using microwave-frequency photons.	[Mi, X.; Putz, S.; Zajac, D. M.; Petta, J. R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Benito, M.; Burkard, Guido] Univ Konstanz, Dept Phys, D-78464 Constance, Germany; [Taylor, J. M.] NIST, Joint Quantum Inst, College Pk, MD 20742 USA	Princeton University; University of Konstanz; National Institute of Standards & Technology (NIST) - USA	Petta, JR (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	petta@princeton.edu	Taylor, Jacob/O-1670-2019; Burkard, Guido/A-6949-2008; Putz, Stefan/N-6847-2013	Taylor, Jacob/0000-0003-0493-5594; Burkard, Guido/0000-0001-9053-2200; Putz, Stefan/0000-0003-4169-2552				Amsuss R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.060502; Baart TA, 2016, NAT NANOTECHNOL, V11, P330, DOI [10.1038/NNANO.2015.291, 10.1038/nnano.2015.291]; Baart TA, 2017, NAT NANOTECHNOL, V12, P26, DOI [10.1038/NNANO.2016.188, 10.1038/nnano.2016.188]; Beaudoin F, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/46/464003; Benito M, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.235434; Bertrand B, 2016, NAT NANOTECHNOL, V11, P672, DOI [10.1038/nnano.2016.82, 10.1038/NNANO.2016.82]; Bienfait A, 2016, NATURE, V531, P74, DOI 10.1038/nature16944; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bruhat L.E, 2016, STRONG COUPLING ELEC; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; Burkard G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041307; Childress L, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042302; Cottet A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.160502; Debnath S, 2016, NATURE, V536, P63, DOI 10.1038/nature18648; Dehollain JP, 2016, NAT NANOTECHNOL, V11, P242, DOI [10.1038/nnano.2015.262, 10.1038/NNANO.2015.262]; Eichler C, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.037701; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Flentje H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00534-3; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Frey T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046807; Hu XD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035314; Imamoglu A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.083602; Jin PQ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.190506; Kawakami E, 2014, NAT NANOTECHNOL, V9, P666, DOI [10.1038/nnano.2014.153, 10.1038/NNANO.2014.153]; Landig A.J, 2017, COHERENT SPIN QUBIT; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; McNeil RPG, 2011, NATURE, V477, P439, DOI 10.1038/nature10444; Mi X, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.176803; Mi X, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4974536; Mi X, 2017, SCIENCE, V355, P156, DOI 10.1126/science.aal2469; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Nigg SE, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.147701; Petersson KD, 2012, NATURE, V490, P380, DOI 10.1038/nature11559; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Probst S, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.5002540; Rau I, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.054521; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Samkharadze N, 2016, PHYS REV APPL, V5, DOI 10.1103/PhysRevApplied.5.044004; Samkharadze N, 2017, STRONG SPIN PHOTON C; Schuster DI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140501; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Stockklauser A, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011030; Takeda K, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600694; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; Trif M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.045434; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Viennot JJ, 2015, SCIENCE, V349, P408, DOI 10.1126/science.aaa3786; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wallraff A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.249701; Watson T., 2018, NATURE; Yoneda J, 2017, 99 9 FIDELITY QUANTU; Zajac DM, 2018, SCIENCE, V359, P439, DOI 10.1126/science.aao5965; Zwanenburg FA, 2013, REV MOD PHYS, V85, P961, DOI 10.1103/RevModPhys.85.961	59	214	215	7	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					599	+		10.1038/nature25769	http://dx.doi.org/10.1038/nature25769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29443961	Green Submitted			2022-12-28	WOS:000428617600038
J	Harari, G; Bandres, MA; Lumer, Y; Rechtsman, MC; Chong, YD; Khajavikhan, M; Christodoulides, DN; Segev, M				Harari, Gal; Bandres, Miguel A.; Lumer, Yaakov; Rechtsman, Mikael C.; Chong, Y. D.; Khajavikhan, Mercedeh; Christodoulides, Demetrios N.; Segev, Mordechai			Topological insulator laser: Theory	SCIENCE			English	Article							REALIZATION; TRANSITION; STATES; PHASE; MODEL	Topological insulators are phases of matter characterized by topological edge states that propagate in a unidirectional manner that is robust to imperfections and disorder. These attributes make topological insulator systems ideal candidates for enabling applications in quantum computation and spintronics. We propose a concept that exploits topological effects in a unique way: the topological insulator laser. These are lasers whose lasing mode exhibits topologically protected transport without magnetic fields. The underlying topological properties lead to a highly efficient laser, robust to defects and disorder, with single-mode lasing even at very high gain values. The topological insulator laser alters current understanding of the interplay between disorder and lasing, and at the same time opens exciting possibilities in topological physics, such as topologically protected transport in systems with gain. On the technological side, the topological insulator laser provides a route to arrays of semiconductor lasers that operate as one single-mode high-power laser coupled efficiently into an output port.	[Harari, Gal; Bandres, Miguel A.; Segev, Mordechai] Technion Israel Inst Technol, Phys Dept, IL-32000 Haifa, Israel; [Harari, Gal; Bandres, Miguel A.; Segev, Mordechai] Technion Israel Inst Technol, Solid State Inst, IL-32000 Haifa, Israel; [Lumer, Yaakov] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Rechtsman, Mikael C.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Chong, Y. D.] Nanyang Technol Univ, Div Phys & Appl Phys, Singapore 637371, Singapore; [Khajavikhan, Mercedeh; Christodoulides, Demetrios N.] Univ Cent Florida, Coll Opt & Photon, CREOL, Orlando, FL 32816 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; State University System of Florida; University of Central Florida	Segev, M (corresponding author), Technion Israel Inst Technol, Phys Dept, IL-32000 Haifa, Israel.; Segev, M (corresponding author), Technion Israel Inst Technol, Solid State Inst, IL-32000 Haifa, Israel.	msegev@tx.technion.ac.il	Chong, Yidong/AAG-5144-2020; Rechtsman, Mikael C./L-8926-2013; Chong, Yidong/E-1375-2012; Chong, Yidong/B-6995-2011	Chong, Yidong/0000-0002-8649-7884; Rechtsman, Mikael C./0000-0002-6909-8355; Chong, Yidong/0000-0002-8649-7884; Chong, Yidong/0000-0002-8649-7884; Bandres, Miguel A./0000-0002-7145-8567; Khajavikhan, Mercedeh/0000-0002-7091-1470; , Gal/0000-0001-5128-3221	Singapore MOE Academic Research Fund [MOE2015T2-2-008, MOE2016-T3-1006]; Penn State NSF MRSEC Center for Nanoscale Science [NSF DMR-1420620]; NSF [DMS-1620422, ECCS 1454531, DMR-1420620, ECCS 1757025]; Packard foundation; Sloan foundation; Kaufman foundation; Israel Science Foundation; Office of Naval Research [N0001416-1-2640]; U.S. Air Force Office of Scientific Research [FA9550-14-1-0037]; U.S.-Israel Binational Science Foundation [2016381]; German-Israeli Deutsch-Israelische Projektkooperation program; Army Research Office [W911NF-16-1-0013, W911NF-17-1-0481]; ERC grant NHQWAVE [MSCA-RISE 691209]	Singapore MOE Academic Research Fund(Ministry of Education, Singapore); Penn State NSF MRSEC Center for Nanoscale Science; NSF(National Science Foundation (NSF)); Packard foundation(The David & Lucile Packard Foundation); Sloan foundation(Alfred P. Sloan Foundation); Kaufman foundation; Israel Science Foundation(Israel Science Foundation); Office of Naval Research(Office of Naval Research); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israeli Deutsch-Israelische Projektkooperation program; Army Research Office; ERC grant NHQWAVE	Supported by Singapore MOE Academic Research Fund Tier 2 Grant MOE2015T2-2-008 and Tier 3 Grant MOE2016-T3-1006 (C.Y.D.); Penn State NSF MRSEC Center for Nanoscale Science (under award NSF DMR-1420620), NSF grant DMS-1620422, and the Packard, Sloan, and Kaufman foundations (M.C.R.); the Israel Science Foundation; Office of Naval Research grant N0001416-1-2640; NSF grants ECCS 1454531, DMR-1420620, and ECCS 1757025; U.S. Air Force Office of Scientific Research grant FA9550-14-1-0037; U.S.-Israel Binational Science Foundation grant 2016381; the German-Israeli Deutsch-Israelische Projektkooperation program; Army Research Office grants W911NF-16-1-0013 and W911NF-17-1-0481; and ERC grant NHQWAVE (MSCA-RISE 691209). M.S. thanks M. Karpovsky and B. Shillman for their support that came at a critical time.	Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Bahari B, 2017, SCIENCE, V358, P636, DOI 10.1126/science.aao4551; Bandres MA, 2018, SCIENCE, V359, DOI 10.1126/science.aar4005; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Cheng XJ, 2016, NAT MATER, V15, P542, DOI [10.1038/NMAT4573, 10.1038/nmat4573]; Esaki K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205128; Fang KJ, 2012, NAT PHOTONICS, V6, P782, DOI [10.1038/NPHOTON.2012.236, 10.1038/nphoton.2012.236]; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Hu YC, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.153101; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kane CL, 2014, NAT PHYS, V10, P39, DOI [10.1038/nphys2835, 10.1038/NPHYS2835]; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Khanikaev AB, 2013, NAT MATER, V12, P233, DOI [10.1038/nmat3520, 10.1038/NMAT3520]; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Liang GQ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203904; Liang SD, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.012118; Liu D, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.023835; Liu J, 2014, NAT NANOTECHNOL, V9, P285, DOI [10.1038/nnano.2014.34, 10.1038/NNANO.2014.34]; Mittal S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.087403; Mittal S, 2016, NAT PHOTONICS, V10, P180, DOI [10.1038/nphoton.2016.10, 10.1038/NPHOTON.2016.10]; Nash LM, 2015, P NATL ACAD SCI USA, V112, P14495, DOI 10.1073/pnas.1507413112; Parto M., 2017, ARXIV170900523; Peano V, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041026; Pilozzi L, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.195317; Raghu S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033834; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Rudner MS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.065703; Segev M, 2013, NAT PHOTONICS, V7, P197, DOI [10.1038/NPHOTON.2013.30, 10.1038/nphoton.2013.30]; Slobozhanyuk AP, 2016, SCI REP-UK, V6, DOI 10.1038/srep22270; St-Jean P., 2017, ARXIV170407310; Umucalilar RO, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043804; Wang P, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.104302; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Wang Z, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013905; Weimann S, 2017, NAT MATER, V16, P433, DOI [10.1038/NMAT4811, 10.1038/nmat4811]; Yang ZJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.114301; Zeuner JM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.040402; Zhao H., 2017, ARXIV170902747	42	452	457	30	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2018	359	6381							eaar4003	10.1126/science.aar4003	http://dx.doi.org/10.1126/science.aar4003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ3SQ	29420260				2022-12-28	WOS:000435218800001
J	Lee, TI; Kesselheim, AS; Kapczynski, A				Lee, Theodore I.; Kesselheim, Aaron S.; Kapczynski, Amy			Legal Challenges to State Drug Pricing Laws	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Lee, Theodore I.] Yale Univ, Yale Law Sch, 127 Wall St, New Haven, CT 06511 USA; [Kesselheim, Aaron S.] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Program Regulat Therapeut & Law, Boston, MA USA; [Kapczynski, Amy] Yale Law Sch, CRIT, New Haven, CT USA	Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University	Lee, TI (corresponding author), Yale Univ, Yale Law Sch, 127 Wall St, New Haven, CT 06511 USA.	theodore.lee@yale.edu			Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Engelberg Foundation	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Engelberg Foundation	Dr Kesselheim's work is funded by the Laura and John Arnold Foundation, with additional support from the Harvard Program in Therapeutic Science and the Engelberg Foundation. Dr Kesselheim reports grants from the FDA Office of Generic Drugs and Division of Health Communication outside the submitted work (2013-2016). Ms Kapczynski is funded in part by the Laura and John Arnold Foundation, through a research grant to Yale University to support the Collaboration for Research Integrity and Transparency (CRIT).	Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Zafar SY, 2013, ONCOLOGIST, V18, P381, DOI 10.1634/theoncologist.2012-0279; Zheng ZY, 2017, CANCER-AM CANCER SOC, V123, P1453, DOI 10.1002/cncr.30560	3	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2018	319	9					865	866		10.1001/jama.2017.20952	http://dx.doi.org/10.1001/jama.2017.20952			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY3FW	29435585				2022-12-28	WOS:000426705100011
J	Ghorani, E; Quezada, SA				Ghorani, Ehsan; Quezada, Sergio A.			Chromatin regulation and immune escape	SCIENCE			English	Editorial Material							RESISTANCE; CANCER; IMMUNOTHERAPY; BLOCKADE; MELANOMA; SYSTEM; STAT5		[Ghorani, Ehsan; Quezada, Sergio A.] UCL, Canc Immunol Unit, Dept Res Haematol, Inst Canc, London, England	University of London; University College London	Quezada, SA (corresponding author), UCL, Canc Immunol Unit, Dept Res Haematol, Inst Canc, London, England.	s.quezada@ucl.ac.uk	Quezada, Sergio/ABF-6466-2020	Quezada, Sergio/0000-0002-9763-1700	Cancer Research UK [16463, 22246] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Abou El Hassan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126466; Ghorani E, 2017, LANCET, V390, P2343, DOI 10.1016/S0140-6736(17)32894-5; Gleixner KV, 2017, HAEMATOLOGICA, V102, P1519, DOI 10.3324/haematol.2016.163436; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Shu XS, 2018, J PATHOL, V244, P36, DOI 10.1002/path.4986; Wellbrock C, 2005, CURR BIOL, V15, P1629, DOI 10.1016/j.cub.2005.08.036; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zingg D, 2017, CELL REP, V20, P854, DOI 10.1016/j.celrep.2017.07.007	15	6	6	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					745	746	aat0383	10.1126/science.aat0383	http://dx.doi.org/10.1126/science.aat0383			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449480	Green Submitted			2022-12-28	WOS:000425116200029
J	Kumar, S; de Lusignan, S; McGovern, A; Correa, A; Hriskova, M; Gatenby, P; Jones, S; Goldsmith, D; Camm, AJ				Kumar, Shankar; de Lusignan, Simon; McGovern, Andrew; Correa, Ana; Hriskova, Mariya; Gatenby, Piers; Jones, Simon; Goldsmith, David; Camm, A. John			Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NET CLINICAL BENEFIT; RENAL IMPAIRMENT; ANTITHROMBOTIC THERAPY; HEMODIALYSIS-PATIENTS; EUROPEAN-SOCIETY; ELDERLY-PATIENTS; GLOBAL BURDEN; WARFARIN USE; MANAGEMENT; OUTCOMES	OBJECTIVE To assess the association between anticoagulation, ischaemic stroke, gastrointestinal and cerebral haemorrhage, and all cause mortality in older people with atrial fibrillation and chronic kidney disease. DESIGN Propensity matched, population based, retrospective cohort analysis from January 2006 through December 2016. SETTING The Royal College of General Practitioners Research and Surveillance Centre database population of almost 2.73 million patients from 110 general practices across England and Wales. PARTICIPANTS Patients aged 65 years and over with a new diagnosis of atrial fibrillation and estimated glomerular filtration rate (eGFR) of <50 mL/min/1.73m(2), calculated using the chronic kidney disease epidemiology collaboration creatinine equation. Patients with a previous diagnosis of atrial fibrillation or receiving anticoagulation in the preceding 120 days were excluded, as were patients requiring dialysis and recipients of renal transplants. INTERVENTION Receipt of an anticoagulant prescription within 60 days of atrial fibrillation diagnosis. MAIN OUTCOME MEASURES Ischaemic stroke, cerebral or gastrointestinal haemorrhage, and all cause mortality. RESULTS 6977 patients with chronic kidney disease and newly diagnosed atrial fibrillation were identified, of whom 2434 were on anticoagulants within 60 days of diagnosis and 4543 were not. 2434 pairs were matched using propensity scores by exposure to anticoagulant or none and followed for a median of 506 days. The crude rates for ischaemic stroke and haemorrhage were 4.6 and 1.2 after taking anticoagulants and 1.5 and 0.4 in patients who were not taking anticoagulant per 100 person years, respectively. The hazard ratios for ischaemic stroke, haemorrhage, and all cause mortality for those on anticoagulants were 2.60 (95% confidence interval 2.00 to 3.38), 2.42 (1.44 to 4.05), and 0.82 (0.74 to 0.91) compared with those who received no anticoagulation. CONCLUSION Giving anticoagulants to older people with concomitant atrial fibrillation and chronic kidney disease was associated with an increased rate of ischaemic stroke and haemorrhage but a paradoxical lowered rate of all cause mortality. Careful consideration should be given before starting anticoagulants in older people with chronic kidney disease who develop atrial fibrillation. There remains an urgent need for adequately powered randomised trials in this population to explore these findings and to provide clarity on correct clinical management.	[Kumar, Shankar] UCL, Ctr Med Imaging, London, England; [de Lusignan, Simon; McGovern, Andrew; Correa, Ana; Hriskova, Mariya; Gatenby, Piers; Jones, Simon] Univ Surrey, Dept Clin & Expt Med, Guildford, Surrey, England; [McGovern, Andrew] Univ Exeter, Exeter Med Sch, Exeter, Devon, England; [Correa, Ana; Hriskova, Mariya] Royal Coll, Gen Practitioners Res & Surveillance Ctr, London, England; [Gatenby, Piers] Royal Surrey Cty Hosp NHS Fdn Trust, Guildford, Surrey, England; [Jones, Simon] NYU, Sch Med, Div Healthcare Delivery Sci, Dept Populat Hlth, New York, NY USA; [Goldsmith, David; Camm, A. John] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [Goldsmith, David] Guys & St Thomas Hosp NHS Fdn Trust, Renal & Transplantat Dept, London, England	University of London; University College London; University of Surrey; University of Exeter; Royal College of Music - UK; Royal Surrey County Hospital; New York University; St Georges University London; Guy's & St Thomas' NHS Foundation Trust	Camm, AJ (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, London, England.	jcamm@sgul.ac.uk	Goldsmith, David J A/H-6965-2018; McGovern, Andrew/N-4179-2015	Goldsmith, David J A/0000-0002-4349-9193; McGovern, Andrew/0000-0002-6833-9399; Jones, Simon/0000-0002-8267-5647; Kumar, Shankar/0000-0002-5945-8791; Hriskova, Mariya/0000-0002-4336-255X; Correa, Ana/0000-0002-0988-061X				Abdelhafiz AH, 2009, CLIN THER, V31, P1534, DOI 10.1016/j.clinthera.2009.07.015; Abel GA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012750; Allan V, 2017, HEART, V103, P210, DOI 10.1136/heartjnl-2016-309910; Andreotti F, 2015, EUR HEART J, V36, P3238, DOI 10.1093/eurheartj/ehv304; Banerjee A, 2014, CHEST, V145, P1370, DOI 10.1378/chest.13-2103; Bansal VK, 2017, AM J KIDNEY DIS, V70, P859, DOI 10.1053/j.ajkd.2017.08.003; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Biteker M, 2017, J AM GERIATR SOC, V65, P1684, DOI 10.1111/jgs.14855; Bohm M, 2015, J AM COLL CARDIOL, V65, P2481, DOI 10.1016/j.jacc.2015.03.577; Bonde AN, 2016, STROKE, V47, P2707, DOI 10.1161/STROKEAHA.116.014422; Bonde AN, 2014, J AM COLL CARDIOL, V64, P2471, DOI 10.1016/j.jacc.2014.09.051; Brodsky SV, 2011, KIDNEY INT, V80, P182, DOI 10.1038/ki.2011.44; Burlacu A, 2017, NEPHROL DIAL TRANSPL, V32, P1967, DOI 10.1093/ndt/gfx041; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Carrero JJ, 2014, JAMA-J AM MED ASSOC, V311, P919, DOI 10.1001/jama.2014.1334; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Correa A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011092; Dahal K, 2016, CHEST, V149, P951, DOI 10.1378/chest.15-1719; de Lusignan Simon, 2005, Inform Prim Care, V13, P65; de Lusignan Simon, 2012, Inform Prim Care, V20, P103; Eikelboom JW, 2017, NEW ENGL J MED, V377, P1319, DOI 10.1056/NEJMoa1709118; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gallagher AM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003839; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008; Holden RM, 2007, NAT CLIN PRACT NEPHR, V3, P522, DOI 10.1038/ncpneph0601; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Jun M, 2017, AM J KIDNEY DIS, V69, P734, DOI 10.1053/j.ajkd.2016.10.018; Jun M, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h246, 10.1136/bmj.h246]; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Keskar V, 2017, KIDNEY INT, V91, P928, DOI 10.1016/j.kint.2016.10.017; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; Kimachi M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011373.pub2; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kooiman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094420; Kumar Shankar, 2014, World J Nephrol, V3, P143, DOI 10.5527/wjn.v3.i4.143; Lai HM, 2009, INT J NEPHROL RENOV, V2, P33; Lee Meng, 2010, BMJ, V341, pc4249, DOI 10.1136/bmj.c4249; Lee Won Chan, 2008, J Med Econ, V11, P281, DOI 10.3111/13696990802063425; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liaw ST, 2013, INT J MED INFORM, V82, P10, DOI 10.1016/j.ijmedinf.2012.10.001; Lip GYH, 2010, AM J MED, V123, P785, DOI 10.1016/j.amjmed.2010.01.031; McGovern A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012801; Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909; Moran GM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008149; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ng KP, 2013, AM J KIDNEY DIS, V62, P615, DOI 10.1053/j.ajkd.2013.02.381; Nimmo C, 2013, AM HEART J, V166, P230, DOI 10.1016/j.ahj.2013.05.010; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Phelan PJ, 2011, CLIN NEPHROL, V75, P204, DOI 10.5414/CN106481; Reinecke H, 2009, J AM SOC NEPHROL, V20, P705, DOI 10.1681/ASN.2007111207; Roldan V, 2013, AM J CARDIOL, V111, P1159, DOI 10.1016/j.amjcard.2012.12.045; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; Szummer K, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004925; Tan JW, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0368-6; Thijs A, 2008, CLIN NEPHROL, V70, P325; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang TKM, 2016, HEART LUNG CIRC, V25, P243, DOI 10.1016/j.hlc.2015.08.012; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Yao XX, 2017, J AM COLL CARDIOL, V70, P2621, DOI 10.1016/j.jacc.2017.09.1087; Ziff OJ, 2016, AM HEART J, V173, P143, DOI 10.1016/j.ahj.2015.10.021	71	45	49	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2018	360								k342	10.1136/bmj.k342	http://dx.doi.org/10.1136/bmj.k342			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KZ	29444881	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-28	WOS:000425582700003
J	Peake, CM; Hughes, K; Yeo, A				Peake, Christopher Mark; Hughes, Katie; Yeo, Andrea			CASE REVIEW A child with a painless, deformed wrist	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENCHONDROMATOSIS OLLIERS-DISEASE		[Peake, Christopher Mark; Hughes, Katie; Yeo, Andrea] St Georges Univ Hosp NHS Fdn Trust, Trauma & Orthopaed Dept, London, England		Peake, CM (corresponding author), St Georges Univ Hosp NHS Fdn Trust, Trauma & Orthopaed Dept, London, England.	cmpeake@doctors.org.uk						Bovee JVMG, 2000, HUM PATHOL, V31, P1299, DOI 10.1053/hupa.2000.19308; Frappaz D, 1999, CHILD NERV SYST, V15, P222, DOI 10.1007/s003810050377; Herget GW, 2014, NEOPLASMA, V61, P365, DOI 10.4149/neo_2014_046; Kim E, 2012, J HAND SURG-AM, V37A, P2294, DOI 10.1016/j.jhsa.2012.08.006; Kumar A, 2015, ORTHOPEDICS, V38, pE497, DOI 10.3928/01477447-20150603-58; SHAPIRO F, 1982, J BONE JOINT SURG AM, V64, P95, DOI 10.2106/00004623-198264010-00014; Silve C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-37; Spranger JV, 1974, BONE DYSPLASIAS	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2018	360								k246	10.1136/bmj.k246	http://dx.doi.org/10.1136/bmj.k246			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KZ	29444886				2022-12-28	WOS:000425582700001
J	Liu, CL; Kershberg, L; Wang, JX; Schneeberger, S; Kaeser, PS				Liu, Changliang; Kershberg, Lauren; Wang, Jiexin; Schneeberger, Shirin; Kaeser, Pascal S.			Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites	CELL			English	Article							RAT; NEURONS; SCHIZOPHRENIA; LOCALIZATION; MODULATION; PLASTICITY; RECEPTORS; TERMINALS; CHANNELS	Dopamine controls essential brain functions through volume transmission. Different from fast synaptic transmission, where neurotransmitter release and receptor activation are tightly coupled by an active zone, dopamine transmission is widespread and may not necessitate these organized release sites. Here, we determine whether striatal dopamine secretion employs specialized machinery for release. Using super resolution microscopy, we identified co-clustering of the active zone scaffolding proteins bassoon, RIM and ELKS in similar to 30% of dopamine varicosities. Conditional RIM knockout disrupted this scaffold and, unexpectedly, abolished dopamine release, while ELKS knockout had no effect. Optogenetic experiments revealed that dopamine release was fast and had a high release probability, indicating the presence of protein scaffolds for coupling Ca2+ influx to vesicle fusion. Hence, dopamine secretion is mediated by sparse, mechanistically specialized active zone-like release sites. This architecture supports spatially and temporally precise coding for dopamine and provides molecular machinery for regulation.	[Liu, Changliang; Kershberg, Lauren; Wang, Jiexin; Schneeberger, Shirin; Kaeser, Pascal S.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Schneeberger, Shirin] Charite, Dept Neuropathol, Berlin, Germany	Harvard University; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kaeser, PS (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	kaeser@hms.harvard.edu	wang, jie/GRS-0942-2022; Liu, Changliang/H-6531-2017	Liu, Changliang/0000-0002-0915-8408	NIH [R01NS083898, R01NS103484]; Harvard Brain Initiative; Goldenson Foundation; Lefler Foundation; Alice and Joseph E. Brooks fellowship; Fix fellowship; Gordon postdoctoral fellowship; P30 Core Center grant [NS072030]; Cellular Imaging Core at Boston Children's Hospital (BCH IDDRC) [HD090255]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072030, R01NS103484, R01NS083898] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Brain Initiative; Goldenson Foundation; Lefler Foundation; Alice and Joseph E. Brooks fellowship; Fix fellowship; Gordon postdoctoral fellowship; P30 Core Center grant; Cellular Imaging Core at Boston Children's Hospital (BCH IDDRC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Bickford for technical support; Dr. W. Regehr, Dr. B. Sabatini, and members of the Kaeser laboratory for comments on the manuscript; Dr. T. Sudhof for antibodies; Dr. B. Lehnert and Dr. D. Ginty for providing VGluT1<SUP>IRES-cre</SUP> and SYP-tdTomato mice; and Dr. B. Sabatini for providing DAT<SUP>IRES-cre</SUP> mice. This work was supported by grants from the NIH (R01NS083898 and R01NS103484 to P.S.K.); the Harvard Brain Initiative; the Goldenson Foundation; the Lefler Foundation (to P.S.K.); and Alice and Joseph E. Brooks, Fix, and Gordon postdoctoral fellowships (to C.L.). We also acknowledge the Neurobiology Imaging Facility (supported by a P30 Core Center grant NS072030), the Electron Microscopy Facility at Harvard Medical School, the Cellular Imaging Core at Boston Children's Hospital (BCH IDDRC, HD090255), and Dr. J. Waters and Dr. T. Lambert from the Cell Biology Microscopy Facility.	Acuna C, 2016, NEURON, V91, P792, DOI 10.1016/j.neuron.2016.07.042; Acuna C, 2015, NEURON, V87, P1234, DOI 10.1016/j.neuron.2015.08.027; AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Brichta L, 2015, NAT NEUROSCI, V18, P1325, DOI 10.1038/nn.4070; Brimblecombe KR, 2015, J PHYSIOL-LONDON, V593, P929, DOI 10.1113/jphysiol.2014.285890; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Cragg SJ, 2003, J NEUROSCI, V23, P4378; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Descarries L, 1996, J COMP NEUROL, V375, P167; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gantz SC, 2013, NEURON, V78, P807, DOI 10.1016/j.neuron.2013.04.013; GRACE AA, 1984, J NEUROSCI, V4, P2877; Grace AA, 2016, NAT REV NEUROSCI, V17, P524, DOI 10.1038/nrn.2016.57; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Held RG, 2016, ELIFE, V5, DOI 10.7554/eLife.14862; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; KUCZENSKI R, 1977, J PHARMACOL EXP THER, V201, P357; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu CL, 2014, J NEUROSCI, V34, P12289, DOI 10.1523/JNEUROSCI.0999-14.2014; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Pereira DB, 2016, NAT NEUROSCI, V19, P578, DOI 10.1038/nn.4252; Pissadaki EK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00013; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Surmeier DJ, 2014, CURR OPIN NEUROBIOL, V29, P109, DOI 10.1016/j.conb.2014.07.008; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Uchigashima M, 2016, P NATL ACAD SCI USA, V113, P4206, DOI 10.1073/pnas.1514074113; Wang SSH, 2016, NEURON, V91, P777, DOI 10.1016/j.neuron.2016.07.005; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zhang SL, 2015, NAT NEUROSCI, V18, P386, DOI 10.1038/nn.3945; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	42	106	106	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					706	+		10.1016/j.cell.2018.01.008	http://dx.doi.org/10.1016/j.cell.2018.01.008			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29398114	Bronze, Green Accepted			2022-12-28	WOS:000424648800012
J	Kvistborg, P; Yewdell, JW				Kvistborg, Pia; Yewdell, Jonathan W.			Enhancing responses to cancer immunotherapy	SCIENCE			English	Editorial Material									[Kvistborg, Pia] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Yewdell, Jonathan W.] NIAID, Lab Viral Dis, Cellular Biol Sect, 9000 Rockville Pike, Bethesda, MD 20892 USA	Netherlands Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kvistborg, P (corresponding author), Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.	p.kvistborg@nki.nl	yewdell, jyewdell@nih.gov jonathan/A-1702-2012		Division of Intramural Research, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001210] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.W.Y. is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases.	Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Robinson J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006862; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Starck SR, 2016, IMMUNOL REV, V272, P8, DOI 10.1111/imr.12434; WILLIAMS DB, 1985, J CELL BIOL, V101, P725, DOI 10.1083/jcb.101.3.725; Wolchok JD, 2017, NEW ENGL J MED, V377, P2503; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	10	25	28	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					516	517		10.1126/science.aar6574	http://dx.doi.org/10.1126/science.aar6574			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420276				2022-12-28	WOS:000423795800021
J	Chen, JS; Ma, EB; Harrington, LB; Da Costa, M; Tian, XR; Palefsky, JM; Doudna, JA				Chen, Janice S.; Ma, Enbo; Harrington, Lucas B.; Da Costa, Maria; Tian, Xinran; Palefsky, Joel M.; Doudna, Jennifer A.			CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity	SCIENCE			English	Article							CRISPR-CAS SYSTEMS; HUMAN-CELLS; CPF1; RNA; ENDONUCLEASE; CLEAVAGE; SPECIFICITIES; DIVERSITY; EVOLUTION; INFECTION	CRISPR-Cas12a (Cpf1) proteins are RNA-guided enzymes that bind and cut DNA as components of bacterial adaptive immune systems. Like CRISPR-Cas9, Cas12a has been harnessed for genome editing on the basis of its ability to generate targeted, double-stranded DNA breaks. Here we show that RNA-guided DNA binding unleashes indiscriminate single-stranded DNA (ssDNA) cleavage activity by Cas12a that completely degrades ssDNA molecules. We find that target-activated, nonspecific single-stranded deoxyribonuclease (ssDNase) cleavage is also a property of other type V CRISPR-Cas12 enzymes. By combining Cas12a ssDNase activation with isothermal amplification, we create a method termed DNA endonuclease-targeted CRISPR trans reporter (DETECTR), which achieves attomolar sensitivity for DNA detection. DETECTR enables rapid and specific detection of human papillomavirus in patient samples, thereby providing a simple platform for molecular diagnostics.	[Chen, Janice S.; Ma, Enbo; Harrington, Lucas B.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Da Costa, Maria; Palefsky, Joel M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Tian, Xinran; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94704 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94704 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Chen, Janice/0000-0003-4797-3056	Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group; NSF [MCB-1244557]; NSF Graduate Research Fellowships	Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group; NSF(National Science Foundation (NSF)); NSF Graduate Research Fellowships(National Science Foundation (NSF))	This research was supported in part by the Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group and the NSF (MCB-1244557 to J.A.D.). J.S.C. and L.B.H. are supported by NSF Graduate Research Fellowships.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005; [Anonymous], 2016, CELL RES; [Anonymous], 2017, MOL CELL; [Anonymous], 2015, CELL; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Bhatia V, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070171; Chen JS, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0078; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Singh D., 2017, 205575 BIORXIV; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stella S, 2017, NATURE, V546, P559, DOI 10.1038/nature22398; Tang X, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.18; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	34	1242	1338	261	1342	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2018	360	6387					436	+		10.1126/science.aar6245	http://dx.doi.org/10.1126/science.aar6245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1AR	29449511	Green Accepted, Green Submitted			2022-12-28	WOS:000430949600042
J	Akseer, N; Kamali, M; Bakhache, N; Mirza, M; Mehta, S; Al-Gashm, S; Bhutta, ZA				Akseer, Nadia; Kamali, Mahdis; Bakhache, Nour; Mirza, Maaz; Mehta, Seema; Al-Gashm, Sara; Bhutta, Zulfiqar A.			Status and drivers of maternal, newborn, child and adolescent health in the Islamic world: a comparative analysis	LANCET			English	Article							EASTERN MEDITERRANEAN REGION; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; UNDER-5 MORTALITY; MUSLIM; DISEASE; COUNTRIES; SURVIVAL; MOTHERS; EMPOWERMENT	Background The Millennium Development Goal (MDG) period saw dramatic gains in health goals MDG 4 and MDG 5 for improving child and maternal health. However, many Muslim countries in the south Asian, Middle Eastern, and African regions lagged behind. In this study, we aimed to evaluate the status of, progress in, and key determinants of reproductive, maternal, newborn, child, and adolescent health in Muslim majority countries (MMCs). The specific objectives were to understand the current status and progress in reproductive, maternal, newborn, child, and adolescent health in MMCs, and the determinants of child survival among the least developed countries among the MMCs; to explore differences in outcomes and the key contextual determinants of health between MMCs and non-MMCs; and to understand the health service coverage and contextual determinants that differ between best and poor or moderate performing MMCs. Methods In this country-level ecological study, we examined data from between 1990 and 2015 from multiple publicly available data repositories. We examined 47 MMCs, of which 26 were among the 75 high-burden Countdown to 2015 countries. These 26 MMCs were compared with 48 non-Muslim Countdown countries. We also examined characteristics of the eight best performing MMCs that had accelerated improvement in child survival (ie, that reached their MDG 4 targets). We estimated adolescent, maternal, under-5, and newborn mortality, and stillbirths, and the causes of death, essential interventions coverage, and contextual determinants for all MMCs and comparative groups using standardised methods. We also did a hierarchical multivariable analysis of determinants of under-5 mortality and newborn mortality in low-income and middle-income MMCs. Findings Despite notable reductions between 1990 and 2015, MMCs compared with a global esimate of all countries including MMCs had higher mortality rates, and MMCs relative to non-MMCs within Countdown countries also performed worse. Coverage of essential interventions across the continuum of care was on average lower among MMCs, especially for indicators of reproductive health, prenatal care, delivery, and labour, and childhood vaccines. Outcomes within MMCs for mortality and many reproductive, maternal, newborn, child, and adolescent health indicators varied considerably. Structural and contextual factors, especially state governance, conflict, and women and girl's empowerment indicators, were significantly worse in MMCs compared with non-MMCs within the high-burden Countdown countries, and were shown to be strongly associated with child and newborn mortality within low-income and middle-income MMCs. In adjusted hierarchical models, among other factors, under-5 mortality in MMCs increased with more refugees originating from a country (beta=23.67, p=0.0116), and decreased with better political stability or absence of terrorism (beta=-0.99, p=0.0285), greater political rights or government effectiveness (beta=-1.17, p<0.0001), improvements in log gross national income per capita (beta=-4.44, p<0.0001), higher total adult literacy (beta=-1.69, p<0.0001), higher female adult literacy (beta=-0.97, p<0.0001), and greater female to male enrolment in secondary school (beta=-16.1, p<0.0001). The best performing MMCs were Azerbaijan, Bangladesh, Egypt, Indonesia, Kyrgyzstan, Morocco, Niger, and Senegal, which had higher coverage of family planning interventions and newborn or child vaccinations, and excelled in many of the above contextual determinants when compared with moderate or poorly performing MMCs. Interpretation The status and progress in reproductive, maternal, newborn, child, and adolescent health is heterogeneous among MMCs, with little indication that religion and its practice affects outcomes systemically. Some Islamic countries such as Niger and Bangladesh have made great progress, despite poverty. Key findings from this study have policy and programmatic implications that could be prioritised by national heads of state and policy makers, development partners, funders, and the Organization of the Islamic Cooperation to scale up and improve these health outcomes in Muslim countries in the post-2015 era.	[Akseer, Nadia; Kamali, Mahdis; Bakhache, Nour; Mirza, Maaz; Mehta, Seema; Al-Gashm, Sara; Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada; [Akseer, Nadia; Bhutta, Zulfiqar A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Aga Khan University	Bhutta, ZA (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada.; Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@sickkids.ca	Bhutta, Zulfiqar/L-7822-2015	Bhutta, Zulfiqar/0000-0003-0637-599X; Kamali, Mahdis/0000-0003-1980-778X	US Fund for UNICEF; Centre for Global Child Health, Hospital for Sick Children; Aga Khan University	US Fund for UNICEF; Centre for Global Child Health, Hospital for Sick Children; Aga Khan University	US Fund for UNICEF under the Countdown to 2015 for Maternal, Newborn, and Child Survival, the Centre for Global Child Health, Hospital for Sick Children, and the Aga Khan University.; This work was supported through funds provided through a sub-grant from the US Fund for UNICEF under the Countdown to 2015 for Maternal, Newborn, and Child Survival and in-kind support from, the Centre for Global Child Health, Hospital for Sick Children (Toronto, ON, Canada), and the Aga Khan University (Karachi, Pakistan). We would like to thank the Countdown Leadership (Jennifer Requejo at John Hopkins University, Baltimore, MD, USA; Cesar Victora at the International Center for Equity in Health, Pelotas, Brazil; Robert Black at the Department of International Health, Johns Hopkins University, Baltimore, MD, USA) for their technical support to various elements of the case study and review of the paper. Additionally, we thank Sabah Husain (Centre for Global Child Health, Hospital for Sick Children, Toronto, ON, Canada) for her assistance with compiling literature for the study.	Abou El Azayem G., 1994, INT J PSYCHOL RELIG, V4, P41, DOI [https://doi.org/10.1207/s15327582ijpr0401_6, DOI 10.1207/s15327582ijpr0401_6]; Akseer N, 2015, E MEDITERR HEALTH J, V21, P361, DOI 10.26719/2015.21.5.361; Alexander AC, 2011, INT REV SOCIOL, V21, P249, DOI 10.1080/03906701.2011.581801; Ali NS, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-57; Amitai Y, 2005, PAEDIATR PERINAT EP, V19, P145, DOI 10.1111/j.1365-3016.2005.00636.x; [Anonymous], POLITY 4 PROJECT; [Anonymous], 2016, ECONOMIST; Aoyama A, 2001, REPR HLTH MIDDL E N; Batniji R, 2014, LANCET, V383, P343, DOI 10.1016/S0140-6736(13)62185-6; Bhatia JC., 1995, HLTH TRANSITION REV, V5, P127; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P839, DOI 10.1136/bmj.38979.379641.68; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutta ZA, 2013, E MEDITERR HEALTH J, V19, P104, DOI 10.26719/2013.19.2.104; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Buchinsky M, 1998, J HUM RESOUR, V33, P88, DOI 10.2307/146316; Centre for Research on the Epidemiology of Disasters, INT DIS DAT; Cherif FM, 2010, J POLIT, V72, P1144, DOI 10.1017/S0022381610000587; Chikvaidze P., 2012, Eastern Mediterranean Health Journal, V18, P911; Chung BD, WORKSH INT PUBL AFF; Deeb M, 1997, INT J EPIDEMIOL, V26, P110, DOI 10.1093/ije/26.1.110; DeJong J, 2006, BMJ-BRIT MED J, V333, P849, DOI 10.1136/bmj.38993.460197.68; Diaz-Cayeros A, 2013, WORLD DEV, V53, P80, DOI 10.1016/j.worlddev.2013.01.008; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Donno D, 2004, WORLD POLIT, V56, P582, DOI 10.1353/wp.2005.0003; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Engels JM, 2003, J CLIN EPIDEMIOL, V56, P968, DOI 10.1016/S0895-4356(03)00170-7; Ercevik Amado Liz, 2004, Reprod Health Matters, V12, P125, DOI 10.1016/S0968-8080(04)23119-6; Ewerling F, 2017, LANCET GLOB HEALTH, V5, pE916, DOI 10.1016/S2214-109X(17)30292-9; Fish MS, 2002, WORLD POLIT, V55, P4, DOI 10.1353/wp.2003.0004; Freedom House, FREED HOUS FREED WOR; Gyimah SO, 2007, J BIOSOC SCI, V39, P923, DOI 10.1017/S0021932007001927; Habib MA, 2017, LANCET GLOB HEALTH, V5, pE593, DOI 10.1016/s2214-109x(17)30184-5; Hasan Ahmad, 1971, ISLAMIC STUDIES, V10, P209; Hasan S., 2012, MUSLIM WORLD 21 CENT; Hurt LS, 2004, J EPIDEMIOL COMMUN H, V58, P315, DOI 10.1136/jech.2003.007351; Inhorn MC, 2011, LANCET, V378, P935, DOI 10.1016/S0140-6736(11)61041-6; JAFAREY SN, 1993, SOC SCI MED, V36, P371, DOI 10.1016/0277-9536(93)90021-U; Karatnycky A, 2002, J DEMOCR, V13, P99, DOI 10.1353/jod.2002.0009; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Koenig H. G., 2014, HLTH WELL BEING ISLA, DOI DOI 10.1007/978-3-319-05873-3_6; Kohler IV, 2011, POP STUD-J DEMOG, V65, P91, DOI 10.1080/00324728.2010.535554; Lassi ZS, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0054-5; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lerch M, 2010, POPULATION, V65, P239, DOI 10.3917/popu.1002.0239; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mahaini R., 2005, Eastern Mediterranean Health Journal, V11, P532; Maziak W, 2009, INT J PUBLIC HEALTH, V54, P349, DOI 10.1007/s00038-009-0061-7; Miah M M, 1993, Int J Sociol Fam, V23, P21; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; *MIN HLTH FAM WELF, 2015, SUCC FACT WOM CHILDR; Ministry of Health and Population Egypt Partnership for Maternal Newborn and Child Health World Health Organization World Bank Alliance for Health Policy and Systems Research, 2014, SUCC FACT WOM CHILDR; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Moten AR, 2013, CULTURA, V10, P7, DOI 10.5840/cultura20131011; National Consortium for the Study of Terrorism and Responses to Terrorism (START), GLOB TERR DAT; OBERMEYER CM, 1995, HUM RIGHTS QUART, V17, P366, DOI 10.1353/hrq.1995.0020; Pew Research Center, 2016, REL ED WORLD; Pew Research Centre, 2010, WORLDS MUSL REL POL; Possamai A., 2015, SOCIOLOGY SHARIA CAS; Rahman FZ, 2012, AUST J POLIT SCI, V47, P347, DOI 10.1080/10361146.2012.704006; Razzak J. A., 2011, Eastern Mediterranean Health Journal, V17, P654; Ross ML, 2008, AM POLIT SCI REV, V102, P107, DOI 10.1017/S0003055408080040; Rust K F, 1996, Stat Methods Med Res, V5, P283, DOI 10.1177/096228029600500305; Sachar Rajindar, 2006, SOCIAL EC ED STATUS; SAKSENA DN, 1980, J BIOSOC SCI, V12, P69, DOI 10.1017/S0021932000012700; Samavat A, 2004, BMJ-BRIT MED J, V329, P1134, DOI 10.1136/bmj.329.7475.1134; Shaikh Babar Tasneem, 2013, J Pak Med Assoc, V63, pS67; Shapiro GK, 2014, HEALTH POLICY PLANN, V29, P483, DOI 10.1093/heapol/czt040; Singh Poonam Khetrapal, 2012, Indian J Public Health, V56, P259, DOI 10.4103/0019-557X.106412; Stenberg K, 2017, LANCET GLOB HEALTH, V5, pE875, DOI [10.1016/S2214-109X(17)30263-2, 10.1016/s2214-109x(17)30263-2]; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; The United Nations Development Programme (UNDP), WORLD POP PROSP; Toni-Uebari Thelma K, 2009, BMC Blood Disord, V9, P6, DOI 10.1186/1471-2326-9-6; Tsai LL, 2007, AM POLIT SCI REV, V101, P355, DOI 10.1017/S0003055407070153; UNDP, 2011, HUM RES SUST MDG PRO; UNFPA/UNICEF, 2020, TECHN NOT GEND TRANS; UNICEF, 2016, UNICEF INF YOUNG CHI; UNICEF, UNICEF GLOB DAT; UNICEF and WHO, 2015, COUNTD 2015 DEC TRAC; UNICEF WHO and the World Bank, 2015, UNICEF WHO WORLD BAN; United Nations Inter agency Group for Child Mortality Estimation (UN IGME), 2015, LEV TRENDS CHILD MOR; Uppsala University, UPPS U CONFL DAT PRO; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WHO, 2008, WOM EMP GEN EQ ESS G; WHO, WHO UNICEF COV EST I; WHO UNICEF, WHO UNICEF JOINT MON; World Bank, 2016, WORLD BANK DEV DAT; World Bank, 2021, GDP; World Bank, 2016, WORLD BANK WOM BUS L; World Health Organization, GLOB HLTH OBS; World Health Organization, MAT NEWB CHILD AD HL; World Health Organization, 2014, FULF HLTH AG WOM CHI; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	101	25	25	2	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2018	391	10129					1493	1512		10.1016/S0140-6736(18)30183-1	http://dx.doi.org/10.1016/S0140-6736(18)30183-1			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GC6TS	29395272				2022-12-28	WOS:000429926000026
J	Norimoto, H; Makino, K; Gao, MX; Shikano, Y; Okamoto, K; Ishikawa, T; Sasaki, T; Hioki, H; Fujisawa, S; Ikegaya, Y				Norimoto, Hiroaki; Makino, Kenichi; Gao, Mengxuan; Shikano, Yu; Okamoto, Kazuki; Ishikawa, Tomoe; Sasaki, Takuya; Hioki, Hiroyuki; Fujisawa, Shigeyoshi; Ikegaya, Yuji			Hippocampal ripples down-regulate synapses	SCIENCE			English	Article							LONG-TERM DEPRESSION; SHARP-WAVE-RIPPLES; SYNAPTIC PLASTICITY; OFFLINE REACTIVATION; MEMORY CONSOLIDATION; IN-VITRO; AREA CA1; SLEEP; RAT; POTENTIATION	The specific effects of sleep on synaptic plasticity remain unclear. We report that mouse hippocampal sharp-wave ripple oscillations serve as intrinsic events that trigger long-lasting synaptic depression. Silencing of sharp-wave ripples during slow-wave states prevented the spontaneous down-regulation of net synaptic weights and impaired the learning of new memories. The synaptic down-regulation was dependent on the N-methyl-D-aspartate receptor and selective for a specific input pathway. Thus, our findings are consistent with the role of slow-wave states in refining memory engrams by reducing recent memory-irrelevant neuronal activity and suggest a previously unrecognized function for sharp-wave ripples.	[Norimoto, Hiroaki; Makino, Kenichi; Gao, Mengxuan; Shikano, Yu; Okamoto, Kazuki; Ishikawa, Tomoe; Sasaki, Takuya; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan; [Norimoto, Hiroaki; Fujisawa, Shigeyoshi] RIKEN, Brain Sci Inst, Lab Syst Neurophysiol, 2-1 Hirosawa, Wako, Saitama, Japan; [Hioki, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto, Japan; [Hioki, Hiroyuki] Juntendo Univ, Dept Cell Biol & Neurosci, Grad Sch Med, Tokyo, Japan; [Ikegaya, Yuji] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Osaka, Japan	University of Tokyo; RIKEN; Kyoto University; Juntendo University; National Institute of Information & Communications Technology (NICT) - Japan	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan.; Fujisawa, S (corresponding author), RIKEN, Brain Sci Inst, Lab Syst Neurophysiol, 2-1 Hirosawa, Wako, Saitama, Japan.; Ikegaya, Y (corresponding author), Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Osaka, Japan.	fujisawa@brain.riken.jp; yuji@ikegaya.jp	Norimoto, Hiroaki/E-1238-2019; Fujisawa, Shigeyoshi/N-6439-2015; Sasaki, Takuya/J-3283-2015; Hioki, Hiroyuki/J-9412-2017	Norimoto, Hiroaki/0000-0002-7351-5457; Fujisawa, Shigeyoshi/0000-0003-3963-4281; Ikegaya, Yuji/0000-0003-2260-8191; Okamoto, Kazuki/0000-0003-1575-6030; Shikano, Yu/0000-0001-8890-7691; Hioki, Hiroyuki/0000-0002-0152-7854	Ministry of Education, Culture, Sports, Science and Technology [25119004, 26250003, 16H01519]; Resonance Bio [16H01426]; Japan Society for the Promotion of Science [16H07453]; RIKEN Special Postdoctoral Researchers Program research grant [201600059347]; Sasakawa Scientific Research Grant from the Japan Science Society [28-402]; Brain/MINDS (Brain Mapping by Integrated Neurotechnologies for Disease Studies) from the Japan Agency for Medical Research and Development (AMED); Strategic Research Program for Brain Sciences on "Development of BMI Technologies for Clinical Application"; Human Frontier Science Program [RGP0019/2016]; Grants-in-Aid for Scientific Research [25119004, 16H01519, 16J07503] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Resonance Bio; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Special Postdoctoral Researchers Program research grant; Sasakawa Scientific Research Grant from the Japan Science Society; Brain/MINDS (Brain Mapping by Integrated Neurotechnologies for Disease Studies) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Strategic Research Program for Brain Sciences on "Development of BMI Technologies for Clinical Application"; Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (25119004 and 26250003 to Y.I. and 16H01519 to S.F.); "Resonance Bio" (16H01426 to H.H.); Japan Society for the Promotion of Science Grant-in-Aid for Research Activity start-up (16H07453 to H.N.); RIKEN Special Postdoctoral Researchers Program research grant (201600059347 to H.N.); the Sasakawa Scientific Research Grant from the Japan Science Society (28-402 to H.N.); Brain/MINDS (Brain Mapping by Integrated Neurotechnologies for Disease Studies) from the Japan Agency for Medical Research and Development (AMED) (to H.H. and S.F.); the Strategic Research Program for Brain Sciences on "Development of BMI Technologies for Clinical Application" (to Y.I.); and a Human Frontier Science Program (RGP0019/2016 to Y.I.). This work was partly facilitated by a programin the International Research Center for Neurointelligence (WPI-IRCN) of The University of Tokyo Institutes for Advanced Study at The University of Tokyo.	Balduzzi D, 2013, THEOR BIOSCI, V132, P27, DOI 10.1007/s12064-012-0165-0; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Bukalo O, 2013, P NATL ACAD SCI USA, V110, P5175, DOI 10.1073/pnas.1210735110; Colgin LL, 2004, J PHYSIOL-LONDON, V558, P953, DOI 10.1113/jphysiol.2004.068080; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; de Vivo L, 2017, SCIENCE, V355, P507, DOI 10.1126/science.aah5982; Diering GH, 2017, SCIENCE, V355, P511, DOI 10.1126/science.aai8355; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eguchi M, 2009, NEUROIMAGE, V44, P1274, DOI 10.1016/j.neuroimage.2008.10.046; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Huber R, 2013, CEREB CORTEX, V23, P1, DOI 10.1093/cercor/bhs014; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mehta MR, 2007, NAT NEUROSCI, V10, P13, DOI 10.1038/nn0107-13; Mizunuma M, 2014, NAT NEUROSCI, V17, P503, DOI 10.1038/nn.3674; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Sadowski JHLP, 2016, CELL REP, V14, P1916, DOI 10.1016/j.celrep.2016.01.061; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; van de Ven GM, 2016, NEURON, V92, P968, DOI 10.1016/j.neuron.2016.10.020; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	30	106	108	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2018	359	6383					1524	+		10.1126/science.aao0702	http://dx.doi.org/10.1126/science.aao0702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA9JI	29439023				2022-12-28	WOS:000428657000046
J	Sorum, P				Sorum, Paul			Why Internists Might Want Single-Payer Health Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							US PHYSICIAN PRACTICES; SATISFACTION		[Sorum, Paul] Albany Med Coll, Albany, NY 12208 USA	Albany Medical College	Sorum, P (corresponding author), Albany Med Ctr Internal Med & Pediat, 724 Watervliet Shaker Rd, Latham, NY 12110 USA.	sorump@amc.edu						Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Erickson SM, 2017, ANN INTERN MED, V166, P659, DOI 10.7326/M16-2697; Johnson OA, 2014, LANCET, V384, P954, DOI 10.1016/S0140-6736(14)61626-3; Kaiser Family Foundation, 2017, 2017 EMPL HLTH BEN S; Mendelson A, 2017, ANN INTERN MED, V166, P341, DOI 10.7326/M16-1881; Morra D, 2011, HEALTH AFFAIR, V30, P1443, DOI 10.1377/hlthaff.2010.0893; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Sinsky CA, 2017, ANN INTERN MED, V166, P677, DOI 10.7326/M17-0524; Tyssen R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-516	10	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					438	+		10.7326/M17-2678	http://dx.doi.org/10.7326/M17-2678			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29435572				2022-12-28	WOS:000427827400020
J	Nosil, P; Villoutreix, R; de Carvalho, CF; Farkas, TE; Soria-Carrasco, V; Feder, JL; Crespi, BJ; Gompert, Z				Nosil, Patrik; Villoutreix, Romain; de Carvalho, Clarissa F.; Farkas, Timothy E.; Soria-Carrasco, Victor; Feder, Jeffrey L.; Crespi, Bernard J.; Gompert, Zach			Natural selection and the predictability of evolution in Timema stick insects	SCIENCE			English	Article							REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; PHENOTYPIC SELECTION; DYNAMICS; ENVIRONMENTS; POLYMORPHISM; FREQUENCIES; ADAPTATION; PREDATION; TRAIT	Predicting evolution remains difficult. We studied the evolution of cryptic body coloration and pattern in a stick insect using 25 years of field data, experiments, and genomics. We found that evolution is more difficult to predict when it involves a balance between multiple selective factors and uncertainty in environmental conditions than when it involves feedback loops that cause consistent back-and-forth fluctuations. Specifically, changes in color-morph frequencies are modestly predictable through time (r(2) = 0.14) and driven by complex selective regimes and yearly fluctuations in climate. In contrast, temporal changes in pattern-morph frequencies are highly predictable due to negative frequency-dependent selection (r(2) = 0.86). For both traits, however, natural selection drives evolution around a dynamic equilibrium, providing some predictability to the process.	[Nosil, Patrik; Villoutreix, Romain; de Carvalho, Clarissa F.; Soria-Carrasco, Victor] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Farkas, Timothy E.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06369 USA; [Feder, Jeffrey L.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Crespi, Bernard J.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Gompert, Zach] Utah State Univ, Dept Biol, Logan, UT 84322 USA	University of Sheffield; University of Connecticut; University of Notre Dame; Simon Fraser University; Utah System of Higher Education; Utah State University	Nosil, P (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.; Gompert, Z (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	p.nosi@sheffield.com; zach.gompert@usu.edu	Villoutreix, Romain/AAO-6617-2021	Villoutreix, Romain/0000-0002-1815-3844; de Carvalho, Clarissa/0000-0002-5780-5454; Soria-Carrasco, Victor/0000-0002-6568-5544	European Research Council [NatHisGen R/129639]; Natural Sciences and Engineering Research Council [NSERC 06505]; Leverhulme Trust; Center for High Performance Computing at the University of Utah	European Research Council(European Research Council (ERC)European Commission); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leverhulme Trust(Leverhulme Trust); Center for High Performance Computing at the University of Utah	The work was funded by a grant from the European Research Council (NatHisGen R/129639) to P.N. and a Natural Sciences and Engineering Research Council grant to B.J.C. (NSERC 06505). V.S.-C. was supported by a Leverhulme Trust Early Career Fellowship. We thank C. Sandoval for contributing data on morph frequencies. C. Sandoval, A. Comeault, M. Muschick, R. Riesch, and T. Reimchen provided discussion and comments on previous versions of the manuscript. The support and resources from the Center for High Performance Computing at the University of Utah are gratefully acknowledged, as well as access to the High Performance Computing Facilities, particularly to the Iceberg HPC cluster, from the Corporate Information and Computing Services at the University of Sheffield. The genome drafts reported in this paper have been deposited in the Genomes database of the National Center for Biotechnology Information (NCBI) under BioProject Accession PRJNA417530. Other data, including custom code written for analyses, have been archived in Dryad Digital Repository (doi:10.5061/dryad.v1q13). R. Ribas drew all the figures. P.N. and Z.G. conceived the project. P.N., R.V., C.F.d.C., T.E.F., V.S.-C., and Z.G. contributed data and analyses. P.N., J.L.F., and Z.G. wrote the manuscript, with feedback from all authors.	Bell G, 2010, PHILOS T R SOC B, V365, P87, DOI 10.1098/rstb.2009.0150; Bolnick DI, 2017, NATURE, V546, P285, DOI 10.1038/nature22351; Bosse M, 2017, SCIENCE, V358, P365, DOI 10.1126/science.aal3298; Chouteau M, 2017, P NATL ACAD SCI USA, V114, P8325, DOI 10.1073/pnas.1702482114; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Comeault AA, 2015, CURR BIOL, V25, P1975, DOI 10.1016/j.cub.2015.05.058; Cook LM, 2005, J HERED, V96, P522, DOI 10.1093/jhered/esi082; Cook LM, 1996, PHILOS T R SOC B, V351, P1623, DOI 10.1098/rstb.1996.0146; Coulson T, 2011, SCIENCE, V334, P1275, DOI 10.1126/science.1209441; Cressie N. A. C., 2011, STAT SPATIO TEMPORAL; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dobzhansky T., 1951, COPEIA; Farkas TE, 2013, CURR BIOL, V23, P1835, DOI 10.1016/j.cub.2013.07.067; Foll M, 2015, MOL ECOL RESOUR, V15, P87, DOI 10.1111/1755-0998.12280; Gompert Z, 2016, MOL ECOL, V25, P121, DOI 10.1111/mec.13323; Gompert Z, 2014, ECOL LETT, V17, P369, DOI 10.1111/ele.12238; Grant P. R., 2014, 40 YEARS EVOLUTION D, DOI DOI 10.2307/J.CTT5HHNCC; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hendry A.P, 2017, ECOEVOLUTIONARY DYNA; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Lassig M, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0077; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; Lindtke D, 2017, MOL ECOL, V26, P6189, DOI 10.1111/mec.14280; Merila J, 2012, BIOESSAYS, V34, P811, DOI 10.1002/bies.201200054; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nosil P, 2004, P ROY SOC B-BIOL SCI, V271, P1521, DOI 10.1098/rspb.2004.2751; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Nosil P, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0001; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Riesch R, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0082; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Sandoval C, 2000, SOUTHWEST NAT, V45, P123, DOI 10.2307/3672452; SANDOVAL CP, 1994, EVOLUTION, V48, P1866, DOI 10.1111/j.1558-5646.1994.tb02220.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Soria-Carrasco V, 2014, SCIENCE, V344, P738, DOI 10.1126/science.1252136; Thibert-Plante X, 2011, J EVOLUTION BIOL, V24, P326, DOI 10.1111/j.1420-9101.2010.02169.x	44	102	103	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					765	+	aap9125	10.1126/science.aap9125	http://dx.doi.org/10.1126/science.aap9125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449486	Green Accepted			2022-12-28	WOS:000425116200038
J	Dafny, LS				Dafny, Leemore S.			Does CVS-Aetna Spell the End of Business as Usual?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dafny, Leemore S.] Harvard Sch Business, Dept Gen Management, Boston, MA 02163 USA; [Dafny, Leemore S.] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA; [Dafny, Leemore S.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard University; National Bureau of Economic Research	Dafny, LS (corresponding author), Harvard Sch Business, Dept Gen Management, Boston, MA 02163 USA.; Dafny, LS (corresponding author), Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA.; Dafny, LS (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.							Ashwood JS, 2016, HEALTH AFFAIR, V35, P449, DOI 10.1377/hlthaff.2015.0995; Starc A, 2015, 21783 NBER, DOI [10.1056/NEJMp1717137, DOI 10.1056/NEJMP1717137]	2	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					593	595		10.1056/NEJMp1717137	http://dx.doi.org/10.1056/NEJMp1717137			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW0QK	29443670	Green Accepted			2022-12-28	WOS:000425000000002
J	Henderson, JT; Webber, EM; Sawaya, GF				Henderson, Jillian T.; Webber, Elizabeth M.; Sawaya, George F.			Screening for Ovarian Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							KINGDOM COLLABORATIVE TRIAL; PLCO TRIAL; MORTALITY; PROSTATE; WOMEN; LUNG; RISK; HYSTERECTOMY; OOPHORECTOMY; MULTICENTER	IMPORTANCE Ovarian cancer is relatively rare but the fifth-leading cause of cancer mortality among United States women. OBJECTIVE To systematically review evidence on benefits and harms of ovarian cancer screening among average-risk women to inform the United States Preventive Services Task Force. DATA SOURCES MEDLINE, PubMed, Cochrane Collaboration Registry of Controlled Trials; studies published in English from January 1, 2003, through January 31, 2017; ongoing surveillance in targeted publications through November 22, 2017. STUDY SELECTION Randomized clinical trials of ovarian cancer screening in average-risk women that reported mortality or quality-of-life outcomes. Interventions included transvaginal ultrasound, cancer antigen 125 (CA-125) testing, or their combination. Comparators were usual care or no screening. DATA EXTRACTION AND SYNTHESIS Independent critical appraisal and data abstraction by 2 reviewers. Meta-analytic pooling of results was not conducted because of the small number of studies and heterogeneity of interventions. MAIN OUTCOMES AND MEASURES Ovarian cancer mortality, false-positive screening results and surgery, surgical complications, and psychological effects of screening. RESULTS Four trials (N = 293 587) were included; of these, 3 (n = 293 038) assessed ovarian cancer mortality, and 1 (n = 549) reported only on psychological outcomes. Evaluated screening interventions included transvaginal ultrasound alone, transvaginal ultrasound plus CA-125 testing, and CA-125 testing alone. Test positivity for CA-125 was defined by a fixed serum level cutpoint or by a proprietary risk algorithm based on CA-125 level, change in CA-125 level over time, and age (risk of ovarian cancer algorithm [ROCA]). No trial found a significant difference in ovarian cancer mortality with screening. In the 2 large screening trials (PLCO and UKCTOCS, n = 271 103), there was not a statistically significant difference in complete intention-to-screen analyses of ovarian, fallopian, and peritoneal cancer cases associated with screening (PLCO: rate ratio, 1.18 [95% CI, 0.82-1.71]; UKCTOCS: hazard ratio [HR], 0.91 [95% CI, 0.76-1.09] for transvaginal ultrasound and HR, 0.89 [95% CI, 0.74-1.08] for CA-125 ROCA). Within these 2 trials, screening led to surgery for suspected ovarian cancer in 1% of women without cancer for CA-125 ROCA and in 3% for transvaginal ultrasound with or without CA-125 screening, with major complications occurring among 3% to 15% of surgery. Evidence on psychological harms was limited but nonsignificant except in the case of repeat follow-up scans and tests, which increased the risk of psychological morbidity in a subsample of UKCTOCS participants based on the General Health Questionnaire 12 (score >= 4) (odds ratio, 1.28 [95% CI, 1.18-1.39]). CONCLUSIONS AND RELEVANCE In randomized trials conducted among average-risk, asymptomatic women, ovarian cancer mortality did not significantly differ between screened women and those with no screening or in usual care. Screening harms included surgery (with major surgical complications) in women found to not have cancer. Further research is needed to identify effective approaches for reducing ovarian cancer incidence and mortality.	[Henderson, Jillian T.; Webber, Elizabeth M.] Kaiser Permanente Northwest, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, 3800 N Interstate Ave, Portland, OR 97227 USA; [Sawaya, George F.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco	Henderson, JT (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, 3800 N Interstate Ave, Portland, OR 97227 USA.	Jillian.T.Henderson@kpchr.org			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500007I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA290201500007I, Task Order 2, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Andersen MR, 2007, PSYCHO-ONCOLOGY, V16, P814, DOI 10.1002/pon.1151; Ansari M., 2014, METHODS GUIDE EFFECT, V10, P314; Barrett J, 2014, BJOG-INT J OBSTET GY, V121, P1071, DOI 10.1111/1471-0528.12870; Barton M, 2012, AHRQ PUBLICATION; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P947, DOI [10.1001/jama.2016.12819, 10.1001/jama.2017.0807]; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; Croswell JM, 2009, ANN FAM MED, V7, P212, DOI 10.1370/afm.942; Danforth KN, 2012, AHRQ PUBLICATION, V12-05165-EF4; Daya D, 2014, WHO CLASSIFICATION T, P92; Doroudi M, 2017, J MED SCREEN, V24, P220, DOI 10.1177/0969141316680381; Drescher CW, 2012, CANCER PREV RES, V5, P1015, DOI 10.1158/1940-6207.CAPR-11-0468; Drescher CW, 2004, CANCER EPIDEM BIOMAR, V13, P600; Evans EC, 2016, OBSTET GYNECOL, V128, P476, DOI 10.1097/AOG.0000000000001592; Gewandter JS, 2014, PAIN, V155, P461, DOI 10.1016/j.pain.2013.11.009; Gren L, 2009, CLIN TRIALS, V6, P52, DOI 10.1177/1740774508100974; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Howlader N, 2011, SEER CANC STAT REV 1; Institute of Medicine Committee on the State of the Science in Ovarian Cancer Research Board on Health Care Services National Academies of Sciences Engineering and Medicine, 2016, OV CANC EV PAR RES C; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Jenkins V, 2015, INT J GYNECOL CANCER, V25, P1519, DOI 10.1097/IGC.0000000000000507; Kaiser Permanente Southern California, 2014, OV CANC SCREEN CLIN; Kobayashi H, 2008, INT J GYNECOL CANCER, V18, P414, DOI 10.1111/j.1525-1438.2007.01035.x; Koshiyama M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934261; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Lai T, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e41; Lowder JL, 2010, AM J OBSTET GYNECOL, V202; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Menon U, 2015, J CLIN ONCOL, V33, P2062, DOI 10.1200/JCO.2014.59.4945; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Miller RW, 2015, GYNECOL ONCOL, V137, P180, DOI 10.1016/j.ygyno.2015.01.452; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moyer VA, 2012, ANN INTERN MED, V157, P900, DOI 10.7326/0003-4819-157-11-201212040-00539; Nelson H, 2004, AHRQ PUBLICATION; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Pinsky PF, 2016, GYNECOL ONCOL, V143, P270, DOI 10.1016/j.ygyno.2016.08.334; Pinsky PF, 2013, INT J CANCER, V132, P2127, DOI 10.1002/ijc.27909; Prat J, 2014, INT J GYNECOL OBSTET, V124, P1, DOI 10.1016/j.ijgo.2013.10.001; Reade CJ, 2014, J OBSTET GYNAECOL CA, V36, P133, DOI 10.1016/S1701-2163(15)30659-9; Reade CJ, 2013, GYNECOL ONCOL, V130, P674, DOI 10.1016/j.ygyno.2013.06.029; Rice MS, 2014, FERTIL STERIL, V102, P192, DOI 10.1016/j.fertnstert.2014.03.041; Russell MR, 2017, ONCOTARGET, V8, P785, DOI 10.18632/oncotarget.13648; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sharma A, 2016, ULTRASOUND OBST GYN, V47, P228, DOI 10.1002/uog.14929; Skates SJ, 2001, J AM STAT ASSOC, V96, P429, DOI 10.1198/016214501753168145; Skates Steven J, 2003, J Clin Oncol, V21, p206s, DOI 10.1200/JCO.2003.02.955; Surveillance Epidemiology and End Results (SEER), SEER STAT FACT SHEET; Temkin SM, 2017, EUR J CANCER, V87, P182, DOI 10.1016/j.ejca.2017.10.015; US Cancer StatisticsWorking Group. United States Cancer Statistics (USCS), 2017, US CANC STAT USCS 19; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; van Nagell JR, 2011, OBSTET GYNECOL, V118, P1212, DOI 10.1097/AOG.0b013e318238d030	55	169	183	5	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					595	606		10.1001/jama.2017.21421	http://dx.doi.org/10.1001/jama.2017.21421			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450530	Bronze			2022-12-28	WOS:000424908400020
J	Bao, H; Das, D; Courtney, NA; Jiang, YH; Briguglio, JS; Lou, XC; Roston, D; Cui, Q; Chanda, B; Chapman, ER				Bao, Huan; Das, Debasis; Courtney, Nicholas A.; Jiang, Yihao; Briguglio, Joseph S.; Lou, Xiaochu; Roston, Daniel; Cui, Qiang; Chanda, Baron; Chapman, Edwin R.			Dynamics and number of trans-SNARE complexes determine nascent fusion pore properties	NATURE			English	Article							MEMBRANE-FUSION; CHROMAFFIN CELLS; SIMULATION; PROTEINS; RECONSTITUTION; SYNAPTOTAGMIN; SYNAPTOBREVIN; TRANSMITTER; ENDOCYTOSIS; SYNAPSES	The fusion pore is the first crucial intermediate formed during exocytosis, yet little is known about the mechanisms that determine the size and kinetic properties of these transient structures(1). Here, we reduced the number of available SNAREs (proteins that mediate vesicle fusion) in neurons and observed changes in transmitter release that are suggestive of alterations in fusion pores. To investigate these changes, we employed reconstituted fusion assays using nanodiscs to trap pores in their initial open state. Optical measurements revealed that increasing the number of SNARE complexes enhanced the rate of release from single pores and enabled the escape of larger cargoes. To determine whether this effect was due to changes in nascent pore size or to changes in stability, we developed an approach that uses nanodiscs and planar lipid bilayer electrophysiology to afford microsecond resolution at the single event level. Both pore size and stability were affected by SNARE copy number. Increasing the number of vesicle (v)-SNAREs per nanodisc from three to five caused a twofold increase in pore size and decreased the rate of pore closure by more than three orders of magnitude. Moreover, pairing of v-SNAREs and target (t)-SNAREs to form trans-SNARE complexes was highly dynamic: flickering nascent pores closed upon addition of a v-SNARE fragment, revealing that the fully assembled, stable SNARE complex does not form at this stage of exocytosis. Finally, a deletion at the base of the SNARE complex, which mimics the action of botulinum neurotoxin A, markedly reduced fusion pore stability. In summary, trans-SNARE complexes are dynamic, and the number of SNAREs recruited to drive fusion determines fundamental properties of individual pores.	[Bao, Huan; Das, Debasis; Courtney, Nicholas A.; Jiang, Yihao; Briguglio, Joseph S.; Lou, Xiaochu; Chanda, Baron; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, 1111 Highland Ave, Madison, WI 53705 USA; [Bao, Huan; Das, Debasis; Courtney, Nicholas A.; Briguglio, Joseph S.; Lou, Xiaochu; Chapman, Edwin R.] Howard Hughes Med Inst, 1111 Highland Ave, Madison, WI 53705 USA; [Roston, Daniel; Cui, Qiang] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Roston, Daniel; Cui, Qiang] Univ Wisconsin, Inst Theoret Chem, Madison, WI 53706 USA; [Chanda, Baron] Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Dept Neurosci, 1111 Highland Ave, Madison, WI 53705 USA.; Chapman, ER (corresponding author), Howard Hughes Med Inst, 1111 Highland Ave, Madison, WI 53705 USA.	chapman@wisc.edu		Bao, Huan/0000-0002-4301-4627; Jiang, Yihao/0000-0001-7694-3089; Chapman, Edwin/0000-0001-9787-8140	NIH [MH061876, NS097362, NS081293, F32GM112371]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM112371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097362, R01NS081293, R01NS101723] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the NIH (MH061876 and NS097362 to E.R.C.; NS081293 to B.C.). H.B. was supported by a postdoctoral fellowship from the Human Frontier Science Program. D.R. was supported by an NIH fellowship (F32GM112371). E.R.C. is an Investigator of the Howard Hughes Medical Institute.	Alabi AA, 2013, ANNU REV PHYSIOL, V75, P393, DOI 10.1146/annurev-physiol-020911-153305; Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Bao H, 2016, NAT STRUCT MOL BIOL, V23, P67, DOI 10.1038/nsmb.3141; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Eastman P, 2013, J CHEM THEORY COMPUT, V9, P461, DOI 10.1021/ct300857j; Finkelstein A, 1974, Methods Enzymol, V32, P489; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Henkel AW, 2000, EMBO J, V19, P84, DOI 10.1093/emboj/19.1.84; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2011, J COMPUT CHEM, V32, P3135, DOI 10.1002/jcc.21886; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Kyoung MJ, 2013, NAT PROTOC, V8, P1, DOI 10.1038/nprot.2012.134; Lai Y, 2013, P NATL ACAD SCI USA, V110, P1333, DOI 10.1073/pnas.1218818110; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Marvin JS, 2011, PROTEINS, V79, P3025, DOI 10.1002/prot.23118; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Nasr ML, 2017, NAT METHODS, V14, P49, DOI [10.1038/NMETH.4079, 10.1038/nmeth.4079]; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Richards DA, 2009, J PHYSIOL-LONDON, V587, P5073, DOI 10.1113/jphysiol.2009.175315; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wiederhold K, 2010, J BIOL CHEM, V285, P21549, DOI 10.1074/jbc.M110.105148; Wu ZY, 2017, ELIFE, V6, DOI 10.7554/eLife.22964; Wu ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27287; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	42	60	60	4	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					260	+		10.1038/nature25481	http://dx.doi.org/10.1038/nature25481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420480	Green Accepted			2022-12-28	WOS:000424332600043
J	Frankel, NW; Lim, WA				Frankel, Nicholas W.; Lim, Wendell A.			Building a Stable Relationship: Ensuring Homeostasis among Cell Types within a Tissue	CELL			English	Editorial Material							MACROPHAGES	Many processes controlling cell growth and death are well characterized for individual cell lineages, but how ensembles of different cell types in a tissue regulate collective size and composition remains unclear. In this issue of Cell, Zhou et al. employ experiments and theory to uncover design principles of tissue homeostasis arising from cross-talk between fibroblasts and macrophages.	[Frankel, Nicholas W.; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA.	wendell.lim@ucsf.edu						Barillot E, 2013, COMPUTATIONAL SYSTEM; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Korolev KS, 2014, NAT REV CANCER, V14, P371, DOI 10.1038/nrc3712; Penzo-Mendez AI, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019240; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Velazquez J. J., 2018, TRENDS BIOTECHNOL; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	9	0	0	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					638	640		10.1016/j.cell.2018.01.024	http://dx.doi.org/10.1016/j.cell.2018.01.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29425483	Bronze			2022-12-28	WOS:000424648800003
J	Peng, Y; McCorvy, JD; Harpsoe, K; Lansu, K; Yuan, SG; Popov, P; Qu, L; Pu, MC; Che, T; Nikolajsen, LF; Huang, XP; Wu, YR; Shen, L; Bjorn-Yoshimoto, WE; Ding, K; Wacker, D; Han, GW; Cheng, JJ; Katritch, V; Jensen, AA; Hanson, MA; Zhao, SW; Gloriam, DE; Roth, BL; Stevens, RC; Liu, ZJ				Peng, Yao; McCorvy, John D.; Harpsoe, Kasper; Lansu, Katherine; Yuan, Shuguang; Popov, Petr; Qu, Lu; Pu, Mengchen; Che, Tao; Nikolajsen, Louise F.; Huang, Xi-Ping; Wu, Yiran; Shen, Ling; Bjorn-Yoshimoto, Walden E.; Ding, Kang; Wacker, Daniel; Han, Gye Won; Cheng, Jianjun; Katritch, Vsevolod; Jensen, Anders A.; Hanson, Michael A.; Zhao, Suwen; Gloriam, David E.; Roth, Bryan L.; Stevens, Raymond C.; Liu, Zhi-Jie			5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology	CELL			English	Article							CRYSTAL-STRUCTURE; FUNCTIONAL SELECTIVITY; MEMBRANE-PROTEINS; DRUG; DISCOVERY; LIGANDS; DESIGN; SYSTEM; ACTIVATION; LORCASERIN	Drugs frequently require interactions with multiple targets-via a process known as poly-pharmacology-to achieve their therapeutic actions. Currently, drugs targeting several serotonin receptors, including the 5-HT2C receptor, are useful for treating obesity, drug abuse, and schizophrenia. The competing challenges of developing selective 5-HT2C receptor ligands or creating drugs with a defined poly-pharmacological profile, especially aimed at G protein-coupled receptors (GPCRs), remain extremely difficult. Here, we solved two structures of the 5-HT2C receptor in complex with the highly promiscuous agonist ergotamine and the 5-HT2A-C receptor-selective inverse agonist ritanserin at resolutions of 3.0 angstrom and 2.7 angstrom, respectively. We analyzed their respective binding poses to provide mechanistic insights into their receptor recognition and opposing pharmacological actions. This study investigates the structural basis of polypharmacology at canonical GPCRs and illustrates how understanding characteristic patterns of ligand-receptor interaction and activation may ultimately facilitate drug design at multiple GPCRs.	[Peng, Yao; Qu, Lu; Pu, Mengchen; Nikolajsen, Louise F.; Wu, Yiran; Shen, Ling; Ding, Kang; Cheng, Jianjun; Zhao, Suwen; Stevens, Raymond C.; Liu, Zhi-Jie] ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China; [Peng, Yao; Liu, Zhi-Jie] Kunming Med Univ, Inst Mol & Clin Med, Yunnan Key Lab Stem Cell & Regenerat Med, Kunming 650500, Yunnan, Peoples R China; [Peng, Yao; Qu, Lu; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [McCorvy, John D.; Lansu, Katherine; Che, Tao; Huang, Xi-Ping; Wacker, Daniel; Roth, Bryan L.] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Harpsoe, Kasper; Nikolajsen, Louise F.; Bjorn-Yoshimoto, Walden E.; Jensen, Anders A.; Gloriam, David E.] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Yuan, Shuguang] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH B3 495,Batiment CH,Stn 6, CH-1015 Lausanne, Switzerland; [Popov, Petr; Han, Gye Won; Katritch, Vsevolod; Stevens, Raymond C.] Univ Southern Calif, Michelson Ctr, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Popov, Petr; Han, Gye Won; Katritch, Vsevolod; Stevens, Raymond C.] Univ Southern Calif, Michelson Ctr, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Popov, Petr; Katritch, Vsevolod] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia; [Huang, Xi-Ping; Roth, Bryan L.] Univ North Carolina Chapel Hill, NIMH PDSP, Chapel Hill, NC 27599 USA; [Shen, Ling; Ding, Kang; Zhao, Suwen; Stevens, Raymond C.; Liu, Zhi-Jie] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Hanson, Michael A.] GPCR Consortium, San Marcos, CA 92078 USA; [Roth, Bryan L.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	ShanghaiTech University; Kunming Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Copenhagen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Southern California; University of Southern California; Moscow Institute of Physics & Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; ShanghaiTech University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Stevens, RC; Liu, ZJ (corresponding author), ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China.; Liu, ZJ (corresponding author), Kunming Med Univ, Inst Mol & Clin Med, Yunnan Key Lab Stem Cell & Regenerat Med, Kunming 650500, Yunnan, Peoples R China.; Liu, ZJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Stevens, RC (corresponding author), Univ Southern Calif, Michelson Ctr, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA.; Stevens, RC (corresponding author), Univ Southern Calif, Michelson Ctr, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA.; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, NIMH PDSP, Chapel Hill, NC 27599 USA.; Stevens, RC; Liu, ZJ (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA.	bryan_roth@med.unc.edu; stevens@shanghaitech.edu.cn; liuzhj@shanghaitech.edu.cn	Roth, Bryan L/F-3928-2010; Han, Gye Won/GLT-1531-2022; Cheng, Jianjun/AAX-1552-2021; Harpsøe, Kasper/V-6870-2018; Gloriam, David E./A-1904-2011; Popov, Petr A/G-9638-2016; YUAN, SHUGUANG/S-9686-2019; Roth, Bryan/ABE-7032-2020; Liu, Zhi-Jie/A-3946-2012; Jensen, Anders/AAJ-3335-2020; Popov, Petr A/O-8970-2015; Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Q-8357-2016; Han, Gye Won/GLQ-8673-2022; Bjørn-Yoshimoto, Walden/ABH-3709-2020; Katritch, Vsevolod/Y-2721-2019	Cheng, Jianjun/0000-0001-6065-2682; Harpsøe, Kasper/0000-0002-9326-9644; Gloriam, David E./0000-0002-4299-7561; YUAN, SHUGUANG/0000-0001-9858-4742; Roth, Bryan/0000-0002-0561-6520; Liu, Zhi-Jie/0000-0001-7279-2893; Jensen, Anders/0000-0002-7927-5052; Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; Nikolajsen, Louise Fletcher/0000-0002-7573-213X; Ding, Kang/0000-0001-8570-8793; Bjorn-Yoshimoto, Walden Emil/0000-0003-1019-9239; Pu, Mengchen/0000-0001-6282-2454; Qu, Lu/0000-0002-5121-2164	Ministry of Science and Technology of China [2014CB910400, 2015CB910104]; National Nature Science Foundation of China [31330019]; NIH [R01MH112205, U19MH82441, U54GM094618]; Michael Hooker Distinguished Professorship; NIMH [271201300017C-4-01]; Russian Science Foundation [16-14-10273]; Lundbeck Foundation [R163-2013-16327]; Shanghai Municipal Government; ShanghaiTech University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH112205, U19MH082441] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Hooker Distinguished Professorship; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Russian Science Foundation(Russian Science Foundation (RSF)); Lundbeck Foundation(Lundbeckfonden); Shanghai Municipal Government; ShanghaiTech University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Ministry of Science and Technology of China (2014CB910400 and 2015CB910104), the National Nature Science Foundation of China (31330019) (to Z.J.L.), the NIH (R01MH112205 and U19MH82441), the Michael Hooker Distinguished Professorship, the NIMH Psychoactive Drug Screening Program (271201300017C-4-01) (to B.L.R., J.M., and others from the Roth lab), the NIH (U54GM094618) (to V.K.), the Russian Science Foundation (16-14-10273) (to P.P.), and the Lundbeck Foundation (R163-2013-16327) (to D.E.G.). We thank the Shanghai Municipal Government and ShanghaiTech University for financial support. The diffraction data were collected at the BL41XU of SPring-8 (JASRI proposal 2015B1031 and 2016A2731), GM/CA at APS of Argonne National Lab, and X06SA beamline at the Swiss Light Source of the Paul Scherrer Institute. We thank K. Hasegawa, H. Okumura, H. Murakami, M. Audet, M. Wang, C. Huang, and V. Olieric for their help with data collection. We thank the Cloning, Cell Expression, Assay, and Protein Purification Core Facilities of iHuman Institute for their support. We thank I. Wilson for careful review and insightful discussions on the manuscript; A. Walker for assistance with the manuscript; and T. Hua, V. Cherezov, T. Tsonkov, G. Song, W. Shui, D. Liu, H. Tao, G. Zhong, F. Xu, B. Wu, Q. Zhao, and W. Liu for helpful discussions.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARKER EL, 1994, J BIOL CHEM, V269, P11687; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bourdon DM, 2006, METHOD ENZYMOL, V406, P489, DOI 10.1016/S0076-6879(06)06037-X; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chaudhari R, 2017, EXPERT OPIN DRUG DIS, V12, P279, DOI 10.1080/17460441.2017.1280024; Cheng JJ, 2016, J MED CHEM, V59, P9866, DOI 10.1021/acs.jmedchem.6b01194; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Den Boer JA, 2000, HUM PSYCHOPHARM CLIN, V15, P179, DOI 10.1002/(SICI)1099-1077(200004)15:3<179::AID-HUP156>3.0.CO;2-N; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garland SL, 2011, CURR TOP MED CHEM, V11, P1872; Huang XP, 2009, MOL PHARMACOL, V76, P710, DOI 10.1124/mol.109.058057; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Jacobson KA, 2014, TRENDS PHARMACOL SCI, V35, P658, DOI 10.1016/j.tips.2014.10.009; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meltzer HY, 2013, J CLIN INVEST, V123, P4986, DOI 10.1172/JCI70678; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Nichols DE, 2016, PHARMACOL REV, V68, P264, DOI 10.1124/pr.115.011478; Palacios JM, 2017, PSYCHOPHARMACOLOGY, V234, P1395, DOI 10.1007/s00213-017-4545-5; Pogorelov VM, 2017, NEUROPSYCHOPHARMACOL, V42, P2163, DOI 10.1038/npp.2017.52; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Toll L, 1998, NIDA Res Monogr, V178, P440; Tuplin EW, 2017, CURR NEUROPHARMACOL, V15, P1192, DOI 10.2174/1570159X15666170413115754; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wang S, 2017, SCIENCE, V358, P381, DOI 10.1126/science.aan5468; Yadav PN, 2011, J PHARMACOL EXP THER, V339, P99, DOI 10.1124/jpet.111.183780; Yadav PN, 2011, NEUROPSYCHOPHARMACOL, V36, P638, DOI 10.1038/npp.2010.195	53	135	135	4	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					719	+		10.1016/j.cell.2018.01.001	http://dx.doi.org/10.1016/j.cell.2018.01.001			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29398112	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000424648800013
J	Muller, O; Pawlowski, MS; Jerjen, H; Lelli, F				Mueller, Oliver; Pawlowski, Marcel S.; Jerjen, Helmut; Lelli, Federico			A whirling plane of satellite galaxies around Centaurus A challenges cold dark matter cosmology	SCIENCE			English	Article							TIDAL DWARF GALAXIES; MILKY-WAY SATELLITES; LOCAL GROUP; THIN PLANE; ANISOTROPIC DISTRIBUTION; TRANSVERSE VELOCITY; ANDROMEDA GALAXY; PROPER MOTIONS; M31; SYSTEM	The Milky Way and Andromeda galaxies are each surrounded by a thin plane of satellite dwarf galaxies that may be corotating. Cosmological simulations predict that most satellite galaxy systems are close to isotropic with random motions, so those two well-studied systems are often interpreted as rare statistical outliers. We test this assumption using the kinematics of satellite galaxies around the Centaurus A galaxy. Our statistical analysis reveals evidence for corotation in a narrow plane: Of the 16 Centaurus A satellites with kinematic data, 14 follow a coherent velocity pattern aligned with the long axis of their spatial distribution. In standard cosmological simulations, <0.5% of Centaurus A-like systems show such behavior. Corotating satellite systems may be common in the universe, challenging small-scale structure formation in the prevailing cosmological paradigm.	[Mueller, Oliver] Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland; [Pawlowski, Marcel S.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Jerjen, Helmut] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT 2611, Australia; [Lelli, Federico] ESO, Karl Schwarschild Str 1, D-85748 Garching, Germany	University of Basel; University of California System; University of California Irvine; Australian National University	Muller, O (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	oliver89.mueller@unibas.ch	Müller, Oliver/AAL-4608-2021	Müller, Oliver/0000-0003-4552-9808; Lelli, Federico/0000-0002-9024-9883; Pawlowski, Marcel Sven/0000-0002-9197-9300	Swiss National Science Foundation; NASA - Space Telescope Science Institute [HST-HF2-51379.001-A]; NASA [NAS5-26555]; Australian Research Council [DP150100862]; ESO postdoctoral fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NASA - Space Telescope Science Institute(Space Telescope Science InstituteNational Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Australian Research Council(Australian Research Council); ESO postdoctoral fellowship	We thank B. Binggeli and M. Rejkuba for interesting discussions and helpful inputs. O.M. thanks E. Schnider for inputs concerning the figures. O.M. is grateful to the Swiss National Science Foundation for financial support. M.S.P. acknowledges support for this work provided by NASA through Hubble Fellowship grant HST-HF2-51379.001-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS5-26555. H.J. acknowledges the support of the Australian Research Council through Discovery Project DP150100862. The work of F.L. is supported by an ESO postdoctoral fellowship. The Millennium-II Simulation databases used in this paper and the web application providing online access to them were constructed as part of the activities of the German Astrophysical Virtual Observatory. The Illustris Simulation databases are provided by the Illustris Collaboration. The observational data we used are given in table S1. The software for our Monte Carlo analysis is provided in data file S1, and the catalogs of Cen A analogs in the simulations are in data files S2 and S3. We thank the anonymous referees for helpful comments that improved the paper.	Bahl H, 2014, MON NOT R ASTRON SOC, V438, P2916, DOI 10.1093/mnras/stt2399; Bournaud F, 2007, SCIENCE, V316, P1166, DOI 10.1126/science.1142114; Boylan-Kolchin M, 2009, MON NOT R ASTRON SOC, V398, P1150, DOI 10.1111/j.1365-2966.2009.15191.x; Buck T, 2016, MON NOT R ASTRON SOC, V460, P4348, DOI 10.1093/mnras/stw1232; Bullock JS, 2017, ANNU REV ASTRON ASTR, V55, P343, DOI 10.1146/annurev-astro-091916-055313; Cautun M, 2015, MON NOT R ASTRON SOC, V452, P3838, DOI 10.1093/mnras/stv1557; Cautun M, 2015, MON NOT R ASTRON SOC, V449, P2576, DOI 10.1093/mnras/stv490; Chiboucas K, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/5/126; Crnojevic D, 2016, ASTROPHYS J, V823, DOI 10.3847/0004-637X/823/1/19; Fouquet S, 2012, MON NOT R ASTRON SOC, V427, P1769, DOI 10.1111/j.1365-2966.2012.22067.x; Garrison-Kimmel S, 2017, MON NOT R ASTRON SOC, V471, P1709, DOI 10.1093/mnras/stx1710; Gillet N, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/34; Hammer F, 2013, MON NOT R ASTRON SOC, V431, P3543, DOI 10.1093/mnras/stt435; Hibbard JE, 2001, ASTRON J, V122, P2969, DOI 10.1086/324102; Ibata NG, 2014, NATURE, V511, P563, DOI 10.1038/nature13481; Ibata RA, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/1/67; Ibata RA, 2013, NATURE, V493, P62, DOI 10.1038/nature11717; Karachentsev ID, 2004, ASTRON J, V127, P2031, DOI 10.1086/382905; Karachentsev ID, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/4/101; Koch A, 2006, ASTRON J, V131, P1405, DOI 10.1086/499534; Kroupa P, 2005, ASTRON ASTROPHYS, V431, P517, DOI 10.1051/0004-6361:20041122; Kunkel W. E., 1976, Royal Greenwich Observatory Bulletins, P241; Lelli F, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201526613; Libeskind NI, 2015, MON NOT R ASTRON SOC, V452, P1052, DOI 10.1093/mnras/stv1302; Lopez-Corredoira M, 2016, ASTROPHYS J, V817, DOI 10.3847/0004-637X/817/1/75; LYNDENBELL D, 1976, MON NOT R ASTRON SOC, V174, P695, DOI 10.1093/mnras/174.3.695; McConnachie AW, 2006, MON NOT R ASTRON SOC, V365, P902, DOI 10.1111/j.1365-2966.2005.09771.x; Muller O, 2017, ASTRON ASTROPHYS, V602, DOI 10.1051/0004-6361/201730434; Muller O, 2017, ASTRON ASTROPHYS, V597, DOI 10.1051/0004-6361/201628921; Muller O, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629298; Muller O, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526748; OSTRIKER JP, 1995, NATURE, V377, P600, DOI 10.1038/377600a0; Pawlowski MS, 2012, MON NOT R ASTRON SOC, V423, P1109, DOI 10.1111/j.1365-2966.2012.20937.x; Pawlowski MS, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201015021; Pawlowski MS, 2015, MON NOT R ASTRON SOC, V453, P1047, DOI 10.1093/mnras/stv1588; Pawlowski MS, 2014, MON NOT R ASTRON SOC, V442, P2362, DOI 10.1093/mnras/stu1005; Pawlowski MS, 2013, MON NOT R ASTRON SOC, V435, P2116, DOI 10.1093/mnras/stt1429; Pawlowski MS, 2013, MON NOT R ASTRON SOC, V435, P1928, DOI 10.1093/mnras/stt1384; Peng EW, 2004, ASTROPHYS J, V602, P685, DOI 10.1086/381160; Phillips JI, 2015, MON NOT R ASTRON SOC, V453, P3839, DOI 10.1093/mnras/stv1770; Ploeckinger S, 2015, MON NOT R ASTRON SOC, V447, P2512, DOI 10.1093/mnras/stu2629; Salomon JB, 2016, MON NOT R ASTRON SOC, V456, P4432, DOI 10.1093/mnras/stv2865; Tully RB, 2015, ASTROPHYS J LETT, V802, DOI 10.1088/2041-8205/802/2/L25; van der Marel RP, 2008, ASTROPHYS J, V678, P187, DOI 10.1086/533430; Vogelsberger M, 2014, NATURE, V509, P177, DOI 10.1038/nature13316; Walsh JR, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424316; Wetzels R, 2012, PSYCHON B REV, V19, P1057, DOI 10.3758/s13423-012-0295-x; WHITE SDM, 1993, NATURE, V366, P429, DOI 10.1038/366429a0; Zentner AR, 2005, ASTROPHYS J, V629, P219, DOI 10.1086/431355	51	100	101	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					534	+		10.1126/science.aao1858	http://dx.doi.org/10.1126/science.aao1858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420285	Green Submitted, Green Accepted			2022-12-28	WOS:000423795800033
J	Ford, TJ; Rocchiccioli, P				Ford, Thomas J.; Rocchiccioli, Paul			SPOT DIAGNOSIS A keen eye for risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ford, Thomas J.; Rocchiccioli, Paul] Univ Glasgow, Inst Cardiovasc & Med Sci, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Ford, Thomas J.] Golden Jubilee Natl Hosp, West Scotland Reg Heart & Lung Ctr, Clydebank, Scotland	University of Glasgow; Golden Jubilee Hospital	Ford, TJ (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.; Ford, TJ (corresponding author), Golden Jubilee Natl Hosp, West Scotland Reg Heart & Lung Ctr, Clydebank, Scotland.	tom.ford@glasgow.ac.uk	Ford, Tom/J-2419-2018	Ford, Tom/0000-0003-4009-6652				National Institute for Health and Care Excellence, 2016, EV TREAT PRIM HYP MI; National Institute for Health and Clinical Excellence, 2008, CLIN GUID EV REV FAM; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Zech LA, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-7	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2018	360								j5884	10.1136/bmj.j5884	http://dx.doi.org/10.1136/bmj.j5884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TT	29419393				2022-12-28	WOS:000423846200002
J	Zarocostas, J				Zarocostas, John			Senior WHO appointments are praised but raise questions	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2018	391	10118					299	299		10.1016/S0140-6736(18)30138-7	http://dx.doi.org/10.1016/S0140-6736(18)30138-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU5CE	29413035				2022-12-28	WOS:000423869500015
J	Watson, TF; Philips, SGJ; Kawakami, E; Ward, DR; Scarlino, P; Veldhorst, M; Savage, DE; Lagally, MG; Friesen, M; Coppersmith, SN; Eriksson, MA; Vandersypen, LMK				Watson, T. F.; Philips, S. G. J.; Kawakami, E.; Ward, D. R.; Scarlino, P.; Veldhorst, M.; Savage, D. E.; Lagally, M. G.; Friesen, Mark; Coppersmith, S. N.; Eriksson, M. A.; Vandersypen, L. M. K.			A programmable two-qubit quantum processor in silicon	NATURE			English	Article							SPIN QUBIT; ELECTRON-SPIN; DOT; FIDELITY; COMPUTATION; TOMOGRAPHY; COHERENCE; RESONANCE; ALGORITHM; COMPUTER	Now that it is possible to achieve measurement and control fidelities for individual quantum bits (qubits) above the threshold for fault tolerance, attention is moving towards the difficult task of scaling up the number of physical qubits to the large numbers that are needed for fault-tolerant quantum computing(1,2). In this context, quantum-dot-based spin qubits could have substantial advantages over other types of qubit owing to their potential for all-electrical operation and ability to be integrated at high density onto an industrial platform(3-5). Initialization, readout and single-and two-qubit gates have been demonstrated in various quantum-dot-based qubit representations(6-9). However, as seen with small-scale demonstrations of quantum computers using other types of qubit(10-13), combining these elements leads to challenges related to qubit crosstalk, state leakage, calibration and control hardware. Here we overcome these challenges by using carefully designed control techniques to demonstrate a programmable two-qubit quantum processor in a silicon device that can perform the Deutsch-Josza algorithm and the Grover search algorithm-canonical examples of quantum algorithms that outperform their classical analogues. We characterize the entanglement in our processor by using quantum-state tomography of Bell states, measuring state fidelities of 85-89 per cent and concurrences of 73-82 per cent. These results pave the way for larger-scale quantum computers that use spins confined to quantum dots.	[Watson, T. F.; Philips, S. G. J.; Kawakami, E.; Scarlino, P.; Veldhorst, M.; Vandersypen, L. M. K.] Delft Univ Technol, QuTech & Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Ward, D. R.; Savage, D. E.; Lagally, M. G.; Friesen, Mark; Coppersmith, S. N.; Eriksson, M. A.] Univ Wisconsin, Madison, WI 53706 USA	Delft University of Technology; University of Wisconsin System; University of Wisconsin Madison	Vandersypen, LMK (corresponding author), Delft Univ Technol, QuTech & Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands.	l.m.k.vandersypen@tudelft.nl	Scarlino, Pasquale/AAX-3685-2020; Scarlino, Pasquale/GYJ-3547-2022; Coppersmith, Susan N/I-9685-2018; Kawakami, Erika/AAA-9271-2021	Scarlino, Pasquale/0000-0002-4570-5958; Coppersmith, Susan N/0000-0002-5630-4893; Kawakami, Erika/0000-0002-0393-3880; Eriksson, Mark/0000-0002-3130-9735; Savage, Donald/0000-0001-8515-4196; Friesen, Mark/0000-0003-2878-2844; Ward, Daniel/0000-0002-9263-5542				Bluhm H, 2011, NAT PHYS, V7, P109, DOI 10.1038/NPHYS1856; Das Sarma S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235314; Debnath S, 2016, NATURE, V536, P63, DOI 10.1038/nature18648; DEUTSCH D, 1992, P ROY SOC LOND A MAT, V439, P553, DOI 10.1098/rspa.1992.0167; Dial OE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.146804; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Gulde S, 2003, NATURE, V421, P48, DOI 10.1038/nature01336; Ithier G, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134519; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Kawakami E, 2014, NAT NANOTECHNOL, V9, P666, DOI [10.1038/nnano.2014.153, 10.1038/NNANO.2014.153]; Kawakami E, 2016, P NATL ACAD SCI USA, V113, P11738, DOI 10.1073/pnas.1603251113; Kim D, 2014, NATURE, V511, P70, DOI 10.1038/nature13407; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Martins F, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.116801; Maurand R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13575; Medford J, 2013, NAT NANOTECHNOL, V8, P654, DOI [10.1038/nnano.2013.168, 10.1038/NNANO.2013.168]; Meunier T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.121403; Muhonen JT, 2014, NAT NANOTECHNOL, V9, P986, DOI [10.1038/nnano.2014.211, 10.1038/NNANO.2014.211]; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Shulman MD, 2012, SCIENCE, V336, P202, DOI 10.1126/science.1217692; Srinivasa V, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.196803; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; van der Sar T, 2012, NATURE, V484, P82, DOI 10.1038/nature10900; Vandersypen LMK, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0038-y; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Yang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3069; Yoneda J, 2018, NAT NANOTECHNOL, V13, P102, DOI 10.1038/s41565-017-0014-x; Zajac DM, 2018, SCIENCE, V359, P439, DOI 10.1126/science.aao5965; Zwanenburg FA, 2013, REV MOD PHYS, V85, P961, DOI 10.1103/RevModPhys.85.961	38	420	420	6	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2018	555	7698					633	+		10.1038/nature25766	http://dx.doi.org/10.1038/nature25766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8UX	29443962	Green Submitted, Green Published			2022-12-28	WOS:000428617600044
J	Allemani, C; Matsuda, T; Di Carlo, V; Harewood, R; Matz, M; Niksic, M; Bonaventure, A; Valkov, M; Johnson, CJ; Esteve, J; Ogunbiyi, OJ; Silva, GAE; Chen, WQ; Eser, S; Engholm, G; Stiller, CA; Monnereau, A; Woods, RR; Visser, O; Lim, GH; Aitken, J; Weir, HK; Coleman, MP				Allemani, Claudia; Matsuda, Tomohiro; Di Carlo, Veronica; Harewood, Rhea; Matz, Melissa; Niksic, Maja; Bonaventure, Audrey; Valkov, Mikhail; Johnson, Christopher J.; Esteve, Jacques; Ogunbiyi, Olufemi J.; Azevedo e Silva, Gulnar; Chen, Wan-Qing; Eser, Sultan; Engholm, Gerda; Stiller, Charles A.; Monnereau, Alain; Woods, Ryan R.; Visser, Otto; Lim, Gek Hsiang; Aitken, Joanne; Weir, Hannah K.; Coleman, Michel P.		CONCORD Working Grp	Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries	LANCET			English	Article							UNITED-STATES; ALTERNATIVE APPROACH; RELATIVE SURVIVAL; CHILDHOOD-CANCER; PUBLIC-HEALTH; CURE; ENGLAND; BURDEN; STAGE; DEATHS	Background In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014. Methods CONCORD-3 includes individual records for 37.5 million patients diagnosed with cancer during the 15-year period 2000-14. Data were provided by 322 population-based cancer registries in 71 countries and territories, 47 of which provided data with 100% population coverage. The study includes 18 cancers or groups of cancers: oesophagus, stomach, colon, rectum, liver, pancreas, lung, breast (women), cervix, ovary, prostate, and melanoma of the skin in adults, and brain tumours, leukaemias, and lymphomas in both adults and children. Standardised quality control procedures were applied; errors were rectified by the registry concerned. We estimated 5-year net survival. Estimates were age-standardised with the International Cancer Survival Standard weights. Findings For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden. For many cancers, Denmark is closing the survival gap with the other Nordic countries. Survival trends are generally increasing, even for some of the more lethal cancers: in some countries, survival has increased by up to 5% for cancers of the liver, pancreas, and lung. For women diagnosed during 2010-14, 5-year survival for breast cancer is now 89.5% in Australia and 90.2% in the USA, but international differences remain very wide, with levels as low as 66.1% in India. For gastrointestinal cancers, the highest levels of 5-year survival are seen in southeast Asia: in South Korea for cancers of the stomach (68.9%), colon (71.8%), and rectum (71.1%); in Japan for oesophageal cancer (36.0%); and in Taiwan for liver cancer (27.9%). By contrast, in the same world region, survival is generally lower than elsewhere for melanoma of the skin (59.9% in South Korea, 52.1% in Taiwan, and 49.6% in China), and for both lymphoid malignancies (52.5%, 50.5%, and 38.3%) and myeloid malignancies (45.9%, 33.4%, and 24.8%). For children diagnosed during 2010-14, 5-year survival for acute lymphoblastic leukaemia ranged from 49.8% in Ecuador to 95.2% in Finland. 5-year survival from brain tumours in children is higher than for adults but the global range is very wide (from 28.9% in Brazil to nearly 80% in Sweden and Denmark). Interpretation The CONCORD programme enables timely comparisons of the overall effectiveness of health systems in providing care for 18 cancers that collectively represent 75% of all cancers diagnosed worldwide every year. It contributes to the evidence base for global policy on cancer control. Since 2017, the Organisation for Economic Co-operation and Development has used findings from the CONCORD programme as the official benchmark of cancer survival, among their indicators of the quality of health care in 48 countries worldwide. Governments must recognise population-based cancer registries as key policy tools that can be used to evaluate both the impact of cancer prevention strategies and the effectiveness of health systems for all patients diagnosed with cancer.	[Allemani, Claudia; Di Carlo, Veronica; Harewood, Rhea; Matz, Melissa; Niksic, Maja; Bonaventure, Audrey; Coleman, Michel P.] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Survival Grp, London WC1E 7HT, England; [Matsuda, Tomohiro] Natl Canc Ctr, Populat Based Canc Registry Sect, Div Surveillance, Ctr Canc Control & Informat Serv, Tokyo, Japan; [Valkov, Mikhail] Northern State Med Univ, Dept Radiol Radiotherapy & Oncol, Arkhangelsk, Russia; [Johnson, Christopher J.] Canc Data Registry Idaho, Boise, ID USA; [Esteve, Jacques] Univ Claude Bernard, Dept Biostat, Lyon, France; [Ogunbiyi, Olufemi J.] Univ City Coll Hosp, Ibadan Canc Registry, Ibadan, Dyo State, Nigeria; [Azevedo e Silva, Gulnar] Univ Estado Rio de Janeiro, Dept Epidemiol, Maracana, RJ, Brazil; [Chen, Wan-Qing] Natl Canc Ctr, Natl Off Canc Prevent & Control, Beijing, Peoples R China; [Chen, Wan-Qing] Natl Canc Ctr, Natl Cent Canc Registry, Beijing, Peoples R China; [Eser, Sultan] Balikesir Univ, Dept Publ Hlth, Balikesir, Turkey; [Engholm, Gerda] Danish Canc Soc, Dept Documentat & Qual, Copenhagen, Denmark; [Stiller, Charles A.] Publ Hlth England, Natl Canc Registrat & Anal Serv, London, England; [Monnereau, Alain] Inst Bergonie, Registre Hemopathies Malignes Gironde, Bordeaux, France; [Monnereau, Alain] French Network Canc Registries, Toulouse, France; [Woods, Ryan R.] BC Canc Agcy, British Columbia Canc Registry, Vancouver, BC, Canada; [Visser, Otto] Netherlands Comprehens Canc Org IKNL, Netherlands Canc Registry, Utrecht, Netherlands; [Lim, Gek Hsiang] Hlth Promot Board, Natl Registry Dis Off, Singapore, Singapore; [Aitken, Joanne] Canc Council Queensland, Fortitude Valley, Qld, Australia; [Weir, Hannah K.] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA	University of London; London School of Hygiene & Tropical Medicine; National Cancer Center - Japan; Northern State Medical University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Ibadan; University College Hospital, Ibadan; Universidade do Estado do Rio de Janeiro; Balikesir University; Danish Cancer Society; Public Health England; UNICANCER; Institut Bergonie; British Columbia Cancer Agency; Cancer Council Queensland; Centers for Disease Control & Prevention - USA	Allemani, C (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Survival Grp, London WC1E 7HT, England.	claudia.allemani@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020; Clavel, Jacqueline/Q-2750-2016; Bulliard, Jean-Luc/AAA-7481-2021; Alonso, Rafael/L-6487-2015; Herrmann, Christian/J-1094-2019; Mangone, Lucia/J-4701-2016; Ogunbiyi, Olufemi/ABE-4224-2020; Tagliabue, Giovanna/D-4194-2017; Bravo, Luis/K-9882-2014; , 雷克思/ABG-3956-2020; Schaffar, Robin/AAB-3436-2021; Calleja, Neville/E-3895-2019; Grosso, Giuseppe/K-6730-2016; Maule, Milena M/K-3858-2018; Beiranvand, Mania/AAA-2899-2020; Grosso, Giuseppe/ABA-1587-2020; Niksic, Maja/GZL-6639-2022; Valkov, Mikhail Yurievich/L-4441-2018; Ochir, Chimedsuren/AAW-7743-2020; falcini, fabio/W-4345-2018; Berrino, Franco/AAC-2364-2020; Mazzucco, Walter/K-4461-2018; Sekerija, Mario/W-8550-2019; Curado, Maria Paula/M-6200-2013; Guevara, Marcela/B-4473-2015; Lima, Carlos A/A-4225-2013; Russo, Antonio Giampiero/O-2244-2019; ORAZIO, Sébastien/T-3270-2019; Katalinic, Alexander/D-2512-2010; Gatta, Gemma/B-8627-2017; BALDI, Isabelle/T-1465-2019; Didkowska, Joanna Aleksandra/ABG-8672-2020; Broggio, John/F-2295-2018; BOUVIER, Véronique/L-7799-2015; Matsuda, Tomohiro/H-7078-2019; Russo, Antonio Giampiero/K-2230-2018; Monnereau, Alain/L-1249-2014; Zucchetto, Antonella/ABC-8649-2020; Galasso, Rocco/AAL-2150-2020; Bianconi, Fortunato/L-7359-2019; Sant, Milena/D-2362-2017; Blaga, Mihaiela Luminita/I-3808-2016; Redondas, Ricardo/T-3743-2017; Bastos, Joana/M-6918-2015; Antunes, Luis/A-8572-2014; Roshandel, Gholamreza/N-2260-2016; Ferretti, Stefano/K-8636-2015; Mancuso, Pamela/J-5408-2016; Gozdz, Stanislaw/D-3300-2013; De Angelis, Roberta/N-3970-2017; JURADO, DANIEL/G-3254-2014; Pikalova, Lidia/E-5347-2017; Marcos-Gragera, Rafael/A-1437-2017	Coleman, Michel/0000-0001-8940-3807; Clavel, Jacqueline/0000-0002-3616-7676; Bulliard, Jean-Luc/0000-0001-9750-2709; Alonso, Rafael/0000-0001-7414-3221; Herrmann, Christian/0000-0001-9349-8917; Mangone, Lucia/0000-0002-5089-5178; Tagliabue, Giovanna/0000-0001-8165-5524; Bravo, Luis/0000-0002-9708-0312; , 雷克思/0000-0003-4102-8934; Schaffar, Robin/0000-0002-4023-8756; Calleja, Neville/0000-0003-1800-2103; Grosso, Giuseppe/0000-0003-3930-5285; Maule, Milena M/0000-0003-2142-1288; Grosso, Giuseppe/0000-0003-3930-5285; Niksic, Maja/0000-0002-3101-4953; Valkov, Mikhail Yurievich/0000-0003-3230-9638; Ochir, Chimedsuren/0000-0002-7134-5255; falcini, fabio/0000-0002-0864-6266; Berrino, Franco/0000-0002-4858-1866; Sekerija, Mario/0000-0001-7508-1501; Curado, Maria Paula/0000-0001-8172-2483; Guevara, Marcela/0000-0001-9242-6364; Lima, Carlos A/0000-0003-4269-7320; Katalinic, Alexander/0000-0003-0490-1554; Gatta, Gemma/0000-0003-4160-6458; BALDI, Isabelle/0000-0003-0738-2673; Didkowska, Joanna Aleksandra/0000-0001-9160-9118; Broggio, John/0000-0001-9429-2275; BOUVIER, Véronique/0000-0002-2016-0779; Russo, Antonio Giampiero/0000-0002-5681-5861; Monnereau, Alain/0000-0002-5056-1397; Zucchetto, Antonella/0000-0003-2812-6345; Galasso, Rocco/0000-0003-4831-6437; Bianconi, Fortunato/0000-0002-3132-0061; Sant, Milena/0000-0002-4148-8597; Blaga, Mihaiela Luminita/0000-0002-6873-118X; Nakata, Kayo/0000-0001-9782-8637; Redondas, Ricardo/0000-0001-6954-7037; Zborovskaya, Anna/0000-0001-5684-9634; Bastos, Joana/0000-0002-9815-5603; Antunes, Luis/0000-0002-3098-0711; Zwierko, Maria/0000-0001-7294-4164; RUGGE, MASSIMO/0000-0002-0679-0563; Roshandel, Gholamreza/0000-0002-5494-0722; Ferretti, Stefano/0000-0001-5241-2101; Aitken, Joanne Frances/0000-0001-6859-2186; Currow, David/0000-0003-1988-1250; Herrera, Victor/0000-0002-6295-1640; DELOUMEAUX, Jacqueline/0000-0001-7841-3313; Shalkow, Jaime/0000-0003-0056-3455; Pildava, Santa/0000-0002-0166-7574; Arias-Ortiz, Nelson/0000-0001-5093-3384; Matthes, Katarina/0000-0002-5263-3542; MAZZUCCO, WALTER/0000-0001-5090-1366; grosclaude, pascale/0000-0002-6755-5970; Olga, Aleinikova/0000-0001-8384-5073; Mancuso, Pamela/0000-0003-1609-2440; Trojanowski, Maciej/0000-0002-9124-1509; tumino, rosario/0000-0003-2666-414X; Johnson, Alison/0000-0002-1113-1191; Rachet, Bernard/0000-0001-5837-7773; Gozdz, Stanislaw/0000-0001-6902-3807; Guthridge, Steven/0000-0003-1495-764X; Rachtan, Jadwiga/0000-0003-1913-8547; Bray, Freddie/0000-0002-3248-7787; Bielska-Lasota, Magdalena/0000-0003-0960-8672; Lavecchia, Anna maria/0000-0001-5979-9775; Bonaventure, Audrey/0000-0001-6665-8145; Chiolero, Arnaud/0000-0002-5544-8510; Matz, Melissa/0000-0003-0132-1108; Sebastien, ORAZIO/0000-0003-2034-0101; D'Onise, Katina/0000-0003-3292-4227; Cuccaro, Francesco/0000-0002-7012-2885; amadeo, brice/0000-0003-2057-598X; JOACHIM, clarisse/0000-0002-2967-7205; Innos, Kaire/0000-0003-0120-2213; ZAIDI, ZOUBIDA/0000-0003-3378-4799; Nadine, BOSSARD/0000-0001-8643-9169; De Angelis, Roberta/0000-0001-7787-3043; Ogunbiyi, Olufemi/0000-0002-8748-2879; CHIANG, CHUN-JU/0000-0002-1330-5319; JURADO, DANIEL/0000-0003-0628-0253; dirican, oya/0000-0002-8123-3126; Jegu, Jeremie/0000-0001-7671-5465; Pikalova, Lidia/0000-0003-1453-2254; Marcos-Gragera, Rafael/0000-0001-9824-3657; Cavalieri d'Oro, Luca/0000-0001-7713-1293; Woods, Ryan/0000-0002-9520-2128; Dusek, Ladislav/0000-0002-8589-4378	American Cancer Society; Centers for Disease Control and Prevention; Swiss Re; Swiss Cancer Research foundation; Swiss Cancer League; Institut National du Cancer; La Ligue Contre le Cancer; Rossy Family Foundation; US National Cancer Institute; Susan G Komen Foundation; NATIONAL CANCER INSTITUTE [P01CA028842] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Swiss Re; Swiss Cancer Research foundation; Swiss Cancer League; Institut National du Cancer(Institut National du Cancer (INCA) France); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Rossy Family Foundation; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	American Cancer Society; Centers for Disease Control and Prevention; Swiss Re; Swiss Cancer Research foundation; Swiss Cancer League; Institut National du Cancer; La Ligue Contre le Cancer; Rossy Family Foundation; US National Cancer Institute; and the Susan G Komen Foundation.	Abdel-Rahman M, 2009, BRIT J CANCER, V101, pS115, DOI 10.1038/sj.bjc.6605401; Abdel-Razeq Hikmat, 2015, Hematol Oncol Stem Cell Ther, V8, P64, DOI 10.1016/j.hemonc.2015.02.001; Allemani C., CANC CONTRO IN PRESS; Allemani C, COLORECTAL CANC SURV; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allemani C, 2017, CANCER-AM CANCER SOC, V123, P4982, DOI 10.1002/cncr.31025; Allemani C, 2017, CANCER-AM CANCER SOC, V123, P4977, DOI 10.1002/cncr.30854; Andersson TML, 2014, CANCER EPIDEMIOL, V38, P93, DOI 10.1016/j.canep.2013.12.006; [Anonymous], 2013, MULT PRIM HIST COD R; Antoni S, 2016, B WORLD HEALTH ORGAN, V94, P174, DOI 10.2471/BLT.15.164384; Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Beaulieu N, 2009, BREAKAWAY GLOBAL BUR; BERKSON J, 1952, J AM STAT ASSOC, V47, P501, DOI 10.2307/2281318; Berrino F, 1995, IARC SCI PUBL, V132, P1; Berrino F, 1999, IARC SCI PUBLICATION, V151; Brass W., 1971, BIOL ASPECTS DEMOGRA, P69; Brawley OW, 2017, ANN INTERN MED, V166, P364, DOI 10.7326/M16-2850; Brenner H, 2003, BRIT J CANCER, V89, P1260, DOI 10.1038/sj.bjc.6601295; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; Brustugun OT, 2014, BRIT J CANCER, V111, P1014, DOI 10.1038/bjc.2014.364; Centers for Disease Control and Prevention, 2015, CANC SURV START GLOB; Chang JWC, 2017, ASIA-PAC J CLIN ONCO, V13, P423, DOI 10.1111/ajco.12670; Choi KS, 2015, BRIT J CANCER, V112, P608, DOI 10.1038/bjc.2014.608; Clerc-Urmes I, 2014, STATA J, V14, P87, DOI 10.1177/1536867X1401400107; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Coleman MP, 2013, CANC CONTROL, P60; Cookson JB, 2000, LANCET, V356, P1611, DOI 10.1016/S0140-6736(05)74461-5; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Curado MP, 2005, EUR J CANCER PREV, V14, P307; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; da Cunha CC, 2017, EPIDEMIOL SERV SAUDE, V26, P19, DOI [10.5123/S1679-49742017000100003, 10.5123/s1679-49742017000100003]; Dickman PW, 2006, J INTERN MED, V260, P103, DOI 10.1111/j.1365-2796.2006.01677.x; Elandt-Johnson R.C., 1980, SURVIVAL MODELS DATA; Ellis L, 2012, EUR J CANCER, V48, P270, DOI 10.1016/j.ejca.2011.10.008; Engeland A, 1998, ACTA ONCOL, V37, P49, DOI 10.1080/028418698423177; Engholm G., 2016, NORDCAN CANC INCIDEN; Environmental Systems Research Institute, 2015, ARCGIS DEKST REL 10; Esteve J., 1994, IARC SCI PUBLICATION, V128; EWBANK DC, 1983, POP STUD-J DEMOG, V37, P105, DOI 10.1080/00324728.1983.10405927; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filippatos G, 2016, HIPPOKRATIA, V20, P19; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Fritz A., 2013, ICD O INT CLASSIFICA, DOI DOI 10.12970/2310-984X.2013.01.01.4; Fritz APC., 2013, INT CLASSIFICATION D; Gatta G, 2013, HAEMATOLOGICA, V98, P744, DOI 10.3324/haematol.2012.071597; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; Ginsburg O, 2017, LANCET, V389, P871, DOI 10.1016/S0140-6736(16)31393-9; Greenwood M., 1926, NATURAL DURATION CAN; Haghighi Mohammad Hosein Hayavi, 2014, Health Inf Manag, V43, P35; Harlan LC, 2015, LANCET, V385, P926, DOI 10.1016/S0140-6736(14)62251-0; Ho GF, 2017, GLOB J HLTH SCI, V9, P32, DOI DOI 10.5539/GJHS.V9N8P32; Independent Cancer Taskforce, 2015, ACH WORLD CLASS CANC; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA; International Atomic Energy Agency, 2015, ACC CANC THER; Ito Y, 2012, CANCER EPIDEMIOL, V36, P128, DOI 10.1016/j.canep.2011.12.008; Jensen OM, 1991, IARC SCI PUBLICATION; Laurenti R, 2000, DEATH CERTIFICATION, P1; Levy H. P, 2015, NEW BI FRONTIER ACCE; Lopez A, 2013, LANCET; Magrath I, 2013, LANCET ONCOL, V14, pE104, DOI 10.1016/S1470-2045(13)70008-1; Marcus PM, 2015, JNCI-J NATL CANCER I, V107, P1; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Matz M, 2017, GYNECOL ONCOL, V144, P405, DOI 10.1016/j.ygyno.2016.10.019; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Micheli A, 2003, ANN ONCOL, V14, pV28, DOI 10.1093/annonc/mdg752; Mirzaei Mohsen, 2016, Asian Pac J Cancer Prev, V17, P101; Morton LM, 2007, BLOOD; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; OECD, 2013, CANC CAR ASS QUAL IM; OECD, 2017, HLTH GLANC 2017 OECD; Ovcharov VK, 2000, DEATH CERTIFICATION, P28; Pech O, 2014, GASTROENTEROLOGY, V146, P652, DOI 10.1053/j.gastro.2013.11.006; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Pokhrel A, 2010, BRIT J CANCER, V103, P1109, DOI 10.1038/sj.bjc.6605861; Pritchard-Jones K, 2007, BR J CANC; Rachet B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2534-3; Sandiford P, 2015, AUST NZ J PUBL HEAL, V39, P157, DOI 10.1111/1753-6405.12344; Sant M, 2010, TUMORI, V96, pi; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Seppa K, 2012, BRIT J CANCER, V106, P1846, DOI 10.1038/bjc.2012.169; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Shack LG, 2012, CANCER EPIDEMIOL, V36, P548, DOI 10.1016/j.canep.2012.06.011; Shulman L., 2011, CLOSING CANC DIVIDE; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; STILLER CA, 1990, BRIT J CANCER, V62, P806, DOI 10.1038/bjc.1990.383; Storm HH, 2010, ACTA ONCOL, V49, P532, DOI 10.3109/02841861003801148; Storm Hans Henrik, 2008, Ugeskr Laeger, V170, P3065; Suh YS, 2015, SURG CLIN N AM, V95, P1053, DOI 10.1016/j.suc.2015.05.012; Sullivan R, 2013, LANCET ONCOL; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Tangka FKL, 2016, J PUBLIC HEALTH MAN, V22, P452, DOI 10.1097/PHH.0000000000000349; Turner JJ, 2010, BLOOD, V116, pE90, DOI 10.1182/blood-2010-06-289561; UICC, 2013, WORLD CANC DECL 2013; UN, WORLD POP PROSP 2015; UN, 2015, SUSTAINABLE DEV GOAL; UN Statistical Division, 2015, STAND COUNTR AR COD; United Nations, 2015, SUST DEV GOAL 3, V3; Vazquez TR, 2017, LANCET, V390, P1473, DOI 10.1016/S0140-6736(17)32470-4; Walters S, 2015, BRIT J CANCER, V113, P848, DOI 10.1038/bjc.2015.265; Weir HK, 2017, CANCER-AM CANCER SOC, V123, P4963, DOI 10.1002/cncr.31028; WHO, 2017, CANC PREV CONTR CONT; WHO, CANC PREV CONTR CONT; WHO, 2017, 5822 WHO; Woods LM, 2016, ANN ONCOL, V27, P2025, DOI 10.1093/annonc/mdw408; Woods LM, 2012, INT J CANCER, V131, pE1120, DOI 10.1002/ijc.27545; Wu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062930; Yoo KY, 2008, JPN J CLIN ONCOL, V38, P327, DOI 10.1093/jjco/hyn026	110	1939	2188	56	591	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1023	1075		10.1016/S0140-6736(17)33326-3	http://dx.doi.org/10.1016/S0140-6736(17)33326-3			53	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ4TP	29395269	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000427585100025
J	Sullivan, R				Sullivan, Richard			Achieving better cancer intelligence for global cancer control	LANCET			English	Editorial Material									[Sullivan, Richard] Kings Coll London, Inst Canc Policy, Kings Hlth Partners Comprehens Canc Ctr, Guys Hosp Campus, London SE1 9RT, England	University of London; King's College London	Sullivan, R (corresponding author), Kings Coll London, Inst Canc Policy, Kings Hlth Partners Comprehens Canc Ctr, Guys Hosp Campus, London SE1 9RT, England.	richard.sullivan@kcl.ac.uk		Sullivan, Richard/0000-0002-6435-1825				Allemani C., 2018, LANCET; Atun R, 2017, LANCET GLOB HEALTH, V5, pE720, DOI [10.1016/S2214-109X(17)30198-5, 10.1016/s2214-109x(17)30198-5]; Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Boyle P, 2017, STATE ONCOLOGY AFRIC; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2; Kingdom J., 1973, AGENDAS ALTERNATIVES; Pramesh CS, 2014, LANCET ONCOL, V15, pE223, DOI 10.1016/S1470-2045(14)70117-2; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5	9	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1003	1004		10.1016/S0140-6736(18)30155-7	http://dx.doi.org/10.1016/S0140-6736(18)30155-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29395271				2022-12-28	WOS:000427585100007
J	Saint-Denis, TG; Zhu, RY; Chen, G; Wu, QF; Yu, JQ				Saint-Denis, Tyler G.; Zhu, Ru-Yi; Chen, Gang; Wu, Qing-Feng; Yu, Jin-Quan			Enantioselective C(sp(3))-H bond activation by chiral transition metal catalysts	SCIENCE			English	Review							C-H ACTIVATION; ASYMMETRIC CATALYSIS; KINETIC RESOLUTION; PD-II; ARYLATION; LIGAND; FUNCTIONALIZATION; ACID; IODINATION; SILYLATION	Organic molecules are rich in carbon-hydrogen bonds; consequently, the transformation of C-H bonds to new functionalities (such as C-C, C-N, and C-O bonds) has garnered much attention by the synthetic chemistry community. The utility of C-H activation in organic synthesis, however, cannot be fully realized until chemists achieve stereocontrol in the modification of C-H bonds. This Review highlights recent efforts to enantioselectively functionalize C(sp(3))-H bonds via transition metal catalysis, with an emphasis on key principles for both the development of chiral ligand scaffolds that can accelerate metalation of C(sp(3))-H bonds and stereomodels for asymmetric metalation of prochiral C-H bonds by these catalysts.	[Saint-Denis, Tyler G.; Zhu, Ru-Yi; Chen, Gang; Wu, Qing-Feng; Yu, Jin-Quan] Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Zhu, Ruyi/AAO-4630-2021	Saint-Denis, Tyler/0000-0002-9152-2415	Scripps Research Institute (TSRI); NIH (National Institute of General Medical Sciences) [2R01GM084019]; Bristol-Myers Squibb; NSF under the Centers for Chemical Innovation Center for Selective C-H Functionalization [CHE-1205646]; NSF; TSRI; Boehringer Ingelheim; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	Scripps Research Institute (TSRI); NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); NSF under the Centers for Chemical Innovation Center for Selective C-H Functionalization; NSF(National Science Foundation (NSF)); TSRI; Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank The Scripps Research Institute (TSRI), NIH (National Institute of General Medical Sciences, grant 2R01GM084019) and Bristol-Myers Squibb, as well as NSF under the Centers for Chemical Innovation Center for Selective C-H Functionalization (CHE-1205646) for financial support. We thank the NSF Graduate Research Fellowship Program and TSRI for financial support of T.G.S.-D. R.-Y.Z. was funded by TSRI and the Boehringer Ingelheim Fellowship. G.C. thanks The Shanghai Institute of Organic Chemistry, Zhejiang Medicine, and Pharmaron. The authors thank A. N. Herron and N. Chekshin for thoughtful discussions.	Anada M, 1999, SYNLETT, P1775; Anas S, 2011, CHEM COMMUN, V47, P11483, DOI 10.1039/c1cc14292e; ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; Bach RD, 2004, J AM CHEM SOC, V126, P4444, DOI 10.1021/ja036309a; Carey JS, 2006, ORG BIOMOL CHEM, V4, P2337, DOI 10.1039/b602413k; Chan KSL, 2015, J AM CHEM SOC, V137, P2042, DOI 10.1021/ja512529e; Chen G, 2016, SCIENCE, V353, P1023, DOI 10.1126/science.aaf4434; Cheng GJ, 2015, CHEM-EUR J, V21, P11180, DOI 10.1002/chem.201501123; Chu L, 2014, SCIENCE, V346, P451, DOI 10.1126/science.1258538; Engle KM, 2013, J ORG CHEM, V78, P8927, DOI 10.1021/jo400159y; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Engle KM, 2011, J AM CHEM SOC, V133, P18183, DOI 10.1021/ja203978r; Engle KM, 2010, J AM CHEM SOC, V132, P14137, DOI 10.1021/ja105044s; Gao DW, 2016, ORGANOMETALLICS, V35, P3227, DOI 10.1021/acs.organomet.6b00569; Gao DW, 2014, ACS CATAL, V4, P2741, DOI 10.1021/cs500813z; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; GOODHUE CT, 1971, BIOTECHNOL BIOENG, V13, P203, DOI 10.1002/bit.260130204; GROVES JT, 1989, J AM CHEM SOC, V111, P8537, DOI 10.1021/ja00204a047; Hartwig J. F, 2009, ORGANOTRANSITION MET; Hartwig JF, 2016, ACS CENTRAL SCI, V2, P281, DOI 10.1021/acscentsci.6b00032; He CF, 2017, ACS CATAL, V7, P5316, DOI 10.1021/acscatal.7b01855; He J, 2017, J AM CHEM SOC, V139, P3344, DOI 10.1021/jacs.6b13389; Holstein PM, 2015, ACS CATAL, V5, P4300, DOI 10.1021/acscatal.5b00898; Huerta FF, 2001, CHEM SOC REV, V30, P321, DOI 10.1039/b105464n; Jain P, 2017, NAT CHEM, V9, P140, DOI [10.1038/NCHEM.2619, 10.1038/nchem.2619]; Katayev D, 2012, CHEM SCI, V3, P1422, DOI 10.1039/c2sc20111a; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; Larionov E, 2013, CHEM SCI, V4, P1995, DOI 10.1039/c3sc00098b; Lee T, 2016, ANGEW CHEM INT EDIT, V55, P8723, DOI 10.1002/anie.201603153; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Liao KB, 2016, NATURE, V533, P230, DOI 10.1038/nature17651; Liu YJ, 2014, NATURE, V515, P389, DOI 10.1038/nature13885; Martin N, 2012, CHEM-EUR J, V18, P4480, DOI 10.1002/chem.201200018; Murahashi SI, 2011, P JPN ACAD B-PHYS, V87, P242, DOI 10.2183/pjab.87.242; Murai M, 2015, J ORG CHEM, V80, P5407, DOI 10.1021/acs.joc.5b00920; Musaev DG, 2014, CHEM SOC REV, V43, P5009, DOI 10.1039/c3cs60447k; Nakanishi M, 2011, ANGEW CHEM INT EDIT, V50, P7438, DOI 10.1002/anie.201102639; NAVARRO R, 1995, J ORGANOMET CHEM, V490, P35, DOI 10.1016/0022-328X(94)05204-O; Newton CG, 2017, CHEM REV, V117, P8908, DOI 10.1021/acs.chemrev.6b00692; Nishioka Y, 2013, ANGEW CHEM INT EDIT, V52, P1739, DOI 10.1002/anie.201208906; Pan SG, 2012, TETRAHEDRON, V68, P9009, DOI 10.1016/j.tet.2012.08.071; Pan SG, 2011, ORG LETT, V13, P4692, DOI 10.1021/ol201907w; Pedroni J, 2014, ANGEW CHEM INT EDIT, V53, P9064, DOI 10.1002/anie.201405508; Pfaltz A, 2004, P NATL ACAD SCI USA, V101, P5723, DOI 10.1073/pnas.0307152101; Pi C, 2014, ORG LETT, V16, P5164, DOI 10.1021/ol502509f; Saget T, 2012, ANGEW CHEM INT EDIT, V51, P2238, DOI 10.1002/anie.201108511; Shi BF, 2008, ANGEW CHEM INT EDIT, V47, P4882, DOI 10.1002/anie.200801030; Shugrue CR, 2017, CHEM REV, V117, P11894, DOI 10.1021/acs.chemrev.7b00022; Smalley AP, 2017, J AM CHEM SOC, V139, P1412, DOI 10.1021/jacs.6b12234; SOKOLOV VI, 1979, DOKL AKAD NAUK SSSR+, V246, P124; Su B, 2017, J AM CHEM SOC, V139, P12137, DOI 10.1021/jacs.7b06679; Su B, 2017, ANGEW CHEM INT EDIT, V56, P7205, DOI 10.1002/anie.201702628; Tahara YK, 2015, CHEM COMMUN, V51, P16660, DOI 10.1039/c5cc07102j; Taylor MS, 2004, P NATL ACAD SCI USA, V101, P5368, DOI 10.1073/pnas.0307893101; Trost BM, 2004, P NATL ACAD SCI USA, V101, P5348, DOI 10.1073/pnas.0306715101; Wang H, 2016, ANGEW CHEM INT EDIT, V55, P15387, DOI 10.1002/anie.201609337; Wasa M, 2012, J AM CHEM SOC, V134, P18570, DOI 10.1021/ja309325e; Wasa M, 2011, J AM CHEM SOC, V133, P19598, DOI 10.1021/ja207607s; Wu QF, 2017, SCIENCE, V355, P499, DOI 10.1126/science.aal5175; Xiao KJ, 2016, J AM CHEM SOC, V138, P7796, DOI 10.1021/jacs.6b04660; Xiao KJ, 2016, ANGEW CHEM INT EDIT, V55, P2856, DOI 10.1002/anie.201510808; Xiao KJ, 2014, J AM CHEM SOC, V136, P8138, DOI 10.1021/ja504196j; Yan SB, 2015, ORG LETT, V17, P2458, DOI 10.1021/acs.orglett.5b00968; Yang L, 2017, CHEM SCI, V8, P1344, DOI 10.1039/c6sc04006c; Yang YF, 2017, J AM CHEM SOC, V139, P8514, DOI 10.1021/jacs.7b01801; Zalatan DN, 2008, J AM CHEM SOC, V130, P9220, DOI 10.1021/ja8031955; Zhang FL, 2016, SCIENCE, V351, P252, DOI 10.1126/science.aad7893	67	404	400	42	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					759	+	aao4798	10.1126/science.aao4798	http://dx.doi.org/10.1126/science.aao4798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29449462	Green Accepted			2022-12-28	WOS:000425116200036
J	Yang, Y; Cui, YH; Sang, KN; Dong, YY; Ni, ZY; Ma, SS; Hu, HL				Yang, Yan; Cui, Yihui; Sang, Kangning; Dong, Yiyan; Ni, Zheyi; Ma, Shuangshuang; Hu, Hailan			Ketamine blocks bursting in the lateral habenula to rapidly relieve depression	NATURE			English	Article							VENTRAL TEGMENTAL AREA; METHYL-D-ASPARTATE; ANTIDEPRESSANT RESPONSES; SUBTHALAMIC NEURONS; PYRAMIDAL NEURONS; DOPAMINE NEURONS; NMDA-RECEPTORS; BASAL GANGLIA; T-TYPE; MECHANISMS	The N-methyl-d-aspartate receptor (NMDAR) antagonist ketamine has attracted enormous interest in mental health research owing to its rapid antidepressant actions, but its mechanism of action has remained elusive. Here we show that blockade of NMDAR-dependent bursting activity in the `anti-reward center', the lateral habenula (LHb), mediates the rapid antidepressant actions of ketamine in rat and mouse models of depression. LHb neurons show a significant increase in burst activity and theta-band synchronization in depressive-like animals, which is reversed by ketamine. Burstevoking photostimulation of LHb drives behavioural despair and anhedonia. Pharmacology and modelling experiments reveal that LHb bursting requires both NMDARs and low-voltage-sensitive T-type calcium channels (T-VSCCs). Furthermore, local blockade of NMDAR or T-VSCCs in the LHb is sufficient to induce rapid antidepressant effects. Our results suggest a simple model whereby ketamine quickly elevates mood by blocking NMDAR-dependent bursting activity of LHb neurons to disinhibit downstream monoaminergic reward centres, and provide a framework for developing new rapid-acting antidepressants.	[Yang, Yan; Cui, Yihui; Sang, Kangning; Dong, Yiyan; Ni, Zheyi; Ma, Shuangshuang; Hu, Hailan] Zhejiang Univ, Interdisciplinary Inst Neurosci & Technol, Qiushi Acad Adv Studies,Ctr Neurosci, Key Lab Med Neurobiol,Minist Hlth China,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Yan; Cui, Yihui; Sang, Kangning; Hu, Hailan] Zhejiang Univ, Mental Hlth Ctr, Sch Med, Hangzhou 310013, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Hu, HL (corresponding author), Zhejiang Univ, Interdisciplinary Inst Neurosci & Technol, Qiushi Acad Adv Studies,Ctr Neurosci, Key Lab Med Neurobiol,Minist Hlth China,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Hu, HL (corresponding author), Zhejiang Univ, Mental Hlth Ctr, Sch Med, Hangzhou 310013, Zhejiang, Peoples R China.	huhailan@zju.edu.cn	Cui, Yihui/AAB-9328-2022	Hu, Hailan/0000-0002-0425-5057; Cui, Yihui/0000-0002-7362-6237; Dong, Yiyan/0000-0002-4664-4579	National Key R&D Program of China [2016YFA0501000]; National Natural Science Foundation of China [91432108, 31225010, 81527901, 81600954]; 111 project [B13026]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project)	We thank L.-S. Yu and J. Pan for performing LC-MS/MS; S.-M. Duan, X.-H. Zhang, X.-W. Chen, Y.-S. Shu, X. Ju, C. Lohmann and W. Yang for advice on experimental design and comments on the manuscript; and N. Lin, L. Zhang and K.-F. Liu for consultation on in vivo recording. This work was supported by grants from the National Key R&D Program of China (2016YFA0501000), the National Natural Science Foundation of China (91432108, 31225010, and 81527901) to H.H. and (81600954) to Y.Y., and the 111 project (B13026) to H.H.	Aizawa H, 2012, J COMP NEUROL, V520, P4051, DOI 10.1002/cne.23167; Ambert Nicolas, 2010, Open Access Bioinformatics, V2, P113; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bon CLM, 1998, EUR J NEUROSCI, V10, P2009, DOI 10.1046/j.1460-9568.1998.00210.x; Caiati MD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00063; Chang SY, 2004, J NEUROSCI, V24, P2172, DOI 10.1523/JNEUROSCI.4891-03.2004; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; CLEMENTS JA, 1982, J PHARM SCI, V71, P539, DOI 10.1002/jps.2600710516; COULTER DA, 1989, J PHYSIOL-LONDON, V414, P587, DOI 10.1113/jphysiol.1989.sp017705; Cui YH, 2018, NATURE, V554, P323, DOI 10.1038/nature25752; Endo M., 2012, PHARM IONIC CHANNEL, V147; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Gideons ES, 2014, P NATL ACAD SCI USA, V111, P8649, DOI 10.1073/pnas.1323920111; Gigliucci V, 2013, PSYCHOPHARMACOLOGY, V228, P157, DOI 10.1007/s00213-013-3024-x; Goren MZ, 2007, CNS DRUG REV, V13, P224, DOI 10.1111/j.1527-3458.2007.00009.x; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GRILLNER S, 1981, ACTA PHYSIOL SCAND, V113, P549, DOI 10.1111/j.1748-1716.1981.tb06937.x; Hasan M, 2017, J PHARMACEUT BIOMED, V139, P87, DOI 10.1016/j.jpba.2017.02.035; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hu HL, 2016, ANNU REV NEUROSCI, V39, P297, DOI 10.1146/annurev-neuro-070815-014106; HUGUENARD JR, 1993, J NEUROPHYSIOL, V70, P158, DOI 10.1152/jn.1993.70.1.158; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lecca S, 2016, NAT MED, V22, P254, DOI 10.1038/nm.4037; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MEHRKE G, 1994, J PHARMACOL EXP THER, V271, P1483; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Powell Timothy R, 2012, Curr Protoc Mouse Biol, V2, P119, DOI 10.1002/9780470942390.mo110176; Rateau Y, 2006, J NEUROPHYSIOL, V95, P3073, DOI 10.1152/jn.00922.005; Ren M, 2014, J NEUROSCI, V34, P6583, DOI 10.1523/JNEUROSCI.0167-14.2014; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Shabel SJ, 2014, SCIENCE, V345, P1494, DOI 10.1126/science.1250469; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stephenson-Jones M, 2016, NATURE, V539, P289, DOI 10.1038/nature19845; Tian J, 2015, NEURON, V87, P1304, DOI 10.1016/j.neuron.2015.08.028; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Valentinova K, 2016, CELL REP, V16, P2298, DOI 10.1016/j.celrep.2016.07.064; Weiss T, 2011, NEUROSCIENCE, V172, P74, DOI 10.1016/j.neuroscience.2010.10.047; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhong P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016970; Zhou L, 2017, CELL REP, V18, P3018, DOI 10.1016/j.celrep.2017.02.077; Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954; Zhu ZT, 2005, NEUROPHARMACOLOGY, V49, P317, DOI 10.1016/j.neuropharm.2005.03.018; Zhu ZT, 2004, EUR J NEUROSCI, V19, P1296, DOI 10.1111/j.1460-9568.2004.03240.x	59	415	446	56	556	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					317	+		10.1038/nature25509	http://dx.doi.org/10.1038/nature25509			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29446381				2022-12-28	WOS:000424996300029
J	Service, RF				Service, Robert F.			Design for US exascale computer takes shape	SCIENCE			English	News Item																			0	14	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					617	618		10.1126/science.359.6376.617	http://dx.doi.org/10.1126/science.359.6376.617			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439217				2022-12-28	WOS:000425117700010
J	Sato, T; Coler-Reilly, ALG; Yagishita, N; Araya, N; Inoue, E; Furuta, R; Watanabe, T; Uchimaru, K; Matsuoka, M; Matsumoto, N; Hasegawa, Y; Yamano, Y				Sato, Tomoo; Coler-Reilly, Ariella L. G.; Yagishita, Naoko; Araya, Natsumi; Inoue, Eisuke; Furuta, Rie; Watanabe, Toshiki; Uchimaru, Kaoru; Matsuoka, Masao; Matsumoto, Naoki; Hasegawa, Yasuhiro; Yamano, Yoshihisa			Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-I; MONOCLONAL-ANTIBODY KW-0761; HTLV-1 PROVIRAL LOAD; HAM/TSP PATIENTS; PROGRESSION; EXPRESSION; CARRIERS; CCR4	BACKGROUND Human T-lymphotropic virus type 1 (HTLV-1) causes the debilitating neuroinflammatory disease HTLV-1-associated myelopathy-tropical spastic paraparesis (HAM-TSP) as well as adult T-cell leukemia-lymphoma (ATLL). In patients with HAM-TSP, HTLV-1 infects mainly CCR4+ T cells and induces functional changes, ultimately causing chronic spinal cord inflammation. We evaluated mogamulizumab, a humanized anti-CCR4 monoclonal antibody that targets infected cells, in patients with HAM-TSP. METHODS In this uncontrolled, phase 1-2a study, we assessed the safety, pharmacokinetics, and efficacy of mogamulizumab in patients with glucocorticoid-refractory HAM-TSP. In the phase 1 dose-escalation study, 21 patients received a single infusion of mogamulizumab (at doses of 0.003 mg per kilogram of body weight, 0.01 mg per kilogram, 0.03 mg per kilogram, 0.1 mg per kilogram, or 0.3 mg per kilogram) and were observed for 85 days. Of those patients, 19 continued on to the phase 2a study and received infusions, over a period of 24 weeks, of 0.003 mg per kilogram, 0.01 mg per kilogram, or 0.03 mg per kilogram at 8-week intervals or infusions of 0.1 mg per kilogram or 0.3 mg per kilogram at 12-week intervals. RESULTS The side effects of mogamulizumab did not limit administration up to the maximum dose (0.3 mg per kilogram). The most frequent side effects were grade 1 or 2 rash (in 48% of the patients) and lymphopenia and leukopenia (each in 33%). The dose-dependent reduction in the proviral load in peripheral-blood mononuclear cells (decrease by day 15 of 64.9%; 95% confidence interval [CI], 51.7 to 78.1) and inflammatory markers in cerebrospinal fluid (decrease by day 29 of 37.3% [95% CI, 24.8 to 49.8] in the CXCL10 level and of 21.0% [95% CI, 10.7 to 31.4] in the neopterin level) was maintained with additional infusions throughout the phase 2a study. A reduction in spasticity was noted in 79% of the patients and a decrease in motor disability in 32%. CONCLUSIONS Mogamulizumab decreased the number of HTLV-1-infected cells and the levels of inflammatory markers. Rash was the chief side effect. The effect of mogamulizumab on clinical HAM-TSP needs to be clarified in future studies.	[Sato, Tomoo; Coler-Reilly, Ariella L. G.; Yagishita, Naoko; Araya, Natsumi; Yamano, Yoshihisa] St Marianna Univ, Sch Med, Inst Med Sci, Dept Rare Dis Res, Kawasaki, Kanagawa, Japan; [Inoue, Eisuke] St Marianna Univ, Sch Med, Med Informat, Kawasaki, Kanagawa, Japan; [Matsumoto, Naoki] St Marianna Univ, Sch Med, Dept Pharmacol, Kawasaki, Kanagawa, Japan; [Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa, Japan; [Watanabe, Toshiki; Yamano, Yoshihisa] St Marianna Univ, Grad Sch Med, Dept Adv Med Innovat, Kawasaki, Kanagawa, Japan; [Furuta, Rie; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto, Japan; [Uchimaru, Kaoru] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan; [Matsuoka, Masao] Kumamoto Univ, Fac Life Sci, Grad Sch Med Sci, Dept Hematol Rheumatol & Infect Dis, Kumamoto, Japan	Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University; Kyoto University; University of Tokyo; Kumamoto University	Yamano, Y (corresponding author), St Marianna Univ, Sch Med, Inst Med Sci, Dept Rare Dis Res,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168512, Japan.	yyamano@marianna-u.ac.jp	Sato, Tomoo/E-3262-2010; Yamano, Yoshihisa/AAG-3955-2020	Sato, Tomoo/0000-0001-8439-3128; Coler-Reilly, Ariella/0000-0001-8549-6559; Matsuoka, Masao/0000-0002-0473-754X	Practical Research Project for Rare or Intractable Diseases of the Japan Agency for Medical Research and Development [JP17ek0109083]; Research Project on Measures for Intractable Disease of the Ministry of Health, Labor, and Welfare; Ministry of Health, Labor, and Welfare; UMIN [UMIN000012655]; Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [16H05157, 16H06277] Funding Source: KAKEN	Practical Research Project for Rare or Intractable Diseases of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Research Project on Measures for Intractable Disease of the Ministry of Health, Labor, and Welfare; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); UMIN; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by a grant (JP17ek0109083) from the Practical Research Project for Rare or Intractable Diseases of the Japan Agency for Medical Research and Development and by the Research Project on Measures for Intractable Disease of the Ministry of Health, Labor, and Welfare.r Funded by the Japan Agency for Medical Research and Development and the Ministry of Health, Labor, and Welfare; UMIN trial number, UMIN000012655.	Abraham L, 2004, UROLOGY, V63, P481, DOI 10.1016/j.urology.2003.10.019; Ando H, 2013, BRAIN, V136, P2876, DOI 10.1093/brain/awt183; Araya N, 2014, J CLIN INVEST, V124, P3431, DOI 10.1172/JCI75250; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Bangham CRM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.12; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Firouzi S, 2017, BLOOD ADV, V1, P1195, DOI 10.1182/bloodadvances.2017005900; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; HOLLSBERG P, 1993, NEW ENGL J MED, V328, P1173, DOI 10.1056/NEJM199304223281608; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; IJICHI S, 1993, MED HYPOTHESES, V41, P542, DOI 10.1016/0306-9877(93)90111-3; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; Kobayashi S, 2014, CLIN CANCER RES, V20, P2851, DOI 10.1158/1078-0432.CCR-13-3169; Matsuzaki T, 2001, J NEUROVIROL, V7, P228; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; Olindo S, 2005, J NEUROL SCI, V237, P53, DOI 10.1016/j.jns.2005.05.010; Olindo S, 2006, ARCH NEUROL-CHICAGO, V63, P1560, DOI 10.1001/archneur.63.11.1560; OSAME M, 1986, LANCET, V1, P1031; OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191; Osame M, 1989, HTLV I NERVOUS SYSTE, P213; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rowan AG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006030; Sato T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002479; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Yamano Y, 2017, J NEUROIMMUNOL, V304, P51, DOI 10.1016/j.jneuroim.2016.08.012; Yamano Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00389; Yamauchi J, 2015, J INFECT DIS, V211, P238, DOI 10.1093/infdis/jiu438; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505	35	49	51	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					529	538		10.1056/NEJMoa1704827	http://dx.doi.org/10.1056/NEJMoa1704827			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV1OX	29414279	Bronze			2022-12-28	WOS:000424335200008
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Mandatory flu vaccination won't fix the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Davies S, 2018, CHIEF MED OFFICER AD; De Serres G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0163586; Donnelly L, 2017, TELEGRAPH; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Kliner M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012149; Pereira M, 2017, CLIN MED, V17, P484, DOI 10.7861/clinmedicine.17-6-484; Public Health England, INFL VACC EFF VE AD; Thomas RE, 2016, COCHRANE DB SYST REV, V6; Twitter, 2017, DRBRUCEKEOGH	9	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2018	360								k402	10.1136/bmj.k402	http://dx.doi.org/10.1136/bmj.k402			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0HT	29437649	Bronze, Green Published			2022-12-28	WOS:000424975300003
J	Green, A				Green, Andrew			A new paradigm for the MRC Units in The Gambia and Uganda	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					418	418		10.1016/S0140-6736(18)30192-2	http://dx.doi.org/10.1016/S0140-6736(18)30192-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29407023				2022-12-28	WOS:000424333600015
J	Zhu, HY; Yi, J; Li, MY; Xiao, J; Zhang, LF; Yang, CW; Kaindl, RA; Li, LJ; Wang, Y; Zhang, X				Zhu, Hanyu; Yi, Jun; Li, Ming-Yang; Xiao, Jun; Zhang, Lifa; Yang, Chih-Wen; Kaindl, Robert A.; Li, Lain-Jong; Wang, Yuan; Zhang, Xiang			Observation of chiral phonons	SCIENCE			English	Article							EXCITON FORMATION; MONOLAYER WSE2; SCATTERING; MOS2; REALIZATION; STATES; MODEL	Chirality reveals symmetry breaking of the fundamental interaction of elementary particles. In condensed matter, for example, the chirality of electrons governs many unconventional transport phenomena such as the quantum Hall effect. Here we show that phonons can exhibit intrinsic chirality in monolayer tungsten diselenide. The broken inversion symmetry of the lattice lifts the degeneracy of clockwise and counterclockwise phonon modes at the corners of the Brillouin zone. We identified the phonons by the intervalley transfer of holes through hole-phonon interactions during the indirect infrared absorption, and we confirmed their chirality by the infrared circular dichroism arising from pseudoangular momentum conservation. The chiral phonons are important for electron-phonon coupling in solids, phonon-driven topological states, and energy-efficient information processing.	[Zhu, Hanyu; Yi, Jun; Xiao, Jun; Wang, Yuan; Zhang, Xiang] Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Zhu, Hanyu; Kaindl, Robert A.; Wang, Yuan; Zhang, Xiang] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Li, Ming-Yang; Yang, Chih-Wen; Li, Lain-Jong] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Zhang, Lifa] Nanjing Normal Univ, Dept Phys, Nanjing 210023, Jiangsu, Peoples R China	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; King Abdullah University of Science & Technology; Nanjing Normal University	Wang, Y; Zhang, X (corresponding author), Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA.; Wang, Y; Zhang, X (corresponding author), Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	yuanwang@berkeley.edu; xzhang@me.berkeley.edu	Wang, Yuan/F-7211-2011; Zhang, Lifa/D-7537-2012; Li, Lain-Jong/D-5244-2011; Yi, Jun/ABE-8199-2020; Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022; Zhang, Xiang/F-6905-2011	Wang, Yuan/0000-0001-7892-2812; Zhang, Lifa/0000-0001-6108-1404; Li, Lain-Jong/0000-0002-4059-7783; Yi, Jun/0000-0003-2186-6615; Zhang, Xiang/0000-0002-3272-894X; Zhu, Hanyu/0000-0003-3376-5352; Xiao, Jun/0000-0003-4248-8190; Yang, Chih-Wen/0000-0002-4381-9222	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05-CH11231, KCWF16, KC12XZ]; Ultrafast Materials Science program [KC2203]; China Scholarship Council (CSC) [201606310094]; National Natural Science Foundation of China [11574154]; King Abdullah University of Science and Technology through a Competitive Research Grant (CRG5)	U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Ultrafast Materials Science program; China Scholarship Council (CSC)(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); King Abdullah University of Science and Technology through a Competitive Research Grant (CRG5)	We thank F. Wang and Q. Niu for helpful discussions. This work was primarily supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division under contract no. DE-AC02-05-CH11231 within the van der Waals Heterostructures program (KCWF16) for sample preparation and theory and data analysis, and within the Subwavelength Metamaterials Program (KC12XZ) for optical design and measurement. R.A.K. was supported under the same contract within the Ultrafast Materials Science program (KC2203) for mid-IR frequency conversion. J.Y. acknowledges a scholarship from the China Scholarship Council (CSC) under grant no. 201606310094. L.Z. thanks M. Gao for helpful calculation and discussion and acknowledges support from the National Natural Science Foundation of China (grant no. 11574154). L.-J.L. acknowledges support from the King Abdullah University of Science and Technology through a Competitive Research Grant (CRG5) for monolayer WSe<INF>2</INF> synthesis. All data needed to evaluate the conclusions in the paper are present in the paper and the supplementary materials.	BARREIRA MMH, 1992, PHYS REV D, V45, P1410, DOI 10.1103/PhysRevD.45.1410; Brendel C, 2017, P NATL ACAD SCI USA, V114, pE3390, DOI 10.1073/pnas.1615503114; Carvalho BR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14670; Ceballos F, 2016, NANOSCALE, V8, P11681, DOI 10.1039/c6nr02516a; Chen SY, 2015, NANO LETT, V15, P2526, DOI 10.1021/acs.nanolett.5b00092; Das Sarma S, 2011, REV MOD PHYS, V83, P407, DOI 10.1103/RevModPhys.83.407; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hasan MZ, 2017, ANNU REV CONDEN MA P, V8, P289, DOI 10.1146/annurev-conmatphys-031016-025225; JOHNSON RC, 1982, PHYS LETT B, V114, P147, DOI 10.1016/0370-2693(82)90134-4; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Katsuki H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3801; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; Li NB, 2012, REV MOD PHYS, V84, P1045, DOI 10.1103/RevModPhys.84.1045; Low T, 2017, NAT MATER, V16, P182, DOI [10.1038/NMAT4792, 10.1038/nmat4792]; Manca M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14927; Nova TF, 2017, NAT PHYS, V13, P132, DOI [10.1038/NPHYS3925, 10.1038/nphys3925]; Poellmann C, 2015, NAT MATER, V14, P889, DOI [10.1038/nmat4356, 10.1038/NMAT4356]; Rini M, 2007, NATURE, V449, P72, DOI 10.1038/nature06119; SCHAACK G, 1976, J PHYS C SOLID STATE, V9, pL297, DOI 10.1088/0022-3719/9/11/009; Schaibley JR, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.55; Spadoni A, 2009, WAVE MOTION, V46, P435, DOI 10.1016/j.wavemoti.2009.04.002; Steinleitner P, 2017, NANO LETT, V17, P1455, DOI 10.1021/acs.nanolett.6b04422; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Yan TF, 2017, PHYS CHEM CHEM PHYS, V19, P3176, DOI 10.1039/c6cp07208a; Yu T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205303; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang LF, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.115502; Zhang XX, 2017, NAT NANOTECHNOL, V12, P883, DOI [10.1038/nnano.2017.105, 10.1038/NNANO.2017.105]	29	146	146	21	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					579	581		10.1126/science.aar2711	http://dx.doi.org/10.1126/science.aar2711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420291	Green Submitted			2022-12-28	WOS:000423795800043
J	Sarantopoulos, S				Sarantopoulos, Stefanie			Allogeneic Stem-Cell Transplantation - A T-Cell Balancing ACT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VERSUS-HOST-DISEASE; ST2		[Sarantopoulos, Stefanie] Duke Univ, Med Ctr, Div Hematol Malignancies & Cellular Therapy, Dept Med,Duke Canc Inst, Durham, NC 27710 USA	Duke University	Sarantopoulos, S (corresponding author), Duke Univ, Med Ctr, Div Hematol Malignancies & Cellular Therapy, Dept Med,Duke Canc Inst, Durham, NC 27710 USA.							Huang Wei, 2017, Hematol Oncol Stem Cell Ther, V10, P211, DOI 10.1016/j.hemonc.2017.05.006; Ramadan A, 2017, J EXP MED, V214, P3577, DOI 10.1084/jem.20170041; Reichenbach DK, 2015, BLOOD, V125, P3183, DOI 10.1182/blood-2014-10-606830; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Walker J. A., 2017, NAT REV IMMUNOL; Zhang JL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0166	6	6	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					480	482		10.1056/NEJMcibr1713238	http://dx.doi.org/10.1056/NEJMcibr1713238			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29385359				2022-12-28	WOS:000423783200015
J	Ahneman, DT; Estrada, JG; Lin, SS; Dreher, SD; Doyle, AG				Ahneman, Derek T.; Estrada, Jesus G.; Lin, Shishi; Dreher, Spencer D.; Doyle, Abigail G.			Predicting reaction performance in C-N cross-coupling using machine learning	SCIENCE			English	Article							DISCOVERY; TOOL	Machine learning methods are becoming integral to scientific inquiry in numerous disciplines. We demonstrated that machine learning can be used to predict the performance of a synthetic reaction in multidimensional chemical space using data obtained via high-throughput experimentation. We created scripts to compute and extract atomic, molecular, and vibrational descriptors for the components of a palladium-catalyzed Buchwald-Hartwig cross-coupling of aryl halides with 4-methylaniline in the presence of various potentially inhibitory additives. Using these descriptors as inputs and reaction yield as output, we showed that a random forest algorithm provides significantly improved predictive performance over linear regression analysis. The random forest model was also successfully applied to sparse training sets and out-of-sample prediction, suggesting its value in facilitating adoption of synthetic methodology.	[Ahneman, Derek T.; Estrada, Jesus G.; Doyle, Abigail G.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Lin, Shishi; Dreher, Spencer D.] Merck Sharp & Dohme Corp, Chem Capabil & Screening, Kenilworth, NJ 07033 USA	Princeton University; Merck & Company	Doyle, AG (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.; Dreher, SD (corresponding author), Merck Sharp & Dohme Corp, Chem Capabil & Screening, Kenilworth, NJ 07033 USA.	spencer_dreher@merck.com; agdoyle@princeton.edu		Doyle, Abigail/0000-0002-6641-0833	Princeton University; Camille Dreyfus Teacher-Scholar Award; Amgen Young Investigator Award	Princeton University(Princeton University); Camille Dreyfus Teacher-Scholar Award; Amgen Young Investigator Award(Amgen)	Financial support was provided by Princeton University, an Amgen Young Investigator Award, and a Camille Dreyfus Teacher-Scholar Award.	Bess EN, 2014, P NATL ACAD SCI USA, V111, P14698, DOI 10.1073/pnas.1409522111; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Coley CW, 2017, ACS CENTRAL SCI, V3, P434, DOI 10.1021/acscentsci.7b00064; Collins KD, 2015, ACCOUNTS CHEM RES, V48, P619, DOI 10.1021/ar500434f; Collins KD, 2014, NAT CHEM, V6, P859, DOI [10.1038/NCHEM.2062, 10.1038/nchem.2062]; Cruz-Monteagudo M, 2014, DRUG DISCOV TODAY, V19, P1069, DOI 10.1016/j.drudis.2014.02.003; Denmark SE, 2011, J ORG CHEM, V76, P4337, DOI 10.1021/jo2005457; Draper NR, 1998, APPL REGRESSION ANAL; Fall Y, 2009, EUR J ORG CHEM, V2009, P4041, DOI 10.1002/ejoc.200900309; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Kayala MA, 2011, J CHEM INF MODEL, V51, P2209, DOI 10.1021/ci200207y; KITO S, 1994, APPL CATAL A-GEN, V114, pL173; Kutchukian PS, 2016, CHEM SCI, V7, P2604, DOI 10.1039/c5sc04751j; Lavecchia A, 2015, DRUG DISCOV TODAY, V20, P318, DOI 10.1016/j.drudis.2014.10.012; Liu BW, 2017, ACS CENTRAL SCI, V3, P1103, DOI 10.1021/acscentsci.7b00303; Ma JS, 2015, J CHEM INF MODEL, V55, P263, DOI 10.1021/ci500747n; Milo A, 2015, SCIENCE, V347, P737, DOI 10.1126/science.1261043; Milo A, 2014, NATURE, V507, P210, DOI 10.1038/nature13019; Omata K, 2011, IND ENG CHEM RES, V50, P10948, DOI 10.1021/ie102477y; Raccuglia P, 2016, NATURE, V533, P73, DOI 10.1038/nature17439; Ruiz-Castillo P, 2016, CHEM REV, V116, P12564, DOI 10.1021/acs.chemrev.6b00512; Santanilla AB, 2015, SCIENCE, V347, P49, DOI 10.1126/science.1259203; Shahlaei M, 2013, CHEM REV, V113, P8093, DOI 10.1021/cr3004339; Shigenobu M, 2015, ANGEW CHEM INT EDIT, V54, P9572, DOI 10.1002/anie.201504552; Sigman MS, 2016, ACCOUNTS CHEM RES, V49, P1292, DOI 10.1021/acs.accounts.6b00194; Skoraczynski G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02303-0; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Szymkuc S, 2016, ANGEW CHEM INT EDIT, V55, P5904, DOI 10.1002/anie.201506101; Tan YC, 2010, J AM CHEM SOC, V132, P3676, DOI 10.1021/ja100676r; Todd MH, 2005, CHEM SOC REV, V34, P247, DOI 10.1039/b104620a; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Wei JN, 2016, ACS CENTRAL SCI, V2, P725, DOI 10.1021/acscentsci.6b00219; Yu SJ, 2016, ANGEW CHEM INT EDIT, V55, P8696, DOI 10.1002/anie.201602224	35	356	359	51	475	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2018	360	6385					186	190		10.1126/science.aar5169	http://dx.doi.org/10.1126/science.aar5169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC5DK	29449509				2022-12-28	WOS:000429805400042
J	Tangcharoensathien, V; Witthayapipopsakul, W; Panichkriangkrai, W; Patcharanarumol, W; Mills, A				Tangcharoensathien, Viroj; Witthayapipopsakul, Woranan; Panichkriangkrai, Warisa; Patcharanarumol, Walaiporn; Mills, Anne			Health systems development in Thailand: a solid platform for successful implementation of universal health coverage	LANCET			English	Review							MEDICAL TOURISM; POLICY; IMPACT; DECISIONS; DETERMINANTS; EXPENDITURE; INSURANCE; MORTALITY; LESSONS; DISEASE	Thailand's health development since the 1970s has been focused on investment in the health delivery infrastructure at the district level and below and on training the health workforce. Deliberate policies increased domestic training capacities for all cadres of health personnel and distributed them to rural and underserved areas. Since 1975, targeted insurance schemes for different population groups have improved financial access to health care until universal health coverage was implemented in 2002. Despite its low gross national income per capita in Thailand, a bold decision was made to use general taxation to finance the Universal Health Coverage Scheme without relying on contributions from members. Empirical evidence shows substantial reduction in levels of out-of-pocket payments, the incidence of catastrophic health spending, and in medical impoverishment. The scheme has also greatly reduced provincial gaps in child mortality. Certain interventions such as antiretroviral therapy and renal replacement therapy have saved the lives of adults. Well designed strategic purchasing contributed to efficiency, cost containment, and equity. Remaining challenges include preparing for an ageing society, primary prevention of non-communicable diseases, law enforcement to prevent road traffic mortality, and effective coverage of diabetes and tuberculosis control.	[Tangcharoensathien, Viroj; Witthayapipopsakul, Woranan; Panichkriangkrai, Warisa; Patcharanarumol, Walaiporn] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi 11000, Thailand; [Mills, Anne] London Sch Hyg & Trop Med, London, England	Ministry of Public Health - Thailand; University of London; London School of Hygiene & Tropical Medicine	Tangcharoensathien, V (corresponding author), Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi 11000, Thailand.	viroj@ihpp.thaigov.net	Supprasert, Warunsicha/F-4602-2017; Witthayapipopsakul, Woranan/Q-8942-2019	Witthayapipopsakul, Woranan/0000-0003-1817-8264				Aekpalakorn V., 2014, 5 NATL HLTH EXAMINAT; Aekpalakorn V., 2009, 4 NATL HLTH EXAMINAT; [Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P84, DOI 10.2471/BLT.10.010210; [Anonymous], 2016, HLTH GLANCE EUROPE 2; [Anonymous], 2016, 2016 USRDS ANN DAT R; Aungkulanon S, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0479-5; Aungkulanon S, 2012, EMERG INFECT DIS, V18, P1794, DOI 10.3201/eid1811.120637; Bundhamcharoen K, 2011, IMPACT DEMOGRAPHIC C, P65; Bundhamcharoen K, 2016, J HEALTH SCI, V25, P342; Bundhamcharoen K, 2016, TOB CONTROL, V25, P532, DOI 10.1136/tobaccocontrol-2015-052319; Bundhamcharoen K, 2013, LANCET, V381, P24; Cameron S., 2006, GLOBAL CORRUPTION RE, P100; Charoenca N, 2012, INT J ENV RES PUB HE, V9, P1111, DOI 10.3390/ijerph9041111; Chokewiwat V, 2013, RXY WELA HLTH HIST; Chuakhamfoo N., 2014, BMC PUBLIC HLTH S1, V14, pP6; Chuengsaman P, 2017, SEMIN NEPHROL, V37, P287, DOI 10.1016/j.semnephrol.2017.02.008; Evans TG, 2012, INDEPENDENT ASSESSME; Fleck F, 2014, B WORLD HEALTH ORGAN, V92, P472, DOI 10.2471/BLT.14.030714; Gerdtham U, 2011, APPL ECON, V33, P643; Ghislandi S, 2015, HEALTH ECON POLICY L, V10, P251, DOI 10.1017/S1744133114000334; Green A, 2007, SOUND CHOICES ENHANC; Gruber J, 2014, AM ECON J-APPL ECON, V6, P91, DOI 10.1257/app.6.1.91; Health Focus, 2014, THAILAND ACHIEVING U; Health systems research institute, 2012, UN HLTH COV CAS STUD; Hsu MC, 2015, SOC SCI MED, V145, P227, DOI 10.1016/j.socscimed.2015.09.036; International Agency for Research on Cancer, 2011, IARC HDB CANC PREV, V14; International Baby Food Action Network (IBFAN) Asia, 2015, WORLD BREASTF TREND; International Health Policy Program, 2017, THAILANDS BURDEN DIS; International Health Policy Program, 2015, DIS ADJ LIF YEAR THA; Jiang H, 2017, ADDICTION, V112, P1508, DOI 10.1111/add.13835; Jongudomsuk P., 2012, EC PUBLIC HLTH CARE, P307; Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Kongkam L, 2011, PRODUCTION GRADUATES; Kongsuk Thoranin, 2017, WHO South East Asia J Public Health, V6, P34, DOI 10.4103/2224-3151.206162; Kuhonta EM, UNIVERSAL HLTH CARE; Lee K, 1998, SOC SCI MED, V47, P949, DOI 10.1016/S0277-9536(98)00168-3; Limwattananon C, 2011, J HLTH SYS RES, V5, P149; Limwattananon S, 2011, J HLTH SYS RES, V5, P25; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Limwattananon S, 2015, J PUBLIC ECON, V121, P79, DOI 10.1016/j.jpubeco.2014.11.012; Limwattananon S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S6; Maeda A, 2014, SYNTHESIS 11 COUNTRY; Mills A, 2000, HEALTH POLICY, V51, P163, DOI 10.1016/S0168-8510(00)00059-2; Miyashita Y, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0241-9; Mohara A, 2012, J COMP EFFECT RES, V1, P137, DOI [10.2217/CER.12.10, 10.2217/cer.12.10]; NaRanong A, 2011, B WORLD HEALTH ORGAN, V89, P336, DOI 10.2471/BLT.09.072249; National Health Security Office, 2017, NHSO ANN REP 2016; National Statistical Office, 2016, 2015 SURV HLTH WELF; National Statistical Office United Nations Children's Fund, 2016, UN CHILDR FUND THAIL; Nepomuceno T, 1991, ICMH Newsl, V18, P1; Nitayarumphong S., 1990, Health Policy and Planning, V5, P246, DOI 10.1093/heapol/5.3.246; Nittayaraiuphong S, 2008, SAFEGUARDING HLTH SE; NITTAYARAMPHONG S, 1994, HEALTH POLICY PLANN, V9, P31; Noree T, 2016, B WORLD HEALTH ORGAN, V94, P30, DOI 10.2471/BLT.14.152165; Office of Collaborative Project to Increase Rural Doctor Production, 2012, NUM STUD ODOD TEACH; Organisation for Economic Co-operation and Development, 2015, DOCT CONS IND; Pagaiya N., 2009, THAILANDS HLTH WORKF; Patcharanarumol W, GOOD HLTH LOW COST 2; Patcharanarumol W, 2009, J INT DEV, V21, P212, DOI 10.1002/jid.1549; Paudel R, 2012, Kathmandu Univ Med J (KUMJ), V10, P18; Pitayarangsarit S, 2009, B WORLD HEALTH ORGAN, V87, P72, DOI 10.2471/BLT.07.044479; Prakongsai P, 2009, ADV HEALTH ECON HEAL, V21, P57, DOI 10.1108/S0731-2199(2009)0000021006; Prakongsai P, 2009, J INT DEV, V21, P291, DOI 10.1002/jid.1553; Putthasri W, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-47; Regional Office for South-East Asia, 2017, ANN REPORT; Reich MR, 2016, LANCET, V387, P811, DOI 10.1016/S0140-6736(15)60002-2; Rieger M, 2017, SOC SCI MED, V172, P46, DOI 10.1016/j.socscimed.2016.11.022; Riegersperger M, 2007, J RENAL CARE, V33, P105, DOI 10.1111/j.1755-6686.2007.tb00053.x; Saloojee Y, 2000, B WORLD HEALTH ORGAN, V78, P902; Sawaengdee K., 2017, NURSE WORKFORCE REQU, V33; Sawaengdee K, 2016, BMC NURS, V15, DOI 10.1186/s12912-016-0131-0; Scheil-Adlung X, 2013, B WORLD HEALTH ORGAN, V91, P888, DOI 10.2471/BLT.13.126953; Sidibe M, 2016, LANCET, V387, P2488, DOI 10.1016/S0140-6736(16)30787-5; Suphanchaimat R, 2016, HEALTH POLICY PLANN, V31, P229, DOI 10.1093/heapol/czv046; Tangcharoensathien V, 2004, B WORLD HEALTH ORGAN, V82, P750; Tangcharoensathien V., 2012, Economic and Political Weekly, V47, P53; Tangcharoensathien V, 2017, INT J HLTH POLICY MA, V6, P1; Tangcharoensathien V, 2017, INT J HEALTH POLICY, V6, P107, DOI 10.15171/ijhpm.2016.99; Tangcharoensathien V, 2017, B WORLD HEALTH ORGAN, V95, P146, DOI [10.2471/BLT.16.179606, 10.2471/blt.16.179606]; Tangcharoensathien V, 2015, HEALTH POLICY PLANN, V30, P1152, DOI 10.1093/heapol/czu120; Tangcharoensathien V, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-25; Tangcharoensathien V, 2010, BUILDING DECENT SOCIETIES: RETHINKING THE ROLE OF SOCIAL SECURITY IN DEVELOPMENT, P310; Tantivess S, 2016, HEALTH SYST REFORM, V2, P106, DOI 10.1080/23288604.2016.1128514; Techakehakij W, 2017, HEALTH POLICY PLANN, V32, P809, DOI 10.1093/heapol/czx026; Teerawattananon Y, 2017, 703 ADBI; Teerawattananon Y, 2007, VALUE HEALTH, V10, P61, DOI 10.1111/j.1524-4733.2006.00145.x; The Collaborative project to increase production of rural doctor (CPIRD), HIST CPIRD; Tiwari R, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-239; Trirat N, 2012, POLITICS POWER BALAN; Vateesatokit P., 2003, TOBACCO CONTROL POLI; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; Wanwong Y., 2017, J HLTH SYST RES, V11, P182; Wasi J., 2013, THESIS; WHO, 2011, 1 GLOB MIN C HLTH LI; WHO, 2015, KIND THAIL HLTH SYST; WHO, 2008, PHARMAFORUM 0121; WHO, 2007, EV BUS STRENGTH HLTH; WHO, 2016, COUNTR PROF 30 HIGH; Wibulpolprasert, 2017, POLITICAL POLICY LES; Wibulpolprasert S., 2003, 20 YEARS RURAL DOCTO; WIBULPOLPRASERT S, 2005, THAILAND HLTH PROFIL; Wibulpolprasert Suwit, 2003, Hum Resour Health, V1, P12, DOI 10.1186/1478-4491-1-12; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Bank, 2016, WORLDW GOV IND 2016; World Bank, WORLD DEV IND DAT; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2014, PREV SUIC PREV SUIC; World Health Organization, 2017, WORLD REP HLTH POL S; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	113	114	114	2	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1205	1223		10.1016/S0140-6736(18)30198-3	http://dx.doi.org/10.1016/S0140-6736(18)30198-3			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GA2MF	29397200	Green Submitted			2022-12-28	WOS:000428156100032
J	Varadkar, S				Varadkar, Sophia			Cannabidiol for drop seizures in Lennox-Gastaut syndrome	LANCET			English	Editorial Material							STIMULATION; EPILEPSY; TRIAL		[Varadkar, Sophia] Great Ormond St Hosp Children NHS Fdn Trust, Neurosci Unit, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Varadkar, S (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Neurosci Unit, London WC1N 3JH, England.	sophia.varadkar@gosh.nhs.uk			Bial; Eisai; LivaNova; UCB	Bial(Bial Group); Eisai(Eisai Co Ltd); LivaNova; UCB(UCB Pharma SA)	I have received remuneration paid to my employer, Great Ormond Street Hospital for Children NHS Foundation Trust, for activities in paediatric epilepsy outside the area commented on here, including advisory board fees from Bial, speaker fees from Eisai, lecture fees and travel expenses from LivaNova, and speaker fees from UCB. I have also participated as an expert clinical adviser in a National Institute for Health and Care Excellence scoping workshop on cannabidiol for adjuvant treatment of seizures associated with Dravet syndrome or Lennox-Gastaut syndrome, representing the International League Against Epilepsy British Chapter in 2018.	Devinsky O, 2017, NEW ENGL J MED, V376, P2011, DOI 10.1056/NEJMoa1611618; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Hancock EC, 2013, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003277.PUB3; Kossoff EHW, 2014, EPILEPSIA, V55, P29, DOI 10.1111/epi.12546; Medicines and Healthcare Products Regulatory Agency, 2016, MHRA STAT PROD CONT; Thiele EA, 2018, LANCET; Valentin A, 2017, EUR J PAEDIATR NEURO, V21, P223, DOI 10.1016/j.ejpn.2016.10.011; Vandrey R, 2015, JAMA-J AM MED ASSOC, V313, P2491, DOI 10.1001/jama.2015.6613	8	1	1	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1006	1007		10.1016/S0140-6736(18)30135-1	http://dx.doi.org/10.1016/S0140-6736(18)30135-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29395274				2022-12-28	WOS:000427585100009
J	Tan, CSH; Go, KD; Bisteau, X; Dai, LY; Yong, CH; Prabhu, N; Ozturk, MB; Lim, YT; Sreekumar, L; Lengqvist, J; Tergaonkar, V; Kaldis, P; Sobota, RM; Nordlund, P				Tan, Chris Soon Heng; Go, Ka Diam; Bisteau, Xavier; Dai, Lingyun; Yong, Chern Han; Prabhu, Nayana; Ozturk, Mert Burak; Lim, Yan Ting; Sreekumar, Lekshmy; Lengqvist, Johan; Tergaonkar, Vinay; Kaldis, Philipp; Sobota, Radoslaw M.; Nordlund, Par			Thermal proximity coaggregation for system-wide profiling of protein complex dynamics in cells	SCIENCE			English	Article							MOLECULAR INTERACTION DATABASE; SACCHAROMYCES-CEREVISIAE; HUMAN INTERACTOME; NETWORKS; TRANSCRIPTION; COMPONENT; RESOURCE; DISEASE; UPDATE; DRUG	Proteins differentially interact with each other across cellular states and conditions, but an efficient proteome-wide strategy to monitor them is lacking. We report the application of thermal proximity coaggregation (TPCA) for high-throughput intracellular monitoring of protein complex dynamics. Significant TPCA signatures observed among well-validated protein-protein interactions correlate positively with interaction stoichiometry and are statistically observable in more than 350 annotated human protein complexes. Using TPCA, we identified many complexes without detectable differential protein expression, including chromatin-associated complexes, modulated in S phase of the cell cycle. Comparison of six cell lines by TPCA revealed cell-specific interactions even in fundamental cellular processes. TPCA constitutes an approach for system-wide studies of protein complexes in nonengineered cells and tissues and might be used to identify protein complexes that are modulated in diseases.	[Tan, Chris Soon Heng; Bisteau, Xavier; Ozturk, Mert Burak; Tergaonkar, Vinay; Kaldis, Philipp; Sobota, Radoslaw M.; Nordlund, Par] ASTAR, IMCB, Singapore, Singapore; [Tan, Chris Soon Heng; Sobota, Radoslaw M.] ASTAR, IMB, Singapore, Singapore; [Go, Ka Diam; Dai, Lingyun; Prabhu, Nayana; Lim, Yan Ting; Sreekumar, Lekshmy; Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Yong, Chern Han] Duke Natl Univ Singapore NUS, Program Canc & Stem Cell Biol, Med Sch, Singapore, Singapore; [Yong, Chern Han] Duke NUS Med Sch, Ctr Computat Biol, Singapore, Singapore; [Ozturk, Mert Burak; Tergaonkar, Vinay; Kaldis, Philipp] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Lengqvist, Johan; Nordlund, Par] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Tergaonkar, Vinay] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Tergaonkar, Vinay] SA Pathology, Adelaide, SA, Australia	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Karolinska Institutet; Centre for Cancer Biology; University of South Australia; SA Pathology	Tan, CSH; Nordlund, P (corresponding author), ASTAR, IMCB, Singapore, Singapore.; Tan, CSH (corresponding author), ASTAR, IMB, Singapore, Singapore.; Nordlund, P (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Nordlund, P (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden.	cshtan@imcb.a-star.edu.sg; pnordlund@ntu.edu.sg	Kaldis, Philipp/G-2714-2010; Bisteau, Xavier/Q-7239-2018; Dai, Lingyun/HIR-6574-2022; Bisteau, Xavier/AAH-6744-2021; Tan, Chris Soon Heng/C-1177-2009; Ozturk, Mert Burak/J-6893-2016	Kaldis, Philipp/0000-0002-7247-7591; Bisteau, Xavier/0000-0002-8896-5098; Dai, Lingyun/0000-0001-9386-5967; Prabhu, Nayana/0000-0002-2350-6552; Tan, Chris Soon Heng/0000-0002-8172-5235; Sobota, Radoslaw/0000-0002-2455-2526; KA DIAM, GO/0000-0003-1782-2775; Ozturk, Mert Burak/0000-0003-1504-1211	Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR) [1610151038]; Nanyang Technological University; Swedish Research Council; Swedish Cancer Society; Knut and Alice Wallenberg foundation; National Medical Research Council (NMRC) [MOHIAFCAT2/004/2015]; National Research Foundation Singapore [NRF2016NRF-CRP001-024]; Biomedical Research Council; A*STAR;  [NMRC-CBRG14nov086]	Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Nanyang Technological University(Nanyang Technological University); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); National Medical Research Council (NMRC)(National Medical Research Council, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); A*STAR(Agency for Science Technology & Research (A*STAR)); 	This research was funded directly by Young Investigator Grant (1610151038) awarded to C.S.H.T. by the Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR). Support for this research was provided by a startup grant from Nanyang Technological University and grants from the Swedish Research Council, the Swedish Cancer Society, and the Knut and Alice Wallenberg foundation awarded to P.N., and by National Medical Research Council (NMRC) grant MOHIAFCAT2/004/2015 to P.N. and R.M.S. Research in the lab of V.T. is supported by grant NRF2016NRF-CRP001-024 from the National Research Foundation Singapore. P.K. and X.B. are supported by the Biomedical Research Council, A*STAR, and NMRC-CBRG14nov086 grants.	Canavan R, 2007, NUCLEIC ACIDS RES, V35, P6268, DOI 10.1093/nar/gkm691; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Dezso Z, 2003, GENOME RES, V13, P2450, DOI 10.1101/gr.1073603; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Huber KVM, 2015, NAT METHODS, V12, P1055, DOI [10.1038/NMETH.3590, 10.1038/nmeth.3590]; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Li M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-398; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Skaar JR, 2015, CELL RES, V25, P288, DOI 10.1038/cr.2015.19; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169	38	93	95	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1170	1176		10.1126/science.aan0346	http://dx.doi.org/10.1126/science.aan0346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29439025	Green Published, Green Accepted			2022-12-28	WOS:000426835900049
J	Lipner, SR				Lipner, Shari R.			Ulcerated Nodule of the Fingernail Subungual amelanotic melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lipner, Shari R.] Weill Cornell Med, Dept Dermatol, 1305 York Ave,9th Floor, New York, NY 10021 USA	Cornell University	Lipner, SR (corresponding author), Weill Cornell Med, Dept Dermatol, 1305 York Ave,9th Floor, New York, NY 10021 USA.	SHL9032@med.cornell.edu	Lipner, Shari R./AAK-8943-2020	Lipner, Shari R./0000-0001-5913-9304				Asgari MM, 2017, BRIT J DERMATOL, V177, P428, DOI 10.1111/bjd.15600; BARAN R, 1994, DIS NAILS THEIR MANA, P417; Cheung WL, 2012, J CUTAN PATHOL, V39, P33, DOI 10.1111/j.1600-0560.2011.01808.x; de Giorgi V, 2005, ARCH DERMATOL, V141, P398, DOI 10.1001/archderm.141.3.398; FINLEY RK, 1994, SURGERY, V116, P96; Levit EK, 2000, J AM ACAD DERMATOL, V42, P269, DOI 10.1016/S0190-9622(00)90137-3; Metzger S, 1998, MELANOMA RES, V8, P181, DOI 10.1097/00008390-199804000-00014; Pizzichetta MA, 2004, BRIT J DERMATOL, V150, P1117, DOI 10.1111/j.1365-2133.2004.05928.x; Starace M, 2017, J EUR ACAD DERMATOL, DOI 10.1111/jdv.14568	9	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2018	319	7					713	714		10.1001/jama.2018.0179	http://dx.doi.org/10.1001/jama.2018.0179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW7MQ	29453865				2022-12-28	WOS:000425508400022
J	Guerra, RE; Kelleher, CP; Hollingsworth, AD; Chaikin, PM				Guerra, Rodrigo E.; Kelleher, Colm P.; Hollingsworth, Andrew D.; Chaikin, Paul M.			Freezing on a sphere	NATURE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GRAIN-BOUNDARY SCARS; 2 DIMENSIONS; CRYSTALS; VORTICES; GLASSES; LIQUIDS; VIRUSES; HELIUM; ORDER	The best understood crystal ordering transition is that of two-dimensional freezing, which proceeds by the rapid eradication of lattice defects as the temperature is lowered below a critical threshold(1-4). But crystals that assemble on closed surfaces are required by topology to have a minimum number of lattice defects, called disclinations, that act as conserved topological charges-consider the 12 pentagons on a football or the 12 pentamers on a viral capsid(5,6). Moreover, crystals assembled on curved surfaces can spontaneously develop additional lattice defects to alleviate the stress imposed by the curvature(6-8). It is therefore unclear how crystallization can proceed on a sphere, the simplest curved surface on which it is impossible to eliminate such defects. Here we show that freezing on the surface of a sphere proceeds by the formation of a single, encompassing crystalline `continent', which forces defects into 12 isolated `seas' with the same icosahedral symmetry as footballs and viruses. We use this broken symmetry-aligning the vertices of an icosahedron with the defect seas and unfolding the faces onto a plane-to construct a new order parameter that reveals the underlying long-range orientational order of the lattice. The effects of geometry on crystallization could be taken into account in the design of nanometre-and micrometre-scale structures in which mobile defects are sequestered into self-ordered arrays. Our results may also be relevant in understanding the properties and occurrence of natural icosahedral structures such as viruses(5,9,10).	[Guerra, Rodrigo E.; Kelleher, Colm P.; Hollingsworth, Andrew D.; Chaikin, Paul M.] NYU, Ctr Soft Matter Res, 550 1St Ave, New York, NY 10003 USA	New York University	Chaikin, PM (corresponding author), NYU, Ctr Soft Matter Res, 550 1St Ave, New York, NY 10003 USA.	chaikin@nyu.edu	Guerra, Rodrigo/V-5051-2019	Guerra, Rodrigo/0000-0003-3082-0248; Kelleher, Colm/0000-0002-3326-5924	National Science Foundation (NSF) [DMR 1105417]; Gordon and Betty Moore Foundation [GBMF3849]; Materials Research Science and Engineering Center (MRSEC) Program of the NSF [DMR-1420073]; National Aeronautics and Space Administration (NASA) [NNX13AR67G]; Direct For Mathematical & Physical Scien [1105417] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Materials Research Science and Engineering Center (MRSEC) Program of the NSF; National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. J. Bowick and A. Travesset for discussions. This research was primarily supported by the National Science Foundation (NSF) under grant DMR 1105417 and grant GBMF3849 from the Gordon and Betty Moore Foundation. This work was supported partially by the Materials Research Science and Engineering Center (MRSEC) Program of the NSF under award number DMR-1420073 and by the National Aeronautics and Space Administration (NASA) under grant NNX13AR67G. This work has used the NYU IT High Performance Computing resources and services.	Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Bausch AR, 2003, SCIENCE, V299, P1716, DOI 10.1126/science.1081160; Bowick MJ, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024115; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; Deutschlander S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.127801; Dharmavaram S, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.062402; Dodgson MJW, 1997, PHYS REV B, V55, P3816, DOI 10.1103/PhysRevB.55.3816; Gasser U, 2010, CHEMPHYSCHEM, V11, P963, DOI 10.1002/cphc.200900755; Glaser J, 2015, COMPUT PHYS COMMUN, V192, P97, DOI 10.1016/j.cpc.2015.02.028; Glotzer SC, 2000, J CHEM PHYS, V112, P509, DOI 10.1063/1.480541; Guillamon I, 2009, NAT PHYS, V5, P651, DOI 10.1038/NPHYS1368; HALPERIN BI, 1978, PHYS REV LETT, V41, P121, DOI 10.1103/PhysRevLett.41.121; Irvine WTM, 2010, NATURE, V468, P947, DOI 10.1038/nature09620; Kelleher C. P., 2017, FREEZING ON A SPHERE; Kelleher CP, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.022602; Kelleher CP, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062306; KOTSUBO V, 1984, PHYS REV LETT, V53, P691, DOI 10.1103/PhysRevLett.53.691; Leimkuhler B, 2016, P ROY SOC A-MATH PHY, V472, DOI 10.1098/rspa.2016.0138; Lipowsky P, 2005, NAT MATER, V4, P407, DOI 10.1038/nmat1376; Nelson D. R., 2002, DEFECTS GEOMETRY CON, V112; OVRUT BA, 1991, PHYS REV D, V43, P1314, DOI 10.1103/PhysRevD.43.1314; Parisi G, 1997, J PHYS A-MATH GEN, V30, pL765, DOI 10.1088/0305-4470/30/22/004; STAN MA, 1989, PHYS REV B, V40, P8995, DOI 10.1103/PhysRevB.40.8995; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; Vitelli V, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021711; YOUNG AP, 1979, PHYS REV B, V19, P1855, DOI 10.1103/PhysRevB.19.1855; Zahn K, 1999, PHYS REV LETT, V82, P2721, DOI 10.1103/PhysRevLett.82.2721	28	68	68	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					346	350		10.1038/nature25468	http://dx.doi.org/10.1038/nature25468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29446378	Green Submitted			2022-12-28	WOS:000424996300035
J	Doshi, P				Doshi, Peter			CDC tightens controls on scientists' communication with news media	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pdoshi@bmj.com						Baker S, 2017, AXIOS           0912; CDC, 2017, STAT COMM SCI INT PR; Pixabay V, 2017, COLUMBIA JOURNALISM; Union of Concerned Scientists, 2008, FREED SPEAK REP CARD	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2018	360								k675	10.1136/bmj.k675	http://dx.doi.org/10.1136/bmj.k675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8KZ	29444880				2022-12-28	WOS:000425582700011
J	Kitada, T; DiAndreth, B; Teague, B; Weiss, R				Kitada, Tasuku; DiAndreth, Breanna; Teague, Brian; Weiss, Ron			Programming gene and engineered-cell therapies with synthetic biology	SCIENCE			English	Review							SPINAL MUSCULAR-ATROPHY; T-CELLS; FEEDBACK-CONTROL; GENOMIC DNA; MOUSE MODEL; RNA; CIRCUIT; CONSTRUCTION; PSORIASIS; NETWORK		[Kitada, Tasuku; DiAndreth, Breanna; Teague, Brian; Weiss, Ron] MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Weiss, R (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rweiss@mit.edu	Kitada, Tasuku/B-8121-2009	Kitada, Tasuku/0000-0003-2265-3363; DiAndreth, Breanna/0000-0002-0302-6834; /0000-0003-0396-2443; /0000-0002-9833-2817	Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; NIH [CA207029]; NSF [CNS-1446607, GRFP 1122374]; Ragon Institute of Massachusetts General Hospital (MGH); Massachusetts Institute of Technology (MIT); Harvard; Division Of Computer and Network Systems [1446474] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Ragon Institute of Massachusetts General Hospital (MGH); Massachusetts Institute of Technology (MIT); Harvard; Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank S. Kiani for critical discussions. This work was supported by research grants to R.W. from the Defense Advanced Research Projects Agency (DARPA-BAA-11-23), the NIH (CA207029), and the NSF (CNS-1446607), and by the Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard. B.D. was supported by a fellowship from the NSF (GRFP 1122374). T.K., B.D., and R.W. are listed as coinventors on patents (granted or pending) assigned to MIT that relate to methods in mammalian synthetic biology.	Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adams D., 1 EUR M ATTR AM DOCT, DOI [10.1016/j.drudis.2014.09.003, DOI 10.1016/J.DRUDIS.2014.09.003]; Aiuti A, 2017, EMBO MOL MED, V9, P737, DOI 10.15252/emmm.201707573; Aronne LJ, 2010, OBESITY, V18, P1739, DOI 10.1038/oby.2009.478; Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007; Bai P, 2016, J HEPATOL, V65, P84, DOI 10.1016/j.jhep.2016.03.020; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Bonger KM, 2011, NAT CHEM BIOL, V7, P531, DOI [10.1038/nchembio.598, 10.1038/NCHEMBIO.598]; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Chung HK, 2015, NAT CHEM BIOL, V11, P713, DOI [10.1038/nchembio.1869, 10.1038/NCHEMBIO.1869]; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Davidsohn N, 2015, ACS SYNTH BIOL, V4, P673, DOI 10.1021/sb500263b; Del Vecchio D, 2015, TRENDS BIOTECHNOL, V33, P111, DOI 10.1016/j.tibtech.2014.11.009; Dolgin E, 2017, NAT BIOTECHNOL, V35, P891, DOI 10.1038/nbt1017-891; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Epstein AL, 2009, GENE THER, V16, P709, DOI 10.1038/gt.2009.42; Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heng BC, 2015, CURR OPIN BIOTECH, V35, P37, DOI 10.1016/j.copbio.2015.01.010; Hoggatt J, 2016, CELL, V166, P263, DOI 10.1016/j.cell.2016.06.049; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kinch MS, 2015, DRUG DISCOV TODAY, V20, P393, DOI 10.1016/j.drudis.2014.09.003; Kishimoto TK, 2016, NAT NANOTECHNOL, V11, P890, DOI [10.1038/NNANO.2016.135, 10.1038/nnano.2016.135]; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Kloks C, 2015, J IMMUNOL METHODS, V417, P1, DOI 10.1016/j.jim.2015.01.003; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lapique N, 2014, NAT CHEM BIOL, V10, P1020, DOI 10.1038/nchembio.1680; Li AF, 2014, MOL THER, V22, pS71; Li YQ, 2015, NAT CHEM BIOL, V11, P207, DOI 10.1038/nchembio.1736; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; MacDonald JT, 2011, INTEGR BIOL-UK, V3, P97, DOI 10.1039/c0ib00077a; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Maldonado RA, 2015, P NATL ACAD SCI USA, V112, pE156, DOI 10.1073/pnas.1408686111; Manning KS, 2017, NAT REV MOL CELL BIO, V18, P102, DOI 10.1038/nrm.2016.139; Meng JH, 2011, NEUROMUSCULAR DISORD, V21, P4, DOI 10.1016/j.nmd.2010.10.004; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Nizzardo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11746; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Rossger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3825; Rossger K, 2013, P NATL ACAD SCI USA, V110, P18150, DOI 10.1073/pnas.1312414110; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/NCHEMBIO.273, 10.1038/nchembio.273]; Sands E., 2017, ANN EUR C RHEUM MADR; Saxena P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11247; Saxena P, 2016, P NATL ACAD SCI USA, V113, P1244, DOI 10.1073/pnas.1514383113; Schukur L, 2016, BIOTECHNOL BIOENG, V113, P588, DOI 10.1002/bit.25828; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Stapleton JA, 2012, ACS SYNTH BIOL, V1, P83, DOI 10.1021/sb200005w; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Wroblewska L, 2015, NAT BIOTECHNOL, V33, P839, DOI 10.1038/nbt.3301; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Xie M, 2016, SCIENCE, V354, P1296, DOI 10.1126/science.aaf4006; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yagi Y, 2014, PLANT J, V78, P772, DOI 10.1111/tpj.12377; Ye HF, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0005; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	102	105	107	8	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					651	+	eaad1067	10.1126/science.aad1067	http://dx.doi.org/10.1126/science.aad1067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1WA	29439214	Green Published, Green Accepted			2022-12-28	WOS:000438784100001
J	da Silva, JA; Tecuapetla, F; Paixao, V; Costa, RM				da Silva, Joaquim Alves; Tecuapetla, Fatuel; Paixao, Vitor; Costa, Rui M.			Dopamine neuron activity before action initiation gates and invigorates future movements	NATURE			English	Article							PARKINSONS-DISEASE; CRE RECOMBINASE; BASAL GANGLIA; SIGNALS; REWARD; REPRESENTATION; PERFORMANCE; TARGETS; VIGOR	Deciding when and whether to move is critical for survival. Loss of dopamine neurons (DANs) of the substantia nigra pars compacta (SNc) in patients with Parkinson's disease causes deficits in movement initiation and slowness of movement(1). The role of DANs in self-paced movement has mostly been attributed to their tonic activity, whereas phasic changes in DAN activity have been linked to reward prediction(2,3). This model has recently been challenged by studies showing transient changes in DAN activity before or during self-paced movement initiation(4-7). Nevertheless, the necessity of this activity for spontaneous movement initiation has not been demonstrated, nor has its relation to initiation versus ongoing movement been described. Here we show that a large proportion of SNc DANs, which did not overlap with reward-responsive DANs, transiently increased their activity before self-paced movement initiation in mice. This activity was not action-specific, and was related to the vigour of future movements. Inhibition of DANs when mice were immobile reduced the probability and vigour of future movements. Conversely, brief activation of DANs when mice were immobile increased the probability and vigour of future movements. Manipulations of dopamine activity after movement initiation did not affect ongoing movements. Similar findings were observed for the initiation and execution of learned action sequences. These findings causally implicate DAN activity before movement initiation in the probability and vigour of future movements.	[da Silva, Joaquim Alves; Tecuapetla, Fatuel; Paixao, Vitor; Costa, Rui M.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [da Silva, Joaquim Alves; Costa, Rui M.] Univ Nova Lisboa, Nova Med Sch, Fac Ciencias Med, Lisbon, Portugal; [Tecuapetla, Fatuel] Univ Nacl Autonoma Mexico, Neuropatol Mol, Inst Fisiol Celular, Mexico City, DF, Mexico; [Costa, Rui M.] Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Neurosci, New York, NY 10027 USA; [Costa, Rui M.] Columbia Univ, Dept Neurol, Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA	Fundacao Champalimaud; Universidade Nova de Lisboa; Universidad Nacional Autonoma de Mexico; Columbia University; Columbia University	Costa, RM (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.; Costa, RM (corresponding author), Univ Nova Lisboa, Nova Med Sch, Fac Ciencias Med, Lisbon, Portugal.; Costa, RM (corresponding author), Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Neurosci, New York, NY 10027 USA.; Costa, RM (corresponding author), Columbia Univ, Dept Neurol, Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA.	rc3031@columbia.edu	da Silva, Joaquim Alves/AAY-1702-2020	da Silva, Joaquim Alves/0000-0002-3967-3603; Tecuapetla, Fatuel/0000-0002-9191-6553; Paixao, Vitor/0000-0003-3722-0747; Costa, Rui M./0000-0003-0495-8374	Gulbenkian Foundation; Fundacao para a Ciencia e Tecnologia, Fronteras de la Ciencia-CONACyT; DGAPA-PAPIIT-UNAM [IN226517]; ERA-NET; European Research Council [COG 617142]; HHMI [IEC 55007415]	Gulbenkian Foundation; Fundacao para a Ciencia e Tecnologia, Fronteras de la Ciencia-CONACyT; DGAPA-PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); ERA-NET; European Research Council(European Research Council (ERC)European Commission); HHMI(Howard Hughes Medical Institute)	We thank A. Vaz for mouse colony management, I. Vaz for the help during photoidentification experiments, L. Perry for help with stereological cell counts, A. Klaus, P. Zhou, L. Paninski for help with the application of the CNMF-E analysis, and the Champalimaud Hardware Platform (F. Carvalho, A. Silva, D. Bento) for help with the development of the motion sensors. This work was supported by fellowships from Gulbenkian Foundation to J.A.d.S. and Grants from Fundacao para a Ciencia e Tecnologia, Fronteras de la Ciencia-CONACyT-2022 and the IN226517 DGAPA-PAPIIT-UNAM to F.T. and from ERA-NET, European Research Council (COG 617142), and HHMI (IEC 55007415) to R.M.C.	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Barter JW, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00039; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Dodson PD, 2016, P NATL ACAD SCI USA, V113, pE2180, DOI 10.1073/pnas.1515941113; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Hamid AA, 2016, NAT NEUROSCI, V19, P117, DOI 10.1038/nn.4173; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Klaus A, 2017, NEURON, V95, P1171, DOI 10.1016/j.neuron.2017.08.015; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mathie MJ, 2002, P ANN INT IEEE EMBS, P2481, DOI 10.1109/IEMBS.2002.1053385; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Niv Y., 2005, NIPS P, V18, P1019, DOI DOI 10.1007/S00213-006-0502-4; Panigrahi B, 2015, CELL, V162, P1418, DOI 10.1016/j.cell.2015.08.014; Parker NF, 2016, NAT NEUROSCI, V19, P845, DOI 10.1038/nn.4287; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Syed ECJ, 2016, NAT NEUROSCI, V19, P34, DOI 10.1038/nn.4187; Tecuapetla F, 2016, CELL, V166, P703, DOI 10.1016/j.cell.2016.06.032; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thura D, 2017, NEURON, V95, P1160, DOI 10.1016/j.neuron.2017.07.039; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wassum KM, 2012, BIOL PSYCHIAT, V71, P846, DOI 10.1016/j.biopsych.2011.12.019; Wong AL, 2015, J NEUROPHYSIOL, V114, P219, DOI 10.1152/jn.00218.2015; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhou P., 2016, PREPRINT	42	221	221	3	83	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					244	+		10.1038/nature25457	http://dx.doi.org/10.1038/nature25457			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29420469				2022-12-28	WOS:000424332600040
J	Starr, D				Starr, Douglas			HUMAN NATURE, OBSERVED	SCIENCE			English	Editorial Material									[Starr, Douglas] Boston Univ, Program Sci Journalism, Boston, MA 02215 USA	Boston University	Starr, D (corresponding author), Boston Univ, Program Sci Journalism, Boston, MA 02215 USA.								0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					510	513		10.1126/science.359.6375.510	http://dx.doi.org/10.1126/science.359.6375.510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420274				2022-12-28	WOS:000423795800019
J	Zhang, DL; Tu, SK; Stubna, M; Wu, WS; Huang, WC; Weng, ZP; Lee, HC				Zhang, Donglei; Tu, Shikui; Stubna, Michael; Wu, Wei-Sheng; Huang, Wei-Che; Weng, Zhiping; Lee, Heng-Chi			The piRNA targeting rules and the resistance to piRNA silencing in endogenous genes	SCIENCE			English	Article							C. ELEGANS GERMLINE; CAENORHABDITIS-ELEGANS; EPIGENETIC MEMORY; ARGONAUTE CSR-1; PIWI; RNA; BIOGENESIS; MICRORNAS; PATHWAY; GENOME	Piwi-interacting RNAs (piRNAs) silence transposons to safeguard genome integrity in animals. However, the functions of the many piRNAs that do not map to transposons remain unknown. Here, we show that piRNA targeting in Caenorhabditis elegans can tolerate a few mismatches but prefer perfect pairing at the seed region. The broad targeting capacity of piRNAs underlies the germline silencing of transgenes in C. elegans. Transgenes engineered to avoid piRNA recognition are stably expressed. Many endogenous germline-expressed genes also contain predicted piRNA targeting sites, and periodic An/Tn clusters (PATCs) are an intrinsic signal that provides resistance to piRNA silencing. Together, our study revealed the piRNA targeting rules and highlights a distinct strategy that C. elegans uses to distinguish endogenous from foreign nucleic acids.	[Zhang, Donglei; Stubna, Michael; Lee, Heng-Chi] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Zhang, Donglei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan, Hubei, Peoples R China; [Tu, Shikui; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Tu, Shikui] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai, Peoples R China; [Wu, Wei-Sheng; Huang, Wei-Che] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan	University of Chicago; Huazhong University of Science & Technology; University of Massachusetts System; University of Massachusetts Worcester; Shanghai Jiao Tong University; National Cheng Kung University	Lee, HC (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	hengchilee@uchicago.edu	Wu, Wei-Sheng/P-5367-2019	Stubna, Michael/0000-0003-4950-9273; Zhang, Donglei/0000-0002-2720-1414; Tu, Shikui/0000-0001-6270-0449; Lee, Heng-Chi/0000-0001-8154-906X	Ministry of Science of Technology of Taiwan [MOST-105-2918-I-006-002, MOST-105-2221-E-006-203-MY2, MOST-106-2628-E-006-006-MY2]; NIH [HD078253, GM108866]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM108866, K99GM108866] Funding Source: NIH RePORTER	Ministry of Science of Technology of Taiwan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Mello for his guidance of H.-C.L. during his postdoctoral training and for resources to initiate the project; J. Staley, E. Ferguson, A. Ruthenburg, and J. Brown for critical comments on the manuscripts; E. Xiao for assistance on designing and cloning transgenes; M. Glotzer and K. Longhini for sharing reagents and unpublished results; and members of the H.-C.L. laboratory and J. Staley laboratory for helpful discussions. The deep sequencing data described in this manuscript are available at the Sequence Read Archive (SRA) of the National Center for Biotechnology Information (accession no. SRP108932). This work is supported by Ministry of Science of Technology of Taiwan grants (MOST-105-2918-I-006-002, MOST-105-2221-E-006-203-MY2, and MOST-106-2628-E-006-006-MY2) to W.-S.W., an NIH P01 grant (HD078253) to Z.W., and an NIH R00 grant (GM108866) to H.-C.L.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Darricarrere N, 2013, P NATL ACAD SCI USA, V110, P1297, DOI 10.1073/pnas.1213283110; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Fire A, 2006, GENETICS, V173, P1259, DOI 10.1534/genetics.106.057364; Frokjaer-Jensen C, 2016, CELL, V166, P343, DOI 10.1016/j.cell.2016.05.072; Goh WSS, 2015, GENE DEV, V29, P1032, DOI 10.1101/gad.260455.115; Gou LT, 2014, CELL RES, V24, P680, DOI 10.1038/cr.2014.41; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; MERRITT C, 2010, WORMBOOK; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Toombs JA, 2017, RNA, V23, P504, DOI 10.1261/rna.058859.116; Tse YC, 2011, MOL BIOL CELL, V22, P3165, DOI 10.1091/mbc.E11-05-0399; Vourekas A, 2016, NATURE, V531, P390, DOI 10.1038/nature17150; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016	39	119	123	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					587	591		10.1126/science.aao2840	http://dx.doi.org/10.1126/science.aao2840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29420292	Green Accepted			2022-12-28	WOS:000423795800045
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Should NHS doctors work in unsafe conditions?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Akhtar Z, 2014, NHS LIABILITY PROVIN; Care Quality Commission, 2017, STAT CAR NHS AC HOSP; Charlie Massey interview by Justin Webb on Today programme, 2018, BBC RADIO; Cohen D., 2017, BAWA GARBA CASE GMC; Cohen D, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5534; Dyer C, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k417; General Medical Council, 2016, GMC STAT REF UNS ROT; General Medical Council, 2018, GMCUK BLOG      0126; Hadiza Bawa-Garba. v The Queen, 2016, QUEEN 2016 EWCA CRIM; Liker J., 2021, TOYOTA WAY 14 MANAGE; Lind S., 2018, PULSE, P26; NHS Employers, 2016, TERMS COND SERV NHS; Rimmer A., 2017, 3 JUNIOR DOCTORS SAY; Royal College of Anaesthetists, 2016, S ROTA GAPS VACANCIE; Royal College of Paediatrics and Child Health, 2017, ROTA COMPLIANCE VACA; Royal College of Physicians, 2016, UND UND OV NHS 2016; Royal College of Physicians, 2016, BEING JUNIOR DOCTOR	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2018	360								k448	10.1136/bmj.k448	http://dx.doi.org/10.1136/bmj.k448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TQ	29386199	Bronze, Green Published			2022-12-28	WOS:000423845900008
J	Kingsbury, SR; Tharmanathan, P; Keding, A; Ronaldson, SJ; Grainger, A; Wakefield, RJ; Arundel, C; Birrell, F; Doherty, M; Vincent, T; Watt, FE; Dziedzic, K; O'Neill, TW; Arden, NK; Scott, DL; Dickson, J; Garrood, T; Green, M; Menon, A; Sheeran, T; Torgerson, D; Conaghan, PG				Kingsbury, S. R.; Tharmanathan, P.; Keding, A.; Ronaldson, S. J.; Grainger, A.; Wakefield, R. J.; Arundel, C.; Birrell, F.; Doherty, M.; Vincent, T.; Watt, F. E.; Dziedzic, K.; O'Neill, T. W.; Arden, N. K.; Scott, D. L.; Dickson, J.; Garrood, T.; Green, M.; Menon, A.; Sheeran, T.; Torgerson, D.; Conaghan, P. G.			Hydroxychloroquine to Reduce Symptoms of Hand Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Grainger, Andrew/0000-0002-6697-1382; O'Neill, Terence/0000-0002-8896-4677; Birrell, Fraser/0000-0002-6163-6155; Vincent, Tonia/0000-0002-3412-5712					0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					I30	I30		10.7326/P17-9055	http://dx.doi.org/10.7326/P17-9055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29459946				2022-12-28	WOS:000427827400002
J	Bandres, MA; Wittek, S; Harari, G; Parto, M; Ren, JH; Segev, M; Christodoulides, DN; Khajavikhan, M				Bandres, Miguel A.; Wittek, Steffen; Harari, Gal; Parto, Midya; Ren, Jinhan; Segev, Mordechai; Christodoulides, Demetrios N.; Khajavikhan, Mercedeh			Topological insulator laser: Experiments	SCIENCE			English	Article							PHASE	Physical systems exhibiting topological invariants are naturally endowed with robustness against perturbations, as manifested in topological insulators-materials exhibiting robust electron transport, immune from scattering by defects and disorder. Recent years have witnessed intense efforts toward exploiting these phenomena in photonics. Here we demonstrate a nonmagnetic topological insulator laser system exhibiting topologically protected transport in the cavity. Its topological properties give rise to single-mode lasing, robustness against defects, and considerably higher slope efficiencies compared to the topologically trivial counterparts. We further exploit the properties of active topological platforms by assembling the system from S-chiral microresonators, enforcing predetermined unidirectional lasing without magnetic fields. This work paves the way toward active topological devices with exciting properties and functionalities.	[Bandres, Miguel A.; Harari, Gal; Segev, Mordechai] Technion, Phys Dept, IL-32000 Haifa, Israel; [Bandres, Miguel A.; Harari, Gal; Segev, Mordechai] Technion, Solid State Inst, IL-32000 Haifa, Israel; [Wittek, Steffen; Parto, Midya; Ren, Jinhan; Christodoulides, Demetrios N.; Khajavikhan, Mercedeh] Univ Cent Florida, Coll Opt & Photon, CREOL, Orlando, FL 32816 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; State University System of Florida; University of Central Florida	Segev, M (corresponding author), Technion, Phys Dept, IL-32000 Haifa, Israel.; Segev, M (corresponding author), Technion, Solid State Inst, IL-32000 Haifa, Israel.; Christodoulides, DN; Khajavikhan, M (corresponding author), Univ Cent Florida, Coll Opt & Photon, CREOL, Orlando, FL 32816 USA.	msegev@techunix.technion.ac.li; demetri@creol.ucf.edu; mercedeh@creol.ucf.edu	Wittek, Steffen/T-8248-2019	Bandres, Miguel A./0000-0002-7145-8567; , Gal/0000-0001-5128-3221; Parto, Midya/0000-0003-2100-5671; Khajavikhan, Mercedeh/0000-0002-7091-1470	Israel Science Foundation; Office of Naval Research [N0001416-1-2640]; NSF [ECCS1454531, DMR-1420620, ECCS1757025]; European Commission Non-Hermitian Quantum Wave Engineering (NHQWAVE) project [MSCA-RISE 691209]; Air Force Office of Scientific Research [FA9550-14-1-0037]; United States-Israel Binational Science Foundation [2016381]; German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation) program; Army Research Office [W911NF-16-1-0013, W911NF-17-1-0481]	Israel Science Foundation(Israel Science Foundation); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); European Commission Non-Hermitian Quantum Wave Engineering (NHQWAVE) project; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation) program; Army Research Office	The authors gratefully acknowledge financial support from the Israel Science Foundation, Office of Naval Research (N0001416-1-2640), NSF (ECCS1454531, DMR-1420620, ECCS1757025), European Commission Non-Hermitian Quantum Wave Engineering (NHQWAVE) project (MSCA-RISE 691209), Air Force Office of Scientific Research (FA9550-14-1-0037), United States-Israel Binational Science Foundation (2016381), German-Israeli Project Cooperation (Deutsch-Israelische Projektkooperation) program, and Army Research Office (W911NF-16-1-0013, W911NF-17-1-0481). M.S. thanks M. Karpovsky and B. Shillman for their support that came at a critical time.	Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Atala M, 2013, NAT PHYS, V9, P795, DOI [10.1038/nphys2790, 10.1038/NPHYS2790]; Bahari B, 2017, SCIENCE, V358, P636, DOI 10.1126/science.aao4551; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Cheng XJ, 2016, NAT MATER, V15, P542, DOI [10.1038/NMAT4573, 10.1038/nmat4573]; Fang KJ, 2012, NAT PHOTONICS, V6, P782, DOI [10.1038/NPHOTON.2012.236, 10.1038/nphoton.2012.236]; Fleury R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11744; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Haldane FDM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013904; Harari G., 2016, C LAS EL OPT OSA OPT; Harari G, 2018, SCIENCE, V359, DOI 10.1126/science.aar4003; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; HOHIMER JP, 1993, APPL PHYS LETT, V62, P1185, DOI 10.1063/1.108728; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kane CL, 2014, NAT PHYS, V10, P39, DOI [10.1038/nphys2835, 10.1038/NPHYS2835]; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Khanikaev AB, 2013, NAT MATER, V12, P233, DOI [10.1038/nmat3520, 10.1038/NMAT3520]; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Parto M., 2017, ARXIV170900523PHYSOP; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Slobozhanyuk AP, 2016, SCI REP-UK, V6, DOI 10.1038/srep22270; St-Jean P, 2017, NAT PHOTONICS, V11, P651, DOI 10.1038/s41566-017-0006-2; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Wittek S., 2017, C LAS EL OPT OSA OPT; Yang ZJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.114301; Yu ZF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.023902; Zhao H., 2016, ARXIV170902747PHYSOP	33	675	679	20	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2018	359	6381							eaar4005	10.1126/science.aar4005	http://dx.doi.org/10.1126/science.aar4005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ3TF	29420263				2022-12-28	WOS:000435220800001
J	Calisi, RM				Calisi, Rebecca M.			Got milk, must conference	SCIENCE			English	Editorial Material									[Calisi, Rebecca M.] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	Calisi, RM (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	SciCareerEditor@aaas.org							0	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					838	838						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW2ET	29449494				2022-12-28	WOS:000425116200048
J	Madhavan, VL; Curran, MA; Lindgren, K				Madhavan, Vandana L.; Curran, Marjorie A.; Lindgren, Kristen			Case 31-2017: A 19-Month-Old Girl with Failure to Thrive REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Madhavan, Vandana L.; Curran, Marjorie A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lindgren, Kristen] Newton Wellesley Hosp, Newton, MA USA	Harvard University; Massachusetts General Hospital; Newton Wellesley Hospital	Curran, MA (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	curran.marjorie@mgh.harvard.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					686	686						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0QK	29443672				2022-12-28	WOS:000425000000030
J	Gupta, R				Gupta, Rahael			I Solemnly Share	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEPRESSIVE SYMPTOMS; METAANALYSIS; PREVALENCE		[Gupta, Rahael] Univ Michigan, Med Sch, 1010 Catherine St,Apt 507, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Gupta, R (corresponding author), Univ Michigan, Med Sch, 1010 Catherine St,Apt 507, Ann Arbor, MI 48104 USA.	rahael@med.umich.edu						Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324; Shanafelt T, 2017, JAMA INTERN MED, V177, P1826, DOI 10.1001/jamainternmed.2017.4340	3	10	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					549	550		10.1001/jama.2017.22135	http://dx.doi.org/10.1001/jama.2017.22135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450528				2022-12-28	WOS:000424908400012
J	Henneman, JR				Henneman, Jennifer R.			In Shadowand Light-Images of Transformation Through Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Henneman, Jennifer R.] Denver Art Museum, Petrie Inst Western Amer Art, Denver, CO USA		Henneman, JR (corresponding author), Denver Art Museum, Petrie Inst Western Amer Art, Western Amer Art, 100 W Ave Pkwy, Denver, CO 80204 USA.	jhenneman@denverartmuseum.org							0	0	0	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					532	534		10.1001/jama.2017.21752	http://dx.doi.org/10.1001/jama.2017.21752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29450505				2022-12-28	WOS:000424908400001
J	Reese, A				Reese, April			As polar ozone mends, UV shield closer to equator thins	SCIENCE			English	News Item																			0	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					623	623		10.1126/science.359.6376.623	http://dx.doi.org/10.1126/science.359.6376.623			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29439223				2022-12-28	WOS:000425117700016
J	Baltimore, RS; Nimkin, K; Sparger, KA; Pierce, VM; Plotkin, SA				Baltimore, Robert S.; Nimkin, Katherine; Sparger, Katherine A.; Pierce, Virginia M.; Plotkin, Stanley A.			Case 4-2018: A Newborn with Thrombocytopenia, Cataracts, and Hepatosplenomegaly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL-RUBELLA SYNDROME; INFECTION; INFANTS; PURPURA		[Baltimore, Robert S.] Yale New Haven Childrens Hosp, Dept Pediat, New Haven, CT 06510 USA; [Baltimore, Robert S.] Yale New Haven Childrens Hosp, Dept Infect Prevent, New Haven, CT 06510 USA; [Baltimore, Robert S.] Yale Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Baltimore, Robert S.] Yale Sch Med, Dept Epidemiol, New Haven, CT 06510 USA; [Baltimore, Robert S.] Yale Sch Publ Hlth, New Haven, CT 06510 USA; [Nimkin, Katherine] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Sparger, Katherine A.; Pierce, Virginia M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Pierce, Virginia M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Nimkin, Katherine] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Sparger, Katherine A.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Pierce, Virginia M.] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Plotkin, Stanley A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania	Baltimore, RS (corresponding author), Yale New Haven Childrens Hosp, Dept Pediat, New Haven, CT 06510 USA.; Baltimore, RS (corresponding author), Yale New Haven Childrens Hosp, Dept Infect Prevent, New Haven, CT 06510 USA.; Baltimore, RS (corresponding author), Yale Sch Med, Dept Pediat, New Haven, CT 06510 USA.; Baltimore, RS (corresponding author), Yale Sch Med, Dept Epidemiol, New Haven, CT 06510 USA.; Baltimore, RS (corresponding author), Yale Sch Publ Hlth, New Haven, CT 06510 USA.			Pierce, Virginia/0000-0002-3723-1326	McNeely Case Records of Massachusetts General Hospital Visiting Professor Series	McNeely Case Records of Massachusetts General Hospital Visiting Professor Series	Supported in part by the McNeely Case Records of Massachusetts General Hospital Visiting Professor Series.	Abernathy E, 2009, J CLIN MICROBIOL, V47, P182, DOI 10.1128/JCM.01231-08; Adler SP, 2002, PEDIAT INFECT DIS PR, P1099; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P126; [Anonymous], 2013, PREV MEAS RUB CONG R; [Anonymous], 2015, WHOIVB1507; BANATVALA JE, 1965, NEW ENGL J MED, V273, P474, DOI 10.1056/NEJM196508262730904; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561; Cremer M, 2016, SEMIN FETAL NEONAT M, V21, P10, DOI 10.1016/j.siny.2015.11.001; Epelman M, 2006, RADIOGRAPHICS, V26, P173, DOI 10.1148/rg.261055033; Krugman S, 1977, INFECT DIS CHILDREN; Leuridan E, 2011, VACCINE, V29, P2222, DOI 10.1016/j.vaccine.2010.06.004; LINDQUIST JM, 1965, BMJ-BRIT MED J, V2, P1401, DOI 10.1136/bmj.2.5475.1401; Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359; Nickerson JP, 2012, J NEUROIMAGING, V22, pe52, DOI 10.1111/j.1552-6569.2011.00699.x; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; PLOTKIN SA, 1984, JAMA-J AM MED ASSOC, V251, P2003; PLOTKIN SA, 1965, ARCH GES VIRUSFORSCH, V16, P496, DOI 10.1007/BF01253863; Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950; Plotkin SA, 2011, HISTORY OF VACCINE DEVELOPMENT, P219, DOI 10.1007/978-1-4419-1339-5_24; Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928; Reef SE, 2018, PLOTKINS VACCINES, DOI [10.1016/S0140-6736(70)91553-9, DOI 10.1016/S0140-6736(70)91553-9]; Remington J. S., 2016, REMINGTON KLEINS INF, V8th, P894, DOI [DOI 10.1016/B978-0-323-24147-2.00029-8, 10.1016/B978-0-323-24147-2.00029-8]; Remington JS, 2011, INFECT DIS FETUS NEW; Rivailler P, 2017, J GEN VIROL, V98, P396, DOI 10.1099/jgv.0.000680; SAIDI M, 1969, CAN MED ASSOC J, V101, P340; Sisman J, 2015, EARLY HUM DEV, V91, P423, DOI 10.1016/j.earlhumdev.2015.04.004; Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160; Zhu Z, 2007, J CLIN MICROBIOL, V45, P2847, DOI 10.1128/JCM.00289-07	30	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					564	572		10.1056/NEJMcpc1706110	http://dx.doi.org/10.1056/NEJMcpc1706110			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV1OX	29414276				2022-12-28	WOS:000424335200012
J	Chung, HC; Calis, JJA; Wu, XF; Sun, T; Yu, YP; Sarbanes, SL; Thi, VLD; Shilvock, AR; Hoffmann, HH; Rosenberg, BR; Rice, CM				Chung, Hachung; Calis, Jorg J. A.; Wu, Xianfang; Sun, Tony; Yu, Yingpu; Sarbanes, Stephanie L.; Viet Loan Dao Thi; Shilvock, Abigail R.; Hoffmann, H. -Heinrich; Rosenberg, Brad R.; Rice, Charles M.			Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown	CELL			English	Article							PROTEIN-KINASE PKR; INTERFERON; INHIBITION; LANDSCAPE; COMPLEX; BINDING	Type I interferon (IFN) is produced when host sensors detect foreign nucleic acids, but how sensors differentiate self from nonself nucleic acids, such as double-stranded RNA (dsRNA), is incompletely understood. Mutations in ADAR1, an adenosine-to-inosine editing enzyme of dsRNA, cause Aicardi-Goutieres syndrome, an autoinflammatory disorder associated with spontaneous interferon production and neurologic sequelae. We generated ADAR1 knockout human cells to explore ADAR1 substrates and function. ADAR1 primarily edited Alu elements in RNA polymerase II (pol II)-transcribed mRNAs, but not putative pol III-transcribed Alus. During the IFN response, ADAR1 blocked translational shutdown by inhibiting hyperactivation of PKR, a dsRNA sensor. ADAR1 dsRNA binding and catalytic activities were required to fully prevent endogenous RNA from activating PKR. Remarkably, ADAR1 knockout neuronal progenitor cells exhibited MDA5 (dsRNA sensor)-dependent spontaneous interferon production, PKR activation, and cell death. Thus, human ADAR1 regulates sensing of self versus nonself RNA, allowing pathogen detection while avoiding autoinflammation.	[Chung, Hachung; Wu, Xianfang; Sun, Tony; Yu, Yingpu; Sarbanes, Stephanie L.; Viet Loan Dao Thi; Shilvock, Abigail R.; Hoffmann, H. -Heinrich; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Calis, Jorg J. A.; Rosenberg, Brad R.] Rockefeller Univ, Program Immunogen, New York, NY 10065 USA; [Rosenberg, Brad R.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	Rockefeller University; Rockefeller University; Icahn School of Medicine at Mount Sinai	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.	ricec@rockefeller.edu	Wu, Xianfang/O-5004-2019; Wu, Xianfang/HII-9315-2022	Wu, Xianfang/0000-0002-2995-935X; Chung, Hachung/0000-0003-3426-0225; Rosenberg, Brad/0000-0002-5885-1276; Shilvock, Abigail/0000-0002-3983-9394	NIAID/NIH [R01-AI091707, F32AI114211]; John C. Whitehead Presidential Fellowship; Netherlands Organization for Scientific Research (NWO Rubicon); Rockefeller University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091707, F32AI114211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012142] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); John C. Whitehead Presidential Fellowship; Netherlands Organization for Scientific Research (NWO Rubicon)(Netherlands Organization for Scientific Research (NWO)); Rockefeller University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank M. MacDonald and W. Schneider for helpful comments on experimental design and the manuscript. We also thank Laboratory for Investigative Dermatology (J. Gonzalez), Genomics Resource Center, and the Flow Cytometry Resource Center at The Rockefeller University; D. Huangfu for HUES8-iCas9 cells; and L. Marraffini for CRISPR reagents. This work was supported by NIAID/NIH grants R01-AI091707 (C.M.R., H.C., B.R.R., and J.J.A.C.), F32AI114211 (H.C.), the John C. Whitehead Presidential Fellowship (B.R.R.), and the Netherlands Organization for Scientific Research (NWO Rubicon) (J.J.A.C.). V.L.D.T. was supported by a Helmsley postdoctoral fellowship at The Rockefeller University.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Conti A, 2015, NUCLEIC ACIDS RES, V43, P817, DOI 10.1093/nar/gku1361; Dittmann M, 2015, CELL, V160, P631, DOI 10.1016/j.cell.2015.01.040; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; John L, 2014, VIROLOGY, V454, P299, DOI 10.1016/j.virol.2014.02.025; Kim Y, 2014, GENE DEV, V28, P1310, DOI 10.1101/gad.242644.114; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li Y, 2017, ELIFE, V6, DOI [10.7554/eLife.29914, 10.7554/eLife.25687]; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; Liu Y, 1996, J VIROL, V70, P1961, DOI 10.1128/JVI.70.3.1961-1968.1996; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Okumura F, 2013, J BIOL CHEM, V288, P2839, DOI 10.1074/jbc.M112.401851; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pham AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005489; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rice GI, 2017, NEUROPEDIATRICS, V48, P166, DOI 10.1055/s-0037-1601449; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodero MP, 2017, J EXP MED, V214, P1547, DOI 10.1084/jem.20161451; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu X., 2018, CELL; Yeo JC, 2010, P NATL ACAD SCI USA, V107, P20715, DOI 10.1073/pnas.1009231107	53	229	232	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					811	+		10.1016/j.cell.2017.12.038	http://dx.doi.org/10.1016/j.cell.2017.12.038			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29395325	Bronze, Green Accepted			2022-12-28	WOS:000424648800020
J	Kunisaki, KM; Greer, N; Khalil, W; Koffel, E; Koeller, E; MacDonald, R; Wilt, TJ				Kunisaki, Ken M.; Greer, Nancy; Khalil, Wajahat; Koffel, Erin; Koeller, Eva; MacDonald, Roderick; Wilt, Timothy J.			Provider Types and Outcomes in Obstructive Sleep Apnea Case Finding and Treatment A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							POSITIVE AIRWAY PRESSURE; CLINICAL-PRACTICE GUIDELINE; PRIMARY-CARE; CARDIOVASCULAR OUTCOMES; AMERICAN-COLLEGE; MANAGEMENT; DIAGNOSIS; MEDICINE; DISEASE; STROKE	Background: Obstructive sleep apnea (OSA) diagnosis and care models rely on sleep specialist physicians (SSPs) and can be expensive and inefficient. Purpose: To assess OSA case-finding accuracy and comparative effectiveness of care by non-sleep specialists (NSSs) and SSPs. Data Sources: MEDLINE and CINAHL from January 2000 through July 2017. Study Selection: English-language trials or observational studies comparing case finding or care by SSPs versus providers not specifically trained as SSPs (NSSs) for adults with suspected or diagnosed OSA. Data Extraction: One investigator extracted data and assessed risk of bias and strength of evidence, with confirmation by a second investigator. Primary outcomes were patient-centered (mortality, access to care, quality of life, patient satisfaction, adherence, symptom scores, and adverse events). Intermediate outcomes included resource use, costs, time to initiation of treatment, and case finding. Data Synthesis: Four observational studies (n = 580; mean age, 52 years; 77% male) reported good agreement between NSSs and SSPs on appropriate diagnostic testing and classification of OSA severity (low-strength evidence). Five randomized trials and 3 observational studies (n = 1515; mean age, 52 years; 68% male) found that care provided by NSSs and SSPs resulted in similar quality of life, adherence, and symptom scores (lowstrength evidence). Evidence was insufficient for access to care and adverse events. Limitations: Many outcomes were reported infrequently or not at all. Many NSSs had extensive training or experience in sleep medicine, which limits generalizability of findings to providers with less experience. Conclusion: Care by NSSs and SSPs resulted in similar outcomes in adults with known or suspected OSA. Studies are needed to determine care model implementation and reproducibility of results in nonacademic settings and among less experienced NSSs.	Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA; Minneapolis Vet Affairs Hlth Care Syst, Evidence Based Synth Program Site, Minneapolis, MN USA; Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Kunisaki, Ken M.; Greer, Nancy; Khalil, Wajahat; Koffel, Erin; Wilt, Timothy J.] Minneapolis VA Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Wilt, TJ (corresponding author), Univ Minnesota, Med, Sch Med, Minneapolis VA Ctr Chron Dis Outcomes Res, 1 Vet Dr 111-0, Minneapolis, MN 55417 USA.	tim.wilt@va.gov	Kunisaki, Ken/A-6950-2009	Kunisaki, Ken/0000-0001-8644-2827	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative [PROSPERO: CRD42016036810]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative(US Department of Veterans Affairs)	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative. (PROSPERO: CRD42016036810 [full Veterans Affairs Evidence-based Synthesis Program report])	Alsharif AM, 2016, SOUTH MED J, V109, P677, DOI 10.14423/SMJ.0000000000000543; Andreu AL, 2012, EUR RESPIR J, V39, P305, DOI 10.1183/09031936.00013311; Antic NA, 2009, AM J RESP CRIT CARE, V179, P501, DOI 10.1164/rccm.200810-1558OC; Aurora RN, 2016, AM J MED, V129, P725, DOI 10.1016/j.amjmed.2016.02.015; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Blackwell T, 2014, SLEEP, V37, P655, DOI 10.5665/sleep.3562; Chai-Coetzer CL, 2013, JAMA-J AM MED ASSOC, V309, P997, DOI 10.1001/jama.2013.1823; Chamorro N, 2013, EUR RESPIR J, V42, P1151, DOI 10.1183/09031936.00192812; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; El Shayeb M, 2014, CAN MED ASSOC J, V186, pE25, DOI 10.1503/cmaj.130952; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Hernandez L, 2007, CHEST, V132, P1853, DOI 10.1378/chest.07-0250; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-20; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Kunisaki KM, 2016, VA EVIDENCE BASED SY; Kushida CA, 2015, SLEEP, V38, P315, DOI 10.5665/sleep.4422; Lettieri CF, 2011, CHEST, V139, P849, DOI 10.1378/chest.10-1060; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Montesi SB, 2012, J CLIN SLEEP MED, V8, P587, DOI 10.5664/jcsm.2170; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Palmer S, 2004, SLEEP MED, V5, P61, DOI 10.1016/S1389-9457(03)00166-7; Pamidi S, 2012, CHEST, V141, P51, DOI 10.1378/chest.11-0709; Parra O, 2011, EUR RESPIR J, V37, P1128, DOI 10.1183/09031936.00034410; Parthasarathy S, 2006, J CLIN SLEEP MED, V2, P133; Parthasarathy S, 2014, J CLIN SLEEP MED, V10, P243, DOI 10.5664/jcsm.3518; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Peker Y, 2016, AM J RESP CRIT CARE, V194, P613, DOI 10.1164/rccm.201601-0088OC; Phillips B, 2015, AM J RESP CRIT CARE, V192, P915, DOI 10.1164/rccm.201508-1544ED; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Qaseem A, 2013, ANN INTERN MED, V159, P471, DOI 10.7326/00030003-4819-159-7-201310010-00704; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Sanchez-de-la-Torre M, 2015, THORAX, V70, P346, DOI 10.1136/thoraxjnl-2014-206287; Scharf Steven M, 2004, Sleep Breath, V8, P111, DOI 10.1007/s11325-004-0111-6; U.S. Preventive Services Task Force, 2017, OBSTR SLEEP APN AD S; Viswanathan M, 2008, METHODS GUIDE EFFECT; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104	41	17	17	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					195	+		10.7326/M17-2511	http://dx.doi.org/10.7326/M17-2511			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29379962				2022-12-28	WOS:000424224300008
J	Ragsdale, SW				Ragsdale, Stephen W.			Stealth reactions driving carbon fixation	SCIENCE			English	Editorial Material							EVOLUTION		[Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Med Sch, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, Med Sch, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu			Department of Energy [DE-FG02-08ER15931]; National Institute of General Medical Sciences [R37-GM39451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039451] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work on the carbon cycle in the author's lab is supported by the Department of Energy (DE-FG02-08ER15931) and National Institute of General Medical Sciences (R37-GM39451).	Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lucker S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00027; Mall A, 2018, SCIENCE, V359, P563, DOI 10.1126/science.aao2410; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Nunoura T, 2018, SCIENCE, V359, P559, DOI 10.1126/science.aao3407; Pachiadaki MG, 2017, SCIENCE, V358, P1046, DOI 10.1126/science.aan8260	9	8	8	6	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					517	518		10.1126/science.aar6329	http://dx.doi.org/10.1126/science.aar6329			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420277				2022-12-28	WOS:000423795800022
J	Whiteman, JP				Whiteman, John P.			Out of balance in the Arctic	SCIENCE			English	Editorial Material							POLAR BEARS; ENERGY; PREDATOR		[Whiteman, John P.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Whiteman, JP (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	jwhiteman@unm.edu						Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Durner GM, 2017, GLOBAL CHANGE BIOL, V23, P3460, DOI 10.1111/gcb.13746; Fei YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep27248; Harvey JA, 2018, BIOSCIENCE, V68, P281, DOI 10.1093/biosci/bix133; Kingsley M. C. S., 1998, RINGED SEALS N ATLAN, V1, P181; MCNAB BK, 1988, Q REV BIOL, V63, P25, DOI 10.1086/415715; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Munoz-Garcia A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1039, DOI 10.1086/432852; Nie YG, 2015, SCIENCE, V349, P171, DOI 10.1126/science.aab2413; Pagano AM, 2018, SCIENCE, V359, P568, DOI 10.1126/science.aan8677; Paisley S, 2006, J ZOOL, V268, P25, DOI 10.1111/j.1469-7998.2005.00019.x; Rode KD, 2015, FRONT ECOL ENVIRON, V13, P138, DOI 10.1890/140202; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; Whiteman JP, 2015, SCIENCE, V349, P295, DOI 10.1126/science.aaa8623	15	1	1	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					514	515		10.1126/science.aar6723	http://dx.doi.org/10.1126/science.aar6723			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU4AS	29420275				2022-12-28	WOS:000423795800020
